data_2dgv_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2dgv _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 18.8 p . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.74 0.305 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -93.24 153.23 18.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.882 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 654' ' ' ILE . . . . . 0.441 HD13 ' CE2' ' A' ' 672' ' ' PHE . 32.7 pt -136.51 177.75 5.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.157 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -130.56 149.56 52.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.875 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 3.3 t -134.58 151.89 32.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.136 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 38.1 mtt85 -148.39 161.99 40.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 658' ' ' ASN . . . . . 0.47 ' ND2' ' HB3' ' A' ' 719' ' ' ARG . 4.6 t30 65.27 47.97 2.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.505 HD23 ' CE2' ' A' ' 663' ' ' PHE . 26.3 mt -96.98 143.65 26.48 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.599 0.714 . . . . 0.0 110.942 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 660' ' ' PRO . . . . . 0.445 ' O ' ' N ' ' A' ' 663' ' ' PHE . 65.5 Cg_exo -47.95 127.82 15.34 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.685 2.257 . . . . 0.0 112.344 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -45.45 -30.96 1.53 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.881 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -83.8 -28.36 28.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.896 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 663' ' ' PHE . . . . . 0.505 ' CE2' HD23 ' A' ' 659' ' ' LEU . 3.8 t80 -40.62 123.14 1.79 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.924 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 80.4 p -106.02 176.77 5.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.138 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 665' ' ' TRP . . . . . 0.648 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 6.6 p-90 -68.97 -50.66 47.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.888 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 666' ' ' LYS . . . . . 0.648 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 2.8 tppp? -47.29 -50.73 20.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.858 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 31.4 mtm -63.37 -46.52 86.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.875 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 14.1 tp -51.52 -42.53 61.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.9 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 29.3 tttm -65.2 -74.15 0.11 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.873 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -46.01 -23.68 0.33 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.874 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 671' ' ' LYS . . . . . 0.43 ' HG3' ' CE ' ' A' ' 711' ' ' MET . 7.5 tppt? -69.88 -40.37 75.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.91 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 672' ' ' PHE . . . . . 0.449 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 20.6 m-85 -90.14 -9.3 48.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -57.63 -34.97 69.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -43.16 -44.76 5.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.903 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 9.4 t -66.98 -63.94 0.96 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.871 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -145.83 -155.06 6.35 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.462 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -93.08 102.83 15.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.88 0.372 . . . . 0.0 110.861 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 43.1 t -75.86 132.88 32.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.073 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 10.2 mt -107.3 -61.53 1.54 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.887 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -97.91 129.61 44.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.918 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -155.48 123.07 5.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.138 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -152.17 165.52 34.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.83 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 18.5 mm -115.8 117.2 54.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.13 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.855 179.867 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 4.6 mmtp . . . . . 0 N--CA 1.458 -0.061 0 CA-C-O 120.82 0.343 . . . . 0.0 110.866 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 80.91 13.36 81.4 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.496 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 8.9 p -126.81 131.89 51.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.835 0.35 . . . . 0.0 110.931 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -139.75 -170.87 12.09 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.518 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 5.2 m -141.07 153.5 20.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.865 0.364 . . . . 0.0 111.116 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 98.9 t -139.64 124.31 20.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.091 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 23.9 tttt -107.57 139.72 41.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.885 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -115.55 172.27 7.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.923 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 699' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -75.52 -44.07 45.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.844 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 58.3 m -107.36 147.71 35.77 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.66 0.743 . . . . 0.0 110.843 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -32.97 17.55 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.649 2.233 . . . . 0.0 112.375 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -63.07 -42.92 99.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.891 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 95.5 t -51.14 -60.24 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.149 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -42.13 -59.44 1.77 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.098 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -43.55 -31.23 0.69 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.89 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 26.2 ttm-85 -81.99 -58.1 3.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.867 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -44.93 -30.15 0.95 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.095 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 708' ' ' CYS . . . . . 0.49 ' O ' ' N ' ' A' ' 712' ' ' ASN . 1.4 t -56.43 -63.96 1.02 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.883 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.15 -41.25 94.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.88 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 58.4 mtp -55.34 -33.6 63.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 711' ' ' MET . . . . . 0.449 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 3.7 mmt -105.8 -14.46 15.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.856 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 712' ' ' ASN . . . . . 0.49 ' N ' ' O ' ' A' ' 708' ' ' CYS . 40.1 t-20 -54.22 109.72 0.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.889 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 83.65 24.06 51.28 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.487 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 714' ' ' MET . . . . . 0.436 ' CE ' ' CE ' ' A' ' 711' ' ' MET . 38.2 ttp -72.16 98.91 2.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.825 0.345 . . . . 0.0 110.854 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 5.5 mmtm -51.94 101.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.887 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 716' ' ' LEU . . . . . 0.464 ' O ' ' N ' ' A' ' 719' ' ' ARG . 24.6 mt -99.78 120.02 39.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.926 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 717' ' ' SER . . . . . . . . . . . . . 20.4 t 40.27 43.67 1.46 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.874 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 75.6 26.52 65.15 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.521 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 719' ' ' ARG . . . . . 0.47 ' HB3' ' ND2' ' A' ' 658' ' ' ASN . 28.5 mtp180 -140.16 110.95 6.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.777 0.322 . . . . 0.0 110.89 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -68.2 127.84 34.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.933 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 26.4 pt -99.69 151.41 4.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.137 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -106.11 99.88 9.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.878 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 723' ' ' VAL . . . . . 0.425 HG23 ' CB ' ' A' ' 711' ' ' MET . 4.4 t -97.53 135.77 30.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.141 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 -158.21 163.97 36.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.876 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 725' ' ' ILE . . . . . . . . . . . . . 31.9 mm -79.27 134.86 26.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.127 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 40.6 t0 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 179.838 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 29.8 m . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.77 0.319 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -94.53 143.1 26.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.932 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 654' ' ' ILE . . . . . 0.444 HD13 ' CE2' ' A' ' 672' ' ' PHE . 36.3 pt -132.94 174.97 12.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.154 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -121.09 158.58 27.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.832 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 21.9 t -147.01 146.47 18.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.095 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 65.6 mtm180 -146.42 157.86 43.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.87 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 658' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 71.17 50.17 0.31 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.853 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . . . . . . . . . 29.0 mt -100.59 143.83 27.3 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.615 0.722 . . . . 0.0 110.872 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 660' ' ' PRO . . . . . 0.483 ' O ' ' N ' ' A' ' 663' ' ' PHE . 65.8 Cg_exo -47.97 124.55 10.23 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.684 2.256 . . . . 0.0 112.331 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -42.37 -36.89 1.4 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.828 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -76.0 -31.5 58.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.881 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 663' ' ' PHE . . . . . 0.483 ' N ' ' O ' ' A' ' 660' ' ' PRO . 3.8 t80 -38.85 128.4 1.57 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.863 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 72.1 p -113.18 174.99 5.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.139 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 665' ' ' TRP . . . . . 0.644 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 5.3 p-90 -64.35 -51.66 62.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.897 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 666' ' ' LYS . . . . . 0.644 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 7.4 tppt? -45.42 -53.31 8.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.877 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 667' ' ' MET . . . . . 0.42 ' HE1' ' CD1' ' A' ' 663' ' ' PHE . 28.2 mtm -58.05 -54.38 47.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.892 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 15.3 tp -41.85 -49.72 4.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.881 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -60.66 -74.2 0.08 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.913 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -46.73 -23.3 0.4 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.9 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 10.3 tptt -70.83 -45.43 64.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.892 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 672' ' ' PHE . . . . . 0.444 ' CE2' HD13 ' A' ' 654' ' ' ILE . 23.4 m-85 -84.57 -11.58 55.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.908 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -54.57 -36.04 63.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.876 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -52.79 -32.08 42.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 10.2 m -80.9 -49.33 11.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.894 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -164.21 168.92 38.85 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.482 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 677' ' ' HIS . . . . . 0.496 ' CD2' HD21 ' A' ' 679' ' ' LEU . 3.0 t-160 -61.95 101.08 0.18 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.836 0.35 . . . . 0.0 110.85 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 73.5 t -80.35 132.83 30.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.114 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 679' ' ' LEU . . . . . 0.496 HD21 ' CD2' ' A' ' 677' ' ' HIS . 13.3 mt -107.47 -61.85 1.5 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.89 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 680' ' ' TYR . . . . . 0.539 ' CE2' HG23 ' A' ' 695' ' ' VAL . 6.5 t80 -95.79 130.15 42.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.922 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -157.77 128.45 6.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.114 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -161.12 156.93 25.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.872 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 30.5 mm -102.11 111.97 33.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.121 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.912 179.84 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 25.0 mmmt . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.838 0.352 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 59.25 18.7 43.44 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.506 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 19.5 p -126.13 151.0 47.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.834 0.349 . . . . 0.0 110.889 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -155.9 -152.0 6.09 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.487 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 695' ' ' VAL . . . . . 0.539 HG23 ' CE2' ' A' ' 680' ' ' TYR . 15.3 m -155.84 152.4 8.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.831 0.348 . . . . 0.0 111.143 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 99.2 t -141.7 120.06 9.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.078 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 14.4 ttpt -104.87 138.1 41.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.902 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 698' ' ' PHE . . . . . 0.497 ' CD2' HG11 ' A' ' 703' ' ' VAL . 97.4 m-85 -113.95 173.87 6.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.903 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 699' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -75.06 -36.79 61.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.913 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 69.0 p -124.57 151.25 67.03 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.636 0.731 . . . . 0.0 110.873 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -30.27 22.63 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.681 2.254 . . . . 0.0 112.357 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -61.68 -39.0 89.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.844 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 703' ' ' VAL . . . . . 0.497 HG11 ' CD2' ' A' ' 698' ' ' PHE . 82.6 t -66.23 -47.21 85.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.086 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -51.47 -47.12 63.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.112 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -55.45 -43.12 75.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.901 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 22.0 ttm180 -68.92 -54.81 13.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.837 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -43.07 -47.53 5.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.107 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 708' ' ' CYS . . . . . 0.48 ' O ' ' CB ' ' A' ' 712' ' ' ASN . 21.3 m -54.54 -34.57 62.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.87 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 8.7 mtm105 -81.66 -45.18 16.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.881 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 22.1 mtm -66.06 -15.27 62.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.921 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 711' ' ' MET . . . . . 0.476 ' O ' ' N ' ' A' ' 714' ' ' MET . 3.2 mmt -113.78 -30.83 6.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.873 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 712' ' ' ASN . . . . . 0.48 ' CB ' ' O ' ' A' ' 708' ' ' CYS . 0.4 OUTLIER -39.79 112.27 0.25 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.875 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 77.25 25.61 63.4 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.48 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 714' ' ' MET . . . . . 0.476 ' N ' ' O ' ' A' ' 711' ' ' MET . 48.9 ttp -71.38 100.35 2.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.863 0.363 . . . . 0.0 110.91 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp -54.07 99.13 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.889 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 716' ' ' LEU . . . . . 0.47 ' O ' ' N ' ' A' ' 719' ' ' ARG . 29.1 mt -99.89 125.21 45.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.929 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 717' ' ' SER . . . . . . . . . . . . . 1.1 t 40.06 43.68 1.35 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.883 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 72.41 29.09 66.57 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.508 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 719' ' ' ARG . . . . . 0.47 ' N ' ' O ' ' A' ' 716' ' ' LEU . 44.1 mtt180 -141.19 114.85 8.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.801 0.334 . . . . 0.0 110.885 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -70.18 128.03 34.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.902 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 721' ' ' ILE . . . . . 0.443 ' CG2' HD12 ' A' ' 716' ' ' LEU . 37.3 pt -100.03 161.89 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.129 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -118.39 98.21 6.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.845 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 723' ' ' VAL . . . . . 0.446 ' CG1' ' HA ' ' A' ' 708' ' ' CYS . 6.2 t -96.59 132.83 40.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.146 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 64.1 mtt180 -155.19 154.15 31.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.879 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 725' ' ' ILE . . . . . . . . . . . . . 15.1 mm -64.15 134.51 28.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.15 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 17.9 t0 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 179.865 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 652' ' ' CYS . . . . . 0.461 ' SG ' ' N ' ' A' ' 701' ' ' PRO . 22.3 m . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.751 0.31 . . . . 0.0 110.869 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -104.32 146.49 28.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.928 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 654' ' ' ILE . . . . . 0.415 ' CD1' ' CE2' ' A' ' 672' ' ' PHE . 38.9 pt -131.32 169.34 21.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.096 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -122.75 149.85 43.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.889 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 3.4 t -132.8 153.38 37.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.152 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 53.4 mtt85 -148.68 160.44 43.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.896 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 658' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 692' ' ' GLY . 0.6 OUTLIER 66.93 44.95 1.91 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.927 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . . . . . . . . . 54.1 mt -93.84 143.52 26.64 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.586 0.707 . . . . 0.0 110.907 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 660' ' ' PRO . . . . . 0.406 ' O ' ' N ' ' A' ' 663' ' ' PHE . 66.7 Cg_exo -48.04 124.12 9.7 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.687 2.258 . . . . 0.0 112.32 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -47.43 -24.43 0.81 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.896 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 662' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 663' ' ' PHE . 73.5 m-20 -88.49 -29.67 19.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.876 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 663' ' ' PHE . . . . . 0.408 ' C ' ' O ' ' A' ' 662' ' ' ASP . 3.5 t80 -37.6 140.03 0.25 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 82.2 p -120.34 169.82 9.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.122 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 665' ' ' TRP . . . . . 0.644 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 6.7 p-90 -63.45 -52.16 62.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.96 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 666' ' ' LYS . . . . . 0.644 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 9.7 tppt? -44.63 -51.57 8.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.877 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 24.3 mtm -61.74 -47.17 86.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.866 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 35.6 tp -47.85 -47.55 31.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.91 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.453 ' HG2' ' N ' ' A' ' 670' ' ' ASP . 0.3 OUTLIER -64.76 -73.69 0.12 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 179.789 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 670' ' ' ASP . . . . . 0.453 ' N ' ' HG2' ' A' ' 669' ' ' LYS . 4.5 m-20 -45.2 -24.22 0.24 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.903 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 671' ' ' LYS . . . . . 0.458 ' HG3' ' CE ' ' A' ' 711' ' ' MET . 7.8 tppt? -69.88 -51.3 34.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.897 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 672' ' ' PHE . . . . . 0.533 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 27.7 m-85 -78.43 -11.15 59.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.878 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -55.9 -39.38 71.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.881 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -47.4 -36.02 9.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.895 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 64.8 m -74.66 -56.5 4.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.826 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -160.41 -175.95 31.97 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.474 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -68.43 109.44 3.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.832 0.348 . . . . 0.0 110.831 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 53.2 t -88.57 128.7 40.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.139 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 11.4 mt -100.5 -64.42 1.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 680' ' ' TYR . . . . . 0.414 ' CE2' HG22 ' A' ' 695' ' ' VAL . 6.9 t80 -97.94 130.34 44.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.879 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -153.9 125.96 7.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.104 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -163.61 157.94 20.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.894 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 25.2 mm -93.87 101.72 12.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.126 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 16.2 mmmt . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.901 179.85 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 691' ' ' LYS . . . . . 0.418 ' O ' ' N ' ' A' ' 693' ' ' CYS . 33.3 mmtt . . . . . 0 N--CA 1.457 -0.091 0 CA-C-O 120.855 0.36 . . . . 0.0 110.932 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 692' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' A' ' 658' ' ' ASN . . . 37.71 31.28 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.512 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 693' ' ' CYS . . . . . 0.418 ' N ' ' O ' ' A' ' 691' ' ' LYS . 26.0 p -132.92 125.43 29.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.896 0.379 . . . . 0.0 110.88 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -130.01 172.91 20.02 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.475 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 695' ' ' VAL . . . . . 0.414 HG22 ' CE2' ' A' ' 680' ' ' TYR . 8.7 m -129.35 150.98 35.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.857 0.36 . . . . 0.0 111.13 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 696' ' ' VAL . . . . . 0.464 HG21 ' CD1' ' A' ' 672' ' ' PHE . 62.9 t -140.77 122.31 14.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.079 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 13.6 tttt -106.78 134.22 50.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.948 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 698' ' ' PHE . . . . . 0.455 ' CD2' ' CG1' ' A' ' 703' ' ' VAL . 94.0 m-85 -109.81 171.39 7.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.893 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 699' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -75.75 -45.19 37.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.921 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 57.7 m -109.83 145.62 32.4 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.673 0.749 . . . . 0.0 110.871 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 701' ' ' PRO . . . . . 0.461 ' N ' ' SG ' ' A' ' 652' ' ' CYS . 53.7 Cg_endo -69.8 -10.89 29.63 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.629 2.22 . . . . 0.0 112.343 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 702' ' ' GLU . . . . . 0.4 ' OE1' ' C ' ' A' ' 702' ' ' GLU . 1.4 pp20? -82.9 -31.02 28.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.866 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 703' ' ' VAL . . . . . 0.455 ' CG1' ' CD2' ' A' ' 698' ' ' PHE . 66.5 t -67.72 -57.4 9.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.121 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -44.23 -58.54 2.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.091 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -44.31 -36.32 2.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.896 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -76.91 -64.77 1.05 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.823 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -39.61 -34.95 0.27 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.105 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 708' ' ' CYS . . . . . 0.434 ' HA ' ' CG1' ' A' ' 723' ' ' VAL . 56.8 m -52.82 -56.69 13.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.945 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -71.14 -39.75 71.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.92 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 18.6 mtm -64.4 -13.1 49.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 711' ' ' MET . . . . . 0.533 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 6.3 mmm -119.21 -16.68 9.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.887 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 712' ' ' ASN . . . . . 0.491 ' ND2' ' O ' ' A' ' 712' ' ' ASN . 0.1 OUTLIER -55.97 122.24 11.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.868 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 76.75 13.53 83.47 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.46 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 714' ' ' MET . . . . . 0.467 ' CE ' ' HE2' ' A' ' 711' ' ' MET . 43.4 ttp -61.34 97.15 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.845 0.355 . . . . 0.0 110.823 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 15.4 mmtt -54.08 101.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.887 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 716' ' ' LEU . . . . . 0.48 ' O ' ' N ' ' A' ' 719' ' ' ARG . 46.0 mt -99.91 123.81 44.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.908 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 717' ' ' SER . . . . . . . . . . . . . 2.0 t 37.64 41.34 0.3 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.838 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 77.05 34.1 43.07 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.487 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 719' ' ' ARG . . . . . 0.48 ' N ' ' O ' ' A' ' 716' ' ' LEU . 9.6 mtt-85 -146.93 111.51 5.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.716 0.293 . . . . 0.0 110.862 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -68.83 125.6 27.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.888 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 22.7 pt -100.0 160.36 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.138 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -115.2 109.43 17.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.832 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 723' ' ' VAL . . . . . 0.434 ' CG1' ' HA ' ' A' ' 708' ' ' CYS . 5.4 t -108.72 129.28 63.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.134 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 36.1 mtp180 -157.56 158.73 36.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.827 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 725' ' ' ILE . . . . . 0.43 HG22 ' N ' ' A' ' 726' ' ' ASP . 31.6 mm -51.43 136.32 11.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.134 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 726' ' ' ASP . . . . . 0.43 ' N ' HG22 ' A' ' 725' ' ' ILE . 24.8 t0 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 24.8 p . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.725 0.297 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -92.12 150.72 20.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.945 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 654' ' ' ILE . . . . . 0.56 ' CD1' ' CE2' ' A' ' 672' ' ' PHE . 30.0 pt -137.26 167.07 23.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.169 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -120.7 159.47 25.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.865 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 16.7 t -145.64 156.77 12.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.174 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 57.4 mtt180 -153.49 162.79 40.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.898 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 658' ' ' ASN . . . . . . . . . . . . . 4.6 t30 69.03 36.83 2.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.895 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.466 HD22 ' CD2' ' A' ' 663' ' ' PHE . 37.6 mt -86.74 143.34 35.5 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.669 0.747 . . . . 0.0 110.935 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 660' ' ' PRO . . . . . 0.47 ' O ' ' N ' ' A' ' 663' ' ' PHE . 64.8 Cg_exo -47.88 126.5 13.03 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.655 2.237 . . . . 0.0 112.375 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -42.42 -33.66 0.7 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.858 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 662' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 663' ' ' PHE . 44.1 m-20 -81.12 -32.59 33.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.912 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 663' ' ' PHE . . . . . 0.47 ' N ' ' O ' ' A' ' 660' ' ' PRO . 4.3 t80 -35.74 124.92 0.7 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.901 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 68.5 p -108.44 174.84 5.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.145 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 665' ' ' TRP . . . . . 0.646 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 8.0 p-90 -65.93 -51.97 53.97 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.896 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 666' ' ' LYS . . . . . 0.646 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 2.3 tppp? -44.57 -54.35 6.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.882 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 20.1 mtm -57.86 -49.45 76.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.9 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 56.6 tp -46.8 -44.56 19.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.887 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 29.7 tttm -65.47 -74.92 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.85 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -46.36 -22.93 0.3 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.864 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 671' ' ' LYS . . . . . 0.454 ' HG3' ' CE ' ' A' ' 711' ' ' MET . 9.3 tppt? -70.88 -41.83 70.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.898 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 672' ' ' PHE . . . . . 0.56 ' CE2' ' CD1' ' A' ' 654' ' ' ILE . 18.5 m-85 -88.58 -11.65 44.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.892 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -54.28 -34.31 60.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.846 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -46.3 -44.91 17.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.899 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 12.9 t -64.47 -55.63 19.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.867 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -159.53 -157.16 8.42 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.476 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -86.5 110.42 19.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.889 0.376 . . . . 0.0 110.862 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 76.3 t -85.87 138.4 19.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.111 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 25.4 mt -112.68 -62.47 1.58 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.908 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -96.68 131.87 42.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.94 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -155.84 125.17 6.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.102 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -158.13 160.82 37.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.875 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 23.2 mm -109.05 108.16 24.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.151 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.914 179.831 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.807 0.336 . . . . 0.0 110.925 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 40.42 33.82 0.59 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.514 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 28.4 p -140.02 133.73 30.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.888 0.375 . . . . 0.0 110.908 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -141.81 -154.4 6.17 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.496 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 14.3 m -155.75 155.84 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.818 0.342 . . . . 0.0 111.123 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 48.7 t -143.7 125.76 11.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.164 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 13.8 ttpt -109.79 137.6 47.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 698' ' ' PHE . . . . . 0.41 ' CD2' HG12 ' A' ' 703' ' ' VAL . 95.5 m-85 -111.6 169.77 8.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.925 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 699' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -74.89 -42.06 58.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.892 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 39.7 m -109.94 151.09 42.21 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.684 0.754 . . . . 0.0 110.864 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -39.26 6.74 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.696 2.264 . . . . 0.0 112.349 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -54.71 -47.82 73.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.899 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 703' ' ' VAL . . . . . 0.41 HG12 ' CD2' ' A' ' 698' ' ' PHE . 93.0 t -49.26 -59.08 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.089 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 704' ' ' ALA . . . . . 0.417 ' O ' ' C ' ' A' ' 705' ' ' GLU . . . -41.47 -67.46 0.25 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.066 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 705' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 704' ' ' ALA . 9.7 mt-10 -36.77 -42.61 0.39 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.91 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 706' ' ' ARG . . . . . 0.425 ' O ' ' C ' ' A' ' 707' ' ' ALA . 15.9 ttm180 -69.25 -64.21 0.92 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.848 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 707' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 706' ' ' ARG . . . -35.78 -47.87 0.52 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.087 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 708' ' ' CYS . . . . . 0.468 ' O ' ' N ' ' A' ' 712' ' ' ASN . 1.2 t -43.96 -60.62 1.76 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.924 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 11.9 mtt180 -69.15 -38.0 78.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.908 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 49.4 mtp -64.04 -16.04 60.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.905 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 711' ' ' MET . . . . . 0.454 ' CE ' ' HG3' ' A' ' 671' ' ' LYS . 4.1 mmt -123.54 -8.83 7.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.85 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 712' ' ' ASN . . . . . 0.468 ' N ' ' O ' ' A' ' 708' ' ' CYS . 27.7 t30 -64.58 118.36 8.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.911 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 78.89 30.06 49.11 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.493 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 714' ' ' MET . . . . . . . . . . . . . 34.2 ttp -80.22 110.46 15.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.851 0.357 . . . . 0.0 110.899 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 18.9 mmtt -67.19 102.27 1.02 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.881 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 716' ' ' LEU . . . . . 0.501 ' O ' ' N ' ' A' ' 719' ' ' ARG . 26.7 mt -99.93 123.08 43.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.939 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 717' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 716' ' ' LEU . 8.7 t 36.66 38.73 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.87 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 80.96 34.18 27.75 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.471 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 719' ' ' ARG . . . . . 0.501 ' N ' ' O ' ' A' ' 716' ' ' LEU . 8.1 mtt-85 -147.27 110.95 4.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.795 0.331 . . . . 0.0 110.887 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -71.33 126.54 29.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.876 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 32.9 pt -97.75 158.82 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.089 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -113.92 99.23 7.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.872 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 10.6 t -99.07 128.91 50.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.127 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 81.3 mtm180 -148.23 173.65 12.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 725' ' ' ILE . . . . . . . . . . . . . 31.5 mm -81.05 134.37 27.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.128 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 8.5 t70 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.894 179.849 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 25.8 p . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.809 0.338 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 653' ' ' GLN . . . . . 0.459 ' HG3' ' N ' ' A' ' 654' ' ' ILE . 10.3 tp60 -89.92 146.32 24.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.876 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 654' ' ' ILE . . . . . 0.459 ' N ' ' HG3' ' A' ' 653' ' ' GLN . 23.6 pt -138.04 178.07 4.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.106 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -134.27 153.02 52.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.897 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 20.5 t -135.77 153.43 32.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.138 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -147.67 157.41 43.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.846 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 658' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 692' ' ' GLY . 4.5 t30 68.63 52.11 0.59 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.448 HD22 ' CE2' ' A' ' 663' ' ' PHE . 39.8 mt -100.2 143.45 26.54 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.594 0.712 . . . . 0.0 110.924 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -47.96 132.97 22.89 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.672 2.248 . . . . 0.0 112.377 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -44.26 -45.66 8.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.884 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 662' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 663' ' ' PHE . 22.8 t0 -68.16 -34.32 76.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.839 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 663' ' ' PHE . . . . . 0.448 ' CE2' HD22 ' A' ' 659' ' ' LEU . 4.2 t80 -36.84 116.59 0.45 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.925 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 59.1 p -107.73 -177.89 3.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.115 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 665' ' ' TRP . . . . . 0.616 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 5.5 p-90 -64.73 -48.65 73.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.866 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 666' ' ' LYS . . . . . 0.616 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 13.8 tptm -48.84 -59.24 3.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.912 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 667' ' ' MET . . . . . 0.492 ' O ' ' CB ' ' A' ' 671' ' ' LYS . 28.6 mtm -53.69 -48.79 69.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 15.3 tp -48.56 -46.67 39.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.908 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -65.49 -73.12 0.13 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.914 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -48.59 -23.9 1.15 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.88 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 671' ' ' LYS . . . . . 0.492 ' CB ' ' O ' ' A' ' 667' ' ' MET . 0.3 OUTLIER -69.98 -42.49 73.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.897 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 672' ' ' PHE . . . . . 0.566 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 15.6 m-85 -86.9 -16.09 37.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.854 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -49.52 -38.62 31.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.905 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -39.45 -44.35 1.36 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.898 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 5.9 t -67.48 -64.09 0.93 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.881 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -148.82 -158.86 8.23 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.516 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 677' ' ' HIS . . . . . 0.449 ' C ' ' CD2' ' A' ' 677' ' ' HIS . 3.4 t60 -86.88 107.52 18.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.871 0.367 . . . . 0.0 110.878 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 60.0 t -81.11 143.2 12.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.109 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 679' ' ' LEU . . . . . 0.416 HD21 ' CD2' ' A' ' 677' ' ' HIS . 23.6 mt -116.14 -62.77 1.54 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.872 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -99.91 128.98 45.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.909 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -155.89 123.75 5.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.08 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -152.5 155.85 38.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.875 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 18.1 mm -104.87 107.3 22.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.114 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 179.804 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 19.3 mmmt . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.801 0.334 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 692' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 658' ' ' ASN . . . 48.62 25.95 5.02 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.478 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 19.1 p -135.16 131.17 36.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.884 0.373 . . . . 0.0 110.847 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -143.52 -164.97 10.56 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.483 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 695' ' ' VAL . . . . . 0.455 ' HB ' ' NE2' ' A' ' 653' ' ' GLN . 17.1 m -140.08 160.1 26.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.922 0.391 . . . . 0.0 111.126 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 696' ' ' VAL . . . . . 0.421 HG22 ' CD1' ' A' ' 672' ' ' PHE . 70.7 t -146.52 115.01 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.099 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 37.0 tttt -96.69 138.37 34.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 698' ' ' PHE . . . . . 0.567 ' CD2' HG11 ' A' ' 703' ' ' VAL . 95.1 m-85 -116.69 164.38 14.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.906 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 699' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -71.11 -41.87 69.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.892 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 3.2 m -113.81 149.51 41.91 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.671 0.748 . . . . 0.0 110.887 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -33.53 16.37 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.638 2.225 . . . . 0.0 112.349 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 702' ' ' GLU . . . . . 0.438 ' HG3' ' N ' ' A' ' 703' ' ' VAL . 9.2 pt-20 -61.86 -42.36 98.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.893 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 703' ' ' VAL . . . . . 0.567 HG11 ' CD2' ' A' ' 698' ' ' PHE . 84.2 t -55.31 -60.51 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.126 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -39.04 -61.43 0.75 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.097 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -44.29 -41.03 5.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.92 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 15.7 ttt180 -67.05 -59.26 3.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.875 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -46.3 -44.0 16.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.056 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 708' ' ' CYS . . . . . 0.495 ' O ' ' CB ' ' A' ' 712' ' ' ASN . 1.8 m -50.74 -41.16 56.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.873 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 3.2 mtt-85 -82.47 -37.66 25.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.868 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 8.7 mtm -72.34 -9.44 58.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.869 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 711' ' ' MET . . . . . 0.566 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 5.5 mmm -120.5 -35.57 3.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.87 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 712' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 708' ' ' CYS . 0.3 OUTLIER -40.87 112.02 0.26 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.862 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 84.79 19.54 59.53 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.51 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 714' ' ' MET . . . . . 0.457 ' N ' ' O ' ' A' ' 711' ' ' MET . 57.2 ttp -69.28 94.07 0.68 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.847 0.356 . . . . 0.0 110.868 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 8.6 mmtp -51.13 98.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.899 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 716' ' ' LEU . . . . . 0.498 ' O ' ' N ' ' A' ' 719' ' ' ARG . 38.1 mt -99.94 129.92 46.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.951 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 717' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 716' ' ' LEU . 27.8 t 36.51 38.93 0.08 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.885 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 76.76 36.76 36.1 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.479 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 719' ' ' ARG . . . . . 0.498 ' N ' ' O ' ' A' ' 716' ' ' LEU . 21.7 mtt180 -147.22 116.04 6.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.748 0.308 . . . . 0.0 110.848 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -71.41 122.89 21.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.865 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 721' ' ' ILE . . . . . 0.428 HG21 ' CD1' ' A' ' 716' ' ' LEU . 19.4 pt -98.99 156.89 3.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.133 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 722' ' ' ASP . . . . . 0.446 ' OD1' ' C ' ' A' ' 722' ' ' ASP . 2.9 t0 -116.01 108.23 15.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.837 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 723' ' ' VAL . . . . . 0.428 ' CG1' ' HA ' ' A' ' 708' ' ' CYS . 17.3 t -107.32 136.02 43.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.177 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 724' ' ' ARG . . . . . 0.45 ' C ' ' SG ' ' A' ' 708' ' ' CYS . 13.5 ptt85 -158.13 165.97 33.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.872 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 725' ' ' ILE . . . . . . . . . . . . . 27.0 mm -62.18 138.0 23.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.126 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 35.7 t0 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.87 179.868 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 24.5 p . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.701 0.286 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -94.51 152.06 18.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.91 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 654' ' ' ILE . . . . . 0.46 ' CD1' ' CE2' ' A' ' 672' ' ' PHE . 27.6 pt -136.01 174.54 12.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.113 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -127.76 157.04 41.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.901 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 3.1 t -140.72 151.07 20.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.114 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 4.1 mtp-105 -148.23 156.16 42.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.902 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 658' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 69.61 45.71 0.77 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.895 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . . . . . . . . . 24.0 mt -94.51 143.71 26.73 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.653 0.74 . . . . 0.0 110.902 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -48.03 136.02 23.75 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.617 2.211 . . . . 0.0 112.383 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -52.34 -33.91 45.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.886 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.16 -30.12 43.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.915 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -39.13 124.96 1.54 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.91 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 77.2 p -110.0 176.6 5.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.21 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 665' ' ' TRP . . . . . 0.644 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 3.5 p-90 -68.26 -50.05 56.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.959 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 666' ' ' LYS . . . . . 0.644 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 13.1 tptp -52.04 -47.48 65.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.943 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 21.2 mtm -64.78 -39.55 93.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.864 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 38.9 tp -56.43 -46.48 80.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.949 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.44 ' O ' ' ND2' ' A' ' 673' ' ' ASN . 0.0 OUTLIER -62.22 -61.07 2.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 179.791 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -54.59 -27.74 41.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 11.0 tptt -66.56 -39.48 88.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 672' ' ' PHE . . . . . 0.46 ' CE2' ' CD1' ' A' ' 654' ' ' ILE . 25.1 m-85 -90.86 -10.51 42.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.856 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 673' ' ' ASN . . . . . 0.44 ' ND2' ' O ' ' A' ' 669' ' ' LYS . 1.0 OUTLIER -54.53 -32.73 58.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.863 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -58.58 -28.88 65.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 17.3 m -81.81 -53.46 6.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.86 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -161.72 -179.0 36.12 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.492 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -70.2 107.1 3.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.8 0.333 . . . . 0.0 110.855 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 58.8 t -84.68 137.53 20.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.143 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 12.1 mt -116.43 -57.98 2.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -99.41 126.11 45.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.925 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -155.6 123.8 5.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.138 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -154.02 158.17 40.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.84 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 27.2 mm -106.87 126.82 62.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.089 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 56.0 mmtt . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.89 179.804 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.808 0.337 . . . . 0.0 110.893 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 95.51 14.63 46.71 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.479 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 21.4 p -133.24 132.22 41.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.871 0.367 . . . . 0.0 110.851 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -139.11 -160.8 8.49 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.509 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 19.3 m -147.21 160.29 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.904 0.383 . . . . 0.0 111.11 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 97.1 t -148.0 113.54 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.137 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 18.9 ttpt -96.24 143.63 27.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 698' ' ' PHE . . . . . 0.403 ' CD2' HG11 ' A' ' 703' ' ' VAL . 96.2 m-85 -119.66 168.66 10.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.834 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 699' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -75.05 -34.44 61.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.918 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 700' ' ' SER . . . . . 0.416 ' CB ' ' OE2' ' A' ' 702' ' ' GLU . 1.4 m -125.34 152.86 71.89 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.696 0.76 . . . . 0.0 110.826 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -50.37 0.47 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.698 2.265 . . . . 0.0 112.36 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 702' ' ' GLU . . . . . 0.416 ' OE2' ' CB ' ' A' ' 700' ' ' SER . 25.6 pm0 -44.54 -27.48 0.47 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.863 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 703' ' ' VAL . . . . . 0.403 HG11 ' CD2' ' A' ' 698' ' ' PHE . 47.0 t -73.4 -54.5 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.095 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -48.61 -57.14 6.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.067 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -45.86 -38.07 6.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.858 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 9.4 ttm-85 -74.03 -58.15 3.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.897 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -47.99 -25.78 1.52 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.11 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 708' ' ' CYS . . . . . . . . . . . . . 1.5 t -60.47 -60.03 4.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.858 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -73.38 -36.97 66.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.812 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 12.1 mmm -59.42 -30.29 68.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.909 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 711' ' ' MET . . . . . 0.426 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 4.8 mmm -107.03 -15.9 14.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.88 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 712' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -53.91 121.83 8.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.923 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 77.14 12.82 84.27 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.524 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 714' ' ' MET . . . . . . . . . . . . . 55.8 ttp -59.64 104.31 0.27 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.849 0.356 . . . . 0.0 110.867 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 7.9 mmtm -61.98 100.22 0.15 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.898 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 716' ' ' LEU . . . . . 0.494 ' O ' ' N ' ' A' ' 719' ' ' ARG . 31.6 mt -99.89 126.86 46.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.958 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 717' ' ' SER . . . . . 0.409 ' C ' ' O ' ' A' ' 716' ' ' LEU . 1.6 t 36.7 39.7 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.887 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 77.18 36.18 35.89 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.484 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 719' ' ' ARG . . . . . 0.494 ' N ' ' O ' ' A' ' 716' ' ' LEU . 5.9 mtt-85 -148.68 114.54 5.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.804 0.335 . . . . 0.0 110.864 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -72.27 127.48 32.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 28.5 pt -100.04 157.05 4.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.149 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -109.22 98.48 7.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.847 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 17.9 t -97.61 130.13 46.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.121 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.19 175.22 13.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.923 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 725' ' ' ILE . . . . . . . . . . . . . 49.4 mm -80.31 133.37 29.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.114 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 9.0 t0 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.861 179.871 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 29.7 p . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.811 0.339 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -163.94 149.44 10.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.913 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 654' ' ' ILE . . . . . 0.517 HD12 ' CE2' ' A' ' 672' ' ' PHE . 37.8 pt -140.66 173.29 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.14 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -130.5 144.69 51.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.871 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 27.6 t -126.99 139.25 52.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.081 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 36.7 mtp85 -133.73 155.76 49.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.86 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 658' ' ' ASN . . . . . 0.467 ' ND2' ' HB3' ' A' ' 719' ' ' ARG . 4.7 t30 70.66 52.12 0.32 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.92 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.412 ' HB2' ' C ' ' A' ' 692' ' ' GLY . 36.7 mt -100.04 145.11 29.64 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.643 0.735 . . . . 0.0 110.875 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -47.92 142.46 15.07 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.654 2.236 . . . . 0.0 112.395 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -60.53 -24.75 65.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.889 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -98.17 13.4 31.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.85 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -80.14 118.48 21.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 69.4 p -105.45 168.99 8.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.079 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 665' ' ' TRP . . . . . 0.639 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 6.9 p-90 -57.23 -49.72 75.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.927 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 666' ' ' LYS . . . . . 0.639 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 5.3 tptm -46.27 -54.35 9.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.886 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 16.6 mtm -59.72 -55.62 32.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.84 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 14.7 tp -42.97 -46.91 5.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.902 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 46.1 tttt -62.49 -71.45 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -46.28 -24.11 0.43 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.878 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 8.8 tptp -68.79 -51.49 40.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.927 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 672' ' ' PHE . . . . . 0.547 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 23.1 m-85 -78.53 -15.24 58.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.892 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -49.92 -34.58 20.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.923 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -53.66 -39.76 65.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.881 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 675' ' ' CYS . . . . . 0.452 ' CB ' ' HB2' ' A' ' 707' ' ' ALA . 31.9 m -71.42 -47.54 55.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.888 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -165.69 -177.33 37.86 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.479 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 677' ' ' HIS . . . . . 0.459 ' CD2' HD23 ' A' ' 679' ' ' LEU . 2.7 t-160 -73.21 96.45 2.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.843 0.354 . . . . 0.0 110.862 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 78.9 t -73.26 138.3 21.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.143 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 679' ' ' LEU . . . . . 0.459 HD23 ' CD2' ' A' ' 677' ' ' HIS . 12.9 mt -113.21 -61.52 1.73 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.931 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 680' ' ' TYR . . . . . 0.505 ' CE2' HG22 ' A' ' 695' ' ' VAL . 4.5 t80 -95.71 129.11 43.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.93 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -156.91 125.2 5.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.075 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -156.0 161.72 40.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.84 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 42.9 mm -109.25 107.27 22.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.129 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 27.8 mmtm . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.882 179.832 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 691' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 693' ' ' CYS . 29.0 mmtt . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.784 0.326 . . . . 0.0 110.867 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 692' ' ' GLY . . . . . 0.412 ' C ' ' HB2' ' A' ' 659' ' ' LEU . . . 38.14 27.84 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.493 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 693' ' ' CYS . . . . . 0.461 ' N ' ' O ' ' A' ' 691' ' ' LYS . 31.2 p -132.46 129.13 38.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.843 0.354 . . . . 0.0 110.89 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -141.79 -163.47 9.62 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.487 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 695' ' ' VAL . . . . . 0.505 HG22 ' CE2' ' A' ' 680' ' ' TYR . 13.4 m -142.93 153.1 17.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.857 0.36 . . . . 0.0 111.086 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 93.4 t -139.34 118.04 12.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.136 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 697' ' ' LYS . . . . . 0.419 ' CB ' ' HB3' ' A' ' 680' ' ' TYR . 27.0 tttt -101.43 148.04 25.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.906 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 698' ' ' PHE . . . . . 0.56 ' CD2' HG11 ' A' ' 703' ' ' VAL . 96.4 m-85 -123.31 173.99 7.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 699' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -82.47 -44.13 16.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.918 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 1.1 t -103.41 143.01 25.77 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.692 0.758 . . . . 0.0 110.863 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -20.71 34.73 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.682 2.254 . . . . 0.0 112.343 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -75.56 -41.68 54.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.853 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 703' ' ' VAL . . . . . 0.56 HG11 ' CD2' ' A' ' 698' ' ' PHE . 66.0 t -56.02 -55.71 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.108 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -46.75 -43.91 18.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.092 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -60.03 -34.07 72.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.845 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 26.9 ttm180 -79.95 -57.83 3.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.89 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 707' ' ' ALA . . . . . 0.452 ' HB2' ' CB ' ' A' ' 675' ' ' CYS . . . -45.4 -33.13 2.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.059 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 708' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -53.17 -52.67 58.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.887 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.73 -40.85 32.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 61.1 mtp -56.86 -17.64 10.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 711' ' ' MET . . . . . 0.547 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 4.9 mmm -117.59 -24.81 7.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.856 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 712' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -48.55 114.06 0.89 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.926 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 82.58 31.88 29.05 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.532 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 714' ' ' MET . . . . . . . . . . . . . 63.0 ttp -82.75 105.86 14.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.84 0.352 . . . . 0.0 110.915 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 7.0 mmtp -60.66 100.42 0.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.889 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 716' ' ' LEU . . . . . 0.498 ' O ' ' N ' ' A' ' 719' ' ' ARG . 31.2 mt -99.89 125.56 45.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.945 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 717' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 716' ' ' LEU . 48.3 t 36.93 38.62 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.854 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 79.39 34.78 31.37 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.517 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 719' ' ' ARG . . . . . 0.498 ' N ' ' O ' ' A' ' 716' ' ' LEU . 37.3 mtp85 -146.65 112.76 5.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.748 0.308 . . . . 0.0 110.891 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -70.74 123.6 22.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.854 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 31.7 pt -99.95 156.23 4.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.16 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -114.46 105.04 12.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.875 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 21.9 t -100.79 132.42 46.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.09 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -154.66 161.43 41.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.878 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 725' ' ' ILE . . . . . . . . . . . . . 14.9 mm -72.53 134.64 29.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.134 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 6.0 t0 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.884 179.834 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 63.1 m . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.787 0.327 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -94.05 151.42 19.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.911 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 654' ' ' ILE . . . . . 0.51 HD13 ' CE2' ' A' ' 672' ' ' PHE . 20.7 pt -138.69 174.04 10.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.162 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -126.56 156.43 40.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.888 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 3.4 t -142.05 149.68 19.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.152 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -144.81 154.64 42.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.874 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 658' ' ' ASN . . . . . 0.457 ' ND2' ' HB3' ' A' ' 719' ' ' ARG . 4.1 t30 73.56 44.88 0.28 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.868 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . . . . . . . . . 36.3 mt -96.71 144.45 27.86 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.66 0.743 . . . . 0.0 110.86 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -48.0 139.5 20.19 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.676 2.251 . . . . 0.0 112.364 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -62.11 -24.92 67.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.894 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -94.32 3.26 55.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.921 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 663' ' ' PHE . . . . . 0.485 ' CD1' ' HE3' ' A' ' 667' ' ' MET . 2.8 t80 -70.72 124.39 24.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.881 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 38.7 p -104.22 169.04 8.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.155 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 665' ' ' TRP . . . . . 0.642 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 7.6 p-90 -63.51 -52.15 62.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.947 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 666' ' ' LYS . . . . . 0.642 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 0.0 OUTLIER -47.06 -43.1 19.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.883 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 667' ' ' MET . . . . . 0.485 ' HE3' ' CD1' ' A' ' 663' ' ' PHE . 30.5 mtm -68.31 -50.86 50.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 668' ' ' LEU . . . . . 0.46 HD12 ' CD1' ' A' ' 672' ' ' PHE . 14.2 tp -48.2 -47.26 35.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.866 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 44.2 tttt -59.54 -74.07 0.08 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.901 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -45.38 -28.23 0.82 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.845 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 26.6 tptt -68.64 -39.65 80.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.855 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 672' ' ' PHE . . . . . 0.51 ' CE2' HD13 ' A' ' 654' ' ' ILE . 13.6 m-85 -88.37 -14.01 39.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.866 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -56.53 -35.85 68.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.877 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -42.22 -41.86 2.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.877 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 3.0 t -70.62 -59.78 2.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.852 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -148.81 -153.96 6.17 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.494 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -95.54 104.52 16.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.859 0.361 . . . . 0.0 110.86 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 678' ' ' VAL . . . . . 0.474 HG23 ' CE2' ' A' ' 698' ' ' PHE . 57.9 t -82.7 136.06 23.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.128 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 12.8 mt -109.97 -59.12 1.97 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.935 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 680' ' ' TYR . . . . . 0.559 ' CE2' HG21 ' A' ' 695' ' ' VAL . 9.5 t80 -96.99 129.79 44.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.956 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -157.78 122.96 4.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.093 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -148.09 166.54 27.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.835 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 45.2 mm -114.47 106.86 21.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.115 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 36.5 mmtm . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.912 179.794 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 19.3 mmtt . . . . . 0 N--CA 1.458 -0.059 0 CA-C-O 120.814 0.34 . . . . 0.0 110.925 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 55.76 23.7 38.12 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.488 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 27.5 p -131.95 127.34 36.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.866 0.365 . . . . 0.0 110.91 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -142.25 -169.16 12.02 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.489 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 695' ' ' VAL . . . . . 0.559 HG21 ' CE2' ' A' ' 680' ' ' TYR . 27.5 m -139.07 166.97 21.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.891 0.377 . . . . 0.0 111.127 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 93.0 t -154.75 121.86 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.129 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 20.7 ttpt -105.97 143.08 34.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.911 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 698' ' ' PHE . . . . . 0.543 ' CD2' HG12 ' A' ' 703' ' ' VAL . 96.6 m-85 -118.4 169.24 9.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.878 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 699' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -76.7 -45.3 30.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.869 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 31.4 m -104.49 147.37 34.28 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.667 0.746 . . . . 0.0 110.887 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -31.53 20.37 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.687 2.258 . . . . 0.0 112.343 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 702' ' ' GLU . . . . . 0.441 ' HG3' ' N ' ' A' ' 703' ' ' VAL . 11.2 pt-20 -61.47 -42.92 99.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.873 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 703' ' ' VAL . . . . . 0.543 HG12 ' CD2' ' A' ' 698' ' ' PHE . 94.6 t -53.0 -59.36 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.168 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -40.63 -65.74 0.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.084 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -41.07 -37.69 0.89 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.891 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -75.43 -64.47 1.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.845 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -40.17 -35.33 0.39 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.109 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 708' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -53.26 -56.19 18.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -77.36 -38.63 49.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.861 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 17.8 mmm -57.12 -23.15 45.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.903 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 711' ' ' MET . . . . . 0.403 ' CB ' HG22 ' A' ' 723' ' ' VAL . 4.7 mmm -111.74 -34.75 5.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 712' ' ' ASN . . . . . 0.436 ' OD1' ' C ' ' A' ' 712' ' ' ASN . 9.9 t-20 -38.03 112.71 0.23 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.894 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 84.21 27.96 35.2 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.493 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 714' ' ' MET . . . . . . . . . . . . . 37.2 ttp -77.67 99.04 5.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.861 0.363 . . . . 0.0 110.902 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 11.8 mmtp -56.06 98.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.874 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 716' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 719' ' ' ARG . 31.5 mt -100.0 125.35 46.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.918 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 717' ' ' SER . . . . . . . . . . . . . 34.7 t 38.86 38.49 0.28 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.843 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 78.55 30.96 47.19 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.487 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 719' ' ' ARG . . . . . 0.504 ' N ' ' O ' ' A' ' 716' ' ' LEU . 45.5 mtt180 -141.13 114.55 8.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.84 0.353 . . . . 0.0 110.873 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -73.34 126.1 29.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.878 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 44.9 pt -100.0 162.77 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.118 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -119.07 101.38 7.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.878 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 723' ' ' VAL . . . . . 0.403 HG22 ' CB ' ' A' ' 711' ' ' MET . 10.0 t -100.83 132.12 47.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.122 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 50.7 mtp180 -155.99 163.55 39.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.874 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 725' ' ' ILE . . . . . . . . . . . . . 25.0 mm -64.8 135.77 27.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.148 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 31.0 t70 . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.893 179.832 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 64.4 m . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.753 0.311 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -96.56 154.06 17.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.945 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 654' ' ' ILE . . . . . 0.457 HD12 ' CE2' ' A' ' 672' ' ' PHE . 28.7 pt -141.87 170.05 13.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.114 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -122.39 153.73 38.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.891 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 3.5 t -139.95 148.41 22.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.142 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 38.4 mtp180 -146.73 155.79 42.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.871 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 658' ' ' ASN . . . . . 0.464 ' ND2' ' HB3' ' A' ' 719' ' ' ARG . 3.8 t30 71.28 51.57 0.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.422 ' HB2' ' C ' ' A' ' 692' ' ' GLY . 39.2 mt -101.35 143.48 26.67 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.623 0.725 . . . . 0.0 110.893 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 660' ' ' PRO . . . . . 0.477 ' O ' ' N ' ' A' ' 663' ' ' PHE . 66.6 Cg_exo -48.01 126.0 12.5 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.701 2.267 . . . . 0.0 112.336 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -40.79 -40.69 1.39 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.864 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 662' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 663' ' ' PHE . 22.8 t70 -73.16 -33.67 65.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.853 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 663' ' ' PHE . . . . . 0.477 ' N ' ' O ' ' A' ' 660' ' ' PRO . 4.1 t80 -36.31 119.91 0.63 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.895 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 74.4 p -104.88 -179.95 4.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.174 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 665' ' ' TRP . . . . . 0.62 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 6.5 p-90 -71.54 -50.23 33.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.894 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 666' ' ' LYS . . . . . 0.62 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 22.7 tptt -48.7 -43.72 37.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.872 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 27.4 mtm -66.09 -51.92 53.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.912 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 15.5 tp -46.21 -45.9 17.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.885 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 29.9 tttm -60.54 -73.99 0.08 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.885 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -47.07 -28.46 1.73 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.887 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 17.5 tptt -64.6 -41.24 96.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.888 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 672' ' ' PHE . . . . . 0.514 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 21.8 m-85 -88.89 -14.57 36.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.848 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -52.51 -40.19 62.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.897 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -44.6 -37.49 3.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.863 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 88.4 m -73.2 -58.51 3.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.883 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -152.95 -153.92 6.52 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.485 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 677' ' ' HIS . . . . . 0.443 ' CD2' ' CD2' ' A' ' 679' ' ' LEU . 8.9 t60 -92.84 106.57 18.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.87 0.367 . . . . 0.0 110.829 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 87.0 t -84.34 127.66 39.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.105 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 679' ' ' LEU . . . . . 0.443 ' CD2' ' CD2' ' A' ' 677' ' ' HIS . 12.0 mt -103.57 -60.16 1.61 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.937 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -99.27 129.06 45.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.921 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -157.65 121.41 4.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.092 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -153.23 156.77 39.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.871 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 37.9 mm -99.44 102.65 13.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.109 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.898 179.824 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.831 0.348 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 692' ' ' GLY . . . . . 0.422 ' C ' ' HB2' ' A' ' 659' ' ' LEU . . . 53.36 25.9 28.11 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.56 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 31.8 p -127.44 142.13 51.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.843 0.354 . . . . 0.0 110.903 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -150.62 -168.07 15.13 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.503 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 7.1 m -141.62 157.97 21.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.87 0.366 . . . . 0.0 111.131 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 91.6 t -147.52 118.67 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.139 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 14.5 ttpt -105.96 137.24 44.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.922 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 698' ' ' PHE . . . . . 0.468 ' CD2' HG13 ' A' ' 703' ' ' VAL . 96.2 m-85 -111.91 173.71 6.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.845 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 699' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -79.14 -40.77 30.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.865 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 5.5 m -110.18 148.64 38.76 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.63 0.729 . . . . 0.0 110.825 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -17.68 37.4 Favored 'Trans proline' 0 N--CA 1.465 -0.153 0 C-N-CA 122.693 2.262 . . . . 0.0 112.351 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -78.21 -49.27 14.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.862 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 703' ' ' VAL . . . . . 0.468 HG13 ' CD2' ' A' ' 698' ' ' PHE . 60.9 t -46.51 -42.1 5.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.159 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -59.48 -61.54 2.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.126 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -45.7 -32.43 2.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.897 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 44.5 ttt180 -80.77 -43.98 19.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.867 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -61.06 -62.5 1.81 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.137 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 708' ' ' CYS . . . . . 0.465 ' HA ' ' CG1' ' A' ' 723' ' ' VAL . 26.5 p -47.13 -29.71 2.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.912 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 16.6 mtt85 -89.56 -25.24 21.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.838 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 44.2 mtp -87.57 -12.02 46.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.874 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 711' ' ' MET . . . . . 0.514 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 8.9 mmm -110.82 -23.15 11.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 712' ' ' ASN . . . . . 0.43 ' CG ' ' O ' ' A' ' 712' ' ' ASN . 0.5 OUTLIER -42.6 117.29 1.0 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.857 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 79.78 21.58 65.83 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.49 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 714' ' ' MET . . . . . 0.439 ' HB3' ' CD1' ' A' ' 721' ' ' ILE . 31.8 ttp -65.54 94.1 0.18 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.843 0.354 . . . . 0.0 110.871 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 715' ' ' LYS . . . . . 0.408 ' NZ ' ' HA2' ' A' ' 718' ' ' GLY . 1.7 mmmt -55.91 99.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.881 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 716' ' ' LEU . . . . . 0.499 ' O ' ' N ' ' A' ' 719' ' ' ARG . 58.2 mt -100.08 132.28 45.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.871 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 717' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 716' ' ' LEU . 15.7 t 35.92 36.41 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.874 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 718' ' ' GLY . . . . . 0.408 ' HA2' ' NZ ' ' A' ' 715' ' ' LYS . . . 77.99 38.98 25.26 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.502 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 719' ' ' ARG . . . . . 0.499 ' N ' ' O ' ' A' ' 716' ' ' LEU . 39.3 mtt85 -149.23 107.52 3.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.77 0.319 . . . . 0.0 110.883 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -62.73 123.83 19.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 721' ' ' ILE . . . . . 0.439 ' CD1' ' HB3' ' A' ' 714' ' ' MET . 24.9 pt -99.62 155.89 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.13 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -110.73 110.12 20.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.876 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 723' ' ' VAL . . . . . 0.465 ' CG1' ' HA ' ' A' ' 708' ' ' CYS . 2.7 t -109.39 136.87 43.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.14 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -157.95 169.99 23.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.851 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 725' ' ' ILE . . . . . . . . . . . . . 46.6 mm -77.31 143.09 13.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.126 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 9.5 t70 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.889 179.842 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 81.6 m . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.804 0.335 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -95.09 150.19 20.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.888 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 654' ' ' ILE . . . . . 0.437 ' CD1' ' CE2' ' A' ' 672' ' ' PHE . 29.2 pt -135.47 176.5 8.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.139 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -131.53 143.47 50.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.884 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 11.1 t -129.97 145.93 34.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.134 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -136.25 168.97 18.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.874 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 658' ' ' ASN . . . . . . . . . . . . . 8.5 t30 60.08 47.23 9.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.869 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.438 HD23 ' CD2' ' A' ' 663' ' ' PHE . 53.8 mt -95.14 143.59 26.37 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.629 0.728 . . . . 0.0 110.916 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -47.94 145.04 10.83 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.651 2.234 . . . . 0.0 112.345 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -61.88 -33.18 73.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.91 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -89.41 7.91 33.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.864 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 663' ' ' PHE . . . . . 0.438 ' CD2' HD23 ' A' ' 659' ' ' LEU . 2.9 t80 -73.87 114.17 11.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 57.9 p -100.14 166.01 11.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.184 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 665' ' ' TRP . . . . . 0.587 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 10.6 p-90 -55.9 -46.72 78.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.906 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 666' ' ' LYS . . . . . 0.587 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 4.2 tppp? -48.53 -52.61 21.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.889 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 14.5 mtm -60.58 -54.81 40.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.869 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 26.2 tp -45.97 -45.59 15.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.942 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.4 ' C ' ' N ' ' A' ' 671' ' ' LYS . 33.9 tttm -64.57 -74.79 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.855 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -45.91 -21.73 0.15 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.851 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 671' ' ' LYS . . . . . 0.408 ' HG3' ' CE ' ' A' ' 711' ' ' MET . 6.2 tppt? -71.61 -45.75 61.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.893 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 672' ' ' PHE . . . . . 0.502 ' CD1' HG23 ' A' ' 696' ' ' VAL . 23.7 m-85 -84.36 -8.81 58.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.904 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -58.88 -30.08 67.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.89 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -49.01 -43.3 40.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.897 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 19.2 t -66.6 -62.27 1.54 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.873 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -147.6 -148.19 4.7 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.489 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 677' ' ' HIS . . . . . 0.479 ' CD2' HD21 ' A' ' 679' ' ' LEU . 6.6 t60 -98.68 101.64 13.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.794 0.33 . . . . 0.0 110.889 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 98.8 t -76.81 136.29 24.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.122 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 679' ' ' LEU . . . . . 0.479 HD21 ' CD2' ' A' ' 677' ' ' HIS . 18.2 mt -110.33 -62.74 1.47 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.928 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -95.98 126.4 41.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.94 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -156.84 125.9 5.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.103 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -157.5 157.24 33.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.862 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 45.5 mm -97.74 104.17 15.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.155 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 179.893 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt . . . . . 0 C--O 1.23 0.051 0 CA-C-O 120.816 0.341 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 43.77 36.37 3.55 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.447 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 28.9 p -137.97 142.49 40.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.845 0.355 . . . . 0.0 110.906 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -152.56 -160.78 9.82 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.468 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 10.3 m -149.54 156.73 7.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.869 0.366 . . . . 0.0 111.127 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 696' ' ' VAL . . . . . 0.502 HG23 ' CD1' ' A' ' 672' ' ' PHE . 67.0 t -146.14 118.37 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.086 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 15.8 tttt -104.22 146.03 29.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.901 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 698' ' ' PHE . . . . . 0.525 ' CD2' HG12 ' A' ' 703' ' ' VAL . 92.1 m-85 -122.11 164.79 17.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.861 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 699' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -68.76 -42.16 77.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.88 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 26.4 m -110.92 147.16 35.94 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.703 0.763 . . . . 0.0 110.824 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -29.16 24.17 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.698 2.265 . . . . 0.0 112.333 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -63.5 -40.92 98.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 703' ' ' VAL . . . . . 0.525 HG12 ' CD2' ' A' ' 698' ' ' PHE . 94.7 t -58.83 -57.1 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.058 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -43.19 -66.71 0.34 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.127 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -39.34 -39.29 0.63 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.902 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 706' ' ' ARG . . . . . 0.429 ' O ' ' N ' ' A' ' 708' ' ' CYS . 16.1 ttm-85 -73.46 -64.11 1.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.882 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -38.95 -29.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.087 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 708' ' ' CYS . . . . . 0.429 ' N ' ' O ' ' A' ' 706' ' ' ARG . 1.2 t -61.81 -49.47 76.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.832 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -77.19 -33.11 56.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.851 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 59.7 mtp -70.04 -16.37 63.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.843 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 711' ' ' MET . . . . . 0.42 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 5.3 mmm -118.93 -20.41 8.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.892 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 712' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -53.28 122.48 9.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.92 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 74.68 23.5 74.97 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.515 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 714' ' ' MET . . . . . . . . . . . . . 42.4 ttp -76.4 111.05 11.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.859 0.362 . . . . 0.0 110.885 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 19.4 mmtt -63.34 102.53 0.41 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.942 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 716' ' ' LEU . . . . . 0.498 ' O ' ' N ' ' A' ' 719' ' ' ARG . 36.9 mt -99.98 122.98 43.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.905 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 717' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 716' ' ' LEU . 1.3 t 37.3 42.1 0.28 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 76.97 32.7 48.4 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.418 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 719' ' ' ARG . . . . . 0.498 ' N ' ' O ' ' A' ' 716' ' ' LEU . 21.9 mtp180 -146.83 110.73 5.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.805 0.336 . . . . 0.0 110.867 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -68.55 125.38 26.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.842 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 721' ' ' ILE . . . . . 0.459 HG21 ' CD1' ' A' ' 716' ' ' LEU . 26.7 pt -99.55 155.0 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.111 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -111.32 104.58 13.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.885 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 3.7 t -100.67 131.99 47.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.096 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -155.56 160.37 40.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.897 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 725' ' ' ILE . . . . . . . . . . . . . 33.9 mm -60.86 135.96 25.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.118 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 21.8 t70 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.917 179.856 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 60.2 m . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.751 0.31 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -98.31 156.27 16.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.913 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 654' ' ' ILE . . . . . 0.425 ' CG2' ' SG ' ' A' ' 708' ' ' CYS . 43.7 pt -142.7 166.94 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.125 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -119.12 156.49 29.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.926 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 3.3 t -143.75 151.06 16.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.133 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 49.3 mtp180 -147.27 156.74 43.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.858 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 658' ' ' ASN . . . . . 0.424 ' ND2' ' HB3' ' A' ' 719' ' ' ARG . 6.6 t30 70.44 51.91 0.35 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.926 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.411 ' CD2' HD12 ' A' ' 716' ' ' LEU . 37.6 mt -100.75 143.55 26.78 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.63 0.728 . . . . 0.0 110.902 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 660' ' ' PRO . . . . . 0.453 ' O ' ' N ' ' A' ' 663' ' ' PHE . 64.4 Cg_exo -47.97 128.64 16.78 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.683 2.255 . . . . 0.0 112.346 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -43.09 -31.96 0.63 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.869 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -82.81 -32.54 27.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.864 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 663' ' ' PHE . . . . . 0.453 ' N ' ' O ' ' A' ' 660' ' ' PRO . 4.2 t80 -40.23 113.16 0.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 24.8 p -104.81 -177.48 3.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.121 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 665' ' ' TRP . . . . . 0.646 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 8.2 p-90 -66.76 -52.26 46.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 666' ' ' LYS . . . . . 0.646 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 22.8 tptp -44.78 -55.0 5.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.907 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 11.9 mtm -60.42 -46.01 91.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.866 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 27.9 tp -51.44 -42.97 61.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.919 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.41 ' O ' ' ND2' ' A' ' 673' ' ' ASN . 29.2 tttm -65.64 -74.41 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.909 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -45.86 -24.42 0.39 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.821 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? -68.9 -52.74 26.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.898 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 672' ' ' PHE . . . . . 0.444 ' CD1' HG22 ' A' ' 696' ' ' VAL . 23.3 m-85 -76.99 -13.72 59.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.899 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 673' ' ' ASN . . . . . 0.41 ' ND2' ' O ' ' A' ' 669' ' ' LYS . 1.5 m-80 -52.86 -28.37 22.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.871 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -50.49 -46.64 57.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.897 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 675' ' ' CYS . . . . . 0.464 ' CB ' ' HB3' ' A' ' 707' ' ' ALA . 12.4 t -64.4 -61.18 2.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.902 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -152.33 -147.38 4.58 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.465 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -95.41 114.13 25.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.79 0.329 . . . . 0.0 110.867 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 77.7 t -88.39 123.51 40.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.135 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 19.2 mt -97.11 -61.93 1.33 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.916 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 680' ' ' TYR . . . . . 0.429 ' CE2' HG21 ' A' ' 695' ' ' VAL . 6.3 t80 -99.84 123.7 44.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.935 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -149.41 121.68 8.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.099 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -155.8 155.81 33.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.878 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 28.1 mm -101.62 105.95 18.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.123 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.874 179.87 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 35.5 mmtm . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.818 0.342 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 58.47 16.81 30.31 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.472 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 1.9 p -123.45 129.68 51.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.826 0.346 . . . . 0.0 110.895 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -136.45 -159.6 8.45 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.5 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 695' ' ' VAL . . . . . 0.429 HG21 ' CE2' ' A' ' 680' ' ' TYR . 13.5 m -148.13 155.82 9.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.872 0.367 . . . . 0.0 111.134 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 696' ' ' VAL . . . . . 0.523 HG13 ' CZ ' ' A' ' 698' ' ' PHE . 91.7 t -143.8 119.42 4.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.182 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 28.2 tttt -104.36 140.45 37.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.916 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 698' ' ' PHE . . . . . 0.556 ' CD2' HG11 ' A' ' 703' ' ' VAL . 96.0 m-85 -117.99 167.99 10.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.899 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 699' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -76.2 -39.25 55.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 1.8 t -108.83 142.98 26.64 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.633 0.73 . . . . 0.0 110.847 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -24.59 29.75 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.676 2.251 . . . . 0.0 112.373 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 702' ' ' GLU . . . . . 0.424 ' HG3' ' N ' ' A' ' 703' ' ' VAL . 6.9 pt-20 -73.76 -34.11 64.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.886 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 703' ' ' VAL . . . . . 0.556 HG11 ' CD2' ' A' ' 698' ' ' PHE . 38.2 t -61.7 -56.96 14.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.142 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -43.39 -62.44 1.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.107 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -43.35 -43.08 4.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.906 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 16.0 ttm180 -66.08 -58.31 5.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.834 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 707' ' ' ALA . . . . . 0.464 ' HB3' ' CB ' ' A' ' 675' ' ' CYS . . . -50.64 -34.05 24.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.097 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 708' ' ' CYS . . . . . 0.425 ' SG ' ' CG2' ' A' ' 654' ' ' ILE . 2.4 m -61.18 -42.25 98.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.892 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 709' ' ' ARG . . . . . 0.407 ' O ' ' ND2' ' A' ' 712' ' ' ASN . 18.8 mtt180 -84.15 -20.11 33.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.849 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 17.1 mtm -88.79 -9.76 50.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.873 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 711' ' ' MET . . . . . 0.436 ' HE1' ' CE ' ' A' ' 714' ' ' MET . 5.7 mmm -120.45 -10.62 9.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.9 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 712' ' ' ASN . . . . . 0.407 ' ND2' ' O ' ' A' ' 709' ' ' ARG . 0.9 OUTLIER -53.98 126.74 23.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.857 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 69.63 8.12 59.58 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.496 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 714' ' ' MET . . . . . 0.436 ' CE ' ' HE1' ' A' ' 711' ' ' MET . 10.3 ttp -49.38 99.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.857 0.36 . . . . 0.0 110.859 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 10.3 mmtp -56.05 102.56 0.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.888 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 716' ' ' LEU . . . . . 0.411 HD12 ' CD2' ' A' ' 659' ' ' LEU . 12.2 mt -99.88 117.0 33.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.923 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 717' ' ' SER . . . . . . . . . . . . . 2.3 t 40.91 44.41 1.96 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.912 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 76.33 31.28 55.18 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.493 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 719' ' ' ARG . . . . . 0.424 ' HB3' ' ND2' ' A' ' 658' ' ' ASN . 23.9 mtp180 -144.26 106.89 4.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.757 0.313 . . . . 0.0 110.876 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -66.18 125.77 26.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.881 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 721' ' ' ILE . . . . . 0.427 ' CD1' ' HB3' ' A' ' 714' ' ' MET . 38.2 pt -97.79 156.4 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.109 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -110.61 98.09 7.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.855 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 3.2 t -94.84 134.93 30.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.12 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 25.6 mtt-85 -158.08 176.11 12.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.859 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 725' ' ' ILE . . . . . . . . . . . . . 10.1 mm -78.23 138.95 19.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.125 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 18.7 t0 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.817 179.906 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 26.4 p . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.792 0.329 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -104.29 146.6 28.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.895 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 654' ' ' ILE . . . . . . . . . . . . . 25.4 pt -135.27 172.66 15.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.138 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -128.21 149.59 50.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.868 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 4.0 t -132.19 152.87 37.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.095 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 69.8 mtt180 -146.81 160.08 42.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.88 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 658' ' ' ASN . . . . . 0.429 ' ND2' ' HB3' ' A' ' 719' ' ' ARG . 1.1 t30 66.94 48.51 1.27 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.914 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . . . . . . . . . 40.5 mt -98.71 145.41 29.87 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.635 0.731 . . . . 0.0 110.909 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_exo -47.98 126.17 12.74 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.692 2.261 . . . . 0.0 112.337 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -49.35 -25.97 2.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.857 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -88.01 -24.95 23.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -41.09 147.69 0.13 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.861 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 35.5 p -128.07 169.55 13.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.115 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 665' ' ' TRP . . . . . 0.644 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 5.6 p-90 -63.96 -53.0 57.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.894 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 666' ' ' LYS . . . . . 0.644 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 3.7 tppp? -47.55 -47.71 28.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.924 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 46.1 mtm -63.16 -50.64 69.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.88 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 29.7 tp -46.66 -45.65 19.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.931 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 30.9 tttm -60.72 -72.36 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.925 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -47.04 -25.07 0.74 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.902 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 17.0 tptt -68.76 -43.63 75.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.892 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 672' ' ' PHE . . . . . 0.506 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 23.8 m-85 -87.38 -13.42 43.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.889 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -50.71 -36.69 37.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.852 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -51.22 -39.79 57.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.857 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 675' ' ' CYS . . . . . 0.455 ' CB ' ' HB1' ' A' ' 707' ' ' ALA . 37.4 m -72.01 -42.29 66.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -177.16 170.12 42.64 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.483 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 677' ' ' HIS . . . . . 0.532 ' CD2' HD21 ' A' ' 679' ' ' LEU . 3.4 t-160 -59.56 114.91 2.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.85 0.357 . . . . 0.0 110.888 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 41.4 t -90.63 139.69 17.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.1 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 679' ' ' LEU . . . . . 0.532 HD21 ' CD2' ' A' ' 677' ' ' HIS . 13.8 mt -110.62 -63.8 1.35 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.932 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 680' ' ' TYR . . . . . 0.444 ' CE2' HG23 ' A' ' 695' ' ' VAL . 10.8 t80 -99.06 131.27 45.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.97 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -157.22 120.86 4.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.115 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -148.26 164.11 34.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.904 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 38.3 mm -109.18 106.58 20.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.11 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.935 179.832 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt . . . . . 0 N--CA 1.458 -0.062 0 CA-C-O 120.811 0.339 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 55.14 15.51 7.31 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.528 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 27.0 p -123.38 139.43 54.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.848 0.356 . . . . 0.0 110.896 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -143.39 -157.19 7.06 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.429 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 695' ' ' VAL . . . . . 0.444 HG23 ' CE2' ' A' ' 680' ' ' TYR . 6.9 m -152.58 151.86 11.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.885 0.374 . . . . 0.0 111.126 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 94.3 t -141.95 119.43 7.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.111 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 17.6 tttt -106.36 134.06 50.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.879 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -109.25 169.06 8.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.864 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 699' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -72.11 -37.67 69.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.867 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -115.15 143.96 31.26 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.658 0.742 . . . . 0.0 110.828 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -10.84 29.57 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.709 2.272 . . . . 0.0 112.327 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -82.6 -46.48 13.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.91 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 65.8 t -50.42 -47.84 26.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.162 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -49.3 -61.32 2.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.145 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -47.57 -23.5 0.67 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.878 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 45.1 ttt180 -87.08 -43.45 12.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.821 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 707' ' ' ALA . . . . . 0.455 ' HB1' ' CB ' ' A' ' 675' ' ' CYS . . . -65.03 -56.94 10.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.108 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 708' ' ' CYS . . . . . 0.42 ' HA ' ' CG1' ' A' ' 723' ' ' VAL . 13.8 p -42.98 -42.13 3.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.876 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 709' ' ' ARG . . . . . 0.405 ' N ' ' SG ' ' A' ' 708' ' ' CYS . 15.8 mtt180 -80.16 -34.91 37.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.897 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 14.8 mtm -78.07 -9.14 59.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.886 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 711' ' ' MET . . . . . 0.506 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 5.9 mmm -116.14 -20.18 9.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.888 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 712' ' ' ASN . . . . . 0.435 ' OD1' ' C ' ' A' ' 712' ' ' ASN . 10.3 t-20 -55.03 115.21 2.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.914 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 85.75 18.67 59.49 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.543 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 714' ' ' MET . . . . . . . . . . . . . 44.7 ttp -71.11 96.64 1.38 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.834 0.35 . . . . 0.0 110.887 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 5.4 mmtp -51.54 101.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 716' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' A' ' 719' ' ' ARG . 33.9 mt -100.2 120.4 39.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.925 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 717' ' ' SER . . . . . . . . . . . . . 1.2 t 40.32 44.95 1.72 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.857 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 74.13 27.25 66.67 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.503 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 719' ' ' ARG . . . . . 0.452 ' N ' ' O ' ' A' ' 716' ' ' LEU . 44.1 mtt85 -139.31 109.57 6.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.728 0.299 . . . . 0.0 110.882 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -67.11 125.28 25.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.866 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 27.5 pt -99.96 156.22 4.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.161 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -116.28 104.55 11.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.862 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 723' ' ' VAL . . . . . 0.42 ' CG1' ' HA ' ' A' ' 708' ' ' CYS . 3.6 t -104.72 135.37 42.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.137 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 22.1 mtp85 -157.89 159.05 36.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.885 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 725' ' ' ILE . . . . . . . . . . . . . 35.6 mm -61.19 135.12 26.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.121 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 5.4 t70 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 179.842 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 22.6 p . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.748 0.308 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 653' ' ' GLN . . . . . 0.457 ' HG3' ' N ' ' A' ' 654' ' ' ILE . 8.1 tp60 -93.1 146.52 23.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.917 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 654' ' ' ILE . . . . . 0.487 ' CD1' ' CE2' ' A' ' 672' ' ' PHE . 40.2 pt -134.51 177.24 7.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.112 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -132.8 159.69 39.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.861 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 6.5 t -140.71 150.44 20.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.069 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -146.68 157.43 43.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.883 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 658' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 67.15 54.43 0.74 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.905 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.443 HD21 ' CE2' ' A' ' 663' ' ' PHE . 38.7 mt -102.42 144.88 29.5 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.628 0.728 . . . . 0.0 110.908 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -48.0 133.47 23.33 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.648 2.232 . . . . 0.0 112.356 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -53.08 -28.34 24.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.867 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -86.64 -19.67 28.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.866 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 663' ' ' PHE . . . . . 0.501 ' CD1' ' HE2' ' A' ' 667' ' ' MET . 3.6 t80 -49.25 136.02 16.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.893 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 72.7 p -120.93 175.27 6.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.114 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 665' ' ' TRP . . . . . 0.65 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 5.3 p-90 -66.57 -51.05 60.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.889 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 666' ' ' LYS . . . . . 0.65 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 0.0 OUTLIER -45.86 -45.02 14.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.859 179.94 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 667' ' ' MET . . . . . 0.501 ' HE2' ' CD1' ' A' ' 663' ' ' PHE . 38.8 mtm -68.54 -52.19 34.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.925 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 30.0 tp -45.89 -42.4 12.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.933 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 44.8 tttt -65.95 -73.09 0.14 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.912 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -48.37 -23.77 1.03 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.876 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 16.1 tptt -69.68 -44.09 71.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.914 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 672' ' ' PHE . . . . . 0.497 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 16.9 m-85 -85.49 -14.8 44.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.911 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -55.25 -27.93 49.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.876 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -63.34 -19.87 65.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 34.1 m -89.38 -36.19 15.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.912 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -177.32 -154.78 12.54 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.485 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -91.93 108.64 20.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.884 0.373 . . . . 0.0 110.87 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 63.7 t -90.58 136.32 24.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.125 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 27.0 mt -110.44 -61.87 1.6 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.964 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -98.67 131.06 45.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.93 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -155.39 125.84 6.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.105 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -156.18 159.57 39.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.878 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 34.3 mm -105.38 97.44 5.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.126 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.943 179.834 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 6.4 mmtp . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.811 0.339 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 60.48 28.17 67.04 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.482 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 26.5 p -136.18 142.24 44.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.88 0.371 . . . . 0.0 110.852 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -152.3 -164.91 12.71 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.499 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 6.8 m -148.51 155.9 8.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.853 0.359 . . . . 0.0 111.128 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 88.5 t -143.13 123.64 10.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.15 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 14.8 ttpt -103.28 139.07 39.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -116.71 165.15 13.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.89 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 699' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -72.32 -43.25 64.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.864 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 79.8 p -111.08 149.45 40.5 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.639 0.733 . . . . 0.0 110.836 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -29.29 24.03 Favored 'Trans proline' 0 C--N 1.34 0.122 0 C-N-CA 122.662 2.241 . . . . 0.0 112.346 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -63.26 -46.7 85.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.909 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 71.6 t -50.78 -56.51 4.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.128 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -45.05 -60.98 1.81 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.109 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -44.03 -35.16 1.98 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.885 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 -77.95 -59.78 2.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.913 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -43.25 -32.43 0.77 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.087 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 708' ' ' CYS . . . . . 0.498 ' O ' ' N ' ' A' ' 712' ' ' ASN . 7.0 t -57.29 -60.51 3.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.889 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -68.39 -30.63 69.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 15.3 mmm -70.59 -30.72 67.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.854 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 711' ' ' MET . . . . . 0.497 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 4.3 mmm -107.68 -9.71 15.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.915 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 712' ' ' ASN . . . . . 0.498 ' N ' ' O ' ' A' ' 708' ' ' CYS . 10.4 t-20 -62.35 114.49 3.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.859 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 85.14 13.2 71.98 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.467 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 714' ' ' MET . . . . . . . . . . . . . 53.1 ttp -59.66 100.9 0.09 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.86 0.362 . . . . 0.0 110.852 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 8.8 mmtp -62.67 100.51 0.2 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.876 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 716' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 719' ' ' ARG . 31.2 mt -100.0 128.23 46.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.931 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 717' ' ' SER . . . . . 0.435 ' C ' ' O ' ' A' ' 716' ' ' LEU . 3.1 t 35.44 37.99 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.897 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 79.5 37.98 22.3 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.492 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 719' ' ' ARG . . . . . 0.504 ' N ' ' O ' ' A' ' 716' ' ' LEU . 6.7 mtt-85 -148.08 113.46 5.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.797 0.332 . . . . 0.0 110.861 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -74.5 125.69 29.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.889 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 46.5 pt -99.67 153.66 4.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.108 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -109.03 97.9 7.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.858 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 723' ' ' VAL . . . . . 0.433 HG21 ' CB ' ' A' ' 711' ' ' MET . 11.9 t -94.46 135.23 29.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.107 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.04 176.04 13.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.832 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 725' ' ' ILE . . . . . . . . . . . . . 39.0 mm -78.5 143.88 12.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.135 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 45.1 t0 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 179.813 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 36.7 m . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.722 0.296 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -105.16 147.43 27.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.869 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 654' ' ' ILE . . . . . 0.484 ' CD1' ' CE2' ' A' ' 672' ' ' PHE . 40.9 pt -135.54 171.56 17.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.091 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -121.86 158.77 28.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.872 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 5.5 t -147.52 145.78 18.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.11 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 51.6 mtp180 -143.78 160.94 39.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.883 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 658' ' ' ASN . . . . . 0.468 ' ND2' ' HB3' ' A' ' 719' ' ' ARG . 3.7 t30 69.73 47.86 0.61 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.894 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . . . . . . . . . 51.1 mt -101.41 143.97 27.64 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.614 0.721 . . . . 0.0 110.898 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -48.04 133.71 23.63 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.71 2.273 . . . . 0.0 112.299 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -47.99 -41.58 25.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.877 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -72.25 -29.94 64.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.888 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -38.87 116.3 0.55 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.864 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 40.7 p -101.58 179.39 4.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.185 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 665' ' ' TRP . . . . . 0.583 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 6.4 p-90 -69.09 -47.52 65.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.907 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 666' ' ' LYS . . . . . 0.583 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 0.0 OUTLIER -50.36 -45.78 55.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.893 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 24.9 mtm -66.05 -52.76 46.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.876 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 18.0 tp -46.46 -47.23 19.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.915 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . 0.453 ' HB2' ' CB ' ' A' ' 681' ' ' ALA . 29.9 tttt -63.3 -72.62 0.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.883 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -45.26 -26.61 0.52 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.864 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 15.3 tptt -67.81 -41.75 82.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.917 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 672' ' ' PHE . . . . . 0.568 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 20.9 m-85 -86.19 -18.91 30.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.91 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -50.32 -35.02 25.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -40.99 -42.33 1.86 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 6.4 t -70.25 -64.96 0.79 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.904 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -142.17 -151.28 5.49 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.464 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 677' ' ' HIS . . . . . 0.494 ' CD2' HD23 ' A' ' 679' ' ' LEU . 4.3 t60 -98.69 101.16 12.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.851 0.358 . . . . 0.0 110.885 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 69.5 t -74.57 141.65 15.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.143 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 679' ' ' LEU . . . . . 0.494 HD23 ' CD2' ' A' ' 677' ' ' HIS . 14.3 mt -114.31 -59.26 2.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.897 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 680' ' ' TYR . . . . . 0.561 ' CE2' HG23 ' A' ' 695' ' ' VAL . 9.3 t80 -98.01 126.35 43.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 681' ' ' ALA . . . . . 0.453 ' CB ' ' HB2' ' A' ' 669' ' ' LYS . . . -154.25 123.71 6.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.109 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -151.94 160.89 43.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.868 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 21.8 mm -111.5 117.7 55.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.114 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.911 179.836 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 120.833 0.349 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 80.29 18.9 70.45 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.446 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 15.1 p -131.67 123.99 28.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.896 0.379 . . . . 0.0 110.875 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -132.86 -162.14 10.13 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.483 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 695' ' ' VAL . . . . . 0.561 HG23 ' CE2' ' A' ' 680' ' ' TYR . 16.8 m -144.31 167.2 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.857 0.361 . . . . 0.0 111.159 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 696' ' ' VAL . . . . . 0.457 HG23 ' CD1' ' A' ' 672' ' ' PHE . 99.1 t -150.9 122.55 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.13 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 10.6 ttpp -107.5 136.74 46.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -113.67 172.34 7.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.903 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 699' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -79.22 -42.3 26.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.903 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 21.7 m -108.18 143.97 28.48 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.632 0.729 . . . . 0.0 110.882 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 -28.42 25.47 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.676 2.25 . . . . 0.0 112.397 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -68.28 -33.42 74.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.895 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 76.0 t -64.15 -57.36 11.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.161 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -44.65 -52.46 8.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.122 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -53.97 -30.36 46.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.919 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 45.0 ttt180 -82.23 -43.55 17.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.87 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -61.35 -56.71 17.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.083 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 708' ' ' CYS . . . . . . . . . . . . . 28.8 p -46.3 -32.81 3.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.881 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 11.8 mtp180 -83.16 -35.93 25.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.819 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 29.0 mtm -77.85 -11.39 59.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.88 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 711' ' ' MET . . . . . 0.568 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 4.3 mmt -112.51 -34.58 5.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.874 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 712' ' ' ASN . . . . . 0.401 ' OD1' ' C ' ' A' ' 712' ' ' ASN . 2.2 t-20 -39.16 106.77 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.882 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 91.04 20.01 40.79 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.512 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 714' ' ' MET . . . . . 0.481 ' N ' ' O ' ' A' ' 711' ' ' MET . 2.9 ttm -64.7 99.79 0.35 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.839 0.352 . . . . 0.0 110.866 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 715' ' ' LYS . . . . . 0.447 ' CD ' ' HG3' ' A' ' 720' ' ' GLU . 22.4 mmtt -59.92 99.78 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.906 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 716' ' ' LEU . . . . . 0.501 ' O ' ' N ' ' A' ' 719' ' ' ARG . 32.6 mt -99.8 125.64 45.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.9 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 717' ' ' SER . . . . . 0.403 ' C ' ' O ' ' A' ' 716' ' ' LEU . 1.7 t 37.72 40.03 0.24 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.846 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 77.96 32.93 42.96 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.476 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 719' ' ' ARG . . . . . 0.501 ' N ' ' O ' ' A' ' 716' ' ' LEU . 18.4 mtp85 -141.9 110.42 6.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.763 0.316 . . . . 0.0 110.894 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 720' ' ' GLU . . . . . 0.447 ' HG3' ' CD ' ' A' ' 715' ' ' LYS . 27.9 mt-10 -71.53 127.73 33.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.886 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 721' ' ' ILE . . . . . 0.468 ' CD1' ' HE1' ' A' ' 714' ' ' MET . 21.2 pt -97.97 160.5 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.127 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -116.8 100.13 7.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.831 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 3.3 t -100.32 136.09 33.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.11 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.89 148.38 20.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.852 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 725' ' ' ILE . . . . . . . . . . . . . 31.3 mm -56.62 134.74 20.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.114 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 21.5 t0 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 179.874 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 30.2 p . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.739 0.304 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -105.44 147.24 28.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.879 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 654' ' ' ILE . . . . . 0.405 ' CD1' ' CE2' ' A' ' 672' ' ' PHE . 33.4 pt -135.12 171.17 18.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.13 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -125.13 151.63 45.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.862 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 23.2 t -133.22 152.45 35.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.159 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -147.86 157.99 43.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.877 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 658' ' ' ASN . . . . . 0.469 ' ND2' ' HB3' ' A' ' 719' ' ' ARG . 6.7 t30 71.5 35.13 1.54 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.903 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.477 HD22 ' CD2' ' A' ' 663' ' ' PHE . 23.8 mt -85.14 143.58 39.82 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.631 0.729 . . . . 0.0 110.86 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -47.94 146.48 8.81 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.686 2.257 . . . . 0.0 112.353 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -64.45 -28.87 69.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.11 13.92 23.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.852 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 663' ' ' PHE . . . . . 0.477 ' CD2' HD22 ' A' ' 659' ' ' LEU . 2.9 t80 -79.04 121.92 25.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.906 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 62.9 p -104.9 169.55 8.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.156 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 665' ' ' TRP . . . . . 0.601 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 5.0 p-90 -62.85 -45.13 94.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.917 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 666' ' ' LYS . . . . . 0.601 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 5.5 tppp? -51.52 -46.11 63.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 30.1 mtm -67.54 -51.9 45.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.887 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 24.3 tp -47.62 -44.81 27.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.908 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 34.7 tttm -64.23 -70.8 0.2 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.903 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -47.36 -24.75 0.84 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.856 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 17.8 tptt -69.41 -42.35 75.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.901 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 672' ' ' PHE . . . . . 0.45 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 20.5 m-85 -85.99 -21.98 27.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.861 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -45.02 -37.34 4.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -46.69 -45.37 19.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.914 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 86.4 m -66.9 -54.99 16.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.864 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -153.93 -170.27 19.73 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.478 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 677' ' ' HIS . . . . . 0.488 ' CD2' HD23 ' A' ' 679' ' ' LEU . 2.5 t-160 -82.88 93.56 7.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.873 0.368 . . . . 0.0 110.867 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 678' ' ' VAL . . . . . 0.439 HG23 ' CE2' ' A' ' 698' ' ' PHE . 84.8 t -70.09 141.21 17.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.149 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 679' ' ' LEU . . . . . 0.488 HD23 ' CD2' ' A' ' 677' ' ' HIS . 12.1 mt -115.24 -59.75 1.97 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.902 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 680' ' ' TYR . . . . . 0.427 ' CE2' HG21 ' A' ' 695' ' ' VAL . 9.8 t80 -98.39 125.83 43.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.889 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -154.61 121.02 5.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.112 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -151.64 157.81 42.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.835 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 50.0 mm -104.34 103.89 15.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.121 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 179.857 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 10.7 mmpt? . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.82 0.343 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 41.05 30.55 0.4 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.466 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 17.7 p -137.38 128.24 27.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.884 0.373 . . . . 0.0 110.863 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -140.96 -150.56 5.42 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.525 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 695' ' ' VAL . . . . . 0.427 HG21 ' CE2' ' A' ' 680' ' ' TYR . 24.7 m -153.08 161.9 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.84 0.353 . . . . 0.0 111.11 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 82.1 t -149.06 114.81 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.122 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 8.3 ttpt -100.9 145.37 28.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 698' ' ' PHE . . . . . 0.439 ' CE2' HG23 ' A' ' 678' ' ' VAL . 93.4 m-85 -121.01 166.3 14.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.923 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 699' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -69.55 -41.17 76.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.941 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 11.5 m -116.45 151.28 46.78 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.712 0.768 . . . . 0.0 110.806 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.77 -44.72 1.91 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.712 2.274 . . . . 0.0 112.351 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -50.88 -33.74 25.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.891 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 53.9 t -63.11 -58.95 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.147 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -44.06 -58.4 2.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.133 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -46.49 -32.69 3.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.929 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 16.4 ttm180 -82.51 -40.12 21.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.832 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -67.23 -57.73 6.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.149 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 708' ' ' CYS . . . . . . . . . . . . . 21.5 p -38.57 -41.53 0.69 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.875 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -83.42 -44.54 14.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.88 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 56.7 mtp -57.44 -13.4 3.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 711' ' ' MET . . . . . 0.45 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 5.1 mmm -118.48 -29.26 5.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 712' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -39.04 105.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.918 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 89.16 26.87 24.86 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.496 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 714' ' ' MET . . . . . 0.442 ' N ' ' O ' ' A' ' 711' ' ' MET . 46.0 ttp -72.55 97.84 2.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.83 0.348 . . . . 0.0 110.895 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -53.79 99.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.899 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 716' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 719' ' ' ARG . 23.9 mt -99.92 129.8 46.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.899 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 717' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 716' ' ' LEU . 9.5 t 35.21 37.32 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.9 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 718' ' ' GLY . . . . . 0.424 ' C ' ' HG3' ' A' ' 719' ' ' ARG . . . 79.84 38.66 19.2 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.517 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 719' ' ' ARG . . . . . 0.5 ' N ' ' O ' ' A' ' 716' ' ' LEU . 25.1 mtp85 -148.45 113.66 5.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.791 0.329 . . . . 0.0 110.842 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -70.19 122.6 19.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.887 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 18.1 pt -99.0 150.6 4.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.109 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.03 99.71 9.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.884 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 5.3 t -102.59 130.14 53.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.126 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 64.8 mtm180 -157.85 159.7 36.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.9 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 725' ' ' ILE . . . . . . . . . . . . . 17.5 mm -53.34 136.6 14.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.13 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 14.5 t70 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.88 179.824 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 3.6 p . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.738 0.304 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -115.59 154.37 29.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.895 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 654' ' ' ILE . . . . . . . . . . . . . 43.5 pt -138.24 167.21 22.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.108 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -118.14 154.84 31.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.889 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 2.9 t -141.19 150.67 19.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.105 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -149.73 165.41 32.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.86 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 658' ' ' ASN . . . . . 0.456 ' ND2' HH11 ' A' ' 719' ' ' ARG . 0.2 OUTLIER 65.18 44.21 3.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.889 -179.942 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . . . . . . . . . 60.6 mt -97.44 143.8 26.82 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.619 0.723 . . . . 0.0 110.95 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -47.97 129.76 18.66 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.693 2.262 . . . . 0.0 112.355 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -48.93 -27.96 3.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.905 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -85.57 -28.71 24.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.85 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -38.62 119.75 0.87 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.861 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 75.6 p -100.23 171.36 7.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.17 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 665' ' ' TRP . . . . . 0.637 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 7.5 p-90 -66.86 -52.29 45.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.948 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 666' ' ' LYS . . . . . 0.637 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 4.3 tppp? -45.42 -47.29 13.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 25.6 mtm -62.95 -53.03 60.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.893 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 16.9 tp -44.46 -48.71 10.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.896 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 25.9 tttt -60.09 -71.16 0.14 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.864 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -49.61 -24.36 2.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.847 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 671' ' ' LYS . . . . . 0.404 ' CG ' ' HE2' ' A' ' 714' ' ' MET . 19.0 tptt -69.0 -42.4 76.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.884 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 672' ' ' PHE . . . . . 0.548 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 21.8 m-85 -87.13 -13.57 43.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -52.64 -39.35 61.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.884 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -48.65 -37.6 18.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.892 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 91.7 m -74.56 -54.96 6.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.87 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -160.04 -175.31 30.88 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.478 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 677' ' ' HIS . . . . . 0.492 ' CD2' HD23 ' A' ' 679' ' ' LEU . 5.2 t60 -71.24 116.76 11.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.851 0.358 . . . . 0.0 110.852 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 84.3 t -96.97 125.06 50.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.125 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 679' ' ' LEU . . . . . 0.492 HD23 ' CD2' ' A' ' 677' ' ' HIS . 17.5 mt -99.29 -62.4 1.24 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.929 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 680' ' ' TYR . . . . . 0.515 ' CE2' HG21 ' A' ' 695' ' ' VAL . 10.8 t80 -98.3 132.63 43.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.923 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -157.01 123.3 4.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.096 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -157.14 156.64 33.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.837 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 32.6 mm -97.35 102.16 13.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.13 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.906 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.783 0.325 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 48.22 32.35 9.56 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.495 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 30.6 p -132.94 129.61 38.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.863 0.363 . . . . 0.0 110.907 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -139.04 -173.32 12.95 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.442 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 695' ' ' VAL . . . . . 0.515 HG21 ' CE2' ' A' ' 680' ' ' TYR . 17.0 m -139.53 155.38 25.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.835 0.35 . . . . 0.0 111.141 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 696' ' ' VAL . . . . . 0.485 HG12 ' CZ ' ' A' ' 698' ' ' PHE . 89.9 t -143.48 121.51 6.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.084 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 15.5 tttt -105.28 143.35 33.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.899 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 698' ' ' PHE . . . . . 0.485 ' CZ ' HG12 ' A' ' 696' ' ' VAL . 97.2 m-85 -120.7 171.0 8.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 699' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -73.68 -44.7 55.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.866 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 29.9 m -112.92 149.63 41.58 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.636 0.731 . . . . 0.0 110.855 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -34.72 14.04 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.692 2.261 . . . . 0.0 112.356 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -57.95 -38.42 75.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.883 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 62.7 t -61.78 -49.77 82.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.125 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -51.85 -55.58 19.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.091 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -46.94 -25.47 0.79 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.911 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 706' ' ' ARG . . . . . 0.441 ' O ' ' N ' ' A' ' 709' ' ' ARG . 21.7 ttt180 -90.39 -62.34 1.48 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.827 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 707' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 706' ' ' ARG . . . -35.75 -39.79 0.16 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.105 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 708' ' ' CYS . . . . . . . . . . . . . 66.7 m -56.56 -47.08 80.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 709' ' ' ARG . . . . . 0.441 ' N ' ' O ' ' A' ' 706' ' ' ARG . 11.6 mtp180 -73.55 -32.89 64.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.864 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 33.3 mmm -71.84 -20.5 61.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.86 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 711' ' ' MET . . . . . 0.548 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 2.7 mmt -114.02 -10.65 12.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.857 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 712' ' ' ASN . . . . . 0.419 ' OD1' ' C ' ' A' ' 712' ' ' ASN . 28.8 t-20 -57.75 105.08 0.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.877 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 91.83 15.44 54.46 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.508 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 714' ' ' MET . . . . . 0.404 ' HE2' ' CG ' ' A' ' 671' ' ' LYS . 34.4 ttp -62.7 101.29 0.24 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.877 0.37 . . . . 0.0 110.869 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 4.6 mmmt -66.22 102.76 0.88 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.905 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 716' ' ' LEU . . . . . 0.494 ' O ' ' N ' ' A' ' 718' ' ' GLY . 23.3 mt -100.01 134.75 42.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.91 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 717' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 716' ' ' LEU . 7.3 t 35.12 31.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.889 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 718' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 716' ' ' LEU . . . 83.65 41.87 8.07 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.475 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 719' ' ' ARG . . . . . 0.485 ' N ' ' O ' ' A' ' 716' ' ' LEU . 2.7 mtt-85 -151.68 117.51 5.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.807 0.337 . . . . 0.0 110.853 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -72.88 125.79 28.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.904 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 721' ' ' ILE . . . . . 0.402 ' CD1' ' HB3' ' A' ' 714' ' ' MET . 41.4 pt -100.11 156.08 4.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.148 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -110.88 103.23 11.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.882 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 723' ' ' VAL . . . . . 0.436 HG23 ' CB ' ' A' ' 711' ' ' MET . 3.4 t -103.98 131.31 52.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.122 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 42.2 mtm-85 -158.18 161.09 37.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.858 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 725' ' ' ILE . . . . . . . . . . . . . 19.8 mm -60.3 131.08 24.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.162 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 6.7 t0 . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 179.854 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 2.8 p . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.783 0.325 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -85.83 148.71 25.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.952 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 654' ' ' ILE . . . . . . . . . . . . . 22.0 pt -134.32 174.29 13.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.121 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -125.79 157.44 37.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.88 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 3.4 t -143.58 151.07 16.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.105 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 27.3 mtp180 -146.62 162.54 38.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.885 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 658' ' ' ASN . . . . . 0.451 ' ND2' ' HB3' ' A' ' 719' ' ' ARG . 9.4 t30 69.19 31.16 4.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.852 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . . . . . . . . . 64.9 mt -82.14 144.44 50.75 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.628 0.728 . . . . 0.0 110.917 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -47.97 150.84 4.38 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.725 2.283 . . . . 0.0 112.326 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -71.26 -22.36 61.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.859 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -98.19 4.74 48.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.854 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 663' ' ' PHE . . . . . 0.412 ' CE2' ' HA ' ' A' ' 668' ' ' LEU . 3.2 t80 -72.62 118.55 15.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 43.3 p -100.45 169.84 8.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.141 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 665' ' ' TRP . . . . . 0.583 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 15.7 p-90 -57.43 -51.41 69.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.937 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 666' ' ' LYS . . . . . 0.583 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 5.3 tppp? -48.76 -60.06 3.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.885 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 22.5 mtm -51.21 -44.63 61.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.888 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 668' ' ' LEU . . . . . 0.412 ' HA ' ' CE2' ' A' ' 663' ' ' PHE . 12.3 tp -56.79 -44.27 81.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.916 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 29.1 ttmt -64.55 -67.85 0.4 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.27 -23.76 2.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.855 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? -69.85 -39.63 76.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.944 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 672' ' ' PHE . . . . . 0.549 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 27.0 m-85 -90.87 -8.39 49.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.899 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -59.41 -27.07 65.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.909 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -62.16 -37.18 84.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.934 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 675' ' ' CYS . . . . . 0.462 ' CB ' ' HB1' ' A' ' 707' ' ' ALA . 3.7 m -73.18 -41.4 63.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.879 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -171.02 -167.24 31.06 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.48 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 677' ' ' HIS . . . . . 0.513 ' CD2' HD23 ' A' ' 679' ' ' LEU . 3.0 t-160 -83.18 106.07 14.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.792 0.329 . . . . 0.0 110.86 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 69.0 t -84.83 144.43 9.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.102 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 679' ' ' LEU . . . . . 0.513 HD23 ' CD2' ' A' ' 677' ' ' HIS . 16.0 mt -119.15 -61.12 1.67 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.939 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 680' ' ' TYR . . . . . 0.52 ' CE2' HG22 ' A' ' 695' ' ' VAL . 5.5 t80 -99.77 125.3 45.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.899 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -149.29 122.12 8.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.058 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -150.95 157.79 43.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.822 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 33.0 mm -104.71 105.0 17.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.115 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.831 179.885 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 24.3 mmmt . . . . . 0 N--CA 1.458 -0.061 0 CA-C-O 120.866 0.365 . . . . 0.0 110.922 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 45.65 38.37 7.4 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.477 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 29.3 p -139.46 130.44 26.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.843 0.354 . . . . 0.0 110.892 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -147.93 -174.69 19.99 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.502 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 695' ' ' VAL . . . . . 0.52 HG22 ' CE2' ' A' ' 680' ' ' TYR . 14.9 m -133.63 164.09 35.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.848 0.356 . . . . 0.0 111.134 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 696' ' ' VAL . . . . . 0.543 HG22 ' CD1' ' A' ' 672' ' ' PHE . 58.3 t -148.91 114.22 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.123 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 27.1 tttt -94.14 146.48 23.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.966 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -122.34 165.79 15.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.896 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 699' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -68.16 -41.82 80.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.918 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 14.3 m -116.21 152.32 47.73 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.684 0.754 . . . . 0.0 110.84 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -39.54 6.39 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.659 2.24 . . . . 0.0 112.339 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -53.57 -47.67 69.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.926 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 69.2 t -50.55 -55.21 6.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.112 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -41.4 -65.89 0.39 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.124 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -42.65 -38.1 1.93 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.936 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 706' ' ' ARG . . . . . 0.401 ' O ' ' C ' ' A' ' 707' ' ' ALA . 12.6 ttt180 -73.91 -65.95 0.77 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.878 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 707' ' ' ALA . . . . . 0.462 ' HB1' ' CB ' ' A' ' 675' ' ' CYS . . . -36.9 -55.23 0.91 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.065 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 708' ' ' CYS . . . . . 0.492 ' O ' ' N ' ' A' ' 712' ' ' ASN . 0.9 OUTLIER -45.31 -51.2 11.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.876 -179.894 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 12.8 mtp180 -66.72 -34.44 77.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 78.1 mtp -73.33 -21.83 60.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.9 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 711' ' ' MET . . . . . 0.549 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 3.8 mmt -108.67 -14.78 14.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.844 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 712' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 708' ' ' CYS . 1.2 p-10 -50.16 121.18 5.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.918 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 70.38 26.48 74.12 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.455 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 714' ' ' MET . . . . . . . . . . . . . 30.5 ttp -69.44 103.53 2.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.794 0.331 . . . . 0.0 110.888 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 15.6 mmtt -59.93 101.41 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.924 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 716' ' ' LEU . . . . . 0.497 ' O ' ' N ' ' A' ' 719' ' ' ARG . 31.4 mt -100.29 126.06 46.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.901 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 717' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 716' ' ' LEU . 3.4 t 36.57 39.79 0.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.876 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 718' ' ' GLY . . . . . 0.427 ' C ' ' HG3' ' A' ' 719' ' ' ARG . . . 78.45 35.03 34.17 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.493 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 719' ' ' ARG . . . . . 0.497 ' N ' ' O ' ' A' ' 716' ' ' LEU . 5.0 mtt-85 -146.63 111.02 5.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.75 0.31 . . . . 0.0 110.869 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -67.76 123.01 19.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.884 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 26.6 pt -99.27 149.49 5.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.088 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -106.14 112.7 25.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.824 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 723' ' ' VAL . . . . . 0.44 ' CG1' ' HA ' ' A' ' 708' ' ' CYS . 2.7 t -105.8 138.57 30.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.113 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 26.5 ptt180 -154.25 171.56 19.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 725' ' ' ILE . . . . . . . . . . . . . 19.3 mm -89.98 137.0 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.14 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 10.6 t0 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.885 179.842 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 2.4 p . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.715 0.293 . . . . 0.0 110.845 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -109.86 150.72 28.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.893 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 654' ' ' ILE . . . . . 0.549 HD12 ' CE2' ' A' ' 672' ' ' PHE . 23.0 pt -139.64 163.8 24.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.171 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -117.6 144.54 45.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.898 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 10.1 t -131.92 150.63 34.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.16 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -146.54 160.31 42.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.849 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 658' ' ' ASN . . . . . 0.466 ' ND2' ' HB3' ' A' ' 719' ' ' ARG . 2.7 t30 65.88 53.81 1.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.935 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.465 HD22 ' CD2' ' A' ' 663' ' ' PHE . 33.4 mt -102.74 143.48 26.7 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.58 0.705 . . . . 0.0 110.924 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 660' ' ' PRO . . . . . 0.488 ' O ' ' N ' ' A' ' 663' ' ' PHE . 65.9 Cg_exo -48.01 125.13 11.13 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.706 2.271 . . . . 0.0 112.32 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -40.63 -37.87 0.79 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.903 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 662' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 663' ' ' PHE . 2.2 m-20 -74.99 -35.07 62.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 663' ' ' PHE . . . . . 0.488 ' N ' ' O ' ' A' ' 660' ' ' PRO . 3.7 t80 -37.5 115.24 0.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.893 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 78.9 p -102.79 178.08 4.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.136 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 665' ' ' TRP . . . . . 0.647 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 3.4 p-90 -64.13 -48.27 76.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.908 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 666' ' ' LYS . . . . . 0.647 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 18.8 tptm -49.0 -56.88 7.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.898 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 32.4 mtm -55.99 -51.48 67.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.846 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 15.1 tp -45.34 -42.84 10.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.905 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -66.55 -70.72 0.23 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -48.51 -24.93 1.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.854 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 18.4 tptt -68.91 -46.08 69.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.934 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 672' ' ' PHE . . . . . 0.549 ' CE2' HD12 ' A' ' 654' ' ' ILE . 22.4 m-85 -83.38 -15.42 49.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.867 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -49.18 -41.4 36.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.9 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -45.64 -37.11 5.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.893 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 675' ' ' CYS . . . . . 0.427 ' CB ' ' HB1' ' A' ' 707' ' ' ALA . 34.1 m -73.62 -48.2 34.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.871 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -164.53 -164.21 19.31 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.779 -0.725 . . . . 0.0 112.504 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 677' ' ' HIS . . . . . 0.506 ' CD2' HD21 ' A' ' 679' ' ' LEU . 3.4 t-160 -85.48 93.6 8.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.806 0.336 . . . . 0.0 110.86 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 71.1 t -69.37 133.39 31.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.114 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 679' ' ' LEU . . . . . 0.506 HD21 ' CD2' ' A' ' 677' ' ' HIS . 10.7 mt -108.67 -60.18 1.78 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.946 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -99.62 130.25 45.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.918 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -156.01 125.76 6.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.107 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -154.62 156.55 36.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.822 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 28.9 mm -105.24 108.48 25.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.166 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.885 179.876 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 14.1 mmmt . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.813 0.339 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 81.91 11.67 82.33 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.521 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 5.6 p -119.92 139.48 52.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.858 0.361 . . . . 0.0 110.88 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -148.38 -158.07 7.82 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.475 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 15.6 m -151.0 156.98 5.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.866 0.365 . . . . 0.0 111.125 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 696' ' ' VAL . . . . . 0.447 HG23 ' CD1' ' A' ' 672' ' ' PHE . 85.9 t -144.89 121.05 4.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.147 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 9.9 ttpp -104.84 147.41 27.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.911 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -123.48 168.4 12.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.893 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 699' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -68.55 -48.24 64.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.858 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 70.8 m -111.25 148.1 38.03 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.66 0.743 . . . . 0.0 110.819 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -23.52 30.6 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.657 2.238 . . . . 0.0 112.359 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 702' ' ' GLU . . . . . 0.442 ' HG3' ' N ' ' A' ' 703' ' ' VAL . 6.8 pt-20 -69.26 -34.51 74.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.905 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 703' ' ' VAL . . . . . 0.442 ' N ' ' HG3' ' A' ' 702' ' ' GLU . 24.7 t -61.19 -59.86 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.149 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -41.3 -61.41 1.03 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.116 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -41.55 -31.74 0.3 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.861 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -80.3 -48.93 12.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.855 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 707' ' ' ALA . . . . . 0.427 ' HB1' ' CB ' ' A' ' 675' ' ' CYS . . . -60.39 -53.04 62.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.109 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 708' ' ' CYS . . . . . 0.434 ' SG ' ' N ' ' A' ' 709' ' ' ARG . 1.8 p -39.15 -41.69 0.86 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.884 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 709' ' ' ARG . . . . . 0.434 ' N ' ' SG ' ' A' ' 708' ' ' CYS . 12.6 mtt85 -84.51 -39.84 18.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.839 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 18.1 mtm -68.03 -7.74 31.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.853 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 711' ' ' MET . . . . . 0.545 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 14.2 mmm -121.57 -30.26 4.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.889 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 712' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -45.54 107.09 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.925 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 90.03 25.98 25.37 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.479 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 714' ' ' MET . . . . . 0.46 ' CE ' ' HE2' ' A' ' 711' ' ' MET . 41.9 ttp -75.3 100.31 4.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.864 0.364 . . . . 0.0 110.874 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 18.3 mmtt -56.27 102.12 0.07 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.899 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 716' ' ' LEU . . . . . 0.459 ' O ' ' N ' ' A' ' 719' ' ' ARG . 34.6 mt -99.86 121.97 42.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.879 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 717' ' ' SER . . . . . . . . . . . . . 36.8 t 37.62 41.83 0.33 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.846 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 718' ' ' GLY . . . . . 0.418 ' C ' ' HG3' ' A' ' 719' ' ' ARG . . . 77.68 34.27 39.83 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.482 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 719' ' ' ARG . . . . . 0.466 ' HB3' ' ND2' ' A' ' 658' ' ' ASN . 1.9 mtp-105 -146.01 109.6 4.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.777 0.323 . . . . 0.0 110.887 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -69.99 124.97 25.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.897 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 31.4 pt -98.9 152.33 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.13 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -106.08 98.27 7.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.869 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 5.1 t -101.69 132.0 48.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.137 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 34.5 mtp180 -156.0 167.58 29.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.857 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 725' ' ' ILE . . . . . . . . . . . . . 33.9 mm -73.92 131.62 34.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.103 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 35.5 t0 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 179.853 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 25.5 p . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.731 0.3 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -90.06 146.36 24.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.918 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 654' ' ' ILE . . . . . . . . . . . . . 40.5 pt -132.91 176.06 9.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.113 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -127.53 159.76 33.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.904 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 21.9 t -146.13 148.68 16.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.116 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 32.0 mtp180 -146.85 162.99 37.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.877 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 658' ' ' ASN . . . . . 0.424 ' N ' ' O ' ' A' ' 692' ' ' GLY . 2.6 t30 65.97 46.41 2.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.922 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . . . . . . . . . 27.8 mt -97.58 142.02 23.9 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.631 0.729 . . . . 0.0 110.939 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -48.01 127.91 15.65 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.678 2.252 . . . . 0.0 112.342 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -39.91 -50.48 2.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.885 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 662' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 663' ' ' PHE . 0.9 OUTLIER -61.79 -38.16 87.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.83 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 663' ' ' PHE . . . . . 0.465 ' HA ' ' CE ' ' A' ' 667' ' ' MET . 4.0 t80 -35.45 116.26 0.35 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.844 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 78.6 p -106.15 174.82 5.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.135 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 665' ' ' TRP . . . . . 0.647 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 3.3 p-90 -62.1 -51.8 66.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.911 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 666' ' ' LYS . . . . . 0.647 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 1.7 tppp? -45.15 -48.93 12.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.884 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 667' ' ' MET . . . . . 0.465 ' CE ' ' HA ' ' A' ' 663' ' ' PHE . 24.3 mtm -64.3 -52.1 60.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.91 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 15.3 tp -43.52 -45.27 6.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -64.61 -70.74 0.21 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.885 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -48.49 -21.48 0.57 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.855 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 17.2 tptt -72.81 -43.54 62.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.859 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 672' ' ' PHE . . . . . 0.521 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 25.8 m-85 -86.62 -15.95 38.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.9 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -50.38 -38.75 44.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.896 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -46.83 -39.94 12.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.888 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 62.8 m -67.65 -60.46 2.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.879 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -152.7 -157.59 8.08 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.524 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -87.77 100.72 13.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.791 0.329 . . . . 0.0 110.899 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 98.1 t -79.55 140.91 16.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.167 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 12.8 mt -117.29 -60.03 1.88 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.88 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 680' ' ' TYR . . . . . 0.451 ' CE2' HG22 ' A' ' 695' ' ' VAL . 7.9 t80 -99.46 126.59 45.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.974 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -153.4 122.51 6.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.103 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -149.67 164.8 34.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 27.3 mm -114.72 101.38 12.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.116 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.878 179.868 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.847 0.356 . . . . 0.0 110.893 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 692' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 658' ' ' ASN . . . 39.15 39.1 0.93 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.49 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 31.3 p -138.09 139.43 39.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.896 0.379 . . . . 0.0 110.858 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -158.7 -173.65 27.38 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.434 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 695' ' ' VAL . . . . . 0.451 HG22 ' CE2' ' A' ' 680' ' ' TYR . 27.0 m -134.13 164.25 34.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.882 0.372 . . . . 0.0 111.114 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 696' ' ' VAL . . . . . 0.502 HG11 ' CE2' ' A' ' 698' ' ' PHE . 85.5 t -148.94 116.91 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.079 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 11.8 tttp -101.24 140.36 35.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 698' ' ' PHE . . . . . 0.502 ' CE2' HG11 ' A' ' 696' ' ' VAL . 96.4 m-85 -116.34 173.79 6.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.871 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 699' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -73.19 -48.47 34.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.903 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 14.0 m -109.01 149.53 39.75 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.664 0.745 . . . . 0.0 110.824 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 -6.88 19.64 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.661 2.24 . . . . 0.0 112.327 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -86.17 -46.79 10.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.892 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 88.9 t -50.88 -42.16 22.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.182 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -56.63 -59.14 5.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.093 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -47.48 -38.76 14.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 16.5 ttt-85 -70.67 -52.95 17.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.84 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -53.64 -42.24 67.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.074 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 708' ' ' CYS . . . . . . . . . . . . . 1.1 t -47.49 -43.98 24.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 3.5 mtt-85 -81.91 -45.76 15.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.899 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 13.9 mtm -57.09 -17.31 9.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.875 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 711' ' ' MET . . . . . 0.521 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 4.2 mmt -113.8 -34.5 5.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.881 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 712' ' ' ASN . . . . . 0.437 ' C ' ' O ' ' A' ' 711' ' ' MET . 3.9 t30 -35.02 117.24 0.38 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.863 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 72.38 31.95 62.88 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.479 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 714' ' ' MET . . . . . 0.41 ' N ' ' O ' ' A' ' 711' ' ' MET . 20.1 ttp -74.16 91.53 2.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.887 0.375 . . . . 0.0 110.869 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 715' ' ' LYS . . . . . 0.483 ' CD ' ' HG3' ' A' ' 720' ' ' GLU . 0.7 OUTLIER -50.84 99.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.898 179.979 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 716' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 719' ' ' ARG . 30.4 mt -99.43 117.82 34.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.908 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 717' ' ' SER . . . . . . . . . . . . . 1.5 t 41.04 37.27 0.53 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.854 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 84.1 25.26 45.2 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.505 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 719' ' ' ARG . . . . . 0.481 ' N ' ' O ' ' A' ' 716' ' ' LEU . 39.2 mtt85 -138.73 106.38 5.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.774 0.321 . . . . 0.0 110.836 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 720' ' ' GLU . . . . . 0.483 ' HG3' ' CD ' ' A' ' 715' ' ' LYS . 30.2 mt-10 -72.45 127.94 34.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.875 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 721' ' ' ILE . . . . . 0.45 HD11 ' CG2' ' A' ' 723' ' ' VAL . 43.1 pt -98.07 159.76 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.089 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -111.33 99.44 8.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.834 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 723' ' ' VAL . . . . . 0.45 ' CG2' HD11 ' A' ' 721' ' ' ILE . 12.7 t -98.97 134.03 39.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.154 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 63.5 mtm180 -156.9 174.91 14.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.844 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 725' ' ' ILE . . . . . . . . . . . . . 25.4 mm -77.28 139.3 18.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.126 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 8.1 t70 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.852 179.852 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 25.7 p . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.791 0.329 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -85.71 144.68 27.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.937 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 654' ' ' ILE . . . . . 0.545 HD12 ' CE2' ' A' ' 672' ' ' PHE . 35.6 pt -131.47 174.64 12.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.083 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 655' ' ' PHE . . . . . 0.4 ' CD2' HG13 ' A' ' 695' ' ' VAL . 7.7 t80 -131.31 148.75 52.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.864 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 11.2 t -131.31 148.47 32.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.129 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -143.89 157.84 44.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.881 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 658' ' ' ASN . . . . . . . . . . . . . 4.9 t30 71.2 46.22 0.45 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.904 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 659' ' ' LEU . . . . . 0.451 HD21 ' CD1' ' A' ' 716' ' ' LEU . 52.5 mt -94.71 142.47 24.77 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.62 0.724 . . . . 0.0 110.886 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -47.95 127.84 15.38 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.666 2.244 . . . . 0.0 112.348 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -44.18 -37.34 3.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.85 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 662' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 663' ' ' PHE . 51.3 m-20 -75.26 -35.56 61.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.864 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 663' ' ' PHE . . . . . 0.565 ' CD1' ' HE1' ' A' ' 667' ' ' MET . 3.8 t80 -34.68 142.9 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.862 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 45.1 p -127.38 172.51 10.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.179 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 665' ' ' TRP . . . . . 0.614 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 6.0 p-90 -63.46 -50.27 70.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.929 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 666' ' ' LYS . . . . . 0.614 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 5.0 tppp? -46.42 -51.0 15.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.867 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 667' ' ' MET . . . . . 0.565 ' HE1' ' CD1' ' A' ' 663' ' ' PHE . 32.3 mtm -62.06 -46.85 87.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.889 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 39.3 tp -48.9 -46.09 42.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.936 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 25.3 ttmt -65.02 -72.97 0.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.917 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -46.17 -25.71 0.64 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.86 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 671' ' ' LYS . . . . . 0.403 ' HG3' ' CE ' ' A' ' 711' ' ' MET . 10.1 tppt? -67.9 -51.66 45.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.899 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 672' ' ' PHE . . . . . 0.565 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 23.7 m-85 -77.77 -16.99 58.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.84 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -48.93 -33.41 10.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -55.83 -39.28 71.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.884 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 675' ' ' CYS . . . . . 0.453 ' CB ' ' HB3' ' A' ' 707' ' ' ALA . 60.4 m -71.58 -41.71 68.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.899 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -174.75 170.84 44.01 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.436 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 677' ' ' HIS . . . . . 0.518 ' CD2' HD22 ' A' ' 679' ' ' LEU . 2.9 t-160 -62.01 103.71 0.39 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.805 0.336 . . . . 0.0 110.861 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 65.1 t -80.32 147.62 6.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.085 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 679' ' ' LEU . . . . . 0.518 HD22 ' CD2' ' A' ' 677' ' ' HIS . 13.7 mt -120.37 -63.83 1.32 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.913 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 680' ' ' TYR . . . . . 0.42 ' HB3' ' CB ' ' A' ' 697' ' ' LYS . 10.1 t80 -98.66 125.32 43.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -152.78 124.59 7.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.131 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -157.41 156.68 32.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.873 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 40.9 mm -96.23 99.28 8.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.152 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.878 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt . . . . . 0 N--CA 1.457 -0.081 0 CA-C-O 120.842 0.354 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 51.89 37.09 43.49 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.448 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 27.2 p -137.81 149.76 46.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.875 0.369 . . . . 0.0 110.882 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -155.68 -175.71 27.01 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.516 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 695' ' ' VAL . . . . . 0.4 HG13 ' CD2' ' A' ' 655' ' ' PHE . 13.8 m -138.25 156.32 30.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.812 0.339 . . . . 0.0 111.162 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 90.7 t -142.96 118.0 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.115 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 697' ' ' LYS . . . . . 0.42 ' CB ' ' HB3' ' A' ' 680' ' ' TYR . 23.7 tttp -101.96 137.39 40.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.88 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -113.49 166.65 11.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.871 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 699' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -68.53 -44.92 73.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.853 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 3.7 m -113.56 151.04 44.19 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.658 0.742 . . . . 0.0 110.869 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -36.7 10.21 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.657 2.238 . . . . 0.0 112.335 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 702' ' ' GLU . . . . . 0.443 ' C ' ' OE1' ' A' ' 702' ' ' GLU . 0.6 OUTLIER -56.81 -40.56 76.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.932 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 79.6 t -53.8 -57.07 6.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.087 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -43.23 -63.25 0.85 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.08 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -41.4 -29.96 0.17 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.883 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 19.8 ttm-85 -82.62 -47.79 11.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.846 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 707' ' ' ALA . . . . . 0.453 ' HB3' ' CB ' ' A' ' 675' ' ' CYS . . . -62.9 -59.34 4.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.06 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 708' ' ' CYS . . . . . 0.421 ' C ' ' O ' ' A' ' 707' ' ' ALA . 11.5 p -36.18 -36.69 0.1 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.877 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 6.3 mtt180 -85.29 -46.16 11.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.872 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 18.7 mtm -61.89 -9.45 6.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.886 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 711' ' ' MET . . . . . 0.565 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 6.3 mmm -120.2 -17.72 8.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.881 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 712' ' ' ASN . . . . . 0.404 ' OD1' ' C ' ' A' ' 712' ' ' ASN . 3.5 t-20 -53.5 117.41 3.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.905 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 80.8 10.4 85.16 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.533 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 714' ' ' MET . . . . . 0.473 ' HB3' ' CD1' ' A' ' 721' ' ' ILE . 46.3 ttp -61.32 91.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.857 0.36 . . . . 0.0 110.9 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 2.9 mttp -58.56 112.0 1.45 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.893 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 716' ' ' LEU . . . . . 0.451 ' CD1' HD21 ' A' ' 659' ' ' LEU . 30.5 mt -100.19 127.46 46.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 717' ' ' SER . . . . . . . . . . . . . 31.1 t 37.66 31.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.861 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 718' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 716' ' ' LEU . . . 89.3 43.11 5.36 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.463 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 719' ' ' ARG . . . . . . . . . . . . . 19.0 mtt180 -152.02 107.37 3.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.764 0.316 . . . . 0.0 110.886 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -62.69 124.22 20.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.884 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 721' ' ' ILE . . . . . 0.473 ' CD1' ' HB3' ' A' ' 714' ' ' MET . 18.9 pt -100.09 151.18 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.161 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -111.1 97.79 7.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.853 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 8.1 t -97.35 136.11 29.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.143 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 79.8 mtt-85 -156.18 161.95 40.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 725' ' ' ILE . . . . . . . . . . . . . 23.0 mm -70.23 131.73 33.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.123 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 35.9 t0 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.823 179.875 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 645' ' ' SER . . . . . . . . . . . . . 7.7 t -164.6 172.3 13.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.876 0.37 . . . . 0.0 110.857 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 646' ' ' SER . . . . . . . . . . . . . 1.3 t -125.16 42.44 3.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.869 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -98.57 -150.46 25.99 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.48 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 49.6 m -56.16 129.3 39.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.901 0.382 . . . . 0.0 110.856 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 69.0 p -73.44 95.8 2.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.871 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 104.93 105.89 3.07 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.467 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 651' ' ' ALA . . . . . 0.428 ' HB2' ' CG2' ' A' ' 725' ' ' ILE . . . -85.79 90.4 8.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.769 0.318 . . . . 0.0 111.113 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 18.8 p -100.23 -29.87 12.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.83 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -93.24 153.23 18.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.882 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 654' ' ' ILE . . . . . 0.441 HD13 ' CE2' ' A' ' 672' ' ' PHE . 32.7 pt -136.51 177.75 5.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.157 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -130.56 149.56 52.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.875 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 3.3 t -134.58 151.89 32.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.136 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 38.1 mtt85 -148.39 161.99 40.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 658' ' ' ASN . . . . . 0.47 ' ND2' ' HB3' ' A' ' 719' ' ' ARG . 4.6 t30 65.27 47.97 2.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.505 HD23 ' CE2' ' A' ' 663' ' ' PHE . 26.3 mt -96.98 143.65 26.48 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.599 0.714 . . . . 0.0 110.942 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 660' ' ' PRO . . . . . 0.445 ' O ' ' N ' ' A' ' 663' ' ' PHE . 65.5 Cg_exo -47.95 127.82 15.34 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.685 2.257 . . . . 0.0 112.344 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -45.45 -30.96 1.53 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.881 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -83.8 -28.36 28.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.896 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 663' ' ' PHE . . . . . 0.505 ' CE2' HD23 ' A' ' 659' ' ' LEU . 3.8 t80 -40.62 123.14 1.79 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.924 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 80.4 p -106.02 176.77 5.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.138 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 665' ' ' TRP . . . . . 0.648 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 6.6 p-90 -68.97 -50.66 47.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.888 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 666' ' ' LYS . . . . . 0.648 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 2.8 tppp? -47.29 -50.73 20.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.858 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 31.4 mtm -63.37 -46.52 86.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.875 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 14.1 tp -51.52 -42.53 61.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.9 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 29.3 tttm -65.2 -74.15 0.11 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.873 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -46.01 -23.68 0.33 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.874 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 671' ' ' LYS . . . . . 0.43 ' HG3' ' CE ' ' A' ' 711' ' ' MET . 7.5 tppt? -69.88 -40.37 75.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.91 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 672' ' ' PHE . . . . . 0.449 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 20.6 m-85 -90.14 -9.3 48.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -57.63 -34.97 69.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -43.16 -44.76 5.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.903 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 9.4 t -66.98 -63.94 0.96 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.871 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -145.83 -155.06 6.35 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.462 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -93.08 102.83 15.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.88 0.372 . . . . 0.0 110.861 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 43.1 t -75.86 132.88 32.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.073 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 10.2 mt -107.3 -61.53 1.54 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.887 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -97.91 129.61 44.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.918 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -155.48 123.07 5.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.138 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -152.17 165.52 34.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.83 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 18.5 mm -115.8 117.2 54.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.13 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -60.05 137.59 58.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.855 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 685' ' ' MET . . . . . . . . . . . . . 29.4 mtp -139.74 156.16 46.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.913 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -131.94 114.38 14.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.902 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 687' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 53.14 35.36 19.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.937 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 688' ' ' GLY . . . . . . . . . . . . . . . 78.18 36.42 31.33 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.462 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 4.9 mmmm -137.99 119.74 15.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.776 0.322 . . . . 0.0 110.883 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 690' ' ' SER . . . . . . . . . . . . . 4.0 m -57.29 136.91 56.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.796 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 4.6 mmtp -102.71 -15.04 16.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.866 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 80.91 13.36 81.4 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.496 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 8.9 p -126.81 131.89 51.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.835 0.35 . . . . 0.0 110.931 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -139.75 -170.87 12.09 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.518 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 5.2 m -141.07 153.5 20.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.865 0.364 . . . . 0.0 111.116 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 98.9 t -139.64 124.31 20.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.091 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 23.9 tttt -107.57 139.72 41.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.885 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -115.55 172.27 7.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.923 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 699' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -75.52 -44.07 45.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.844 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 58.3 m -107.36 147.71 35.77 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.66 0.743 . . . . 0.0 110.843 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -32.97 17.55 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.649 2.233 . . . . 0.0 112.375 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -63.07 -42.92 99.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.891 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 95.5 t -51.14 -60.24 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.149 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -42.13 -59.44 1.77 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.098 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 22.0 mt-10 -43.55 -31.23 0.69 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.89 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 26.2 ttm-85 -81.99 -58.1 3.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.867 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -44.93 -30.15 0.95 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.095 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 708' ' ' CYS . . . . . 0.49 ' O ' ' N ' ' A' ' 712' ' ' ASN . 1.4 t -56.43 -63.96 1.02 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.883 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.15 -41.25 94.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.88 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 58.4 mtp -55.34 -33.6 63.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 711' ' ' MET . . . . . 0.449 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 3.7 mmt -105.8 -14.46 15.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.856 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 712' ' ' ASN . . . . . 0.49 ' N ' ' O ' ' A' ' 708' ' ' CYS . 40.1 t-20 -54.22 109.72 0.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.889 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 83.65 24.06 51.28 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.487 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 714' ' ' MET . . . . . 0.436 ' CE ' ' CE ' ' A' ' 711' ' ' MET . 38.2 ttp -72.16 98.91 2.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.825 0.345 . . . . 0.0 110.854 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 5.5 mmtm -51.94 101.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.887 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 716' ' ' LEU . . . . . 0.464 ' O ' ' N ' ' A' ' 719' ' ' ARG . 24.6 mt -99.78 120.02 39.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.926 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 717' ' ' SER . . . . . . . . . . . . . 20.4 t 40.27 43.67 1.46 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.874 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 75.6 26.52 65.15 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.521 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 719' ' ' ARG . . . . . 0.47 ' HB3' ' ND2' ' A' ' 658' ' ' ASN . 28.5 mtp180 -140.16 110.95 6.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.777 0.322 . . . . 0.0 110.89 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -68.2 127.84 34.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.933 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 26.4 pt -99.69 151.41 4.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.137 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -106.11 99.88 9.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.878 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 723' ' ' VAL . . . . . 0.425 HG23 ' CB ' ' A' ' 711' ' ' MET . 4.4 t -97.53 135.77 30.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.141 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 -158.21 163.97 36.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.876 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 725' ' ' ILE . . . . . 0.428 ' CG2' ' HB2' ' A' ' 651' ' ' ALA . 31.9 mm -79.27 134.86 26.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.127 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -89.05 116.86 27.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 727' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 -91.4 -24.25 19.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.867 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 728' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -114.36 71.36 0.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 729' ' ' ALA . . . . . . . . . . . . . . . -107.97 24.5 12.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.094 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 45.8 t -96.18 104.02 15.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.864 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 731' ' ' GLY . . . . . . . . . . . . . . . 86.53 177.33 49.54 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.514 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 732' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 144.25 53.68 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.729 2.286 . . . . 0.0 112.339 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 733' ' ' SER . . . . . . . . . . . . . 31.1 t -115.17 86.37 2.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.902 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 734' ' ' SER . . . . . . . . . . . . . 22.8 t -165.13 132.82 3.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.895 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 735' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.48 -179.971 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 645' ' ' SER . . . . . . . . . . . . . 3.2 m -83.53 166.36 18.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.881 0.372 . . . . 0.0 110.868 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 646' ' ' SER . . . . . . . . . . . . . 88.8 p -159.99 124.04 3.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.867 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . 169.58 111.27 0.24 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.503 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 9.8 m -119.14 127.6 53.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.865 0.364 . . . . 0.0 110.826 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 67.3 m -115.29 168.8 9.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.876 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . -66.41 92.68 0.18 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.52 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 651' ' ' ALA . . . . . 0.448 ' HB3' ' CG2' ' A' ' 725' ' ' ILE . . . -81.78 55.39 2.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.789 0.328 . . . . 0.0 111.073 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 29.8 m -81.36 -20.5 40.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.911 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -94.53 143.1 26.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.932 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 654' ' ' ILE . . . . . 0.444 HD13 ' CE2' ' A' ' 672' ' ' PHE . 36.3 pt -132.94 174.97 12.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.154 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -121.09 158.58 27.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.832 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 21.9 t -147.01 146.47 18.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.095 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 65.6 mtm180 -146.42 157.86 43.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.87 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 658' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 71.17 50.17 0.31 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.853 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . . . . . . . . . 29.0 mt -100.59 143.83 27.3 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.615 0.722 . . . . 0.0 110.872 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 660' ' ' PRO . . . . . 0.483 ' O ' ' N ' ' A' ' 663' ' ' PHE . 65.8 Cg_exo -47.97 124.55 10.23 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.684 2.256 . . . . 0.0 112.331 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -42.37 -36.89 1.4 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.828 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -76.0 -31.5 58.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.881 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 663' ' ' PHE . . . . . 0.483 ' N ' ' O ' ' A' ' 660' ' ' PRO . 3.8 t80 -38.85 128.4 1.57 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.863 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 72.1 p -113.18 174.99 5.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.139 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 665' ' ' TRP . . . . . 0.644 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 5.3 p-90 -64.35 -51.66 62.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.897 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 666' ' ' LYS . . . . . 0.644 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 7.4 tppt? -45.42 -53.31 8.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.877 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 667' ' ' MET . . . . . 0.42 ' HE1' ' CD1' ' A' ' 663' ' ' PHE . 28.2 mtm -58.05 -54.38 47.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.892 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 15.3 tp -41.85 -49.72 4.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.881 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -60.66 -74.2 0.08 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.913 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -46.73 -23.3 0.4 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.9 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 10.3 tptt -70.83 -45.43 64.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.892 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 672' ' ' PHE . . . . . 0.444 ' CE2' HD13 ' A' ' 654' ' ' ILE . 23.4 m-85 -84.57 -11.58 55.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.908 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -54.57 -36.04 63.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.876 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -52.79 -32.08 42.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 10.2 m -80.9 -49.33 11.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.894 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -164.21 168.92 38.85 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.482 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 677' ' ' HIS . . . . . 0.496 ' CD2' HD21 ' A' ' 679' ' ' LEU . 3.0 t-160 -61.95 101.08 0.18 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.836 0.35 . . . . 0.0 110.85 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 73.5 t -80.35 132.83 30.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.114 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 679' ' ' LEU . . . . . 0.496 HD21 ' CD2' ' A' ' 677' ' ' HIS . 13.3 mt -107.47 -61.85 1.5 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.89 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 680' ' ' TYR . . . . . 0.539 ' CE2' HG23 ' A' ' 695' ' ' VAL . 6.5 t80 -95.79 130.15 42.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.922 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -157.77 128.45 6.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.114 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -161.12 156.93 25.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.872 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 30.5 mm -102.11 111.97 33.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.121 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -64.05 134.33 54.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.912 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 685' ' ' MET . . . . . . . . . . . . . 23.6 mtp -132.87 147.26 52.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.873 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -118.92 88.05 2.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.889 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 687' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 70.98 48.68 0.37 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.86 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 688' ' ' GLY . . . . . . . . . . . . . . . 62.92 36.63 93.69 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.494 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 689' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 690' ' ' SER . 6.0 mtmp? -134.31 87.5 2.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.751 0.31 . . . . 0.0 110.901 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 690' ' ' SER . . . . . 0.403 ' C ' ' O ' ' A' ' 689' ' ' LYS . 19.9 t -37.69 128.3 1.15 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.899 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 25.0 mmmt -102.54 8.45 39.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.904 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 59.25 18.7 43.44 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.506 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 19.5 p -126.13 151.0 47.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.834 0.349 . . . . 0.0 110.889 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -155.9 -152.0 6.09 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.487 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . 0.539 HG23 ' CE2' ' A' ' 680' ' ' TYR . 15.3 m -155.84 152.4 8.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.831 0.348 . . . . 0.0 111.143 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 99.2 t -141.7 120.06 9.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.078 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 14.4 ttpt -104.87 138.1 41.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.902 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 698' ' ' PHE . . . . . 0.497 ' CD2' HG11 ' A' ' 703' ' ' VAL . 97.4 m-85 -113.95 173.87 6.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.903 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 699' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -75.06 -36.79 61.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.913 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 69.0 p -124.57 151.25 67.03 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.636 0.731 . . . . 0.0 110.873 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -30.27 22.63 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.681 2.254 . . . . 0.0 112.357 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -61.68 -39.0 89.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.844 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 703' ' ' VAL . . . . . 0.497 HG11 ' CD2' ' A' ' 698' ' ' PHE . 82.6 t -66.23 -47.21 85.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.086 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -51.47 -47.12 63.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.112 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -55.45 -43.12 75.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.901 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 22.0 ttm180 -68.92 -54.81 13.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.837 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -43.07 -47.53 5.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.107 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 708' ' ' CYS . . . . . 0.48 ' O ' ' CB ' ' A' ' 712' ' ' ASN . 21.3 m -54.54 -34.57 62.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.87 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 8.7 mtm105 -81.66 -45.18 16.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.881 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 22.1 mtm -66.06 -15.27 62.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.921 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 711' ' ' MET . . . . . 0.476 ' O ' ' N ' ' A' ' 714' ' ' MET . 3.2 mmt -113.78 -30.83 6.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.873 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 712' ' ' ASN . . . . . 0.48 ' CB ' ' O ' ' A' ' 708' ' ' CYS . 0.4 OUTLIER -39.79 112.27 0.25 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.875 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 77.25 25.61 63.4 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.48 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 714' ' ' MET . . . . . 0.476 ' N ' ' O ' ' A' ' 711' ' ' MET . 48.9 ttp -71.38 100.35 2.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.863 0.363 . . . . 0.0 110.91 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp -54.07 99.13 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.889 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 716' ' ' LEU . . . . . 0.47 ' O ' ' N ' ' A' ' 719' ' ' ARG . 29.1 mt -99.89 125.21 45.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.929 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 717' ' ' SER . . . . . . . . . . . . . 1.1 t 40.06 43.68 1.35 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.883 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 72.41 29.09 66.57 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.508 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 719' ' ' ARG . . . . . 0.47 ' N ' ' O ' ' A' ' 716' ' ' LEU . 44.1 mtt180 -141.19 114.85 8.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.801 0.334 . . . . 0.0 110.885 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -70.18 128.03 34.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.902 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . 0.443 ' CG2' HD12 ' A' ' 716' ' ' LEU . 37.3 pt -100.03 161.89 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.129 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -118.39 98.21 6.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.845 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 723' ' ' VAL . . . . . 0.446 ' CG1' ' HA ' ' A' ' 708' ' ' CYS . 6.2 t -96.59 132.83 40.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.146 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 64.1 mtt180 -155.19 154.15 31.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.879 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 725' ' ' ILE . . . . . 0.448 ' CG2' ' HB3' ' A' ' 651' ' ' ALA . 15.1 mm -64.15 134.51 28.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.15 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -81.89 87.33 6.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 727' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -44.11 -51.34 8.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.886 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 728' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -95.35 91.47 6.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.91 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 729' ' ' ALA . . . . . . . . . . . . . . . -131.38 -49.65 0.99 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.094 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 22.7 t -132.64 109.52 9.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.875 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 731' ' ' GLY . . . . . . . . . . . . . . . -73.33 145.01 35.33 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.488 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 732' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 93.83 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.66 2.24 . . . . 0.0 112.343 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 733' ' ' SER . . . . . . . . . . . . . 36.2 m -100.7 82.17 2.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.881 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 734' ' ' SER . . . . . . . . . . . . . 16.4 m -123.55 104.98 9.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.854 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 735' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.492 -179.996 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 645' ' ' SER . . . . . . . . . . . . . 35.1 m -110.75 42.97 1.5 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.923 0.392 . . . . 0.0 110.876 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 646' ' ' SER . . . . . . . . . . . . . 12.8 t -113.21 154.43 26.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.906 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . 156.14 43.01 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.446 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 38.5 p -42.38 158.08 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.877 0.37 . . . . 0.0 110.903 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 20.0 t -72.71 -57.99 3.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.828 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . -174.64 169.35 42.29 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.502 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 651' ' ' ALA . . . . . 0.413 ' CB ' HG23 ' A' ' 725' ' ' ILE . . . -121.22 99.5 6.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.772 0.32 . . . . 0.0 111.066 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 652' ' ' CYS . . . . . 0.461 ' SG ' ' N ' ' A' ' 701' ' ' PRO . 22.3 m -106.5 -23.18 12.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.869 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -104.32 146.49 28.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.928 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 654' ' ' ILE . . . . . 0.415 ' CD1' ' CE2' ' A' ' 672' ' ' PHE . 38.9 pt -131.32 169.34 21.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.096 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -122.75 149.85 43.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.889 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 3.4 t -132.8 153.38 37.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.152 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 53.4 mtt85 -148.68 160.44 43.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.896 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 658' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 692' ' ' GLY . 0.6 OUTLIER 66.93 44.95 1.91 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.927 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . . . . . . . . . 54.1 mt -93.84 143.52 26.64 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.586 0.707 . . . . 0.0 110.907 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 660' ' ' PRO . . . . . 0.406 ' O ' ' N ' ' A' ' 663' ' ' PHE . 66.7 Cg_exo -48.04 124.12 9.7 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.687 2.258 . . . . 0.0 112.32 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -47.43 -24.43 0.81 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.896 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 662' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 663' ' ' PHE . 73.5 m-20 -88.49 -29.67 19.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.876 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 663' ' ' PHE . . . . . 0.408 ' C ' ' O ' ' A' ' 662' ' ' ASP . 3.5 t80 -37.6 140.03 0.25 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 82.2 p -120.34 169.82 9.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.122 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 665' ' ' TRP . . . . . 0.644 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 6.7 p-90 -63.45 -52.16 62.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.96 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 666' ' ' LYS . . . . . 0.644 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 9.7 tppt? -44.63 -51.57 8.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.877 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 24.3 mtm -61.74 -47.17 86.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.866 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 35.6 tp -47.85 -47.55 31.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.91 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.453 ' HG2' ' N ' ' A' ' 670' ' ' ASP . 0.3 OUTLIER -64.76 -73.69 0.12 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 179.789 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 670' ' ' ASP . . . . . 0.453 ' N ' ' HG2' ' A' ' 669' ' ' LYS . 4.5 m-20 -45.2 -24.22 0.24 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.903 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 671' ' ' LYS . . . . . 0.458 ' HG3' ' CE ' ' A' ' 711' ' ' MET . 7.8 tppt? -69.88 -51.3 34.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.897 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 672' ' ' PHE . . . . . 0.533 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 27.7 m-85 -78.43 -11.15 59.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.878 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -55.9 -39.38 71.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.881 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -47.4 -36.02 9.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.895 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 64.8 m -74.66 -56.5 4.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.826 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -160.41 -175.95 31.97 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.474 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -68.43 109.44 3.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.832 0.348 . . . . 0.0 110.831 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 53.2 t -88.57 128.7 40.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.139 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 11.4 mt -100.5 -64.42 1.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 680' ' ' TYR . . . . . 0.414 ' CE2' HG22 ' A' ' 695' ' ' VAL . 6.9 t80 -97.94 130.34 44.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.879 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -153.9 125.96 7.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.104 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -163.61 157.94 20.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.894 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 25.2 mm -93.87 101.72 12.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.126 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 16.2 mmmt -60.77 129.73 42.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.901 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 685' ' ' MET . . . . . . . . . . . . . 14.1 mtp -128.36 176.19 7.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.864 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -130.21 114.83 16.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 687' ' ' ASN . . . . . . . . . . . . . 18.7 t30 50.07 35.19 9.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.881 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 688' ' ' GLY . . . . . . . . . . . . . . . 79.36 34.9 31.13 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.462 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 21.0 mtmm -134.71 118.21 16.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.75 0.31 . . . . 0.0 110.905 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 690' ' ' SER . . . . . . . . . . . . . 7.3 p -51.09 124.89 12.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.901 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 691' ' ' LYS . . . . . 0.418 ' O ' ' N ' ' A' ' 693' ' ' CYS . 33.3 mmtt -112.05 26.15 10.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.932 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' A' ' 658' ' ' ASN . . . 37.71 31.28 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.512 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 693' ' ' CYS . . . . . 0.418 ' N ' ' O ' ' A' ' 691' ' ' LYS . 26.0 p -132.92 125.43 29.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.896 0.379 . . . . 0.0 110.88 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -130.01 172.91 20.02 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.475 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . 0.414 HG22 ' CE2' ' A' ' 680' ' ' TYR . 8.7 m -129.35 150.98 35.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.857 0.36 . . . . 0.0 111.13 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 696' ' ' VAL . . . . . 0.464 HG21 ' CD1' ' A' ' 672' ' ' PHE . 62.9 t -140.77 122.31 14.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.079 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 13.6 tttt -106.78 134.22 50.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.948 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 698' ' ' PHE . . . . . 0.455 ' CD2' ' CG1' ' A' ' 703' ' ' VAL . 94.0 m-85 -109.81 171.39 7.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.893 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 699' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -75.75 -45.19 37.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.921 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 57.7 m -109.83 145.62 32.4 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.673 0.749 . . . . 0.0 110.871 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 701' ' ' PRO . . . . . 0.461 ' N ' ' SG ' ' A' ' 652' ' ' CYS . 53.7 Cg_endo -69.8 -10.89 29.63 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.629 2.22 . . . . 0.0 112.343 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 702' ' ' GLU . . . . . 0.4 ' OE1' ' C ' ' A' ' 702' ' ' GLU . 1.4 pp20? -82.9 -31.02 28.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.866 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 703' ' ' VAL . . . . . 0.455 ' CG1' ' CD2' ' A' ' 698' ' ' PHE . 66.5 t -67.72 -57.4 9.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.121 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -44.23 -58.54 2.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.091 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -44.31 -36.32 2.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.896 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -76.91 -64.77 1.05 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.823 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -39.61 -34.95 0.27 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.105 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 708' ' ' CYS . . . . . 0.434 ' HA ' ' CG1' ' A' ' 723' ' ' VAL . 56.8 m -52.82 -56.69 13.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.945 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -71.14 -39.75 71.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.92 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 18.6 mtm -64.4 -13.1 49.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 711' ' ' MET . . . . . 0.533 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 6.3 mmm -119.21 -16.68 9.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.887 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 712' ' ' ASN . . . . . 0.491 ' ND2' ' O ' ' A' ' 712' ' ' ASN . 0.1 OUTLIER -55.97 122.24 11.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.868 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 76.75 13.53 83.47 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.46 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 714' ' ' MET . . . . . 0.467 ' CE ' ' HE2' ' A' ' 711' ' ' MET . 43.4 ttp -61.34 97.15 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.845 0.355 . . . . 0.0 110.823 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 15.4 mmtt -54.08 101.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.887 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 716' ' ' LEU . . . . . 0.48 ' O ' ' N ' ' A' ' 719' ' ' ARG . 46.0 mt -99.91 123.81 44.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.908 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 717' ' ' SER . . . . . . . . . . . . . 2.0 t 37.64 41.34 0.3 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.838 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 77.05 34.1 43.07 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.487 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 719' ' ' ARG . . . . . 0.48 ' N ' ' O ' ' A' ' 716' ' ' LEU . 9.6 mtt-85 -146.93 111.51 5.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.716 0.293 . . . . 0.0 110.862 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -68.83 125.6 27.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.888 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 22.7 pt -100.0 160.36 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.138 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -115.2 109.43 17.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.832 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 723' ' ' VAL . . . . . 0.434 ' CG1' ' HA ' ' A' ' 708' ' ' CYS . 5.4 t -108.72 129.28 63.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.134 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 36.1 mtp180 -157.56 158.73 36.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.827 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 725' ' ' ILE . . . . . 0.43 HG22 ' N ' ' A' ' 726' ' ' ASP . 31.6 mm -51.43 136.32 11.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.134 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 726' ' ' ASP . . . . . 0.43 ' N ' HG22 ' A' ' 725' ' ' ILE . 24.8 t0 -81.23 91.63 6.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 727' ' ' ARG . . . . . . . . . . . . . 7.2 tpt180 -55.33 -55.41 31.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 728' ' ' ASN . . . . . . . . . . . . . 59.5 m-20 -98.2 90.29 4.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.862 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 729' ' ' ALA . . . . . . . . . . . . . . . -116.4 -56.15 2.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.1 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 1.4 t -73.58 -52.38 13.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 731' ' ' GLY . . . . . . . . . . . . . . . -167.01 -172.11 33.87 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.517 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 732' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 733' ' ' SER . 53.7 Cg_endo -69.81 -5.94 17.43 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.683 2.255 . . . . 0.0 112.355 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 733' ' ' SER . . . . . 0.434 ' C ' ' O ' ' A' ' 732' ' ' PRO . 7.6 m -35.38 110.72 0.11 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.891 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 734' ' ' SER . . . . . . . . . . . . . 12.0 t -58.86 -44.81 91.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.866 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 735' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.504 -179.986 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 112.524 -0.231 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 645' ' ' SER . . . . . . . . . . . . . 23.3 t -42.92 -50.09 5.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.885 0.374 . . . . 0.0 110.844 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 646' ' ' SER . . . . . . . . . . . . . 2.3 p -92.8 -16.43 25.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.855 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . 50.01 -126.61 22.74 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.52 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 12.0 t -91.08 137.71 32.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.874 0.368 . . . . 0.0 110.884 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 96.3 p -135.54 130.92 35.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.814 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 57.11 41.08 92.45 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.526 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 651' ' ' ALA . . . . . 0.441 ' CB ' HG23 ' A' ' 725' ' ' ILE . . . -70.09 100.45 1.64 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.79 0.329 . . . . 0.0 111.075 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 24.8 p -109.45 -33.64 6.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.849 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -92.12 150.72 20.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.945 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 654' ' ' ILE . . . . . 0.56 ' CD1' ' CE2' ' A' ' 672' ' ' PHE . 30.0 pt -137.26 167.07 23.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.169 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -120.7 159.47 25.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.865 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 16.7 t -145.64 156.77 12.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.174 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 57.4 mtt180 -153.49 162.79 40.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.898 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 658' ' ' ASN . . . . . . . . . . . . . 4.6 t30 69.03 36.83 2.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.895 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.466 HD22 ' CD2' ' A' ' 663' ' ' PHE . 37.6 mt -86.74 143.34 35.5 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.669 0.747 . . . . 0.0 110.935 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 660' ' ' PRO . . . . . 0.47 ' O ' ' N ' ' A' ' 663' ' ' PHE . 64.8 Cg_exo -47.88 126.5 13.03 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.655 2.237 . . . . 0.0 112.375 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -42.42 -33.66 0.7 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.858 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 662' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 663' ' ' PHE . 44.1 m-20 -81.12 -32.59 33.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.912 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 663' ' ' PHE . . . . . 0.47 ' N ' ' O ' ' A' ' 660' ' ' PRO . 4.3 t80 -35.74 124.92 0.7 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.901 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 68.5 p -108.44 174.84 5.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.145 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 665' ' ' TRP . . . . . 0.646 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 8.0 p-90 -65.93 -51.97 53.97 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.896 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 666' ' ' LYS . . . . . 0.646 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 2.3 tppp? -44.57 -54.35 6.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.882 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 20.1 mtm -57.86 -49.45 76.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.9 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 56.6 tp -46.8 -44.56 19.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.887 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 29.7 tttm -65.47 -74.92 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.85 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -46.36 -22.93 0.3 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.864 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 671' ' ' LYS . . . . . 0.454 ' HG3' ' CE ' ' A' ' 711' ' ' MET . 9.3 tppt? -70.88 -41.83 70.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.898 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 672' ' ' PHE . . . . . 0.56 ' CE2' ' CD1' ' A' ' 654' ' ' ILE . 18.5 m-85 -88.58 -11.65 44.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.892 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -54.28 -34.31 60.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.846 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -46.3 -44.91 17.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.899 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 12.9 t -64.47 -55.63 19.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.867 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -159.53 -157.16 8.42 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.476 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -86.5 110.42 19.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.889 0.376 . . . . 0.0 110.862 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 76.3 t -85.87 138.4 19.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.111 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 25.4 mt -112.68 -62.47 1.58 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.908 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -96.68 131.87 42.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.94 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -155.84 125.17 6.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.102 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -158.13 160.82 37.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.875 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 23.2 mm -109.05 108.16 24.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.151 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -57.77 136.44 56.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.914 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 685' ' ' MET . . . . . . . . . . . . . 39.7 mtp -135.13 168.73 18.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.89 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -132.11 110.45 10.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.893 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 687' ' ' ASN . . . . . . . . . . . . . 36.8 m-20 45.64 43.97 9.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.87 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 688' ' ' GLY . . . . . . . . . . . . . . . 76.71 32.39 50.5 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.484 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 36.2 mtpt -130.46 118.64 21.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.845 0.355 . . . . 0.0 110.886 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 690' ' ' SER . . . . . . . . . . . . . 2.8 m -58.91 134.13 56.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.828 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -115.44 18.7 15.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.925 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 40.42 33.82 0.59 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.514 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 28.4 p -140.02 133.73 30.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.888 0.375 . . . . 0.0 110.908 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -141.81 -154.4 6.17 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.496 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 14.3 m -155.75 155.84 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.818 0.342 . . . . 0.0 111.123 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 48.7 t -143.7 125.76 11.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.164 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 13.8 ttpt -109.79 137.6 47.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 698' ' ' PHE . . . . . 0.41 ' CD2' HG12 ' A' ' 703' ' ' VAL . 95.5 m-85 -111.6 169.77 8.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.925 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 699' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -74.89 -42.06 58.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.892 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 39.7 m -109.94 151.09 42.21 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.684 0.754 . . . . 0.0 110.864 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -39.26 6.74 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.696 2.264 . . . . 0.0 112.349 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -54.71 -47.82 73.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.899 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 703' ' ' VAL . . . . . 0.41 HG12 ' CD2' ' A' ' 698' ' ' PHE . 93.0 t -49.26 -59.08 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.089 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 704' ' ' ALA . . . . . 0.417 ' O ' ' C ' ' A' ' 705' ' ' GLU . . . -41.47 -67.46 0.25 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.066 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 704' ' ' ALA . 9.7 mt-10 -36.77 -42.61 0.39 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.91 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 706' ' ' ARG . . . . . 0.425 ' O ' ' C ' ' A' ' 707' ' ' ALA . 15.9 ttm180 -69.25 -64.21 0.92 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.848 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 707' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 706' ' ' ARG . . . -35.78 -47.87 0.52 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.087 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 708' ' ' CYS . . . . . 0.468 ' O ' ' N ' ' A' ' 712' ' ' ASN . 1.2 t -43.96 -60.62 1.76 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.924 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 11.9 mtt180 -69.15 -38.0 78.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.908 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 49.4 mtp -64.04 -16.04 60.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.905 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 711' ' ' MET . . . . . 0.454 ' CE ' ' HG3' ' A' ' 671' ' ' LYS . 4.1 mmt -123.54 -8.83 7.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.85 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 712' ' ' ASN . . . . . 0.468 ' N ' ' O ' ' A' ' 708' ' ' CYS . 27.7 t30 -64.58 118.36 8.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.911 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 78.89 30.06 49.11 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.493 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 714' ' ' MET . . . . . . . . . . . . . 34.2 ttp -80.22 110.46 15.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.851 0.357 . . . . 0.0 110.899 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 18.9 mmtt -67.19 102.27 1.02 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.881 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 716' ' ' LEU . . . . . 0.501 ' O ' ' N ' ' A' ' 719' ' ' ARG . 26.7 mt -99.93 123.08 43.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.939 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 717' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 716' ' ' LEU . 8.7 t 36.66 38.73 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.87 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 80.96 34.18 27.75 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.471 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 719' ' ' ARG . . . . . 0.501 ' N ' ' O ' ' A' ' 716' ' ' LEU . 8.1 mtt-85 -147.27 110.95 4.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.795 0.331 . . . . 0.0 110.887 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -71.33 126.54 29.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.876 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 32.9 pt -97.75 158.82 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.089 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -113.92 99.23 7.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.872 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 10.6 t -99.07 128.91 50.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.127 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 81.3 mtm180 -148.23 173.65 12.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 725' ' ' ILE . . . . . 0.441 HG23 ' CB ' ' A' ' 651' ' ' ALA . 31.5 mm -81.05 134.37 27.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.128 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -85.34 103.5 14.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.894 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 727' ' ' ARG . . . . . 0.431 ' O ' ' C ' ' A' ' 728' ' ' ASN . 0.9 OUTLIER -62.67 -50.3 71.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.888 -179.878 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 728' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 727' ' ' ARG . 32.0 t30 -35.92 -44.93 0.38 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.889 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 729' ' ' ALA . . . . . . . . . . . . . . . -39.93 -61.47 0.85 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.078 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 39.2 p -137.8 129.92 28.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.863 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 731' ' ' GLY . . . . . . . . . . . . . . . -176.02 83.66 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.484 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 732' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 132.91 24.37 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.701 2.267 . . . . 0.0 112.34 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 733' ' ' SER . . . . . . . . . . . . . 92.5 p -96.2 167.07 11.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.868 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 734' ' ' SER . . . . . . . . . . . . . 21.3 m -139.62 167.31 22.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.817 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 735' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.512 -179.986 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 645' ' ' SER . . . . . . . . . . . . . 50.8 p -90.46 149.71 22.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.849 0.357 . . . . 0.0 110.834 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 646' ' ' SER . . . . . . . . . . . . . 71.3 m -138.04 172.81 12.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.871 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -146.38 41.76 0.98 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.477 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 3.9 m -93.16 106.1 18.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.862 0.363 . . . . 0.0 110.883 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 6.2 t -134.03 130.4 37.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.845 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 107.32 56.09 0.62 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.528 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 651' ' ' ALA . . . . . . . . . . . . . . . -87.15 91.7 8.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.77 0.319 . . . . 0.0 111.135 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 25.8 p -107.14 -28.51 9.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.87 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 653' ' ' GLN . . . . . 0.459 ' HG3' ' N ' ' A' ' 654' ' ' ILE . 10.3 tp60 -89.92 146.32 24.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.876 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 654' ' ' ILE . . . . . 0.459 ' N ' ' HG3' ' A' ' 653' ' ' GLN . 23.6 pt -138.04 178.07 4.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.106 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -134.27 153.02 52.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.897 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 20.5 t -135.77 153.43 32.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.138 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -147.67 157.41 43.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.846 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 658' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 692' ' ' GLY . 4.5 t30 68.63 52.11 0.59 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.448 HD22 ' CE2' ' A' ' 663' ' ' PHE . 39.8 mt -100.2 143.45 26.54 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.594 0.712 . . . . 0.0 110.924 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -47.96 132.97 22.89 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.672 2.248 . . . . 0.0 112.377 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -44.26 -45.66 8.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.884 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 662' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 663' ' ' PHE . 22.8 t0 -68.16 -34.32 76.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.839 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 663' ' ' PHE . . . . . 0.448 ' CE2' HD22 ' A' ' 659' ' ' LEU . 4.2 t80 -36.84 116.59 0.45 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.925 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 59.1 p -107.73 -177.89 3.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.115 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 665' ' ' TRP . . . . . 0.616 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 5.5 p-90 -64.73 -48.65 73.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.866 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 666' ' ' LYS . . . . . 0.616 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 13.8 tptm -48.84 -59.24 3.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.912 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 667' ' ' MET . . . . . 0.492 ' O ' ' CB ' ' A' ' 671' ' ' LYS . 28.6 mtm -53.69 -48.79 69.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 15.3 tp -48.56 -46.67 39.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.908 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -65.49 -73.12 0.13 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.914 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -48.59 -23.9 1.15 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.88 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 671' ' ' LYS . . . . . 0.492 ' CB ' ' O ' ' A' ' 667' ' ' MET . 0.3 OUTLIER -69.98 -42.49 73.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.897 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 672' ' ' PHE . . . . . 0.566 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 15.6 m-85 -86.9 -16.09 37.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.854 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -49.52 -38.62 31.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.905 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -39.45 -44.35 1.36 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.898 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 5.9 t -67.48 -64.09 0.93 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.881 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -148.82 -158.86 8.23 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.516 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 677' ' ' HIS . . . . . 0.449 ' C ' ' CD2' ' A' ' 677' ' ' HIS . 3.4 t60 -86.88 107.52 18.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.871 0.367 . . . . 0.0 110.878 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 60.0 t -81.11 143.2 12.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.109 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 679' ' ' LEU . . . . . 0.416 HD21 ' CD2' ' A' ' 677' ' ' HIS . 23.6 mt -116.14 -62.77 1.54 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.872 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -99.91 128.98 45.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.909 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -155.89 123.75 5.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.08 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -152.5 155.85 38.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.875 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 18.1 mm -104.87 107.3 22.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.114 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -54.51 136.26 44.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 685' ' ' MET . . . . . . . . . . . . . 17.9 mtp -135.07 150.87 50.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.88 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -126.04 95.14 4.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.858 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 687' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 65.03 40.21 5.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.83 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 688' ' ' GLY . . . . . . . . . . . . . . . 72.86 31.86 61.74 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.51 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 689' ' ' LYS . . . . . 0.428 ' O ' ' C ' ' A' ' 690' ' ' SER . 1.0 OUTLIER -134.19 85.95 2.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.792 0.33 . . . . 0.0 110.859 -179.926 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 690' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 689' ' ' LYS . 4.9 t -35.26 137.56 0.16 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.819 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 19.3 mmmt -108.1 18.21 21.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.881 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 658' ' ' ASN . . . 48.62 25.95 5.02 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.478 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 19.1 p -135.16 131.17 36.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.884 0.373 . . . . 0.0 110.847 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -143.52 -164.97 10.56 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.483 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . 0.455 ' HB ' ' NE2' ' A' ' 653' ' ' GLN . 17.1 m -140.08 160.1 26.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.922 0.391 . . . . 0.0 111.126 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 696' ' ' VAL . . . . . 0.421 HG22 ' CD1' ' A' ' 672' ' ' PHE . 70.7 t -146.52 115.01 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.099 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 37.0 tttt -96.69 138.37 34.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 698' ' ' PHE . . . . . 0.567 ' CD2' HG11 ' A' ' 703' ' ' VAL . 95.1 m-85 -116.69 164.38 14.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.906 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 699' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -71.11 -41.87 69.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.892 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 3.2 m -113.81 149.51 41.91 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.671 0.748 . . . . 0.0 110.887 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -33.53 16.37 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.638 2.225 . . . . 0.0 112.349 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 702' ' ' GLU . . . . . 0.438 ' HG3' ' N ' ' A' ' 703' ' ' VAL . 9.2 pt-20 -61.86 -42.36 98.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.893 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 703' ' ' VAL . . . . . 0.567 HG11 ' CD2' ' A' ' 698' ' ' PHE . 84.2 t -55.31 -60.51 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.126 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -39.04 -61.43 0.75 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.097 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -44.29 -41.03 5.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.92 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 15.7 ttt180 -67.05 -59.26 3.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.875 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -46.3 -44.0 16.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.056 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 708' ' ' CYS . . . . . 0.495 ' O ' ' CB ' ' A' ' 712' ' ' ASN . 1.8 m -50.74 -41.16 56.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.873 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 3.2 mtt-85 -82.47 -37.66 25.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.868 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 8.7 mtm -72.34 -9.44 58.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.869 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 711' ' ' MET . . . . . 0.566 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 5.5 mmm -120.5 -35.57 3.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.87 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 712' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 708' ' ' CYS . 0.3 OUTLIER -40.87 112.02 0.26 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.862 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 84.79 19.54 59.53 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.51 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 714' ' ' MET . . . . . 0.457 ' N ' ' O ' ' A' ' 711' ' ' MET . 57.2 ttp -69.28 94.07 0.68 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.847 0.356 . . . . 0.0 110.868 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 8.6 mmtp -51.13 98.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.899 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 716' ' ' LEU . . . . . 0.498 ' O ' ' N ' ' A' ' 719' ' ' ARG . 38.1 mt -99.94 129.92 46.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.951 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 717' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 716' ' ' LEU . 27.8 t 36.51 38.93 0.08 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.885 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 76.76 36.76 36.1 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.479 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 719' ' ' ARG . . . . . 0.498 ' N ' ' O ' ' A' ' 716' ' ' LEU . 21.7 mtt180 -147.22 116.04 6.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.748 0.308 . . . . 0.0 110.848 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -71.41 122.89 21.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.865 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . 0.428 HG21 ' CD1' ' A' ' 716' ' ' LEU . 19.4 pt -98.99 156.89 3.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.133 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 722' ' ' ASP . . . . . 0.446 ' OD1' ' C ' ' A' ' 722' ' ' ASP . 2.9 t0 -116.01 108.23 15.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.837 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 723' ' ' VAL . . . . . 0.428 ' CG1' ' HA ' ' A' ' 708' ' ' CYS . 17.3 t -107.32 136.02 43.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.177 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 724' ' ' ARG . . . . . 0.45 ' C ' ' SG ' ' A' ' 708' ' ' CYS . 13.5 ptt85 -158.13 165.97 33.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.872 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 725' ' ' ILE . . . . . . . . . . . . . 27.0 mm -62.18 138.0 23.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.126 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -88.03 86.49 7.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.87 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 727' ' ' ARG . . . . . . . . . . . . . 27.2 mmt85 -60.15 -65.66 0.65 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.892 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 728' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -75.5 89.02 2.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.852 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 729' ' ' ALA . . . . . . . . . . . . . . . -140.31 109.18 6.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.088 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 15.2 t -122.16 -67.9 0.93 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 731' ' ' GLY . . . . . . . . . . . . . . . 128.97 174.92 13.86 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.501 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 732' ' ' PRO . . . . . 0.447 ' O ' ' C ' ' A' ' 733' ' ' SER . 53.6 Cg_endo -69.72 0.28 5.84 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.657 2.238 . . . . 0.0 112.357 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 733' ' ' SER . . . . . 0.447 ' C ' ' O ' ' A' ' 732' ' ' PRO . 34.3 m -34.59 98.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.864 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 734' ' ' SER . . . . . . . . . . . . . 14.0 t -89.99 -39.87 12.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.886 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 735' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.48 -179.986 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 645' ' ' SER . . . . . . . . . . . . . 51.2 p -122.64 175.74 6.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.861 0.362 . . . . 0.0 110.867 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 646' ' ' SER . . . . . . . . . . . . . 23.9 t -52.31 98.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.821 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . 86.32 151.72 18.97 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.457 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 73.4 m -94.35 -52.88 4.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.855 0.359 . . . . 0.0 110.829 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 14.1 m -76.99 168.91 19.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.872 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 176.3 43.27 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.459 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 651' ' ' ALA . . . . . . . . . . . . . . . -89.98 96.79 10.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.756 0.312 . . . . 0.0 111.09 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 24.5 p -104.08 -30.91 9.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.847 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -94.51 152.06 18.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.91 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 654' ' ' ILE . . . . . 0.46 ' CD1' ' CE2' ' A' ' 672' ' ' PHE . 27.6 pt -136.01 174.54 12.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.113 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -127.76 157.04 41.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.901 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 3.1 t -140.72 151.07 20.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.114 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 4.1 mtp-105 -148.23 156.16 42.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.902 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 658' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 69.61 45.71 0.77 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.895 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . . . . . . . . . 24.0 mt -94.51 143.71 26.73 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.653 0.74 . . . . 0.0 110.902 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -48.03 136.02 23.75 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.617 2.211 . . . . 0.0 112.383 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -52.34 -33.91 45.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.886 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.16 -30.12 43.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.915 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -39.13 124.96 1.54 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.91 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 77.2 p -110.0 176.6 5.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.21 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 665' ' ' TRP . . . . . 0.644 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 3.5 p-90 -68.26 -50.05 56.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.959 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 666' ' ' LYS . . . . . 0.644 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 13.1 tptp -52.04 -47.48 65.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.943 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 21.2 mtm -64.78 -39.55 93.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.864 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 38.9 tp -56.43 -46.48 80.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.949 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.44 ' O ' ' ND2' ' A' ' 673' ' ' ASN . 0.0 OUTLIER -62.22 -61.07 2.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 179.791 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -54.59 -27.74 41.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 11.0 tptt -66.56 -39.48 88.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 672' ' ' PHE . . . . . 0.46 ' CE2' ' CD1' ' A' ' 654' ' ' ILE . 25.1 m-85 -90.86 -10.51 42.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.856 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 673' ' ' ASN . . . . . 0.44 ' ND2' ' O ' ' A' ' 669' ' ' LYS . 1.0 OUTLIER -54.53 -32.73 58.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.863 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -58.58 -28.88 65.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 17.3 m -81.81 -53.46 6.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.86 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -161.72 -179.0 36.12 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.492 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -70.2 107.1 3.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.8 0.333 . . . . 0.0 110.855 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 58.8 t -84.68 137.53 20.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.143 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 12.1 mt -116.43 -57.98 2.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 8.3 t80 -99.41 126.11 45.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.925 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -155.6 123.8 5.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.138 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -154.02 158.17 40.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.84 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 27.2 mm -106.87 126.82 62.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.089 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 56.0 mmtt -72.89 137.87 45.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.89 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 685' ' ' MET . . . . . . . . . . . . . 31.7 mtp -139.38 156.21 47.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.872 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 49.6 tt0 -133.31 120.33 20.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.936 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 687' ' ' ASN . . . . . . . . . . . . . 15.9 m120 50.63 38.49 19.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.898 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 688' ' ' GLY . . . . . . . . . . . . . . . 70.05 35.63 71.63 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.473 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt -137.35 111.67 8.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.793 0.33 . . . . 0.0 110.888 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 690' ' ' SER . . . . . . . . . . . . . 3.0 m -41.09 154.16 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.886 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -118.86 -34.59 3.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.893 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 95.51 14.63 46.71 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.479 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 21.4 p -133.24 132.22 41.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.871 0.367 . . . . 0.0 110.851 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -139.11 -160.8 8.49 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.509 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 19.3 m -147.21 160.29 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.904 0.383 . . . . 0.0 111.11 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 97.1 t -148.0 113.54 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.137 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 18.9 ttpt -96.24 143.63 27.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 698' ' ' PHE . . . . . 0.403 ' CD2' HG11 ' A' ' 703' ' ' VAL . 96.2 m-85 -119.66 168.66 10.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.834 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 699' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -75.05 -34.44 61.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.918 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 700' ' ' SER . . . . . 0.416 ' CB ' ' OE2' ' A' ' 702' ' ' GLU . 1.4 m -125.34 152.86 71.89 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.696 0.76 . . . . 0.0 110.826 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -50.37 0.47 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.698 2.265 . . . . 0.0 112.36 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 702' ' ' GLU . . . . . 0.416 ' OE2' ' CB ' ' A' ' 700' ' ' SER . 25.6 pm0 -44.54 -27.48 0.47 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.863 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 703' ' ' VAL . . . . . 0.403 HG11 ' CD2' ' A' ' 698' ' ' PHE . 47.0 t -73.4 -54.5 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.095 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -48.61 -57.14 6.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.067 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -45.86 -38.07 6.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.858 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 9.4 ttm-85 -74.03 -58.15 3.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.897 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -47.99 -25.78 1.52 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.11 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 708' ' ' CYS . . . . . . . . . . . . . 1.5 t -60.47 -60.03 4.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.858 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -73.38 -36.97 66.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.812 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 12.1 mmm -59.42 -30.29 68.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.909 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 711' ' ' MET . . . . . 0.426 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 4.8 mmm -107.03 -15.9 14.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.88 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 712' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -53.91 121.83 8.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.923 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 77.14 12.82 84.27 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.524 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 714' ' ' MET . . . . . . . . . . . . . 55.8 ttp -59.64 104.31 0.27 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.849 0.356 . . . . 0.0 110.867 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 7.9 mmtm -61.98 100.22 0.15 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.898 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 716' ' ' LEU . . . . . 0.494 ' O ' ' N ' ' A' ' 719' ' ' ARG . 31.6 mt -99.89 126.86 46.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.958 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 717' ' ' SER . . . . . 0.409 ' C ' ' O ' ' A' ' 716' ' ' LEU . 1.6 t 36.7 39.7 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.887 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 77.18 36.18 35.89 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.484 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 719' ' ' ARG . . . . . 0.494 ' N ' ' O ' ' A' ' 716' ' ' LEU . 5.9 mtt-85 -148.68 114.54 5.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.804 0.335 . . . . 0.0 110.864 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -72.27 127.48 32.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 28.5 pt -100.04 157.05 4.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.149 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -109.22 98.48 7.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.847 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 17.9 t -97.61 130.13 46.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.121 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.19 175.22 13.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.923 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 725' ' ' ILE . . . . . . . . . . . . . 49.4 mm -80.31 133.37 29.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.114 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -84.01 118.92 24.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.861 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 727' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -83.44 -30.82 26.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.895 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 728' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -96.18 56.74 1.66 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.891 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 729' ' ' ALA . . . . . . . . . . . . . . . -99.95 -55.64 2.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.149 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 84.1 p -111.62 169.16 9.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.838 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 731' ' ' GLY . . . . . . . . . . . . . . . -106.18 144.24 15.81 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.49 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 732' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -173.05 0.64 Allowed 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.659 2.239 . . . . 0.0 112.37 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 733' ' ' SER . . . . . . . . . . . . . 16.0 m -136.58 105.35 5.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.894 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 734' ' ' SER . . . . . . . . . . . . . 5.0 t -169.83 114.66 0.52 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.843 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 735' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.455 179.966 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 645' ' ' SER . . . . . . . . . . . . . 43.4 m 54.83 43.36 30.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.908 0.385 . . . . 0.0 110.89 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 646' ' ' SER . . . . . . . . . . . . . 5.8 t -94.69 -58.85 2.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.835 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . 127.93 95.85 0.87 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.473 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 91.8 p -89.82 -49.63 6.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.896 0.379 . . . . 0.0 110.88 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 7.5 t -100.13 123.94 44.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.887 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . -71.99 119.76 7.6 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.462 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 651' ' ' ALA . . . . . . . . . . . . . . . -69.6 74.78 0.41 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.726 0.298 . . . . 0.0 111.082 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 29.7 p -97.14 47.2 1.04 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.879 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -163.94 149.44 10.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.913 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 654' ' ' ILE . . . . . 0.517 HD12 ' CE2' ' A' ' 672' ' ' PHE . 37.8 pt -140.66 173.29 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.14 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -130.5 144.69 51.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.871 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 27.6 t -126.99 139.25 52.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.081 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 36.7 mtp85 -133.73 155.76 49.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.86 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 658' ' ' ASN . . . . . 0.467 ' ND2' ' HB3' ' A' ' 719' ' ' ARG . 4.7 t30 70.66 52.12 0.32 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.92 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.412 ' HB2' ' C ' ' A' ' 692' ' ' GLY . 36.7 mt -100.04 145.11 29.64 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.643 0.735 . . . . 0.0 110.875 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -47.92 142.46 15.07 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.654 2.236 . . . . 0.0 112.395 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -60.53 -24.75 65.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.889 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -98.17 13.4 31.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.85 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -80.14 118.48 21.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 69.4 p -105.45 168.99 8.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.079 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 665' ' ' TRP . . . . . 0.639 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 6.9 p-90 -57.23 -49.72 75.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.927 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 666' ' ' LYS . . . . . 0.639 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 5.3 tptm -46.27 -54.35 9.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.886 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 16.6 mtm -59.72 -55.62 32.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.84 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 14.7 tp -42.97 -46.91 5.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.902 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 46.1 tttt -62.49 -71.45 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -46.28 -24.11 0.43 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.878 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 8.8 tptp -68.79 -51.49 40.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.927 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 672' ' ' PHE . . . . . 0.547 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 23.1 m-85 -78.53 -15.24 58.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.892 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -49.92 -34.58 20.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.923 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -53.66 -39.76 65.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.881 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 675' ' ' CYS . . . . . 0.452 ' CB ' ' HB2' ' A' ' 707' ' ' ALA . 31.9 m -71.42 -47.54 55.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.888 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -165.69 -177.33 37.86 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.479 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 677' ' ' HIS . . . . . 0.459 ' CD2' HD23 ' A' ' 679' ' ' LEU . 2.7 t-160 -73.21 96.45 2.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.843 0.354 . . . . 0.0 110.862 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 78.9 t -73.26 138.3 21.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.143 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 679' ' ' LEU . . . . . 0.459 HD23 ' CD2' ' A' ' 677' ' ' HIS . 12.9 mt -113.21 -61.52 1.73 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.931 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 680' ' ' TYR . . . . . 0.505 ' CE2' HG22 ' A' ' 695' ' ' VAL . 4.5 t80 -95.71 129.11 43.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.93 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -156.91 125.2 5.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.075 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -156.0 161.72 40.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.84 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 42.9 mm -109.25 107.27 22.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.129 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 27.8 mmtm -60.82 132.44 53.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.882 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 685' ' ' MET . . . . . . . . . . . . . 32.6 mtp -133.62 146.54 51.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.897 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -107.66 113.74 27.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.88 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 687' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 50.53 41.98 26.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.875 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 688' ' ' GLY . . . . . . . . . . . . . . . 76.9 38.19 31.5 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.527 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 39.7 mtpt -135.81 130.18 33.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.785 0.326 . . . . 0.0 110.897 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 690' ' ' SER . . . . . . . . . . . . . 3.1 m -70.02 131.46 44.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.836 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 691' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 693' ' ' CYS . 29.0 mmtt -113.4 24.38 12.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.867 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . 0.412 ' C ' ' HB2' ' A' ' 659' ' ' LEU . . . 38.14 27.84 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.493 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 693' ' ' CYS . . . . . 0.461 ' N ' ' O ' ' A' ' 691' ' ' LYS . 31.2 p -132.46 129.13 38.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.843 0.354 . . . . 0.0 110.89 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -141.79 -163.47 9.62 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.487 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . 0.505 HG22 ' CE2' ' A' ' 680' ' ' TYR . 13.4 m -142.93 153.1 17.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.857 0.36 . . . . 0.0 111.086 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 93.4 t -139.34 118.04 12.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.136 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 697' ' ' LYS . . . . . 0.419 ' CB ' ' HB3' ' A' ' 680' ' ' TYR . 27.0 tttt -101.43 148.04 25.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.906 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 698' ' ' PHE . . . . . 0.56 ' CD2' HG11 ' A' ' 703' ' ' VAL . 96.4 m-85 -123.31 173.99 7.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 699' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -82.47 -44.13 16.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.918 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 1.1 t -103.41 143.01 25.77 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.692 0.758 . . . . 0.0 110.863 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -20.71 34.73 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.682 2.254 . . . . 0.0 112.343 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -75.56 -41.68 54.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.853 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 703' ' ' VAL . . . . . 0.56 HG11 ' CD2' ' A' ' 698' ' ' PHE . 66.0 t -56.02 -55.71 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.108 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -46.75 -43.91 18.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.092 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -60.03 -34.07 72.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.845 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 26.9 ttm180 -79.95 -57.83 3.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.89 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 707' ' ' ALA . . . . . 0.452 ' HB2' ' CB ' ' A' ' 675' ' ' CYS . . . -45.4 -33.13 2.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.059 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 708' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -53.17 -52.67 58.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.887 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.73 -40.85 32.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 61.1 mtp -56.86 -17.64 10.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 711' ' ' MET . . . . . 0.547 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 4.9 mmm -117.59 -24.81 7.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.856 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 712' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -48.55 114.06 0.89 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.926 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 82.58 31.88 29.05 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.532 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 714' ' ' MET . . . . . . . . . . . . . 63.0 ttp -82.75 105.86 14.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.84 0.352 . . . . 0.0 110.915 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 7.0 mmtp -60.66 100.42 0.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.889 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 716' ' ' LEU . . . . . 0.498 ' O ' ' N ' ' A' ' 719' ' ' ARG . 31.2 mt -99.89 125.56 45.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.945 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 717' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 716' ' ' LEU . 48.3 t 36.93 38.62 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.854 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 79.39 34.78 31.37 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.517 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 719' ' ' ARG . . . . . 0.498 ' N ' ' O ' ' A' ' 716' ' ' LEU . 37.3 mtp85 -146.65 112.76 5.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.748 0.308 . . . . 0.0 110.891 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -70.74 123.6 22.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.854 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 31.7 pt -99.95 156.23 4.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.16 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -114.46 105.04 12.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.875 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 21.9 t -100.79 132.42 46.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.09 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -154.66 161.43 41.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.878 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 725' ' ' ILE . . . . . . . . . . . . . 14.9 mm -72.53 134.64 29.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.134 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -84.98 82.39 8.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.884 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 727' ' ' ARG . . . . . . . . . . . . . 33.0 mtt180 -81.65 40.79 0.6 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.843 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 728' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -129.22 -37.76 1.64 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.87 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 729' ' ' ALA . . . . . . . . . . . . . . . -42.38 -47.54 4.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.141 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 34.5 t -53.26 108.05 0.29 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.835 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 731' ' ' GLY . . . . . . . . . . . . . . . 114.56 76.43 0.69 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.516 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 732' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -7.62 21.53 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.628 2.219 . . . . 0.0 112.344 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 733' ' ' SER . . . . . . . . . . . . . 20.7 t 64.23 37.42 8.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.891 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 734' ' ' SER . . . . . . . . . . . . . 28.6 t -137.93 125.94 22.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.879 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 735' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.479 -179.956 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 645' ' ' SER . . . . . . . . . . . . . 41.5 t -139.02 110.22 6.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.859 0.362 . . . . 0.0 110.84 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 646' ' ' SER . . . . . . . . . . . . . 35.5 p -109.64 -44.41 3.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.899 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -150.12 -149.19 4.95 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.519 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 2.2 t -99.9 91.24 4.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.874 0.368 . . . . 0.0 110.839 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 82.5 p -97.68 152.46 19.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.877 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . -175.69 127.88 1.32 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.453 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 651' ' ' ALA . . . . . . . . . . . . . . . -73.81 110.71 8.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.76 0.314 . . . . 0.0 111.061 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 63.1 m -113.32 -36.86 4.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.917 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -94.05 151.42 19.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.911 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 654' ' ' ILE . . . . . 0.51 HD13 ' CE2' ' A' ' 672' ' ' PHE . 20.7 pt -138.69 174.04 10.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.162 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -126.56 156.43 40.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.888 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 3.4 t -142.05 149.68 19.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.152 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -144.81 154.64 42.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.874 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 658' ' ' ASN . . . . . 0.457 ' ND2' ' HB3' ' A' ' 719' ' ' ARG . 4.1 t30 73.56 44.88 0.28 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.868 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . . . . . . . . . 36.3 mt -96.71 144.45 27.86 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.66 0.743 . . . . 0.0 110.86 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -48.0 139.5 20.19 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.676 2.251 . . . . 0.0 112.364 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -62.11 -24.92 67.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.894 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -94.32 3.26 55.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.921 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 663' ' ' PHE . . . . . 0.485 ' CD1' ' HE3' ' A' ' 667' ' ' MET . 2.8 t80 -70.72 124.39 24.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.881 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 38.7 p -104.22 169.04 8.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.155 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 665' ' ' TRP . . . . . 0.642 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 7.6 p-90 -63.51 -52.15 62.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.947 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 666' ' ' LYS . . . . . 0.642 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 0.0 OUTLIER -47.06 -43.1 19.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.883 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 667' ' ' MET . . . . . 0.485 ' HE3' ' CD1' ' A' ' 663' ' ' PHE . 30.5 mtm -68.31 -50.86 50.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 668' ' ' LEU . . . . . 0.46 HD12 ' CD1' ' A' ' 672' ' ' PHE . 14.2 tp -48.2 -47.26 35.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.866 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 44.2 tttt -59.54 -74.07 0.08 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.901 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -45.38 -28.23 0.82 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.845 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 26.6 tptt -68.64 -39.65 80.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.855 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 672' ' ' PHE . . . . . 0.51 ' CE2' HD13 ' A' ' 654' ' ' ILE . 13.6 m-85 -88.37 -14.01 39.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.866 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -56.53 -35.85 68.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.877 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -42.22 -41.86 2.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.877 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 3.0 t -70.62 -59.78 2.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.852 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -148.81 -153.96 6.17 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.494 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -95.54 104.52 16.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.859 0.361 . . . . 0.0 110.86 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 678' ' ' VAL . . . . . 0.474 HG23 ' CE2' ' A' ' 698' ' ' PHE . 57.9 t -82.7 136.06 23.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.128 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 12.8 mt -109.97 -59.12 1.97 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.935 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 680' ' ' TYR . . . . . 0.559 ' CE2' HG21 ' A' ' 695' ' ' VAL . 9.5 t80 -96.99 129.79 44.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.956 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -157.78 122.96 4.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.093 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -148.09 166.54 27.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.835 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 45.2 mm -114.47 106.86 21.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.115 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 36.5 mmtm -62.03 143.29 56.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.912 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 685' ' ' MET . . . . . . . . . . . . . 40.7 mtp -138.13 154.98 49.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.851 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -137.12 118.09 14.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 687' ' ' ASN . . . . . . . . . . . . . 21.4 t30 73.56 27.8 1.77 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.898 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 688' ' ' GLY . . . . . . . . . . . . . . . 78.84 17.17 77.78 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.526 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 17.7 pttt -138.42 131.46 29.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.771 0.319 . . . . 0.0 110.882 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 690' ' ' SER . . . . . . . . . . . . . 7.9 t -48.93 162.78 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.885 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 19.3 mmtt -129.8 17.29 5.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.925 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 55.76 23.7 38.12 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.488 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 27.5 p -131.95 127.34 36.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.866 0.365 . . . . 0.0 110.91 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -142.25 -169.16 12.02 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.489 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . 0.559 HG21 ' CE2' ' A' ' 680' ' ' TYR . 27.5 m -139.07 166.97 21.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.891 0.377 . . . . 0.0 111.127 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 93.0 t -154.75 121.86 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.129 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 20.7 ttpt -105.97 143.08 34.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.911 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 698' ' ' PHE . . . . . 0.543 ' CD2' HG12 ' A' ' 703' ' ' VAL . 96.6 m-85 -118.4 169.24 9.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.878 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 699' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -76.7 -45.3 30.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.869 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 31.4 m -104.49 147.37 34.28 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.667 0.746 . . . . 0.0 110.887 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -31.53 20.37 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.687 2.258 . . . . 0.0 112.343 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 702' ' ' GLU . . . . . 0.441 ' HG3' ' N ' ' A' ' 703' ' ' VAL . 11.2 pt-20 -61.47 -42.92 99.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.873 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 703' ' ' VAL . . . . . 0.543 HG12 ' CD2' ' A' ' 698' ' ' PHE . 94.6 t -53.0 -59.36 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.168 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -40.63 -65.74 0.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.084 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -41.07 -37.69 0.89 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.891 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -75.43 -64.47 1.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.845 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -40.17 -35.33 0.39 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.109 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 708' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -53.26 -56.19 18.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -77.36 -38.63 49.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.861 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 17.8 mmm -57.12 -23.15 45.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.903 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 711' ' ' MET . . . . . 0.403 ' CB ' HG22 ' A' ' 723' ' ' VAL . 4.7 mmm -111.74 -34.75 5.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 712' ' ' ASN . . . . . 0.436 ' OD1' ' C ' ' A' ' 712' ' ' ASN . 9.9 t-20 -38.03 112.71 0.23 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.894 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 84.21 27.96 35.2 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.493 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 714' ' ' MET . . . . . . . . . . . . . 37.2 ttp -77.67 99.04 5.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.861 0.363 . . . . 0.0 110.902 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 11.8 mmtp -56.06 98.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.874 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 716' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 719' ' ' ARG . 31.5 mt -100.0 125.35 46.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.918 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 717' ' ' SER . . . . . . . . . . . . . 34.7 t 38.86 38.49 0.28 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.843 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 78.55 30.96 47.19 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.487 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 719' ' ' ARG . . . . . 0.504 ' N ' ' O ' ' A' ' 716' ' ' LEU . 45.5 mtt180 -141.13 114.55 8.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.84 0.353 . . . . 0.0 110.873 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -73.34 126.1 29.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.878 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 44.9 pt -100.0 162.77 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.118 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -119.07 101.38 7.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.878 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 723' ' ' VAL . . . . . 0.403 HG22 ' CB ' ' A' ' 711' ' ' MET . 10.0 t -100.83 132.12 47.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.122 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 50.7 mtp180 -155.99 163.55 39.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.874 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 725' ' ' ILE . . . . . . . . . . . . . 25.0 mm -64.8 135.77 27.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.148 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -91.79 74.6 5.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.893 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 727' ' ' ARG . . . . . . . . . . . . . 2.7 tpm_? -49.04 149.63 1.85 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.884 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 728' ' ' ASN . . . . . . . . . . . . . 33.7 t-20 63.95 44.04 4.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.93 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 729' ' ' ALA . . . . . . . . . . . . . . . -75.2 -59.65 2.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.093 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 11.5 t -99.05 -57.38 2.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.863 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 731' ' ' GLY . . . . . . . . . . . . . . . 151.57 167.79 15.32 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.478 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 732' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 136.31 32.86 Favored 'Trans proline' 0 N--CA 1.465 -0.153 0 C-N-CA 122.726 2.284 . . . . 0.0 112.363 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 733' ' ' SER . . . . . . . . . . . . . 82.6 p -78.39 130.03 35.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.843 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 734' ' ' SER . . . . . . . . . . . . . 15.5 t -88.22 -49.6 6.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.877 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 735' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.272 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.439 179.979 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 645' ' ' SER . . . . . . . . . . . . . 1.8 t -81.59 126.41 31.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.855 0.36 . . . . 0.0 110.887 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 646' ' ' SER . . . . . . . . . . . . . 26.1 m -142.35 163.88 31.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.836 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . 85.46 -60.48 4.71 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.506 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 28.7 p -86.34 92.68 8.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.858 0.361 . . . . 0.0 110.84 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 14.7 m -85.12 131.37 34.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.85 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 97.75 119.48 3.95 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.503 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 651' ' ' ALA . . . . . 0.419 ' O ' ' CB ' ' A' ' 704' ' ' ALA . . . -133.85 107.84 8.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.793 0.33 . . . . 0.0 111.111 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 64.4 m -108.14 -30.43 8.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.852 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -96.56 154.06 17.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.945 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 654' ' ' ILE . . . . . 0.457 HD12 ' CE2' ' A' ' 672' ' ' PHE . 28.7 pt -141.87 170.05 13.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.114 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -122.39 153.73 38.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.891 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 3.5 t -139.95 148.41 22.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.142 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 38.4 mtp180 -146.73 155.79 42.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.871 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 658' ' ' ASN . . . . . 0.464 ' ND2' ' HB3' ' A' ' 719' ' ' ARG . 3.8 t30 71.28 51.57 0.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.422 ' HB2' ' C ' ' A' ' 692' ' ' GLY . 39.2 mt -101.35 143.48 26.67 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.623 0.725 . . . . 0.0 110.893 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 660' ' ' PRO . . . . . 0.477 ' O ' ' N ' ' A' ' 663' ' ' PHE . 66.6 Cg_exo -48.01 126.0 12.5 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.701 2.267 . . . . 0.0 112.336 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -40.79 -40.69 1.39 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.864 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 662' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 663' ' ' PHE . 22.8 t70 -73.16 -33.67 65.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.853 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 663' ' ' PHE . . . . . 0.477 ' N ' ' O ' ' A' ' 660' ' ' PRO . 4.1 t80 -36.31 119.91 0.63 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.895 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 74.4 p -104.88 -179.95 4.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.174 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 665' ' ' TRP . . . . . 0.62 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 6.5 p-90 -71.54 -50.23 33.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.894 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 666' ' ' LYS . . . . . 0.62 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 22.7 tptt -48.7 -43.72 37.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.872 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 27.4 mtm -66.09 -51.92 53.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.912 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 15.5 tp -46.21 -45.9 17.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.885 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 29.9 tttm -60.54 -73.99 0.08 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.885 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -47.07 -28.46 1.73 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.887 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 17.5 tptt -64.6 -41.24 96.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.888 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 672' ' ' PHE . . . . . 0.514 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 21.8 m-85 -88.89 -14.57 36.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.848 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -52.51 -40.19 62.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.897 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -44.6 -37.49 3.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.863 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 88.4 m -73.2 -58.51 3.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.883 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -152.95 -153.92 6.52 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.485 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 677' ' ' HIS . . . . . 0.443 ' CD2' ' CD2' ' A' ' 679' ' ' LEU . 8.9 t60 -92.84 106.57 18.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.87 0.367 . . . . 0.0 110.829 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 87.0 t -84.34 127.66 39.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.105 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 679' ' ' LEU . . . . . 0.443 ' CD2' ' CD2' ' A' ' 677' ' ' HIS . 12.0 mt -103.57 -60.16 1.61 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.937 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -99.27 129.06 45.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.921 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -157.65 121.41 4.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.092 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -153.23 156.77 39.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.871 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 37.9 mm -99.44 102.65 13.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.109 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -57.64 139.22 54.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.898 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 685' ' ' MET . . . . . 0.443 ' HE1' ' N ' ' A' ' 690' ' ' SER . 21.6 mtp -137.06 166.82 22.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.904 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -129.59 94.88 3.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.86 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 687' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 70.93 39.36 1.03 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 688' ' ' GLY . . . . . . . . . . . . . . . 74.04 43.64 32.74 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.496 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 689' ' ' LYS . . . . . 0.402 ' C ' ' HE1' ' A' ' 685' ' ' MET . 26.8 mmmt -139.14 135.69 34.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.788 0.328 . . . . 0.0 110.889 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 690' ' ' SER . . . . . 0.443 ' N ' ' HE1' ' A' ' 685' ' ' MET . 35.9 p -75.61 119.78 20.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.824 -179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm -103.53 13.96 32.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.941 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . 0.422 ' C ' ' HB2' ' A' ' 659' ' ' LEU . . . 53.36 25.9 28.11 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.56 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 31.8 p -127.44 142.13 51.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.843 0.354 . . . . 0.0 110.903 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -150.62 -168.07 15.13 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.503 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 7.1 m -141.62 157.97 21.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.87 0.366 . . . . 0.0 111.131 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 91.6 t -147.52 118.67 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.139 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 14.5 ttpt -105.96 137.24 44.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.922 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 698' ' ' PHE . . . . . 0.468 ' CD2' HG13 ' A' ' 703' ' ' VAL . 96.2 m-85 -111.91 173.71 6.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.845 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 699' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -79.14 -40.77 30.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.865 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 5.5 m -110.18 148.64 38.76 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.63 0.729 . . . . 0.0 110.825 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -17.68 37.4 Favored 'Trans proline' 0 N--CA 1.465 -0.153 0 C-N-CA 122.693 2.262 . . . . 0.0 112.351 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -78.21 -49.27 14.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.862 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 703' ' ' VAL . . . . . 0.468 HG13 ' CD2' ' A' ' 698' ' ' PHE . 60.9 t -46.51 -42.1 5.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.159 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 704' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 651' ' ' ALA . . . -59.48 -61.54 2.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.126 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -45.7 -32.43 2.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.897 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 44.5 ttt180 -80.77 -43.98 19.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.867 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -61.06 -62.5 1.81 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.137 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 708' ' ' CYS . . . . . 0.465 ' HA ' ' CG1' ' A' ' 723' ' ' VAL . 26.5 p -47.13 -29.71 2.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.912 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 16.6 mtt85 -89.56 -25.24 21.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.838 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 44.2 mtp -87.57 -12.02 46.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.874 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 711' ' ' MET . . . . . 0.514 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 8.9 mmm -110.82 -23.15 11.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 712' ' ' ASN . . . . . 0.43 ' O ' ' CG ' ' A' ' 712' ' ' ASN . 0.5 OUTLIER -42.6 117.29 1.0 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.857 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 79.78 21.58 65.83 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.49 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 714' ' ' MET . . . . . 0.439 ' HB3' ' CD1' ' A' ' 721' ' ' ILE . 31.8 ttp -65.54 94.1 0.18 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.843 0.354 . . . . 0.0 110.871 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 715' ' ' LYS . . . . . 0.408 ' NZ ' ' HA2' ' A' ' 718' ' ' GLY . 1.7 mmmt -55.91 99.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.881 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 716' ' ' LEU . . . . . 0.499 ' O ' ' N ' ' A' ' 719' ' ' ARG . 58.2 mt -100.08 132.28 45.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.871 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 717' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 716' ' ' LEU . 15.7 t 35.92 36.41 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.874 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 718' ' ' GLY . . . . . 0.408 ' HA2' ' NZ ' ' A' ' 715' ' ' LYS . . . 77.99 38.98 25.26 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.502 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 719' ' ' ARG . . . . . 0.499 ' N ' ' O ' ' A' ' 716' ' ' LEU . 39.3 mtt85 -149.23 107.52 3.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.77 0.319 . . . . 0.0 110.883 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -62.73 123.83 19.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . 0.439 ' CD1' ' HB3' ' A' ' 714' ' ' MET . 24.9 pt -99.62 155.89 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.13 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -110.73 110.12 20.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.876 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 723' ' ' VAL . . . . . 0.465 ' CG1' ' HA ' ' A' ' 708' ' ' CYS . 2.7 t -109.39 136.87 43.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.14 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -157.95 169.99 23.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.851 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 725' ' ' ILE . . . . . . . . . . . . . 46.6 mm -77.31 143.09 13.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.126 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -94.12 98.95 11.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.889 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 727' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -59.69 -45.96 90.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.836 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 728' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -96.1 77.92 3.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.871 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 729' ' ' ALA . . . . . . . . . . . . . . . -119.89 114.52 22.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.127 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 3.5 m -156.57 159.18 38.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.854 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 731' ' ' GLY . . . . . . . . . . . . . . . 170.75 172.42 37.03 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.494 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 732' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 -14.94 36.8 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.727 2.284 . . . . 0.0 112.347 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 733' ' ' SER . . . . . 0.425 ' O ' ' C ' ' A' ' 734' ' ' SER . 4.5 t -46.6 104.61 0.05 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.889 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 734' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 733' ' ' SER . 32.5 p -36.56 -47.27 0.62 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.832 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 735' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.547 -179.922 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 645' ' ' SER . . . . . . . . . . . . . 6.3 t -66.07 -57.21 8.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.897 0.379 . . . . 0.0 110.861 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 646' ' ' SER . . . . . . . . . . . . . 56.9 p -105.82 139.96 39.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.867 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . 165.01 67.79 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.472 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 29.0 t -105.75 131.59 52.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.885 0.374 . . . . 0.0 110.881 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 39.7 m -116.36 94.53 4.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.886 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 138.22 70.27 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.481 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 651' ' ' ALA . . . . . . . . . . . . . . . -128.96 110.45 12.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.748 0.309 . . . . 0.0 111.094 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 81.6 m -105.37 -34.71 7.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.883 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -95.09 150.19 20.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.888 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 654' ' ' ILE . . . . . 0.437 ' CD1' ' CE2' ' A' ' 672' ' ' PHE . 29.2 pt -135.47 176.5 8.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.139 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -131.53 143.47 50.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.884 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 11.1 t -129.97 145.93 34.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.134 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -136.25 168.97 18.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.874 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 658' ' ' ASN . . . . . . . . . . . . . 8.5 t30 60.08 47.23 9.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.869 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.438 HD23 ' CD2' ' A' ' 663' ' ' PHE . 53.8 mt -95.14 143.59 26.37 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.629 0.728 . . . . 0.0 110.916 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -47.94 145.04 10.83 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.651 2.234 . . . . 0.0 112.345 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -61.88 -33.18 73.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.91 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -89.41 7.91 33.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.864 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 663' ' ' PHE . . . . . 0.438 ' CD2' HD23 ' A' ' 659' ' ' LEU . 2.9 t80 -73.87 114.17 11.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 57.9 p -100.14 166.01 11.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.184 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 665' ' ' TRP . . . . . 0.587 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 10.6 p-90 -55.9 -46.72 78.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.906 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 666' ' ' LYS . . . . . 0.587 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 4.2 tppp? -48.53 -52.61 21.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.889 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 14.5 mtm -60.58 -54.81 40.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.869 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 26.2 tp -45.97 -45.59 15.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.942 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.4 ' C ' ' N ' ' A' ' 671' ' ' LYS . 33.9 tttm -64.57 -74.79 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.855 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -45.91 -21.73 0.15 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.851 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 671' ' ' LYS . . . . . 0.408 ' HG3' ' CE ' ' A' ' 711' ' ' MET . 6.2 tppt? -71.61 -45.75 61.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.893 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 672' ' ' PHE . . . . . 0.502 ' CD1' HG23 ' A' ' 696' ' ' VAL . 23.7 m-85 -84.36 -8.81 58.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.904 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -58.88 -30.08 67.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.89 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -49.01 -43.3 40.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.897 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 19.2 t -66.6 -62.27 1.54 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.873 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -147.6 -148.19 4.7 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.489 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 677' ' ' HIS . . . . . 0.479 ' CD2' HD21 ' A' ' 679' ' ' LEU . 6.6 t60 -98.68 101.64 13.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.794 0.33 . . . . 0.0 110.889 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 98.8 t -76.81 136.29 24.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.122 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 679' ' ' LEU . . . . . 0.479 HD21 ' CD2' ' A' ' 677' ' ' HIS . 18.2 mt -110.33 -62.74 1.47 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.928 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -95.98 126.4 41.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.94 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -156.84 125.9 5.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.103 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -157.5 157.24 33.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.862 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 45.5 mm -97.74 104.17 15.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.155 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -60.19 135.87 57.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 685' ' ' MET . . . . . . . . . . . . . 25.5 mtp -134.8 167.42 20.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.926 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -131.12 106.85 8.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.9 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 687' ' ' ASN . . . . . . . . . . . . . 45.8 t30 56.26 43.38 26.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.917 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 688' ' ' GLY . . . . . . . . . . . . . . . 74.21 37.51 48.48 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.458 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 25.9 mtmm -139.38 129.69 25.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.844 0.354 . . . . 0.0 110.89 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 690' ' ' SER . . . . . . . . . . . . . 19.4 t -72.62 132.24 43.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -112.27 24.41 12.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.886 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 43.77 36.37 3.55 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.447 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 28.9 p -137.97 142.49 40.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.845 0.355 . . . . 0.0 110.906 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -152.56 -160.78 9.82 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.468 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 10.3 m -149.54 156.73 7.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.869 0.366 . . . . 0.0 111.127 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 696' ' ' VAL . . . . . 0.502 HG23 ' CD1' ' A' ' 672' ' ' PHE . 67.0 t -146.14 118.37 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.086 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 15.8 tttt -104.22 146.03 29.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.901 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 698' ' ' PHE . . . . . 0.525 ' CD2' HG12 ' A' ' 703' ' ' VAL . 92.1 m-85 -122.11 164.79 17.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.861 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 699' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -68.76 -42.16 77.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.88 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 26.4 m -110.92 147.16 35.94 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.703 0.763 . . . . 0.0 110.824 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -29.16 24.17 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.698 2.265 . . . . 0.0 112.333 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -63.5 -40.92 98.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 703' ' ' VAL . . . . . 0.525 HG12 ' CD2' ' A' ' 698' ' ' PHE . 94.7 t -58.83 -57.1 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.058 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -43.19 -66.71 0.34 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.127 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -39.34 -39.29 0.63 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.902 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 706' ' ' ARG . . . . . 0.429 ' O ' ' N ' ' A' ' 708' ' ' CYS . 16.1 ttm-85 -73.46 -64.11 1.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.882 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -38.95 -29.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.087 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 708' ' ' CYS . . . . . 0.429 ' N ' ' O ' ' A' ' 706' ' ' ARG . 1.2 t -61.81 -49.47 76.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.832 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -77.19 -33.11 56.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.851 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 59.7 mtp -70.04 -16.37 63.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.843 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 711' ' ' MET . . . . . 0.42 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 5.3 mmm -118.93 -20.41 8.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.892 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 712' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -53.28 122.48 9.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.92 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 74.68 23.5 74.97 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.515 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 714' ' ' MET . . . . . . . . . . . . . 42.4 ttp -76.4 111.05 11.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.859 0.362 . . . . 0.0 110.885 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 19.4 mmtt -63.34 102.53 0.41 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.942 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 716' ' ' LEU . . . . . 0.498 ' O ' ' N ' ' A' ' 719' ' ' ARG . 36.9 mt -99.98 122.98 43.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.905 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 717' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 716' ' ' LEU . 1.3 t 37.3 42.1 0.28 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 76.97 32.7 48.4 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.418 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 719' ' ' ARG . . . . . 0.498 ' N ' ' O ' ' A' ' 716' ' ' LEU . 21.9 mtp180 -146.83 110.73 5.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.805 0.336 . . . . 0.0 110.867 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -68.55 125.38 26.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.842 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . 0.459 HG21 ' CD1' ' A' ' 716' ' ' LEU . 26.7 pt -99.55 155.0 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.111 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -111.32 104.58 13.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.885 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 3.7 t -100.67 131.99 47.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.096 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -155.56 160.37 40.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.897 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 725' ' ' ILE . . . . . . . . . . . . . 33.9 mm -60.86 135.96 25.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.118 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -87.38 86.39 7.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.917 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 727' ' ' ARG . . . . . . . . . . . . . 4.1 tpt85 -44.98 144.6 1.16 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.889 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 728' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 63.62 54.53 1.86 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.914 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 729' ' ' ALA . . . . . . . . . . . . . . . -99.0 41.41 1.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.081 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 77.9 p -123.69 118.44 27.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.852 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 731' ' ' GLY . . . . . . . . . . . . . . . -51.06 -76.28 0.18 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.496 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 732' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 85.18 0.63 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.666 2.244 . . . . 0.0 112.35 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 733' ' ' SER . . . . . . . . . . . . . 37.5 t -72.44 -42.96 64.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.874 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 734' ' ' SER . . . . . . . . . . . . . 58.2 m -53.66 171.74 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.802 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 735' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.477 179.95 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 645' ' ' SER . . . . . . . . . . . . . 84.7 p -167.97 112.48 0.65 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.854 0.359 . . . . 0.0 110.885 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 646' ' ' SER . . . . . . . . . . . . . 38.7 m -43.94 126.95 5.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.882 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . 142.11 105.59 0.57 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.493 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 22.1 m -138.74 148.16 43.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.881 0.372 . . . . 0.0 110.861 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 70.1 p -98.53 115.48 28.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.879 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 156.48 83.6 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.513 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 651' ' ' ALA . . . . . . . . . . . . . . . -134.22 90.54 2.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.801 0.334 . . . . 0.0 111.119 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 60.2 m -96.52 -30.84 13.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.868 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -98.31 156.27 16.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.913 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 654' ' ' ILE . . . . . 0.425 ' CG2' ' SG ' ' A' ' 708' ' ' CYS . 43.7 pt -142.7 166.94 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.125 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -119.12 156.49 29.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.926 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 3.3 t -143.75 151.06 16.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.133 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 49.3 mtp180 -147.27 156.74 43.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.858 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 658' ' ' ASN . . . . . 0.424 ' ND2' ' HB3' ' A' ' 719' ' ' ARG . 6.6 t30 70.44 51.91 0.35 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.926 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.411 ' CD2' HD12 ' A' ' 716' ' ' LEU . 37.6 mt -100.75 143.55 26.78 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.63 0.728 . . . . 0.0 110.902 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 660' ' ' PRO . . . . . 0.453 ' O ' ' N ' ' A' ' 663' ' ' PHE . 64.4 Cg_exo -47.97 128.64 16.78 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.683 2.255 . . . . 0.0 112.346 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -43.09 -31.96 0.63 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.869 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -82.81 -32.54 27.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.864 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 663' ' ' PHE . . . . . 0.453 ' N ' ' O ' ' A' ' 660' ' ' PRO . 4.2 t80 -40.23 113.16 0.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 24.8 p -104.81 -177.48 3.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.121 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 665' ' ' TRP . . . . . 0.646 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 8.2 p-90 -66.76 -52.26 46.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 666' ' ' LYS . . . . . 0.646 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 22.8 tptp -44.78 -55.0 5.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.907 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 11.9 mtm -60.42 -46.01 91.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.866 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 27.9 tp -51.44 -42.97 61.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.919 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.41 ' O ' ' ND2' ' A' ' 673' ' ' ASN . 29.2 tttm -65.64 -74.41 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.909 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -45.86 -24.42 0.39 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.821 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? -68.9 -52.74 26.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.898 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 672' ' ' PHE . . . . . 0.444 ' CD1' HG22 ' A' ' 696' ' ' VAL . 23.3 m-85 -76.99 -13.72 59.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.899 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 673' ' ' ASN . . . . . 0.41 ' ND2' ' O ' ' A' ' 669' ' ' LYS . 1.5 m-80 -52.86 -28.37 22.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.871 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -50.49 -46.64 57.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.897 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 675' ' ' CYS . . . . . 0.464 ' CB ' ' HB3' ' A' ' 707' ' ' ALA . 12.4 t -64.4 -61.18 2.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.902 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -152.33 -147.38 4.58 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.465 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -95.41 114.13 25.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.79 0.329 . . . . 0.0 110.867 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 77.7 t -88.39 123.51 40.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.135 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 19.2 mt -97.11 -61.93 1.33 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.916 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 680' ' ' TYR . . . . . 0.429 ' CE2' HG21 ' A' ' 695' ' ' VAL . 6.3 t80 -99.84 123.7 44.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.935 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -149.41 121.68 8.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.099 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -155.8 155.81 33.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.878 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 28.1 mm -101.62 105.95 18.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.123 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -53.76 142.1 24.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.874 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 685' ' ' MET . . . . . . . . . . . . . 31.3 mtp -139.94 166.26 25.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -134.72 115.47 13.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.863 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 687' ' ' ASN . . . . . . . . . . . . . 23.5 m-20 46.69 40.84 9.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.887 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 688' ' ' GLY . . . . . . . . . . . . . . . 76.42 32.62 50.87 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.483 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -131.82 128.97 39.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.789 0.328 . . . . 0.0 110.873 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 690' ' ' SER . . . . . . . . . . . . . 7.3 m -72.63 143.16 48.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.872 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 35.5 mmtm -120.53 7.75 10.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.921 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 58.47 16.81 30.31 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.472 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 1.9 p -123.45 129.68 51.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.826 0.346 . . . . 0.0 110.895 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -136.45 -159.6 8.45 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.5 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . 0.429 HG21 ' CE2' ' A' ' 680' ' ' TYR . 13.5 m -148.13 155.82 9.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.872 0.367 . . . . 0.0 111.134 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 696' ' ' VAL . . . . . 0.523 HG13 ' CZ ' ' A' ' 698' ' ' PHE . 91.7 t -143.8 119.42 4.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.182 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 28.2 tttt -104.36 140.45 37.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.916 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 698' ' ' PHE . . . . . 0.556 ' CD2' HG11 ' A' ' 703' ' ' VAL . 96.0 m-85 -117.99 167.99 10.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.899 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 699' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -76.2 -39.25 55.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 1.8 t -108.83 142.98 26.64 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.633 0.73 . . . . 0.0 110.847 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -24.59 29.75 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.676 2.251 . . . . 0.0 112.373 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 702' ' ' GLU . . . . . 0.424 ' HG3' ' N ' ' A' ' 703' ' ' VAL . 6.9 pt-20 -73.76 -34.11 64.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.886 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 703' ' ' VAL . . . . . 0.556 HG11 ' CD2' ' A' ' 698' ' ' PHE . 38.2 t -61.7 -56.96 14.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.142 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -43.39 -62.44 1.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.107 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -43.35 -43.08 4.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.906 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 16.0 ttm180 -66.08 -58.31 5.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.834 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 707' ' ' ALA . . . . . 0.464 ' HB3' ' CB ' ' A' ' 675' ' ' CYS . . . -50.64 -34.05 24.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.097 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 708' ' ' CYS . . . . . 0.425 ' SG ' ' CG2' ' A' ' 654' ' ' ILE . 2.4 m -61.18 -42.25 98.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.892 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 709' ' ' ARG . . . . . 0.407 ' O ' ' ND2' ' A' ' 712' ' ' ASN . 18.8 mtt180 -84.15 -20.11 33.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.849 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 17.1 mtm -88.79 -9.76 50.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.873 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 711' ' ' MET . . . . . 0.436 ' HE1' ' CE ' ' A' ' 714' ' ' MET . 5.7 mmm -120.45 -10.62 9.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.9 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 712' ' ' ASN . . . . . 0.407 ' ND2' ' O ' ' A' ' 709' ' ' ARG . 0.9 OUTLIER -53.98 126.74 23.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.857 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 69.63 8.12 59.58 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.496 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 714' ' ' MET . . . . . 0.436 ' CE ' ' HE1' ' A' ' 711' ' ' MET . 10.3 ttp -49.38 99.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.857 0.36 . . . . 0.0 110.859 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 10.3 mmtp -56.05 102.56 0.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.888 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 716' ' ' LEU . . . . . 0.411 HD12 ' CD2' ' A' ' 659' ' ' LEU . 12.2 mt -99.88 117.0 33.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.923 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 717' ' ' SER . . . . . . . . . . . . . 2.3 t 40.91 44.41 1.96 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.912 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 76.33 31.28 55.18 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.493 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 719' ' ' ARG . . . . . 0.424 ' HB3' ' ND2' ' A' ' 658' ' ' ASN . 23.9 mtp180 -144.26 106.89 4.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.757 0.313 . . . . 0.0 110.876 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -66.18 125.77 26.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.881 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . 0.427 ' CD1' ' HB3' ' A' ' 714' ' ' MET . 38.2 pt -97.79 156.4 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.109 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -110.61 98.09 7.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.855 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 3.2 t -94.84 134.93 30.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.12 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 25.6 mtt-85 -158.08 176.11 12.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.859 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 725' ' ' ILE . . . . . . . . . . . . . 10.1 mm -78.23 138.95 19.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.125 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -92.15 77.42 5.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.817 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 727' ' ' ARG . . . . . . . . . . . . . 7.1 tpp85 -45.34 -62.09 1.4 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 728' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -83.41 91.49 7.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.878 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 729' ' ' ALA . . . . . . . . . . . . . . . -128.46 110.52 12.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.125 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 41.6 t -115.44 -50.77 2.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 731' ' ' GLY . . . . . . . . . . . . . . . 117.92 -159.68 14.1 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.454 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 732' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 152.54 69.51 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.696 2.264 . . . . 0.0 112.351 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 733' ' ' SER . . . . . . . . . . . . . 49.9 m -44.73 -62.75 1.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.881 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 734' ' ' SER . . . . . . . . . . . . . 24.7 p -64.73 155.1 34.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.882 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 735' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.475 -179.998 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.467 -0.253 . . . . 0.0 112.467 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 645' ' ' SER . . . . . . . . . . . . . 26.5 p -53.69 117.61 3.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.851 0.357 . . . . 0.0 110.888 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 646' ' ' SER . . . . . . . . . . . . . 14.9 t -100.79 129.6 46.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.877 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . 149.95 121.51 1.07 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.531 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 34.0 p -138.64 141.27 39.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.841 0.353 . . . . 0.0 110.84 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 61.0 p -131.95 -53.63 0.99 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.882 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . -156.72 167.13 33.58 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.503 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 651' ' ' ALA . . . . . 0.416 ' CB ' HG22 ' A' ' 725' ' ' ILE . . . -101.34 95.86 6.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.793 0.33 . . . . 0.0 111.06 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 26.4 p -104.21 -26.13 12.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.883 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -104.29 146.6 28.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.895 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 654' ' ' ILE . . . . . . . . . . . . . 25.4 pt -135.27 172.66 15.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.138 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -128.21 149.59 50.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.868 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 4.0 t -132.19 152.87 37.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.095 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 69.8 mtt180 -146.81 160.08 42.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.88 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 658' ' ' ASN . . . . . 0.429 ' ND2' ' HB3' ' A' ' 719' ' ' ARG . 1.1 t30 66.94 48.51 1.27 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.914 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . . . . . . . . . 40.5 mt -98.71 145.41 29.87 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.635 0.731 . . . . 0.0 110.909 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_exo -47.98 126.17 12.74 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.692 2.261 . . . . 0.0 112.337 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -49.35 -25.97 2.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.857 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -88.01 -24.95 23.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -41.09 147.69 0.13 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.861 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 35.5 p -128.07 169.55 13.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.115 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 665' ' ' TRP . . . . . 0.644 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 5.6 p-90 -63.96 -53.0 57.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.894 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 666' ' ' LYS . . . . . 0.644 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 3.7 tppp? -47.55 -47.71 28.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.924 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 46.1 mtm -63.16 -50.64 69.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.88 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 29.7 tp -46.66 -45.65 19.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.931 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 30.9 tttm -60.72 -72.36 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.925 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -47.04 -25.07 0.74 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.902 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 17.0 tptt -68.76 -43.63 75.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.892 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 672' ' ' PHE . . . . . 0.506 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 23.8 m-85 -87.38 -13.42 43.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.889 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -50.71 -36.69 37.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.852 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -51.22 -39.79 57.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.857 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 675' ' ' CYS . . . . . 0.455 ' CB ' ' HB1' ' A' ' 707' ' ' ALA . 37.4 m -72.01 -42.29 66.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -177.16 170.12 42.64 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.483 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 677' ' ' HIS . . . . . 0.532 ' CD2' HD21 ' A' ' 679' ' ' LEU . 3.4 t-160 -59.56 114.91 2.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.85 0.357 . . . . 0.0 110.888 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 41.4 t -90.63 139.69 17.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.1 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 679' ' ' LEU . . . . . 0.532 HD21 ' CD2' ' A' ' 677' ' ' HIS . 13.8 mt -110.62 -63.8 1.35 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.932 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 680' ' ' TYR . . . . . 0.444 ' CE2' HG23 ' A' ' 695' ' ' VAL . 10.8 t80 -99.06 131.27 45.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.97 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -157.22 120.86 4.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.115 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -148.26 164.11 34.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.904 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 38.3 mm -109.18 106.58 20.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.11 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -57.02 133.34 54.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.935 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 685' ' ' MET . . . . . . . . . . . . . 22.0 mtp -130.54 160.84 32.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.881 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -133.05 96.73 3.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.887 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 687' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 61.51 39.29 15.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.865 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 688' ' ' GLY . . . . . . . . . . . . . . . 77.24 36.5 34.69 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.49 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 43.9 mttp -139.29 113.63 8.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.813 0.339 . . . . 0.0 110.856 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 690' ' ' SER . . . . . . . . . . . . . 77.1 p -56.99 131.58 50.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt -104.49 12.66 32.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 55.14 15.51 7.31 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.528 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 27.0 p -123.38 139.43 54.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.848 0.356 . . . . 0.0 110.896 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -143.39 -157.19 7.06 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.429 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . 0.444 HG23 ' CE2' ' A' ' 680' ' ' TYR . 6.9 m -152.58 151.86 11.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.885 0.374 . . . . 0.0 111.126 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 94.3 t -141.95 119.43 7.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.111 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 17.6 tttt -106.36 134.06 50.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.879 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -109.25 169.06 8.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.864 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 699' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -72.11 -37.67 69.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.867 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -115.15 143.96 31.26 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.658 0.742 . . . . 0.0 110.828 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -10.84 29.57 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.709 2.272 . . . . 0.0 112.327 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -82.6 -46.48 13.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.91 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 65.8 t -50.42 -47.84 26.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.162 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -49.3 -61.32 2.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.145 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -47.57 -23.5 0.67 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.878 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 45.1 ttt180 -87.08 -43.45 12.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.821 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 707' ' ' ALA . . . . . 0.455 ' HB1' ' CB ' ' A' ' 675' ' ' CYS . . . -65.03 -56.94 10.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.108 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 708' ' ' CYS . . . . . 0.42 ' HA ' ' CG1' ' A' ' 723' ' ' VAL . 13.8 p -42.98 -42.13 3.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.876 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 709' ' ' ARG . . . . . 0.405 ' N ' ' SG ' ' A' ' 708' ' ' CYS . 15.8 mtt180 -80.16 -34.91 37.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.897 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 14.8 mtm -78.07 -9.14 59.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.886 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 711' ' ' MET . . . . . 0.506 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 5.9 mmm -116.14 -20.18 9.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.888 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 712' ' ' ASN . . . . . 0.435 ' OD1' ' C ' ' A' ' 712' ' ' ASN . 10.3 t-20 -55.03 115.21 2.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.914 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 85.75 18.67 59.49 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.543 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 714' ' ' MET . . . . . . . . . . . . . 44.7 ttp -71.11 96.64 1.38 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.834 0.35 . . . . 0.0 110.887 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 5.4 mmtp -51.54 101.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 716' ' ' LEU . . . . . 0.452 ' O ' ' N ' ' A' ' 719' ' ' ARG . 33.9 mt -100.2 120.4 39.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.925 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 717' ' ' SER . . . . . . . . . . . . . 1.2 t 40.32 44.95 1.72 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.857 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 74.13 27.25 66.67 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.503 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 719' ' ' ARG . . . . . 0.452 ' N ' ' O ' ' A' ' 716' ' ' LEU . 44.1 mtt85 -139.31 109.57 6.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.728 0.299 . . . . 0.0 110.882 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -67.11 125.28 25.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.866 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 27.5 pt -99.96 156.22 4.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.161 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -116.28 104.55 11.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.862 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 723' ' ' VAL . . . . . 0.42 ' CG1' ' HA ' ' A' ' 708' ' ' CYS . 3.6 t -104.72 135.37 42.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.137 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 22.1 mtp85 -157.89 159.05 36.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.885 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 725' ' ' ILE . . . . . 0.416 HG22 ' CB ' ' A' ' 651' ' ' ALA . 35.6 mm -61.19 135.12 26.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.121 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -87.43 80.02 8.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 727' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -45.24 -45.07 11.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.817 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 728' ' ' ASN . . . . . 0.407 ' O ' ' C ' ' A' ' 729' ' ' ALA . 25.1 t-20 -86.62 41.47 0.95 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.907 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 729' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 728' ' ' ASN . . . -36.78 -55.46 0.89 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.13 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 1.4 t 41.53 36.29 0.54 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.867 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 731' ' ' GLY . . . . . . . . . . . . . . . -142.88 70.78 0.41 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.501 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 732' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -22.08 32.63 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.685 2.256 . . . . 0.0 112.347 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 733' ' ' SER . . . . . . . . . . . . . 33.5 t -40.1 145.36 0.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.846 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 734' ' ' SER . . . . . . . . . . . . . 32.9 t -149.36 112.75 4.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.806 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 735' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.498 179.984 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.371 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 645' ' ' SER . . . . . . . . . . . . . 83.5 p -131.81 139.88 49.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.915 0.388 . . . . 0.0 110.809 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 646' ' ' SER . . . . . . . . . . . . . 30.4 t -56.04 164.13 1.32 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.896 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . 74.27 96.54 0.11 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.494 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 2.5 m -122.45 44.8 2.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.857 0.361 . . . . 0.0 110.869 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 14.5 m -75.25 114.73 14.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.878 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 134.47 93.47 0.46 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.494 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 651' ' ' ALA . . . . . . . . . . . . . . . -166.64 105.32 0.61 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.779 0.323 . . . . 0.0 111.11 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 22.6 p -108.05 -24.79 11.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.867 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 653' ' ' GLN . . . . . 0.457 ' HG3' ' N ' ' A' ' 654' ' ' ILE . 8.1 tp60 -93.1 146.52 23.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.917 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 654' ' ' ILE . . . . . 0.487 ' CD1' ' CE2' ' A' ' 672' ' ' PHE . 40.2 pt -134.51 177.24 7.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.112 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -132.8 159.69 39.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.861 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 6.5 t -140.71 150.44 20.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.069 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 81.6 mtm-85 -146.68 157.43 43.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.883 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 658' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 67.15 54.43 0.74 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.905 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.443 HD21 ' CE2' ' A' ' 663' ' ' PHE . 38.7 mt -102.42 144.88 29.5 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.628 0.728 . . . . 0.0 110.908 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -48.0 133.47 23.33 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.648 2.232 . . . . 0.0 112.356 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -53.08 -28.34 24.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.867 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -86.64 -19.67 28.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.866 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 663' ' ' PHE . . . . . 0.501 ' CD1' ' HE2' ' A' ' 667' ' ' MET . 3.6 t80 -49.25 136.02 16.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.893 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 72.7 p -120.93 175.27 6.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.114 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 665' ' ' TRP . . . . . 0.65 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 5.3 p-90 -66.57 -51.05 60.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.889 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 666' ' ' LYS . . . . . 0.65 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 0.0 OUTLIER -45.86 -45.02 14.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.859 179.94 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 667' ' ' MET . . . . . 0.501 ' HE2' ' CD1' ' A' ' 663' ' ' PHE . 38.8 mtm -68.54 -52.19 34.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.925 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 30.0 tp -45.89 -42.4 12.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.933 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 44.8 tttt -65.95 -73.09 0.14 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.912 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -48.37 -23.77 1.03 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.876 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 16.1 tptt -69.68 -44.09 71.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.914 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 672' ' ' PHE . . . . . 0.497 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 16.9 m-85 -85.49 -14.8 44.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.911 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -55.25 -27.93 49.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.876 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -63.34 -19.87 65.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 34.1 m -89.38 -36.19 15.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.912 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -177.32 -154.78 12.54 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.485 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -91.93 108.64 20.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.884 0.373 . . . . 0.0 110.87 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 63.7 t -90.58 136.32 24.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.125 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 27.0 mt -110.44 -61.87 1.6 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.964 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -98.67 131.06 45.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.93 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -155.39 125.84 6.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.105 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -156.18 159.57 39.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.878 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 34.3 mm -105.38 97.44 5.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.126 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt -52.5 133.8 35.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.943 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 685' ' ' MET . . . . . . . . . . . . . 33.7 mtp -130.34 170.37 14.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.902 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -128.13 89.51 2.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.85 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 687' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 72.21 36.97 1.02 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.915 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 688' ' ' GLY . . . . . . . . . . . . . . . 78.59 35.01 33.67 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.444 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -135.58 125.65 26.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.778 0.323 . . . . 0.0 110.903 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 690' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.5 128.76 38.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.843 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 6.4 mmtp -110.15 4.78 21.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.871 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 60.48 28.17 67.04 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.482 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 26.5 p -136.18 142.24 44.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.88 0.371 . . . . 0.0 110.852 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -152.3 -164.91 12.71 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.499 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 6.8 m -148.51 155.9 8.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.853 0.359 . . . . 0.0 111.128 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 88.5 t -143.13 123.64 10.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.15 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 14.8 ttpt -103.28 139.07 39.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -116.71 165.15 13.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.89 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 699' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -72.32 -43.25 64.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.864 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 79.8 p -111.08 149.45 40.5 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.639 0.733 . . . . 0.0 110.836 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -29.29 24.03 Favored 'Trans proline' 0 C--N 1.34 0.122 0 C-N-CA 122.662 2.241 . . . . 0.0 112.346 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -63.26 -46.7 85.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.909 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 71.6 t -50.78 -56.51 4.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.128 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -45.05 -60.98 1.81 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.109 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -44.03 -35.16 1.98 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.885 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 -77.95 -59.78 2.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.913 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -43.25 -32.43 0.77 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.087 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 708' ' ' CYS . . . . . 0.498 ' O ' ' N ' ' A' ' 712' ' ' ASN . 7.0 t -57.29 -60.51 3.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.889 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -68.39 -30.63 69.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 15.3 mmm -70.59 -30.72 67.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.854 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 711' ' ' MET . . . . . 0.497 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 4.3 mmm -107.68 -9.71 15.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.915 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 712' ' ' ASN . . . . . 0.498 ' N ' ' O ' ' A' ' 708' ' ' CYS . 10.4 t-20 -62.35 114.49 3.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.859 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 85.14 13.2 71.98 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.467 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 714' ' ' MET . . . . . . . . . . . . . 53.1 ttp -59.66 100.9 0.09 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.86 0.362 . . . . 0.0 110.852 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 8.8 mmtp -62.67 100.51 0.2 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.876 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 716' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 719' ' ' ARG . 31.2 mt -100.0 128.23 46.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.931 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 717' ' ' SER . . . . . 0.435 ' C ' ' O ' ' A' ' 716' ' ' LEU . 3.1 t 35.44 37.99 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.897 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 79.5 37.98 22.3 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.492 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 719' ' ' ARG . . . . . 0.504 ' N ' ' O ' ' A' ' 716' ' ' LEU . 6.7 mtt-85 -148.08 113.46 5.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.797 0.332 . . . . 0.0 110.861 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -74.5 125.69 29.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.889 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 46.5 pt -99.67 153.66 4.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.108 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -109.03 97.9 7.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.858 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 723' ' ' VAL . . . . . 0.433 HG21 ' CB ' ' A' ' 711' ' ' MET . 11.9 t -94.46 135.23 29.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.107 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.04 176.04 13.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.832 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 725' ' ' ILE . . . . . . . . . . . . . 39.0 mm -78.5 143.88 12.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.135 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -97.82 103.25 15.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 727' ' ' ARG . . . . . 0.434 ' NH1' ' HB3' ' A' ' 727' ' ' ARG . 5.4 mmm180 -74.66 -54.96 6.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.859 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 728' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -42.9 -37.56 1.88 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.877 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 729' ' ' ALA . . . . . . . . . . . . . . . -46.1 -69.53 0.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.092 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 41.2 p -72.37 107.45 4.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.837 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 731' ' ' GLY . . . . . . . . . . . . . . . 79.23 86.09 0.55 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.507 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 732' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -23.94 30.29 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.645 2.23 . . . . 0.0 112.396 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 733' ' ' SER . . . . . . . . . . . . . 7.3 m -91.1 -54.18 4.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.87 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 734' ' ' SER . . . . . . . . . . . . . 11.9 t -63.95 116.98 6.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.882 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 735' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.466 -179.996 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 645' ' ' SER . . . . . . . . . . . . . 26.9 t -173.63 123.15 0.36 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.85 0.357 . . . . 0.0 110.833 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 646' ' ' SER . . . . . . . . . . . . . 27.1 p -136.98 144.42 43.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.868 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . 119.92 -127.73 7.24 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.457 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 67.0 p -145.74 144.86 30.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.842 0.353 . . . . 0.0 110.865 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 95.4 p -95.54 107.69 19.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.882 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . -175.59 69.32 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.45 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 651' ' ' ALA . . . . . 0.4 ' CB ' HG23 ' A' ' 725' ' ' ILE . . . -106.83 97.01 6.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.733 0.301 . . . . 0.0 111.089 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 36.7 m -108.23 -19.88 13.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.815 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -105.16 147.43 27.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.869 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 654' ' ' ILE . . . . . 0.484 ' CD1' ' CE2' ' A' ' 672' ' ' PHE . 40.9 pt -135.54 171.56 17.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.091 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -121.86 158.77 28.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.872 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 5.5 t -147.52 145.78 18.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.11 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 51.6 mtp180 -143.78 160.94 39.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.883 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 658' ' ' ASN . . . . . 0.468 ' ND2' ' HB3' ' A' ' 719' ' ' ARG . 3.7 t30 69.73 47.86 0.61 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.894 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . . . . . . . . . 51.1 mt -101.41 143.97 27.64 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.614 0.721 . . . . 0.0 110.898 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -48.04 133.71 23.63 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.71 2.273 . . . . 0.0 112.299 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 661' ' ' PHE . . . . . 0.502 ' CE1' ' HB3' ' A' ' 690' ' ' SER . 4.0 t80 -47.99 -41.58 25.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.877 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -72.25 -29.94 64.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.888 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -38.87 116.3 0.55 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.864 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 40.7 p -101.58 179.39 4.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.185 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 665' ' ' TRP . . . . . 0.583 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 6.4 p-90 -69.09 -47.52 65.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.907 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 666' ' ' LYS . . . . . 0.583 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 0.0 OUTLIER -50.36 -45.78 55.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.893 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 24.9 mtm -66.05 -52.76 46.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.876 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 18.0 tp -46.46 -47.23 19.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.915 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . 0.453 ' HB2' ' CB ' ' A' ' 681' ' ' ALA . 29.9 tttt -63.3 -72.62 0.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.883 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -45.26 -26.61 0.52 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.864 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 15.3 tptt -67.81 -41.75 82.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.917 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 672' ' ' PHE . . . . . 0.568 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 20.9 m-85 -86.19 -18.91 30.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.91 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -50.32 -35.02 25.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -40.99 -42.33 1.86 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 6.4 t -70.25 -64.96 0.79 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.904 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -142.17 -151.28 5.49 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.464 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 677' ' ' HIS . . . . . 0.494 ' CD2' HD23 ' A' ' 679' ' ' LEU . 4.3 t60 -98.69 101.16 12.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.851 0.358 . . . . 0.0 110.885 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 69.5 t -74.57 141.65 15.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.143 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 679' ' ' LEU . . . . . 0.494 HD23 ' CD2' ' A' ' 677' ' ' HIS . 14.3 mt -114.31 -59.26 2.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.897 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 680' ' ' TYR . . . . . 0.561 ' CE2' HG23 ' A' ' 695' ' ' VAL . 9.3 t80 -98.01 126.35 43.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 681' ' ' ALA . . . . . 0.453 ' CB ' ' HB2' ' A' ' 669' ' ' LYS . . . -154.25 123.71 6.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.109 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -151.94 160.89 43.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.868 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 21.8 mm -111.5 117.7 55.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.114 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -61.58 134.96 57.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.911 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 685' ' ' MET . . . . . . . . . . . . . 33.7 mtp -139.77 144.36 37.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.853 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -125.24 116.38 21.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.916 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 687' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 53.73 41.14 32.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.9 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 688' ' ' GLY . . . . . . . . . . . . . . . 66.81 32.16 80.35 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.502 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 689' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 690' ' ' SER . 23.3 mtmm -131.21 93.93 3.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.802 0.334 . . . . 0.0 110.867 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 690' ' ' SER . . . . . 0.502 ' HB3' ' CE1' ' A' ' 661' ' ' PHE . 28.3 t -37.7 139.23 0.31 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.842 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -103.79 -17.93 14.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.959 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 80.29 18.9 70.45 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.446 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 15.1 p -131.67 123.99 28.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.896 0.379 . . . . 0.0 110.875 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -132.86 -162.14 10.13 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.483 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . 0.561 HG23 ' CE2' ' A' ' 680' ' ' TYR . 16.8 m -144.31 167.2 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.857 0.361 . . . . 0.0 111.159 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 696' ' ' VAL . . . . . 0.457 HG23 ' CD1' ' A' ' 672' ' ' PHE . 99.1 t -150.9 122.55 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.13 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 10.6 ttpp -107.5 136.74 46.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -113.67 172.34 7.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.903 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 699' ' ' GLU . . . . . . . . . . . . . 65.9 mt-10 -79.22 -42.3 26.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.903 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 21.7 m -108.18 143.97 28.48 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.632 0.729 . . . . 0.0 110.882 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 -28.42 25.47 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.676 2.25 . . . . 0.0 112.397 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -68.28 -33.42 74.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.895 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 76.0 t -64.15 -57.36 11.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.161 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -44.65 -52.46 8.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.122 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -53.97 -30.36 46.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.919 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 45.0 ttt180 -82.23 -43.55 17.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.87 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -61.35 -56.71 17.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.083 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 708' ' ' CYS . . . . . . . . . . . . . 28.8 p -46.3 -32.81 3.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.881 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 11.8 mtp180 -83.16 -35.93 25.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.819 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 29.0 mtm -77.85 -11.39 59.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.88 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 711' ' ' MET . . . . . 0.568 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 4.3 mmt -112.51 -34.58 5.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.874 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 712' ' ' ASN . . . . . 0.401 ' OD1' ' C ' ' A' ' 712' ' ' ASN . 2.2 t-20 -39.16 106.77 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.882 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 91.04 20.01 40.79 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.512 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 714' ' ' MET . . . . . 0.481 ' N ' ' O ' ' A' ' 711' ' ' MET . 2.9 ttm -64.7 99.79 0.35 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.839 0.352 . . . . 0.0 110.866 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 715' ' ' LYS . . . . . 0.447 ' CD ' ' HG3' ' A' ' 720' ' ' GLU . 22.4 mmtt -59.92 99.78 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.906 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 716' ' ' LEU . . . . . 0.501 ' O ' ' N ' ' A' ' 719' ' ' ARG . 32.6 mt -99.8 125.64 45.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.9 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 717' ' ' SER . . . . . 0.403 ' C ' ' O ' ' A' ' 716' ' ' LEU . 1.7 t 37.72 40.03 0.24 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.846 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 77.96 32.93 42.96 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.476 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 719' ' ' ARG . . . . . 0.501 ' N ' ' O ' ' A' ' 716' ' ' LEU . 18.4 mtp85 -141.9 110.42 6.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.763 0.316 . . . . 0.0 110.894 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 720' ' ' GLU . . . . . 0.447 ' HG3' ' CD ' ' A' ' 715' ' ' LYS . 27.9 mt-10 -71.53 127.73 33.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.886 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . 0.468 ' CD1' ' HE1' ' A' ' 714' ' ' MET . 21.2 pt -97.97 160.5 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.127 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -116.8 100.13 7.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.831 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 3.3 t -100.32 136.09 33.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.11 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.89 148.38 20.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.852 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 725' ' ' ILE . . . . . 0.4 HG23 ' CB ' ' A' ' 651' ' ' ALA . 31.3 mm -56.62 134.74 20.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.114 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -91.73 77.87 5.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 727' ' ' ARG . . . . . . . . . . . . . 37.3 mtt180 -69.79 -41.18 75.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.835 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 728' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -48.17 -42.79 30.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.881 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 729' ' ' ALA . . . . . . . . . . . . . . . -39.45 97.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.126 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 91.5 p -50.25 -47.13 55.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.839 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 731' ' ' GLY . . . . . . . . . . . . . . . 84.64 -156.71 31.96 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.496 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 732' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.81 162.26 42.77 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.686 2.257 . . . . 0.0 112.352 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 733' ' ' SER . . . . . . . . . . . . . 4.8 t -154.48 159.84 41.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.859 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 734' ' ' SER . . . . . . . . . . . . . 58.3 p -88.15 -54.06 4.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.811 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 735' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.508 -179.938 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 645' ' ' SER . . . . . . . . . . . . . 12.2 m -96.87 151.02 20.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.87 0.367 . . . . 0.0 110.893 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 646' ' ' SER . . . . . . . . . . . . . 1.7 t -165.85 137.04 3.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.836 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -121.35 112.79 2.16 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.477 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 48.8 m -88.76 50.9 2.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.902 0.382 . . . . 0.0 110.856 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 34.4 p -45.04 -47.3 11.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.838 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 75.79 -75.37 1.48 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.459 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 651' ' ' ALA . . . . . . . . . . . . . . . 59.88 54.49 4.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.803 0.335 . . . . 0.0 111.098 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 30.2 p -78.45 -10.53 59.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -105.44 147.24 28.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.879 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 654' ' ' ILE . . . . . 0.405 ' CD1' ' CE2' ' A' ' 672' ' ' PHE . 33.4 pt -135.12 171.17 18.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.13 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -125.13 151.63 45.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.862 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 23.2 t -133.22 152.45 35.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.159 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -147.86 157.99 43.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.877 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 658' ' ' ASN . . . . . 0.469 ' ND2' ' HB3' ' A' ' 719' ' ' ARG . 6.7 t30 71.5 35.13 1.54 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.903 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.477 HD22 ' CD2' ' A' ' 663' ' ' PHE . 23.8 mt -85.14 143.58 39.82 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.631 0.729 . . . . 0.0 110.86 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -47.94 146.48 8.81 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.686 2.257 . . . . 0.0 112.353 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -64.45 -28.87 69.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.11 13.92 23.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.852 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 663' ' ' PHE . . . . . 0.477 ' CD2' HD22 ' A' ' 659' ' ' LEU . 2.9 t80 -79.04 121.92 25.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.906 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 62.9 p -104.9 169.55 8.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.156 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 665' ' ' TRP . . . . . 0.601 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 5.0 p-90 -62.85 -45.13 94.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.917 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 666' ' ' LYS . . . . . 0.601 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 5.5 tppp? -51.52 -46.11 63.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 30.1 mtm -67.54 -51.9 45.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.887 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 24.3 tp -47.62 -44.81 27.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.908 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 34.7 tttm -64.23 -70.8 0.2 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.903 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -47.36 -24.75 0.84 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.856 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 17.8 tptt -69.41 -42.35 75.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.901 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 672' ' ' PHE . . . . . 0.45 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 20.5 m-85 -85.99 -21.98 27.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.861 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -45.02 -37.34 4.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -46.69 -45.37 19.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.914 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 86.4 m -66.9 -54.99 16.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.864 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -153.93 -170.27 19.73 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.478 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 677' ' ' HIS . . . . . 0.488 ' CD2' HD23 ' A' ' 679' ' ' LEU . 2.5 t-160 -82.88 93.56 7.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.873 0.368 . . . . 0.0 110.867 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 678' ' ' VAL . . . . . 0.439 HG23 ' CE2' ' A' ' 698' ' ' PHE . 84.8 t -70.09 141.21 17.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.149 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 679' ' ' LEU . . . . . 0.488 HD23 ' CD2' ' A' ' 677' ' ' HIS . 12.1 mt -115.24 -59.75 1.97 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.902 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 680' ' ' TYR . . . . . 0.427 ' CE2' HG21 ' A' ' 695' ' ' VAL . 9.8 t80 -98.39 125.83 43.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.889 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -154.61 121.02 5.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.112 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -151.64 157.81 42.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.835 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 50.0 mm -104.34 103.89 15.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.121 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm -62.12 136.78 58.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 685' ' ' MET . . . . . . . . . . . . . 22.9 mtp -131.34 150.15 52.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.828 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -111.11 97.05 6.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.873 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 687' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 67.54 44.08 1.78 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.886 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 688' ' ' GLY . . . . . . . . . . . . . . . 72.5 30.74 63.99 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.46 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -134.46 118.11 17.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.832 0.349 . . . . 0.0 110.874 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 690' ' ' SER . . . . . . . . . . . . . 3.1 t -60.72 125.4 23.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.843 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 10.7 mmpt? -103.81 27.79 7.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.924 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 41.05 30.55 0.4 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.466 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 17.7 p -137.38 128.24 27.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.884 0.373 . . . . 0.0 110.863 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -140.96 -150.56 5.42 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.525 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . 0.427 HG21 ' CE2' ' A' ' 680' ' ' TYR . 24.7 m -153.08 161.9 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.84 0.353 . . . . 0.0 111.11 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 82.1 t -149.06 114.81 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.122 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 8.3 ttpt -100.9 145.37 28.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 698' ' ' PHE . . . . . 0.439 ' CE2' HG23 ' A' ' 678' ' ' VAL . 93.4 m-85 -121.01 166.3 14.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.923 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 699' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -69.55 -41.17 76.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.941 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 11.5 m -116.45 151.28 46.78 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.712 0.768 . . . . 0.0 110.806 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.77 -44.72 1.91 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.712 2.274 . . . . 0.0 112.351 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -50.88 -33.74 25.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.891 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 53.9 t -63.11 -58.95 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.147 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -44.06 -58.4 2.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.133 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -46.49 -32.69 3.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.929 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 16.4 ttm180 -82.51 -40.12 21.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.832 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -67.23 -57.73 6.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.149 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 708' ' ' CYS . . . . . . . . . . . . . 21.5 p -38.57 -41.53 0.69 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.875 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -83.42 -44.54 14.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.88 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 56.7 mtp -57.44 -13.4 3.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 711' ' ' MET . . . . . 0.45 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 5.1 mmm -118.48 -29.26 5.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 712' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -39.04 105.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.918 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 89.16 26.87 24.86 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.496 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 714' ' ' MET . . . . . 0.442 ' N ' ' O ' ' A' ' 711' ' ' MET . 46.0 ttp -72.55 97.84 2.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.83 0.348 . . . . 0.0 110.895 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -53.79 99.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.899 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 716' ' ' LEU . . . . . 0.5 ' O ' ' N ' ' A' ' 719' ' ' ARG . 23.9 mt -99.92 129.8 46.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.899 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 717' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 716' ' ' LEU . 9.5 t 35.21 37.32 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.9 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 718' ' ' GLY . . . . . 0.424 ' C ' ' HG3' ' A' ' 719' ' ' ARG . . . 79.84 38.66 19.2 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.517 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 719' ' ' ARG . . . . . 0.5 ' N ' ' O ' ' A' ' 716' ' ' LEU . 25.1 mtp85 -148.45 113.66 5.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.791 0.329 . . . . 0.0 110.842 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -70.19 122.6 19.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.887 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 18.1 pt -99.0 150.6 4.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.109 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.03 99.71 9.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.884 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 5.3 t -102.59 130.14 53.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.126 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 64.8 mtm180 -157.85 159.7 36.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.9 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 725' ' ' ILE . . . . . . . . . . . . . 17.5 mm -53.34 136.6 14.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.13 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -84.24 89.69 7.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.88 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 727' ' ' ARG . . . . . . . . . . . . . 9.1 tpt85 -45.89 153.04 0.32 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.873 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 728' ' ' ASN . . . . . . . . . . . . . 50.2 t30 65.09 47.55 2.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.908 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 729' ' ' ALA . . . . . . . . . . . . . . . -112.3 91.21 3.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.132 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 1.3 t -139.51 112.24 7.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.903 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 731' ' ' GLY . . . . . . . . . . . . . . . -63.51 140.24 44.46 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.488 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 732' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 96.16 0.58 Allowed 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.689 2.26 . . . . 0.0 112.349 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 733' ' ' SER . . . . . . . . . . . . . 3.3 t -107.93 160.2 15.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.903 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 734' ' ' SER . . . . . . . . . . . . . 59.8 m -122.72 154.01 38.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.887 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 735' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.5 -179.971 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 N-CA-C 112.486 -0.245 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 645' ' ' SER . . . . . . . . . . . . . 53.9 p -162.3 148.36 13.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.855 0.36 . . . . 0.0 110.875 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 646' ' ' SER . . . . . . . . . . . . . 2.1 m -90.1 -56.38 3.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.839 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . 55.59 60.12 9.37 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.465 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 24.3 p -82.99 124.6 30.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.879 0.371 . . . . 0.0 110.892 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 86.7 p -106.78 102.94 12.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.836 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 58.19 74.54 0.34 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.477 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 651' ' ' ALA . . . . . 0.427 ' HB3' ' CG2' ' A' ' 725' ' ' ILE . . . -80.26 68.64 6.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.777 0.322 . . . . 0.0 111.094 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 3.6 p -83.81 -6.92 59.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.846 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -115.59 154.37 29.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.895 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 654' ' ' ILE . . . . . . . . . . . . . 43.5 pt -138.24 167.21 22.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.108 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -118.14 154.84 31.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.889 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 2.9 t -141.19 150.67 19.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.105 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -149.73 165.41 32.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.86 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 658' ' ' ASN . . . . . 0.456 ' ND2' HH11 ' A' ' 719' ' ' ARG . 0.2 OUTLIER 65.18 44.21 3.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.889 -179.942 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . . . . . . . . . 60.6 mt -97.44 143.8 26.82 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.619 0.723 . . . . 0.0 110.95 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -47.97 129.76 18.66 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.693 2.262 . . . . 0.0 112.355 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 661' ' ' PHE . . . . . 0.4 ' CE1' ' HB3' ' A' ' 690' ' ' SER . 7.7 t80 -48.93 -27.96 3.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.905 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -85.57 -28.71 24.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.85 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -38.62 119.75 0.87 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.861 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 75.6 p -100.23 171.36 7.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.17 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 665' ' ' TRP . . . . . 0.637 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 7.5 p-90 -66.86 -52.29 45.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.948 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 666' ' ' LYS . . . . . 0.637 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 4.3 tppp? -45.42 -47.29 13.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 25.6 mtm -62.95 -53.03 60.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.893 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 16.9 tp -44.46 -48.71 10.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.896 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 25.9 tttt -60.09 -71.16 0.14 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.864 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -49.61 -24.36 2.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.847 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 671' ' ' LYS . . . . . 0.404 ' CG ' ' HE2' ' A' ' 714' ' ' MET . 19.0 tptt -69.0 -42.4 76.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.884 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 672' ' ' PHE . . . . . 0.548 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 21.8 m-85 -87.13 -13.57 43.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -52.64 -39.35 61.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.884 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -48.65 -37.6 18.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.892 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 91.7 m -74.56 -54.96 6.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.87 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -160.04 -175.31 30.88 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.478 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 677' ' ' HIS . . . . . 0.492 ' CD2' HD23 ' A' ' 679' ' ' LEU . 5.2 t60 -71.24 116.76 11.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.851 0.358 . . . . 0.0 110.852 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 84.3 t -96.97 125.06 50.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.125 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 679' ' ' LEU . . . . . 0.492 HD23 ' CD2' ' A' ' 677' ' ' HIS . 17.5 mt -99.29 -62.4 1.24 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.929 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 680' ' ' TYR . . . . . 0.515 ' CE2' HG21 ' A' ' 695' ' ' VAL . 10.8 t80 -98.3 132.63 43.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.923 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -157.01 123.3 4.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.096 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -157.14 156.64 33.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.837 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 32.6 mm -97.35 102.16 13.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.13 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.3 135.9 57.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.906 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 685' ' ' MET . . . . . . . . . . . . . 15.3 mtp -134.31 172.59 12.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.899 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -130.66 95.44 3.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.939 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 687' ' ' ASN . . . . . . . . . . . . . 50.6 t30 68.79 37.37 2.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.863 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 688' ' ' GLY . . . . . . . . . . . . . . . 77.38 40.88 22.36 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.472 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 5.3 mmmm -139.29 128.54 24.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.768 0.318 . . . . 0.0 110.865 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 690' ' ' SER . . . . . 0.4 ' HB3' ' CE1' ' A' ' 661' ' ' PHE . 17.6 t -67.75 122.38 17.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.879 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -108.9 20.07 18.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.891 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 48.22 32.35 9.56 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.495 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 30.6 p -132.94 129.61 38.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.863 0.363 . . . . 0.0 110.907 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -139.04 -173.32 12.95 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.442 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . 0.515 HG21 ' CE2' ' A' ' 680' ' ' TYR . 17.0 m -139.53 155.38 25.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.835 0.35 . . . . 0.0 111.141 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 696' ' ' VAL . . . . . 0.485 HG12 ' CZ ' ' A' ' 698' ' ' PHE . 89.9 t -143.48 121.51 6.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.084 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 15.5 tttt -105.28 143.35 33.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.899 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 698' ' ' PHE . . . . . 0.485 ' CZ ' HG12 ' A' ' 696' ' ' VAL . 97.2 m-85 -120.7 171.0 8.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 699' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -73.68 -44.7 55.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.866 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 29.9 m -112.92 149.63 41.58 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.636 0.731 . . . . 0.0 110.855 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -34.72 14.04 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.692 2.261 . . . . 0.0 112.356 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -57.95 -38.42 75.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.883 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 62.7 t -61.78 -49.77 82.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.125 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -51.85 -55.58 19.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.091 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -46.94 -25.47 0.79 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.911 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 706' ' ' ARG . . . . . 0.441 ' O ' ' N ' ' A' ' 709' ' ' ARG . 21.7 ttt180 -90.39 -62.34 1.48 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.827 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 707' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 706' ' ' ARG . . . -35.75 -39.79 0.16 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.105 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 708' ' ' CYS . . . . . . . . . . . . . 66.7 m -56.56 -47.08 80.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 709' ' ' ARG . . . . . 0.441 ' N ' ' O ' ' A' ' 706' ' ' ARG . 11.6 mtp180 -73.55 -32.89 64.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.864 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 33.3 mmm -71.84 -20.5 61.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.86 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 711' ' ' MET . . . . . 0.548 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 2.7 mmt -114.02 -10.65 12.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.857 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 712' ' ' ASN . . . . . 0.419 ' OD1' ' C ' ' A' ' 712' ' ' ASN . 28.8 t-20 -57.75 105.08 0.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.877 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 91.83 15.44 54.46 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.508 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 714' ' ' MET . . . . . 0.404 ' HE2' ' CG ' ' A' ' 671' ' ' LYS . 34.4 ttp -62.7 101.29 0.24 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.877 0.37 . . . . 0.0 110.869 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 4.6 mmmt -66.22 102.76 0.88 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.905 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 716' ' ' LEU . . . . . 0.494 ' O ' ' N ' ' A' ' 718' ' ' GLY . 23.3 mt -100.01 134.75 42.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.91 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 717' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 716' ' ' LEU . 7.3 t 35.12 31.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.889 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 718' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 716' ' ' LEU . . . 83.65 41.87 8.07 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.475 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 719' ' ' ARG . . . . . 0.485 ' N ' ' O ' ' A' ' 716' ' ' LEU . 2.7 mtt-85 -151.68 117.51 5.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.807 0.337 . . . . 0.0 110.853 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -72.88 125.79 28.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.904 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . 0.402 ' CD1' ' HB3' ' A' ' 714' ' ' MET . 41.4 pt -100.11 156.08 4.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.148 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -110.88 103.23 11.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.882 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 723' ' ' VAL . . . . . 0.436 HG23 ' CB ' ' A' ' 711' ' ' MET . 3.4 t -103.98 131.31 52.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.122 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 42.2 mtm-85 -158.18 161.09 37.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.858 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 725' ' ' ILE . . . . . 0.427 ' CG2' ' HB3' ' A' ' 651' ' ' ALA . 19.8 mm -60.3 131.08 24.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.162 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -80.11 107.23 12.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 727' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -63.98 -34.92 79.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 728' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -88.24 68.32 8.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 729' ' ' ALA . . . . . . . . . . . . . . . -115.71 19.05 15.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.126 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 86.6 p -127.88 149.36 50.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.875 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 731' ' ' GLY . . . . . . . . . . . . . . . -90.86 177.37 41.68 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.48 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 732' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -8.23 23.07 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.674 2.25 . . . . 0.0 112.367 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 733' ' ' SER . . . . . . . . . . . . . 68.8 m 61.86 46.2 6.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.866 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 734' ' ' SER . . . . . . . . . . . . . 69.4 p -87.1 122.67 31.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.858 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 735' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.482 -179.958 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 645' ' ' SER . . . . . . . . . . . . . 77.9 p -120.45 -44.3 2.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.886 0.374 . . . . 0.0 110.883 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 646' ' ' SER . . . . . . . . . . . . . 56.9 p -73.12 -42.94 62.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.887 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . 118.55 116.35 2.69 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.496 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 62.0 m -105.55 140.51 38.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.866 0.365 . . . . 0.0 110.831 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 3.9 t -159.69 110.64 1.97 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.849 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 159.16 36.61 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.468 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 651' ' ' ALA . . . . . 0.476 ' CB ' ' CG2' ' A' ' 725' ' ' ILE . . . -109.28 97.35 6.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.763 0.315 . . . . 0.0 111.098 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 2.8 p -101.34 -30.0 11.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.857 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -85.83 148.71 25.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.952 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 654' ' ' ILE . . . . . . . . . . . . . 22.0 pt -134.32 174.29 13.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.121 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -125.79 157.44 37.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.88 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 3.4 t -143.58 151.07 16.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.105 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 27.3 mtp180 -146.62 162.54 38.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.885 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 658' ' ' ASN . . . . . 0.451 ' ND2' ' HB3' ' A' ' 719' ' ' ARG . 9.4 t30 69.19 31.16 4.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.852 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . . . . . . . . . 64.9 mt -82.14 144.44 50.75 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.628 0.728 . . . . 0.0 110.917 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -47.97 150.84 4.38 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.725 2.283 . . . . 0.0 112.326 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -71.26 -22.36 61.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.859 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -98.19 4.74 48.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.854 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 663' ' ' PHE . . . . . 0.412 ' CE2' ' HA ' ' A' ' 668' ' ' LEU . 3.2 t80 -72.62 118.55 15.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 43.3 p -100.45 169.84 8.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.141 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 665' ' ' TRP . . . . . 0.583 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 15.7 p-90 -57.43 -51.41 69.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.937 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 666' ' ' LYS . . . . . 0.583 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 5.3 tppp? -48.76 -60.06 3.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.885 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 22.5 mtm -51.21 -44.63 61.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.888 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 668' ' ' LEU . . . . . 0.412 ' HA ' ' CE2' ' A' ' 663' ' ' PHE . 12.3 tp -56.79 -44.27 81.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.916 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 29.1 ttmt -64.55 -67.85 0.4 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.27 -23.76 2.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.855 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? -69.85 -39.63 76.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.944 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 672' ' ' PHE . . . . . 0.549 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 27.0 m-85 -90.87 -8.39 49.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.899 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -59.41 -27.07 65.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.909 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -62.16 -37.18 84.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.934 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 675' ' ' CYS . . . . . 0.462 ' CB ' ' HB1' ' A' ' 707' ' ' ALA . 3.7 m -73.18 -41.4 63.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.879 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -171.02 -167.24 31.06 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.48 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 677' ' ' HIS . . . . . 0.513 ' CD2' HD23 ' A' ' 679' ' ' LEU . 3.0 t-160 -83.18 106.07 14.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.792 0.329 . . . . 0.0 110.86 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 69.0 t -84.83 144.43 9.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.102 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 679' ' ' LEU . . . . . 0.513 HD23 ' CD2' ' A' ' 677' ' ' HIS . 16.0 mt -119.15 -61.12 1.67 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.939 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 680' ' ' TYR . . . . . 0.52 ' CE2' HG22 ' A' ' 695' ' ' VAL . 5.5 t80 -99.77 125.3 45.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.899 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -149.29 122.12 8.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.058 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -150.95 157.79 43.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.822 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 33.0 mm -104.71 105.0 17.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.115 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -58.34 133.54 55.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.831 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 685' ' ' MET . . . . . . . . . . . . . 31.8 mtp -130.53 158.71 39.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.895 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -119.95 111.12 17.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.888 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 687' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 53.62 39.28 29.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.904 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 688' ' ' GLY . . . . . . . . . . . . . . . 76.18 40.99 27.82 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.52 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 3.9 mmpt? -140.0 141.93 36.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.774 0.321 . . . . 0.0 110.921 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 690' ' ' SER . . . . . . . . . . . . . 17.3 m -77.01 122.76 25.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.816 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 24.3 mmmt -107.88 18.0 21.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.922 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 45.65 38.37 7.4 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.477 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 29.3 p -139.46 130.44 26.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.843 0.354 . . . . 0.0 110.892 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -147.93 -174.69 19.99 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.502 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . 0.52 HG22 ' CE2' ' A' ' 680' ' ' TYR . 14.9 m -133.63 164.09 35.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.848 0.356 . . . . 0.0 111.134 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 696' ' ' VAL . . . . . 0.543 HG22 ' CD1' ' A' ' 672' ' ' PHE . 58.3 t -148.91 114.22 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.123 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 27.1 tttt -94.14 146.48 23.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.966 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -122.34 165.79 15.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.896 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 699' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -68.16 -41.82 80.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.918 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 14.3 m -116.21 152.32 47.73 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.684 0.754 . . . . 0.0 110.84 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -39.54 6.39 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.659 2.24 . . . . 0.0 112.339 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -53.57 -47.67 69.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.926 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 69.2 t -50.55 -55.21 6.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.112 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -41.4 -65.89 0.39 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.124 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -42.65 -38.1 1.93 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.936 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 706' ' ' ARG . . . . . 0.401 ' O ' ' C ' ' A' ' 707' ' ' ALA . 12.6 ttt180 -73.91 -65.95 0.77 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.878 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 707' ' ' ALA . . . . . 0.462 ' HB1' ' CB ' ' A' ' 675' ' ' CYS . . . -36.9 -55.23 0.91 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.065 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 708' ' ' CYS . . . . . 0.492 ' O ' ' N ' ' A' ' 712' ' ' ASN . 0.9 OUTLIER -45.31 -51.2 11.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.876 -179.894 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 12.8 mtp180 -66.72 -34.44 77.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 78.1 mtp -73.33 -21.83 60.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.9 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 711' ' ' MET . . . . . 0.549 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 3.8 mmt -108.67 -14.78 14.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.844 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 712' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 708' ' ' CYS . 1.2 p-10 -50.16 121.18 5.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.918 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 70.38 26.48 74.12 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.455 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 714' ' ' MET . . . . . . . . . . . . . 30.5 ttp -69.44 103.53 2.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.794 0.331 . . . . 0.0 110.888 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 15.6 mmtt -59.93 101.41 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.924 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 716' ' ' LEU . . . . . 0.497 ' O ' ' N ' ' A' ' 719' ' ' ARG . 31.4 mt -100.29 126.06 46.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.901 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 717' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 716' ' ' LEU . 3.4 t 36.57 39.79 0.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.876 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 718' ' ' GLY . . . . . 0.427 ' C ' ' HG3' ' A' ' 719' ' ' ARG . . . 78.45 35.03 34.17 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.493 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 719' ' ' ARG . . . . . 0.497 ' N ' ' O ' ' A' ' 716' ' ' LEU . 5.0 mtt-85 -146.63 111.02 5.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.75 0.31 . . . . 0.0 110.869 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -67.76 123.01 19.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.884 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 26.6 pt -99.27 149.49 5.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.088 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -106.14 112.7 25.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.824 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 723' ' ' VAL . . . . . 0.44 ' CG1' ' HA ' ' A' ' 708' ' ' CYS . 2.7 t -105.8 138.57 30.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.113 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 26.5 ptt180 -154.25 171.56 19.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 725' ' ' ILE . . . . . 0.476 ' CG2' ' CB ' ' A' ' 651' ' ' ALA . 19.3 mm -89.98 137.0 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.14 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -92.91 92.0 7.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.885 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 727' ' ' ARG . . . . . . . . . . . . . 8.5 tpt85 -53.0 -43.04 66.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.893 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 728' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -86.64 74.34 9.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.942 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 729' ' ' ALA . . . . . . . . . . . . . . . -109.31 120.39 42.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.087 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 3.2 t -85.78 124.76 32.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.843 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 731' ' ' GLY . . . . . . . . . . . . . . . -149.02 175.57 28.2 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.502 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 732' ' ' PRO . . . . . 0.442 ' O ' ' C ' ' A' ' 733' ' ' SER . 53.4 Cg_endo -69.77 -5.23 15.72 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.675 2.25 . . . . 0.0 112.324 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 733' ' ' SER . . . . . 0.442 ' C ' ' O ' ' A' ' 732' ' ' PRO . 21.5 t -34.86 120.06 0.48 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.884 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 734' ' ' SER . . . . . . . . . . . . . 14.8 t -147.76 108.28 4.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.86 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 735' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.536 -179.979 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 645' ' ' SER . . . . . . . . . . . . . 5.1 m -71.81 -54.45 10.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.877 0.37 . . . . 0.0 110.853 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 646' ' ' SER . . . . . . . . . . . . . 41.1 t -48.11 126.91 11.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.831 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . 145.38 82.78 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.481 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 41.8 t -57.17 -51.17 70.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.84 0.353 . . . . 0.0 110.858 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 32.8 m -87.71 103.11 15.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . -77.03 144.88 30.33 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.487 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 651' ' ' ALA . . . . . . . . . . . . . . . -91.61 90.39 7.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.788 0.328 . . . . 0.0 111.142 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 2.4 p -103.95 -10.97 17.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.845 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -109.86 150.72 28.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.893 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 654' ' ' ILE . . . . . 0.549 HD12 ' CE2' ' A' ' 672' ' ' PHE . 23.0 pt -139.64 163.8 24.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.171 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -117.6 144.54 45.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.898 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 10.1 t -131.92 150.63 34.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.16 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -146.54 160.31 42.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.849 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 658' ' ' ASN . . . . . 0.466 ' ND2' ' HB3' ' A' ' 719' ' ' ARG . 2.7 t30 65.88 53.81 1.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.935 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.465 HD22 ' CD2' ' A' ' 663' ' ' PHE . 33.4 mt -102.74 143.48 26.7 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.58 0.705 . . . . 0.0 110.924 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 660' ' ' PRO . . . . . 0.488 ' O ' ' N ' ' A' ' 663' ' ' PHE . 65.9 Cg_exo -48.01 125.13 11.13 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.706 2.271 . . . . 0.0 112.32 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 661' ' ' PHE . . . . . 0.494 ' CE1' ' HB3' ' A' ' 690' ' ' SER . 4.6 t80 -40.63 -37.87 0.79 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.903 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 662' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 663' ' ' PHE . 2.2 m-20 -74.99 -35.07 62.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 663' ' ' PHE . . . . . 0.488 ' N ' ' O ' ' A' ' 660' ' ' PRO . 3.7 t80 -37.5 115.24 0.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.893 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 78.9 p -102.79 178.08 4.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.136 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 665' ' ' TRP . . . . . 0.647 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 3.4 p-90 -64.13 -48.27 76.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.908 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 666' ' ' LYS . . . . . 0.647 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 18.8 tptm -49.0 -56.88 7.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.898 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 32.4 mtm -55.99 -51.48 67.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.846 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 15.1 tp -45.34 -42.84 10.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.905 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -66.55 -70.72 0.23 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -48.51 -24.93 1.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.854 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 18.4 tptt -68.91 -46.08 69.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.934 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 672' ' ' PHE . . . . . 0.549 ' CE2' HD12 ' A' ' 654' ' ' ILE . 22.4 m-85 -83.38 -15.42 49.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.867 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -49.18 -41.4 36.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.9 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -45.64 -37.11 5.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.893 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 675' ' ' CYS . . . . . 0.427 ' CB ' ' HB1' ' A' ' 707' ' ' ALA . 34.1 m -73.62 -48.2 34.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.871 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -164.53 -164.21 19.31 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.779 -0.725 . . . . 0.0 112.504 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 677' ' ' HIS . . . . . 0.506 ' CD2' HD21 ' A' ' 679' ' ' LEU . 3.4 t-160 -85.48 93.6 8.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.806 0.336 . . . . 0.0 110.86 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 71.1 t -69.37 133.39 31.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.114 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 679' ' ' LEU . . . . . 0.506 HD21 ' CD2' ' A' ' 677' ' ' HIS . 10.7 mt -108.67 -60.18 1.78 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.946 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -99.62 130.25 45.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.918 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -156.01 125.76 6.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.107 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -154.62 156.55 36.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.822 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 28.9 mm -105.24 108.48 25.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.166 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -60.8 142.49 56.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.885 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 685' ' ' MET . . . . . . . . . . . . . 25.6 mtp -137.93 148.24 45.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.914 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 686' ' ' GLU . . . . . 0.402 ' OE1' ' C ' ' A' ' 686' ' ' GLU . 0.0 OUTLIER -115.63 98.78 6.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.888 -179.958 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 687' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 71.04 38.8 1.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.896 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 688' ' ' GLY . . . . . . . . . . . . . . . 70.47 30.3 69.11 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.464 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 28.7 mmtm -134.62 111.97 10.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.794 0.33 . . . . 0.0 110.891 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 690' ' ' SER . . . . . 0.494 ' HB3' ' CE1' ' A' ' 661' ' ' PHE . 29.6 t -47.1 131.86 12.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.862 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 14.1 mmmt -106.13 -9.29 17.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.891 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 81.91 11.67 82.33 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.521 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 5.6 p -119.92 139.48 52.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.858 0.361 . . . . 0.0 110.88 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -148.38 -158.07 7.82 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.475 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 15.6 m -151.0 156.98 5.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.866 0.365 . . . . 0.0 111.125 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 696' ' ' VAL . . . . . 0.447 HG23 ' CD1' ' A' ' 672' ' ' PHE . 85.9 t -144.89 121.05 4.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.147 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 9.9 ttpp -104.84 147.41 27.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.911 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -123.48 168.4 12.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.893 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 699' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -68.55 -48.24 64.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.858 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 70.8 m -111.25 148.1 38.03 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.66 0.743 . . . . 0.0 110.819 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -23.52 30.6 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.657 2.238 . . . . 0.0 112.359 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 702' ' ' GLU . . . . . 0.442 ' HG3' ' N ' ' A' ' 703' ' ' VAL . 6.8 pt-20 -69.26 -34.51 74.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.905 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 703' ' ' VAL . . . . . 0.442 ' N ' ' HG3' ' A' ' 702' ' ' GLU . 24.7 t -61.19 -59.86 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.149 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -41.3 -61.41 1.03 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.116 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -41.55 -31.74 0.3 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.861 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -80.3 -48.93 12.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.855 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 707' ' ' ALA . . . . . 0.427 ' HB1' ' CB ' ' A' ' 675' ' ' CYS . . . -60.39 -53.04 62.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.109 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 708' ' ' CYS . . . . . 0.434 ' SG ' ' N ' ' A' ' 709' ' ' ARG . 1.8 p -39.15 -41.69 0.86 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.884 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 709' ' ' ARG . . . . . 0.434 ' N ' ' SG ' ' A' ' 708' ' ' CYS . 12.6 mtt85 -84.51 -39.84 18.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.839 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 18.1 mtm -68.03 -7.74 31.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.853 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 711' ' ' MET . . . . . 0.545 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 14.2 mmm -121.57 -30.26 4.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.889 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 712' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -45.54 107.09 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.925 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 90.03 25.98 25.37 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.479 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 714' ' ' MET . . . . . 0.46 ' CE ' ' HE2' ' A' ' 711' ' ' MET . 41.9 ttp -75.3 100.31 4.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.864 0.364 . . . . 0.0 110.874 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 18.3 mmtt -56.27 102.12 0.07 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.899 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 716' ' ' LEU . . . . . 0.459 ' O ' ' N ' ' A' ' 719' ' ' ARG . 34.6 mt -99.86 121.97 42.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.879 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 717' ' ' SER . . . . . . . . . . . . . 36.8 t 37.62 41.83 0.33 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.846 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 718' ' ' GLY . . . . . 0.418 ' C ' ' HG3' ' A' ' 719' ' ' ARG . . . 77.68 34.27 39.83 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.482 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 719' ' ' ARG . . . . . 0.466 ' HB3' ' ND2' ' A' ' 658' ' ' ASN . 1.9 mtp-105 -146.01 109.6 4.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.777 0.323 . . . . 0.0 110.887 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -69.99 124.97 25.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.897 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 31.4 pt -98.9 152.33 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.13 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -106.08 98.27 7.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.869 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 5.1 t -101.69 132.0 48.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.137 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 34.5 mtp180 -156.0 167.58 29.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.857 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 725' ' ' ILE . . . . . . . . . . . . . 33.9 mm -73.92 131.62 34.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.103 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -78.25 135.04 37.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 727' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.04 -44.23 6.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.875 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 728' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -95.6 41.28 1.1 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.886 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 729' ' ' ALA . . . . . . . . . . . . . . . -61.11 -44.13 97.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.092 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 4.8 m -158.99 154.58 26.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.854 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 731' ' ' GLY . . . . . . . . . . . . . . . -52.88 122.37 19.84 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.484 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 732' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.71 174.32 9.64 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.722 2.281 . . . . 0.0 112.364 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 733' ' ' SER . . . . . . . . . . . . . 74.8 m -53.67 150.6 6.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.85 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 734' ' ' SER . . . . . . . . . . . . . 30.0 t -100.75 -48.82 4.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.839 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 735' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.501 -179.941 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 645' ' ' SER . . . . . . . . . . . . . 74.6 m -145.54 173.8 11.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.855 0.359 . . . . 0.0 110.876 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 646' ' ' SER . . . . . . . . . . . . . 1.8 m -147.71 118.53 7.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.883 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . 163.3 -150.25 18.78 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.503 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 78.3 p 44.72 43.32 6.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.86 0.362 . . . . 0.0 110.861 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 52.0 p -145.38 124.7 13.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.832 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 42.22 69.69 0.56 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.452 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 651' ' ' ALA . . . . . . . . . . . . . . . -92.74 109.11 20.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.771 0.32 . . . . 0.0 111.133 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 25.5 p -109.69 -33.97 6.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.895 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -90.06 146.36 24.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.918 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 654' ' ' ILE . . . . . . . . . . . . . 40.5 pt -132.91 176.06 9.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.113 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -127.53 159.76 33.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.904 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 21.9 t -146.13 148.68 16.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.116 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 32.0 mtp180 -146.85 162.99 37.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.877 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 658' ' ' ASN . . . . . 0.424 ' N ' ' O ' ' A' ' 692' ' ' GLY . 2.6 t30 65.97 46.41 2.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.922 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . . . . . . . . . 27.8 mt -97.58 142.02 23.9 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.631 0.729 . . . . 0.0 110.939 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -48.01 127.91 15.65 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.678 2.252 . . . . 0.0 112.342 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -39.91 -50.48 2.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.885 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 662' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 663' ' ' PHE . 0.9 OUTLIER -61.79 -38.16 87.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.83 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 663' ' ' PHE . . . . . 0.465 ' HA ' ' CE ' ' A' ' 667' ' ' MET . 4.0 t80 -35.45 116.26 0.35 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.844 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 78.6 p -106.15 174.82 5.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.135 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 665' ' ' TRP . . . . . 0.647 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 3.3 p-90 -62.1 -51.8 66.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.911 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 666' ' ' LYS . . . . . 0.647 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 1.7 tppp? -45.15 -48.93 12.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.884 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 667' ' ' MET . . . . . 0.465 ' CE ' ' HA ' ' A' ' 663' ' ' PHE . 24.3 mtm -64.3 -52.1 60.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.91 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 15.3 tp -43.52 -45.27 6.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -64.61 -70.74 0.21 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.885 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -48.49 -21.48 0.57 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.855 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 17.2 tptt -72.81 -43.54 62.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.859 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 672' ' ' PHE . . . . . 0.521 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 25.8 m-85 -86.62 -15.95 38.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.9 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -50.38 -38.75 44.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.896 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -46.83 -39.94 12.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.888 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 62.8 m -67.65 -60.46 2.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.879 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -152.7 -157.59 8.08 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.524 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -87.77 100.72 13.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.791 0.329 . . . . 0.0 110.899 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 98.1 t -79.55 140.91 16.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.167 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 12.8 mt -117.29 -60.03 1.88 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.88 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 680' ' ' TYR . . . . . 0.451 ' CE2' HG22 ' A' ' 695' ' ' VAL . 7.9 t80 -99.46 126.59 45.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.974 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -153.4 122.51 6.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.103 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -149.67 164.8 34.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 27.3 mm -114.72 101.38 12.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.116 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -54.74 141.88 30.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.878 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 685' ' ' MET . . . . . . . . . . . . . 26.5 mtp -135.84 168.47 19.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.889 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -129.53 94.41 3.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.863 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 687' ' ' ASN . . . . . . . . . . . . . 5.0 t30 67.33 39.83 2.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.912 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 688' ' ' GLY . . . . . . . . . . . . . . . 79.73 28.39 51.29 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.504 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.59 128.78 43.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.788 0.328 . . . . 0.0 110.896 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 690' ' ' SER . . . . . . . . . . . . . 44.7 p -72.26 120.29 17.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.811 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -102.5 30.25 4.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.893 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 658' ' ' ASN . . . 39.15 39.1 0.93 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.49 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 31.3 p -138.09 139.43 39.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.896 0.379 . . . . 0.0 110.858 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -158.7 -173.65 27.38 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.434 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . 0.451 HG22 ' CE2' ' A' ' 680' ' ' TYR . 27.0 m -134.13 164.25 34.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.882 0.372 . . . . 0.0 111.114 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 696' ' ' VAL . . . . . 0.502 HG11 ' CE2' ' A' ' 698' ' ' PHE . 85.5 t -148.94 116.91 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.079 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 11.8 tttp -101.24 140.36 35.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 698' ' ' PHE . . . . . 0.502 ' CE2' HG11 ' A' ' 696' ' ' VAL . 96.4 m-85 -116.34 173.79 6.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.871 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 699' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -73.19 -48.47 34.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.903 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 14.0 m -109.01 149.53 39.75 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.664 0.745 . . . . 0.0 110.824 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 -6.88 19.64 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.661 2.24 . . . . 0.0 112.327 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -86.17 -46.79 10.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.892 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 88.9 t -50.88 -42.16 22.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.182 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -56.63 -59.14 5.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.093 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -47.48 -38.76 14.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 16.5 ttt-85 -70.67 -52.95 17.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.84 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -53.64 -42.24 67.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.074 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 708' ' ' CYS . . . . . . . . . . . . . 1.1 t -47.49 -43.98 24.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 3.5 mtt-85 -81.91 -45.76 15.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.899 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 13.9 mtm -57.09 -17.31 9.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.875 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 711' ' ' MET . . . . . 0.521 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 4.2 mmt -113.8 -34.5 5.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.881 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 712' ' ' ASN . . . . . 0.437 ' C ' ' O ' ' A' ' 711' ' ' MET . 3.9 t30 -35.02 117.24 0.38 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.863 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 72.38 31.95 62.88 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.479 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 714' ' ' MET . . . . . 0.41 ' N ' ' O ' ' A' ' 711' ' ' MET . 20.1 ttp -74.16 91.53 2.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.887 0.375 . . . . 0.0 110.869 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 715' ' ' LYS . . . . . 0.483 ' CD ' ' HG3' ' A' ' 720' ' ' GLU . 0.7 OUTLIER -50.84 99.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.898 179.979 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 716' ' ' LEU . . . . . 0.481 ' O ' ' N ' ' A' ' 719' ' ' ARG . 30.4 mt -99.43 117.82 34.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.908 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 717' ' ' SER . . . . . . . . . . . . . 1.5 t 41.04 37.27 0.53 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.854 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 84.1 25.26 45.2 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.505 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 719' ' ' ARG . . . . . 0.481 ' N ' ' O ' ' A' ' 716' ' ' LEU . 39.2 mtt85 -138.73 106.38 5.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.774 0.321 . . . . 0.0 110.836 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 720' ' ' GLU . . . . . 0.483 ' HG3' ' CD ' ' A' ' 715' ' ' LYS . 30.2 mt-10 -72.45 127.94 34.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.875 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . 0.45 HD11 ' CG2' ' A' ' 723' ' ' VAL . 43.1 pt -98.07 159.76 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.089 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -111.33 99.44 8.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.834 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 723' ' ' VAL . . . . . 0.45 ' CG2' HD11 ' A' ' 721' ' ' ILE . 12.7 t -98.97 134.03 39.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.154 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 63.5 mtm180 -156.9 174.91 14.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.844 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 725' ' ' ILE . . . . . . . . . . . . . 25.4 mm -77.28 139.3 18.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.126 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -90.83 100.21 13.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.852 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 727' ' ' ARG . . . . . . . . . . . . . 20.4 mmm-85 -69.36 155.75 39.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 728' ' ' ASN . . . . . . . . . . . . . 34.6 m-20 49.24 43.23 22.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.879 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 729' ' ' ALA . . . . . . . . . . . . . . . -94.31 -60.38 1.74 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.115 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 17.6 m -154.73 137.36 15.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.834 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 731' ' ' GLY . . . . . . . . . . . . . . . -161.75 83.64 0.12 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.488 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 732' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 -46.56 1.2 Allowed 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.661 2.24 . . . . 0.0 112.359 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 733' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 734' ' ' SER . 1.6 t -92.89 119.35 32.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.831 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 734' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 733' ' ' SER . 40.6 p -36.18 151.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.854 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 735' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.51 -179.978 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 645' ' ' SER . . . . . . . . . . . . . 13.0 t -138.73 154.47 48.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.934 0.397 . . . . 0.0 110.851 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 646' ' ' SER . . . . . . . . . . . . . 1.2 t -59.03 127.17 30.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.83 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . 169.24 106.14 0.19 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.475 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 73.7 m -92.95 130.53 38.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.922 0.392 . . . . 0.0 110.843 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 15.6 m -97.38 119.74 36.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.879 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 49.87 63.16 4.39 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.469 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 651' ' ' ALA . . . . . 0.435 ' HB3' ' CG2' ' A' ' 725' ' ' ILE . . . -107.42 86.8 2.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.755 0.312 . . . . 0.0 111.104 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 25.7 p -101.96 -22.9 14.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.892 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -85.71 144.68 27.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.937 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 654' ' ' ILE . . . . . 0.545 HD12 ' CE2' ' A' ' 672' ' ' PHE . 35.6 pt -131.47 174.64 12.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.083 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 655' ' ' PHE . . . . . 0.4 ' CD2' HG13 ' A' ' 695' ' ' VAL . 7.7 t80 -131.31 148.75 52.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.864 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 11.2 t -131.31 148.47 32.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.129 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -143.89 157.84 44.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.881 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 658' ' ' ASN . . . . . . . . . . . . . 4.9 t30 71.2 46.22 0.45 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.904 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 659' ' ' LEU . . . . . 0.451 HD21 ' CD1' ' A' ' 716' ' ' LEU . 52.5 mt -94.71 142.47 24.77 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.62 0.724 . . . . 0.0 110.886 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -47.95 127.84 15.38 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.666 2.244 . . . . 0.0 112.348 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -44.18 -37.34 3.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.85 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 662' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 663' ' ' PHE . 51.3 m-20 -75.26 -35.56 61.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.864 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 663' ' ' PHE . . . . . 0.565 ' CD1' ' HE1' ' A' ' 667' ' ' MET . 3.8 t80 -34.68 142.9 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.862 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 45.1 p -127.38 172.51 10.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.179 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 665' ' ' TRP . . . . . 0.614 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 6.0 p-90 -63.46 -50.27 70.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.929 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 666' ' ' LYS . . . . . 0.614 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 5.0 tppp? -46.42 -51.0 15.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.867 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 667' ' ' MET . . . . . 0.565 ' HE1' ' CD1' ' A' ' 663' ' ' PHE . 32.3 mtm -62.06 -46.85 87.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.889 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 39.3 tp -48.9 -46.09 42.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.936 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 25.3 ttmt -65.02 -72.97 0.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.917 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -46.17 -25.71 0.64 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.86 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 671' ' ' LYS . . . . . 0.403 ' HG3' ' CE ' ' A' ' 711' ' ' MET . 10.1 tppt? -67.9 -51.66 45.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.899 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 672' ' ' PHE . . . . . 0.565 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 23.7 m-85 -77.77 -16.99 58.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.84 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -48.93 -33.41 10.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -55.83 -39.28 71.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.884 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 675' ' ' CYS . . . . . 0.453 ' CB ' ' HB3' ' A' ' 707' ' ' ALA . 60.4 m -71.58 -41.71 68.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.899 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -174.75 170.84 44.01 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.436 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 677' ' ' HIS . . . . . 0.518 ' CD2' HD22 ' A' ' 679' ' ' LEU . 2.9 t-160 -62.01 103.71 0.39 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.805 0.336 . . . . 0.0 110.861 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 65.1 t -80.32 147.62 6.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.085 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 679' ' ' LEU . . . . . 0.518 HD22 ' CD2' ' A' ' 677' ' ' HIS . 13.7 mt -120.37 -63.83 1.32 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.913 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 680' ' ' TYR . . . . . 0.42 ' HB3' ' CB ' ' A' ' 697' ' ' LYS . 10.1 t80 -98.66 125.32 43.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -152.78 124.59 7.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.131 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -157.41 156.68 32.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.873 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 40.9 mm -96.23 99.28 8.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.152 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.62 141.6 20.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.878 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 685' ' ' MET . . . . . . . . . . . . . 31.2 mtp -137.31 158.65 43.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.847 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -125.0 106.01 9.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.887 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 687' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 62.98 40.27 9.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.876 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 688' ' ' GLY . . . . . . . . . . . . . . . 67.93 39.44 89.35 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.463 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 35.0 mmtt -137.32 124.34 21.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.82 0.343 . . . . 0.0 110.891 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 690' ' ' SER . . . . . . . . . . . . . 16.5 m -59.49 120.86 10.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.866 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -104.65 13.44 31.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.907 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 51.89 37.09 43.49 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.448 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 27.2 p -137.81 149.76 46.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.875 0.369 . . . . 0.0 110.882 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -155.68 -175.71 27.01 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.516 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 695' ' ' VAL . . . . . 0.4 HG13 ' CD2' ' A' ' 655' ' ' PHE . 13.8 m -138.25 156.32 30.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.812 0.339 . . . . 0.0 111.162 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 90.7 t -142.96 118.0 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.115 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 697' ' ' LYS . . . . . 0.42 ' CB ' ' HB3' ' A' ' 680' ' ' TYR . 23.7 tttp -101.96 137.39 40.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.88 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -113.49 166.65 11.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.871 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 699' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -68.53 -44.92 73.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.853 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 3.7 m -113.56 151.04 44.19 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.658 0.742 . . . . 0.0 110.869 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -36.7 10.21 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.657 2.238 . . . . 0.0 112.335 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 702' ' ' GLU . . . . . 0.443 ' C ' ' OE1' ' A' ' 702' ' ' GLU . 0.6 OUTLIER -56.81 -40.56 76.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.932 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 79.6 t -53.8 -57.07 6.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.087 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -43.23 -63.25 0.85 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.08 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -41.4 -29.96 0.17 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.883 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 19.8 ttm-85 -82.62 -47.79 11.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.846 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 707' ' ' ALA . . . . . 0.453 ' HB3' ' CB ' ' A' ' 675' ' ' CYS . . . -62.9 -59.34 4.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.06 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 708' ' ' CYS . . . . . 0.421 ' C ' ' O ' ' A' ' 707' ' ' ALA . 11.5 p -36.18 -36.69 0.1 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.877 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 6.3 mtt180 -85.29 -46.16 11.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.872 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 18.7 mtm -61.89 -9.45 6.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.886 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 711' ' ' MET . . . . . 0.565 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 6.3 mmm -120.2 -17.72 8.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.881 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 712' ' ' ASN . . . . . 0.404 ' OD1' ' C ' ' A' ' 712' ' ' ASN . 3.5 t-20 -53.5 117.41 3.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.905 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 80.8 10.4 85.16 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.533 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 714' ' ' MET . . . . . 0.473 ' HB3' ' CD1' ' A' ' 721' ' ' ILE . 46.3 ttp -61.32 91.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.857 0.36 . . . . 0.0 110.9 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 2.9 mttp -58.56 112.0 1.45 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.893 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 716' ' ' LEU . . . . . 0.451 ' CD1' HD21 ' A' ' 659' ' ' LEU . 30.5 mt -100.19 127.46 46.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 717' ' ' SER . . . . . . . . . . . . . 31.1 t 37.66 31.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.861 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 718' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 716' ' ' LEU . . . 89.3 43.11 5.36 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.463 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 719' ' ' ARG . . . . . . . . . . . . . 19.0 mtt180 -152.02 107.37 3.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.764 0.316 . . . . 0.0 110.886 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -62.69 124.22 20.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.884 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . 0.473 ' CD1' ' HB3' ' A' ' 714' ' ' MET . 18.9 pt -100.09 151.18 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.161 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -111.1 97.79 7.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.853 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 8.1 t -97.35 136.11 29.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.143 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 79.8 mtt-85 -156.18 161.95 40.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 725' ' ' ILE . . . . . 0.435 ' CG2' ' HB3' ' A' ' 651' ' ' ALA . 23.0 mm -70.23 131.73 33.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.123 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -90.61 83.84 5.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.823 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 727' ' ' ARG . . . . . . . . . . . . . 27.4 ttt180 -80.37 -36.79 33.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.882 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 728' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -86.19 41.96 0.96 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.866 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 729' ' ' ALA . . . . . . . . . . . . . . . -86.8 -53.9 4.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.1 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 33.9 m -129.08 172.85 11.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.865 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 731' ' ' GLY . . . . . . . . . . . . . . . -150.06 -175.86 22.61 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.501 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 732' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 100.28 0.81 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.725 2.283 . . . . 0.0 112.355 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 733' ' ' SER . . . . . . . . . . . . . 3.6 t -58.25 112.74 1.65 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.833 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 734' ' ' SER . . . . . . . . . . . . . 3.1 m -108.78 153.85 22.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.895 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 735' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.511 -179.971 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 652' ' ' CYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 704' ' ' ALA . 18.8 p . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.74 0.305 . . . . 0.0 110.83 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -93.24 153.23 18.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.882 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 654' ' ' ILE . . . . . 0.652 HG22 HD13 ' A' ' 725' ' ' ILE . 32.7 pt -136.51 177.75 5.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.157 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -130.56 149.56 52.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.875 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 3.3 t -134.58 151.89 32.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.136 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 38.1 mtt85 -148.39 161.99 40.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 658' ' ' ASN . . . . . 0.425 ' O ' HG22 ' A' ' 721' ' ' ILE . 1.9 t-20 65.27 47.97 2.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.739 HD22 ' CD2' ' A' ' 663' ' ' PHE . 26.3 mt -96.98 143.65 26.48 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.599 0.714 . . . . 0.0 110.942 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 660' ' ' PRO . . . . . 0.445 ' O ' ' N ' ' A' ' 663' ' ' PHE . 65.5 Cg_exo -47.95 127.82 15.34 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.685 2.257 . . . . 0.0 112.344 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -45.45 -30.96 1.53 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.881 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -83.8 -28.36 28.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.896 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 663' ' ' PHE . . . . . 0.739 ' CD2' HD22 ' A' ' 659' ' ' LEU . 3.8 t80 -40.62 123.14 1.79 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.924 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 80.4 p -106.02 176.77 5.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.138 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 665' ' ' TRP . . . . . 0.648 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 6.6 p-90 -68.97 -50.66 47.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.888 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 666' ' ' LYS . . . . . 0.648 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 2.8 tppp? -47.29 -50.73 20.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.858 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 31.4 mtm -63.37 -46.52 86.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.875 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 14.1 tp -51.52 -42.53 61.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.9 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 29.3 tttm -65.2 -74.15 0.11 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.873 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -46.01 -23.68 0.33 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.874 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 671' ' ' LYS . . . . . 0.442 ' HG3' ' CE ' ' A' ' 711' ' ' MET . 7.5 tppt? -69.88 -40.37 75.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.91 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 672' ' ' PHE . . . . . 0.466 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 20.6 m-85 -90.14 -9.3 48.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -57.63 -34.97 69.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -43.16 -44.76 5.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.903 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 9.4 t -66.98 -63.94 0.96 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.871 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -145.83 -155.06 6.35 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.462 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -93.08 102.83 15.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.88 0.372 . . . . 0.0 110.861 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 43.1 t -75.86 132.88 32.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.073 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 679' ' ' LEU . . . . . 0.403 HD21 ' HG2' ' A' ' 699' ' ' GLU . 10.2 mt -107.3 -61.53 1.54 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.887 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -97.91 129.61 44.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.918 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -155.48 123.07 5.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.138 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -152.17 165.52 34.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.83 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 18.5 mm -115.8 117.2 54.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.13 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.855 179.867 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 4.6 mmtp . . . . . 0 N--CA 1.458 -0.061 0 CA-C-O 120.82 0.343 . . . . 0.0 110.866 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 80.91 13.36 81.4 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.496 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 8.9 p -126.81 131.89 51.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.835 0.35 . . . . 0.0 110.931 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -139.75 -170.87 12.09 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.518 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 5.2 m -141.07 153.5 20.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.865 0.364 . . . . 0.0 111.116 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 98.9 t -139.64 124.31 20.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.091 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 23.9 tttt -107.57 139.72 41.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.885 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -115.55 172.27 7.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.923 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 699' ' ' GLU . . . . . 0.403 ' HG2' HD21 ' A' ' 679' ' ' LEU . 25.7 mt-10 -75.52 -44.07 45.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.844 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 58.3 m -107.36 147.71 35.77 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.66 0.743 . . . . 0.0 110.843 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -32.97 17.55 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.649 2.233 . . . . 0.0 112.375 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -63.07 -42.92 99.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.891 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 95.5 t -51.14 -60.24 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.149 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 704' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 652' ' ' CYS . . . -42.13 -59.44 1.77 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.098 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 705' ' ' GLU . . . . . 0.761 ' HA ' HD11 ' A' ' 725' ' ' ILE . 22.0 mt-10 -43.55 -31.23 0.69 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.89 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 26.2 ttm-85 -81.99 -58.1 3.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.867 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -44.93 -30.15 0.95 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.095 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 708' ' ' CYS . . . . . 0.49 ' O ' ' N ' ' A' ' 712' ' ' ASN . 1.4 t -56.43 -63.96 1.02 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.883 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.15 -41.25 94.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.88 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 58.4 mtp -55.34 -33.6 63.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 711' ' ' MET . . . . . 0.469 ' CB ' HG21 ' A' ' 723' ' ' VAL . 3.7 mmt -105.8 -14.46 15.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.856 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 712' ' ' ASN . . . . . 0.49 ' N ' ' O ' ' A' ' 708' ' ' CYS . 40.1 t-20 -54.22 109.72 0.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.889 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 83.65 24.06 51.28 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.487 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 714' ' ' MET . . . . . 0.436 ' CE ' ' CE ' ' A' ' 711' ' ' MET . 38.2 ttp -72.16 98.91 2.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.825 0.345 . . . . 0.0 110.854 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 5.5 mmtm -51.94 101.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.887 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 716' ' ' LEU . . . . . 0.883 HD12 HG21 ' A' ' 721' ' ' ILE . 24.6 mt -99.78 120.02 39.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.926 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 717' ' ' SER . . . . . . . . . . . . . 20.4 t 40.27 43.67 1.46 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.874 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 75.6 26.52 65.15 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.521 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 719' ' ' ARG . . . . . 0.464 ' N ' ' O ' ' A' ' 716' ' ' LEU . 28.5 mtp180 -140.16 110.95 6.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.777 0.322 . . . . 0.0 110.89 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -68.2 127.84 34.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.933 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 721' ' ' ILE . . . . . 0.883 HG21 HD12 ' A' ' 716' ' ' LEU . 26.4 pt -99.69 151.41 4.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.137 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -106.11 99.88 9.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.878 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 723' ' ' VAL . . . . . 0.469 HG21 ' CB ' ' A' ' 711' ' ' MET . 4.4 t -97.53 135.77 30.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.141 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 -158.21 163.97 36.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.876 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 725' ' ' ILE . . . . . 0.761 HD11 ' HA ' ' A' ' 705' ' ' GLU . 31.9 mm -79.27 134.86 26.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.127 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 40.6 t0 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 179.838 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 29.8 m . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.77 0.319 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -94.53 143.1 26.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.932 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 654' ' ' ILE . . . . . 0.455 HD11 ' CE2' ' A' ' 672' ' ' PHE . 36.3 pt -132.94 174.97 12.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.154 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -121.09 158.58 27.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.832 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 21.9 t -147.01 146.47 18.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.095 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 65.6 mtm180 -146.42 157.86 43.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.87 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 658' ' ' ASN . . . . . 0.444 ' O ' HG22 ' A' ' 721' ' ' ILE . 3.2 t-20 71.17 50.17 0.31 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.853 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.525 HD22 ' CD2' ' A' ' 663' ' ' PHE . 29.0 mt -100.59 143.83 27.3 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.615 0.722 . . . . 0.0 110.872 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 660' ' ' PRO . . . . . 0.483 ' O ' ' N ' ' A' ' 663' ' ' PHE . 65.8 Cg_exo -47.97 124.55 10.23 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.684 2.256 . . . . 0.0 112.331 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -42.37 -36.89 1.4 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.828 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -76.0 -31.5 58.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.881 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 663' ' ' PHE . . . . . 0.525 ' CD2' HD22 ' A' ' 659' ' ' LEU . 3.8 t80 -38.85 128.4 1.57 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.863 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 72.1 p -113.18 174.99 5.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.139 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 665' ' ' TRP . . . . . 0.644 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 5.3 p-90 -64.35 -51.66 62.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.897 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 666' ' ' LYS . . . . . 0.644 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 7.4 tppt? -45.42 -53.31 8.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.877 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 28.2 mtm -58.05 -54.38 47.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.892 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 15.3 tp -41.85 -49.72 4.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.881 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -60.66 -74.2 0.08 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.913 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -46.73 -23.3 0.4 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.9 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 10.3 tptt -70.83 -45.43 64.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.892 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 672' ' ' PHE . . . . . 0.455 ' CE2' HD11 ' A' ' 654' ' ' ILE . 23.4 m-85 -84.57 -11.58 55.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.908 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -54.57 -36.04 63.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.876 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -52.79 -32.08 42.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 10.2 m -80.9 -49.33 11.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.894 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 676' ' ' GLY . . . . . 0.621 ' HA3' HG11 ' A' ' 703' ' ' VAL . . . -164.21 168.92 38.85 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.482 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -61.95 101.08 0.18 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.836 0.35 . . . . 0.0 110.85 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 73.5 t -80.35 132.83 30.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.114 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 13.3 mt -107.47 -61.85 1.5 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.89 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -95.79 130.15 42.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.922 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -157.77 128.45 6.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.114 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -161.12 156.93 25.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.872 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 30.5 mm -102.11 111.97 33.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.121 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.912 179.84 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 25.0 mmmt . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.838 0.352 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 59.25 18.7 43.44 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.506 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 19.5 p -126.13 151.0 47.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.834 0.349 . . . . 0.0 110.889 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 694' ' ' GLY . . . . . 0.415 ' O ' HG13 ' A' ' 695' ' ' VAL . . . -155.9 -152.0 6.09 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.487 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 695' ' ' VAL . . . . . 0.415 HG13 ' O ' ' A' ' 694' ' ' GLY . 15.3 m -155.84 152.4 8.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.831 0.348 . . . . 0.0 111.143 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 99.2 t -141.7 120.06 9.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.078 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 14.4 ttpt -104.87 138.1 41.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.902 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -113.95 173.87 6.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.903 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 699' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -75.06 -36.79 61.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.913 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 700' ' ' SER . . . . . 0.456 ' OG ' HG23 ' A' ' 703' ' ' VAL . 69.0 p -124.57 151.25 67.03 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.636 0.731 . . . . 0.0 110.873 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -30.27 22.63 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.681 2.254 . . . . 0.0 112.357 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -61.68 -39.0 89.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.844 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 703' ' ' VAL . . . . . 0.621 HG11 ' HA3' ' A' ' 676' ' ' GLY . 82.6 t -66.23 -47.21 85.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.086 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -51.47 -47.12 63.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.112 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 705' ' ' GLU . . . . . 0.76 ' HA ' HD11 ' A' ' 725' ' ' ILE . 14.4 mt-10 -55.45 -43.12 75.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.901 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 22.0 ttm180 -68.92 -54.81 13.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.837 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -43.07 -47.53 5.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.107 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 708' ' ' CYS . . . . . 0.48 ' O ' ' CB ' ' A' ' 712' ' ' ASN . 21.3 m -54.54 -34.57 62.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.87 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 8.7 mtm105 -81.66 -45.18 16.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.881 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 22.1 mtm -66.06 -15.27 62.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.921 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 711' ' ' MET . . . . . 0.476 ' O ' ' N ' ' A' ' 714' ' ' MET . 3.2 mmt -113.78 -30.83 6.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.873 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 712' ' ' ASN . . . . . 0.48 ' CB ' ' O ' ' A' ' 708' ' ' CYS . 0.5 OUTLIER -39.79 112.27 0.25 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.875 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 77.25 25.61 63.4 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.48 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 714' ' ' MET . . . . . 0.553 ' HE3' HD21 ' A' ' 716' ' ' LEU . 48.9 ttp -71.38 100.35 2.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.863 0.363 . . . . 0.0 110.91 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp -54.07 99.13 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.889 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 716' ' ' LEU . . . . . 0.846 HD12 HG21 ' A' ' 721' ' ' ILE . 29.1 mt -99.89 125.21 45.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.929 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 717' ' ' SER . . . . . . . . . . . . . 1.1 t 40.06 43.68 1.35 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.883 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 72.41 29.09 66.57 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.508 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 719' ' ' ARG . . . . . 0.47 ' N ' ' O ' ' A' ' 716' ' ' LEU . 44.1 mtt180 -141.19 114.85 8.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.801 0.334 . . . . 0.0 110.885 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -70.18 128.03 34.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.902 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 721' ' ' ILE . . . . . 0.846 HG21 HD12 ' A' ' 716' ' ' LEU . 37.3 pt -100.03 161.89 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.129 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -118.39 98.21 6.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.845 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 723' ' ' VAL . . . . . 0.457 ' CG1' ' HA ' ' A' ' 708' ' ' CYS . 6.2 t -96.59 132.83 40.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.146 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 64.1 mtt180 -155.19 154.15 31.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.879 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 725' ' ' ILE . . . . . 0.76 HD11 ' HA ' ' A' ' 705' ' ' GLU . 15.1 mm -64.15 134.51 28.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.15 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 17.9 t0 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 179.865 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 652' ' ' CYS . . . . . 0.461 ' SG ' ' N ' ' A' ' 701' ' ' PRO . 22.3 m . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.751 0.31 . . . . 0.0 110.869 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -104.32 146.49 28.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.928 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 654' ' ' ILE . . . . . 0.587 HD11 ' CE2' ' A' ' 672' ' ' PHE . 38.9 pt -131.32 169.34 21.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.096 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -122.75 149.85 43.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.889 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 3.4 t -132.8 153.38 37.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.152 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 53.4 mtt85 -148.68 160.44 43.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.896 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 658' ' ' ASN . . . . . 0.448 ' O ' HG22 ' A' ' 721' ' ' ILE . 0.6 OUTLIER 66.93 44.95 1.91 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.927 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.439 HD23 HD12 ' A' ' 716' ' ' LEU . 54.1 mt -93.84 143.52 26.64 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.586 0.707 . . . . 0.0 110.907 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 660' ' ' PRO . . . . . 0.406 ' O ' ' N ' ' A' ' 663' ' ' PHE . 66.7 Cg_exo -48.04 124.12 9.7 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.687 2.258 . . . . 0.0 112.32 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -47.43 -24.43 0.81 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.896 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 662' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 663' ' ' PHE . 73.5 m-20 -88.49 -29.67 19.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.876 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 663' ' ' PHE . . . . . 0.408 ' C ' ' O ' ' A' ' 662' ' ' ASP . 3.5 t80 -37.6 140.03 0.25 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 82.2 p -120.34 169.82 9.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.122 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 665' ' ' TRP . . . . . 0.644 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 6.7 p-90 -63.45 -52.16 62.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.96 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 666' ' ' LYS . . . . . 0.644 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 9.7 tppt? -44.63 -51.57 8.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.877 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 24.3 mtm -61.74 -47.17 86.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.866 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 668' ' ' LEU . . . . . 0.443 HD22 HD13 ' A' ' 683' ' ' ILE . 35.6 tp -47.85 -47.55 31.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.91 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.448 ' HG2' ' N ' ' A' ' 670' ' ' ASP . 0.3 OUTLIER -64.76 -73.69 0.12 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 179.789 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 670' ' ' ASP . . . . . 0.448 ' N ' ' HG2' ' A' ' 669' ' ' LYS . 4.5 m-20 -45.2 -24.22 0.24 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.903 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 671' ' ' LYS . . . . . 0.479 ' HG3' ' CE ' ' A' ' 711' ' ' MET . 7.8 tppt? -69.88 -51.3 34.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.897 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 672' ' ' PHE . . . . . 0.587 ' CE2' HD11 ' A' ' 654' ' ' ILE . 27.7 m-85 -78.43 -11.15 59.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.878 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -55.9 -39.38 71.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.881 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -47.4 -36.02 9.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.895 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 64.8 m -74.66 -56.5 4.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.826 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -160.41 -175.95 31.97 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.474 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -68.43 109.44 3.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.832 0.348 . . . . 0.0 110.831 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 53.2 t -88.57 128.7 40.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.139 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 679' ' ' LEU . . . . . 0.535 HD11 ' HG2' ' A' ' 699' ' ' GLU . 11.4 mt -100.5 -64.42 1.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -97.94 130.34 44.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.879 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -153.9 125.96 7.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.104 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -163.61 157.94 20.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.894 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 683' ' ' ILE . . . . . 0.443 HD13 HD22 ' A' ' 668' ' ' LEU . 25.2 mm -93.87 101.72 12.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.126 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 16.2 mmmt . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.901 179.85 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 691' ' ' LYS . . . . . 0.418 ' O ' ' N ' ' A' ' 693' ' ' CYS . 33.3 mmtt . . . . . 0 N--CA 1.457 -0.091 0 CA-C-O 120.855 0.36 . . . . 0.0 110.932 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 692' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' A' ' 658' ' ' ASN . . . 37.71 31.28 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.512 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 693' ' ' CYS . . . . . 0.418 ' N ' ' O ' ' A' ' 691' ' ' LYS . 26.0 p -132.92 125.43 29.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.896 0.379 . . . . 0.0 110.88 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -130.01 172.91 20.02 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.475 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 8.7 m -129.35 150.98 35.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.857 0.36 . . . . 0.0 111.13 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 696' ' ' VAL . . . . . 0.485 HG21 ' CD1' ' A' ' 672' ' ' PHE . 62.9 t -140.77 122.31 14.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.079 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 13.6 tttt -106.78 134.22 50.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.948 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 698' ' ' PHE . . . . . 0.506 ' CD2' HG11 ' A' ' 703' ' ' VAL . 94.0 m-85 -109.81 171.39 7.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.893 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 699' ' ' GLU . . . . . 0.535 ' HG2' HD11 ' A' ' 679' ' ' LEU . 10.2 mm-40 -75.75 -45.19 37.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.921 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 57.7 m -109.83 145.62 32.4 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.673 0.749 . . . . 0.0 110.871 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 701' ' ' PRO . . . . . 0.461 ' N ' ' SG ' ' A' ' 652' ' ' CYS . 53.7 Cg_endo -69.8 -10.89 29.63 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.629 2.22 . . . . 0.0 112.343 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 702' ' ' GLU . . . . . 0.4 ' OE1' ' C ' ' A' ' 702' ' ' GLU . 1.4 pp20? -82.9 -31.02 28.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.866 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 703' ' ' VAL . . . . . 0.506 HG11 ' CD2' ' A' ' 698' ' ' PHE . 66.5 t -67.72 -57.4 9.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.121 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -44.23 -58.54 2.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.091 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 705' ' ' GLU . . . . . 0.498 ' HA ' HD11 ' A' ' 725' ' ' ILE . 19.0 mt-10 -44.31 -36.32 2.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.896 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -76.91 -64.77 1.05 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.823 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -39.61 -34.95 0.27 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.105 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 708' ' ' CYS . . . . . 0.446 ' HA ' ' CG1' ' A' ' 723' ' ' VAL . 56.8 m -52.82 -56.69 13.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.945 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -71.14 -39.75 71.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.92 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 18.6 mtm -64.4 -13.1 49.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 711' ' ' MET . . . . . 0.545 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 6.3 mmm -119.21 -16.68 9.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.887 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 712' ' ' ASN . . . . . 0.491 ' ND2' ' O ' ' A' ' 712' ' ' ASN . 0.1 OUTLIER -55.97 122.24 11.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.868 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 76.75 13.53 83.47 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.46 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 714' ' ' MET . . . . . . . . . . . . . 43.4 ttp -61.34 97.15 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.845 0.355 . . . . 0.0 110.823 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 15.4 mmtt -54.08 101.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.887 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 716' ' ' LEU . . . . . 0.946 HD12 HG21 ' A' ' 721' ' ' ILE . 46.0 mt -99.91 123.81 44.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.908 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 717' ' ' SER . . . . . . . . . . . . . 2.0 t 37.64 41.34 0.3 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.838 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 77.05 34.1 43.07 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.487 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 719' ' ' ARG . . . . . 0.48 ' N ' ' O ' ' A' ' 716' ' ' LEU . 9.6 mtt-85 -146.93 111.51 5.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.716 0.293 . . . . 0.0 110.862 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -68.83 125.6 27.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.888 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 721' ' ' ILE . . . . . 0.946 HG21 HD12 ' A' ' 716' ' ' LEU . 22.7 pt -100.0 160.36 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.138 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -115.2 109.43 17.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.832 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 723' ' ' VAL . . . . . 0.446 ' CG1' ' HA ' ' A' ' 708' ' ' CYS . 5.4 t -108.72 129.28 63.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.134 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 36.1 mtp180 -157.56 158.73 36.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.827 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 725' ' ' ILE . . . . . 0.498 HD11 ' HA ' ' A' ' 705' ' ' GLU . 31.6 mm -51.43 136.32 11.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.134 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 24.8 t0 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 179.856 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 24.8 p . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.725 0.297 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -92.12 150.72 20.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.945 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 654' ' ' ILE . . . . . 0.581 HG22 HD13 ' A' ' 725' ' ' ILE . 30.0 pt -137.26 167.07 23.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.169 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -120.7 159.47 25.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.865 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.436 HG12 ' N ' ' A' ' 657' ' ' ARG . 16.7 t -145.64 156.77 12.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.174 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 657' ' ' ARG . . . . . 0.436 ' N ' HG12 ' A' ' 656' ' ' VAL . 57.4 mtt180 -153.49 162.79 40.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.898 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 658' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 69.03 36.83 2.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.895 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.521 HD22 ' CD2' ' A' ' 663' ' ' PHE . 37.6 mt -86.74 143.34 35.5 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.669 0.747 . . . . 0.0 110.935 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 660' ' ' PRO . . . . . 0.47 ' O ' ' N ' ' A' ' 663' ' ' PHE . 64.8 Cg_exo -47.88 126.5 13.03 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.655 2.237 . . . . 0.0 112.375 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -42.42 -33.66 0.7 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.858 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 662' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 663' ' ' PHE . 44.1 m-20 -81.12 -32.59 33.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.912 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 663' ' ' PHE . . . . . 0.521 ' CD2' HD22 ' A' ' 659' ' ' LEU . 4.3 t80 -35.74 124.92 0.7 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.901 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 68.5 p -108.44 174.84 5.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.145 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 665' ' ' TRP . . . . . 0.646 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 8.0 p-90 -65.93 -51.97 53.97 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.896 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 666' ' ' LYS . . . . . 0.646 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 2.3 tppp? -44.57 -54.35 6.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.882 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 20.1 mtm -57.86 -49.45 76.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.9 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 56.6 tp -46.8 -44.56 19.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.887 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 29.7 tttm -65.47 -74.92 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.85 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -46.36 -22.93 0.3 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.864 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 671' ' ' LYS . . . . . 0.468 ' HG3' ' CE ' ' A' ' 711' ' ' MET . 9.3 tppt? -70.88 -41.83 70.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.898 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 672' ' ' PHE . . . . . 0.56 ' CE2' ' CD1' ' A' ' 654' ' ' ILE . 18.5 m-85 -88.58 -11.65 44.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.892 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -54.28 -34.31 60.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.846 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -46.3 -44.91 17.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.899 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 12.9 t -64.47 -55.63 19.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.867 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -159.53 -157.16 8.42 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.476 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -86.5 110.42 19.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.889 0.376 . . . . 0.0 110.862 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 76.3 t -85.87 138.4 19.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.111 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 679' ' ' LEU . . . . . 0.591 HD11 ' HG2' ' A' ' 699' ' ' GLU . 25.4 mt -112.68 -62.47 1.58 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.908 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -96.68 131.87 42.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.94 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -155.84 125.17 6.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.102 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -158.13 160.82 37.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.875 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 23.2 mm -109.05 108.16 24.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.151 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.914 179.831 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.807 0.336 . . . . 0.0 110.925 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 40.42 33.82 0.59 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.514 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 28.4 p -140.02 133.73 30.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.888 0.375 . . . . 0.0 110.908 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 694' ' ' GLY . . . . . 0.402 ' O ' HG13 ' A' ' 695' ' ' VAL . . . -141.81 -154.4 6.17 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.496 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 695' ' ' VAL . . . . . 0.402 HG13 ' O ' ' A' ' 694' ' ' GLY . 14.3 m -155.75 155.84 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.818 0.342 . . . . 0.0 111.123 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 48.7 t -143.7 125.76 11.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.164 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 13.8 ttpt -109.79 137.6 47.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -111.6 169.77 8.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.925 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 699' ' ' GLU . . . . . 0.591 ' HG2' HD11 ' A' ' 679' ' ' LEU . 15.7 mt-10 -74.89 -42.06 58.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.892 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 39.7 m -109.94 151.09 42.21 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.684 0.754 . . . . 0.0 110.864 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -39.26 6.74 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.696 2.264 . . . . 0.0 112.349 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -54.71 -47.82 73.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.899 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 93.0 t -49.26 -59.08 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.089 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 704' ' ' ALA . . . . . 0.417 ' O ' ' C ' ' A' ' 705' ' ' GLU . . . -41.47 -67.46 0.25 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.066 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 705' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 704' ' ' ALA . 9.7 mt-10 -36.77 -42.61 0.39 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.91 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 706' ' ' ARG . . . . . 0.425 ' O ' ' C ' ' A' ' 707' ' ' ALA . 15.9 ttm180 -69.25 -64.21 0.92 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.848 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 707' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 706' ' ' ARG . . . -35.78 -47.87 0.52 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.087 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 708' ' ' CYS . . . . . 0.468 ' O ' ' N ' ' A' ' 712' ' ' ASN . 1.2 t -43.96 -60.62 1.76 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.924 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 11.9 mtt180 -69.15 -38.0 78.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.908 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 49.4 mtp -64.04 -16.04 60.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.905 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 711' ' ' MET . . . . . 0.468 ' CE ' ' HG3' ' A' ' 671' ' ' LYS . 4.1 mmt -123.54 -8.83 7.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.85 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 712' ' ' ASN . . . . . 0.468 ' N ' ' O ' ' A' ' 708' ' ' CYS . 27.7 t30 -64.58 118.36 8.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.911 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 78.89 30.06 49.11 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.493 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 714' ' ' MET . . . . . . . . . . . . . 34.2 ttp -80.22 110.46 15.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.851 0.357 . . . . 0.0 110.899 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 18.9 mmtt -67.19 102.27 1.02 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.881 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 716' ' ' LEU . . . . . 0.945 HD12 HG21 ' A' ' 721' ' ' ILE . 26.7 mt -99.93 123.08 43.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.939 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 717' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 716' ' ' LEU . 8.7 t 36.66 38.73 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.87 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 80.96 34.18 27.75 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.471 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 719' ' ' ARG . . . . . 0.501 ' N ' ' O ' ' A' ' 716' ' ' LEU . 8.1 mtt-85 -147.27 110.95 4.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.795 0.331 . . . . 0.0 110.887 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -71.33 126.54 29.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.876 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 721' ' ' ILE . . . . . 0.945 HG21 HD12 ' A' ' 716' ' ' LEU . 32.9 pt -97.75 158.82 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.089 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -113.92 99.23 7.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.872 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 723' ' ' VAL . . . . . 0.45 HG21 ' HB3' ' A' ' 711' ' ' MET . 10.6 t -99.07 128.91 50.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.127 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 81.3 mtm180 -148.23 173.65 12.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 725' ' ' ILE . . . . . 0.581 HD13 HG22 ' A' ' 654' ' ' ILE . 31.5 mm -81.05 134.37 27.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.128 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 8.5 t70 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.894 179.849 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 25.8 p . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.809 0.338 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 653' ' ' GLN . . . . . 0.466 ' NE2' ' HB ' ' A' ' 695' ' ' VAL . 10.3 tp60 -89.92 146.32 24.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.876 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 654' ' ' ILE . . . . . 0.485 HD12 ' CG1' ' A' ' 723' ' ' VAL . 23.6 pt -138.04 178.07 4.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.106 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -134.27 153.02 52.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.897 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 20.5 t -135.77 153.43 32.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.138 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -147.67 157.41 43.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.846 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 658' ' ' ASN . . . . . 0.668 ' O ' HG22 ' A' ' 721' ' ' ILE . 1.9 t-20 68.63 52.11 0.59 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.556 HD22 ' CE2' ' A' ' 663' ' ' PHE . 39.8 mt -100.2 143.45 26.54 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.594 0.712 . . . . 0.0 110.924 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -47.96 132.97 22.89 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.672 2.248 . . . . 0.0 112.377 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -44.26 -45.66 8.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.884 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 662' ' ' ASP . . . . . 0.479 ' O ' HG23 ' A' ' 664' ' ' THR . 22.8 t0 -68.16 -34.32 76.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.839 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 663' ' ' PHE . . . . . 0.556 ' CE2' HD22 ' A' ' 659' ' ' LEU . 4.2 t80 -36.84 116.59 0.45 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.925 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 664' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 662' ' ' ASP . 59.1 p -107.73 -177.89 3.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.115 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 665' ' ' TRP . . . . . 0.616 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 5.5 p-90 -64.73 -48.65 73.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.866 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 666' ' ' LYS . . . . . 0.616 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 13.8 tptm -48.84 -59.24 3.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.912 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 667' ' ' MET . . . . . 0.492 ' O ' ' CB ' ' A' ' 671' ' ' LYS . 28.6 mtm -53.69 -48.79 69.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 668' ' ' LEU . . . . . 0.427 HD11 ' CG2' ' A' ' 696' ' ' VAL . 15.3 tp -48.56 -46.67 39.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.908 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -65.49 -73.12 0.13 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.914 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -48.59 -23.9 1.15 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.88 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 671' ' ' LYS . . . . . 0.492 ' CB ' ' O ' ' A' ' 667' ' ' MET . 0.3 OUTLIER -69.98 -42.49 73.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.897 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 672' ' ' PHE . . . . . 0.582 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 15.6 m-85 -86.9 -16.09 37.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.854 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -49.52 -38.62 31.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.905 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -39.45 -44.35 1.36 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.898 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 5.9 t -67.48 -64.09 0.93 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.881 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -148.82 -158.86 8.23 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.516 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 677' ' ' HIS . . . . . 0.449 ' C ' ' CD2' ' A' ' 677' ' ' HIS . 3.4 t60 -86.88 107.52 18.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.871 0.367 . . . . 0.0 110.878 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 60.0 t -81.11 143.2 12.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.109 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 679' ' ' LEU . . . . . 0.597 HD11 ' HG2' ' A' ' 699' ' ' GLU . 23.6 mt -116.14 -62.77 1.54 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.872 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -99.91 128.98 45.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.909 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -155.89 123.75 5.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.08 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -152.5 155.85 38.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.875 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 18.1 mm -104.87 107.3 22.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.114 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 179.804 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 19.3 mmmt . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.801 0.334 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 692' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 658' ' ' ASN . . . 48.62 25.95 5.02 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.478 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 19.1 p -135.16 131.17 36.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.884 0.373 . . . . 0.0 110.847 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -143.52 -164.97 10.56 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.483 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 695' ' ' VAL . . . . . 0.466 ' HB ' ' NE2' ' A' ' 653' ' ' GLN . 17.1 m -140.08 160.1 26.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.922 0.391 . . . . 0.0 111.126 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 696' ' ' VAL . . . . . 0.438 HG21 ' CD1' ' A' ' 672' ' ' PHE . 70.7 t -146.52 115.01 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.099 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 37.0 tttt -96.69 138.37 34.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -116.69 164.38 14.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.906 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 699' ' ' GLU . . . . . 0.597 ' HG2' HD11 ' A' ' 679' ' ' LEU . 48.9 mt-10 -71.11 -41.87 69.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.892 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 3.2 m -113.81 149.51 41.91 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.671 0.748 . . . . 0.0 110.887 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -33.53 16.37 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.638 2.225 . . . . 0.0 112.349 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 702' ' ' GLU . . . . . 0.449 ' HG3' ' N ' ' A' ' 703' ' ' VAL . 9.2 pt-20 -61.86 -42.36 98.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.893 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 703' ' ' VAL . . . . . 0.449 ' N ' ' HG3' ' A' ' 702' ' ' GLU . 84.2 t -55.31 -60.51 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.126 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -39.04 -61.43 0.75 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.097 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 705' ' ' GLU . . . . . 0.44 ' HG2' HD11 ' A' ' 725' ' ' ILE . 12.7 mt-10 -44.29 -41.03 5.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.92 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 15.7 ttt180 -67.05 -59.26 3.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.875 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -46.3 -44.0 16.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.056 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 708' ' ' CYS . . . . . 0.495 ' O ' ' CB ' ' A' ' 712' ' ' ASN . 1.8 m -50.74 -41.16 56.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.873 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 3.2 mtt-85 -82.47 -37.66 25.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.868 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 8.7 mtm -72.34 -9.44 58.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.869 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 711' ' ' MET . . . . . 0.582 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 5.5 mmm -120.5 -35.57 3.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.87 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 712' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 708' ' ' CYS . 0.5 OUTLIER -40.87 112.02 0.26 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.862 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 84.79 19.54 59.53 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.51 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 714' ' ' MET . . . . . 0.457 ' N ' ' O ' ' A' ' 711' ' ' MET . 57.2 ttp -69.28 94.07 0.68 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.847 0.356 . . . . 0.0 110.868 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 8.6 mmtp -51.13 98.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.899 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 716' ' ' LEU . . . . . 1.027 HD12 HG21 ' A' ' 721' ' ' ILE . 38.1 mt -99.94 129.92 46.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.951 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 717' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 716' ' ' LEU . 27.8 t 36.51 38.93 0.08 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.885 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 76.76 36.76 36.1 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.479 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 719' ' ' ARG . . . . . 0.498 ' N ' ' O ' ' A' ' 716' ' ' LEU . 21.7 mtt180 -147.22 116.04 6.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.748 0.308 . . . . 0.0 110.848 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -71.41 122.89 21.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.865 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 721' ' ' ILE . . . . . 1.027 HG21 HD12 ' A' ' 716' ' ' LEU . 19.4 pt -98.99 156.89 3.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.133 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 722' ' ' ASP . . . . . 0.446 ' OD1' ' C ' ' A' ' 722' ' ' ASP . 2.9 t0 -116.01 108.23 15.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.837 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 723' ' ' VAL . . . . . 0.485 ' CG1' HD12 ' A' ' 654' ' ' ILE . 17.3 t -107.32 136.02 43.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.177 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 724' ' ' ARG . . . . . 0.45 ' C ' ' SG ' ' A' ' 708' ' ' CYS . 13.5 ptt85 -158.13 165.97 33.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.872 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 725' ' ' ILE . . . . . 0.44 HD11 ' HG2' ' A' ' 705' ' ' GLU . 27.0 mm -62.18 138.0 23.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.126 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 726' ' ' ASP . . . . . 0.406 ' HB2' ' CA ' ' A' ' 654' ' ' ILE . 35.7 t0 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.87 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 24.5 p . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.701 0.286 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -94.51 152.06 18.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.91 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 654' ' ' ILE . . . . . 0.479 HD11 ' CE2' ' A' ' 672' ' ' PHE . 27.6 pt -136.01 174.54 12.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.113 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -127.76 157.04 41.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.901 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 3.1 t -140.72 151.07 20.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.114 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 4.1 mtp-105 -148.23 156.16 42.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.902 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 658' ' ' ASN . . . . . 0.436 ' O ' HG22 ' A' ' 721' ' ' ILE . 3.5 t-20 69.61 45.71 0.77 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.895 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.546 HD22 ' CD2' ' A' ' 663' ' ' PHE . 24.0 mt -94.51 143.71 26.73 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.653 0.74 . . . . 0.0 110.902 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -48.03 136.02 23.75 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.617 2.211 . . . . 0.0 112.383 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -52.34 -33.91 45.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.886 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.16 -30.12 43.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.915 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 663' ' ' PHE . . . . . 0.546 ' CD2' HD22 ' A' ' 659' ' ' LEU . 4.1 t80 -39.13 124.96 1.54 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.91 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 77.2 p -110.0 176.6 5.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.21 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 665' ' ' TRP . . . . . 0.644 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 3.5 p-90 -68.26 -50.05 56.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.959 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 666' ' ' LYS . . . . . 0.644 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 13.1 tptp -52.04 -47.48 65.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.943 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 21.2 mtm -64.78 -39.55 93.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.864 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 38.9 tp -56.43 -46.48 80.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.949 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.22 -61.07 2.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -54.59 -27.74 41.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 671' ' ' LYS . . . . . 0.48 ' O ' ' HE2' ' A' ' 711' ' ' MET . 11.0 tptt -66.56 -39.48 88.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 672' ' ' PHE . . . . . 0.479 ' CE2' HD11 ' A' ' 654' ' ' ILE . 25.1 m-85 -90.86 -10.51 42.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.856 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -54.53 -32.73 58.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.863 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -58.58 -28.88 65.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 17.3 m -81.81 -53.46 6.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.86 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -161.72 -179.0 36.12 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.492 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -70.2 107.1 3.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.8 0.333 . . . . 0.0 110.855 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 58.8 t -84.68 137.53 20.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.143 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 679' ' ' LEU . . . . . 0.829 HD11 ' HG2' ' A' ' 699' ' ' GLU . 12.1 mt -116.43 -57.98 2.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 680' ' ' TYR . . . . . 0.411 ' HB3' ' CB ' ' A' ' 697' ' ' LYS . 8.3 t80 -99.41 126.11 45.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.925 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -155.6 123.8 5.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.138 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -154.02 158.17 40.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.84 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 27.2 mm -106.87 126.82 62.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.089 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 56.0 mmtt . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.89 179.804 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.808 0.337 . . . . 0.0 110.893 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 95.51 14.63 46.71 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.479 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 21.4 p -133.24 132.22 41.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.871 0.367 . . . . 0.0 110.851 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -139.11 -160.8 8.49 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.509 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 19.3 m -147.21 160.29 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.904 0.383 . . . . 0.0 111.11 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 97.1 t -148.0 113.54 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.137 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 697' ' ' LYS . . . . . 0.411 ' CB ' ' HB3' ' A' ' 680' ' ' TYR . 18.9 ttpt -96.24 143.63 27.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 698' ' ' PHE . . . . . 0.437 ' CD2' HG11 ' A' ' 703' ' ' VAL . 96.2 m-85 -119.66 168.66 10.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.834 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 699' ' ' GLU . . . . . 0.829 ' HG2' HD11 ' A' ' 679' ' ' LEU . 17.7 mt-10 -75.05 -34.44 61.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.918 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 700' ' ' SER . . . . . 0.416 ' CB ' ' OE2' ' A' ' 702' ' ' GLU . 1.4 m -125.34 152.86 71.89 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.696 0.76 . . . . 0.0 110.826 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -50.37 0.47 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.698 2.265 . . . . 0.0 112.36 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 702' ' ' GLU . . . . . 0.416 ' OE2' ' CB ' ' A' ' 700' ' ' SER . 25.6 pm0 -44.54 -27.48 0.47 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.863 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 703' ' ' VAL . . . . . 0.437 HG11 ' CD2' ' A' ' 698' ' ' PHE . 47.0 t -73.4 -54.5 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.095 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -48.61 -57.14 6.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.067 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 705' ' ' GLU . . . . . 0.576 ' HA ' HD11 ' A' ' 725' ' ' ILE . 26.5 mt-10 -45.86 -38.07 6.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.858 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 9.4 ttm-85 -74.03 -58.15 3.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.897 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -47.99 -25.78 1.52 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.11 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 708' ' ' CYS . . . . . 0.5 ' HA ' HG12 ' A' ' 723' ' ' VAL . 1.5 t -60.47 -60.03 4.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.858 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -73.38 -36.97 66.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.812 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 12.1 mmm -59.42 -30.29 68.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.909 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 711' ' ' MET . . . . . 0.48 ' HE2' ' O ' ' A' ' 671' ' ' LYS . 4.8 mmm -107.03 -15.9 14.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.88 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 712' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -53.91 121.83 8.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.923 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 77.14 12.82 84.27 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.524 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 714' ' ' MET . . . . . . . . . . . . . 55.8 ttp -59.64 104.31 0.27 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.849 0.356 . . . . 0.0 110.867 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 7.9 mmtm -61.98 100.22 0.15 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.898 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 716' ' ' LEU . . . . . 0.616 HD12 HG21 ' A' ' 721' ' ' ILE . 31.6 mt -99.89 126.86 46.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.958 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 717' ' ' SER . . . . . 0.409 ' C ' ' O ' ' A' ' 716' ' ' LEU . 1.6 t 36.7 39.7 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.887 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 77.18 36.18 35.89 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.484 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 719' ' ' ARG . . . . . 0.494 ' N ' ' O ' ' A' ' 716' ' ' LEU . 5.9 mtt-85 -148.68 114.54 5.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.804 0.335 . . . . 0.0 110.864 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -72.27 127.48 32.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 721' ' ' ILE . . . . . 0.616 HG21 HD12 ' A' ' 716' ' ' LEU . 28.5 pt -100.04 157.05 4.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.149 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -109.22 98.48 7.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.847 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 723' ' ' VAL . . . . . 0.5 HG12 ' HA ' ' A' ' 708' ' ' CYS . 17.9 t -97.61 130.13 46.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.121 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.19 175.22 13.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.923 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 725' ' ' ILE . . . . . 0.576 HD11 ' HA ' ' A' ' 705' ' ' GLU . 49.4 mm -80.31 133.37 29.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.114 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 9.0 t0 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.861 179.871 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 29.7 p . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.811 0.339 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -163.94 149.44 10.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.913 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 654' ' ' ILE . . . . . 0.659 HG22 HD13 ' A' ' 725' ' ' ILE . 37.8 pt -140.66 173.29 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.14 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -130.5 144.69 51.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.871 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 27.6 t -126.99 139.25 52.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.081 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 36.7 mtp85 -133.73 155.76 49.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.86 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 658' ' ' ASN . . . . . 0.559 ' O ' HG22 ' A' ' 721' ' ' ILE . 2.1 t-20 70.66 52.12 0.32 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.92 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.659 HD22 ' CD2' ' A' ' 663' ' ' PHE . 36.7 mt -100.04 145.11 29.64 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.643 0.735 . . . . 0.0 110.875 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -47.92 142.46 15.07 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.654 2.236 . . . . 0.0 112.395 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -60.53 -24.75 65.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.889 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -98.17 13.4 31.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.85 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 663' ' ' PHE . . . . . 0.659 ' CD2' HD22 ' A' ' 659' ' ' LEU . 3.4 t80 -80.14 118.48 21.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 69.4 p -105.45 168.99 8.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.079 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 665' ' ' TRP . . . . . 0.639 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 6.9 p-90 -57.23 -49.72 75.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.927 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 666' ' ' LYS . . . . . 0.639 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 5.3 tptm -46.27 -54.35 9.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.886 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 16.6 mtm -59.72 -55.62 32.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.84 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 14.7 tp -42.97 -46.91 5.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.902 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 46.1 tttt -62.49 -71.45 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -46.28 -24.11 0.43 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.878 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 8.8 tptp -68.79 -51.49 40.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.927 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 672' ' ' PHE . . . . . 0.56 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 23.1 m-85 -78.53 -15.24 58.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.892 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -49.92 -34.58 20.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.923 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -53.66 -39.76 65.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.881 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 31.9 m -71.42 -47.54 55.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -165.69 -177.33 37.86 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.479 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -73.21 96.45 2.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.843 0.354 . . . . 0.0 110.862 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 78.9 t -73.26 138.3 21.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.143 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 679' ' ' LEU . . . . . 0.474 HD11 ' HG2' ' A' ' 699' ' ' GLU . 12.9 mt -113.21 -61.52 1.73 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.931 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 680' ' ' TYR . . . . . 0.433 ' HB3' ' CB ' ' A' ' 697' ' ' LYS . 4.5 t80 -95.71 129.11 43.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.93 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -156.91 125.2 5.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.075 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -156.0 161.72 40.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.84 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 42.9 mm -109.25 107.27 22.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.129 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 27.8 mmtm . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.882 179.832 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 691' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 693' ' ' CYS . 29.0 mmtt . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.784 0.326 . . . . 0.0 110.867 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 692' ' ' GLY . . . . . 0.413 ' C ' ' HB2' ' A' ' 659' ' ' LEU . . . 38.14 27.84 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.493 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 693' ' ' CYS . . . . . 0.461 ' N ' ' O ' ' A' ' 691' ' ' LYS . 31.2 p -132.46 129.13 38.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.843 0.354 . . . . 0.0 110.89 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -141.79 -163.47 9.62 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.487 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 13.4 m -142.93 153.1 17.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.857 0.36 . . . . 0.0 111.086 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 696' ' ' VAL . . . . . 0.501 HG21 ' CD1' ' A' ' 672' ' ' PHE . 93.4 t -139.34 118.04 12.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.136 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 697' ' ' LYS . . . . . 0.433 ' CB ' ' HB3' ' A' ' 680' ' ' TYR . 27.0 tttt -101.43 148.04 25.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.906 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -123.31 173.99 7.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 699' ' ' GLU . . . . . 0.474 ' HG2' HD11 ' A' ' 679' ' ' LEU . 4.6 mt-10 -82.47 -44.13 16.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.918 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 1.1 t -103.41 143.01 25.77 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.692 0.758 . . . . 0.0 110.863 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -20.71 34.73 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.682 2.254 . . . . 0.0 112.343 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -75.56 -41.68 54.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.853 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 66.0 t -56.02 -55.71 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.108 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -46.75 -43.91 18.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.092 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 705' ' ' GLU . . . . . 0.548 ' HA ' HD11 ' A' ' 725' ' ' ILE . 13.3 mt-10 -60.03 -34.07 72.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.845 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 26.9 ttm180 -79.95 -57.83 3.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.89 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -45.4 -33.13 2.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.059 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 708' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -53.17 -52.67 58.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.887 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.73 -40.85 32.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 61.1 mtp -56.86 -17.64 10.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 711' ' ' MET . . . . . 0.56 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 4.9 mmm -117.59 -24.81 7.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.856 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 712' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -48.55 114.06 0.89 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.926 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 82.58 31.88 29.05 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.532 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 714' ' ' MET . . . . . . . . . . . . . 63.0 ttp -82.75 105.86 14.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.84 0.352 . . . . 0.0 110.915 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 7.0 mmtp -60.66 100.42 0.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.889 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 716' ' ' LEU . . . . . 0.922 HD12 HG21 ' A' ' 721' ' ' ILE . 31.2 mt -99.89 125.56 45.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.945 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 717' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 716' ' ' LEU . 48.3 t 36.93 38.62 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.854 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 718' ' ' GLY . . . . . 0.406 ' C ' ' HG3' ' A' ' 719' ' ' ARG . . . 79.39 34.78 31.37 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.517 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 719' ' ' ARG . . . . . 0.498 ' N ' ' O ' ' A' ' 716' ' ' LEU . 37.3 mtp85 -146.65 112.76 5.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.748 0.308 . . . . 0.0 110.891 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -70.74 123.6 22.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.854 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 721' ' ' ILE . . . . . 0.922 HG21 HD12 ' A' ' 716' ' ' LEU . 31.7 pt -99.95 156.23 4.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.16 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -114.46 105.04 12.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.875 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 723' ' ' VAL . . . . . 0.429 HG21 ' CB ' ' A' ' 711' ' ' MET . 21.9 t -100.79 132.42 46.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.09 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -154.66 161.43 41.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.878 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 725' ' ' ILE . . . . . 0.659 HD13 HG22 ' A' ' 654' ' ' ILE . 14.9 mm -72.53 134.64 29.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.134 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 6.0 t0 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.884 179.834 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 63.1 m . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.787 0.327 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -94.05 151.42 19.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.911 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 654' ' ' ILE . . . . . 0.483 HD11 ' CE2' ' A' ' 672' ' ' PHE . 20.7 pt -138.69 174.04 10.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.162 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -126.56 156.43 40.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.888 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 3.4 t -142.05 149.68 19.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.152 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -144.81 154.64 42.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.874 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 658' ' ' ASN . . . . . 0.42 ' O ' HG22 ' A' ' 721' ' ' ILE . 1.8 t-20 73.56 44.88 0.28 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.868 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 659' ' ' LEU . . . . . . . . . . . . . 36.3 mt -96.71 144.45 27.86 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.66 0.743 . . . . 0.0 110.86 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -48.0 139.5 20.19 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.676 2.251 . . . . 0.0 112.364 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -62.11 -24.92 67.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.894 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -94.32 3.26 55.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.921 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -70.72 124.39 24.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.881 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 38.7 p -104.22 169.04 8.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.155 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 665' ' ' TRP . . . . . 0.642 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 7.6 p-90 -63.51 -52.15 62.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.947 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 666' ' ' LYS . . . . . 0.642 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 0.0 OUTLIER -47.06 -43.1 19.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.883 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 30.5 mtm -68.31 -50.86 50.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 14.2 tp -48.2 -47.26 35.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.866 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 44.2 tttt -59.54 -74.07 0.08 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.901 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -45.38 -28.23 0.82 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.845 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 671' ' ' LYS . . . . . 0.467 ' HE2' HD21 ' A' ' 716' ' ' LEU . 26.6 tptt -68.64 -39.65 80.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.855 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 672' ' ' PHE . . . . . 0.483 ' CE2' HD11 ' A' ' 654' ' ' ILE . 13.6 m-85 -88.37 -14.01 39.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.866 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -56.53 -35.85 68.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.877 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -42.22 -41.86 2.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.877 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 3.0 t -70.62 -59.78 2.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.852 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -148.81 -153.96 6.17 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.494 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -95.54 104.52 16.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.859 0.361 . . . . 0.0 110.86 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 57.9 t -82.7 136.06 23.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.128 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 679' ' ' LEU . . . . . 0.463 HD11 ' HG2' ' A' ' 699' ' ' GLU . 12.8 mt -109.97 -59.12 1.97 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.935 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -96.99 129.79 44.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.956 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -157.78 122.96 4.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.093 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -148.09 166.54 27.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.835 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 45.2 mm -114.47 106.86 21.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.115 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 36.5 mmtm . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.912 179.794 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 19.3 mmtt . . . . . 0 N--CA 1.458 -0.059 0 CA-C-O 120.814 0.34 . . . . 0.0 110.925 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 55.76 23.7 38.12 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.488 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 27.5 p -131.95 127.34 36.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.866 0.365 . . . . 0.0 110.91 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -142.25 -169.16 12.02 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.489 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 27.5 m -139.07 166.97 21.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.891 0.377 . . . . 0.0 111.127 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 93.0 t -154.75 121.86 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.129 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 20.7 ttpt -105.97 143.08 34.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.911 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 698' ' ' PHE . . . . . 0.429 ' CD2' HG11 ' A' ' 703' ' ' VAL . 96.6 m-85 -118.4 169.24 9.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.878 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 699' ' ' GLU . . . . . 0.463 ' HG2' HD11 ' A' ' 679' ' ' LEU . 6.2 mm-40 -76.7 -45.3 30.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.869 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 31.4 m -104.49 147.37 34.28 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.667 0.746 . . . . 0.0 110.887 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -31.53 20.37 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.687 2.258 . . . . 0.0 112.343 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 702' ' ' GLU . . . . . 0.452 ' HG3' ' N ' ' A' ' 703' ' ' VAL . 11.2 pt-20 -61.47 -42.92 99.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.873 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 703' ' ' VAL . . . . . 0.452 ' N ' ' HG3' ' A' ' 702' ' ' GLU . 94.6 t -53.0 -59.36 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.168 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -40.63 -65.74 0.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.084 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 705' ' ' GLU . . . . . 0.55 ' HA ' HD11 ' A' ' 725' ' ' ILE . 9.8 mt-10 -41.07 -37.69 0.89 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.891 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -75.43 -64.47 1.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.845 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -40.17 -35.33 0.39 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.109 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 708' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -53.26 -56.19 18.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -77.36 -38.63 49.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.861 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 17.8 mmm -57.12 -23.15 45.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.903 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 711' ' ' MET . . . . . 0.403 ' O ' ' C ' ' A' ' 712' ' ' ASN . 4.7 mmm -111.74 -34.75 5.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 712' ' ' ASN . . . . . 0.436 ' OD1' ' C ' ' A' ' 712' ' ' ASN . 9.9 t-20 -38.03 112.71 0.23 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.894 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 84.21 27.96 35.2 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.493 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 714' ' ' MET . . . . . . . . . . . . . 37.2 ttp -77.67 99.04 5.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.861 0.363 . . . . 0.0 110.902 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 715' ' ' LYS . . . . . 0.416 ' HE3' ' CD ' ' A' ' 720' ' ' GLU . 11.8 mmtp -56.06 98.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.874 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 716' ' ' LEU . . . . . 0.665 HD12 HG21 ' A' ' 721' ' ' ILE . 31.5 mt -100.0 125.35 46.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.918 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 717' ' ' SER . . . . . . . . . . . . . 34.7 t 38.86 38.49 0.28 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.843 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 78.55 30.96 47.19 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.487 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 719' ' ' ARG . . . . . 0.499 ' N ' ' O ' ' A' ' 716' ' ' LEU . 45.5 mtt180 -141.13 114.55 8.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.84 0.353 . . . . 0.0 110.873 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 720' ' ' GLU . . . . . 0.416 ' CD ' ' HE3' ' A' ' 715' ' ' LYS . 5.3 mt-10 -73.34 126.1 29.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.878 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 721' ' ' ILE . . . . . 0.665 HG21 HD12 ' A' ' 716' ' ' LEU . 44.9 pt -100.0 162.77 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.118 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -119.07 101.38 7.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.878 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 10.0 t -100.83 132.12 47.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.122 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 50.7 mtp180 -155.99 163.55 39.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.874 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 725' ' ' ILE . . . . . 0.55 HD11 ' HA ' ' A' ' 705' ' ' GLU . 25.0 mm -64.8 135.77 27.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.148 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 31.0 t70 . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.893 179.832 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 64.4 m . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.753 0.311 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -96.56 154.06 17.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.945 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 654' ' ' ILE . . . . . 0.505 HG22 HD13 ' A' ' 725' ' ' ILE . 28.7 pt -141.87 170.05 13.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.114 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -122.39 153.73 38.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.891 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 3.5 t -139.95 148.41 22.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.142 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 38.4 mtp180 -146.73 155.79 42.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.871 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 658' ' ' ASN . . . . . 0.607 ' O ' HG22 ' A' ' 721' ' ' ILE . 1.8 t-20 71.28 51.57 0.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.52 HD22 ' CD2' ' A' ' 663' ' ' PHE . 39.2 mt -101.35 143.48 26.67 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.623 0.725 . . . . 0.0 110.893 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 660' ' ' PRO . . . . . 0.477 ' O ' ' N ' ' A' ' 663' ' ' PHE . 66.6 Cg_exo -48.01 126.0 12.5 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.701 2.267 . . . . 0.0 112.336 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -40.79 -40.69 1.39 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.864 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 662' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 663' ' ' PHE . 22.8 t70 -73.16 -33.67 65.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.853 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 663' ' ' PHE . . . . . 0.52 ' CD2' HD22 ' A' ' 659' ' ' LEU . 4.1 t80 -36.31 119.91 0.63 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.895 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 74.4 p -104.88 -179.95 4.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.174 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 665' ' ' TRP . . . . . 0.62 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 6.5 p-90 -71.54 -50.23 33.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.894 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 666' ' ' LYS . . . . . 0.62 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 22.7 tptt -48.7 -43.72 37.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.872 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 667' ' ' MET . . . . . 0.401 ' CE ' ' HA ' ' A' ' 663' ' ' PHE . 27.4 mtm -66.09 -51.92 53.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.912 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 15.5 tp -46.21 -45.9 17.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.885 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 29.9 tttm -60.54 -73.99 0.08 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.885 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -47.07 -28.46 1.73 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.887 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 17.5 tptt -64.6 -41.24 96.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.888 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 672' ' ' PHE . . . . . 0.53 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 21.8 m-85 -88.89 -14.57 36.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.848 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -52.51 -40.19 62.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.897 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -44.6 -37.49 3.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.863 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 88.4 m -73.2 -58.51 3.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.883 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -152.95 -153.92 6.52 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.485 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 677' ' ' HIS . . . . . 0.554 ' CE1' HD23 ' A' ' 679' ' ' LEU . 29.2 t-80 -92.84 106.57 18.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.87 0.367 . . . . 0.0 110.829 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 678' ' ' VAL . . . . . 0.467 HG13 HG13 ' A' ' 696' ' ' VAL . 87.0 t -84.34 127.66 39.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.105 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 679' ' ' LEU . . . . . 0.574 HD11 ' HG2' ' A' ' 699' ' ' GLU . 12.0 mt -103.57 -60.16 1.61 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.937 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -99.27 129.06 45.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.921 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -157.65 121.41 4.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.092 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -153.23 156.77 39.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.871 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 37.9 mm -99.44 102.65 13.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.109 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.898 179.824 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.831 0.348 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 692' ' ' GLY . . . . . 0.42 ' C ' ' HB2' ' A' ' 659' ' ' LEU . . . 53.36 25.9 28.11 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.56 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 31.8 p -127.44 142.13 51.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.843 0.354 . . . . 0.0 110.903 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -150.62 -168.07 15.13 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.503 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 7.1 m -141.62 157.97 21.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.87 0.366 . . . . 0.0 111.131 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 696' ' ' VAL . . . . . 0.467 HG13 HG13 ' A' ' 678' ' ' VAL . 91.6 t -147.52 118.67 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.139 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 14.5 ttpt -105.96 137.24 44.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.922 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -111.91 173.71 6.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.845 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 699' ' ' GLU . . . . . 0.574 ' HG2' HD11 ' A' ' 679' ' ' LEU . 44.9 mt-10 -79.14 -40.77 30.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.865 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 5.5 m -110.18 148.64 38.76 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.63 0.729 . . . . 0.0 110.825 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -17.68 37.4 Favored 'Trans proline' 0 N--CA 1.465 -0.153 0 C-N-CA 122.693 2.262 . . . . 0.0 112.351 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -78.21 -49.27 14.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.862 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 60.9 t -46.51 -42.1 5.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.159 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -59.48 -61.54 2.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.126 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -45.7 -32.43 2.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.897 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 44.5 ttt180 -80.77 -43.98 19.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.867 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -61.06 -62.5 1.81 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.137 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 708' ' ' CYS . . . . . 0.475 ' HA ' ' CG1' ' A' ' 723' ' ' VAL . 26.5 p -47.13 -29.71 2.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.912 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 709' ' ' ARG . . . . . 0.405 ' O ' ' ND2' ' A' ' 712' ' ' ASN . 16.6 mtt85 -89.56 -25.24 21.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.838 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 44.2 mtp -87.57 -12.02 46.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.874 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 711' ' ' MET . . . . . 0.53 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 8.9 mmm -110.82 -23.15 11.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 712' ' ' ASN . . . . . 0.43 ' O ' ' CG ' ' A' ' 712' ' ' ASN . 2.6 p30 -42.6 117.29 1.0 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.857 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 79.78 21.58 65.83 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.49 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 714' ' ' MET . . . . . 0.489 ' HB3' HD11 ' A' ' 721' ' ' ILE . 31.8 ttp -65.54 94.1 0.18 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.843 0.354 . . . . 0.0 110.871 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 715' ' ' LYS . . . . . 0.417 ' NZ ' ' HA2' ' A' ' 718' ' ' GLY . 1.7 mmmt -55.91 99.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.881 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 716' ' ' LEU . . . . . 0.677 HD12 HG21 ' A' ' 721' ' ' ILE . 58.2 mt -100.08 132.28 45.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.871 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 717' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 716' ' ' LEU . 15.7 t 35.92 36.41 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.874 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 718' ' ' GLY . . . . . 0.417 ' HA2' ' NZ ' ' A' ' 715' ' ' LYS . . . 77.99 38.98 25.26 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.502 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 719' ' ' ARG . . . . . 0.499 ' N ' ' O ' ' A' ' 716' ' ' LEU . 39.3 mtt85 -149.23 107.52 3.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.77 0.319 . . . . 0.0 110.883 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -62.73 123.83 19.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 721' ' ' ILE . . . . . 0.677 HG21 HD12 ' A' ' 716' ' ' LEU . 24.9 pt -99.62 155.89 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.13 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -110.73 110.12 20.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.876 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 723' ' ' VAL . . . . . 0.475 ' CG1' ' HA ' ' A' ' 708' ' ' CYS . 2.7 t -109.39 136.87 43.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.14 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -157.95 169.99 23.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.851 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 725' ' ' ILE . . . . . 0.505 HD13 HG22 ' A' ' 654' ' ' ILE . 46.6 mm -77.31 143.09 13.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.126 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 9.5 t70 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.889 179.842 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 81.6 m . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.804 0.335 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -95.09 150.19 20.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.888 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 654' ' ' ILE . . . . . 0.501 HD11 ' CE2' ' A' ' 672' ' ' PHE . 29.2 pt -135.47 176.5 8.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.139 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -131.53 143.47 50.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.884 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 11.1 t -129.97 145.93 34.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.134 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -136.25 168.97 18.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.874 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 658' ' ' ASN . . . . . 0.436 ' O ' HG22 ' A' ' 721' ' ' ILE . 2.8 t-20 60.08 47.23 9.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.869 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.607 HD22 ' CE2' ' A' ' 663' ' ' PHE . 53.8 mt -95.14 143.59 26.37 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.629 0.728 . . . . 0.0 110.916 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -47.94 145.04 10.83 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.651 2.234 . . . . 0.0 112.345 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -61.88 -33.18 73.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.91 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -89.41 7.91 33.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.864 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 663' ' ' PHE . . . . . 0.607 ' CE2' HD22 ' A' ' 659' ' ' LEU . 2.9 t80 -73.87 114.17 11.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 57.9 p -100.14 166.01 11.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.184 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 665' ' ' TRP . . . . . 0.587 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 10.6 p-90 -55.9 -46.72 78.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.906 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 666' ' ' LYS . . . . . 0.587 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 4.2 tppp? -48.53 -52.61 21.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.889 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 14.5 mtm -60.58 -54.81 40.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.869 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 26.2 tp -45.97 -45.59 15.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.942 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.4 ' C ' ' N ' ' A' ' 671' ' ' LYS . 33.9 tttm -64.57 -74.79 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.855 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -45.91 -21.73 0.15 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.851 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 671' ' ' LYS . . . . . 0.419 ' HG3' ' CE ' ' A' ' 711' ' ' MET . 6.2 tppt? -71.61 -45.75 61.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.893 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 672' ' ' PHE . . . . . 0.573 ' CD1' HG21 ' A' ' 696' ' ' VAL . 23.7 m-85 -84.36 -8.81 58.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.904 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -58.88 -30.08 67.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.89 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -49.01 -43.3 40.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.897 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 675' ' ' CYS . . . . . 0.502 ' SG ' ' HB2' ' A' ' 707' ' ' ALA . 19.2 t -66.6 -62.27 1.54 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.873 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -147.6 -148.19 4.7 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.489 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 677' ' ' HIS . . . . . 0.507 ' CE1' HD23 ' A' ' 679' ' ' LEU . 13.8 t-80 -98.68 101.64 13.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.794 0.33 . . . . 0.0 110.889 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 678' ' ' VAL . . . . . 0.431 ' CG1' HG13 ' A' ' 696' ' ' VAL . 98.8 t -76.81 136.29 24.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.122 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 679' ' ' LEU . . . . . 0.507 HD23 ' CE1' ' A' ' 677' ' ' HIS . 18.2 mt -110.33 -62.74 1.47 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.928 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 680' ' ' TYR . . . . . 0.422 ' CE2' HG21 ' A' ' 695' ' ' VAL . 9.1 t80 -95.98 126.4 41.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.94 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -156.84 125.9 5.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.103 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -157.5 157.24 33.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.862 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 45.5 mm -97.74 104.17 15.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.155 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 179.893 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt . . . . . 0 C--O 1.23 0.051 0 CA-C-O 120.816 0.341 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 43.77 36.37 3.55 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.447 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 28.9 p -137.97 142.49 40.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.845 0.355 . . . . 0.0 110.906 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -152.56 -160.78 9.82 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.468 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 695' ' ' VAL . . . . . 0.422 HG21 ' CE2' ' A' ' 680' ' ' TYR . 10.3 m -149.54 156.73 7.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.869 0.366 . . . . 0.0 111.127 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 696' ' ' VAL . . . . . 0.573 HG21 ' CD1' ' A' ' 672' ' ' PHE . 67.0 t -146.14 118.37 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.086 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 15.8 tttt -104.22 146.03 29.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.901 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -122.11 164.79 17.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.861 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 699' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -68.76 -42.16 77.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.88 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 26.4 m -110.92 147.16 35.94 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.703 0.763 . . . . 0.0 110.824 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -29.16 24.17 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.698 2.265 . . . . 0.0 112.333 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -63.5 -40.92 98.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 94.7 t -58.83 -57.1 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.058 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -43.19 -66.71 0.34 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.127 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 705' ' ' GLU . . . . . 0.738 ' HA ' HD11 ' A' ' 725' ' ' ILE . 27.9 mt-10 -39.34 -39.29 0.63 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.902 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 706' ' ' ARG . . . . . 0.429 ' O ' ' N ' ' A' ' 708' ' ' CYS . 16.1 ttm-85 -73.46 -64.11 1.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.882 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 707' ' ' ALA . . . . . 0.502 ' HB2' ' SG ' ' A' ' 675' ' ' CYS . . . -38.95 -29.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.087 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 708' ' ' CYS . . . . . 0.429 ' N ' ' O ' ' A' ' 706' ' ' ARG . 1.2 t -61.81 -49.47 76.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.832 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -77.19 -33.11 56.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.851 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 59.7 mtp -70.04 -16.37 63.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.843 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 711' ' ' MET . . . . . 0.431 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 5.3 mmm -118.93 -20.41 8.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.892 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 712' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -53.28 122.48 9.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.92 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 74.68 23.5 74.97 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.515 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 714' ' ' MET . . . . . . . . . . . . . 42.4 ttp -76.4 111.05 11.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.859 0.362 . . . . 0.0 110.885 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 19.4 mmtt -63.34 102.53 0.41 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.942 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 716' ' ' LEU . . . . . 1.081 HD12 HG21 ' A' ' 721' ' ' ILE . 36.9 mt -99.98 122.98 43.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.905 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 717' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 716' ' ' LEU . 1.3 t 37.3 42.1 0.28 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 76.97 32.7 48.4 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.418 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 719' ' ' ARG . . . . . 0.498 ' N ' ' O ' ' A' ' 716' ' ' LEU . 21.9 mtp180 -146.83 110.73 5.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.805 0.336 . . . . 0.0 110.867 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -68.55 125.38 26.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.842 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 721' ' ' ILE . . . . . 1.081 HG21 HD12 ' A' ' 716' ' ' LEU . 26.7 pt -99.55 155.0 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.111 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -111.32 104.58 13.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.885 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 723' ' ' VAL . . . . . 0.411 HG21 ' CB ' ' A' ' 711' ' ' MET . 3.7 t -100.67 131.99 47.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.096 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -155.56 160.37 40.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.897 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 725' ' ' ILE . . . . . 0.738 HD11 ' HA ' ' A' ' 705' ' ' GLU . 33.9 mm -60.86 135.96 25.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.118 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 21.8 t70 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.917 179.856 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 60.2 m . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.751 0.31 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -98.31 156.27 16.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.913 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 654' ' ' ILE . . . . . 0.452 HD11 ' CE2' ' A' ' 672' ' ' PHE . 43.7 pt -142.7 166.94 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.125 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -119.12 156.49 29.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.926 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 3.3 t -143.75 151.06 16.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.133 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 49.3 mtp180 -147.27 156.74 43.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.858 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 658' ' ' ASN . . . . . 0.56 ' O ' HG22 ' A' ' 721' ' ' ILE . 2.5 t-20 70.44 51.91 0.35 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.926 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.801 HD23 HD12 ' A' ' 716' ' ' LEU . 37.6 mt -100.75 143.55 26.78 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.63 0.728 . . . . 0.0 110.902 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 660' ' ' PRO . . . . . 0.447 ' O ' ' N ' ' A' ' 663' ' ' PHE . 64.4 Cg_exo -47.97 128.64 16.78 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.683 2.255 . . . . 0.0 112.346 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -43.09 -31.96 0.63 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.869 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 662' ' ' ASP . . . . . 0.446 ' O ' HG23 ' A' ' 664' ' ' THR . 9.1 m-20 -82.81 -32.54 27.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.864 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 663' ' ' PHE . . . . . 0.447 ' N ' ' O ' ' A' ' 660' ' ' PRO . 4.2 t80 -40.23 113.16 0.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 664' ' ' THR . . . . . 0.446 HG23 ' O ' ' A' ' 662' ' ' ASP . 24.8 p -104.81 -177.48 3.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.121 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 665' ' ' TRP . . . . . 0.646 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 8.2 p-90 -66.76 -52.26 46.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 666' ' ' LYS . . . . . 0.646 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 22.8 tptp -44.78 -55.0 5.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.907 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 11.9 mtm -60.42 -46.01 91.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.866 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 27.9 tp -51.44 -42.97 61.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.919 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 29.2 tttm -65.64 -74.41 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.909 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -45.86 -24.42 0.39 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.821 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? -68.9 -52.74 26.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.898 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 672' ' ' PHE . . . . . 0.455 ' CD1' HG21 ' A' ' 696' ' ' VAL . 23.3 m-85 -76.99 -13.72 59.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.899 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -52.86 -28.37 22.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.871 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -50.49 -46.64 57.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.897 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 675' ' ' CYS . . . . . 0.612 ' SG ' ' HB2' ' A' ' 707' ' ' ALA . 12.4 t -64.4 -61.18 2.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.902 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -152.33 -147.38 4.58 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.465 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 17.7 t-80 -95.41 114.13 25.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.79 0.329 . . . . 0.0 110.867 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 77.7 t -88.39 123.51 40.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.135 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 679' ' ' LEU . . . . . 0.739 HD11 ' HG2' ' A' ' 699' ' ' GLU . 19.2 mt -97.11 -61.93 1.33 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.916 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -99.84 123.7 44.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.935 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -149.41 121.68 8.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.099 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -155.8 155.81 33.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.878 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 28.1 mm -101.62 105.95 18.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.123 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.874 179.87 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 35.5 mmtm . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.818 0.342 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 58.47 16.81 30.31 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.472 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 1.9 p -123.45 129.68 51.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.826 0.346 . . . . 0.0 110.895 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -136.45 -159.6 8.45 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.5 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 13.5 m -148.13 155.82 9.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.872 0.367 . . . . 0.0 111.134 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 696' ' ' VAL . . . . . 0.455 HG21 ' CD1' ' A' ' 672' ' ' PHE . 91.7 t -143.8 119.42 4.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.182 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 28.2 tttt -104.36 140.45 37.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.916 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -117.99 167.99 10.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.899 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 699' ' ' GLU . . . . . 0.739 ' HG2' HD11 ' A' ' 679' ' ' LEU . 9.7 mm-40 -76.2 -39.25 55.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 1.8 t -108.83 142.98 26.64 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.633 0.73 . . . . 0.0 110.847 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -24.59 29.75 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.676 2.251 . . . . 0.0 112.373 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 702' ' ' GLU . . . . . 0.435 ' HG3' ' N ' ' A' ' 703' ' ' VAL . 6.9 pt-20 -73.76 -34.11 64.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.886 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 703' ' ' VAL . . . . . 0.435 ' N ' ' HG3' ' A' ' 702' ' ' GLU . 38.2 t -61.7 -56.96 14.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.142 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -43.39 -62.44 1.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.107 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -43.35 -43.08 4.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.906 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 16.0 ttm180 -66.08 -58.31 5.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.834 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 707' ' ' ALA . . . . . 0.612 ' HB2' ' SG ' ' A' ' 675' ' ' CYS . . . -50.64 -34.05 24.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.097 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 708' ' ' CYS . . . . . 0.425 ' SG ' ' CG2' ' A' ' 654' ' ' ILE . 2.4 m -61.18 -42.25 98.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.892 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 709' ' ' ARG . . . . . 0.407 ' O ' ' ND2' ' A' ' 712' ' ' ASN . 18.8 mtt180 -84.15 -20.11 33.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.849 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 17.1 mtm -88.79 -9.76 50.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.873 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 711' ' ' MET . . . . . . . . . . . . . 5.7 mmm -120.45 -10.62 9.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.9 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 712' ' ' ASN . . . . . 0.407 ' ND2' ' O ' ' A' ' 709' ' ' ARG . 0.9 OUTLIER -53.98 126.74 23.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.857 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 69.63 8.12 59.58 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.496 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 714' ' ' MET . . . . . 0.58 ' HB3' HD11 ' A' ' 721' ' ' ILE . 10.3 ttp -49.38 99.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.857 0.36 . . . . 0.0 110.859 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 10.3 mmtp -56.05 102.56 0.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.888 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 716' ' ' LEU . . . . . 0.801 HD12 HD23 ' A' ' 659' ' ' LEU . 12.2 mt -99.88 117.0 33.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.923 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 717' ' ' SER . . . . . . . . . . . . . 2.3 t 40.91 44.41 1.96 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.912 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 76.33 31.28 55.18 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.493 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 719' ' ' ARG . . . . . . . . . . . . . 23.9 mtp180 -144.26 106.89 4.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.757 0.313 . . . . 0.0 110.876 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -66.18 125.77 26.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.881 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 721' ' ' ILE . . . . . 0.58 HD11 ' HB3' ' A' ' 714' ' ' MET . 38.2 pt -97.79 156.4 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.109 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -110.61 98.09 7.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.855 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 3.2 t -94.84 134.93 30.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.12 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 25.6 mtt-85 -158.08 176.11 12.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.859 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 725' ' ' ILE . . . . . 0.46 HD13 ' HA ' ' A' ' 725' ' ' ILE . 10.1 mm -78.23 138.95 19.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.125 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 18.7 t0 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.817 179.906 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 26.4 p . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.792 0.329 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -104.29 146.6 28.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.895 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 654' ' ' ILE . . . . . . . . . . . . . 25.4 pt -135.27 172.66 15.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.138 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -128.21 149.59 50.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.868 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 4.0 t -132.19 152.87 37.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.095 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 69.8 mtt180 -146.81 160.08 42.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.88 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 658' ' ' ASN . . . . . 0.467 ' O ' HG22 ' A' ' 721' ' ' ILE . 3.1 t-20 66.94 48.51 1.27 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.914 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 659' ' ' LEU . . . . . . . . . . . . . 40.5 mt -98.71 145.41 29.87 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.635 0.731 . . . . 0.0 110.909 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_exo -47.98 126.17 12.74 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.692 2.261 . . . . 0.0 112.337 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -49.35 -25.97 2.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.857 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -88.01 -24.95 23.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -41.09 147.69 0.13 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.861 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 35.5 p -128.07 169.55 13.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.115 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 665' ' ' TRP . . . . . 0.644 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 5.6 p-90 -63.96 -53.0 57.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.894 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 666' ' ' LYS . . . . . 0.644 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 3.7 tppp? -47.55 -47.71 28.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.924 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 46.1 mtm -63.16 -50.64 69.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.88 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 29.7 tp -46.66 -45.65 19.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.931 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 30.9 tttm -60.72 -72.36 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.925 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -47.04 -25.07 0.74 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.902 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 17.0 tptt -68.76 -43.63 75.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.892 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 672' ' ' PHE . . . . . 0.517 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 23.8 m-85 -87.38 -13.42 43.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.889 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -50.71 -36.69 37.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.852 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -51.22 -39.79 57.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.857 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 37.4 m -72.01 -42.29 66.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 676' ' ' GLY . . . . . 0.417 ' HA3' HG11 ' A' ' 703' ' ' VAL . . . -177.16 170.12 42.64 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.483 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -59.56 114.91 2.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.85 0.357 . . . . 0.0 110.888 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 41.4 t -90.63 139.69 17.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.1 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 679' ' ' LEU . . . . . 0.402 HD21 ' HG2' ' A' ' 699' ' ' GLU . 13.8 mt -110.62 -63.8 1.35 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.932 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -99.06 131.27 45.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.97 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -157.22 120.86 4.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.115 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -148.26 164.11 34.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.904 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 38.3 mm -109.18 106.58 20.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.11 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.935 179.832 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt . . . . . 0 N--CA 1.458 -0.062 0 CA-C-O 120.811 0.339 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 55.14 15.51 7.31 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.528 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 27.0 p -123.38 139.43 54.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.848 0.356 . . . . 0.0 110.896 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -143.39 -157.19 7.06 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.429 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 6.9 m -152.58 151.86 11.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.885 0.374 . . . . 0.0 111.126 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 94.3 t -141.95 119.43 7.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.111 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 17.6 tttt -106.36 134.06 50.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.879 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -109.25 169.06 8.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.864 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 699' ' ' GLU . . . . . 0.402 ' HG2' HD21 ' A' ' 679' ' ' LEU . 21.4 mt-10 -72.11 -37.67 69.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.867 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -115.15 143.96 31.26 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.658 0.742 . . . . 0.0 110.828 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -10.84 29.57 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.709 2.272 . . . . 0.0 112.327 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -82.6 -46.48 13.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.91 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 703' ' ' VAL . . . . . 0.417 HG11 ' HA3' ' A' ' 676' ' ' GLY . 65.8 t -50.42 -47.84 26.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.162 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -49.3 -61.32 2.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.145 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 705' ' ' GLU . . . . . 0.481 ' HA ' HD11 ' A' ' 725' ' ' ILE . 42.8 mt-10 -47.57 -23.5 0.67 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.878 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 706' ' ' ARG . . . . . 0.408 ' HG2' ' HE2' ' A' ' 710' ' ' MET . 45.1 ttt180 -87.08 -43.45 12.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.821 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 707' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' ' 711' ' ' MET . . . -65.03 -56.94 10.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.108 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 708' ' ' CYS . . . . . 0.431 ' HA ' ' CG1' ' A' ' 723' ' ' VAL . 13.8 p -42.98 -42.13 3.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.876 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 709' ' ' ARG . . . . . 0.405 ' N ' ' SG ' ' A' ' 708' ' ' CYS . 15.8 mtt180 -80.16 -34.91 37.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.897 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 710' ' ' MET . . . . . 0.408 ' HE2' ' HG2' ' A' ' 706' ' ' ARG . 14.8 mtm -78.07 -9.14 59.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.886 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 711' ' ' MET . . . . . 0.517 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 5.9 mmm -116.14 -20.18 9.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.888 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 712' ' ' ASN . . . . . 0.435 ' OD1' ' C ' ' A' ' 712' ' ' ASN . 10.3 t-20 -55.03 115.21 2.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.914 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 85.75 18.67 59.49 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.543 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 714' ' ' MET . . . . . . . . . . . . . 44.7 ttp -71.11 96.64 1.38 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.834 0.35 . . . . 0.0 110.887 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 5.4 mmtp -51.54 101.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 716' ' ' LEU . . . . . 1.077 HD12 HG21 ' A' ' 721' ' ' ILE . 33.9 mt -100.2 120.4 39.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.925 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 717' ' ' SER . . . . . . . . . . . . . 1.2 t 40.32 44.95 1.72 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.857 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 74.13 27.25 66.67 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.503 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 719' ' ' ARG . . . . . 0.452 ' N ' ' O ' ' A' ' 716' ' ' LEU . 44.1 mtt85 -139.31 109.57 6.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.728 0.299 . . . . 0.0 110.882 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -67.11 125.28 25.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.866 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 721' ' ' ILE . . . . . 1.077 HG21 HD12 ' A' ' 716' ' ' LEU . 27.5 pt -99.96 156.22 4.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.161 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -116.28 104.55 11.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.862 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 723' ' ' VAL . . . . . 0.431 ' CG1' ' HA ' ' A' ' 708' ' ' CYS . 3.6 t -104.72 135.37 42.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.137 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 22.1 mtp85 -157.89 159.05 36.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.885 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 725' ' ' ILE . . . . . 0.481 HD11 ' HA ' ' A' ' 705' ' ' GLU . 35.6 mm -61.19 135.12 26.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.121 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 5.4 t70 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 179.842 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 22.6 p . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.748 0.308 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 653' ' ' GLN . . . . . 0.45 ' HG3' ' N ' ' A' ' 654' ' ' ILE . 8.1 tp60 -93.1 146.52 23.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.917 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 654' ' ' ILE . . . . . 0.59 HG22 HD13 ' A' ' 725' ' ' ILE . 40.2 pt -134.51 177.24 7.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.112 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -132.8 159.69 39.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.861 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 6.5 t -140.71 150.44 20.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.069 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 657' ' ' ARG . . . . . 0.418 ' NH2' ' HB3' ' A' ' 722' ' ' ASP . 81.6 mtm-85 -146.68 157.43 43.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.883 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 658' ' ' ASN . . . . . 0.634 ' O ' HG22 ' A' ' 721' ' ' ILE . 3.2 t-20 67.15 54.43 0.74 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.905 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.449 HD22 ' CD2' ' A' ' 663' ' ' PHE . 38.7 mt -102.42 144.88 29.5 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.628 0.728 . . . . 0.0 110.908 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -48.0 133.47 23.33 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.648 2.232 . . . . 0.0 112.356 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -53.08 -28.34 24.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.867 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -86.64 -19.67 28.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.866 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 663' ' ' PHE . . . . . 0.449 ' CD2' HD22 ' A' ' 659' ' ' LEU . 3.6 t80 -49.25 136.02 16.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.893 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 72.7 p -120.93 175.27 6.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.114 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 665' ' ' TRP . . . . . 0.65 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 5.3 p-90 -66.57 -51.05 60.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.889 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 666' ' ' LYS . . . . . 0.65 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 0.0 OUTLIER -45.86 -45.02 14.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.859 179.94 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 38.8 mtm -68.54 -52.19 34.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.925 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 30.0 tp -45.89 -42.4 12.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.933 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 44.8 tttt -65.95 -73.09 0.14 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.912 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -48.37 -23.77 1.03 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.876 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 16.1 tptt -69.68 -44.09 71.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.914 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 672' ' ' PHE . . . . . 0.512 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 16.9 m-85 -85.49 -14.8 44.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.911 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -55.25 -27.93 49.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.876 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -63.34 -19.87 65.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 34.1 m -89.38 -36.19 15.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.912 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -177.32 -154.78 12.54 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.485 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -91.93 108.64 20.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.884 0.373 . . . . 0.0 110.87 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 63.7 t -90.58 136.32 24.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.125 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 679' ' ' LEU . . . . . 0.526 HD11 ' HG2' ' A' ' 699' ' ' GLU . 27.0 mt -110.44 -61.87 1.6 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.964 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -98.67 131.06 45.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.93 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -155.39 125.84 6.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.105 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -156.18 159.57 39.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.878 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 34.3 mm -105.38 97.44 5.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.126 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.943 179.834 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 6.4 mmtp . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.811 0.339 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 60.48 28.17 67.04 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.482 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 26.5 p -136.18 142.24 44.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.88 0.371 . . . . 0.0 110.852 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -152.3 -164.91 12.71 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.499 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 6.8 m -148.51 155.9 8.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.853 0.359 . . . . 0.0 111.128 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 88.5 t -143.13 123.64 10.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.15 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 14.8 ttpt -103.28 139.07 39.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 698' ' ' PHE . . . . . 0.433 ' CD2' HG11 ' A' ' 703' ' ' VAL . 96.0 m-85 -116.71 165.15 13.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.89 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 699' ' ' GLU . . . . . 0.526 ' HG2' HD11 ' A' ' 679' ' ' LEU . 38.8 mt-10 -72.32 -43.25 64.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.864 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 700' ' ' SER . . . . . 0.667 ' OG ' HG23 ' A' ' 703' ' ' VAL . 79.8 p -111.08 149.45 40.5 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.639 0.733 . . . . 0.0 110.836 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -29.29 24.03 Favored 'Trans proline' 0 C--N 1.34 0.122 0 C-N-CA 122.662 2.241 . . . . 0.0 112.346 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 702' ' ' GLU . . . . . 0.409 ' HG3' ' N ' ' A' ' 703' ' ' VAL . 13.9 pt-20 -63.26 -46.7 85.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.909 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 703' ' ' VAL . . . . . 0.667 HG23 ' OG ' ' A' ' 700' ' ' SER . 71.6 t -50.78 -56.51 4.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.128 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -45.05 -60.98 1.81 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.109 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -44.03 -35.16 1.98 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.885 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 -77.95 -59.78 2.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.913 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -43.25 -32.43 0.77 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.087 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 708' ' ' CYS . . . . . 0.498 ' O ' ' N ' ' A' ' 712' ' ' ASN . 7.0 t -57.29 -60.51 3.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.889 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -68.39 -30.63 69.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 15.3 mmm -70.59 -30.72 67.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.854 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 711' ' ' MET . . . . . 0.512 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 4.3 mmm -107.68 -9.71 15.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.915 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 712' ' ' ASN . . . . . 0.498 ' N ' ' O ' ' A' ' 708' ' ' CYS . 10.4 t-20 -62.35 114.49 3.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.859 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 85.14 13.2 71.98 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.467 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 714' ' ' MET . . . . . . . . . . . . . 53.1 ttp -59.66 100.9 0.09 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.86 0.362 . . . . 0.0 110.852 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 8.8 mmtp -62.67 100.51 0.2 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.876 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 716' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 719' ' ' ARG . 31.2 mt -100.0 128.23 46.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.931 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 717' ' ' SER . . . . . 0.435 ' C ' ' O ' ' A' ' 716' ' ' LEU . 3.1 t 35.44 37.99 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.897 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 79.5 37.98 22.3 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.492 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 719' ' ' ARG . . . . . 0.504 ' N ' ' O ' ' A' ' 716' ' ' LEU . 6.7 mtt-85 -148.08 113.46 5.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.797 0.332 . . . . 0.0 110.861 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -74.5 125.69 29.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.889 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 721' ' ' ILE . . . . . 0.634 HG22 ' O ' ' A' ' 658' ' ' ASN . 46.5 pt -99.67 153.66 4.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.108 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 722' ' ' ASP . . . . . 0.418 ' HB3' ' NH2' ' A' ' 657' ' ' ARG . 54.7 m-20 -109.03 97.9 7.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.858 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 723' ' ' VAL . . . . . 0.47 HG21 ' CB ' ' A' ' 711' ' ' MET . 11.9 t -94.46 135.23 29.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.107 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.04 176.04 13.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.832 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 725' ' ' ILE . . . . . 0.59 HD13 HG22 ' A' ' 654' ' ' ILE . 39.0 mm -78.5 143.88 12.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.135 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 45.1 t0 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 179.813 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 36.7 m . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.722 0.296 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -105.16 147.43 27.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.869 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 654' ' ' ILE . . . . . 0.515 HD11 ' CE2' ' A' ' 672' ' ' PHE . 40.9 pt -135.54 171.56 17.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.091 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -121.86 158.77 28.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.872 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 5.5 t -147.52 145.78 18.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.11 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 51.6 mtp180 -143.78 160.94 39.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.883 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 658' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 69.73 47.86 0.61 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.894 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 659' ' ' LEU . . . . . . . . . . . . . 51.1 mt -101.41 143.97 27.64 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.614 0.721 . . . . 0.0 110.898 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -48.04 133.71 23.63 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.71 2.273 . . . . 0.0 112.299 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -47.99 -41.58 25.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.877 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -72.25 -29.94 64.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.888 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -38.87 116.3 0.55 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.864 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 40.7 p -101.58 179.39 4.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.185 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 665' ' ' TRP . . . . . 0.583 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 6.4 p-90 -69.09 -47.52 65.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.907 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 666' ' ' LYS . . . . . 0.583 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 0.0 OUTLIER -50.36 -45.78 55.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.893 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 24.9 mtm -66.05 -52.76 46.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.876 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 18.0 tp -46.46 -47.23 19.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.915 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.46 ' HB2' ' CB ' ' A' ' 681' ' ' ALA . 29.9 tttt -63.3 -72.62 0.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.883 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -45.26 -26.61 0.52 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.864 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 15.3 tptt -67.81 -41.75 82.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.917 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 672' ' ' PHE . . . . . 0.581 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 20.9 m-85 -86.19 -18.91 30.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.91 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -50.32 -35.02 25.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -40.99 -42.33 1.86 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 6.4 t -70.25 -64.96 0.79 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.904 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -142.17 -151.28 5.49 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.464 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 8.3 t-80 -98.69 101.16 12.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.851 0.358 . . . . 0.0 110.885 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 69.5 t -74.57 141.65 15.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.143 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 679' ' ' LEU . . . . . 0.465 HD11 ' HG2' ' A' ' 699' ' ' GLU . 14.3 mt -114.31 -59.26 2.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.897 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -98.01 126.35 43.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 681' ' ' ALA . . . . . 0.46 ' CB ' ' HB2' ' A' ' 669' ' ' LYS . . . -154.25 123.71 6.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.109 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -151.94 160.89 43.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.868 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 21.8 mm -111.5 117.7 55.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.114 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.911 179.836 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 120.833 0.349 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 80.29 18.9 70.45 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.446 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 15.1 p -131.67 123.99 28.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.896 0.379 . . . . 0.0 110.875 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -132.86 -162.14 10.13 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.483 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 16.8 m -144.31 167.2 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.857 0.361 . . . . 0.0 111.159 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 696' ' ' VAL . . . . . 0.491 HG21 ' CD1' ' A' ' 672' ' ' PHE . 99.1 t -150.9 122.55 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.13 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 10.6 ttpp -107.5 136.74 46.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -113.67 172.34 7.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.903 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 699' ' ' GLU . . . . . 0.465 ' HG2' HD11 ' A' ' 679' ' ' LEU . 65.9 mt-10 -79.22 -42.3 26.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.903 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 21.7 m -108.18 143.97 28.48 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.632 0.729 . . . . 0.0 110.882 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 -28.42 25.47 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.676 2.25 . . . . 0.0 112.397 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -68.28 -33.42 74.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.895 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 76.0 t -64.15 -57.36 11.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.161 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -44.65 -52.46 8.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.122 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -53.97 -30.36 46.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.919 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 45.0 ttt180 -82.23 -43.55 17.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.87 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -61.35 -56.71 17.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.083 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 708' ' ' CYS . . . . . . . . . . . . . 28.8 p -46.3 -32.81 3.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.881 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 11.8 mtp180 -83.16 -35.93 25.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.819 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 29.0 mtm -77.85 -11.39 59.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.88 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 711' ' ' MET . . . . . 0.581 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 4.3 mmt -112.51 -34.58 5.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.874 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 712' ' ' ASN . . . . . 0.401 ' OD1' ' C ' ' A' ' 712' ' ' ASN . 2.2 t-20 -39.16 106.77 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.882 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 91.04 20.01 40.79 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.512 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 714' ' ' MET . . . . . 0.58 ' HE3' HD11 ' A' ' 721' ' ' ILE . 2.9 ttm -64.7 99.79 0.35 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.839 0.352 . . . . 0.0 110.866 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 715' ' ' LYS . . . . . 0.457 ' CD ' ' HG3' ' A' ' 720' ' ' GLU . 22.4 mmtt -59.92 99.78 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.906 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 716' ' ' LEU . . . . . 0.501 ' O ' ' N ' ' A' ' 719' ' ' ARG . 32.6 mt -99.8 125.64 45.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.9 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 717' ' ' SER . . . . . 0.403 ' C ' ' O ' ' A' ' 716' ' ' LEU . 1.7 t 37.72 40.03 0.24 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.846 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 77.96 32.93 42.96 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.476 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 719' ' ' ARG . . . . . 0.501 ' N ' ' O ' ' A' ' 716' ' ' LEU . 18.4 mtp85 -141.9 110.42 6.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.763 0.316 . . . . 0.0 110.894 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 720' ' ' GLU . . . . . 0.457 ' HG3' ' CD ' ' A' ' 715' ' ' LYS . 27.9 mt-10 -71.53 127.73 33.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.886 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 721' ' ' ILE . . . . . 0.58 HD11 ' HE3' ' A' ' 714' ' ' MET . 21.2 pt -97.97 160.5 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.127 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -116.8 100.13 7.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.831 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 3.3 t -100.32 136.09 33.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.11 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.89 148.38 20.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.852 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 725' ' ' ILE . . . . . 0.413 HD13 HG22 ' A' ' 654' ' ' ILE . 31.3 mm -56.62 134.74 20.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.114 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 21.5 t0 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 179.874 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 30.2 p . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.739 0.304 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -105.44 147.24 28.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.879 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 654' ' ' ILE . . . . . 0.454 HD11 ' CE2' ' A' ' 672' ' ' PHE . 33.4 pt -135.12 171.17 18.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.13 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -125.13 151.63 45.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.862 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 23.2 t -133.22 152.45 35.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.159 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -147.86 157.99 43.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.877 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 658' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 71.5 35.13 1.54 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.903 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.815 HD22 ' CD2' ' A' ' 663' ' ' PHE . 23.8 mt -85.14 143.58 39.82 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.631 0.729 . . . . 0.0 110.86 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -47.94 146.48 8.81 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.686 2.257 . . . . 0.0 112.353 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -64.45 -28.87 69.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.11 13.92 23.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.852 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 663' ' ' PHE . . . . . 0.815 ' CD2' HD22 ' A' ' 659' ' ' LEU . 2.9 t80 -79.04 121.92 25.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.906 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 62.9 p -104.9 169.55 8.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.156 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 665' ' ' TRP . . . . . 0.601 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 5.0 p-90 -62.85 -45.13 94.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.917 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 666' ' ' LYS . . . . . 0.601 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 5.5 tppp? -51.52 -46.11 63.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 30.1 mtm -67.54 -51.9 45.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.887 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 24.3 tp -47.62 -44.81 27.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.908 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 34.7 tttm -64.23 -70.8 0.2 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.903 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -47.36 -24.75 0.84 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.856 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 17.8 tptt -69.41 -42.35 75.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.901 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 672' ' ' PHE . . . . . 0.466 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 20.5 m-85 -85.99 -21.98 27.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.861 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -45.02 -37.34 4.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -46.69 -45.37 19.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.914 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 86.4 m -66.9 -54.99 16.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.864 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -153.93 -170.27 19.73 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.478 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -82.88 93.56 7.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.873 0.368 . . . . 0.0 110.867 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 84.8 t -70.09 141.21 17.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.149 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 679' ' ' LEU . . . . . 0.786 HD11 ' HG2' ' A' ' 699' ' ' GLU . 12.1 mt -115.24 -59.75 1.97 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.902 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 680' ' ' TYR . . . . . 0.408 ' HB3' ' CB ' ' A' ' 697' ' ' LYS . 9.8 t80 -98.39 125.83 43.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.889 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -154.61 121.02 5.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.112 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -151.64 157.81 42.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.835 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 50.0 mm -104.34 103.89 15.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.121 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 179.857 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 10.7 mmpt? . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.82 0.343 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 41.05 30.55 0.4 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.466 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 17.7 p -137.38 128.24 27.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.884 0.373 . . . . 0.0 110.863 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -140.96 -150.56 5.42 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.525 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 24.7 m -153.08 161.9 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.84 0.353 . . . . 0.0 111.11 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 82.1 t -149.06 114.81 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.122 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 697' ' ' LYS . . . . . 0.408 ' CB ' ' HB3' ' A' ' 680' ' ' TYR . 8.3 ttpt -100.9 145.37 28.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -121.01 166.3 14.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.923 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 699' ' ' GLU . . . . . 0.786 ' HG2' HD11 ' A' ' 679' ' ' LEU . 29.2 mt-10 -69.55 -41.17 76.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.941 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 11.5 m -116.45 151.28 46.78 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.712 0.768 . . . . 0.0 110.806 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.77 -44.72 1.91 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.712 2.274 . . . . 0.0 112.351 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -50.88 -33.74 25.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.891 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 53.9 t -63.11 -58.95 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.147 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -44.06 -58.4 2.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.133 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -46.49 -32.69 3.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.929 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 16.4 ttm180 -82.51 -40.12 21.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.832 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -67.23 -57.73 6.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.149 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 708' ' ' CYS . . . . . 0.467 ' HA ' HG12 ' A' ' 723' ' ' VAL . 21.5 p -38.57 -41.53 0.69 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.875 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -83.42 -44.54 14.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.88 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 56.7 mtp -57.44 -13.4 3.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 711' ' ' MET . . . . . 0.466 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 5.1 mmm -118.48 -29.26 5.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 712' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -39.04 105.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.918 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 89.16 26.87 24.86 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.496 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 714' ' ' MET . . . . . 0.456 ' SD ' ' HE1' ' A' ' 711' ' ' MET . 46.0 ttp -72.55 97.84 2.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.83 0.348 . . . . 0.0 110.895 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -53.79 99.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.899 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 716' ' ' LEU . . . . . 0.94 HD12 HG21 ' A' ' 721' ' ' ILE . 23.9 mt -99.92 129.8 46.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.899 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 717' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 716' ' ' LEU . 9.5 t 35.21 37.32 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.9 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 718' ' ' GLY . . . . . 0.43 ' C ' ' HG3' ' A' ' 719' ' ' ARG . . . 79.84 38.66 19.2 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.517 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 719' ' ' ARG . . . . . 0.5 ' N ' ' O ' ' A' ' 716' ' ' LEU . 25.1 mtp85 -148.45 113.66 5.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.791 0.329 . . . . 0.0 110.842 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -70.19 122.6 19.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.887 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 721' ' ' ILE . . . . . 0.94 HG21 HD12 ' A' ' 716' ' ' LEU . 18.1 pt -99.0 150.6 4.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.109 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.03 99.71 9.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.884 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 723' ' ' VAL . . . . . 0.467 HG12 ' HA ' ' A' ' 708' ' ' CYS . 5.3 t -102.59 130.14 53.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.126 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 64.8 mtm180 -157.85 159.7 36.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.9 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 725' ' ' ILE . . . . . . . . . . . . . 17.5 mm -53.34 136.6 14.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.13 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 14.5 t70 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.88 179.824 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 3.6 p . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.738 0.304 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -115.59 154.37 29.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.895 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 654' ' ' ILE . . . . . 0.484 HD11 ' CE2' ' A' ' 672' ' ' PHE . 43.5 pt -138.24 167.21 22.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.108 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -118.14 154.84 31.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.889 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 2.9 t -141.19 150.67 19.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.105 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -149.73 165.41 32.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.86 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 658' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 65.18 44.21 3.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.889 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 659' ' ' LEU . . . . . . . . . . . . . 60.6 mt -97.44 143.8 26.82 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.619 0.723 . . . . 0.0 110.95 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -47.97 129.76 18.66 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.693 2.262 . . . . 0.0 112.355 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -48.93 -27.96 3.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.905 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -85.57 -28.71 24.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.85 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -38.62 119.75 0.87 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.861 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 75.6 p -100.23 171.36 7.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.17 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 665' ' ' TRP . . . . . 0.637 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 7.5 p-90 -66.86 -52.29 45.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.948 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 666' ' ' LYS . . . . . 0.637 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 4.3 tppp? -45.42 -47.29 13.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 25.6 mtm -62.95 -53.03 60.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.893 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 16.9 tp -44.46 -48.71 10.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.896 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 669' ' ' LYS . . . . . 0.403 ' HG2' ' N ' ' A' ' 670' ' ' ASP . 25.9 tttt -60.09 -71.16 0.14 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.864 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 670' ' ' ASP . . . . . 0.403 ' N ' ' HG2' ' A' ' 669' ' ' LYS . 14.9 t70 -49.61 -24.36 2.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.847 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 19.0 tptt -69.0 -42.4 76.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.884 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 672' ' ' PHE . . . . . 0.564 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 21.8 m-85 -87.13 -13.57 43.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -52.64 -39.35 61.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.884 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -48.65 -37.6 18.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.892 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 91.7 m -74.56 -54.96 6.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.87 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -160.04 -175.31 30.88 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.478 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -71.24 116.76 11.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.851 0.358 . . . . 0.0 110.852 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 678' ' ' VAL . . . . . 0.422 HG13 HG13 ' A' ' 696' ' ' VAL . 84.3 t -96.97 125.06 50.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.125 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 17.5 mt -99.29 -62.4 1.24 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.929 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -98.3 132.63 43.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.923 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -157.01 123.3 4.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.096 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -157.14 156.64 33.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.837 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 32.6 mm -97.35 102.16 13.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.13 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.906 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.783 0.325 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 48.22 32.35 9.56 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.495 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 30.6 p -132.94 129.61 38.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.863 0.363 . . . . 0.0 110.907 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -139.04 -173.32 12.95 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.442 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 17.0 m -139.53 155.38 25.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.835 0.35 . . . . 0.0 111.141 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 696' ' ' VAL . . . . . 0.422 HG13 HG13 ' A' ' 678' ' ' VAL . 89.9 t -143.48 121.51 6.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.084 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 15.5 tttt -105.28 143.35 33.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.899 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -120.7 171.0 8.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 699' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -73.68 -44.7 55.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.866 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 29.9 m -112.92 149.63 41.58 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.636 0.731 . . . . 0.0 110.855 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -34.72 14.04 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.692 2.261 . . . . 0.0 112.356 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -57.95 -38.42 75.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.883 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 62.7 t -61.78 -49.77 82.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.125 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -51.85 -55.58 19.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.091 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 705' ' ' GLU . . . . . 0.405 ' HA ' HD11 ' A' ' 725' ' ' ILE . 56.4 mt-10 -46.94 -25.47 0.79 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.911 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 706' ' ' ARG . . . . . 0.441 ' O ' ' N ' ' A' ' 709' ' ' ARG . 21.7 ttt180 -90.39 -62.34 1.48 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.827 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 707' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 706' ' ' ARG . . . -35.75 -39.79 0.16 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.105 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 708' ' ' CYS . . . . . . . . . . . . . 66.7 m -56.56 -47.08 80.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 709' ' ' ARG . . . . . 0.441 ' N ' ' O ' ' A' ' 706' ' ' ARG . 11.6 mtp180 -73.55 -32.89 64.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.864 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 33.3 mmm -71.84 -20.5 61.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.86 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 711' ' ' MET . . . . . 0.564 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 2.7 mmt -114.02 -10.65 12.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.857 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 712' ' ' ASN . . . . . 0.419 ' OD1' ' C ' ' A' ' 712' ' ' ASN . 28.8 t-20 -57.75 105.08 0.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.877 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 91.83 15.44 54.46 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.508 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 714' ' ' MET . . . . . 0.542 ' HB3' HD11 ' A' ' 721' ' ' ILE . 34.4 ttp -62.7 101.29 0.24 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.877 0.37 . . . . 0.0 110.869 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 4.6 mmmt -66.22 102.76 0.88 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.905 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 716' ' ' LEU . . . . . 0.56 HD12 HG21 ' A' ' 721' ' ' ILE . 23.3 mt -100.01 134.75 42.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.91 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 717' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 716' ' ' LEU . 7.3 t 35.12 31.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.889 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 718' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 716' ' ' LEU . . . 83.65 41.87 8.07 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.475 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 719' ' ' ARG . . . . . 0.485 ' N ' ' O ' ' A' ' 716' ' ' LEU . 2.7 mtt-85 -151.68 117.51 5.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.807 0.337 . . . . 0.0 110.853 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -72.88 125.79 28.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.904 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 721' ' ' ILE . . . . . 0.56 HG21 HD12 ' A' ' 716' ' ' LEU . 41.4 pt -100.11 156.08 4.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.148 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -110.88 103.23 11.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.882 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 723' ' ' VAL . . . . . 0.521 HG21 ' CB ' ' A' ' 711' ' ' MET . 3.4 t -103.98 131.31 52.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.122 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 42.2 mtm-85 -158.18 161.09 37.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.858 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 725' ' ' ILE . . . . . 0.405 HD11 ' HA ' ' A' ' 705' ' ' GLU . 19.8 mm -60.3 131.08 24.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.162 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 6.7 t0 . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 179.854 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 2.8 p . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.783 0.325 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -85.83 148.71 25.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.952 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 654' ' ' ILE . . . . . . . . . . . . . 22.0 pt -134.32 174.29 13.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.121 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -125.79 157.44 37.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.88 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 3.4 t -143.58 151.07 16.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.105 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 27.3 mtp180 -146.62 162.54 38.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.885 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 658' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 69.19 31.16 4.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.852 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 659' ' ' LEU . . . . . . . . . . . . . 64.9 mt -82.14 144.44 50.75 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.628 0.728 . . . . 0.0 110.917 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -47.97 150.84 4.38 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.725 2.283 . . . . 0.0 112.326 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -71.26 -22.36 61.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.859 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -98.19 4.74 48.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.854 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 663' ' ' PHE . . . . . 0.412 ' CE2' ' HA ' ' A' ' 668' ' ' LEU . 3.2 t80 -72.62 118.55 15.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 43.3 p -100.45 169.84 8.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.141 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 665' ' ' TRP . . . . . 0.583 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 15.7 p-90 -57.43 -51.41 69.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.937 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 666' ' ' LYS . . . . . 0.583 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 5.3 tppp? -48.76 -60.06 3.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.885 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 22.5 mtm -51.21 -44.63 61.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.888 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 668' ' ' LEU . . . . . 0.412 ' HA ' ' CE2' ' A' ' 663' ' ' PHE . 12.3 tp -56.79 -44.27 81.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.916 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 29.1 ttmt -64.55 -67.85 0.4 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.27 -23.76 2.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.855 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? -69.85 -39.63 76.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.944 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 672' ' ' PHE . . . . . 0.585 ' CD1' HG21 ' A' ' 696' ' ' VAL . 27.0 m-85 -90.87 -8.39 49.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.899 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -59.41 -27.07 65.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.909 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -62.16 -37.18 84.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.934 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 3.7 m -73.18 -41.4 63.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.879 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -171.02 -167.24 31.06 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.48 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 677' ' ' HIS . . . . . 0.41 ' CD2' ' C ' ' A' ' 677' ' ' HIS . 3.0 t-160 -83.18 106.07 14.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.792 0.329 . . . . 0.0 110.86 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 69.0 t -84.83 144.43 9.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.102 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 16.0 mt -119.15 -61.12 1.67 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.939 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -99.77 125.3 45.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.899 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -149.29 122.12 8.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.058 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -150.95 157.79 43.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.822 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 33.0 mm -104.71 105.0 17.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.115 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.831 179.885 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 24.3 mmmt . . . . . 0 N--CA 1.458 -0.061 0 CA-C-O 120.866 0.365 . . . . 0.0 110.922 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 45.65 38.37 7.4 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.477 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 29.3 p -139.46 130.44 26.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.843 0.354 . . . . 0.0 110.892 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -147.93 -174.69 19.99 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.502 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 14.9 m -133.63 164.09 35.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.848 0.356 . . . . 0.0 111.134 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 696' ' ' VAL . . . . . 0.585 HG21 ' CD1' ' A' ' 672' ' ' PHE . 58.3 t -148.91 114.22 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.123 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 27.1 tttt -94.14 146.48 23.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.966 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -122.34 165.79 15.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.896 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 699' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -68.16 -41.82 80.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.918 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 14.3 m -116.21 152.32 47.73 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.684 0.754 . . . . 0.0 110.84 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -39.54 6.39 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.659 2.24 . . . . 0.0 112.339 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -53.57 -47.67 69.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.926 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 69.2 t -50.55 -55.21 6.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.112 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -41.4 -65.89 0.39 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.124 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 705' ' ' GLU . . . . . 0.695 ' HA ' HD11 ' A' ' 725' ' ' ILE . 49.5 mt-10 -42.65 -38.1 1.93 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.936 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 706' ' ' ARG . . . . . 0.401 ' O ' ' C ' ' A' ' 707' ' ' ALA . 12.6 ttt180 -73.91 -65.95 0.77 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.878 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 707' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 706' ' ' ARG . . . -36.9 -55.23 0.91 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.065 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 708' ' ' CYS . . . . . 0.498 ' HA ' HG11 ' A' ' 723' ' ' VAL . 0.9 OUTLIER -45.31 -51.2 11.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.876 -179.894 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 12.8 mtp180 -66.72 -34.44 77.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 78.1 mtp -73.33 -21.83 60.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.9 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 711' ' ' MET . . . . . 0.564 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 3.8 mmt -108.67 -14.78 14.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.844 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 712' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 708' ' ' CYS . 1.2 p-10 -50.16 121.18 5.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.918 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 70.38 26.48 74.12 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.455 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 714' ' ' MET . . . . . 0.401 ' HB3' HD11 ' A' ' 721' ' ' ILE . 30.5 ttp -69.44 103.53 2.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.794 0.331 . . . . 0.0 110.888 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 15.6 mmtt -59.93 101.41 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.924 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 716' ' ' LEU . . . . . 0.956 HD12 HG21 ' A' ' 721' ' ' ILE . 31.4 mt -100.29 126.06 46.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.901 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 717' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 716' ' ' LEU . 3.4 t 36.57 39.79 0.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.876 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 718' ' ' GLY . . . . . 0.429 ' C ' ' HG3' ' A' ' 719' ' ' ARG . . . 78.45 35.03 34.17 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.493 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 719' ' ' ARG . . . . . 0.497 ' N ' ' O ' ' A' ' 716' ' ' LEU . 5.0 mtt-85 -146.63 111.02 5.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.75 0.31 . . . . 0.0 110.869 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -67.76 123.01 19.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.884 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 721' ' ' ILE . . . . . 0.956 HG21 HD12 ' A' ' 716' ' ' LEU . 26.6 pt -99.27 149.49 5.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.088 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -106.14 112.7 25.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.824 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 723' ' ' VAL . . . . . 0.498 HG11 ' HA ' ' A' ' 708' ' ' CYS . 2.7 t -105.8 138.57 30.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.113 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 26.5 ptt180 -154.25 171.56 19.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 725' ' ' ILE . . . . . 0.695 HD11 ' HA ' ' A' ' 705' ' ' GLU . 19.3 mm -89.98 137.0 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.14 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 10.6 t0 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.885 179.842 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 2.4 p . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.715 0.293 . . . . 0.0 110.845 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -109.86 150.72 28.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.893 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 654' ' ' ILE . . . . . 0.598 HG22 HD13 ' A' ' 725' ' ' ILE . 23.0 pt -139.64 163.8 24.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.171 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -117.6 144.54 45.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.898 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 10.1 t -131.92 150.63 34.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.16 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -146.54 160.31 42.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.849 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 658' ' ' ASN . . . . . 0.613 ' O ' HG22 ' A' ' 721' ' ' ILE . 2.2 t-20 65.88 53.81 1.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.935 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.513 HD22 ' CD2' ' A' ' 663' ' ' PHE . 33.4 mt -102.74 143.48 26.7 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.58 0.705 . . . . 0.0 110.924 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 660' ' ' PRO . . . . . 0.478 ' O ' ' N ' ' A' ' 663' ' ' PHE . 65.9 Cg_exo -48.01 125.13 11.13 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.706 2.271 . . . . 0.0 112.32 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -40.63 -37.87 0.79 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.903 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 662' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 663' ' ' PHE . 2.2 m-20 -74.99 -35.07 62.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 663' ' ' PHE . . . . . 0.513 ' CD2' HD22 ' A' ' 659' ' ' LEU . 3.7 t80 -37.5 115.24 0.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.893 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 78.9 p -102.79 178.08 4.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.136 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 665' ' ' TRP . . . . . 0.647 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 3.4 p-90 -64.13 -48.27 76.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.908 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 666' ' ' LYS . . . . . 0.647 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 18.8 tptm -49.0 -56.88 7.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.898 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 32.4 mtm -55.99 -51.48 67.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.846 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 15.1 tp -45.34 -42.84 10.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.905 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -66.55 -70.72 0.23 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -48.51 -24.93 1.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.854 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 18.4 tptt -68.91 -46.08 69.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.934 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 672' ' ' PHE . . . . . 0.554 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 22.4 m-85 -83.38 -15.42 49.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.867 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -49.18 -41.4 36.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.9 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -45.64 -37.11 5.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.893 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 34.1 m -73.62 -48.2 34.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.871 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -164.53 -164.21 19.31 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.779 -0.725 . . . . 0.0 112.504 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 6.5 t-80 -85.48 93.6 8.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.806 0.336 . . . . 0.0 110.86 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 71.1 t -69.37 133.39 31.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.114 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 10.7 mt -108.67 -60.18 1.78 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.946 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -99.62 130.25 45.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.918 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -156.01 125.76 6.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.107 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -154.62 156.55 36.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.822 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 28.9 mm -105.24 108.48 25.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.166 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.885 179.876 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 14.1 mmmt . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.813 0.339 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 81.91 11.67 82.33 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.521 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 5.6 p -119.92 139.48 52.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.858 0.361 . . . . 0.0 110.88 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -148.38 -158.07 7.82 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.475 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 15.6 m -151.0 156.98 5.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.866 0.365 . . . . 0.0 111.125 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 696' ' ' VAL . . . . . 0.468 HG21 ' CD1' ' A' ' 672' ' ' PHE . 85.9 t -144.89 121.05 4.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.147 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 9.9 ttpp -104.84 147.41 27.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.911 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -123.48 168.4 12.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.893 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 699' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -68.55 -48.24 64.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.858 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 70.8 m -111.25 148.1 38.03 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.66 0.743 . . . . 0.0 110.819 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -23.52 30.6 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.657 2.238 . . . . 0.0 112.359 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 702' ' ' GLU . . . . . 0.453 ' HG3' ' N ' ' A' ' 703' ' ' VAL . 6.8 pt-20 -69.26 -34.51 74.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.905 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 703' ' ' VAL . . . . . 0.453 ' N ' ' HG3' ' A' ' 702' ' ' GLU . 24.7 t -61.19 -59.86 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.149 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -41.3 -61.41 1.03 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.116 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -41.55 -31.74 0.3 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.861 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -80.3 -48.93 12.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.855 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -60.39 -53.04 62.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.109 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 708' ' ' CYS . . . . . 0.434 ' SG ' ' N ' ' A' ' 709' ' ' ARG . 1.8 p -39.15 -41.69 0.86 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.884 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 709' ' ' ARG . . . . . 0.434 ' N ' ' SG ' ' A' ' 708' ' ' CYS . 12.6 mtt85 -84.51 -39.84 18.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.839 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 18.1 mtm -68.03 -7.74 31.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.853 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 711' ' ' MET . . . . . 0.554 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 14.2 mmm -121.57 -30.26 4.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.889 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 712' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -45.54 107.09 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.925 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 90.03 25.98 25.37 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.479 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 714' ' ' MET . . . . . . . . . . . . . 41.9 ttp -75.3 100.31 4.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.864 0.364 . . . . 0.0 110.874 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 18.3 mmtt -56.27 102.12 0.07 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.899 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 716' ' ' LEU . . . . . 0.849 HD12 HG21 ' A' ' 721' ' ' ILE . 34.6 mt -99.86 121.97 42.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.879 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 717' ' ' SER . . . . . . . . . . . . . 36.8 t 37.62 41.83 0.33 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.846 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 718' ' ' GLY . . . . . 0.422 ' C ' ' HG3' ' A' ' 719' ' ' ARG . . . 77.68 34.27 39.83 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.482 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 719' ' ' ARG . . . . . 0.459 ' N ' ' O ' ' A' ' 716' ' ' LEU . 1.9 mtp-105 -146.01 109.6 4.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.777 0.323 . . . . 0.0 110.887 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -69.99 124.97 25.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.897 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 721' ' ' ILE . . . . . 0.849 HG21 HD12 ' A' ' 716' ' ' LEU . 31.4 pt -98.9 152.33 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.13 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -106.08 98.27 7.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.869 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 5.1 t -101.69 132.0 48.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.137 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 34.5 mtp180 -156.0 167.58 29.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.857 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 725' ' ' ILE . . . . . 0.598 HD13 HG22 ' A' ' 654' ' ' ILE . 33.9 mm -73.92 131.62 34.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.103 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 35.5 t0 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 179.853 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 652' ' ' CYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 704' ' ' ALA . 25.5 p . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.731 0.3 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -90.06 146.36 24.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.918 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 654' ' ' ILE . . . . . 0.425 HD11 ' CE2' ' A' ' 672' ' ' PHE . 40.5 pt -132.91 176.06 9.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.113 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -127.53 159.76 33.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.904 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 656' ' ' VAL . . . . . 0.411 HG13 HD12 ' A' ' 721' ' ' ILE . 21.9 t -146.13 148.68 16.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.116 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 32.0 mtp180 -146.85 162.99 37.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.877 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 658' ' ' ASN . . . . . 0.431 ' O ' HG22 ' A' ' 721' ' ' ILE . 2.3 t-20 65.97 46.41 2.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.922 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.474 HD22 ' CD2' ' A' ' 663' ' ' PHE . 27.8 mt -97.58 142.02 23.9 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.631 0.729 . . . . 0.0 110.939 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -48.01 127.91 15.65 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.678 2.252 . . . . 0.0 112.342 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -39.91 -50.48 2.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.885 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 662' ' ' ASP . . . . . 0.428 ' O ' HG23 ' A' ' 664' ' ' THR . 0.9 OUTLIER -61.79 -38.16 87.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.83 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 663' ' ' PHE . . . . . 0.477 ' HA ' ' CE ' ' A' ' 667' ' ' MET . 4.0 t80 -35.45 116.26 0.35 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.844 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 664' ' ' THR . . . . . 0.428 HG23 ' O ' ' A' ' 662' ' ' ASP . 78.6 p -106.15 174.82 5.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.135 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 665' ' ' TRP . . . . . 0.647 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 3.3 p-90 -62.1 -51.8 66.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.911 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 666' ' ' LYS . . . . . 0.647 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 1.7 tppp? -45.15 -48.93 12.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.884 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 667' ' ' MET . . . . . 0.477 ' CE ' ' HA ' ' A' ' 663' ' ' PHE . 24.3 mtm -64.3 -52.1 60.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.91 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 15.3 tp -43.52 -45.27 6.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -64.61 -70.74 0.21 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.885 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -48.49 -21.48 0.57 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.855 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 671' ' ' LYS . . . . . 0.44 ' HE2' HD21 ' A' ' 716' ' ' LEU . 17.2 tptt -72.81 -43.54 62.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.859 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 672' ' ' PHE . . . . . 0.534 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 25.8 m-85 -86.62 -15.95 38.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.9 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -50.38 -38.75 44.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.896 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -46.83 -39.94 12.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.888 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 675' ' ' CYS . . . . . 0.448 ' HA ' ' HE3' ' A' ' 710' ' ' MET . 62.8 m -67.65 -60.46 2.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.879 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -152.7 -157.59 8.08 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.524 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -87.77 100.72 13.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.791 0.329 . . . . 0.0 110.899 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 98.1 t -79.55 140.91 16.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.167 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 679' ' ' LEU . . . . . 0.419 HD11 ' HG2' ' A' ' 699' ' ' GLU . 12.8 mt -117.29 -60.03 1.88 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.88 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 680' ' ' TYR . . . . . 0.402 ' HB3' ' CB ' ' A' ' 697' ' ' LYS . 7.9 t80 -99.46 126.59 45.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.974 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -153.4 122.51 6.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.103 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -149.67 164.8 34.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 27.3 mm -114.72 101.38 12.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.116 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.878 179.868 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.847 0.356 . . . . 0.0 110.893 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 692' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 658' ' ' ASN . . . 39.15 39.1 0.93 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.49 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 31.3 p -138.09 139.43 39.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.896 0.379 . . . . 0.0 110.858 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -158.7 -173.65 27.38 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.434 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 27.0 m -134.13 164.25 34.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.882 0.372 . . . . 0.0 111.114 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 85.5 t -148.94 116.91 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.079 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 697' ' ' LYS . . . . . 0.402 ' CB ' ' HB3' ' A' ' 680' ' ' TYR . 11.8 tttp -101.24 140.36 35.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -116.34 173.79 6.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.871 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 699' ' ' GLU . . . . . 0.419 ' HG2' HD11 ' A' ' 679' ' ' LEU . 48.0 mt-10 -73.19 -48.47 34.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.903 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 14.0 m -109.01 149.53 39.75 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.664 0.745 . . . . 0.0 110.824 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 -6.88 19.64 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.661 2.24 . . . . 0.0 112.327 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -86.17 -46.79 10.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.892 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 88.9 t -50.88 -42.16 22.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.182 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 704' ' ' ALA . . . . . 0.407 ' HB2' ' O ' ' A' ' 652' ' ' CYS . . . -56.63 -59.14 5.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.093 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -47.48 -38.76 14.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 706' ' ' ARG . . . . . 0.517 ' HD3' ' HE1' ' A' ' 710' ' ' MET . 16.5 ttt-85 -70.67 -52.95 17.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.84 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -53.64 -42.24 67.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.074 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 708' ' ' CYS . . . . . . . . . . . . . 1.1 t -47.49 -43.98 24.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 3.5 mtt-85 -81.91 -45.76 15.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.899 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 710' ' ' MET . . . . . 0.517 ' HE1' ' HD3' ' A' ' 706' ' ' ARG . 13.9 mtm -57.09 -17.31 9.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.875 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 711' ' ' MET . . . . . 0.534 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 4.2 mmt -113.8 -34.5 5.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.881 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 712' ' ' ASN . . . . . 0.437 ' C ' ' O ' ' A' ' 711' ' ' MET . 3.9 t30 -35.02 117.24 0.38 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.863 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 72.38 31.95 62.88 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.479 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 714' ' ' MET . . . . . 0.669 ' HE3' HD21 ' A' ' 716' ' ' LEU . 20.1 ttp -74.16 91.53 2.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.887 0.375 . . . . 0.0 110.869 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 715' ' ' LYS . . . . . 0.497 ' CD ' ' HG3' ' A' ' 720' ' ' GLU . 0.7 OUTLIER -50.84 99.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.898 179.979 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 716' ' ' LEU . . . . . 0.669 HD21 ' HE3' ' A' ' 714' ' ' MET . 30.4 mt -99.43 117.82 34.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.908 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 717' ' ' SER . . . . . . . . . . . . . 1.5 t 41.04 37.27 0.53 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.854 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 84.1 25.26 45.2 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.505 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 719' ' ' ARG . . . . . 0.481 ' N ' ' O ' ' A' ' 716' ' ' LEU . 39.2 mtt85 -138.73 106.38 5.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.774 0.321 . . . . 0.0 110.836 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 720' ' ' GLU . . . . . 0.497 ' HG3' ' CD ' ' A' ' 715' ' ' LYS . 30.2 mt-10 -72.45 127.94 34.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.875 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 721' ' ' ILE . . . . . 0.606 HG21 HD12 ' A' ' 716' ' ' LEU . 43.1 pt -98.07 159.76 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.089 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -111.33 99.44 8.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.834 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 12.7 t -98.97 134.03 39.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.154 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 63.5 mtm180 -156.9 174.91 14.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.844 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 725' ' ' ILE . . . . . . . . . . . . . 25.4 mm -77.28 139.3 18.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.126 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 8.1 t70 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.852 179.852 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 25.7 p . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.791 0.329 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -85.71 144.68 27.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.937 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 654' ' ' ILE . . . . . 0.668 HG22 HD13 ' A' ' 725' ' ' ILE . 35.6 pt -131.47 174.64 12.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.083 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -131.31 148.75 52.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.864 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 11.2 t -131.31 148.47 32.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.129 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -143.89 157.84 44.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.881 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 658' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 71.2 46.22 0.45 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.904 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 659' ' ' LEU . . . . . 0.503 HD23 ' CD1' ' A' ' 716' ' ' LEU . 52.5 mt -94.71 142.47 24.77 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.62 0.724 . . . . 0.0 110.886 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -47.95 127.84 15.38 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.666 2.244 . . . . 0.0 112.348 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -44.18 -37.34 3.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.85 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 662' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 663' ' ' PHE . 51.3 m-20 -75.26 -35.56 61.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.864 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 663' ' ' PHE . . . . . 0.433 ' C ' ' O ' ' A' ' 662' ' ' ASP . 3.8 t80 -34.68 142.9 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.862 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 45.1 p -127.38 172.51 10.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.179 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 665' ' ' TRP . . . . . 0.614 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 6.0 p-90 -63.46 -50.27 70.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.929 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 666' ' ' LYS . . . . . 0.614 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 5.0 tppp? -46.42 -51.0 15.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.867 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 32.3 mtm -62.06 -46.85 87.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.889 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 39.3 tp -48.9 -46.09 42.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.936 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 25.3 ttmt -65.02 -72.97 0.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.917 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -46.17 -25.71 0.64 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.86 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 671' ' ' LYS . . . . . 0.432 ' HE3' HD21 ' A' ' 716' ' ' LEU . 10.1 tppt? -67.9 -51.66 45.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.899 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 672' ' ' PHE . . . . . 0.576 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 23.7 m-85 -77.77 -16.99 58.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.84 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -48.93 -33.41 10.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -55.83 -39.28 71.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.884 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 60.4 m -71.58 -41.71 68.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.899 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -174.75 170.84 44.01 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.436 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -62.01 103.71 0.39 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.805 0.336 . . . . 0.0 110.861 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 65.1 t -80.32 147.62 6.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.085 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 679' ' ' LEU . . . . . 0.699 HD11 ' HG2' ' A' ' 699' ' ' GLU . 13.7 mt -120.37 -63.83 1.32 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.913 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 680' ' ' TYR . . . . . 0.435 ' HB3' ' CB ' ' A' ' 697' ' ' LYS . 10.1 t80 -98.66 125.32 43.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -152.78 124.59 7.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.131 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -157.41 156.68 32.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.873 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 40.9 mm -96.23 99.28 8.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.152 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.878 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt . . . . . 0 N--CA 1.457 -0.081 0 CA-C-O 120.842 0.354 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 51.89 37.09 43.49 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.448 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 27.2 p -137.81 149.76 46.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.875 0.369 . . . . 0.0 110.882 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -155.68 -175.71 27.01 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.516 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 13.8 m -138.25 156.32 30.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.812 0.339 . . . . 0.0 111.162 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 90.7 t -142.96 118.0 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.115 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 697' ' ' LYS . . . . . 0.435 ' CB ' ' HB3' ' A' ' 680' ' ' TYR . 23.7 tttp -101.96 137.39 40.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.88 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -113.49 166.65 11.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.871 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 699' ' ' GLU . . . . . 0.699 ' HG2' HD11 ' A' ' 679' ' ' LEU . 22.5 mt-10 -68.53 -44.92 73.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.853 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 3.7 m -113.56 151.04 44.19 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.658 0.742 . . . . 0.0 110.869 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -36.7 10.21 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.657 2.238 . . . . 0.0 112.335 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 702' ' ' GLU . . . . . 0.443 ' OE1' ' C ' ' A' ' 702' ' ' GLU . 0.6 OUTLIER -56.81 -40.56 76.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.932 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 79.6 t -53.8 -57.07 6.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.087 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -43.23 -63.25 0.85 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.08 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -41.4 -29.96 0.17 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.883 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 19.8 ttm-85 -82.62 -47.79 11.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.846 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 707' ' ' ALA . . . . . 0.421 ' O ' ' C ' ' A' ' 708' ' ' CYS . . . -62.9 -59.34 4.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.06 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 708' ' ' CYS . . . . . 0.421 ' C ' ' O ' ' A' ' 707' ' ' ALA . 11.5 p -36.18 -36.69 0.1 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.877 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 6.3 mtt180 -85.29 -46.16 11.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.872 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 18.7 mtm -61.89 -9.45 6.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.886 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 711' ' ' MET . . . . . 0.576 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 6.3 mmm -120.2 -17.72 8.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.881 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 712' ' ' ASN . . . . . 0.404 ' OD1' ' C ' ' A' ' 712' ' ' ASN . 3.5 t-20 -53.5 117.41 3.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.905 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 80.8 10.4 85.16 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.533 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 714' ' ' MET . . . . . 0.575 ' HB3' HD11 ' A' ' 721' ' ' ILE . 46.3 ttp -61.32 91.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.857 0.36 . . . . 0.0 110.9 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 2.9 mttp -58.56 112.0 1.45 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.893 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 716' ' ' LEU . . . . . 0.59 HD12 HG21 ' A' ' 721' ' ' ILE . 30.5 mt -100.19 127.46 46.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 717' ' ' SER . . . . . . . . . . . . . 31.1 t 37.66 31.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.861 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 718' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 716' ' ' LEU . . . 89.3 43.11 5.36 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.463 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 719' ' ' ARG . . . . . . . . . . . . . 19.0 mtt180 -152.02 107.37 3.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.764 0.316 . . . . 0.0 110.886 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -62.69 124.22 20.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.884 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 721' ' ' ILE . . . . . 0.59 HG21 HD12 ' A' ' 716' ' ' LEU . 18.9 pt -100.09 151.18 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.161 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -111.1 97.79 7.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.853 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 8.1 t -97.35 136.11 29.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.143 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 79.8 mtt-85 -156.18 161.95 40.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 725' ' ' ILE . . . . . 0.668 HD13 HG22 ' A' ' 654' ' ' ILE . 23.0 mm -70.23 131.73 33.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.123 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 35.9 t0 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.823 179.875 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 645' ' ' SER . . . . . . . . . . . . . 7.7 t -164.6 172.3 13.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.876 0.37 . . . . 0.0 110.857 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 646' ' ' SER . . . . . . . . . . . . . 1.3 t -125.16 42.44 3.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.869 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -98.57 -150.46 25.99 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.48 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 49.6 m -56.16 129.3 39.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.901 0.382 . . . . 0.0 110.856 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 69.0 p -73.44 95.8 2.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.871 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 104.93 105.89 3.07 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.467 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 651' ' ' ALA . . . . . 0.71 ' HB1' ' CG2' ' A' ' 725' ' ' ILE . . . -85.79 90.4 8.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.769 0.318 . . . . 0.0 111.113 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 652' ' ' CYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 704' ' ' ALA . 18.8 p -100.23 -29.87 12.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.83 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -93.24 153.23 18.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.882 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 654' ' ' ILE . . . . . 0.652 HG22 HD13 ' A' ' 725' ' ' ILE . 32.7 pt -136.51 177.75 5.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.157 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -130.56 149.56 52.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.875 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 3.3 t -134.58 151.89 32.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.136 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 38.1 mtt85 -148.39 161.99 40.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 658' ' ' ASN . . . . . 0.425 ' O ' HG22 ' A' ' 721' ' ' ILE . 1.9 t-20 65.27 47.97 2.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.739 HD22 ' CD2' ' A' ' 663' ' ' PHE . 26.3 mt -96.98 143.65 26.48 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.599 0.714 . . . . 0.0 110.942 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 660' ' ' PRO . . . . . 0.445 ' O ' ' N ' ' A' ' 663' ' ' PHE . 65.5 Cg_exo -47.95 127.82 15.34 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.685 2.257 . . . . 0.0 112.344 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -45.45 -30.96 1.53 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.881 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -83.8 -28.36 28.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.896 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 663' ' ' PHE . . . . . 0.739 ' CD2' HD22 ' A' ' 659' ' ' LEU . 3.8 t80 -40.62 123.14 1.79 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.924 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 80.4 p -106.02 176.77 5.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.138 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 665' ' ' TRP . . . . . 0.648 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 6.6 p-90 -68.97 -50.66 47.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.888 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 666' ' ' LYS . . . . . 0.648 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 2.8 tppp? -47.29 -50.73 20.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.858 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 31.4 mtm -63.37 -46.52 86.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.875 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 14.1 tp -51.52 -42.53 61.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.9 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 29.3 tttm -65.2 -74.15 0.11 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.873 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -46.01 -23.68 0.33 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.874 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 671' ' ' LYS . . . . . 0.442 ' HG3' ' CE ' ' A' ' 711' ' ' MET . 7.5 tppt? -69.88 -40.37 75.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.91 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 672' ' ' PHE . . . . . 0.466 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 20.6 m-85 -90.14 -9.3 48.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -57.63 -34.97 69.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -43.16 -44.76 5.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.903 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 9.4 t -66.98 -63.94 0.96 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.871 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -145.83 -155.06 6.35 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.462 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -93.08 102.83 15.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.88 0.372 . . . . 0.0 110.861 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 43.1 t -75.86 132.88 32.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.073 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 679' ' ' LEU . . . . . 0.403 HD21 ' HG2' ' A' ' 699' ' ' GLU . 10.2 mt -107.3 -61.53 1.54 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.887 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -97.91 129.61 44.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.918 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -155.48 123.07 5.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.138 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -152.17 165.52 34.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.83 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 18.5 mm -115.8 117.2 54.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.13 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -60.05 137.59 58.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.855 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 685' ' ' MET . . . . . . . . . . . . . 29.4 mtp -139.74 156.16 46.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.913 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -131.94 114.38 14.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.902 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 687' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 53.14 35.36 19.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.937 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 688' ' ' GLY . . . . . . . . . . . . . . . 78.18 36.42 31.33 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.462 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 4.9 mmmm -137.99 119.74 15.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.776 0.322 . . . . 0.0 110.883 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 690' ' ' SER . . . . . . . . . . . . . 4.0 m -57.29 136.91 56.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.796 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 4.6 mmtp -102.71 -15.04 16.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.866 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 80.91 13.36 81.4 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.496 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 8.9 p -126.81 131.89 51.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.835 0.35 . . . . 0.0 110.931 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -139.75 -170.87 12.09 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.518 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 5.2 m -141.07 153.5 20.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.865 0.364 . . . . 0.0 111.116 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 98.9 t -139.64 124.31 20.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.091 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 23.9 tttt -107.57 139.72 41.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.885 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -115.55 172.27 7.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.923 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 699' ' ' GLU . . . . . 0.403 ' HG2' HD21 ' A' ' 679' ' ' LEU . 25.7 mt-10 -75.52 -44.07 45.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.844 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 58.3 m -107.36 147.71 35.77 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.66 0.743 . . . . 0.0 110.843 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -32.97 17.55 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.649 2.233 . . . . 0.0 112.375 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -63.07 -42.92 99.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.891 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 95.5 t -51.14 -60.24 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.149 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 704' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 651' ' ' ALA . . . -42.13 -59.44 1.77 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.098 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.761 ' HA ' HD11 ' A' ' 725' ' ' ILE . 22.0 mt-10 -43.55 -31.23 0.69 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.89 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 26.2 ttm-85 -81.99 -58.1 3.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.867 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -44.93 -30.15 0.95 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.095 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 708' ' ' CYS . . . . . 0.49 ' O ' ' N ' ' A' ' 712' ' ' ASN . 1.4 t -56.43 -63.96 1.02 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.883 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.15 -41.25 94.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.88 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 58.4 mtp -55.34 -33.6 63.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 711' ' ' MET . . . . . 0.469 ' CB ' HG21 ' A' ' 723' ' ' VAL . 3.7 mmt -105.8 -14.46 15.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.856 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 712' ' ' ASN . . . . . 0.49 ' N ' ' O ' ' A' ' 708' ' ' CYS . 40.1 t-20 -54.22 109.72 0.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.889 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 83.65 24.06 51.28 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.487 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 714' ' ' MET . . . . . 0.436 ' CE ' ' CE ' ' A' ' 711' ' ' MET . 38.2 ttp -72.16 98.91 2.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.825 0.345 . . . . 0.0 110.854 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 5.5 mmtm -51.94 101.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.887 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 716' ' ' LEU . . . . . 0.883 HD12 HG21 ' A' ' 721' ' ' ILE . 24.6 mt -99.78 120.02 39.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.926 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 717' ' ' SER . . . . . . . . . . . . . 20.4 t 40.27 43.67 1.46 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.874 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 75.6 26.52 65.15 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.521 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 719' ' ' ARG . . . . . 0.464 ' N ' ' O ' ' A' ' 716' ' ' LEU . 28.5 mtp180 -140.16 110.95 6.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.777 0.322 . . . . 0.0 110.89 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -68.2 127.84 34.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.933 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 721' ' ' ILE . . . . . 0.883 HG21 HD12 ' A' ' 716' ' ' LEU . 26.4 pt -99.69 151.41 4.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.137 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -106.11 99.88 9.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.878 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 723' ' ' VAL . . . . . 0.469 HG21 ' CB ' ' A' ' 711' ' ' MET . 4.4 t -97.53 135.77 30.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.141 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 -158.21 163.97 36.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.876 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 725' ' ' ILE . . . . . 0.761 HD11 ' HA ' ' A' ' 705' ' ' GLU . 31.9 mm -79.27 134.86 26.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.127 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -89.05 116.86 27.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 727' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 -91.4 -24.25 19.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.867 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 728' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -114.36 71.36 0.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 729' ' ' ALA . . . . . . . . . . . . . . . -107.97 24.5 12.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.094 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 45.8 t -96.18 104.02 15.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.864 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 731' ' ' GLY . . . . . . . . . . . . . . . 86.53 177.33 49.54 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.514 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 732' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 144.25 53.68 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.729 2.286 . . . . 0.0 112.339 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 733' ' ' SER . . . . . . . . . . . . . 31.1 t -115.17 86.37 2.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.902 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 734' ' ' SER . . . . . . . . . . . . . 22.8 t -165.13 132.82 3.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.895 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 735' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.48 -179.971 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 645' ' ' SER . . . . . . . . . . . . . 3.2 m -83.53 166.36 18.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.881 0.372 . . . . 0.0 110.868 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 646' ' ' SER . . . . . . . . . . . . . 88.8 p -159.99 124.04 3.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.867 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . 169.58 111.27 0.24 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.503 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 9.8 m -119.14 127.6 53.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.865 0.364 . . . . 0.0 110.826 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 67.3 m -115.29 168.8 9.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.876 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . -66.41 92.68 0.18 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.52 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 651' ' ' ALA . . . . . 0.437 ' HB1' ' CG2' ' A' ' 725' ' ' ILE . . . -81.78 55.39 2.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.789 0.328 . . . . 0.0 111.073 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 29.8 m -81.36 -20.5 40.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.911 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -94.53 143.1 26.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.932 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 654' ' ' ILE . . . . . 0.455 HD11 ' CE2' ' A' ' 672' ' ' PHE . 36.3 pt -132.94 174.97 12.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.154 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -121.09 158.58 27.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.832 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 21.9 t -147.01 146.47 18.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.095 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 65.6 mtm180 -146.42 157.86 43.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.87 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 658' ' ' ASN . . . . . 0.444 ' O ' HG22 ' A' ' 721' ' ' ILE . 3.2 t-20 71.17 50.17 0.31 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.853 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.525 HD22 ' CD2' ' A' ' 663' ' ' PHE . 29.0 mt -100.59 143.83 27.3 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.615 0.722 . . . . 0.0 110.872 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 660' ' ' PRO . . . . . 0.483 ' O ' ' N ' ' A' ' 663' ' ' PHE . 65.8 Cg_exo -47.97 124.55 10.23 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.684 2.256 . . . . 0.0 112.331 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -42.37 -36.89 1.4 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.828 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -76.0 -31.5 58.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.881 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 663' ' ' PHE . . . . . 0.525 ' CD2' HD22 ' A' ' 659' ' ' LEU . 3.8 t80 -38.85 128.4 1.57 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.863 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 72.1 p -113.18 174.99 5.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.139 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 665' ' ' TRP . . . . . 0.644 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 5.3 p-90 -64.35 -51.66 62.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.897 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 666' ' ' LYS . . . . . 0.644 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 7.4 tppt? -45.42 -53.31 8.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.877 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 28.2 mtm -58.05 -54.38 47.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.892 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 15.3 tp -41.85 -49.72 4.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.881 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -60.66 -74.2 0.08 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.913 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -46.73 -23.3 0.4 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.9 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 10.3 tptt -70.83 -45.43 64.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.892 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 672' ' ' PHE . . . . . 0.455 ' CE2' HD11 ' A' ' 654' ' ' ILE . 23.4 m-85 -84.57 -11.58 55.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.908 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -54.57 -36.04 63.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.876 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -52.79 -32.08 42.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 10.2 m -80.9 -49.33 11.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.894 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 676' ' ' GLY . . . . . 0.621 ' HA3' HG11 ' A' ' 703' ' ' VAL . . . -164.21 168.92 38.85 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.482 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -61.95 101.08 0.18 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.836 0.35 . . . . 0.0 110.85 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 73.5 t -80.35 132.83 30.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.114 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 13.3 mt -107.47 -61.85 1.5 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.89 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -95.79 130.15 42.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.922 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -157.77 128.45 6.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.114 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -161.12 156.93 25.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.872 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 30.5 mm -102.11 111.97 33.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.121 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -64.05 134.33 54.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.912 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 685' ' ' MET . . . . . . . . . . . . . 23.6 mtp -132.87 147.26 52.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.873 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -118.92 88.05 2.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.889 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 687' ' ' ASN . . . . . 0.437 ' O ' ' ND2' ' A' ' 687' ' ' ASN . 0.5 OUTLIER 70.98 48.68 0.37 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.86 -179.973 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 688' ' ' GLY . . . . . . . . . . . . . . . 62.92 36.63 93.69 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.494 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 689' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 690' ' ' SER . 6.0 mtmp? -134.31 87.5 2.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.751 0.31 . . . . 0.0 110.901 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 690' ' ' SER . . . . . 0.403 ' C ' ' O ' ' A' ' 689' ' ' LYS . 19.9 t -37.69 128.3 1.15 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.899 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 25.0 mmmt -102.54 8.45 39.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.904 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 59.25 18.7 43.44 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.506 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 19.5 p -126.13 151.0 47.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.834 0.349 . . . . 0.0 110.889 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 694' ' ' GLY . . . . . 0.415 ' O ' HG13 ' A' ' 695' ' ' VAL . . . -155.9 -152.0 6.09 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.487 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 695' ' ' VAL . . . . . 0.415 HG13 ' O ' ' A' ' 694' ' ' GLY . 15.3 m -155.84 152.4 8.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.831 0.348 . . . . 0.0 111.143 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 99.2 t -141.7 120.06 9.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.078 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 14.4 ttpt -104.87 138.1 41.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.902 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -113.95 173.87 6.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.903 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 699' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -75.06 -36.79 61.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.913 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 700' ' ' SER . . . . . 0.456 ' OG ' HG23 ' A' ' 703' ' ' VAL . 69.0 p -124.57 151.25 67.03 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.636 0.731 . . . . 0.0 110.873 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -30.27 22.63 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.681 2.254 . . . . 0.0 112.357 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -61.68 -39.0 89.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.844 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 703' ' ' VAL . . . . . 0.621 HG11 ' HA3' ' A' ' 676' ' ' GLY . 82.6 t -66.23 -47.21 85.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.086 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 704' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 651' ' ' ALA . . . -51.47 -47.12 63.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.112 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.76 ' HA ' HD11 ' A' ' 725' ' ' ILE . 14.4 mt-10 -55.45 -43.12 75.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.901 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 22.0 ttm180 -68.92 -54.81 13.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.837 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -43.07 -47.53 5.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.107 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 708' ' ' CYS . . . . . 0.48 ' O ' ' CB ' ' A' ' 712' ' ' ASN . 21.3 m -54.54 -34.57 62.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.87 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 8.7 mtm105 -81.66 -45.18 16.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.881 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 22.1 mtm -66.06 -15.27 62.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.921 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 711' ' ' MET . . . . . 0.476 ' O ' ' N ' ' A' ' 714' ' ' MET . 3.2 mmt -113.78 -30.83 6.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.873 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 712' ' ' ASN . . . . . 0.48 ' CB ' ' O ' ' A' ' 708' ' ' CYS . 0.5 OUTLIER -39.79 112.27 0.25 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.875 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 77.25 25.61 63.4 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.48 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 714' ' ' MET . . . . . 0.553 ' HE3' HD21 ' A' ' 716' ' ' LEU . 48.9 ttp -71.38 100.35 2.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.863 0.363 . . . . 0.0 110.91 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp -54.07 99.13 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.889 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 716' ' ' LEU . . . . . 0.846 HD12 HG21 ' A' ' 721' ' ' ILE . 29.1 mt -99.89 125.21 45.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.929 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 717' ' ' SER . . . . . . . . . . . . . 1.1 t 40.06 43.68 1.35 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.883 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 72.41 29.09 66.57 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.508 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 719' ' ' ARG . . . . . 0.47 ' N ' ' O ' ' A' ' 716' ' ' LEU . 44.1 mtt180 -141.19 114.85 8.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.801 0.334 . . . . 0.0 110.885 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -70.18 128.03 34.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.902 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 721' ' ' ILE . . . . . 0.846 HG21 HD12 ' A' ' 716' ' ' LEU . 37.3 pt -100.03 161.89 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.129 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -118.39 98.21 6.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.845 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 723' ' ' VAL . . . . . 0.457 ' CG1' ' HA ' ' A' ' 708' ' ' CYS . 6.2 t -96.59 132.83 40.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.146 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 64.1 mtt180 -155.19 154.15 31.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.879 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 725' ' ' ILE . . . . . 0.76 HD11 ' HA ' ' A' ' 705' ' ' GLU . 15.1 mm -64.15 134.51 28.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.15 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -81.89 87.33 6.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 727' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -44.11 -51.34 8.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.886 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 728' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -95.35 91.47 6.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.91 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 729' ' ' ALA . . . . . . . . . . . . . . . -131.38 -49.65 0.99 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.094 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 22.7 t -132.64 109.52 9.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.875 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 731' ' ' GLY . . . . . . . . . . . . . . . -73.33 145.01 35.33 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.488 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 732' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 93.83 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.66 2.24 . . . . 0.0 112.343 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 733' ' ' SER . . . . . . . . . . . . . 36.2 m -100.7 82.17 2.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.881 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 734' ' ' SER . . . . . . . . . . . . . 16.4 m -123.55 104.98 9.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.854 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 735' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.492 -179.996 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 645' ' ' SER . . . . . . . . . . . . . 35.1 m -110.75 42.97 1.5 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.923 0.392 . . . . 0.0 110.876 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 646' ' ' SER . . . . . . . . . . . . . 12.8 t -113.21 154.43 26.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.906 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . 156.14 43.01 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.446 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 38.5 p -42.38 158.08 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.877 0.37 . . . . 0.0 110.903 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 20.0 t -72.71 -57.99 3.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.828 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . -174.64 169.35 42.29 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.502 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 651' ' ' ALA . . . . . 0.711 ' HB1' HD12 ' A' ' 725' ' ' ILE . . . -121.22 99.5 6.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.772 0.32 . . . . 0.0 111.066 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 652' ' ' CYS . . . . . 0.461 ' SG ' ' N ' ' A' ' 701' ' ' PRO . 22.3 m -106.5 -23.18 12.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.869 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -104.32 146.49 28.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.928 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 654' ' ' ILE . . . . . 0.587 HD11 ' CE2' ' A' ' 672' ' ' PHE . 38.9 pt -131.32 169.34 21.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.096 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -122.75 149.85 43.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.889 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 3.4 t -132.8 153.38 37.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.152 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 53.4 mtt85 -148.68 160.44 43.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.896 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 658' ' ' ASN . . . . . 0.448 ' O ' HG22 ' A' ' 721' ' ' ILE . 0.6 OUTLIER 66.93 44.95 1.91 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.927 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.439 HD23 HD12 ' A' ' 716' ' ' LEU . 54.1 mt -93.84 143.52 26.64 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.586 0.707 . . . . 0.0 110.907 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 660' ' ' PRO . . . . . 0.406 ' O ' ' N ' ' A' ' 663' ' ' PHE . 66.7 Cg_exo -48.04 124.12 9.7 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.687 2.258 . . . . 0.0 112.32 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -47.43 -24.43 0.81 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.896 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 662' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 663' ' ' PHE . 73.5 m-20 -88.49 -29.67 19.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.876 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 663' ' ' PHE . . . . . 0.408 ' C ' ' O ' ' A' ' 662' ' ' ASP . 3.5 t80 -37.6 140.03 0.25 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 82.2 p -120.34 169.82 9.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.122 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 665' ' ' TRP . . . . . 0.644 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 6.7 p-90 -63.45 -52.16 62.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.96 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 666' ' ' LYS . . . . . 0.644 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 9.7 tppt? -44.63 -51.57 8.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.877 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 24.3 mtm -61.74 -47.17 86.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.866 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 668' ' ' LEU . . . . . 0.443 HD22 HD13 ' A' ' 683' ' ' ILE . 35.6 tp -47.85 -47.55 31.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.91 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.448 ' HG2' ' N ' ' A' ' 670' ' ' ASP . 0.3 OUTLIER -64.76 -73.69 0.12 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 179.789 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 670' ' ' ASP . . . . . 0.448 ' N ' ' HG2' ' A' ' 669' ' ' LYS . 4.5 m-20 -45.2 -24.22 0.24 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.903 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 671' ' ' LYS . . . . . 0.479 ' HG3' ' CE ' ' A' ' 711' ' ' MET . 7.8 tppt? -69.88 -51.3 34.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.897 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 672' ' ' PHE . . . . . 0.587 ' CE2' HD11 ' A' ' 654' ' ' ILE . 27.7 m-85 -78.43 -11.15 59.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.878 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -55.9 -39.38 71.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.881 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -47.4 -36.02 9.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.895 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 64.8 m -74.66 -56.5 4.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.826 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -160.41 -175.95 31.97 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.474 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -68.43 109.44 3.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.832 0.348 . . . . 0.0 110.831 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 53.2 t -88.57 128.7 40.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.139 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 679' ' ' LEU . . . . . 0.535 HD11 ' HG2' ' A' ' 699' ' ' GLU . 11.4 mt -100.5 -64.42 1.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -97.94 130.34 44.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.879 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -153.9 125.96 7.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.104 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -163.61 157.94 20.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.894 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 683' ' ' ILE . . . . . 0.443 HD13 HD22 ' A' ' 668' ' ' LEU . 25.2 mm -93.87 101.72 12.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.126 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 16.2 mmmt -60.77 129.73 42.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.901 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 685' ' ' MET . . . . . . . . . . . . . 14.1 mtp -128.36 176.19 7.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.864 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -130.21 114.83 16.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 687' ' ' ASN . . . . . . . . . . . . . 18.7 t30 50.07 35.19 9.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.881 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 688' ' ' GLY . . . . . . . . . . . . . . . 79.36 34.9 31.13 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.462 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 21.0 mtmm -134.71 118.21 16.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.75 0.31 . . . . 0.0 110.905 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 690' ' ' SER . . . . . . . . . . . . . 7.3 p -51.09 124.89 12.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.901 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 691' ' ' LYS . . . . . 0.418 ' O ' ' N ' ' A' ' 693' ' ' CYS . 33.3 mmtt -112.05 26.15 10.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.932 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 692' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' A' ' 658' ' ' ASN . . . 37.71 31.28 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.512 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 693' ' ' CYS . . . . . 0.418 ' N ' ' O ' ' A' ' 691' ' ' LYS . 26.0 p -132.92 125.43 29.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.896 0.379 . . . . 0.0 110.88 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -130.01 172.91 20.02 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.475 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 8.7 m -129.35 150.98 35.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.857 0.36 . . . . 0.0 111.13 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 696' ' ' VAL . . . . . 0.485 HG21 ' CD1' ' A' ' 672' ' ' PHE . 62.9 t -140.77 122.31 14.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.079 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 13.6 tttt -106.78 134.22 50.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.948 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 698' ' ' PHE . . . . . 0.506 ' CD2' HG11 ' A' ' 703' ' ' VAL . 94.0 m-85 -109.81 171.39 7.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.893 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 699' ' ' GLU . . . . . 0.535 ' HG2' HD11 ' A' ' 679' ' ' LEU . 10.2 mm-40 -75.75 -45.19 37.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.921 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 57.7 m -109.83 145.62 32.4 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.673 0.749 . . . . 0.0 110.871 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 701' ' ' PRO . . . . . 0.461 ' N ' ' SG ' ' A' ' 652' ' ' CYS . 53.7 Cg_endo -69.8 -10.89 29.63 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.629 2.22 . . . . 0.0 112.343 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 702' ' ' GLU . . . . . 0.4 ' OE1' ' C ' ' A' ' 702' ' ' GLU . 1.4 pp20? -82.9 -31.02 28.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.866 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 703' ' ' VAL . . . . . 0.506 HG11 ' CD2' ' A' ' 698' ' ' PHE . 66.5 t -67.72 -57.4 9.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.121 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -44.23 -58.54 2.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.091 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.498 ' HA ' HD11 ' A' ' 725' ' ' ILE . 19.0 mt-10 -44.31 -36.32 2.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.896 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -76.91 -64.77 1.05 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.823 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -39.61 -34.95 0.27 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.105 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 708' ' ' CYS . . . . . 0.446 ' HA ' ' CG1' ' A' ' 723' ' ' VAL . 56.8 m -52.82 -56.69 13.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.945 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -71.14 -39.75 71.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.92 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 18.6 mtm -64.4 -13.1 49.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 711' ' ' MET . . . . . 0.545 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 6.3 mmm -119.21 -16.68 9.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.887 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 712' ' ' ASN . . . . . 0.491 ' ND2' ' O ' ' A' ' 712' ' ' ASN . 0.1 OUTLIER -55.97 122.24 11.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.868 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 76.75 13.53 83.47 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.46 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 714' ' ' MET . . . . . . . . . . . . . 43.4 ttp -61.34 97.15 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.845 0.355 . . . . 0.0 110.823 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 15.4 mmtt -54.08 101.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.887 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 716' ' ' LEU . . . . . 0.946 HD12 HG21 ' A' ' 721' ' ' ILE . 46.0 mt -99.91 123.81 44.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.908 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 717' ' ' SER . . . . . . . . . . . . . 2.0 t 37.64 41.34 0.3 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.838 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 77.05 34.1 43.07 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.487 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 719' ' ' ARG . . . . . 0.48 ' N ' ' O ' ' A' ' 716' ' ' LEU . 9.6 mtt-85 -146.93 111.51 5.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.716 0.293 . . . . 0.0 110.862 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -68.83 125.6 27.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.888 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 721' ' ' ILE . . . . . 0.946 HG21 HD12 ' A' ' 716' ' ' LEU . 22.7 pt -100.0 160.36 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.138 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -115.2 109.43 17.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.832 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 723' ' ' VAL . . . . . 0.446 ' CG1' ' HA ' ' A' ' 708' ' ' CYS . 5.4 t -108.72 129.28 63.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.134 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 36.1 mtp180 -157.56 158.73 36.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.827 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 725' ' ' ILE . . . . . 0.711 HD12 ' HB1' ' A' ' 651' ' ' ALA . 31.6 mm -51.43 136.32 11.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.134 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -81.23 91.63 6.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 727' ' ' ARG . . . . . . . . . . . . . 7.2 tpt180 -55.33 -55.41 31.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 728' ' ' ASN . . . . . . . . . . . . . 59.5 m-20 -98.2 90.29 4.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.862 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 729' ' ' ALA . . . . . . . . . . . . . . . -116.4 -56.15 2.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.1 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 1.4 t -73.58 -52.38 13.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 731' ' ' GLY . . . . . . . . . . . . . . . -167.01 -172.11 33.87 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.517 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 732' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 733' ' ' SER . 53.7 Cg_endo -69.81 -5.94 17.43 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.683 2.255 . . . . 0.0 112.355 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 733' ' ' SER . . . . . 0.434 ' C ' ' O ' ' A' ' 732' ' ' PRO . 7.6 m -35.38 110.72 0.11 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.891 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 734' ' ' SER . . . . . . . . . . . . . 12.0 t -58.86 -44.81 91.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.866 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 735' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.504 -179.986 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 112.524 -0.231 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 645' ' ' SER . . . . . . . . . . . . . 23.3 t -42.92 -50.09 5.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.885 0.374 . . . . 0.0 110.844 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 646' ' ' SER . . . . . . . . . . . . . 2.3 p -92.8 -16.43 25.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.855 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . 50.01 -126.61 22.74 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.52 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 12.0 t -91.08 137.71 32.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.874 0.368 . . . . 0.0 110.884 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 96.3 p -135.54 130.92 35.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.814 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 57.11 41.08 92.45 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.526 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 651' ' ' ALA . . . . . 0.645 ' O ' ' HB3' ' A' ' 704' ' ' ALA . . . -70.09 100.45 1.64 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.79 0.329 . . . . 0.0 111.075 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 24.8 p -109.45 -33.64 6.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.849 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -92.12 150.72 20.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.945 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 654' ' ' ILE . . . . . 0.581 HG22 HD13 ' A' ' 725' ' ' ILE . 30.0 pt -137.26 167.07 23.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.169 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -120.7 159.47 25.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.865 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.436 HG12 ' N ' ' A' ' 657' ' ' ARG . 16.7 t -145.64 156.77 12.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.174 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 657' ' ' ARG . . . . . 0.436 ' N ' HG12 ' A' ' 656' ' ' VAL . 57.4 mtt180 -153.49 162.79 40.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.898 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 658' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 69.03 36.83 2.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.895 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.521 HD22 ' CD2' ' A' ' 663' ' ' PHE . 37.6 mt -86.74 143.34 35.5 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.669 0.747 . . . . 0.0 110.935 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 660' ' ' PRO . . . . . 0.47 ' O ' ' N ' ' A' ' 663' ' ' PHE . 64.8 Cg_exo -47.88 126.5 13.03 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.655 2.237 . . . . 0.0 112.375 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -42.42 -33.66 0.7 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.858 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 662' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 663' ' ' PHE . 44.1 m-20 -81.12 -32.59 33.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.912 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 663' ' ' PHE . . . . . 0.521 ' CD2' HD22 ' A' ' 659' ' ' LEU . 4.3 t80 -35.74 124.92 0.7 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.901 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 68.5 p -108.44 174.84 5.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.145 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 665' ' ' TRP . . . . . 0.646 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 8.0 p-90 -65.93 -51.97 53.97 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.896 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 666' ' ' LYS . . . . . 0.646 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 2.3 tppp? -44.57 -54.35 6.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.882 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 20.1 mtm -57.86 -49.45 76.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.9 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 56.6 tp -46.8 -44.56 19.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.887 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 29.7 tttm -65.47 -74.92 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.85 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -46.36 -22.93 0.3 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.864 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 671' ' ' LYS . . . . . 0.468 ' HG3' ' CE ' ' A' ' 711' ' ' MET . 9.3 tppt? -70.88 -41.83 70.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.898 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 672' ' ' PHE . . . . . 0.56 ' CE2' ' CD1' ' A' ' 654' ' ' ILE . 18.5 m-85 -88.58 -11.65 44.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.892 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -54.28 -34.31 60.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.846 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -46.3 -44.91 17.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.899 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 12.9 t -64.47 -55.63 19.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.867 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -159.53 -157.16 8.42 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.476 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -86.5 110.42 19.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.889 0.376 . . . . 0.0 110.862 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 76.3 t -85.87 138.4 19.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.111 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 679' ' ' LEU . . . . . 0.591 HD11 ' HG2' ' A' ' 699' ' ' GLU . 25.4 mt -112.68 -62.47 1.58 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.908 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -96.68 131.87 42.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.94 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -155.84 125.17 6.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.102 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -158.13 160.82 37.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.875 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 23.2 mm -109.05 108.16 24.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.151 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -57.77 136.44 56.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.914 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 685' ' ' MET . . . . . . . . . . . . . 39.7 mtp -135.13 168.73 18.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.89 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -132.11 110.45 10.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.893 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 687' ' ' ASN . . . . . . . . . . . . . 36.8 m-20 45.64 43.97 9.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.87 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 688' ' ' GLY . . . . . . . . . . . . . . . 76.71 32.39 50.5 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.484 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 36.2 mtpt -130.46 118.64 21.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.845 0.355 . . . . 0.0 110.886 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 690' ' ' SER . . . . . . . . . . . . . 2.8 m -58.91 134.13 56.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.828 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -115.44 18.7 15.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.925 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 40.42 33.82 0.59 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.514 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 28.4 p -140.02 133.73 30.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.888 0.375 . . . . 0.0 110.908 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 694' ' ' GLY . . . . . 0.402 ' O ' HG13 ' A' ' 695' ' ' VAL . . . -141.81 -154.4 6.17 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.496 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 695' ' ' VAL . . . . . 0.402 HG13 ' O ' ' A' ' 694' ' ' GLY . 14.3 m -155.75 155.84 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.818 0.342 . . . . 0.0 111.123 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 48.7 t -143.7 125.76 11.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.164 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 13.8 ttpt -109.79 137.6 47.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -111.6 169.77 8.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.925 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 699' ' ' GLU . . . . . 0.591 ' HG2' HD11 ' A' ' 679' ' ' LEU . 15.7 mt-10 -74.89 -42.06 58.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.892 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 39.7 m -109.94 151.09 42.21 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.684 0.754 . . . . 0.0 110.864 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -39.26 6.74 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.696 2.264 . . . . 0.0 112.349 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -54.71 -47.82 73.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.899 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 93.0 t -49.26 -59.08 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.089 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 704' ' ' ALA . . . . . 0.645 ' HB3' ' O ' ' A' ' 651' ' ' ALA . . . -41.47 -67.46 0.25 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.066 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 704' ' ' ALA . 9.7 mt-10 -36.77 -42.61 0.39 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.91 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 706' ' ' ARG . . . . . 0.425 ' O ' ' C ' ' A' ' 707' ' ' ALA . 15.9 ttm180 -69.25 -64.21 0.92 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.848 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 707' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 706' ' ' ARG . . . -35.78 -47.87 0.52 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.087 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 708' ' ' CYS . . . . . 0.468 ' O ' ' N ' ' A' ' 712' ' ' ASN . 1.2 t -43.96 -60.62 1.76 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.924 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 11.9 mtt180 -69.15 -38.0 78.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.908 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 49.4 mtp -64.04 -16.04 60.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.905 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 711' ' ' MET . . . . . 0.468 ' CE ' ' HG3' ' A' ' 671' ' ' LYS . 4.1 mmt -123.54 -8.83 7.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.85 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 712' ' ' ASN . . . . . 0.468 ' N ' ' O ' ' A' ' 708' ' ' CYS . 27.7 t30 -64.58 118.36 8.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.911 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 78.89 30.06 49.11 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.493 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 714' ' ' MET . . . . . . . . . . . . . 34.2 ttp -80.22 110.46 15.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.851 0.357 . . . . 0.0 110.899 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 18.9 mmtt -67.19 102.27 1.02 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.881 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 716' ' ' LEU . . . . . 0.945 HD12 HG21 ' A' ' 721' ' ' ILE . 26.7 mt -99.93 123.08 43.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.939 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 717' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 716' ' ' LEU . 8.7 t 36.66 38.73 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.87 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 80.96 34.18 27.75 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.471 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 719' ' ' ARG . . . . . 0.501 ' N ' ' O ' ' A' ' 716' ' ' LEU . 8.1 mtt-85 -147.27 110.95 4.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.795 0.331 . . . . 0.0 110.887 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -71.33 126.54 29.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.876 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 721' ' ' ILE . . . . . 0.945 HG21 HD12 ' A' ' 716' ' ' LEU . 32.9 pt -97.75 158.82 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.089 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -113.92 99.23 7.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.872 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 723' ' ' VAL . . . . . 0.45 HG21 ' HB3' ' A' ' 711' ' ' MET . 10.6 t -99.07 128.91 50.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.127 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 81.3 mtm180 -148.23 173.65 12.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 725' ' ' ILE . . . . . 0.581 HD13 HG22 ' A' ' 654' ' ' ILE . 31.5 mm -81.05 134.37 27.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.128 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -85.34 103.5 14.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.894 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 727' ' ' ARG . . . . . 0.431 ' O ' ' C ' ' A' ' 728' ' ' ASN . 0.9 OUTLIER -62.67 -50.3 71.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.888 -179.878 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 728' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 727' ' ' ARG . 32.0 t30 -35.92 -44.93 0.38 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.889 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 729' ' ' ALA . . . . . . . . . . . . . . . -39.93 -61.47 0.85 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.078 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 39.2 p -137.8 129.92 28.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.863 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 731' ' ' GLY . . . . . . . . . . . . . . . -176.02 83.66 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.484 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 732' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 132.91 24.37 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.701 2.267 . . . . 0.0 112.34 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 733' ' ' SER . . . . . . . . . . . . . 92.5 p -96.2 167.07 11.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.868 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 734' ' ' SER . . . . . . . . . . . . . 21.3 m -139.62 167.31 22.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.817 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 735' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.512 -179.986 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 645' ' ' SER . . . . . . . . . . . . . 50.8 p -90.46 149.71 22.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.849 0.357 . . . . 0.0 110.834 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 646' ' ' SER . . . . . . . . . . . . . 71.3 m -138.04 172.81 12.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.871 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -146.38 41.76 0.98 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.477 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 3.9 m -93.16 106.1 18.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.862 0.363 . . . . 0.0 110.883 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 6.2 t -134.03 130.4 37.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.845 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 107.32 56.09 0.62 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.528 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 651' ' ' ALA . . . . . 0.637 ' HB1' HD12 ' A' ' 725' ' ' ILE . . . -87.15 91.7 8.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.77 0.319 . . . . 0.0 111.135 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 25.8 p -107.14 -28.51 9.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.87 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 653' ' ' GLN . . . . . 0.466 ' NE2' ' HB ' ' A' ' 695' ' ' VAL . 10.3 tp60 -89.92 146.32 24.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.876 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 654' ' ' ILE . . . . . 0.485 HD12 ' CG1' ' A' ' 723' ' ' VAL . 23.6 pt -138.04 178.07 4.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.106 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -134.27 153.02 52.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.897 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 20.5 t -135.77 153.43 32.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.138 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -147.67 157.41 43.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.846 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 658' ' ' ASN . . . . . 0.668 ' O ' HG22 ' A' ' 721' ' ' ILE . 1.9 t-20 68.63 52.11 0.59 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.556 HD22 ' CE2' ' A' ' 663' ' ' PHE . 39.8 mt -100.2 143.45 26.54 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.594 0.712 . . . . 0.0 110.924 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -47.96 132.97 22.89 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.672 2.248 . . . . 0.0 112.377 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -44.26 -45.66 8.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.884 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 662' ' ' ASP . . . . . 0.479 ' O ' HG23 ' A' ' 664' ' ' THR . 22.8 t0 -68.16 -34.32 76.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.839 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 663' ' ' PHE . . . . . 0.556 ' CE2' HD22 ' A' ' 659' ' ' LEU . 4.2 t80 -36.84 116.59 0.45 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.925 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 664' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 662' ' ' ASP . 59.1 p -107.73 -177.89 3.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.115 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 665' ' ' TRP . . . . . 0.616 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 5.5 p-90 -64.73 -48.65 73.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.866 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 666' ' ' LYS . . . . . 0.616 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 13.8 tptm -48.84 -59.24 3.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.912 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 667' ' ' MET . . . . . 0.492 ' O ' ' CB ' ' A' ' 671' ' ' LYS . 28.6 mtm -53.69 -48.79 69.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 668' ' ' LEU . . . . . 0.427 HD11 ' CG2' ' A' ' 696' ' ' VAL . 15.3 tp -48.56 -46.67 39.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.908 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -65.49 -73.12 0.13 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.914 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -48.59 -23.9 1.15 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.88 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 671' ' ' LYS . . . . . 0.492 ' CB ' ' O ' ' A' ' 667' ' ' MET . 0.3 OUTLIER -69.98 -42.49 73.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.897 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 672' ' ' PHE . . . . . 0.582 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 15.6 m-85 -86.9 -16.09 37.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.854 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -49.52 -38.62 31.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.905 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -39.45 -44.35 1.36 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.898 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 5.9 t -67.48 -64.09 0.93 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.881 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -148.82 -158.86 8.23 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.516 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 677' ' ' HIS . . . . . 0.449 ' C ' ' CD2' ' A' ' 677' ' ' HIS . 3.4 t60 -86.88 107.52 18.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.871 0.367 . . . . 0.0 110.878 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 60.0 t -81.11 143.2 12.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.109 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 679' ' ' LEU . . . . . 0.597 HD11 ' HG2' ' A' ' 699' ' ' GLU . 23.6 mt -116.14 -62.77 1.54 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.872 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -99.91 128.98 45.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.909 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -155.89 123.75 5.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.08 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -152.5 155.85 38.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.875 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 18.1 mm -104.87 107.3 22.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.114 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -54.51 136.26 44.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 685' ' ' MET . . . . . . . . . . . . . 17.9 mtp -135.07 150.87 50.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.88 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -126.04 95.14 4.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.858 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 687' ' ' ASN . . . . . . . . . . . . . 22.8 m120 65.03 40.21 5.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.83 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 688' ' ' GLY . . . . . . . . . . . . . . . 72.86 31.86 61.74 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.51 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 689' ' ' LYS . . . . . 0.428 ' O ' ' C ' ' A' ' 690' ' ' SER . 1.0 OUTLIER -134.19 85.95 2.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.792 0.33 . . . . 0.0 110.859 -179.926 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 690' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 689' ' ' LYS . 4.9 t -35.26 137.56 0.16 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.819 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 19.3 mmmt -108.1 18.21 21.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.881 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 692' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 658' ' ' ASN . . . 48.62 25.95 5.02 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.478 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 19.1 p -135.16 131.17 36.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.884 0.373 . . . . 0.0 110.847 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -143.52 -164.97 10.56 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.483 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 695' ' ' VAL . . . . . 0.466 ' HB ' ' NE2' ' A' ' 653' ' ' GLN . 17.1 m -140.08 160.1 26.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.922 0.391 . . . . 0.0 111.126 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 696' ' ' VAL . . . . . 0.438 HG21 ' CD1' ' A' ' 672' ' ' PHE . 70.7 t -146.52 115.01 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.099 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 37.0 tttt -96.69 138.37 34.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -116.69 164.38 14.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.906 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 699' ' ' GLU . . . . . 0.597 ' HG2' HD11 ' A' ' 679' ' ' LEU . 48.9 mt-10 -71.11 -41.87 69.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.892 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 3.2 m -113.81 149.51 41.91 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.671 0.748 . . . . 0.0 110.887 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -33.53 16.37 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.638 2.225 . . . . 0.0 112.349 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 702' ' ' GLU . . . . . 0.449 ' HG3' ' N ' ' A' ' 703' ' ' VAL . 9.2 pt-20 -61.86 -42.36 98.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.893 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 703' ' ' VAL . . . . . 0.449 ' N ' ' HG3' ' A' ' 702' ' ' GLU . 84.2 t -55.31 -60.51 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.126 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 704' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 651' ' ' ALA . . . -39.04 -61.43 0.75 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.097 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.44 ' HG2' HD11 ' A' ' 725' ' ' ILE . 12.7 mt-10 -44.29 -41.03 5.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.92 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 15.7 ttt180 -67.05 -59.26 3.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.875 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -46.3 -44.0 16.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.056 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 708' ' ' CYS . . . . . 0.495 ' O ' ' CB ' ' A' ' 712' ' ' ASN . 1.8 m -50.74 -41.16 56.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.873 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 3.2 mtt-85 -82.47 -37.66 25.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.868 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 8.7 mtm -72.34 -9.44 58.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.869 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 711' ' ' MET . . . . . 0.582 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 5.5 mmm -120.5 -35.57 3.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.87 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 712' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 708' ' ' CYS . 0.5 OUTLIER -40.87 112.02 0.26 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.862 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 84.79 19.54 59.53 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.51 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 714' ' ' MET . . . . . 0.457 ' N ' ' O ' ' A' ' 711' ' ' MET . 57.2 ttp -69.28 94.07 0.68 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.847 0.356 . . . . 0.0 110.868 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 8.6 mmtp -51.13 98.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.899 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 716' ' ' LEU . . . . . 1.027 HD12 HG21 ' A' ' 721' ' ' ILE . 38.1 mt -99.94 129.92 46.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.951 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 717' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 716' ' ' LEU . 27.8 t 36.51 38.93 0.08 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.885 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 76.76 36.76 36.1 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.479 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 719' ' ' ARG . . . . . 0.498 ' N ' ' O ' ' A' ' 716' ' ' LEU . 21.7 mtt180 -147.22 116.04 6.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.748 0.308 . . . . 0.0 110.848 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -71.41 122.89 21.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.865 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 721' ' ' ILE . . . . . 1.027 HG21 HD12 ' A' ' 716' ' ' LEU . 19.4 pt -98.99 156.89 3.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.133 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 722' ' ' ASP . . . . . 0.446 ' OD1' ' C ' ' A' ' 722' ' ' ASP . 2.9 t0 -116.01 108.23 15.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.837 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 723' ' ' VAL . . . . . 0.485 ' CG1' HD12 ' A' ' 654' ' ' ILE . 17.3 t -107.32 136.02 43.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.177 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 724' ' ' ARG . . . . . 0.45 ' C ' ' SG ' ' A' ' 708' ' ' CYS . 13.5 ptt85 -158.13 165.97 33.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.872 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 725' ' ' ILE . . . . . 0.637 HD12 ' HB1' ' A' ' 651' ' ' ALA . 27.0 mm -62.18 138.0 23.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.126 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 726' ' ' ASP . . . . . 0.406 ' HB2' ' CA ' ' A' ' 654' ' ' ILE . 35.7 t0 -88.03 86.49 7.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.87 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 727' ' ' ARG . . . . . . . . . . . . . 27.2 mmt85 -60.15 -65.66 0.65 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.892 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 728' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -75.5 89.02 2.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.852 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 729' ' ' ALA . . . . . . . . . . . . . . . -140.31 109.18 6.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.088 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 15.2 t -122.16 -67.9 0.93 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 731' ' ' GLY . . . . . . . . . . . . . . . 128.97 174.92 13.86 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.501 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 732' ' ' PRO . . . . . 0.447 ' O ' ' C ' ' A' ' 733' ' ' SER . 53.6 Cg_endo -69.72 0.28 5.84 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.657 2.238 . . . . 0.0 112.357 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 733' ' ' SER . . . . . 0.447 ' C ' ' O ' ' A' ' 732' ' ' PRO . 34.3 m -34.59 98.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.864 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 734' ' ' SER . . . . . . . . . . . . . 14.0 t -89.99 -39.87 12.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.886 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 735' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.48 -179.986 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 645' ' ' SER . . . . . . . . . . . . . 51.2 p -122.64 175.74 6.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.861 0.362 . . . . 0.0 110.867 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 646' ' ' SER . . . . . . . . . . . . . 23.9 t -52.31 98.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.821 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . 86.32 151.72 18.97 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.457 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 73.4 m -94.35 -52.88 4.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.855 0.359 . . . . 0.0 110.829 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 14.1 m -76.99 168.91 19.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.872 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 176.3 43.27 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.459 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 651' ' ' ALA . . . . . 0.553 ' O ' ' HB3' ' A' ' 704' ' ' ALA . . . -89.98 96.79 10.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.756 0.312 . . . . 0.0 111.09 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 24.5 p -104.08 -30.91 9.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.847 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -94.51 152.06 18.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.91 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 654' ' ' ILE . . . . . 0.479 HD11 ' CE2' ' A' ' 672' ' ' PHE . 27.6 pt -136.01 174.54 12.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.113 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -127.76 157.04 41.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.901 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 3.1 t -140.72 151.07 20.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.114 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 4.1 mtp-105 -148.23 156.16 42.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.902 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 658' ' ' ASN . . . . . 0.436 ' O ' HG22 ' A' ' 721' ' ' ILE . 3.5 t-20 69.61 45.71 0.77 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.895 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.546 HD22 ' CD2' ' A' ' 663' ' ' PHE . 24.0 mt -94.51 143.71 26.73 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.653 0.74 . . . . 0.0 110.902 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -48.03 136.02 23.75 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.617 2.211 . . . . 0.0 112.383 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -52.34 -33.91 45.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.886 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.16 -30.12 43.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.915 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 663' ' ' PHE . . . . . 0.546 ' CD2' HD22 ' A' ' 659' ' ' LEU . 4.1 t80 -39.13 124.96 1.54 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.91 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 77.2 p -110.0 176.6 5.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.21 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 665' ' ' TRP . . . . . 0.644 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 3.5 p-90 -68.26 -50.05 56.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.959 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 666' ' ' LYS . . . . . 0.644 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 13.1 tptp -52.04 -47.48 65.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.943 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 21.2 mtm -64.78 -39.55 93.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.864 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 38.9 tp -56.43 -46.48 80.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.949 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.22 -61.07 2.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -54.59 -27.74 41.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 671' ' ' LYS . . . . . 0.431 ' O ' ' HE2' ' A' ' 711' ' ' MET . 11.0 tptt -66.56 -39.48 88.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 672' ' ' PHE . . . . . 0.479 ' CE2' HD11 ' A' ' 654' ' ' ILE . 25.1 m-85 -90.86 -10.51 42.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.856 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -54.53 -32.73 58.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.863 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -58.58 -28.88 65.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 17.3 m -81.81 -53.46 6.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.86 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -161.72 -179.0 36.12 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.492 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -70.2 107.1 3.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.8 0.333 . . . . 0.0 110.855 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 58.8 t -84.68 137.53 20.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.143 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 679' ' ' LEU . . . . . 0.829 HD11 ' HG2' ' A' ' 699' ' ' GLU . 12.1 mt -116.43 -57.98 2.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 680' ' ' TYR . . . . . 0.411 ' HB3' ' CB ' ' A' ' 697' ' ' LYS . 8.3 t80 -99.41 126.11 45.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.925 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -155.6 123.8 5.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.138 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -154.02 158.17 40.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.84 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 27.2 mm -106.87 126.82 62.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.089 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 56.0 mmtt -72.89 137.87 45.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.89 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 685' ' ' MET . . . . . . . . . . . . . 31.7 mtp -139.38 156.21 47.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.872 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 49.6 tt0 -133.31 120.33 20.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.936 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 687' ' ' ASN . . . . . . . . . . . . . 15.9 m120 50.63 38.49 19.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.898 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 688' ' ' GLY . . . . . . . . . . . . . . . 70.05 35.63 71.63 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.473 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt -137.35 111.67 8.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.793 0.33 . . . . 0.0 110.888 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 690' ' ' SER . . . . . . . . . . . . . 3.0 m -41.09 154.16 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.886 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -118.86 -34.59 3.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.893 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 95.51 14.63 46.71 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.479 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 21.4 p -133.24 132.22 41.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.871 0.367 . . . . 0.0 110.851 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -139.11 -160.8 8.49 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.509 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 19.3 m -147.21 160.29 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.904 0.383 . . . . 0.0 111.11 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 97.1 t -148.0 113.54 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.137 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 697' ' ' LYS . . . . . 0.411 ' CB ' ' HB3' ' A' ' 680' ' ' TYR . 18.9 ttpt -96.24 143.63 27.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 698' ' ' PHE . . . . . 0.437 ' CD2' HG11 ' A' ' 703' ' ' VAL . 96.2 m-85 -119.66 168.66 10.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.834 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 699' ' ' GLU . . . . . 0.829 ' HG2' HD11 ' A' ' 679' ' ' LEU . 17.7 mt-10 -75.05 -34.44 61.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.918 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 700' ' ' SER . . . . . 0.416 ' CB ' ' OE2' ' A' ' 702' ' ' GLU . 1.4 m -125.34 152.86 71.89 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.696 0.76 . . . . 0.0 110.826 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -50.37 0.47 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.698 2.265 . . . . 0.0 112.36 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 702' ' ' GLU . . . . . 0.416 ' OE2' ' CB ' ' A' ' 700' ' ' SER . 25.6 pm0 -44.54 -27.48 0.47 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.863 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 703' ' ' VAL . . . . . 0.437 HG11 ' CD2' ' A' ' 698' ' ' PHE . 47.0 t -73.4 -54.5 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.095 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 704' ' ' ALA . . . . . 0.553 ' HB3' ' O ' ' A' ' 651' ' ' ALA . . . -48.61 -57.14 6.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.067 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.576 ' HA ' HD11 ' A' ' 725' ' ' ILE . 26.5 mt-10 -45.86 -38.07 6.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.858 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 9.4 ttm-85 -74.03 -58.15 3.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.897 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -47.99 -25.78 1.52 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.11 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 708' ' ' CYS . . . . . 0.5 ' HA ' HG12 ' A' ' 723' ' ' VAL . 1.5 t -60.47 -60.03 4.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.858 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -73.38 -36.97 66.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.812 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 12.1 mmm -59.42 -30.29 68.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.909 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 711' ' ' MET . . . . . 0.442 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 4.8 mmm -107.03 -15.9 14.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.88 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 712' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -53.91 121.83 8.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.923 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 77.14 12.82 84.27 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.524 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 714' ' ' MET . . . . . . . . . . . . . 55.8 ttp -59.64 104.31 0.27 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.849 0.356 . . . . 0.0 110.867 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 7.9 mmtm -61.98 100.22 0.15 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.898 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 716' ' ' LEU . . . . . 0.616 HD12 HG21 ' A' ' 721' ' ' ILE . 31.6 mt -99.89 126.86 46.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.958 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 717' ' ' SER . . . . . 0.409 ' C ' ' O ' ' A' ' 716' ' ' LEU . 1.6 t 36.7 39.7 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.887 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 77.18 36.18 35.89 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.484 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 719' ' ' ARG . . . . . 0.494 ' N ' ' O ' ' A' ' 716' ' ' LEU . 5.9 mtt-85 -148.68 114.54 5.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.804 0.335 . . . . 0.0 110.864 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -72.27 127.48 32.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 721' ' ' ILE . . . . . 0.616 HG21 HD12 ' A' ' 716' ' ' LEU . 28.5 pt -100.04 157.05 4.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.149 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -109.22 98.48 7.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.847 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 723' ' ' VAL . . . . . 0.5 HG12 ' HA ' ' A' ' 708' ' ' CYS . 17.9 t -97.61 130.13 46.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.121 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.19 175.22 13.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.923 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 725' ' ' ILE . . . . . 0.576 HD11 ' HA ' ' A' ' 705' ' ' GLU . 49.4 mm -80.31 133.37 29.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.114 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -84.01 118.92 24.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.861 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 727' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -83.44 -30.82 26.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.895 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 728' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -96.18 56.74 1.66 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.891 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 729' ' ' ALA . . . . . . . . . . . . . . . -99.95 -55.64 2.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.149 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 84.1 p -111.62 169.16 9.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.838 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 731' ' ' GLY . . . . . . . . . . . . . . . -106.18 144.24 15.81 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.49 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 732' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -173.05 0.64 Allowed 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.659 2.239 . . . . 0.0 112.37 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 733' ' ' SER . . . . . . . . . . . . . 16.0 m -136.58 105.35 5.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.894 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 734' ' ' SER . . . . . . . . . . . . . 5.0 t -169.83 114.66 0.52 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.843 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 735' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.455 179.966 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 645' ' ' SER . . . . . . . . . . . . . 43.4 m 54.83 43.36 30.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.908 0.385 . . . . 0.0 110.89 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 646' ' ' SER . . . . . . . . . . . . . 5.8 t -94.69 -58.85 2.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.835 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . 127.93 95.85 0.87 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.473 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 91.8 p -89.82 -49.63 6.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.896 0.379 . . . . 0.0 110.88 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 7.5 t -100.13 123.94 44.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.887 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . -71.99 119.76 7.6 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.462 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 651' ' ' ALA . . . . . 0.481 ' HB1' ' CG2' ' A' ' 725' ' ' ILE . . . -69.6 74.78 0.41 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.726 0.298 . . . . 0.0 111.082 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 29.7 p -97.14 47.2 1.04 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.879 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -163.94 149.44 10.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.913 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 654' ' ' ILE . . . . . 0.659 HG22 HD13 ' A' ' 725' ' ' ILE . 37.8 pt -140.66 173.29 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.14 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -130.5 144.69 51.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.871 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 27.6 t -126.99 139.25 52.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.081 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 36.7 mtp85 -133.73 155.76 49.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.86 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 658' ' ' ASN . . . . . 0.559 ' O ' HG22 ' A' ' 721' ' ' ILE . 2.1 t-20 70.66 52.12 0.32 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.92 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.659 HD22 ' CD2' ' A' ' 663' ' ' PHE . 36.7 mt -100.04 145.11 29.64 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.643 0.735 . . . . 0.0 110.875 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -47.92 142.46 15.07 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.654 2.236 . . . . 0.0 112.395 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -60.53 -24.75 65.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.889 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -98.17 13.4 31.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.85 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 663' ' ' PHE . . . . . 0.659 ' CD2' HD22 ' A' ' 659' ' ' LEU . 3.4 t80 -80.14 118.48 21.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 69.4 p -105.45 168.99 8.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.079 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 665' ' ' TRP . . . . . 0.639 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 6.9 p-90 -57.23 -49.72 75.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.927 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 666' ' ' LYS . . . . . 0.639 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 5.3 tptm -46.27 -54.35 9.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.886 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 16.6 mtm -59.72 -55.62 32.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.84 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 14.7 tp -42.97 -46.91 5.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.902 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 46.1 tttt -62.49 -71.45 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -46.28 -24.11 0.43 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.878 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 8.8 tptp -68.79 -51.49 40.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.927 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 672' ' ' PHE . . . . . 0.56 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 23.1 m-85 -78.53 -15.24 58.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.892 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -49.92 -34.58 20.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.923 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -53.66 -39.76 65.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.881 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 31.9 m -71.42 -47.54 55.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -165.69 -177.33 37.86 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.479 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -73.21 96.45 2.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.843 0.354 . . . . 0.0 110.862 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 78.9 t -73.26 138.3 21.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.143 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 679' ' ' LEU . . . . . 0.474 HD11 ' HG2' ' A' ' 699' ' ' GLU . 12.9 mt -113.21 -61.52 1.73 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.931 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 680' ' ' TYR . . . . . 0.433 ' HB3' ' CB ' ' A' ' 697' ' ' LYS . 4.5 t80 -95.71 129.11 43.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.93 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -156.91 125.2 5.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.075 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -156.0 161.72 40.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.84 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 42.9 mm -109.25 107.27 22.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.129 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 27.8 mmtm -60.82 132.44 53.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.882 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 685' ' ' MET . . . . . . . . . . . . . 32.6 mtp -133.62 146.54 51.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.897 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -107.66 113.74 27.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.88 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 687' ' ' ASN . . . . . . . . . . . . . 3.4 m120 50.53 41.98 26.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.875 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 688' ' ' GLY . . . . . . . . . . . . . . . 76.9 38.19 31.5 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.527 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 39.7 mtpt -135.81 130.18 33.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.785 0.326 . . . . 0.0 110.897 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 690' ' ' SER . . . . . . . . . . . . . 3.1 m -70.02 131.46 44.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.836 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 691' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 693' ' ' CYS . 29.0 mmtt -113.4 24.38 12.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.867 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 692' ' ' GLY . . . . . 0.413 ' C ' ' HB2' ' A' ' 659' ' ' LEU . . . 38.14 27.84 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.493 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 693' ' ' CYS . . . . . 0.461 ' N ' ' O ' ' A' ' 691' ' ' LYS . 31.2 p -132.46 129.13 38.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.843 0.354 . . . . 0.0 110.89 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -141.79 -163.47 9.62 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.487 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 13.4 m -142.93 153.1 17.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.857 0.36 . . . . 0.0 111.086 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 696' ' ' VAL . . . . . 0.501 HG21 ' CD1' ' A' ' 672' ' ' PHE . 93.4 t -139.34 118.04 12.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.136 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 697' ' ' LYS . . . . . 0.433 ' CB ' ' HB3' ' A' ' 680' ' ' TYR . 27.0 tttt -101.43 148.04 25.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.906 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -123.31 173.99 7.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 699' ' ' GLU . . . . . 0.474 ' HG2' HD11 ' A' ' 679' ' ' LEU . 4.6 mt-10 -82.47 -44.13 16.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.918 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 1.1 t -103.41 143.01 25.77 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.692 0.758 . . . . 0.0 110.863 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -20.71 34.73 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.682 2.254 . . . . 0.0 112.343 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -75.56 -41.68 54.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.853 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 66.0 t -56.02 -55.71 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.108 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -46.75 -43.91 18.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.092 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.548 ' HA ' HD11 ' A' ' 725' ' ' ILE . 13.3 mt-10 -60.03 -34.07 72.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.845 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 26.9 ttm180 -79.95 -57.83 3.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.89 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -45.4 -33.13 2.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.059 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 708' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -53.17 -52.67 58.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.887 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.73 -40.85 32.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 61.1 mtp -56.86 -17.64 10.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 711' ' ' MET . . . . . 0.56 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 4.9 mmm -117.59 -24.81 7.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.856 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 712' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -48.55 114.06 0.89 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.926 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 82.58 31.88 29.05 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.532 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 714' ' ' MET . . . . . . . . . . . . . 63.0 ttp -82.75 105.86 14.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.84 0.352 . . . . 0.0 110.915 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 7.0 mmtp -60.66 100.42 0.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.889 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 716' ' ' LEU . . . . . 0.922 HD12 HG21 ' A' ' 721' ' ' ILE . 31.2 mt -99.89 125.56 45.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.945 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 717' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 716' ' ' LEU . 48.3 t 36.93 38.62 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.854 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 718' ' ' GLY . . . . . 0.406 ' C ' ' HG3' ' A' ' 719' ' ' ARG . . . 79.39 34.78 31.37 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.517 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 719' ' ' ARG . . . . . 0.498 ' N ' ' O ' ' A' ' 716' ' ' LEU . 37.3 mtp85 -146.65 112.76 5.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.748 0.308 . . . . 0.0 110.891 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -70.74 123.6 22.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.854 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 721' ' ' ILE . . . . . 0.922 HG21 HD12 ' A' ' 716' ' ' LEU . 31.7 pt -99.95 156.23 4.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.16 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -114.46 105.04 12.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.875 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 723' ' ' VAL . . . . . 0.429 HG21 ' CB ' ' A' ' 711' ' ' MET . 21.9 t -100.79 132.42 46.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.09 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -154.66 161.43 41.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.878 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 725' ' ' ILE . . . . . 0.659 HD13 HG22 ' A' ' 654' ' ' ILE . 14.9 mm -72.53 134.64 29.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.134 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -84.98 82.39 8.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.884 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 727' ' ' ARG . . . . . . . . . . . . . 33.0 mtt180 -81.65 40.79 0.6 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.843 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 728' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -129.22 -37.76 1.64 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.87 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 729' ' ' ALA . . . . . . . . . . . . . . . -42.38 -47.54 4.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.141 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 34.5 t -53.26 108.05 0.29 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.835 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 731' ' ' GLY . . . . . . . . . . . . . . . 114.56 76.43 0.69 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.516 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 732' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -7.62 21.53 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.628 2.219 . . . . 0.0 112.344 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 733' ' ' SER . . . . . . . . . . . . . 20.7 t 64.23 37.42 8.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.891 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 734' ' ' SER . . . . . . . . . . . . . 28.6 t -137.93 125.94 22.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.879 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 735' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.479 -179.956 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 645' ' ' SER . . . . . . . . . . . . . 41.5 t -139.02 110.22 6.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.859 0.362 . . . . 0.0 110.84 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 646' ' ' SER . . . . . . . . . . . . . 35.5 p -109.64 -44.41 3.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.899 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -150.12 -149.19 4.95 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.519 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 2.2 t -99.9 91.24 4.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.874 0.368 . . . . 0.0 110.839 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 82.5 p -97.68 152.46 19.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.877 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . -175.69 127.88 1.32 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.453 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 651' ' ' ALA . . . . . 0.627 ' O ' ' HB3' ' A' ' 704' ' ' ALA . . . -73.81 110.71 8.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.76 0.314 . . . . 0.0 111.061 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 63.1 m -113.32 -36.86 4.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.917 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -94.05 151.42 19.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.911 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 654' ' ' ILE . . . . . 0.483 HD11 ' CE2' ' A' ' 672' ' ' PHE . 20.7 pt -138.69 174.04 10.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.162 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -126.56 156.43 40.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.888 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 3.4 t -142.05 149.68 19.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.152 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -144.81 154.64 42.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.874 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 658' ' ' ASN . . . . . 0.42 ' O ' HG22 ' A' ' 721' ' ' ILE . 1.8 t-20 73.56 44.88 0.28 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.868 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 659' ' ' LEU . . . . . . . . . . . . . 36.3 mt -96.71 144.45 27.86 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.66 0.743 . . . . 0.0 110.86 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -48.0 139.5 20.19 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.676 2.251 . . . . 0.0 112.364 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -62.11 -24.92 67.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.894 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -94.32 3.26 55.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.921 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -70.72 124.39 24.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.881 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 38.7 p -104.22 169.04 8.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.155 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 665' ' ' TRP . . . . . 0.642 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 7.6 p-90 -63.51 -52.15 62.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.947 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 666' ' ' LYS . . . . . 0.642 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 0.0 OUTLIER -47.06 -43.1 19.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.883 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 30.5 mtm -68.31 -50.86 50.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 14.2 tp -48.2 -47.26 35.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.866 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 44.2 tttt -59.54 -74.07 0.08 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.901 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -45.38 -28.23 0.82 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.845 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 671' ' ' LYS . . . . . 0.467 ' HE2' HD21 ' A' ' 716' ' ' LEU . 26.6 tptt -68.64 -39.65 80.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.855 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 672' ' ' PHE . . . . . 0.483 ' CE2' HD11 ' A' ' 654' ' ' ILE . 13.6 m-85 -88.37 -14.01 39.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.866 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -56.53 -35.85 68.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.877 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -42.22 -41.86 2.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.877 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 3.0 t -70.62 -59.78 2.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.852 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -148.81 -153.96 6.17 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.494 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -95.54 104.52 16.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.859 0.361 . . . . 0.0 110.86 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 57.9 t -82.7 136.06 23.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.128 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 679' ' ' LEU . . . . . 0.463 HD11 ' HG2' ' A' ' 699' ' ' GLU . 12.8 mt -109.97 -59.12 1.97 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.935 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -96.99 129.79 44.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.956 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -157.78 122.96 4.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.093 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -148.09 166.54 27.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.835 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 45.2 mm -114.47 106.86 21.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.115 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 36.5 mmtm -62.03 143.29 56.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.912 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 685' ' ' MET . . . . . . . . . . . . . 40.7 mtp -138.13 154.98 49.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.851 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -137.12 118.09 14.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 687' ' ' ASN . . . . . . . . . . . . . 21.4 t30 73.56 27.8 1.77 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.898 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 688' ' ' GLY . . . . . . . . . . . . . . . 78.84 17.17 77.78 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.526 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 17.7 pttt -138.42 131.46 29.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.771 0.319 . . . . 0.0 110.882 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 690' ' ' SER . . . . . . . . . . . . . 7.9 t -48.93 162.78 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.885 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 19.3 mmtt -129.8 17.29 5.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.925 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 55.76 23.7 38.12 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.488 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 27.5 p -131.95 127.34 36.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.866 0.365 . . . . 0.0 110.91 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -142.25 -169.16 12.02 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.489 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 27.5 m -139.07 166.97 21.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.891 0.377 . . . . 0.0 111.127 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 93.0 t -154.75 121.86 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.129 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 20.7 ttpt -105.97 143.08 34.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.911 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 698' ' ' PHE . . . . . 0.429 ' CD2' HG11 ' A' ' 703' ' ' VAL . 96.6 m-85 -118.4 169.24 9.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.878 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 699' ' ' GLU . . . . . 0.463 ' HG2' HD11 ' A' ' 679' ' ' LEU . 6.2 mm-40 -76.7 -45.3 30.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.869 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 31.4 m -104.49 147.37 34.28 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.667 0.746 . . . . 0.0 110.887 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -31.53 20.37 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.687 2.258 . . . . 0.0 112.343 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 702' ' ' GLU . . . . . 0.452 ' HG3' ' N ' ' A' ' 703' ' ' VAL . 11.2 pt-20 -61.47 -42.92 99.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.873 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 703' ' ' VAL . . . . . 0.452 ' N ' ' HG3' ' A' ' 702' ' ' GLU . 94.6 t -53.0 -59.36 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.168 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 704' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 651' ' ' ALA . . . -40.63 -65.74 0.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.084 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.55 ' HA ' HD11 ' A' ' 725' ' ' ILE . 9.8 mt-10 -41.07 -37.69 0.89 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.891 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -75.43 -64.47 1.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.845 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -40.17 -35.33 0.39 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.109 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 708' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -53.26 -56.19 18.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -77.36 -38.63 49.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.861 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 17.8 mmm -57.12 -23.15 45.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.903 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 711' ' ' MET . . . . . 0.403 ' O ' ' C ' ' A' ' 712' ' ' ASN . 4.7 mmm -111.74 -34.75 5.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 712' ' ' ASN . . . . . 0.436 ' OD1' ' C ' ' A' ' 712' ' ' ASN . 9.9 t-20 -38.03 112.71 0.23 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.894 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 84.21 27.96 35.2 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.493 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 714' ' ' MET . . . . . . . . . . . . . 37.2 ttp -77.67 99.04 5.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.861 0.363 . . . . 0.0 110.902 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 715' ' ' LYS . . . . . 0.416 ' HE3' ' CD ' ' A' ' 720' ' ' GLU . 11.8 mmtp -56.06 98.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.874 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 716' ' ' LEU . . . . . 0.665 HD12 HG21 ' A' ' 721' ' ' ILE . 31.5 mt -100.0 125.35 46.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.918 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 717' ' ' SER . . . . . . . . . . . . . 34.7 t 38.86 38.49 0.28 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.843 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 78.55 30.96 47.19 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.487 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 719' ' ' ARG . . . . . 0.499 ' N ' ' O ' ' A' ' 716' ' ' LEU . 45.5 mtt180 -141.13 114.55 8.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.84 0.353 . . . . 0.0 110.873 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 720' ' ' GLU . . . . . 0.416 ' CD ' ' HE3' ' A' ' 715' ' ' LYS . 5.3 mt-10 -73.34 126.1 29.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.878 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 721' ' ' ILE . . . . . 0.665 HG21 HD12 ' A' ' 716' ' ' LEU . 44.9 pt -100.0 162.77 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.118 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -119.07 101.38 7.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.878 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 10.0 t -100.83 132.12 47.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.122 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 50.7 mtp180 -155.99 163.55 39.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.874 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 725' ' ' ILE . . . . . 0.55 HD11 ' HA ' ' A' ' 705' ' ' GLU . 25.0 mm -64.8 135.77 27.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.148 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -91.79 74.6 5.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.893 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 727' ' ' ARG . . . . . . . . . . . . . 2.7 tpm_? -49.04 149.63 1.85 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.884 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 728' ' ' ASN . . . . . . . . . . . . . 33.7 t-20 63.95 44.04 4.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.93 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 729' ' ' ALA . . . . . . . . . . . . . . . -75.2 -59.65 2.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.093 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 11.5 t -99.05 -57.38 2.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.863 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 731' ' ' GLY . . . . . . . . . . . . . . . 151.57 167.79 15.32 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.478 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 732' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 136.31 32.86 Favored 'Trans proline' 0 N--CA 1.465 -0.153 0 C-N-CA 122.726 2.284 . . . . 0.0 112.363 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 733' ' ' SER . . . . . . . . . . . . . 82.6 p -78.39 130.03 35.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.843 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 734' ' ' SER . . . . . . . . . . . . . 15.5 t -88.22 -49.6 6.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.877 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 735' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.272 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.439 179.979 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 645' ' ' SER . . . . . . . . . . . . . 1.8 t -81.59 126.41 31.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.855 0.36 . . . . 0.0 110.887 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 646' ' ' SER . . . . . . . . . . . . . 26.1 m -142.35 163.88 31.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.836 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . 85.46 -60.48 4.71 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.506 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 28.7 p -86.34 92.68 8.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.858 0.361 . . . . 0.0 110.84 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 14.7 m -85.12 131.37 34.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.85 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 97.75 119.48 3.95 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.503 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 651' ' ' ALA . . . . . 0.747 ' O ' ' HB3' ' A' ' 704' ' ' ALA . . . -133.85 107.84 8.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.793 0.33 . . . . 0.0 111.111 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 64.4 m -108.14 -30.43 8.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.852 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -96.56 154.06 17.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.945 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 654' ' ' ILE . . . . . 0.505 HG22 HD13 ' A' ' 725' ' ' ILE . 28.7 pt -141.87 170.05 13.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.114 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -122.39 153.73 38.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.891 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 3.5 t -139.95 148.41 22.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.142 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 38.4 mtp180 -146.73 155.79 42.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.871 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 658' ' ' ASN . . . . . 0.607 ' O ' HG22 ' A' ' 721' ' ' ILE . 1.8 t-20 71.28 51.57 0.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.52 HD22 ' CD2' ' A' ' 663' ' ' PHE . 39.2 mt -101.35 143.48 26.67 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.623 0.725 . . . . 0.0 110.893 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 660' ' ' PRO . . . . . 0.477 ' O ' ' N ' ' A' ' 663' ' ' PHE . 66.6 Cg_exo -48.01 126.0 12.5 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.701 2.267 . . . . 0.0 112.336 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -40.79 -40.69 1.39 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.864 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 662' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 663' ' ' PHE . 22.8 t70 -73.16 -33.67 65.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.853 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 663' ' ' PHE . . . . . 0.52 ' CD2' HD22 ' A' ' 659' ' ' LEU . 4.1 t80 -36.31 119.91 0.63 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.895 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 74.4 p -104.88 -179.95 4.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.174 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 665' ' ' TRP . . . . . 0.62 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 6.5 p-90 -71.54 -50.23 33.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.894 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 666' ' ' LYS . . . . . 0.62 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 22.7 tptt -48.7 -43.72 37.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.872 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 667' ' ' MET . . . . . 0.401 ' CE ' ' HA ' ' A' ' 663' ' ' PHE . 27.4 mtm -66.09 -51.92 53.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.912 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 15.5 tp -46.21 -45.9 17.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.885 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 29.9 tttm -60.54 -73.99 0.08 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.885 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -47.07 -28.46 1.73 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.887 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 17.5 tptt -64.6 -41.24 96.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.888 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 672' ' ' PHE . . . . . 0.53 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 21.8 m-85 -88.89 -14.57 36.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.848 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -52.51 -40.19 62.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.897 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -44.6 -37.49 3.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.863 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 88.4 m -73.2 -58.51 3.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.883 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -152.95 -153.92 6.52 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.485 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 677' ' ' HIS . . . . . 0.554 ' CE1' HD23 ' A' ' 679' ' ' LEU . 29.2 t-80 -92.84 106.57 18.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.87 0.367 . . . . 0.0 110.829 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 678' ' ' VAL . . . . . 0.467 HG13 HG13 ' A' ' 696' ' ' VAL . 87.0 t -84.34 127.66 39.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.105 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 679' ' ' LEU . . . . . 0.574 HD11 ' HG2' ' A' ' 699' ' ' GLU . 12.0 mt -103.57 -60.16 1.61 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.937 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -99.27 129.06 45.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.921 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -157.65 121.41 4.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.092 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -153.23 156.77 39.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.871 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 37.9 mm -99.44 102.65 13.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.109 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -57.64 139.22 54.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.898 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 685' ' ' MET . . . . . . . . . . . . . 21.6 mtp -137.06 166.82 22.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.904 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -129.59 94.88 3.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.86 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 687' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 70.93 39.36 1.03 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 688' ' ' GLY . . . . . . . . . . . . . . . 74.04 43.64 32.74 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.496 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -139.14 135.69 34.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.788 0.328 . . . . 0.0 110.889 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 690' ' ' SER . . . . . . . . . . . . . 35.9 p -75.61 119.78 20.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.824 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm -103.53 13.96 32.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.941 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 692' ' ' GLY . . . . . 0.42 ' C ' ' HB2' ' A' ' 659' ' ' LEU . . . 53.36 25.9 28.11 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.56 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 31.8 p -127.44 142.13 51.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.843 0.354 . . . . 0.0 110.903 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -150.62 -168.07 15.13 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.503 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 7.1 m -141.62 157.97 21.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.87 0.366 . . . . 0.0 111.131 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 696' ' ' VAL . . . . . 0.467 HG13 HG13 ' A' ' 678' ' ' VAL . 91.6 t -147.52 118.67 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.139 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 14.5 ttpt -105.96 137.24 44.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.922 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -111.91 173.71 6.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.845 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 699' ' ' GLU . . . . . 0.574 ' HG2' HD11 ' A' ' 679' ' ' LEU . 44.9 mt-10 -79.14 -40.77 30.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.865 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 5.5 m -110.18 148.64 38.76 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.63 0.729 . . . . 0.0 110.825 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -17.68 37.4 Favored 'Trans proline' 0 N--CA 1.465 -0.153 0 C-N-CA 122.693 2.262 . . . . 0.0 112.351 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -78.21 -49.27 14.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.862 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 60.9 t -46.51 -42.1 5.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.159 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 704' ' ' ALA . . . . . 0.747 ' HB3' ' O ' ' A' ' 651' ' ' ALA . . . -59.48 -61.54 2.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.126 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -45.7 -32.43 2.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.897 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 44.5 ttt180 -80.77 -43.98 19.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.867 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -61.06 -62.5 1.81 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.137 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 708' ' ' CYS . . . . . 0.475 ' HA ' ' CG1' ' A' ' 723' ' ' VAL . 26.5 p -47.13 -29.71 2.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.912 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 709' ' ' ARG . . . . . 0.405 ' O ' ' ND2' ' A' ' 712' ' ' ASN . 16.6 mtt85 -89.56 -25.24 21.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.838 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 44.2 mtp -87.57 -12.02 46.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.874 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 711' ' ' MET . . . . . 0.53 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 8.9 mmm -110.82 -23.15 11.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 712' ' ' ASN . . . . . 0.43 ' O ' ' CG ' ' A' ' 712' ' ' ASN . 2.6 p30 -42.6 117.29 1.0 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.857 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 79.78 21.58 65.83 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.49 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 714' ' ' MET . . . . . 0.489 ' HB3' HD11 ' A' ' 721' ' ' ILE . 31.8 ttp -65.54 94.1 0.18 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.843 0.354 . . . . 0.0 110.871 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 715' ' ' LYS . . . . . 0.417 ' NZ ' ' HA2' ' A' ' 718' ' ' GLY . 1.7 mmmt -55.91 99.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.881 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 716' ' ' LEU . . . . . 0.677 HD12 HG21 ' A' ' 721' ' ' ILE . 58.2 mt -100.08 132.28 45.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.871 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 717' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 716' ' ' LEU . 15.7 t 35.92 36.41 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.874 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 718' ' ' GLY . . . . . 0.417 ' HA2' ' NZ ' ' A' ' 715' ' ' LYS . . . 77.99 38.98 25.26 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.502 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 719' ' ' ARG . . . . . 0.499 ' N ' ' O ' ' A' ' 716' ' ' LEU . 39.3 mtt85 -149.23 107.52 3.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.77 0.319 . . . . 0.0 110.883 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -62.73 123.83 19.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 721' ' ' ILE . . . . . 0.677 HG21 HD12 ' A' ' 716' ' ' LEU . 24.9 pt -99.62 155.89 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.13 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -110.73 110.12 20.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.876 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 723' ' ' VAL . . . . . 0.475 ' CG1' ' HA ' ' A' ' 708' ' ' CYS . 2.7 t -109.39 136.87 43.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.14 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -157.95 169.99 23.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.851 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 725' ' ' ILE . . . . . 0.505 HD13 HG22 ' A' ' 654' ' ' ILE . 46.6 mm -77.31 143.09 13.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.126 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -94.12 98.95 11.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.889 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 727' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -59.69 -45.96 90.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.836 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 728' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -96.1 77.92 3.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.871 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 729' ' ' ALA . . . . . . . . . . . . . . . -119.89 114.52 22.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.127 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 3.5 m -156.57 159.18 38.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.854 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 731' ' ' GLY . . . . . . . . . . . . . . . 170.75 172.42 37.03 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.494 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 732' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 -14.94 36.8 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.727 2.284 . . . . 0.0 112.347 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 733' ' ' SER . . . . . 0.425 ' O ' ' C ' ' A' ' 734' ' ' SER . 4.5 t -46.6 104.61 0.05 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.889 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 734' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 733' ' ' SER . 32.5 p -36.56 -47.27 0.62 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.832 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 735' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.547 -179.922 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 645' ' ' SER . . . . . . . . . . . . . 6.3 t -66.07 -57.21 8.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.897 0.379 . . . . 0.0 110.861 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 646' ' ' SER . . . . . . . . . . . . . 56.9 p -105.82 139.96 39.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.867 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . 165.01 67.79 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.472 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 29.0 t -105.75 131.59 52.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.885 0.374 . . . . 0.0 110.881 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 39.7 m -116.36 94.53 4.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.886 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 138.22 70.27 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.481 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 651' ' ' ALA . . . . . 0.714 ' O ' ' HB3' ' A' ' 704' ' ' ALA . . . -128.96 110.45 12.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.748 0.309 . . . . 0.0 111.094 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 81.6 m -105.37 -34.71 7.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.883 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -95.09 150.19 20.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.888 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 654' ' ' ILE . . . . . 0.501 HD11 ' CE2' ' A' ' 672' ' ' PHE . 29.2 pt -135.47 176.5 8.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.139 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -131.53 143.47 50.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.884 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 11.1 t -129.97 145.93 34.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.134 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -136.25 168.97 18.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.874 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 658' ' ' ASN . . . . . 0.436 ' O ' HG22 ' A' ' 721' ' ' ILE . 2.8 t-20 60.08 47.23 9.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.869 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.607 HD22 ' CE2' ' A' ' 663' ' ' PHE . 53.8 mt -95.14 143.59 26.37 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.629 0.728 . . . . 0.0 110.916 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -47.94 145.04 10.83 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.651 2.234 . . . . 0.0 112.345 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -61.88 -33.18 73.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.91 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -89.41 7.91 33.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.864 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 663' ' ' PHE . . . . . 0.607 ' CE2' HD22 ' A' ' 659' ' ' LEU . 2.9 t80 -73.87 114.17 11.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 57.9 p -100.14 166.01 11.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.184 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 665' ' ' TRP . . . . . 0.587 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 10.6 p-90 -55.9 -46.72 78.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.906 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 666' ' ' LYS . . . . . 0.587 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 4.2 tppp? -48.53 -52.61 21.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.889 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 14.5 mtm -60.58 -54.81 40.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.869 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 26.2 tp -45.97 -45.59 15.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.942 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.4 ' C ' ' N ' ' A' ' 671' ' ' LYS . 33.9 tttm -64.57 -74.79 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.855 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -45.91 -21.73 0.15 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.851 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 671' ' ' LYS . . . . . 0.419 ' HG3' ' CE ' ' A' ' 711' ' ' MET . 6.2 tppt? -71.61 -45.75 61.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.893 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 672' ' ' PHE . . . . . 0.573 ' CD1' HG21 ' A' ' 696' ' ' VAL . 23.7 m-85 -84.36 -8.81 58.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.904 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -58.88 -30.08 67.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.89 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -49.01 -43.3 40.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.897 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 675' ' ' CYS . . . . . 0.502 ' SG ' ' HB2' ' A' ' 707' ' ' ALA . 19.2 t -66.6 -62.27 1.54 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.873 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -147.6 -148.19 4.7 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.489 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 677' ' ' HIS . . . . . 0.507 ' CE1' HD23 ' A' ' 679' ' ' LEU . 13.8 t-80 -98.68 101.64 13.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.794 0.33 . . . . 0.0 110.889 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 678' ' ' VAL . . . . . 0.431 ' CG1' HG13 ' A' ' 696' ' ' VAL . 98.8 t -76.81 136.29 24.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.122 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 679' ' ' LEU . . . . . 0.507 HD23 ' CE1' ' A' ' 677' ' ' HIS . 18.2 mt -110.33 -62.74 1.47 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.928 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 680' ' ' TYR . . . . . 0.422 ' CE2' HG21 ' A' ' 695' ' ' VAL . 9.1 t80 -95.98 126.4 41.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.94 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -156.84 125.9 5.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.103 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -157.5 157.24 33.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.862 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 45.5 mm -97.74 104.17 15.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.155 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -60.19 135.87 57.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 685' ' ' MET . . . . . . . . . . . . . 25.5 mtp -134.8 167.42 20.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.926 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -131.12 106.85 8.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.9 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 687' ' ' ASN . . . . . . . . . . . . . 45.8 t30 56.26 43.38 26.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.917 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 688' ' ' GLY . . . . . . . . . . . . . . . 74.21 37.51 48.48 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.458 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 25.9 mtmm -139.38 129.69 25.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.844 0.354 . . . . 0.0 110.89 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 690' ' ' SER . . . . . . . . . . . . . 19.4 t -72.62 132.24 43.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -112.27 24.41 12.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.886 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 43.77 36.37 3.55 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.447 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 28.9 p -137.97 142.49 40.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.845 0.355 . . . . 0.0 110.906 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -152.56 -160.78 9.82 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.468 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 695' ' ' VAL . . . . . 0.422 HG21 ' CE2' ' A' ' 680' ' ' TYR . 10.3 m -149.54 156.73 7.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.869 0.366 . . . . 0.0 111.127 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 696' ' ' VAL . . . . . 0.573 HG21 ' CD1' ' A' ' 672' ' ' PHE . 67.0 t -146.14 118.37 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.086 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 15.8 tttt -104.22 146.03 29.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.901 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -122.11 164.79 17.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.861 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 699' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -68.76 -42.16 77.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.88 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 26.4 m -110.92 147.16 35.94 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.703 0.763 . . . . 0.0 110.824 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -29.16 24.17 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.698 2.265 . . . . 0.0 112.333 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -63.5 -40.92 98.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 94.7 t -58.83 -57.1 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.058 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 704' ' ' ALA . . . . . 0.714 ' HB3' ' O ' ' A' ' 651' ' ' ALA . . . -43.19 -66.71 0.34 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.127 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.738 ' HA ' HD11 ' A' ' 725' ' ' ILE . 27.9 mt-10 -39.34 -39.29 0.63 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.902 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 706' ' ' ARG . . . . . 0.429 ' O ' ' N ' ' A' ' 708' ' ' CYS . 16.1 ttm-85 -73.46 -64.11 1.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.882 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 707' ' ' ALA . . . . . 0.502 ' HB2' ' SG ' ' A' ' 675' ' ' CYS . . . -38.95 -29.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.087 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 708' ' ' CYS . . . . . 0.429 ' N ' ' O ' ' A' ' 706' ' ' ARG . 1.2 t -61.81 -49.47 76.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.832 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -77.19 -33.11 56.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.851 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 59.7 mtp -70.04 -16.37 63.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.843 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 711' ' ' MET . . . . . 0.431 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 5.3 mmm -118.93 -20.41 8.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.892 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 712' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -53.28 122.48 9.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.92 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 74.68 23.5 74.97 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.515 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 714' ' ' MET . . . . . . . . . . . . . 42.4 ttp -76.4 111.05 11.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.859 0.362 . . . . 0.0 110.885 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 19.4 mmtt -63.34 102.53 0.41 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.942 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 716' ' ' LEU . . . . . 1.081 HD12 HG21 ' A' ' 721' ' ' ILE . 36.9 mt -99.98 122.98 43.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.905 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 717' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 716' ' ' LEU . 1.3 t 37.3 42.1 0.28 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 76.97 32.7 48.4 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.418 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 719' ' ' ARG . . . . . 0.498 ' N ' ' O ' ' A' ' 716' ' ' LEU . 21.9 mtp180 -146.83 110.73 5.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.805 0.336 . . . . 0.0 110.867 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -68.55 125.38 26.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.842 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 721' ' ' ILE . . . . . 1.081 HG21 HD12 ' A' ' 716' ' ' LEU . 26.7 pt -99.55 155.0 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.111 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -111.32 104.58 13.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.885 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 723' ' ' VAL . . . . . 0.411 HG21 ' CB ' ' A' ' 711' ' ' MET . 3.7 t -100.67 131.99 47.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.096 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -155.56 160.37 40.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.897 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 725' ' ' ILE . . . . . 0.738 HD11 ' HA ' ' A' ' 705' ' ' GLU . 33.9 mm -60.86 135.96 25.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.118 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -87.38 86.39 7.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.917 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 727' ' ' ARG . . . . . . . . . . . . . 4.1 tpt85 -44.98 144.6 1.16 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.889 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 728' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 63.62 54.53 1.86 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.914 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 729' ' ' ALA . . . . . . . . . . . . . . . -99.0 41.41 1.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.081 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 77.9 p -123.69 118.44 27.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.852 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 731' ' ' GLY . . . . . . . . . . . . . . . -51.06 -76.28 0.18 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.496 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 732' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 85.18 0.63 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.666 2.244 . . . . 0.0 112.35 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 733' ' ' SER . . . . . . . . . . . . . 37.5 t -72.44 -42.96 64.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.874 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 734' ' ' SER . . . . . . . . . . . . . 58.2 m -53.66 171.74 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.802 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 735' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.477 179.95 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 645' ' ' SER . . . . . . . . . . . . . 84.7 p -167.97 112.48 0.65 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.854 0.359 . . . . 0.0 110.885 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 646' ' ' SER . . . . . . . . . . . . . 38.7 m -43.94 126.95 5.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.882 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . 142.11 105.59 0.57 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.493 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 22.1 m -138.74 148.16 43.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.881 0.372 . . . . 0.0 110.861 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 70.1 p -98.53 115.48 28.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.879 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 156.48 83.6 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.513 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 651' ' ' ALA . . . . . 0.807 ' HB1' HD12 ' A' ' 725' ' ' ILE . . . -134.22 90.54 2.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.801 0.334 . . . . 0.0 111.119 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 60.2 m -96.52 -30.84 13.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.868 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 653' ' ' GLN . . . . . 0.607 ' OE1' ' HB1' ' A' ' 729' ' ' ALA . 50.3 tt0 -98.31 156.27 16.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.913 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 654' ' ' ILE . . . . . 0.452 HD11 ' CE2' ' A' ' 672' ' ' PHE . 43.7 pt -142.7 166.94 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.125 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -119.12 156.49 29.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.926 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 3.3 t -143.75 151.06 16.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.133 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 49.3 mtp180 -147.27 156.74 43.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.858 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 658' ' ' ASN . . . . . 0.56 ' O ' HG22 ' A' ' 721' ' ' ILE . 2.5 t-20 70.44 51.91 0.35 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.926 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.801 HD23 HD12 ' A' ' 716' ' ' LEU . 37.6 mt -100.75 143.55 26.78 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.63 0.728 . . . . 0.0 110.902 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 660' ' ' PRO . . . . . 0.447 ' O ' ' N ' ' A' ' 663' ' ' PHE . 64.4 Cg_exo -47.97 128.64 16.78 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.683 2.255 . . . . 0.0 112.346 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -43.09 -31.96 0.63 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.869 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 662' ' ' ASP . . . . . 0.446 ' O ' HG23 ' A' ' 664' ' ' THR . 9.1 m-20 -82.81 -32.54 27.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.864 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 663' ' ' PHE . . . . . 0.447 ' N ' ' O ' ' A' ' 660' ' ' PRO . 4.2 t80 -40.23 113.16 0.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 664' ' ' THR . . . . . 0.446 HG23 ' O ' ' A' ' 662' ' ' ASP . 24.8 p -104.81 -177.48 3.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.121 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 665' ' ' TRP . . . . . 0.646 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 8.2 p-90 -66.76 -52.26 46.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 666' ' ' LYS . . . . . 0.646 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 22.8 tptp -44.78 -55.0 5.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.907 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 11.9 mtm -60.42 -46.01 91.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.866 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 27.9 tp -51.44 -42.97 61.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.919 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 29.2 tttm -65.64 -74.41 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.909 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -45.86 -24.42 0.39 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.821 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? -68.9 -52.74 26.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.898 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 672' ' ' PHE . . . . . 0.455 ' CD1' HG21 ' A' ' 696' ' ' VAL . 23.3 m-85 -76.99 -13.72 59.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.899 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -52.86 -28.37 22.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.871 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -50.49 -46.64 57.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.897 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 675' ' ' CYS . . . . . 0.612 ' SG ' ' HB2' ' A' ' 707' ' ' ALA . 12.4 t -64.4 -61.18 2.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.902 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -152.33 -147.38 4.58 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.465 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 17.7 t-80 -95.41 114.13 25.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.79 0.329 . . . . 0.0 110.867 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 77.7 t -88.39 123.51 40.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.135 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 679' ' ' LEU . . . . . 0.739 HD11 ' HG2' ' A' ' 699' ' ' GLU . 19.2 mt -97.11 -61.93 1.33 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.916 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -99.84 123.7 44.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.935 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -149.41 121.68 8.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.099 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -155.8 155.81 33.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.878 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 28.1 mm -101.62 105.95 18.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.123 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -53.76 142.1 24.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.874 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 685' ' ' MET . . . . . . . . . . . . . 31.3 mtp -139.94 166.26 25.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -134.72 115.47 13.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.863 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 687' ' ' ASN . . . . . . . . . . . . . 23.5 m-20 46.69 40.84 9.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.887 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 688' ' ' GLY . . . . . . . . . . . . . . . 76.42 32.62 50.87 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.483 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -131.82 128.97 39.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.789 0.328 . . . . 0.0 110.873 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 690' ' ' SER . . . . . . . . . . . . . 7.3 m -72.63 143.16 48.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.872 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 35.5 mmtm -120.53 7.75 10.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.921 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 58.47 16.81 30.31 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.472 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 1.9 p -123.45 129.68 51.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.826 0.346 . . . . 0.0 110.895 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -136.45 -159.6 8.45 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.5 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 13.5 m -148.13 155.82 9.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.872 0.367 . . . . 0.0 111.134 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 696' ' ' VAL . . . . . 0.455 HG21 ' CD1' ' A' ' 672' ' ' PHE . 91.7 t -143.8 119.42 4.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.182 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 28.2 tttt -104.36 140.45 37.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.916 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -117.99 167.99 10.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.899 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 699' ' ' GLU . . . . . 0.739 ' HG2' HD11 ' A' ' 679' ' ' LEU . 9.7 mm-40 -76.2 -39.25 55.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 1.8 t -108.83 142.98 26.64 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.633 0.73 . . . . 0.0 110.847 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -24.59 29.75 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.676 2.251 . . . . 0.0 112.373 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 702' ' ' GLU . . . . . 0.435 ' HG3' ' N ' ' A' ' 703' ' ' VAL . 6.9 pt-20 -73.76 -34.11 64.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.886 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 703' ' ' VAL . . . . . 0.435 ' N ' ' HG3' ' A' ' 702' ' ' GLU . 38.2 t -61.7 -56.96 14.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.142 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 704' ' ' ALA . . . . . 0.721 ' HB3' ' O ' ' A' ' 651' ' ' ALA . . . -43.39 -62.44 1.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.107 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -43.35 -43.08 4.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.906 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 16.0 ttm180 -66.08 -58.31 5.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.834 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 707' ' ' ALA . . . . . 0.612 ' HB2' ' SG ' ' A' ' 675' ' ' CYS . . . -50.64 -34.05 24.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.097 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 708' ' ' CYS . . . . . 0.425 ' SG ' ' CG2' ' A' ' 654' ' ' ILE . 2.4 m -61.18 -42.25 98.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.892 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 709' ' ' ARG . . . . . 0.407 ' O ' ' ND2' ' A' ' 712' ' ' ASN . 18.8 mtt180 -84.15 -20.11 33.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.849 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 17.1 mtm -88.79 -9.76 50.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.873 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 711' ' ' MET . . . . . . . . . . . . . 5.7 mmm -120.45 -10.62 9.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.9 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 712' ' ' ASN . . . . . 0.407 ' ND2' ' O ' ' A' ' 709' ' ' ARG . 0.9 OUTLIER -53.98 126.74 23.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.857 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 69.63 8.12 59.58 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.496 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 714' ' ' MET . . . . . 0.58 ' HB3' HD11 ' A' ' 721' ' ' ILE . 10.3 ttp -49.38 99.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.857 0.36 . . . . 0.0 110.859 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 10.3 mmtp -56.05 102.56 0.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.888 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 716' ' ' LEU . . . . . 0.801 HD12 HD23 ' A' ' 659' ' ' LEU . 12.2 mt -99.88 117.0 33.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.923 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 717' ' ' SER . . . . . . . . . . . . . 2.3 t 40.91 44.41 1.96 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.912 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 76.33 31.28 55.18 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.493 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 719' ' ' ARG . . . . . . . . . . . . . 23.9 mtp180 -144.26 106.89 4.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.757 0.313 . . . . 0.0 110.876 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -66.18 125.77 26.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.881 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 721' ' ' ILE . . . . . 0.58 HD11 ' HB3' ' A' ' 714' ' ' MET . 38.2 pt -97.79 156.4 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.109 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -110.61 98.09 7.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.855 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 3.2 t -94.84 134.93 30.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.12 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 25.6 mtt-85 -158.08 176.11 12.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.859 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 725' ' ' ILE . . . . . 0.807 HD12 ' HB1' ' A' ' 651' ' ' ALA . 10.1 mm -78.23 138.95 19.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.125 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -92.15 77.42 5.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.817 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 727' ' ' ARG . . . . . . . . . . . . . 7.1 tpp85 -45.34 -62.09 1.4 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 728' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -83.41 91.49 7.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.878 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 729' ' ' ALA . . . . . 0.607 ' HB1' ' OE1' ' A' ' 653' ' ' GLN . . . -128.46 110.52 12.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.125 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 41.6 t -115.44 -50.77 2.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 731' ' ' GLY . . . . . . . . . . . . . . . 117.92 -159.68 14.1 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.454 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 732' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 152.54 69.51 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.696 2.264 . . . . 0.0 112.351 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 733' ' ' SER . . . . . . . . . . . . . 49.9 m -44.73 -62.75 1.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.881 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 734' ' ' SER . . . . . . . . . . . . . 24.7 p -64.73 155.1 34.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.882 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 735' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.475 -179.998 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.467 -0.253 . . . . 0.0 112.467 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 645' ' ' SER . . . . . . . . . . . . . 26.5 p -53.69 117.61 3.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.851 0.357 . . . . 0.0 110.888 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 646' ' ' SER . . . . . . . . . . . . . 14.9 t -100.79 129.6 46.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.877 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . 149.95 121.51 1.07 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.531 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 34.0 p -138.64 141.27 39.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.841 0.353 . . . . 0.0 110.84 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 61.0 p -131.95 -53.63 0.99 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.882 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . -156.72 167.13 33.58 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.503 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 651' ' ' ALA . . . . . 0.649 ' O ' ' HB3' ' A' ' 704' ' ' ALA . . . -101.34 95.86 6.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.793 0.33 . . . . 0.0 111.06 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 26.4 p -104.21 -26.13 12.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.883 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -104.29 146.6 28.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.895 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 654' ' ' ILE . . . . . . . . . . . . . 25.4 pt -135.27 172.66 15.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.138 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -128.21 149.59 50.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.868 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 4.0 t -132.19 152.87 37.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.095 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 69.8 mtt180 -146.81 160.08 42.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.88 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 658' ' ' ASN . . . . . 0.467 ' O ' HG22 ' A' ' 721' ' ' ILE . 3.1 t-20 66.94 48.51 1.27 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.914 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 659' ' ' LEU . . . . . . . . . . . . . 40.5 mt -98.71 145.41 29.87 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.635 0.731 . . . . 0.0 110.909 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_exo -47.98 126.17 12.74 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.692 2.261 . . . . 0.0 112.337 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -49.35 -25.97 2.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.857 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -88.01 -24.95 23.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -41.09 147.69 0.13 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.861 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 35.5 p -128.07 169.55 13.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.115 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 665' ' ' TRP . . . . . 0.644 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 5.6 p-90 -63.96 -53.0 57.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.894 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 666' ' ' LYS . . . . . 0.644 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 3.7 tppp? -47.55 -47.71 28.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.924 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 46.1 mtm -63.16 -50.64 69.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.88 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 29.7 tp -46.66 -45.65 19.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.931 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 30.9 tttm -60.72 -72.36 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.925 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -47.04 -25.07 0.74 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.902 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 17.0 tptt -68.76 -43.63 75.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.892 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 672' ' ' PHE . . . . . 0.517 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 23.8 m-85 -87.38 -13.42 43.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.889 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -50.71 -36.69 37.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.852 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -51.22 -39.79 57.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.857 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 37.4 m -72.01 -42.29 66.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 676' ' ' GLY . . . . . 0.417 ' HA3' HG11 ' A' ' 703' ' ' VAL . . . -177.16 170.12 42.64 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.483 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -59.56 114.91 2.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.85 0.357 . . . . 0.0 110.888 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 41.4 t -90.63 139.69 17.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.1 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 679' ' ' LEU . . . . . 0.402 HD21 ' HG2' ' A' ' 699' ' ' GLU . 13.8 mt -110.62 -63.8 1.35 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.932 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -99.06 131.27 45.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.97 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -157.22 120.86 4.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.115 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -148.26 164.11 34.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.904 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 38.3 mm -109.18 106.58 20.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.11 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -57.02 133.34 54.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.935 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 685' ' ' MET . . . . . . . . . . . . . 22.0 mtp -130.54 160.84 32.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.881 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -133.05 96.73 3.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.887 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 687' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 61.51 39.29 15.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.865 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 688' ' ' GLY . . . . . . . . . . . . . . . 77.24 36.5 34.69 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.49 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 43.9 mttp -139.29 113.63 8.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.813 0.339 . . . . 0.0 110.856 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 690' ' ' SER . . . . . . . . . . . . . 77.1 p -56.99 131.58 50.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt -104.49 12.66 32.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 55.14 15.51 7.31 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.528 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 27.0 p -123.38 139.43 54.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.848 0.356 . . . . 0.0 110.896 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -143.39 -157.19 7.06 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.429 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 6.9 m -152.58 151.86 11.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.885 0.374 . . . . 0.0 111.126 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 94.3 t -141.95 119.43 7.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.111 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 17.6 tttt -106.36 134.06 50.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.879 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -109.25 169.06 8.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.864 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 699' ' ' GLU . . . . . 0.402 ' HG2' HD21 ' A' ' 679' ' ' LEU . 21.4 mt-10 -72.11 -37.67 69.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.867 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -115.15 143.96 31.26 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.658 0.742 . . . . 0.0 110.828 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -10.84 29.57 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.709 2.272 . . . . 0.0 112.327 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -82.6 -46.48 13.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.91 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 703' ' ' VAL . . . . . 0.417 HG11 ' HA3' ' A' ' 676' ' ' GLY . 65.8 t -50.42 -47.84 26.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.162 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 704' ' ' ALA . . . . . 0.649 ' HB3' ' O ' ' A' ' 651' ' ' ALA . . . -49.3 -61.32 2.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.145 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.481 ' HA ' HD11 ' A' ' 725' ' ' ILE . 42.8 mt-10 -47.57 -23.5 0.67 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.878 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 706' ' ' ARG . . . . . 0.408 ' HG2' ' HE2' ' A' ' 710' ' ' MET . 45.1 ttt180 -87.08 -43.45 12.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.821 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 707' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' ' 711' ' ' MET . . . -65.03 -56.94 10.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.108 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 708' ' ' CYS . . . . . 0.431 ' HA ' ' CG1' ' A' ' 723' ' ' VAL . 13.8 p -42.98 -42.13 3.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.876 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 709' ' ' ARG . . . . . 0.405 ' N ' ' SG ' ' A' ' 708' ' ' CYS . 15.8 mtt180 -80.16 -34.91 37.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.897 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 710' ' ' MET . . . . . 0.408 ' HE2' ' HG2' ' A' ' 706' ' ' ARG . 14.8 mtm -78.07 -9.14 59.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.886 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 711' ' ' MET . . . . . 0.517 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 5.9 mmm -116.14 -20.18 9.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.888 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 712' ' ' ASN . . . . . 0.435 ' OD1' ' C ' ' A' ' 712' ' ' ASN . 10.3 t-20 -55.03 115.21 2.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.914 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 85.75 18.67 59.49 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.543 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 714' ' ' MET . . . . . . . . . . . . . 44.7 ttp -71.11 96.64 1.38 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.834 0.35 . . . . 0.0 110.887 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 5.4 mmtp -51.54 101.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 716' ' ' LEU . . . . . 1.077 HD12 HG21 ' A' ' 721' ' ' ILE . 33.9 mt -100.2 120.4 39.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.925 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 717' ' ' SER . . . . . . . . . . . . . 1.2 t 40.32 44.95 1.72 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.857 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 74.13 27.25 66.67 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.503 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 719' ' ' ARG . . . . . 0.452 ' N ' ' O ' ' A' ' 716' ' ' LEU . 44.1 mtt85 -139.31 109.57 6.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.728 0.299 . . . . 0.0 110.882 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -67.11 125.28 25.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.866 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 721' ' ' ILE . . . . . 1.077 HG21 HD12 ' A' ' 716' ' ' LEU . 27.5 pt -99.96 156.22 4.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.161 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -116.28 104.55 11.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.862 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 723' ' ' VAL . . . . . 0.431 ' CG1' ' HA ' ' A' ' 708' ' ' CYS . 3.6 t -104.72 135.37 42.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.137 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 22.1 mtp85 -157.89 159.05 36.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.885 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 725' ' ' ILE . . . . . 0.481 HD11 ' HA ' ' A' ' 705' ' ' GLU . 35.6 mm -61.19 135.12 26.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.121 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -87.43 80.02 8.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 727' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -45.24 -45.07 11.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.817 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 728' ' ' ASN . . . . . 0.407 ' O ' ' C ' ' A' ' 729' ' ' ALA . 25.1 t-20 -86.62 41.47 0.95 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.907 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 729' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 728' ' ' ASN . . . -36.78 -55.46 0.89 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.13 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 1.4 t 41.53 36.29 0.54 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.867 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 731' ' ' GLY . . . . . . . . . . . . . . . -142.88 70.78 0.41 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.501 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 732' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -22.08 32.63 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.685 2.256 . . . . 0.0 112.347 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 733' ' ' SER . . . . . . . . . . . . . 33.5 t -40.1 145.36 0.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.846 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 734' ' ' SER . . . . . . . . . . . . . 32.9 t -149.36 112.75 4.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.806 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 735' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.498 179.984 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.371 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 645' ' ' SER . . . . . . . . . . . . . 83.5 p -131.81 139.88 49.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.915 0.388 . . . . 0.0 110.809 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 646' ' ' SER . . . . . . . . . . . . . 30.4 t -56.04 164.13 1.32 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.896 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . 74.27 96.54 0.11 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.494 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 2.5 m -122.45 44.8 2.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.857 0.361 . . . . 0.0 110.869 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 14.5 m -75.25 114.73 14.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.878 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 134.47 93.47 0.46 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.494 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 651' ' ' ALA . . . . . 0.489 ' O ' ' HB3' ' A' ' 704' ' ' ALA . . . -166.64 105.32 0.61 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.779 0.323 . . . . 0.0 111.11 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 22.6 p -108.05 -24.79 11.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.867 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 653' ' ' GLN . . . . . 0.45 ' HG3' ' N ' ' A' ' 654' ' ' ILE . 8.1 tp60 -93.1 146.52 23.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.917 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 654' ' ' ILE . . . . . 0.59 HG22 HD13 ' A' ' 725' ' ' ILE . 40.2 pt -134.51 177.24 7.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.112 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -132.8 159.69 39.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.861 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 6.5 t -140.71 150.44 20.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.069 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 657' ' ' ARG . . . . . 0.418 ' NH2' ' HB3' ' A' ' 722' ' ' ASP . 81.6 mtm-85 -146.68 157.43 43.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.883 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 658' ' ' ASN . . . . . 0.634 ' O ' HG22 ' A' ' 721' ' ' ILE . 3.2 t-20 67.15 54.43 0.74 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.905 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.449 HD22 ' CD2' ' A' ' 663' ' ' PHE . 38.7 mt -102.42 144.88 29.5 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.628 0.728 . . . . 0.0 110.908 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -48.0 133.47 23.33 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.648 2.232 . . . . 0.0 112.356 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -53.08 -28.34 24.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.867 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -86.64 -19.67 28.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.866 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 663' ' ' PHE . . . . . 0.449 ' CD2' HD22 ' A' ' 659' ' ' LEU . 3.6 t80 -49.25 136.02 16.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.893 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 72.7 p -120.93 175.27 6.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.114 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 665' ' ' TRP . . . . . 0.65 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 5.3 p-90 -66.57 -51.05 60.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.889 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 666' ' ' LYS . . . . . 0.65 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 0.0 OUTLIER -45.86 -45.02 14.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.859 179.94 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 38.8 mtm -68.54 -52.19 34.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.925 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 30.0 tp -45.89 -42.4 12.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.933 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 44.8 tttt -65.95 -73.09 0.14 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.912 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -48.37 -23.77 1.03 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.876 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 16.1 tptt -69.68 -44.09 71.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.914 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 672' ' ' PHE . . . . . 0.512 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 16.9 m-85 -85.49 -14.8 44.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.911 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -55.25 -27.93 49.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.876 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -63.34 -19.87 65.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 34.1 m -89.38 -36.19 15.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.912 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -177.32 -154.78 12.54 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.485 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -91.93 108.64 20.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.884 0.373 . . . . 0.0 110.87 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 63.7 t -90.58 136.32 24.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.125 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 679' ' ' LEU . . . . . 0.526 HD11 ' HG2' ' A' ' 699' ' ' GLU . 27.0 mt -110.44 -61.87 1.6 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.964 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -98.67 131.06 45.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.93 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -155.39 125.84 6.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.105 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -156.18 159.57 39.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.878 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 34.3 mm -105.38 97.44 5.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.126 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt -52.5 133.8 35.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.943 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 685' ' ' MET . . . . . . . . . . . . . 33.7 mtp -130.34 170.37 14.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.902 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -128.13 89.51 2.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.85 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 687' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 72.21 36.97 1.02 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.915 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 688' ' ' GLY . . . . . . . . . . . . . . . 78.59 35.01 33.67 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.444 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -135.58 125.65 26.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.778 0.323 . . . . 0.0 110.903 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 690' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.5 128.76 38.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.843 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 6.4 mmtp -110.15 4.78 21.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.871 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 60.48 28.17 67.04 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.482 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 26.5 p -136.18 142.24 44.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.88 0.371 . . . . 0.0 110.852 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -152.3 -164.91 12.71 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.499 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 6.8 m -148.51 155.9 8.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.853 0.359 . . . . 0.0 111.128 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 88.5 t -143.13 123.64 10.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.15 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 14.8 ttpt -103.28 139.07 39.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 698' ' ' PHE . . . . . 0.433 ' CD2' HG11 ' A' ' 703' ' ' VAL . 96.0 m-85 -116.71 165.15 13.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.89 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 699' ' ' GLU . . . . . 0.526 ' HG2' HD11 ' A' ' 679' ' ' LEU . 38.8 mt-10 -72.32 -43.25 64.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.864 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 700' ' ' SER . . . . . 0.667 ' OG ' HG23 ' A' ' 703' ' ' VAL . 79.8 p -111.08 149.45 40.5 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.639 0.733 . . . . 0.0 110.836 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -29.29 24.03 Favored 'Trans proline' 0 C--N 1.34 0.122 0 C-N-CA 122.662 2.241 . . . . 0.0 112.346 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 702' ' ' GLU . . . . . 0.409 ' HG3' ' N ' ' A' ' 703' ' ' VAL . 13.9 pt-20 -63.26 -46.7 85.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.909 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 703' ' ' VAL . . . . . 0.667 HG23 ' OG ' ' A' ' 700' ' ' SER . 71.6 t -50.78 -56.51 4.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.128 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 704' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' A' ' 651' ' ' ALA . . . -45.05 -60.98 1.81 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.109 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -44.03 -35.16 1.98 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.885 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 -77.95 -59.78 2.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.913 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -43.25 -32.43 0.77 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.087 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 708' ' ' CYS . . . . . 0.498 ' O ' ' N ' ' A' ' 712' ' ' ASN . 7.0 t -57.29 -60.51 3.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.889 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -68.39 -30.63 69.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 15.3 mmm -70.59 -30.72 67.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.854 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 711' ' ' MET . . . . . 0.512 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 4.3 mmm -107.68 -9.71 15.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.915 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 712' ' ' ASN . . . . . 0.498 ' N ' ' O ' ' A' ' 708' ' ' CYS . 10.4 t-20 -62.35 114.49 3.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.859 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 85.14 13.2 71.98 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.467 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 714' ' ' MET . . . . . . . . . . . . . 53.1 ttp -59.66 100.9 0.09 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.86 0.362 . . . . 0.0 110.852 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 8.8 mmtp -62.67 100.51 0.2 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.876 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 716' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 719' ' ' ARG . 31.2 mt -100.0 128.23 46.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.931 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 717' ' ' SER . . . . . 0.435 ' C ' ' O ' ' A' ' 716' ' ' LEU . 3.1 t 35.44 37.99 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.897 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 79.5 37.98 22.3 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.492 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 719' ' ' ARG . . . . . 0.504 ' N ' ' O ' ' A' ' 716' ' ' LEU . 6.7 mtt-85 -148.08 113.46 5.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.797 0.332 . . . . 0.0 110.861 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -74.5 125.69 29.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.889 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 721' ' ' ILE . . . . . 0.634 HG22 ' O ' ' A' ' 658' ' ' ASN . 46.5 pt -99.67 153.66 4.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.108 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 722' ' ' ASP . . . . . 0.418 ' HB3' ' NH2' ' A' ' 657' ' ' ARG . 54.7 m-20 -109.03 97.9 7.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.858 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 723' ' ' VAL . . . . . 0.47 HG21 ' CB ' ' A' ' 711' ' ' MET . 11.9 t -94.46 135.23 29.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.107 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.04 176.04 13.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.832 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 725' ' ' ILE . . . . . 0.59 HD13 HG22 ' A' ' 654' ' ' ILE . 39.0 mm -78.5 143.88 12.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.135 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 726' ' ' ASP . . . . . 0.554 ' OD2' ' HB2' ' A' ' 729' ' ' ALA . 45.1 t0 -97.82 103.25 15.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 727' ' ' ARG . . . . . 0.426 ' HB3' ' NH1' ' A' ' 727' ' ' ARG . 5.4 mmm180 -74.66 -54.96 6.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.859 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 728' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -42.9 -37.56 1.88 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.877 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 729' ' ' ALA . . . . . 0.554 ' HB2' ' OD2' ' A' ' 726' ' ' ASP . . . -46.1 -69.53 0.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.092 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 41.2 p -72.37 107.45 4.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.837 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 731' ' ' GLY . . . . . . . . . . . . . . . 79.23 86.09 0.55 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.507 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 732' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -23.94 30.29 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.645 2.23 . . . . 0.0 112.396 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 733' ' ' SER . . . . . . . . . . . . . 7.3 m -91.1 -54.18 4.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.87 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 734' ' ' SER . . . . . . . . . . . . . 11.9 t -63.95 116.98 6.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.882 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 735' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.466 -179.996 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 645' ' ' SER . . . . . . . . . . . . . 26.9 t -173.63 123.15 0.36 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.85 0.357 . . . . 0.0 110.833 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 646' ' ' SER . . . . . . . . . . . . . 27.1 p -136.98 144.42 43.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.868 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . 119.92 -127.73 7.24 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.457 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 67.0 p -145.74 144.86 30.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.842 0.353 . . . . 0.0 110.865 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 95.4 p -95.54 107.69 19.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.882 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . -175.59 69.32 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.45 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 651' ' ' ALA . . . . . 0.463 ' O ' ' HB3' ' A' ' 704' ' ' ALA . . . -106.83 97.01 6.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.733 0.301 . . . . 0.0 111.089 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 36.7 m -108.23 -19.88 13.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.815 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -105.16 147.43 27.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.869 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 654' ' ' ILE . . . . . 0.515 HD11 ' CE2' ' A' ' 672' ' ' PHE . 40.9 pt -135.54 171.56 17.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.091 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -121.86 158.77 28.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.872 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 5.5 t -147.52 145.78 18.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.11 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 51.6 mtp180 -143.78 160.94 39.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.883 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 658' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 69.73 47.86 0.61 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.894 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 659' ' ' LEU . . . . . . . . . . . . . 51.1 mt -101.41 143.97 27.64 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.614 0.721 . . . . 0.0 110.898 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -48.04 133.71 23.63 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.71 2.273 . . . . 0.0 112.299 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 661' ' ' PHE . . . . . 0.501 ' CE1' ' HB3' ' A' ' 690' ' ' SER . 4.0 t80 -47.99 -41.58 25.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.877 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -72.25 -29.94 64.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.888 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -38.87 116.3 0.55 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.864 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 40.7 p -101.58 179.39 4.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.185 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 665' ' ' TRP . . . . . 0.583 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 6.4 p-90 -69.09 -47.52 65.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.907 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 666' ' ' LYS . . . . . 0.583 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 0.0 OUTLIER -50.36 -45.78 55.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.893 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 24.9 mtm -66.05 -52.76 46.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.876 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 18.0 tp -46.46 -47.23 19.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.915 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.46 ' HB2' ' CB ' ' A' ' 681' ' ' ALA . 29.9 tttt -63.3 -72.62 0.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.883 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -45.26 -26.61 0.52 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.864 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 15.3 tptt -67.81 -41.75 82.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.917 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 672' ' ' PHE . . . . . 0.581 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 20.9 m-85 -86.19 -18.91 30.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.91 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -50.32 -35.02 25.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -40.99 -42.33 1.86 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 6.4 t -70.25 -64.96 0.79 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.904 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -142.17 -151.28 5.49 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.464 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 8.3 t-80 -98.69 101.16 12.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.851 0.358 . . . . 0.0 110.885 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 69.5 t -74.57 141.65 15.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.143 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 679' ' ' LEU . . . . . 0.465 HD11 ' HG2' ' A' ' 699' ' ' GLU . 14.3 mt -114.31 -59.26 2.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.897 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -98.01 126.35 43.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 681' ' ' ALA . . . . . 0.46 ' CB ' ' HB2' ' A' ' 669' ' ' LYS . . . -154.25 123.71 6.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.109 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -151.94 160.89 43.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.868 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 21.8 mm -111.5 117.7 55.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.114 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -61.58 134.96 57.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.911 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 685' ' ' MET . . . . . . . . . . . . . 33.7 mtp -139.77 144.36 37.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.853 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -125.24 116.38 21.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.916 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 687' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 53.73 41.14 32.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.9 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 688' ' ' GLY . . . . . . . . . . . . . . . 66.81 32.16 80.35 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.502 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 689' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 690' ' ' SER . 23.3 mtmm -131.21 93.93 3.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.802 0.334 . . . . 0.0 110.867 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 690' ' ' SER . . . . . 0.501 ' HB3' ' CE1' ' A' ' 661' ' ' PHE . 28.3 t -37.7 139.23 0.31 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.842 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -103.79 -17.93 14.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.959 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 80.29 18.9 70.45 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.446 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 15.1 p -131.67 123.99 28.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.896 0.379 . . . . 0.0 110.875 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -132.86 -162.14 10.13 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.483 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 16.8 m -144.31 167.2 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.857 0.361 . . . . 0.0 111.159 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 696' ' ' VAL . . . . . 0.491 HG21 ' CD1' ' A' ' 672' ' ' PHE . 99.1 t -150.9 122.55 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.13 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 10.6 ttpp -107.5 136.74 46.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -113.67 172.34 7.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.903 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 699' ' ' GLU . . . . . 0.465 ' HG2' HD11 ' A' ' 679' ' ' LEU . 65.9 mt-10 -79.22 -42.3 26.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.903 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 21.7 m -108.18 143.97 28.48 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.632 0.729 . . . . 0.0 110.882 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 -28.42 25.47 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.676 2.25 . . . . 0.0 112.397 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -68.28 -33.42 74.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.895 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 76.0 t -64.15 -57.36 11.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.161 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 704' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 651' ' ' ALA . . . -44.65 -52.46 8.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.122 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -53.97 -30.36 46.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.919 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 45.0 ttt180 -82.23 -43.55 17.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.87 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -61.35 -56.71 17.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.083 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 708' ' ' CYS . . . . . . . . . . . . . 28.8 p -46.3 -32.81 3.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.881 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 11.8 mtp180 -83.16 -35.93 25.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.819 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 29.0 mtm -77.85 -11.39 59.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.88 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 711' ' ' MET . . . . . 0.581 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 4.3 mmt -112.51 -34.58 5.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.874 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 712' ' ' ASN . . . . . 0.401 ' OD1' ' C ' ' A' ' 712' ' ' ASN . 2.2 t-20 -39.16 106.77 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.882 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 91.04 20.01 40.79 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.512 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 714' ' ' MET . . . . . 0.58 ' HE3' HD11 ' A' ' 721' ' ' ILE . 2.9 ttm -64.7 99.79 0.35 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.839 0.352 . . . . 0.0 110.866 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 715' ' ' LYS . . . . . 0.457 ' CD ' ' HG3' ' A' ' 720' ' ' GLU . 22.4 mmtt -59.92 99.78 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.906 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 716' ' ' LEU . . . . . 0.501 ' O ' ' N ' ' A' ' 719' ' ' ARG . 32.6 mt -99.8 125.64 45.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.9 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 717' ' ' SER . . . . . 0.403 ' C ' ' O ' ' A' ' 716' ' ' LEU . 1.7 t 37.72 40.03 0.24 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.846 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 77.96 32.93 42.96 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.476 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 719' ' ' ARG . . . . . 0.501 ' N ' ' O ' ' A' ' 716' ' ' LEU . 18.4 mtp85 -141.9 110.42 6.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.763 0.316 . . . . 0.0 110.894 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 720' ' ' GLU . . . . . 0.457 ' HG3' ' CD ' ' A' ' 715' ' ' LYS . 27.9 mt-10 -71.53 127.73 33.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.886 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 721' ' ' ILE . . . . . 0.58 HD11 ' HE3' ' A' ' 714' ' ' MET . 21.2 pt -97.97 160.5 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.127 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -116.8 100.13 7.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.831 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 3.3 t -100.32 136.09 33.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.11 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.89 148.38 20.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.852 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 725' ' ' ILE . . . . . 0.419 HG23 ' HB1' ' A' ' 651' ' ' ALA . 31.3 mm -56.62 134.74 20.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.114 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -91.73 77.87 5.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 727' ' ' ARG . . . . . . . . . . . . . 37.3 mtt180 -69.79 -41.18 75.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.835 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 728' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -48.17 -42.79 30.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.881 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 729' ' ' ALA . . . . . . . . . . . . . . . -39.45 97.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.126 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 91.5 p -50.25 -47.13 55.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.839 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 731' ' ' GLY . . . . . . . . . . . . . . . 84.64 -156.71 31.96 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.496 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 732' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.81 162.26 42.77 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.686 2.257 . . . . 0.0 112.352 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 733' ' ' SER . . . . . . . . . . . . . 4.8 t -154.48 159.84 41.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.859 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 734' ' ' SER . . . . . . . . . . . . . 58.3 p -88.15 -54.06 4.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.811 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 735' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.508 -179.938 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 645' ' ' SER . . . . . . . . . . . . . 12.2 m -96.87 151.02 20.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.87 0.367 . . . . 0.0 110.893 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 646' ' ' SER . . . . . . . . . . . . . 1.7 t -165.85 137.04 3.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.836 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -121.35 112.79 2.16 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.477 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 48.8 m -88.76 50.9 2.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.902 0.382 . . . . 0.0 110.856 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 34.4 p -45.04 -47.3 11.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.838 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 75.79 -75.37 1.48 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.459 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 651' ' ' ALA . . . . . 0.654 ' HB1' HD12 ' A' ' 725' ' ' ILE . . . 59.88 54.49 4.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.803 0.335 . . . . 0.0 111.098 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 30.2 p -78.45 -10.53 59.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -105.44 147.24 28.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.879 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 654' ' ' ILE . . . . . 0.454 HD11 ' CE2' ' A' ' 672' ' ' PHE . 33.4 pt -135.12 171.17 18.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.13 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -125.13 151.63 45.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.862 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 23.2 t -133.22 152.45 35.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.159 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -147.86 157.99 43.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.877 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 658' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 71.5 35.13 1.54 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.903 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.815 HD22 ' CD2' ' A' ' 663' ' ' PHE . 23.8 mt -85.14 143.58 39.82 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.631 0.729 . . . . 0.0 110.86 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -47.94 146.48 8.81 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.686 2.257 . . . . 0.0 112.353 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -64.45 -28.87 69.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.11 13.92 23.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.852 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 663' ' ' PHE . . . . . 0.815 ' CD2' HD22 ' A' ' 659' ' ' LEU . 2.9 t80 -79.04 121.92 25.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.906 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 62.9 p -104.9 169.55 8.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.156 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 665' ' ' TRP . . . . . 0.601 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 5.0 p-90 -62.85 -45.13 94.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.917 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 666' ' ' LYS . . . . . 0.601 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 5.5 tppp? -51.52 -46.11 63.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 30.1 mtm -67.54 -51.9 45.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.887 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 24.3 tp -47.62 -44.81 27.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.908 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 34.7 tttm -64.23 -70.8 0.2 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.903 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -47.36 -24.75 0.84 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.856 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 17.8 tptt -69.41 -42.35 75.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.901 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 672' ' ' PHE . . . . . 0.466 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 20.5 m-85 -85.99 -21.98 27.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.861 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -45.02 -37.34 4.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -46.69 -45.37 19.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.914 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 86.4 m -66.9 -54.99 16.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.864 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -153.93 -170.27 19.73 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.478 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -82.88 93.56 7.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.873 0.368 . . . . 0.0 110.867 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 84.8 t -70.09 141.21 17.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.149 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 679' ' ' LEU . . . . . 0.786 HD11 ' HG2' ' A' ' 699' ' ' GLU . 12.1 mt -115.24 -59.75 1.97 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.902 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 680' ' ' TYR . . . . . 0.408 ' HB3' ' CB ' ' A' ' 697' ' ' LYS . 9.8 t80 -98.39 125.83 43.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.889 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -154.61 121.02 5.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.112 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -151.64 157.81 42.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.835 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 50.0 mm -104.34 103.89 15.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.121 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm -62.12 136.78 58.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 685' ' ' MET . . . . . . . . . . . . . 22.9 mtp -131.34 150.15 52.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.828 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -111.11 97.05 6.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.873 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 687' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 67.54 44.08 1.78 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.886 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 688' ' ' GLY . . . . . . . . . . . . . . . 72.5 30.74 63.99 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.46 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -134.46 118.11 17.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.832 0.349 . . . . 0.0 110.874 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 690' ' ' SER . . . . . . . . . . . . . 3.1 t -60.72 125.4 23.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.843 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 10.7 mmpt? -103.81 27.79 7.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.924 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 41.05 30.55 0.4 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.466 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 17.7 p -137.38 128.24 27.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.884 0.373 . . . . 0.0 110.863 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -140.96 -150.56 5.42 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.525 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 24.7 m -153.08 161.9 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.84 0.353 . . . . 0.0 111.11 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 82.1 t -149.06 114.81 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.122 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 697' ' ' LYS . . . . . 0.408 ' CB ' ' HB3' ' A' ' 680' ' ' TYR . 8.3 ttpt -100.9 145.37 28.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -121.01 166.3 14.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.923 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 699' ' ' GLU . . . . . 0.786 ' HG2' HD11 ' A' ' 679' ' ' LEU . 29.2 mt-10 -69.55 -41.17 76.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.941 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 11.5 m -116.45 151.28 46.78 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.712 0.768 . . . . 0.0 110.806 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.77 -44.72 1.91 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.712 2.274 . . . . 0.0 112.351 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -50.88 -33.74 25.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.891 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 53.9 t -63.11 -58.95 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.147 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -44.06 -58.4 2.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.133 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -46.49 -32.69 3.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.929 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 16.4 ttm180 -82.51 -40.12 21.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.832 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -67.23 -57.73 6.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.149 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 708' ' ' CYS . . . . . 0.467 ' HA ' HG12 ' A' ' 723' ' ' VAL . 21.5 p -38.57 -41.53 0.69 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.875 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -83.42 -44.54 14.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.88 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 56.7 mtp -57.44 -13.4 3.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 711' ' ' MET . . . . . 0.466 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 5.1 mmm -118.48 -29.26 5.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 712' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -39.04 105.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.918 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 89.16 26.87 24.86 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.496 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 714' ' ' MET . . . . . 0.456 ' SD ' ' HE1' ' A' ' 711' ' ' MET . 46.0 ttp -72.55 97.84 2.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.83 0.348 . . . . 0.0 110.895 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -53.79 99.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.899 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 716' ' ' LEU . . . . . 0.94 HD12 HG21 ' A' ' 721' ' ' ILE . 23.9 mt -99.92 129.8 46.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.899 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 717' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 716' ' ' LEU . 9.5 t 35.21 37.32 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.9 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 718' ' ' GLY . . . . . 0.43 ' C ' ' HG3' ' A' ' 719' ' ' ARG . . . 79.84 38.66 19.2 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.517 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 719' ' ' ARG . . . . . 0.5 ' N ' ' O ' ' A' ' 716' ' ' LEU . 25.1 mtp85 -148.45 113.66 5.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.791 0.329 . . . . 0.0 110.842 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -70.19 122.6 19.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.887 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 721' ' ' ILE . . . . . 0.94 HG21 HD12 ' A' ' 716' ' ' LEU . 18.1 pt -99.0 150.6 4.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.109 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.03 99.71 9.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.884 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 723' ' ' VAL . . . . . 0.467 HG12 ' HA ' ' A' ' 708' ' ' CYS . 5.3 t -102.59 130.14 53.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.126 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 64.8 mtm180 -157.85 159.7 36.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.9 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 725' ' ' ILE . . . . . 0.654 HD12 ' HB1' ' A' ' 651' ' ' ALA . 17.5 mm -53.34 136.6 14.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.13 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -84.24 89.69 7.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.88 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 727' ' ' ARG . . . . . . . . . . . . . 9.1 tpt85 -45.89 153.04 0.32 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.873 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 728' ' ' ASN . . . . . . . . . . . . . 50.2 t30 65.09 47.55 2.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.908 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 729' ' ' ALA . . . . . . . . . . . . . . . -112.3 91.21 3.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.132 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 1.3 t -139.51 112.24 7.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.903 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 731' ' ' GLY . . . . . . . . . . . . . . . -63.51 140.24 44.46 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.488 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 732' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 96.16 0.58 Allowed 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.689 2.26 . . . . 0.0 112.349 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 733' ' ' SER . . . . . . . . . . . . . 3.3 t -107.93 160.2 15.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.903 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 734' ' ' SER . . . . . . . . . . . . . 59.8 m -122.72 154.01 38.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.887 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 735' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.5 -179.971 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 N-CA-C 112.486 -0.245 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 645' ' ' SER . . . . . . . . . . . . . 53.9 p -162.3 148.36 13.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.855 0.36 . . . . 0.0 110.875 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 646' ' ' SER . . . . . . . . . . . . . 2.1 m -90.1 -56.38 3.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.839 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . 55.59 60.12 9.37 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.465 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 24.3 p -82.99 124.6 30.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.879 0.371 . . . . 0.0 110.892 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 86.7 p -106.78 102.94 12.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.836 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 58.19 74.54 0.34 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.477 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 651' ' ' ALA . . . . . 0.665 ' HB1' HG23 ' A' ' 725' ' ' ILE . . . -80.26 68.64 6.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.777 0.322 . . . . 0.0 111.094 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 3.6 p -83.81 -6.92 59.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.846 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -115.59 154.37 29.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.895 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 654' ' ' ILE . . . . . 0.484 HD11 ' CE2' ' A' ' 672' ' ' PHE . 43.5 pt -138.24 167.21 22.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.108 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -118.14 154.84 31.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.889 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 2.9 t -141.19 150.67 19.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.105 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -149.73 165.41 32.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.86 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 658' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 65.18 44.21 3.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.889 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 659' ' ' LEU . . . . . . . . . . . . . 60.6 mt -97.44 143.8 26.82 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.619 0.723 . . . . 0.0 110.95 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -47.97 129.76 18.66 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.693 2.262 . . . . 0.0 112.355 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -48.93 -27.96 3.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.905 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -85.57 -28.71 24.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.85 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -38.62 119.75 0.87 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.861 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 75.6 p -100.23 171.36 7.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.17 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 665' ' ' TRP . . . . . 0.637 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 7.5 p-90 -66.86 -52.29 45.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.948 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 666' ' ' LYS . . . . . 0.637 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 4.3 tppp? -45.42 -47.29 13.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 25.6 mtm -62.95 -53.03 60.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.893 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 16.9 tp -44.46 -48.71 10.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.896 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 669' ' ' LYS . . . . . 0.403 ' HG2' ' N ' ' A' ' 670' ' ' ASP . 25.9 tttt -60.09 -71.16 0.14 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.864 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 670' ' ' ASP . . . . . 0.403 ' N ' ' HG2' ' A' ' 669' ' ' LYS . 14.9 t70 -49.61 -24.36 2.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.847 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 19.0 tptt -69.0 -42.4 76.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.884 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 672' ' ' PHE . . . . . 0.564 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 21.8 m-85 -87.13 -13.57 43.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -52.64 -39.35 61.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.884 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -48.65 -37.6 18.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.892 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 91.7 m -74.56 -54.96 6.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.87 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -160.04 -175.31 30.88 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.478 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -71.24 116.76 11.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.851 0.358 . . . . 0.0 110.852 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 678' ' ' VAL . . . . . 0.422 HG13 HG13 ' A' ' 696' ' ' VAL . 84.3 t -96.97 125.06 50.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.125 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 17.5 mt -99.29 -62.4 1.24 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.929 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -98.3 132.63 43.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.923 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -157.01 123.3 4.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.096 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -157.14 156.64 33.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.837 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 32.6 mm -97.35 102.16 13.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.13 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.3 135.9 57.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.906 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 685' ' ' MET . . . . . . . . . . . . . 15.3 mtp -134.31 172.59 12.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.899 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -130.66 95.44 3.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.939 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 687' ' ' ASN . . . . . . . . . . . . . 50.6 t30 68.79 37.37 2.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.863 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 688' ' ' GLY . . . . . . . . . . . . . . . 77.38 40.88 22.36 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.472 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 5.3 mmmm -139.29 128.54 24.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.768 0.318 . . . . 0.0 110.865 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 690' ' ' SER . . . . . . . . . . . . . 17.6 t -67.75 122.38 17.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.879 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -108.9 20.07 18.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.891 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 48.22 32.35 9.56 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.495 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 30.6 p -132.94 129.61 38.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.863 0.363 . . . . 0.0 110.907 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -139.04 -173.32 12.95 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.442 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 17.0 m -139.53 155.38 25.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.835 0.35 . . . . 0.0 111.141 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 696' ' ' VAL . . . . . 0.422 HG13 HG13 ' A' ' 678' ' ' VAL . 89.9 t -143.48 121.51 6.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.084 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 15.5 tttt -105.28 143.35 33.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.899 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -120.7 171.0 8.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 699' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -73.68 -44.7 55.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.866 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 29.9 m -112.92 149.63 41.58 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.636 0.731 . . . . 0.0 110.855 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -34.72 14.04 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.692 2.261 . . . . 0.0 112.356 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -57.95 -38.42 75.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.883 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 62.7 t -61.78 -49.77 82.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.125 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 704' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 651' ' ' ALA . . . -51.85 -55.58 19.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.091 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.405 ' HA ' HD11 ' A' ' 725' ' ' ILE . 56.4 mt-10 -46.94 -25.47 0.79 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.911 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 706' ' ' ARG . . . . . 0.441 ' O ' ' N ' ' A' ' 709' ' ' ARG . 21.7 ttt180 -90.39 -62.34 1.48 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.827 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 707' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 706' ' ' ARG . . . -35.75 -39.79 0.16 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.105 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 708' ' ' CYS . . . . . . . . . . . . . 66.7 m -56.56 -47.08 80.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 709' ' ' ARG . . . . . 0.441 ' N ' ' O ' ' A' ' 706' ' ' ARG . 11.6 mtp180 -73.55 -32.89 64.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.864 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 33.3 mmm -71.84 -20.5 61.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.86 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 711' ' ' MET . . . . . 0.564 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 2.7 mmt -114.02 -10.65 12.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.857 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 712' ' ' ASN . . . . . 0.419 ' OD1' ' C ' ' A' ' 712' ' ' ASN . 28.8 t-20 -57.75 105.08 0.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.877 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 91.83 15.44 54.46 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.508 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 714' ' ' MET . . . . . 0.542 ' HB3' HD11 ' A' ' 721' ' ' ILE . 34.4 ttp -62.7 101.29 0.24 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.877 0.37 . . . . 0.0 110.869 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 4.6 mmmt -66.22 102.76 0.88 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.905 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 716' ' ' LEU . . . . . 0.56 HD12 HG21 ' A' ' 721' ' ' ILE . 23.3 mt -100.01 134.75 42.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.91 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 717' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 716' ' ' LEU . 7.3 t 35.12 31.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.889 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 718' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 716' ' ' LEU . . . 83.65 41.87 8.07 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.475 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 719' ' ' ARG . . . . . 0.485 ' N ' ' O ' ' A' ' 716' ' ' LEU . 2.7 mtt-85 -151.68 117.51 5.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.807 0.337 . . . . 0.0 110.853 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -72.88 125.79 28.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.904 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 721' ' ' ILE . . . . . 0.56 HG21 HD12 ' A' ' 716' ' ' LEU . 41.4 pt -100.11 156.08 4.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.148 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -110.88 103.23 11.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.882 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 723' ' ' VAL . . . . . 0.521 HG21 ' CB ' ' A' ' 711' ' ' MET . 3.4 t -103.98 131.31 52.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.122 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 42.2 mtm-85 -158.18 161.09 37.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.858 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 725' ' ' ILE . . . . . 0.665 HG23 ' HB1' ' A' ' 651' ' ' ALA . 19.8 mm -60.3 131.08 24.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.162 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -80.11 107.23 12.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 727' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -63.98 -34.92 79.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 728' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -88.24 68.32 8.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 729' ' ' ALA . . . . . . . . . . . . . . . -115.71 19.05 15.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.126 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 86.6 p -127.88 149.36 50.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.875 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 731' ' ' GLY . . . . . . . . . . . . . . . -90.86 177.37 41.68 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.48 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 732' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -8.23 23.07 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.674 2.25 . . . . 0.0 112.367 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 733' ' ' SER . . . . . . . . . . . . . 68.8 m 61.86 46.2 6.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.866 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 734' ' ' SER . . . . . . . . . . . . . 69.4 p -87.1 122.67 31.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.858 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 735' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.482 -179.958 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 645' ' ' SER . . . . . . . . . . . . . 77.9 p -120.45 -44.3 2.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.886 0.374 . . . . 0.0 110.883 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 646' ' ' SER . . . . . . . . . . . . . 56.9 p -73.12 -42.94 62.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.887 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . 118.55 116.35 2.69 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.496 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 62.0 m -105.55 140.51 38.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.866 0.365 . . . . 0.0 110.831 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 3.9 t -159.69 110.64 1.97 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.849 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 159.16 36.61 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.468 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 651' ' ' ALA . . . . . 0.812 ' HB1' ' CG2' ' A' ' 725' ' ' ILE . . . -109.28 97.35 6.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.763 0.315 . . . . 0.0 111.098 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 2.8 p -101.34 -30.0 11.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.857 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -85.83 148.71 25.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.952 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 654' ' ' ILE . . . . . . . . . . . . . 22.0 pt -134.32 174.29 13.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.121 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -125.79 157.44 37.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.88 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 3.4 t -143.58 151.07 16.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.105 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 27.3 mtp180 -146.62 162.54 38.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.885 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 658' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 69.19 31.16 4.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.852 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 659' ' ' LEU . . . . . . . . . . . . . 64.9 mt -82.14 144.44 50.75 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.628 0.728 . . . . 0.0 110.917 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -47.97 150.84 4.38 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.725 2.283 . . . . 0.0 112.326 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -71.26 -22.36 61.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.859 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -98.19 4.74 48.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.854 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 663' ' ' PHE . . . . . 0.412 ' CE2' ' HA ' ' A' ' 668' ' ' LEU . 3.2 t80 -72.62 118.55 15.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 43.3 p -100.45 169.84 8.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.141 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 665' ' ' TRP . . . . . 0.583 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 15.7 p-90 -57.43 -51.41 69.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.937 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 666' ' ' LYS . . . . . 0.583 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 5.3 tppp? -48.76 -60.06 3.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.885 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 22.5 mtm -51.21 -44.63 61.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.888 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 668' ' ' LEU . . . . . 0.412 ' HA ' ' CE2' ' A' ' 663' ' ' PHE . 12.3 tp -56.79 -44.27 81.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.916 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 29.1 ttmt -64.55 -67.85 0.4 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.27 -23.76 2.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.855 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? -69.85 -39.63 76.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.944 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 672' ' ' PHE . . . . . 0.585 ' CD1' HG21 ' A' ' 696' ' ' VAL . 27.0 m-85 -90.87 -8.39 49.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.899 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -59.41 -27.07 65.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.909 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -62.16 -37.18 84.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.934 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 3.7 m -73.18 -41.4 63.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.879 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -171.02 -167.24 31.06 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.48 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 677' ' ' HIS . . . . . 0.41 ' CD2' ' C ' ' A' ' 677' ' ' HIS . 3.0 t-160 -83.18 106.07 14.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.792 0.329 . . . . 0.0 110.86 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 69.0 t -84.83 144.43 9.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.102 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 16.0 mt -119.15 -61.12 1.67 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.939 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -99.77 125.3 45.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.899 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -149.29 122.12 8.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.058 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -150.95 157.79 43.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.822 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 33.0 mm -104.71 105.0 17.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.115 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -58.34 133.54 55.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.831 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 685' ' ' MET . . . . . . . . . . . . . 31.8 mtp -130.53 158.71 39.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.895 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -119.95 111.12 17.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.888 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 687' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 53.62 39.28 29.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.904 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 688' ' ' GLY . . . . . . . . . . . . . . . 76.18 40.99 27.82 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.52 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 3.9 mmpt? -140.0 141.93 36.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.774 0.321 . . . . 0.0 110.921 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 690' ' ' SER . . . . . . . . . . . . . 17.3 m -77.01 122.76 25.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.816 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 24.3 mmmt -107.88 18.0 21.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.922 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 45.65 38.37 7.4 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.477 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 29.3 p -139.46 130.44 26.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.843 0.354 . . . . 0.0 110.892 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -147.93 -174.69 19.99 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.502 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 14.9 m -133.63 164.09 35.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.848 0.356 . . . . 0.0 111.134 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 696' ' ' VAL . . . . . 0.585 HG21 ' CD1' ' A' ' 672' ' ' PHE . 58.3 t -148.91 114.22 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.123 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 27.1 tttt -94.14 146.48 23.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.966 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -122.34 165.79 15.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.896 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 699' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -68.16 -41.82 80.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.918 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 14.3 m -116.21 152.32 47.73 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.684 0.754 . . . . 0.0 110.84 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -39.54 6.39 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.659 2.24 . . . . 0.0 112.339 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -53.57 -47.67 69.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.926 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 69.2 t -50.55 -55.21 6.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.112 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 704' ' ' ALA . . . . . 0.468 ' HB3' ' O ' ' A' ' 651' ' ' ALA . . . -41.4 -65.89 0.39 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.124 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 705' ' ' GLU . . . . . 0.695 ' HA ' HD11 ' A' ' 725' ' ' ILE . 49.5 mt-10 -42.65 -38.1 1.93 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.936 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 706' ' ' ARG . . . . . 0.401 ' O ' ' C ' ' A' ' 707' ' ' ALA . 12.6 ttt180 -73.91 -65.95 0.77 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.878 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 707' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 706' ' ' ARG . . . -36.9 -55.23 0.91 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.065 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 708' ' ' CYS . . . . . 0.498 ' HA ' HG11 ' A' ' 723' ' ' VAL . 0.9 OUTLIER -45.31 -51.2 11.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.876 -179.894 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 12.8 mtp180 -66.72 -34.44 77.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 78.1 mtp -73.33 -21.83 60.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.9 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 711' ' ' MET . . . . . 0.564 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 3.8 mmt -108.67 -14.78 14.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.844 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 712' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 708' ' ' CYS . 1.2 p-10 -50.16 121.18 5.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.918 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 70.38 26.48 74.12 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.455 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 714' ' ' MET . . . . . 0.401 ' HB3' HD11 ' A' ' 721' ' ' ILE . 30.5 ttp -69.44 103.53 2.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.794 0.331 . . . . 0.0 110.888 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 15.6 mmtt -59.93 101.41 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.924 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 716' ' ' LEU . . . . . 0.956 HD12 HG21 ' A' ' 721' ' ' ILE . 31.4 mt -100.29 126.06 46.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.901 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 717' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 716' ' ' LEU . 3.4 t 36.57 39.79 0.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.876 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 718' ' ' GLY . . . . . 0.429 ' C ' ' HG3' ' A' ' 719' ' ' ARG . . . 78.45 35.03 34.17 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.493 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 719' ' ' ARG . . . . . 0.497 ' N ' ' O ' ' A' ' 716' ' ' LEU . 5.0 mtt-85 -146.63 111.02 5.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.75 0.31 . . . . 0.0 110.869 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -67.76 123.01 19.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.884 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 721' ' ' ILE . . . . . 0.956 HG21 HD12 ' A' ' 716' ' ' LEU . 26.6 pt -99.27 149.49 5.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.088 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -106.14 112.7 25.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.824 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 723' ' ' VAL . . . . . 0.498 HG11 ' HA ' ' A' ' 708' ' ' CYS . 2.7 t -105.8 138.57 30.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.113 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 26.5 ptt180 -154.25 171.56 19.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 725' ' ' ILE . . . . . 0.812 ' CG2' ' HB1' ' A' ' 651' ' ' ALA . 19.3 mm -89.98 137.0 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.14 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -92.91 92.0 7.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.885 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 727' ' ' ARG . . . . . . . . . . . . . 8.5 tpt85 -53.0 -43.04 66.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.893 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 728' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -86.64 74.34 9.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.942 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 729' ' ' ALA . . . . . . . . . . . . . . . -109.31 120.39 42.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.087 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 3.2 t -85.78 124.76 32.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.843 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 731' ' ' GLY . . . . . . . . . . . . . . . -149.02 175.57 28.2 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.502 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 732' ' ' PRO . . . . . 0.442 ' O ' ' C ' ' A' ' 733' ' ' SER . 53.4 Cg_endo -69.77 -5.23 15.72 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.675 2.25 . . . . 0.0 112.324 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 733' ' ' SER . . . . . 0.442 ' C ' ' O ' ' A' ' 732' ' ' PRO . 21.5 t -34.86 120.06 0.48 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.884 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 734' ' ' SER . . . . . . . . . . . . . 14.8 t -147.76 108.28 4.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.86 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 735' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.536 -179.979 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 645' ' ' SER . . . . . . . . . . . . . 5.1 m -71.81 -54.45 10.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.877 0.37 . . . . 0.0 110.853 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 646' ' ' SER . . . . . . . . . . . . . 41.1 t -48.11 126.91 11.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.831 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . 145.38 82.78 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.481 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 41.8 t -57.17 -51.17 70.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.84 0.353 . . . . 0.0 110.858 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 32.8 m -87.71 103.11 15.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . -77.03 144.88 30.33 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.487 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 651' ' ' ALA . . . . . 0.599 ' O ' ' HB3' ' A' ' 704' ' ' ALA . . . -91.61 90.39 7.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.788 0.328 . . . . 0.0 111.142 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 2.4 p -103.95 -10.97 17.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.845 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -109.86 150.72 28.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.893 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 654' ' ' ILE . . . . . 0.598 HG22 HD13 ' A' ' 725' ' ' ILE . 23.0 pt -139.64 163.8 24.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.171 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -117.6 144.54 45.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.898 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 10.1 t -131.92 150.63 34.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.16 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -146.54 160.31 42.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.849 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 658' ' ' ASN . . . . . 0.613 ' O ' HG22 ' A' ' 721' ' ' ILE . 2.2 t-20 65.88 53.81 1.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.935 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.513 HD22 ' CD2' ' A' ' 663' ' ' PHE . 33.4 mt -102.74 143.48 26.7 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.58 0.705 . . . . 0.0 110.924 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 660' ' ' PRO . . . . . 0.478 ' O ' ' N ' ' A' ' 663' ' ' PHE . 65.9 Cg_exo -48.01 125.13 11.13 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.706 2.271 . . . . 0.0 112.32 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 661' ' ' PHE . . . . . 0.498 ' CE1' ' HB3' ' A' ' 690' ' ' SER . 4.6 t80 -40.63 -37.87 0.79 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.903 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 662' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 663' ' ' PHE . 2.2 m-20 -74.99 -35.07 62.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 663' ' ' PHE . . . . . 0.513 ' CD2' HD22 ' A' ' 659' ' ' LEU . 3.7 t80 -37.5 115.24 0.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.893 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 78.9 p -102.79 178.08 4.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.136 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 665' ' ' TRP . . . . . 0.647 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 3.4 p-90 -64.13 -48.27 76.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.908 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 666' ' ' LYS . . . . . 0.647 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 18.8 tptm -49.0 -56.88 7.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.898 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 32.4 mtm -55.99 -51.48 67.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.846 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 15.1 tp -45.34 -42.84 10.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.905 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -66.55 -70.72 0.23 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -48.51 -24.93 1.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.854 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 18.4 tptt -68.91 -46.08 69.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.934 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 672' ' ' PHE . . . . . 0.554 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 22.4 m-85 -83.38 -15.42 49.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.867 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -49.18 -41.4 36.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.9 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -45.64 -37.11 5.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.893 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 34.1 m -73.62 -48.2 34.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.871 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -164.53 -164.21 19.31 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.779 -0.725 . . . . 0.0 112.504 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 6.5 t-80 -85.48 93.6 8.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.806 0.336 . . . . 0.0 110.86 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 71.1 t -69.37 133.39 31.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.114 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 10.7 mt -108.67 -60.18 1.78 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.946 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -99.62 130.25 45.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.918 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -156.01 125.76 6.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.107 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -154.62 156.55 36.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.822 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 28.9 mm -105.24 108.48 25.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.166 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -60.8 142.49 56.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.885 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 685' ' ' MET . . . . . . . . . . . . . 25.6 mtp -137.93 148.24 45.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.914 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 686' ' ' GLU . . . . . 0.402 ' OE1' ' C ' ' A' ' 686' ' ' GLU . 0.0 OUTLIER -115.63 98.78 6.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.888 -179.958 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 687' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 71.04 38.8 1.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.896 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 688' ' ' GLY . . . . . . . . . . . . . . . 70.47 30.3 69.11 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.464 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 28.7 mmtm -134.62 111.97 10.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.794 0.33 . . . . 0.0 110.891 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 690' ' ' SER . . . . . 0.498 ' HB3' ' CE1' ' A' ' 661' ' ' PHE . 29.6 t -47.1 131.86 12.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.862 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 14.1 mmmt -106.13 -9.29 17.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.891 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 81.91 11.67 82.33 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.521 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 5.6 p -119.92 139.48 52.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.858 0.361 . . . . 0.0 110.88 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -148.38 -158.07 7.82 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.475 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 15.6 m -151.0 156.98 5.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.866 0.365 . . . . 0.0 111.125 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 696' ' ' VAL . . . . . 0.468 HG21 ' CD1' ' A' ' 672' ' ' PHE . 85.9 t -144.89 121.05 4.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.147 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 9.9 ttpp -104.84 147.41 27.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.911 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -123.48 168.4 12.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.893 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 699' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -68.55 -48.24 64.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.858 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 70.8 m -111.25 148.1 38.03 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.66 0.743 . . . . 0.0 110.819 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -23.52 30.6 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.657 2.238 . . . . 0.0 112.359 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 702' ' ' GLU . . . . . 0.453 ' HG3' ' N ' ' A' ' 703' ' ' VAL . 6.8 pt-20 -69.26 -34.51 74.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.905 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 703' ' ' VAL . . . . . 0.453 ' N ' ' HG3' ' A' ' 702' ' ' GLU . 24.7 t -61.19 -59.86 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.149 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 704' ' ' ALA . . . . . 0.599 ' HB3' ' O ' ' A' ' 651' ' ' ALA . . . -41.3 -61.41 1.03 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.116 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -41.55 -31.74 0.3 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.861 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -80.3 -48.93 12.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.855 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -60.39 -53.04 62.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.109 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 708' ' ' CYS . . . . . 0.434 ' SG ' ' N ' ' A' ' 709' ' ' ARG . 1.8 p -39.15 -41.69 0.86 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.884 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 709' ' ' ARG . . . . . 0.434 ' N ' ' SG ' ' A' ' 708' ' ' CYS . 12.6 mtt85 -84.51 -39.84 18.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.839 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 18.1 mtm -68.03 -7.74 31.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.853 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 711' ' ' MET . . . . . 0.554 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 14.2 mmm -121.57 -30.26 4.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.889 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 712' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -45.54 107.09 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.925 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 90.03 25.98 25.37 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.479 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 714' ' ' MET . . . . . . . . . . . . . 41.9 ttp -75.3 100.31 4.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.864 0.364 . . . . 0.0 110.874 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 18.3 mmtt -56.27 102.12 0.07 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.899 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 716' ' ' LEU . . . . . 0.849 HD12 HG21 ' A' ' 721' ' ' ILE . 34.6 mt -99.86 121.97 42.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.879 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 717' ' ' SER . . . . . . . . . . . . . 36.8 t 37.62 41.83 0.33 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.846 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 718' ' ' GLY . . . . . 0.422 ' C ' ' HG3' ' A' ' 719' ' ' ARG . . . 77.68 34.27 39.83 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.482 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 719' ' ' ARG . . . . . 0.459 ' N ' ' O ' ' A' ' 716' ' ' LEU . 1.9 mtp-105 -146.01 109.6 4.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.777 0.323 . . . . 0.0 110.887 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -69.99 124.97 25.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.897 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 721' ' ' ILE . . . . . 0.849 HG21 HD12 ' A' ' 716' ' ' LEU . 31.4 pt -98.9 152.33 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.13 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -106.08 98.27 7.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.869 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 5.1 t -101.69 132.0 48.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.137 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 34.5 mtp180 -156.0 167.58 29.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.857 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 725' ' ' ILE . . . . . 0.598 HD13 HG22 ' A' ' 654' ' ' ILE . 33.9 mm -73.92 131.62 34.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.103 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -78.25 135.04 37.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 727' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.04 -44.23 6.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.875 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 728' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -95.6 41.28 1.1 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.886 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 729' ' ' ALA . . . . . . . . . . . . . . . -61.11 -44.13 97.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.092 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 4.8 m -158.99 154.58 26.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.854 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 731' ' ' GLY . . . . . . . . . . . . . . . -52.88 122.37 19.84 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.484 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 732' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.71 174.32 9.64 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.722 2.281 . . . . 0.0 112.364 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 733' ' ' SER . . . . . . . . . . . . . 74.8 m -53.67 150.6 6.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.85 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 734' ' ' SER . . . . . . . . . . . . . 30.0 t -100.75 -48.82 4.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.839 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 735' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.501 -179.941 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 645' ' ' SER . . . . . . . . . . . . . 74.6 m -145.54 173.8 11.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.855 0.359 . . . . 0.0 110.876 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 646' ' ' SER . . . . . . . . . . . . . 1.8 m -147.71 118.53 7.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.883 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . 163.3 -150.25 18.78 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.503 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 78.3 p 44.72 43.32 6.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.86 0.362 . . . . 0.0 110.861 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 52.0 p -145.38 124.7 13.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.832 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 42.22 69.69 0.56 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.452 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 651' ' ' ALA . . . . . 0.579 ' HB1' HG23 ' A' ' 725' ' ' ILE . . . -92.74 109.11 20.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.771 0.32 . . . . 0.0 111.133 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 652' ' ' CYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 704' ' ' ALA . 25.5 p -109.69 -33.97 6.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.895 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -90.06 146.36 24.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.918 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 654' ' ' ILE . . . . . 0.425 HD11 ' CE2' ' A' ' 672' ' ' PHE . 40.5 pt -132.91 176.06 9.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.113 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -127.53 159.76 33.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.904 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 656' ' ' VAL . . . . . 0.411 HG13 HD12 ' A' ' 721' ' ' ILE . 21.9 t -146.13 148.68 16.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.116 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 32.0 mtp180 -146.85 162.99 37.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.877 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 658' ' ' ASN . . . . . 0.431 ' O ' HG22 ' A' ' 721' ' ' ILE . 2.3 t-20 65.97 46.41 2.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.922 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.474 HD22 ' CD2' ' A' ' 663' ' ' PHE . 27.8 mt -97.58 142.02 23.9 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.631 0.729 . . . . 0.0 110.939 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -48.01 127.91 15.65 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.678 2.252 . . . . 0.0 112.342 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -39.91 -50.48 2.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.885 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 662' ' ' ASP . . . . . 0.428 ' O ' HG23 ' A' ' 664' ' ' THR . 0.9 OUTLIER -61.79 -38.16 87.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.83 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 663' ' ' PHE . . . . . 0.477 ' HA ' ' CE ' ' A' ' 667' ' ' MET . 4.0 t80 -35.45 116.26 0.35 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.844 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 664' ' ' THR . . . . . 0.428 HG23 ' O ' ' A' ' 662' ' ' ASP . 78.6 p -106.15 174.82 5.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.135 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 665' ' ' TRP . . . . . 0.647 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 3.3 p-90 -62.1 -51.8 66.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.911 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 666' ' ' LYS . . . . . 0.647 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 1.7 tppp? -45.15 -48.93 12.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.884 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 667' ' ' MET . . . . . 0.477 ' CE ' ' HA ' ' A' ' 663' ' ' PHE . 24.3 mtm -64.3 -52.1 60.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.91 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 15.3 tp -43.52 -45.27 6.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -64.61 -70.74 0.21 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.885 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -48.49 -21.48 0.57 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.855 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 671' ' ' LYS . . . . . 0.44 ' HE2' HD21 ' A' ' 716' ' ' LEU . 17.2 tptt -72.81 -43.54 62.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.859 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 672' ' ' PHE . . . . . 0.534 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 25.8 m-85 -86.62 -15.95 38.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.9 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -50.38 -38.75 44.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.896 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -46.83 -39.94 12.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.888 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 675' ' ' CYS . . . . . 0.448 ' HA ' ' HE3' ' A' ' 710' ' ' MET . 62.8 m -67.65 -60.46 2.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.879 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -152.7 -157.59 8.08 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.524 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -87.77 100.72 13.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.791 0.329 . . . . 0.0 110.899 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 98.1 t -79.55 140.91 16.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.167 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 679' ' ' LEU . . . . . 0.419 HD11 ' HG2' ' A' ' 699' ' ' GLU . 12.8 mt -117.29 -60.03 1.88 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.88 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 680' ' ' TYR . . . . . 0.402 ' HB3' ' CB ' ' A' ' 697' ' ' LYS . 7.9 t80 -99.46 126.59 45.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.974 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -153.4 122.51 6.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.103 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -149.67 164.8 34.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 27.3 mm -114.72 101.38 12.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.116 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -54.74 141.88 30.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.878 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 685' ' ' MET . . . . . . . . . . . . . 26.5 mtp -135.84 168.47 19.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.889 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -129.53 94.41 3.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.863 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 687' ' ' ASN . . . . . . . . . . . . . 5.0 t30 67.33 39.83 2.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.912 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 688' ' ' GLY . . . . . . . . . . . . . . . 79.73 28.39 51.29 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.504 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.59 128.78 43.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.788 0.328 . . . . 0.0 110.896 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 690' ' ' SER . . . . . . . . . . . . . 44.7 p -72.26 120.29 17.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.811 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -102.5 30.25 4.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.893 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 692' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 658' ' ' ASN . . . 39.15 39.1 0.93 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.49 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 31.3 p -138.09 139.43 39.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.896 0.379 . . . . 0.0 110.858 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -158.7 -173.65 27.38 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.434 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 27.0 m -134.13 164.25 34.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.882 0.372 . . . . 0.0 111.114 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 85.5 t -148.94 116.91 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.079 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 697' ' ' LYS . . . . . 0.402 ' CB ' ' HB3' ' A' ' 680' ' ' TYR . 11.8 tttp -101.24 140.36 35.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -116.34 173.79 6.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.871 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 699' ' ' GLU . . . . . 0.419 ' HG2' HD11 ' A' ' 679' ' ' LEU . 48.0 mt-10 -73.19 -48.47 34.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.903 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 14.0 m -109.01 149.53 39.75 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.664 0.745 . . . . 0.0 110.824 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 -6.88 19.64 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.661 2.24 . . . . 0.0 112.327 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -86.17 -46.79 10.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.892 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 88.9 t -50.88 -42.16 22.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.182 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 704' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 651' ' ' ALA . . . -56.63 -59.14 5.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.093 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -47.48 -38.76 14.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 706' ' ' ARG . . . . . 0.517 ' HD3' ' HE1' ' A' ' 710' ' ' MET . 16.5 ttt-85 -70.67 -52.95 17.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.84 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -53.64 -42.24 67.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.074 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 708' ' ' CYS . . . . . . . . . . . . . 1.1 t -47.49 -43.98 24.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 3.5 mtt-85 -81.91 -45.76 15.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.899 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 710' ' ' MET . . . . . 0.517 ' HE1' ' HD3' ' A' ' 706' ' ' ARG . 13.9 mtm -57.09 -17.31 9.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.875 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 711' ' ' MET . . . . . 0.534 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 4.2 mmt -113.8 -34.5 5.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.881 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 712' ' ' ASN . . . . . 0.437 ' C ' ' O ' ' A' ' 711' ' ' MET . 3.9 t30 -35.02 117.24 0.38 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.863 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 72.38 31.95 62.88 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.479 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 714' ' ' MET . . . . . 0.669 ' HE3' HD21 ' A' ' 716' ' ' LEU . 20.1 ttp -74.16 91.53 2.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.887 0.375 . . . . 0.0 110.869 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 715' ' ' LYS . . . . . 0.497 ' CD ' ' HG3' ' A' ' 720' ' ' GLU . 0.7 OUTLIER -50.84 99.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.898 179.979 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 716' ' ' LEU . . . . . 0.669 HD21 ' HE3' ' A' ' 714' ' ' MET . 30.4 mt -99.43 117.82 34.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.908 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 717' ' ' SER . . . . . . . . . . . . . 1.5 t 41.04 37.27 0.53 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.854 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 84.1 25.26 45.2 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.505 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 719' ' ' ARG . . . . . 0.481 ' N ' ' O ' ' A' ' 716' ' ' LEU . 39.2 mtt85 -138.73 106.38 5.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.774 0.321 . . . . 0.0 110.836 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 720' ' ' GLU . . . . . 0.497 ' HG3' ' CD ' ' A' ' 715' ' ' LYS . 30.2 mt-10 -72.45 127.94 34.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.875 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 721' ' ' ILE . . . . . 0.606 HG21 HD12 ' A' ' 716' ' ' LEU . 43.1 pt -98.07 159.76 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.089 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -111.33 99.44 8.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.834 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 12.7 t -98.97 134.03 39.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.154 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 63.5 mtm180 -156.9 174.91 14.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.844 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 725' ' ' ILE . . . . . 0.579 HG23 ' HB1' ' A' ' 651' ' ' ALA . 25.4 mm -77.28 139.3 18.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.126 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -90.83 100.21 13.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.852 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 727' ' ' ARG . . . . . . . . . . . . . 20.4 mmm-85 -69.36 155.75 39.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 728' ' ' ASN . . . . . . . . . . . . . 34.6 m-20 49.24 43.23 22.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.879 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 729' ' ' ALA . . . . . . . . . . . . . . . -94.31 -60.38 1.74 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.115 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 17.6 m -154.73 137.36 15.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.834 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 731' ' ' GLY . . . . . . . . . . . . . . . -161.75 83.64 0.12 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.488 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 732' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 -46.56 1.2 Allowed 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.661 2.24 . . . . 0.0 112.359 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 733' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 734' ' ' SER . 1.6 t -92.89 119.35 32.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.831 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 734' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 733' ' ' SER . 40.6 p -36.18 151.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.854 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 735' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.51 -179.978 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 645' ' ' SER . . . . . . . . . . . . . 13.0 t -138.73 154.47 48.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.934 0.397 . . . . 0.0 110.851 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 646' ' ' SER . . . . . . . . . . . . . 1.2 t -59.03 127.17 30.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.83 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . 169.24 106.14 0.19 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.475 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 648' ' ' SER . . . . . 0.403 ' HA ' ' NH1' ' A' ' 727' ' ' ARG . 73.7 m -92.95 130.53 38.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.922 0.392 . . . . 0.0 110.843 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 15.6 m -97.38 119.74 36.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.879 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 49.87 63.16 4.39 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.469 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 651' ' ' ALA . . . . . 0.654 ' HB1' ' CG2' ' A' ' 725' ' ' ILE . . . -107.42 86.8 2.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.755 0.312 . . . . 0.0 111.104 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 25.7 p -101.96 -22.9 14.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.892 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -85.71 144.68 27.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.937 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 654' ' ' ILE . . . . . 0.668 HG22 HD13 ' A' ' 725' ' ' ILE . 35.6 pt -131.47 174.64 12.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.083 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -131.31 148.75 52.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.864 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 11.2 t -131.31 148.47 32.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.129 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -143.89 157.84 44.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.881 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 658' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 71.2 46.22 0.45 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.904 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 659' ' ' LEU . . . . . 0.503 HD23 ' CD1' ' A' ' 716' ' ' LEU . 52.5 mt -94.71 142.47 24.77 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.62 0.724 . . . . 0.0 110.886 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -47.95 127.84 15.38 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.666 2.244 . . . . 0.0 112.348 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -44.18 -37.34 3.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.85 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 662' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 663' ' ' PHE . 51.3 m-20 -75.26 -35.56 61.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.864 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 663' ' ' PHE . . . . . 0.433 ' C ' ' O ' ' A' ' 662' ' ' ASP . 3.8 t80 -34.68 142.9 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.862 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 45.1 p -127.38 172.51 10.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.179 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 665' ' ' TRP . . . . . 0.614 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 6.0 p-90 -63.46 -50.27 70.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.929 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 666' ' ' LYS . . . . . 0.614 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 5.0 tppp? -46.42 -51.0 15.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.867 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 32.3 mtm -62.06 -46.85 87.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.889 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 39.3 tp -48.9 -46.09 42.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.936 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 25.3 ttmt -65.02 -72.97 0.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.917 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -46.17 -25.71 0.64 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.86 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 671' ' ' LYS . . . . . 0.432 ' HE3' HD21 ' A' ' 716' ' ' LEU . 10.1 tppt? -67.9 -51.66 45.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.899 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 672' ' ' PHE . . . . . 0.576 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 23.7 m-85 -77.77 -16.99 58.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.84 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -48.93 -33.41 10.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -55.83 -39.28 71.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.884 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 60.4 m -71.58 -41.71 68.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.899 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -174.75 170.84 44.01 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.436 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -62.01 103.71 0.39 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.805 0.336 . . . . 0.0 110.861 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 65.1 t -80.32 147.62 6.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.085 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 679' ' ' LEU . . . . . 0.699 HD11 ' HG2' ' A' ' 699' ' ' GLU . 13.7 mt -120.37 -63.83 1.32 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.913 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 680' ' ' TYR . . . . . 0.435 ' HB3' ' CB ' ' A' ' 697' ' ' LYS . 10.1 t80 -98.66 125.32 43.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -152.78 124.59 7.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.131 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -157.41 156.68 32.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.873 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 40.9 mm -96.23 99.28 8.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.152 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.62 141.6 20.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.878 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 685' ' ' MET . . . . . . . . . . . . . 31.2 mtp -137.31 158.65 43.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.847 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -125.0 106.01 9.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.887 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 687' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 62.98 40.27 9.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.876 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 688' ' ' GLY . . . . . . . . . . . . . . . 67.93 39.44 89.35 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.463 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 35.0 mmtt -137.32 124.34 21.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.82 0.343 . . . . 0.0 110.891 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 690' ' ' SER . . . . . . . . . . . . . 16.5 m -59.49 120.86 10.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.866 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -104.65 13.44 31.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.907 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 51.89 37.09 43.49 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.448 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 27.2 p -137.81 149.76 46.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.875 0.369 . . . . 0.0 110.882 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -155.68 -175.71 27.01 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.516 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 13.8 m -138.25 156.32 30.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.812 0.339 . . . . 0.0 111.162 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 90.7 t -142.96 118.0 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.115 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 697' ' ' LYS . . . . . 0.435 ' CB ' ' HB3' ' A' ' 680' ' ' TYR . 23.7 tttp -101.96 137.39 40.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.88 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -113.49 166.65 11.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.871 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 699' ' ' GLU . . . . . 0.699 ' HG2' HD11 ' A' ' 679' ' ' LEU . 22.5 mt-10 -68.53 -44.92 73.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.853 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 3.7 m -113.56 151.04 44.19 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.658 0.742 . . . . 0.0 110.869 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -36.7 10.21 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.657 2.238 . . . . 0.0 112.335 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 702' ' ' GLU . . . . . 0.443 ' OE1' ' C ' ' A' ' 702' ' ' GLU . 0.6 OUTLIER -56.81 -40.56 76.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.932 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 79.6 t -53.8 -57.07 6.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.087 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -43.23 -63.25 0.85 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.08 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -41.4 -29.96 0.17 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.883 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 19.8 ttm-85 -82.62 -47.79 11.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.846 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 707' ' ' ALA . . . . . 0.421 ' O ' ' C ' ' A' ' 708' ' ' CYS . . . -62.9 -59.34 4.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.06 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 708' ' ' CYS . . . . . 0.421 ' C ' ' O ' ' A' ' 707' ' ' ALA . 11.5 p -36.18 -36.69 0.1 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.877 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 6.3 mtt180 -85.29 -46.16 11.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.872 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 18.7 mtm -61.89 -9.45 6.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.886 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 711' ' ' MET . . . . . 0.576 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 6.3 mmm -120.2 -17.72 8.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.881 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 712' ' ' ASN . . . . . 0.404 ' OD1' ' C ' ' A' ' 712' ' ' ASN . 3.5 t-20 -53.5 117.41 3.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.905 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 80.8 10.4 85.16 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.533 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 714' ' ' MET . . . . . 0.575 ' HB3' HD11 ' A' ' 721' ' ' ILE . 46.3 ttp -61.32 91.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.857 0.36 . . . . 0.0 110.9 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 2.9 mttp -58.56 112.0 1.45 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.893 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 716' ' ' LEU . . . . . 0.59 HD12 HG21 ' A' ' 721' ' ' ILE . 30.5 mt -100.19 127.46 46.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 717' ' ' SER . . . . . . . . . . . . . 31.1 t 37.66 31.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.861 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 718' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 716' ' ' LEU . . . 89.3 43.11 5.36 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.463 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 719' ' ' ARG . . . . . . . . . . . . . 19.0 mtt180 -152.02 107.37 3.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.764 0.316 . . . . 0.0 110.886 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -62.69 124.22 20.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.884 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 721' ' ' ILE . . . . . 0.59 HG21 HD12 ' A' ' 716' ' ' LEU . 18.9 pt -100.09 151.18 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.161 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -111.1 97.79 7.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.853 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 8.1 t -97.35 136.11 29.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.143 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 79.8 mtt-85 -156.18 161.95 40.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 725' ' ' ILE . . . . . 0.668 HD13 HG22 ' A' ' 654' ' ' ILE . 23.0 mm -70.23 131.73 33.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.123 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -90.61 83.84 5.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.823 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 727' ' ' ARG . . . . . 0.403 ' NH1' ' HA ' ' A' ' 648' ' ' SER . 27.4 ttt180 -80.37 -36.79 33.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.882 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 728' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -86.19 41.96 0.96 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.866 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 729' ' ' ALA . . . . . . . . . . . . . . . -86.8 -53.9 4.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.1 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 33.9 m -129.08 172.85 11.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.865 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 731' ' ' GLY . . . . . . . . . . . . . . . -150.06 -175.86 22.61 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.501 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 732' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 100.28 0.81 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.725 2.283 . . . . 0.0 112.355 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 733' ' ' SER . . . . . . . . . . . . . 3.6 t -58.25 112.74 1.65 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.833 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 734' ' ' SER . . . . . . . . . . . . . 3.1 m -108.78 153.85 22.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.895 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 735' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.511 -179.971 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 652' ' ' CYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 704' ' ' ALA . 18.8 p . . . . . 0 C--O 1.23 0.055 0 CA-C-O 120.74 0.305 . . . . 0.0 110.83 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -93.24 153.23 18.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.882 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 654' ' ' ILE . . . . . 0.652 HG22 HD13 ' A' ' 725' ' ' ILE . 32.7 pt -136.51 177.75 5.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.157 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -130.56 149.56 52.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.875 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 3.3 t -134.58 151.89 32.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.136 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 38.1 mtt85 -148.39 161.99 40.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 658' ' ' ASN . . . . . 0.48 ' ND2' ' HB3' ' A' ' 719' ' ' ARG . 4.6 t30 65.27 47.97 2.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.739 HD22 ' CD2' ' A' ' 663' ' ' PHE . 26.3 mt -96.98 143.65 26.48 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.599 0.714 . . . . 0.0 110.942 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 660' ' ' PRO . . . . . 0.445 ' O ' ' N ' ' A' ' 663' ' ' PHE . 65.5 Cg_exo -47.95 127.82 15.34 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.685 2.257 . . . . 0.0 112.344 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -45.45 -30.96 1.53 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.881 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -83.8 -28.36 28.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.896 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 663' ' ' PHE . . . . . 0.739 ' CD2' HD22 ' A' ' 659' ' ' LEU . 3.8 t80 -40.62 123.14 1.79 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.924 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 80.4 p -106.02 176.77 5.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.138 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 665' ' ' TRP . . . . . 0.648 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 6.6 p-90 -68.97 -50.66 47.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.888 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 666' ' ' LYS . . . . . 0.648 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 2.8 tppp? -47.29 -50.73 20.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.858 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 31.4 mtm -63.37 -46.52 86.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.875 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 14.1 tp -51.52 -42.53 61.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.9 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 29.3 tttm -65.2 -74.15 0.11 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.873 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -46.01 -23.68 0.33 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.874 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 671' ' ' LYS . . . . . 0.442 ' HG3' ' CE ' ' A' ' 711' ' ' MET . 7.5 tppt? -69.88 -40.37 75.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.91 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 672' ' ' PHE . . . . . 0.466 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 20.6 m-85 -90.14 -9.3 48.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -57.63 -34.97 69.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -43.16 -44.76 5.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.903 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 9.4 t -66.98 -63.94 0.96 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.871 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -145.83 -155.06 6.35 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.462 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -93.08 102.83 15.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.88 0.372 . . . . 0.0 110.861 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 43.1 t -75.86 132.88 32.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.073 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 679' ' ' LEU . . . . . 0.403 HD21 ' HG2' ' A' ' 699' ' ' GLU . 10.2 mt -107.3 -61.53 1.54 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.887 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -97.91 129.61 44.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.918 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -155.48 123.07 5.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.138 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -152.17 165.52 34.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.83 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 18.5 mm -115.8 117.2 54.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.13 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp . . . . . 0 C--N 1.328 -0.356 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.855 179.867 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 4.6 mmtp . . . . . 0 N--CA 1.458 -0.061 0 CA-C-O 120.82 0.343 . . . . 0.0 110.866 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 80.91 13.36 81.4 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.496 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 8.9 p -126.81 131.89 51.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.835 0.35 . . . . 0.0 110.931 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -139.75 -170.87 12.09 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.518 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 5.2 m -141.07 153.5 20.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.865 0.364 . . . . 0.0 111.116 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 98.9 t -139.64 124.31 20.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.091 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 23.9 tttt -107.57 139.72 41.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.885 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -115.55 172.27 7.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.923 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 699' ' ' GLU . . . . . 0.403 ' HG2' HD21 ' A' ' 679' ' ' LEU . 25.7 mt-10 -75.52 -44.07 45.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.844 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 58.3 m -107.36 147.71 35.77 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.66 0.743 . . . . 0.0 110.843 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -32.97 17.55 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.649 2.233 . . . . 0.0 112.375 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -63.07 -42.92 99.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.891 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 95.5 t -51.14 -60.24 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.149 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 704' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 652' ' ' CYS . . . -42.13 -59.44 1.77 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.098 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 705' ' ' GLU . . . . . 0.761 ' HA ' HD11 ' A' ' 725' ' ' ILE . 22.0 mt-10 -43.55 -31.23 0.69 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.89 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 26.2 ttm-85 -81.99 -58.1 3.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.867 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -44.93 -30.15 0.95 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.095 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 708' ' ' CYS . . . . . 0.49 ' O ' ' N ' ' A' ' 712' ' ' ASN . 1.4 t -56.43 -63.96 1.02 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.883 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.15 -41.25 94.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.88 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 58.4 mtp -55.34 -33.6 63.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 711' ' ' MET . . . . . 0.469 ' CB ' HG21 ' A' ' 723' ' ' VAL . 3.7 mmt -105.8 -14.46 15.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.856 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 712' ' ' ASN . . . . . 0.49 ' N ' ' O ' ' A' ' 708' ' ' CYS . 40.1 t-20 -54.22 109.72 0.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.889 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 83.65 24.06 51.28 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.487 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 714' ' ' MET . . . . . 0.436 ' CE ' ' CE ' ' A' ' 711' ' ' MET . 38.2 ttp -72.16 98.91 2.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.825 0.345 . . . . 0.0 110.854 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 5.5 mmtm -51.94 101.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.887 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 716' ' ' LEU . . . . . 0.883 HD12 HG21 ' A' ' 721' ' ' ILE . 24.6 mt -99.78 120.02 39.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.926 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 717' ' ' SER . . . . . . . . . . . . . 20.4 t 40.27 43.67 1.46 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.874 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 75.6 26.52 65.15 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.521 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 719' ' ' ARG . . . . . 0.48 ' HB3' ' ND2' ' A' ' 658' ' ' ASN . 28.5 mtp180 -140.16 110.95 6.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.777 0.322 . . . . 0.0 110.89 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -68.2 127.84 34.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.933 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 721' ' ' ILE . . . . . 0.883 HG21 HD12 ' A' ' 716' ' ' LEU . 26.4 pt -99.69 151.41 4.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.137 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -106.11 99.88 9.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.878 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 723' ' ' VAL . . . . . 0.469 HG21 ' CB ' ' A' ' 711' ' ' MET . 4.4 t -97.53 135.77 30.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.141 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 -158.21 163.97 36.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.876 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 725' ' ' ILE . . . . . 0.761 HD11 ' HA ' ' A' ' 705' ' ' GLU . 31.9 mm -79.27 134.86 26.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.127 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 40.6 t0 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 179.838 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 29.8 m . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.77 0.319 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -94.53 143.1 26.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.932 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 654' ' ' ILE . . . . . 0.455 HD11 ' CE2' ' A' ' 672' ' ' PHE . 36.3 pt -132.94 174.97 12.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.154 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -121.09 158.58 27.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.832 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 21.9 t -147.01 146.47 18.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.095 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 65.6 mtm180 -146.42 157.86 43.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.87 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 658' ' ' ASN . . . . . 0.444 ' O ' HG22 ' A' ' 721' ' ' ILE . 0.6 OUTLIER 71.17 50.17 0.31 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.853 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.525 HD22 ' CD2' ' A' ' 663' ' ' PHE . 29.0 mt -100.59 143.83 27.3 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.615 0.722 . . . . 0.0 110.872 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 660' ' ' PRO . . . . . 0.483 ' O ' ' N ' ' A' ' 663' ' ' PHE . 65.8 Cg_exo -47.97 124.55 10.23 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.684 2.256 . . . . 0.0 112.331 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -42.37 -36.89 1.4 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.828 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -76.0 -31.5 58.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.881 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 663' ' ' PHE . . . . . 0.525 ' CD2' HD22 ' A' ' 659' ' ' LEU . 3.8 t80 -38.85 128.4 1.57 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.863 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 72.1 p -113.18 174.99 5.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.139 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 665' ' ' TRP . . . . . 0.644 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 5.3 p-90 -64.35 -51.66 62.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.897 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 666' ' ' LYS . . . . . 0.644 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 7.4 tppt? -45.42 -53.31 8.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.877 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 28.2 mtm -58.05 -54.38 47.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.892 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 15.3 tp -41.85 -49.72 4.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.881 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -60.66 -74.2 0.08 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.913 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -46.73 -23.3 0.4 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.9 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 10.3 tptt -70.83 -45.43 64.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.892 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 672' ' ' PHE . . . . . 0.455 ' CE2' HD11 ' A' ' 654' ' ' ILE . 23.4 m-85 -84.57 -11.58 55.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.908 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -54.57 -36.04 63.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.876 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -52.79 -32.08 42.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 10.2 m -80.9 -49.33 11.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.894 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 676' ' ' GLY . . . . . 0.621 ' HA3' HG11 ' A' ' 703' ' ' VAL . . . -164.21 168.92 38.85 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.482 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -61.95 101.08 0.18 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.836 0.35 . . . . 0.0 110.85 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 73.5 t -80.35 132.83 30.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.114 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 13.3 mt -107.47 -61.85 1.5 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.89 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -95.79 130.15 42.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.922 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -157.77 128.45 6.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.114 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -161.12 156.93 25.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.872 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 30.5 mm -102.11 111.97 33.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.121 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.912 179.84 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 25.0 mmmt . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.838 0.352 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 59.25 18.7 43.44 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.506 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 19.5 p -126.13 151.0 47.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.834 0.349 . . . . 0.0 110.889 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 694' ' ' GLY . . . . . 0.415 ' O ' HG13 ' A' ' 695' ' ' VAL . . . -155.9 -152.0 6.09 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.487 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 695' ' ' VAL . . . . . 0.415 HG13 ' O ' ' A' ' 694' ' ' GLY . 15.3 m -155.84 152.4 8.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.831 0.348 . . . . 0.0 111.143 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 99.2 t -141.7 120.06 9.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.078 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 14.4 ttpt -104.87 138.1 41.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.902 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -113.95 173.87 6.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.903 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 699' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -75.06 -36.79 61.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.913 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 700' ' ' SER . . . . . 0.456 ' OG ' HG23 ' A' ' 703' ' ' VAL . 69.0 p -124.57 151.25 67.03 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.636 0.731 . . . . 0.0 110.873 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -30.27 22.63 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.681 2.254 . . . . 0.0 112.357 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -61.68 -39.0 89.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.844 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 703' ' ' VAL . . . . . 0.621 HG11 ' HA3' ' A' ' 676' ' ' GLY . 82.6 t -66.23 -47.21 85.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.086 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -51.47 -47.12 63.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.112 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 705' ' ' GLU . . . . . 0.76 ' HA ' HD11 ' A' ' 725' ' ' ILE . 14.4 mt-10 -55.45 -43.12 75.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.901 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 22.0 ttm180 -68.92 -54.81 13.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.837 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -43.07 -47.53 5.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.107 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 708' ' ' CYS . . . . . 0.48 ' O ' ' CB ' ' A' ' 712' ' ' ASN . 21.3 m -54.54 -34.57 62.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.87 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 8.7 mtm105 -81.66 -45.18 16.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.881 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 22.1 mtm -66.06 -15.27 62.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.921 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 711' ' ' MET . . . . . 0.476 ' O ' ' N ' ' A' ' 714' ' ' MET . 3.2 mmt -113.78 -30.83 6.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.873 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 712' ' ' ASN . . . . . 0.48 ' CB ' ' O ' ' A' ' 708' ' ' CYS . 0.4 OUTLIER -39.79 112.27 0.25 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.875 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 77.25 25.61 63.4 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.48 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 714' ' ' MET . . . . . 0.553 ' HE3' HD21 ' A' ' 716' ' ' LEU . 48.9 ttp -71.38 100.35 2.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.863 0.363 . . . . 0.0 110.91 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp -54.07 99.13 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.889 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 716' ' ' LEU . . . . . 0.846 HD12 HG21 ' A' ' 721' ' ' ILE . 29.1 mt -99.89 125.21 45.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.929 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 717' ' ' SER . . . . . . . . . . . . . 1.1 t 40.06 43.68 1.35 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.883 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 72.41 29.09 66.57 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.508 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 719' ' ' ARG . . . . . 0.47 ' N ' ' O ' ' A' ' 716' ' ' LEU . 44.1 mtt180 -141.19 114.85 8.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.801 0.334 . . . . 0.0 110.885 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -70.18 128.03 34.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.902 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 721' ' ' ILE . . . . . 0.846 HG21 HD12 ' A' ' 716' ' ' LEU . 37.3 pt -100.03 161.89 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.129 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -118.39 98.21 6.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.845 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 723' ' ' VAL . . . . . 0.457 ' CG1' ' HA ' ' A' ' 708' ' ' CYS . 6.2 t -96.59 132.83 40.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.146 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 64.1 mtt180 -155.19 154.15 31.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.879 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 725' ' ' ILE . . . . . 0.76 HD11 ' HA ' ' A' ' 705' ' ' GLU . 15.1 mm -64.15 134.51 28.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.15 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 17.9 t0 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 179.865 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 652' ' ' CYS . . . . . 0.461 ' SG ' ' N ' ' A' ' 701' ' ' PRO . 22.3 m . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.751 0.31 . . . . 0.0 110.869 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -104.32 146.49 28.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.928 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 654' ' ' ILE . . . . . 0.587 HD11 ' CE2' ' A' ' 672' ' ' PHE . 38.9 pt -131.32 169.34 21.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.096 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -122.75 149.85 43.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.889 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 3.4 t -132.8 153.38 37.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.152 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 53.4 mtt85 -148.68 160.44 43.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.896 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 658' ' ' ASN . . . . . 0.448 ' O ' HG22 ' A' ' 721' ' ' ILE . 0.6 OUTLIER 66.93 44.95 1.91 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.927 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.439 HD23 HD12 ' A' ' 716' ' ' LEU . 54.1 mt -93.84 143.52 26.64 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.586 0.707 . . . . 0.0 110.907 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 660' ' ' PRO . . . . . 0.406 ' O ' ' N ' ' A' ' 663' ' ' PHE . 66.7 Cg_exo -48.04 124.12 9.7 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.687 2.258 . . . . 0.0 112.32 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -47.43 -24.43 0.81 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.896 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 662' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 663' ' ' PHE . 73.5 m-20 -88.49 -29.67 19.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.876 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 663' ' ' PHE . . . . . 0.408 ' C ' ' O ' ' A' ' 662' ' ' ASP . 3.5 t80 -37.6 140.03 0.25 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 82.2 p -120.34 169.82 9.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.122 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 665' ' ' TRP . . . . . 0.644 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 6.7 p-90 -63.45 -52.16 62.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.96 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 666' ' ' LYS . . . . . 0.644 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 9.7 tppt? -44.63 -51.57 8.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.877 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 24.3 mtm -61.74 -47.17 86.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.866 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 668' ' ' LEU . . . . . 0.443 HD22 HD13 ' A' ' 683' ' ' ILE . 35.6 tp -47.85 -47.55 31.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.91 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.448 ' HG2' ' N ' ' A' ' 670' ' ' ASP . 0.3 OUTLIER -64.76 -73.69 0.12 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 179.789 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 670' ' ' ASP . . . . . 0.448 ' N ' ' HG2' ' A' ' 669' ' ' LYS . 4.5 m-20 -45.2 -24.22 0.24 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.903 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 671' ' ' LYS . . . . . 0.479 ' HG3' ' CE ' ' A' ' 711' ' ' MET . 7.8 tppt? -69.88 -51.3 34.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.897 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 672' ' ' PHE . . . . . 0.587 ' CE2' HD11 ' A' ' 654' ' ' ILE . 27.7 m-85 -78.43 -11.15 59.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.878 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -55.9 -39.38 71.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.881 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -47.4 -36.02 9.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.895 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 64.8 m -74.66 -56.5 4.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.826 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -160.41 -175.95 31.97 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.474 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -68.43 109.44 3.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.832 0.348 . . . . 0.0 110.831 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 53.2 t -88.57 128.7 40.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.139 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 679' ' ' LEU . . . . . 0.535 HD11 ' HG2' ' A' ' 699' ' ' GLU . 11.4 mt -100.5 -64.42 1.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -97.94 130.34 44.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.879 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -153.9 125.96 7.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.104 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -163.61 157.94 20.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.894 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 683' ' ' ILE . . . . . 0.443 HD13 HD22 ' A' ' 668' ' ' LEU . 25.2 mm -93.87 101.72 12.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.126 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 16.2 mmmt . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.901 179.85 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 691' ' ' LYS . . . . . 0.418 ' O ' ' N ' ' A' ' 693' ' ' CYS . 33.3 mmtt . . . . . 0 N--CA 1.457 -0.091 0 CA-C-O 120.855 0.36 . . . . 0.0 110.932 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 692' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' A' ' 658' ' ' ASN . . . 37.71 31.28 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.512 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 693' ' ' CYS . . . . . 0.418 ' N ' ' O ' ' A' ' 691' ' ' LYS . 26.0 p -132.92 125.43 29.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.896 0.379 . . . . 0.0 110.88 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -130.01 172.91 20.02 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.475 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 8.7 m -129.35 150.98 35.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.857 0.36 . . . . 0.0 111.13 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 696' ' ' VAL . . . . . 0.485 HG21 ' CD1' ' A' ' 672' ' ' PHE . 62.9 t -140.77 122.31 14.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.079 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 13.6 tttt -106.78 134.22 50.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.948 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 698' ' ' PHE . . . . . 0.506 ' CD2' HG11 ' A' ' 703' ' ' VAL . 94.0 m-85 -109.81 171.39 7.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.893 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 699' ' ' GLU . . . . . 0.535 ' HG2' HD11 ' A' ' 679' ' ' LEU . 10.2 mm-40 -75.75 -45.19 37.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.921 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 57.7 m -109.83 145.62 32.4 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.673 0.749 . . . . 0.0 110.871 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 701' ' ' PRO . . . . . 0.461 ' N ' ' SG ' ' A' ' 652' ' ' CYS . 53.7 Cg_endo -69.8 -10.89 29.63 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.629 2.22 . . . . 0.0 112.343 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 702' ' ' GLU . . . . . 0.4 ' OE1' ' C ' ' A' ' 702' ' ' GLU . 1.4 pp20? -82.9 -31.02 28.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.866 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 703' ' ' VAL . . . . . 0.506 HG11 ' CD2' ' A' ' 698' ' ' PHE . 66.5 t -67.72 -57.4 9.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.121 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -44.23 -58.54 2.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.091 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 705' ' ' GLU . . . . . 0.498 ' HA ' HD11 ' A' ' 725' ' ' ILE . 19.0 mt-10 -44.31 -36.32 2.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.896 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -76.91 -64.77 1.05 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.823 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -39.61 -34.95 0.27 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.105 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 708' ' ' CYS . . . . . 0.446 ' HA ' ' CG1' ' A' ' 723' ' ' VAL . 56.8 m -52.82 -56.69 13.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.945 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -71.14 -39.75 71.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.92 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 18.6 mtm -64.4 -13.1 49.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 711' ' ' MET . . . . . 0.545 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 6.3 mmm -119.21 -16.68 9.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.887 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 712' ' ' ASN . . . . . 0.491 ' O ' ' ND2' ' A' ' 712' ' ' ASN . 0.1 OUTLIER -55.97 122.24 11.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.868 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 76.75 13.53 83.47 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.46 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 714' ' ' MET . . . . . . . . . . . . . 43.4 ttp -61.34 97.15 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.845 0.355 . . . . 0.0 110.823 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 15.4 mmtt -54.08 101.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.887 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 716' ' ' LEU . . . . . 0.946 HD12 HG21 ' A' ' 721' ' ' ILE . 46.0 mt -99.91 123.81 44.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.908 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 717' ' ' SER . . . . . . . . . . . . . 2.0 t 37.64 41.34 0.3 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.838 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 77.05 34.1 43.07 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.487 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 719' ' ' ARG . . . . . 0.48 ' N ' ' O ' ' A' ' 716' ' ' LEU . 9.6 mtt-85 -146.93 111.51 5.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.716 0.293 . . . . 0.0 110.862 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -68.83 125.6 27.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.888 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 721' ' ' ILE . . . . . 0.946 HG21 HD12 ' A' ' 716' ' ' LEU . 22.7 pt -100.0 160.36 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.138 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -115.2 109.43 17.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.832 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 723' ' ' VAL . . . . . 0.446 ' CG1' ' HA ' ' A' ' 708' ' ' CYS . 5.4 t -108.72 129.28 63.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.134 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 36.1 mtp180 -157.56 158.73 36.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.827 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 725' ' ' ILE . . . . . 0.498 HD11 ' HA ' ' A' ' 705' ' ' GLU . 31.6 mm -51.43 136.32 11.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.134 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 24.8 t0 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 179.856 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 24.8 p . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.725 0.297 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -92.12 150.72 20.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.945 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 654' ' ' ILE . . . . . 0.581 HG22 HD13 ' A' ' 725' ' ' ILE . 30.0 pt -137.26 167.07 23.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.169 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -120.7 159.47 25.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.865 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.436 HG12 ' N ' ' A' ' 657' ' ' ARG . 16.7 t -145.64 156.77 12.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.174 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 657' ' ' ARG . . . . . 0.436 ' N ' HG12 ' A' ' 656' ' ' VAL . 57.4 mtt180 -153.49 162.79 40.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.898 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 658' ' ' ASN . . . . . . . . . . . . . 4.6 t30 69.03 36.83 2.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.895 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.521 HD22 ' CD2' ' A' ' 663' ' ' PHE . 37.6 mt -86.74 143.34 35.5 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.669 0.747 . . . . 0.0 110.935 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 660' ' ' PRO . . . . . 0.47 ' O ' ' N ' ' A' ' 663' ' ' PHE . 64.8 Cg_exo -47.88 126.5 13.03 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.655 2.237 . . . . 0.0 112.375 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -42.42 -33.66 0.7 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.858 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 662' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 663' ' ' PHE . 44.1 m-20 -81.12 -32.59 33.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.912 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 663' ' ' PHE . . . . . 0.521 ' CD2' HD22 ' A' ' 659' ' ' LEU . 4.3 t80 -35.74 124.92 0.7 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.901 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 68.5 p -108.44 174.84 5.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.145 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 665' ' ' TRP . . . . . 0.646 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 8.0 p-90 -65.93 -51.97 53.97 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.896 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 666' ' ' LYS . . . . . 0.646 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 2.3 tppp? -44.57 -54.35 6.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.882 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 20.1 mtm -57.86 -49.45 76.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.9 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 56.6 tp -46.8 -44.56 19.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.887 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 29.7 tttm -65.47 -74.92 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.85 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -46.36 -22.93 0.3 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.864 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 671' ' ' LYS . . . . . 0.468 ' HG3' ' CE ' ' A' ' 711' ' ' MET . 9.3 tppt? -70.88 -41.83 70.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.898 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 672' ' ' PHE . . . . . 0.56 ' CE2' ' CD1' ' A' ' 654' ' ' ILE . 18.5 m-85 -88.58 -11.65 44.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.892 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -54.28 -34.31 60.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.846 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -46.3 -44.91 17.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.899 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 12.9 t -64.47 -55.63 19.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.867 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -159.53 -157.16 8.42 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.476 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -86.5 110.42 19.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.889 0.376 . . . . 0.0 110.862 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 76.3 t -85.87 138.4 19.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.111 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 679' ' ' LEU . . . . . 0.591 HD11 ' HG2' ' A' ' 699' ' ' GLU . 25.4 mt -112.68 -62.47 1.58 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.908 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -96.68 131.87 42.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.94 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -155.84 125.17 6.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.102 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -158.13 160.82 37.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.875 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 23.2 mm -109.05 108.16 24.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.151 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.914 179.831 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 120.807 0.336 . . . . 0.0 110.925 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 40.42 33.82 0.59 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.514 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 28.4 p -140.02 133.73 30.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.888 0.375 . . . . 0.0 110.908 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 694' ' ' GLY . . . . . 0.402 ' O ' HG13 ' A' ' 695' ' ' VAL . . . -141.81 -154.4 6.17 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.496 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 695' ' ' VAL . . . . . 0.402 HG13 ' O ' ' A' ' 694' ' ' GLY . 14.3 m -155.75 155.84 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.818 0.342 . . . . 0.0 111.123 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 48.7 t -143.7 125.76 11.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.164 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 13.8 ttpt -109.79 137.6 47.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -111.6 169.77 8.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.925 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 699' ' ' GLU . . . . . 0.591 ' HG2' HD11 ' A' ' 679' ' ' LEU . 15.7 mt-10 -74.89 -42.06 58.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.892 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 39.7 m -109.94 151.09 42.21 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.684 0.754 . . . . 0.0 110.864 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -39.26 6.74 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.696 2.264 . . . . 0.0 112.349 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -54.71 -47.82 73.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.899 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 93.0 t -49.26 -59.08 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.089 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 704' ' ' ALA . . . . . 0.417 ' O ' ' C ' ' A' ' 705' ' ' GLU . . . -41.47 -67.46 0.25 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.066 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 705' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 704' ' ' ALA . 9.7 mt-10 -36.77 -42.61 0.39 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.91 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 706' ' ' ARG . . . . . 0.425 ' O ' ' C ' ' A' ' 707' ' ' ALA . 15.9 ttm180 -69.25 -64.21 0.92 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.848 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 707' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 706' ' ' ARG . . . -35.78 -47.87 0.52 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.087 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 708' ' ' CYS . . . . . 0.468 ' O ' ' N ' ' A' ' 712' ' ' ASN . 1.2 t -43.96 -60.62 1.76 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.924 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 11.9 mtt180 -69.15 -38.0 78.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.908 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 49.4 mtp -64.04 -16.04 60.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.905 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 711' ' ' MET . . . . . 0.468 ' CE ' ' HG3' ' A' ' 671' ' ' LYS . 4.1 mmt -123.54 -8.83 7.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.85 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 712' ' ' ASN . . . . . 0.468 ' N ' ' O ' ' A' ' 708' ' ' CYS . 27.7 t30 -64.58 118.36 8.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.911 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 78.89 30.06 49.11 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.493 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 714' ' ' MET . . . . . . . . . . . . . 34.2 ttp -80.22 110.46 15.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.851 0.357 . . . . 0.0 110.899 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 18.9 mmtt -67.19 102.27 1.02 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.881 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 716' ' ' LEU . . . . . 0.945 HD12 HG21 ' A' ' 721' ' ' ILE . 26.7 mt -99.93 123.08 43.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.939 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 717' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 716' ' ' LEU . 8.7 t 36.66 38.73 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.87 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 80.96 34.18 27.75 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.471 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 719' ' ' ARG . . . . . 0.501 ' N ' ' O ' ' A' ' 716' ' ' LEU . 8.1 mtt-85 -147.27 110.95 4.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.795 0.331 . . . . 0.0 110.887 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -71.33 126.54 29.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.876 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 721' ' ' ILE . . . . . 0.945 HG21 HD12 ' A' ' 716' ' ' LEU . 32.9 pt -97.75 158.82 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.089 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -113.92 99.23 7.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.872 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 723' ' ' VAL . . . . . 0.45 HG21 ' HB3' ' A' ' 711' ' ' MET . 10.6 t -99.07 128.91 50.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.127 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 81.3 mtm180 -148.23 173.65 12.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 725' ' ' ILE . . . . . 0.581 HD13 HG22 ' A' ' 654' ' ' ILE . 31.5 mm -81.05 134.37 27.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.128 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 8.5 t70 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.894 179.849 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 25.8 p . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.809 0.338 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 653' ' ' GLN . . . . . 0.466 ' NE2' ' HB ' ' A' ' 695' ' ' VAL . 10.3 tp60 -89.92 146.32 24.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.876 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 654' ' ' ILE . . . . . 0.485 HD12 ' CG1' ' A' ' 723' ' ' VAL . 23.6 pt -138.04 178.07 4.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.106 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -134.27 153.02 52.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.897 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 20.5 t -135.77 153.43 32.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.138 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -147.67 157.41 43.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.846 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 658' ' ' ASN . . . . . 0.668 ' O ' HG22 ' A' ' 721' ' ' ILE . 4.5 t30 68.63 52.11 0.59 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.556 HD22 ' CE2' ' A' ' 663' ' ' PHE . 39.8 mt -100.2 143.45 26.54 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.594 0.712 . . . . 0.0 110.924 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -47.96 132.97 22.89 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.672 2.248 . . . . 0.0 112.377 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -44.26 -45.66 8.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.884 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 662' ' ' ASP . . . . . 0.479 ' O ' HG23 ' A' ' 664' ' ' THR . 22.8 t0 -68.16 -34.32 76.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.839 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 663' ' ' PHE . . . . . 0.556 ' CE2' HD22 ' A' ' 659' ' ' LEU . 4.2 t80 -36.84 116.59 0.45 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.925 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 664' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 662' ' ' ASP . 59.1 p -107.73 -177.89 3.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.115 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 665' ' ' TRP . . . . . 0.616 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 5.5 p-90 -64.73 -48.65 73.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.866 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 666' ' ' LYS . . . . . 0.616 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 13.8 tptm -48.84 -59.24 3.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.912 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 667' ' ' MET . . . . . 0.492 ' O ' ' CB ' ' A' ' 671' ' ' LYS . 28.6 mtm -53.69 -48.79 69.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 668' ' ' LEU . . . . . 0.427 HD11 ' CG2' ' A' ' 696' ' ' VAL . 15.3 tp -48.56 -46.67 39.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.908 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -65.49 -73.12 0.13 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.914 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -48.59 -23.9 1.15 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.88 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 671' ' ' LYS . . . . . 0.492 ' CB ' ' O ' ' A' ' 667' ' ' MET . 0.3 OUTLIER -69.98 -42.49 73.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.897 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 672' ' ' PHE . . . . . 0.582 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 15.6 m-85 -86.9 -16.09 37.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.854 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -49.52 -38.62 31.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.905 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -39.45 -44.35 1.36 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.898 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 5.9 t -67.48 -64.09 0.93 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.881 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -148.82 -158.86 8.23 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.516 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 677' ' ' HIS . . . . . 0.449 ' C ' ' CD2' ' A' ' 677' ' ' HIS . 3.4 t60 -86.88 107.52 18.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.871 0.367 . . . . 0.0 110.878 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 60.0 t -81.11 143.2 12.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.109 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 679' ' ' LEU . . . . . 0.597 HD11 ' HG2' ' A' ' 699' ' ' GLU . 23.6 mt -116.14 -62.77 1.54 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.872 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -99.91 128.98 45.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.909 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -155.89 123.75 5.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.08 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -152.5 155.85 38.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.875 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 18.1 mm -104.87 107.3 22.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.114 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 179.804 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 19.3 mmmt . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.801 0.334 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 692' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 658' ' ' ASN . . . 48.62 25.95 5.02 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.478 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 19.1 p -135.16 131.17 36.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.884 0.373 . . . . 0.0 110.847 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -143.52 -164.97 10.56 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.483 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 695' ' ' VAL . . . . . 0.466 ' HB ' ' NE2' ' A' ' 653' ' ' GLN . 17.1 m -140.08 160.1 26.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.922 0.391 . . . . 0.0 111.126 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 696' ' ' VAL . . . . . 0.438 HG21 ' CD1' ' A' ' 672' ' ' PHE . 70.7 t -146.52 115.01 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.099 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 37.0 tttt -96.69 138.37 34.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -116.69 164.38 14.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.906 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 699' ' ' GLU . . . . . 0.597 ' HG2' HD11 ' A' ' 679' ' ' LEU . 48.9 mt-10 -71.11 -41.87 69.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.892 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 3.2 m -113.81 149.51 41.91 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.671 0.748 . . . . 0.0 110.887 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -33.53 16.37 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.638 2.225 . . . . 0.0 112.349 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 702' ' ' GLU . . . . . 0.449 ' HG3' ' N ' ' A' ' 703' ' ' VAL . 9.2 pt-20 -61.86 -42.36 98.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.893 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 703' ' ' VAL . . . . . 0.449 ' N ' ' HG3' ' A' ' 702' ' ' GLU . 84.2 t -55.31 -60.51 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.126 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -39.04 -61.43 0.75 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.097 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 705' ' ' GLU . . . . . 0.44 ' HG2' HD11 ' A' ' 725' ' ' ILE . 12.7 mt-10 -44.29 -41.03 5.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.92 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 15.7 ttt180 -67.05 -59.26 3.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.875 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -46.3 -44.0 16.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.056 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 708' ' ' CYS . . . . . 0.495 ' O ' ' CB ' ' A' ' 712' ' ' ASN . 1.8 m -50.74 -41.16 56.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.873 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 3.2 mtt-85 -82.47 -37.66 25.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.868 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 8.7 mtm -72.34 -9.44 58.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.869 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 711' ' ' MET . . . . . 0.582 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 5.5 mmm -120.5 -35.57 3.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.87 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 712' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 708' ' ' CYS . 0.3 OUTLIER -40.87 112.02 0.26 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.862 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 84.79 19.54 59.53 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.51 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 714' ' ' MET . . . . . 0.457 ' N ' ' O ' ' A' ' 711' ' ' MET . 57.2 ttp -69.28 94.07 0.68 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.847 0.356 . . . . 0.0 110.868 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 8.6 mmtp -51.13 98.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.899 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 716' ' ' LEU . . . . . 1.027 HD12 HG21 ' A' ' 721' ' ' ILE . 38.1 mt -99.94 129.92 46.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.951 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 717' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 716' ' ' LEU . 27.8 t 36.51 38.93 0.08 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.885 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 76.76 36.76 36.1 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.479 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 719' ' ' ARG . . . . . 0.498 ' N ' ' O ' ' A' ' 716' ' ' LEU . 21.7 mtt180 -147.22 116.04 6.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.748 0.308 . . . . 0.0 110.848 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -71.41 122.89 21.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.865 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 721' ' ' ILE . . . . . 1.027 HG21 HD12 ' A' ' 716' ' ' LEU . 19.4 pt -98.99 156.89 3.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.133 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 722' ' ' ASP . . . . . 0.446 ' OD1' ' C ' ' A' ' 722' ' ' ASP . 2.9 t0 -116.01 108.23 15.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.837 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 723' ' ' VAL . . . . . 0.485 ' CG1' HD12 ' A' ' 654' ' ' ILE . 17.3 t -107.32 136.02 43.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.177 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 724' ' ' ARG . . . . . 0.45 ' C ' ' SG ' ' A' ' 708' ' ' CYS . 13.5 ptt85 -158.13 165.97 33.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.872 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 725' ' ' ILE . . . . . 0.44 HD11 ' HG2' ' A' ' 705' ' ' GLU . 27.0 mm -62.18 138.0 23.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.126 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 726' ' ' ASP . . . . . 0.406 ' HB2' ' CA ' ' A' ' 654' ' ' ILE . 35.7 t0 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.87 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 24.5 p . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.701 0.286 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -94.51 152.06 18.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.91 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 654' ' ' ILE . . . . . 0.479 HD11 ' CE2' ' A' ' 672' ' ' PHE . 27.6 pt -136.01 174.54 12.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.113 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -127.76 157.04 41.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.901 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 3.1 t -140.72 151.07 20.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.114 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 4.1 mtp-105 -148.23 156.16 42.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.902 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 658' ' ' ASN . . . . . 0.436 ' O ' HG22 ' A' ' 721' ' ' ILE . 0.5 OUTLIER 69.61 45.71 0.77 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.895 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.546 HD22 ' CD2' ' A' ' 663' ' ' PHE . 24.0 mt -94.51 143.71 26.73 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.653 0.74 . . . . 0.0 110.902 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -48.03 136.02 23.75 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.617 2.211 . . . . 0.0 112.383 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -52.34 -33.91 45.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.886 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.16 -30.12 43.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.915 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 663' ' ' PHE . . . . . 0.546 ' CD2' HD22 ' A' ' 659' ' ' LEU . 4.1 t80 -39.13 124.96 1.54 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.91 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 77.2 p -110.0 176.6 5.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.21 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 665' ' ' TRP . . . . . 0.644 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 3.5 p-90 -68.26 -50.05 56.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.959 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 666' ' ' LYS . . . . . 0.644 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 13.1 tptp -52.04 -47.48 65.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.943 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 21.2 mtm -64.78 -39.55 93.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.864 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 38.9 tp -56.43 -46.48 80.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.949 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.44 ' O ' ' ND2' ' A' ' 673' ' ' ASN . 0.0 OUTLIER -62.22 -61.07 2.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 179.791 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -54.59 -27.74 41.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 671' ' ' LYS . . . . . 0.48 ' O ' ' HE2' ' A' ' 711' ' ' MET . 11.0 tptt -66.56 -39.48 88.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 672' ' ' PHE . . . . . 0.479 ' CE2' HD11 ' A' ' 654' ' ' ILE . 25.1 m-85 -90.86 -10.51 42.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.856 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 673' ' ' ASN . . . . . 0.44 ' ND2' ' O ' ' A' ' 669' ' ' LYS . 1.0 OUTLIER -54.53 -32.73 58.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.863 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -58.58 -28.88 65.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 17.3 m -81.81 -53.46 6.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.86 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -161.72 -179.0 36.12 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.492 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -70.2 107.1 3.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.8 0.333 . . . . 0.0 110.855 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 58.8 t -84.68 137.53 20.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.143 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 679' ' ' LEU . . . . . 0.829 HD11 ' HG2' ' A' ' 699' ' ' GLU . 12.1 mt -116.43 -57.98 2.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 680' ' ' TYR . . . . . 0.411 ' HB3' ' CB ' ' A' ' 697' ' ' LYS . 8.3 t80 -99.41 126.11 45.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.925 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -155.6 123.8 5.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.138 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -154.02 158.17 40.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.84 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 27.2 mm -106.87 126.82 62.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.089 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 56.0 mmtt . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.89 179.804 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.808 0.337 . . . . 0.0 110.893 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 95.51 14.63 46.71 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.479 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 21.4 p -133.24 132.22 41.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.871 0.367 . . . . 0.0 110.851 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -139.11 -160.8 8.49 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.509 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 19.3 m -147.21 160.29 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.904 0.383 . . . . 0.0 111.11 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 97.1 t -148.0 113.54 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.137 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 697' ' ' LYS . . . . . 0.411 ' CB ' ' HB3' ' A' ' 680' ' ' TYR . 18.9 ttpt -96.24 143.63 27.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 698' ' ' PHE . . . . . 0.437 ' CD2' HG11 ' A' ' 703' ' ' VAL . 96.2 m-85 -119.66 168.66 10.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.834 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 699' ' ' GLU . . . . . 0.829 ' HG2' HD11 ' A' ' 679' ' ' LEU . 17.7 mt-10 -75.05 -34.44 61.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.918 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 700' ' ' SER . . . . . 0.416 ' CB ' ' OE2' ' A' ' 702' ' ' GLU . 1.4 m -125.34 152.86 71.89 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.696 0.76 . . . . 0.0 110.826 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -50.37 0.47 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.698 2.265 . . . . 0.0 112.36 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 702' ' ' GLU . . . . . 0.416 ' OE2' ' CB ' ' A' ' 700' ' ' SER . 25.6 pm0 -44.54 -27.48 0.47 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.863 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 703' ' ' VAL . . . . . 0.437 HG11 ' CD2' ' A' ' 698' ' ' PHE . 47.0 t -73.4 -54.5 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.095 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -48.61 -57.14 6.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.067 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 705' ' ' GLU . . . . . 0.576 ' HA ' HD11 ' A' ' 725' ' ' ILE . 26.5 mt-10 -45.86 -38.07 6.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.858 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 9.4 ttm-85 -74.03 -58.15 3.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.897 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -47.99 -25.78 1.52 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.11 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 708' ' ' CYS . . . . . 0.5 ' HA ' HG12 ' A' ' 723' ' ' VAL . 1.5 t -60.47 -60.03 4.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.858 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -73.38 -36.97 66.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.812 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 12.1 mmm -59.42 -30.29 68.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.909 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 711' ' ' MET . . . . . 0.48 ' HE2' ' O ' ' A' ' 671' ' ' LYS . 4.8 mmm -107.03 -15.9 14.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.88 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 712' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -53.91 121.83 8.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.923 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 77.14 12.82 84.27 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.524 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 714' ' ' MET . . . . . . . . . . . . . 55.8 ttp -59.64 104.31 0.27 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.849 0.356 . . . . 0.0 110.867 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 7.9 mmtm -61.98 100.22 0.15 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.898 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 716' ' ' LEU . . . . . 0.616 HD12 HG21 ' A' ' 721' ' ' ILE . 31.6 mt -99.89 126.86 46.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.958 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 717' ' ' SER . . . . . 0.409 ' C ' ' O ' ' A' ' 716' ' ' LEU . 1.6 t 36.7 39.7 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.887 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 77.18 36.18 35.89 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.484 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 719' ' ' ARG . . . . . 0.494 ' N ' ' O ' ' A' ' 716' ' ' LEU . 5.9 mtt-85 -148.68 114.54 5.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.804 0.335 . . . . 0.0 110.864 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -72.27 127.48 32.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 721' ' ' ILE . . . . . 0.616 HG21 HD12 ' A' ' 716' ' ' LEU . 28.5 pt -100.04 157.05 4.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.149 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -109.22 98.48 7.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.847 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 723' ' ' VAL . . . . . 0.5 HG12 ' HA ' ' A' ' 708' ' ' CYS . 17.9 t -97.61 130.13 46.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.121 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.19 175.22 13.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.923 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 725' ' ' ILE . . . . . 0.576 HD11 ' HA ' ' A' ' 705' ' ' GLU . 49.4 mm -80.31 133.37 29.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.114 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 9.0 t0 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.861 179.871 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 29.7 p . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.811 0.339 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -163.94 149.44 10.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.913 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 654' ' ' ILE . . . . . 0.659 HG22 HD13 ' A' ' 725' ' ' ILE . 37.8 pt -140.66 173.29 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.14 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -130.5 144.69 51.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.871 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 27.6 t -126.99 139.25 52.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.081 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 36.7 mtp85 -133.73 155.76 49.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.86 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 658' ' ' ASN . . . . . 0.559 ' O ' HG22 ' A' ' 721' ' ' ILE . 4.7 t30 70.66 52.12 0.32 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.92 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.659 HD22 ' CD2' ' A' ' 663' ' ' PHE . 36.7 mt -100.04 145.11 29.64 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.643 0.735 . . . . 0.0 110.875 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -47.92 142.46 15.07 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.654 2.236 . . . . 0.0 112.395 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -60.53 -24.75 65.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.889 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -98.17 13.4 31.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.85 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 663' ' ' PHE . . . . . 0.659 ' CD2' HD22 ' A' ' 659' ' ' LEU . 3.4 t80 -80.14 118.48 21.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 69.4 p -105.45 168.99 8.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.079 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 665' ' ' TRP . . . . . 0.639 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 6.9 p-90 -57.23 -49.72 75.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.927 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 666' ' ' LYS . . . . . 0.639 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 5.3 tptm -46.27 -54.35 9.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.886 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 16.6 mtm -59.72 -55.62 32.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.84 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 14.7 tp -42.97 -46.91 5.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.902 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.4 ' CG ' HD21 ' A' ' 673' ' ' ASN . 46.1 tttt -62.49 -71.45 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -46.28 -24.11 0.43 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.878 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 8.8 tptp -68.79 -51.49 40.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.927 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 672' ' ' PHE . . . . . 0.56 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 23.1 m-85 -78.53 -15.24 58.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.892 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 673' ' ' ASN . . . . . 0.4 HD21 ' CG ' ' A' ' 669' ' ' LYS . 1.6 m-80 -49.92 -34.58 20.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.923 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -53.66 -39.76 65.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.881 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 31.9 m -71.42 -47.54 55.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -165.69 -177.33 37.86 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.479 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -73.21 96.45 2.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.843 0.354 . . . . 0.0 110.862 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 78.9 t -73.26 138.3 21.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.143 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 679' ' ' LEU . . . . . 0.474 HD11 ' HG2' ' A' ' 699' ' ' GLU . 12.9 mt -113.21 -61.52 1.73 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.931 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 680' ' ' TYR . . . . . 0.433 ' HB3' ' CB ' ' A' ' 697' ' ' LYS . 4.5 t80 -95.71 129.11 43.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.93 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -156.91 125.2 5.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.075 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -156.0 161.72 40.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.84 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 42.9 mm -109.25 107.27 22.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.129 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 27.8 mmtm . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.882 179.832 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 691' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 693' ' ' CYS . 29.0 mmtt . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.784 0.326 . . . . 0.0 110.867 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 692' ' ' GLY . . . . . 0.413 ' C ' ' HB2' ' A' ' 659' ' ' LEU . . . 38.14 27.84 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.493 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 693' ' ' CYS . . . . . 0.461 ' N ' ' O ' ' A' ' 691' ' ' LYS . 31.2 p -132.46 129.13 38.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.843 0.354 . . . . 0.0 110.89 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -141.79 -163.47 9.62 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.487 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 13.4 m -142.93 153.1 17.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.857 0.36 . . . . 0.0 111.086 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 696' ' ' VAL . . . . . 0.501 HG21 ' CD1' ' A' ' 672' ' ' PHE . 93.4 t -139.34 118.04 12.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.136 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 697' ' ' LYS . . . . . 0.433 ' CB ' ' HB3' ' A' ' 680' ' ' TYR . 27.0 tttt -101.43 148.04 25.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.906 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -123.31 173.99 7.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 699' ' ' GLU . . . . . 0.474 ' HG2' HD11 ' A' ' 679' ' ' LEU . 4.6 mt-10 -82.47 -44.13 16.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.918 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 1.1 t -103.41 143.01 25.77 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.692 0.758 . . . . 0.0 110.863 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -20.71 34.73 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.682 2.254 . . . . 0.0 112.343 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -75.56 -41.68 54.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.853 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 66.0 t -56.02 -55.71 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.108 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -46.75 -43.91 18.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.092 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 705' ' ' GLU . . . . . 0.548 ' HA ' HD11 ' A' ' 725' ' ' ILE . 13.3 mt-10 -60.03 -34.07 72.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.845 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 26.9 ttm180 -79.95 -57.83 3.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.89 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -45.4 -33.13 2.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.059 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 708' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -53.17 -52.67 58.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.887 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.73 -40.85 32.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 61.1 mtp -56.86 -17.64 10.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 711' ' ' MET . . . . . 0.56 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 4.9 mmm -117.59 -24.81 7.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.856 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 712' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -48.55 114.06 0.89 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.926 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 82.58 31.88 29.05 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.532 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 714' ' ' MET . . . . . . . . . . . . . 63.0 ttp -82.75 105.86 14.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.84 0.352 . . . . 0.0 110.915 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 7.0 mmtp -60.66 100.42 0.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.889 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 716' ' ' LEU . . . . . 0.922 HD12 HG21 ' A' ' 721' ' ' ILE . 31.2 mt -99.89 125.56 45.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.945 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 717' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 716' ' ' LEU . 48.3 t 36.93 38.62 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.854 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 718' ' ' GLY . . . . . 0.406 ' C ' ' HG3' ' A' ' 719' ' ' ARG . . . 79.39 34.78 31.37 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.517 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 719' ' ' ARG . . . . . 0.498 ' N ' ' O ' ' A' ' 716' ' ' LEU . 37.3 mtp85 -146.65 112.76 5.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.748 0.308 . . . . 0.0 110.891 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -70.74 123.6 22.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.854 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 721' ' ' ILE . . . . . 0.922 HG21 HD12 ' A' ' 716' ' ' LEU . 31.7 pt -99.95 156.23 4.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.16 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -114.46 105.04 12.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.875 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 723' ' ' VAL . . . . . 0.429 HG21 ' CB ' ' A' ' 711' ' ' MET . 21.9 t -100.79 132.42 46.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.09 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -154.66 161.43 41.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.878 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 725' ' ' ILE . . . . . 0.659 HD13 HG22 ' A' ' 654' ' ' ILE . 14.9 mm -72.53 134.64 29.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.134 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 6.0 t0 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.884 179.834 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 63.1 m . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.787 0.327 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -94.05 151.42 19.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.911 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 654' ' ' ILE . . . . . 0.483 HD11 ' CE2' ' A' ' 672' ' ' PHE . 20.7 pt -138.69 174.04 10.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.162 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -126.56 156.43 40.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.888 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 3.4 t -142.05 149.68 19.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.152 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -144.81 154.64 42.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.874 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 658' ' ' ASN . . . . . 0.468 ' ND2' ' HB3' ' A' ' 719' ' ' ARG . 4.1 t30 73.56 44.88 0.28 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.868 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . . . . . . . . . 36.3 mt -96.71 144.45 27.86 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.66 0.743 . . . . 0.0 110.86 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -48.0 139.5 20.19 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.676 2.251 . . . . 0.0 112.364 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -62.11 -24.92 67.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.894 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -94.32 3.26 55.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.921 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -70.72 124.39 24.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.881 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 38.7 p -104.22 169.04 8.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.155 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 665' ' ' TRP . . . . . 0.642 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 7.6 p-90 -63.51 -52.15 62.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.947 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 666' ' ' LYS . . . . . 0.642 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 0.0 OUTLIER -47.06 -43.1 19.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.883 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 30.5 mtm -68.31 -50.86 50.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 14.2 tp -48.2 -47.26 35.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.866 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 44.2 tttt -59.54 -74.07 0.08 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.901 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -45.38 -28.23 0.82 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.845 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 671' ' ' LYS . . . . . 0.467 ' HE2' HD21 ' A' ' 716' ' ' LEU . 26.6 tptt -68.64 -39.65 80.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.855 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 672' ' ' PHE . . . . . 0.483 ' CE2' HD11 ' A' ' 654' ' ' ILE . 13.6 m-85 -88.37 -14.01 39.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.866 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -56.53 -35.85 68.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.877 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -42.22 -41.86 2.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.877 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 3.0 t -70.62 -59.78 2.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.852 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -148.81 -153.96 6.17 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.494 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -95.54 104.52 16.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.859 0.361 . . . . 0.0 110.86 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 57.9 t -82.7 136.06 23.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.128 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 679' ' ' LEU . . . . . 0.463 HD11 ' HG2' ' A' ' 699' ' ' GLU . 12.8 mt -109.97 -59.12 1.97 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.935 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -96.99 129.79 44.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.956 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -157.78 122.96 4.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.093 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -148.09 166.54 27.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.835 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 45.2 mm -114.47 106.86 21.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.115 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 36.5 mmtm . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.912 179.794 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 19.3 mmtt . . . . . 0 N--CA 1.458 -0.059 0 CA-C-O 120.814 0.34 . . . . 0.0 110.925 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 55.76 23.7 38.12 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.488 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 27.5 p -131.95 127.34 36.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.866 0.365 . . . . 0.0 110.91 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -142.25 -169.16 12.02 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.489 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 27.5 m -139.07 166.97 21.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.891 0.377 . . . . 0.0 111.127 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 93.0 t -154.75 121.86 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.129 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 20.7 ttpt -105.97 143.08 34.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.911 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 698' ' ' PHE . . . . . 0.429 ' CD2' HG11 ' A' ' 703' ' ' VAL . 96.6 m-85 -118.4 169.24 9.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.878 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 699' ' ' GLU . . . . . 0.463 ' HG2' HD11 ' A' ' 679' ' ' LEU . 6.2 mm-40 -76.7 -45.3 30.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.869 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 31.4 m -104.49 147.37 34.28 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.667 0.746 . . . . 0.0 110.887 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -31.53 20.37 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.687 2.258 . . . . 0.0 112.343 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 702' ' ' GLU . . . . . 0.452 ' HG3' ' N ' ' A' ' 703' ' ' VAL . 11.2 pt-20 -61.47 -42.92 99.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.873 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 703' ' ' VAL . . . . . 0.452 ' N ' ' HG3' ' A' ' 702' ' ' GLU . 94.6 t -53.0 -59.36 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.168 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -40.63 -65.74 0.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.084 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 705' ' ' GLU . . . . . 0.55 ' HA ' HD11 ' A' ' 725' ' ' ILE . 9.8 mt-10 -41.07 -37.69 0.89 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.891 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -75.43 -64.47 1.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.845 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -40.17 -35.33 0.39 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.109 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 708' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -53.26 -56.19 18.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -77.36 -38.63 49.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.861 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 17.8 mmm -57.12 -23.15 45.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.903 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 711' ' ' MET . . . . . 0.403 ' O ' ' C ' ' A' ' 712' ' ' ASN . 4.7 mmm -111.74 -34.75 5.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 712' ' ' ASN . . . . . 0.436 ' OD1' ' C ' ' A' ' 712' ' ' ASN . 9.9 t-20 -38.03 112.71 0.23 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.894 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 84.21 27.96 35.2 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.493 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 714' ' ' MET . . . . . . . . . . . . . 37.2 ttp -77.67 99.04 5.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.861 0.363 . . . . 0.0 110.902 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 715' ' ' LYS . . . . . 0.416 ' HE3' ' CD ' ' A' ' 720' ' ' GLU . 11.8 mmtp -56.06 98.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.874 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 716' ' ' LEU . . . . . 0.665 HD12 HG21 ' A' ' 721' ' ' ILE . 31.5 mt -100.0 125.35 46.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.918 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 717' ' ' SER . . . . . . . . . . . . . 34.7 t 38.86 38.49 0.28 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.843 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 78.55 30.96 47.19 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.487 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 719' ' ' ARG . . . . . 0.499 ' N ' ' O ' ' A' ' 716' ' ' LEU . 45.5 mtt180 -141.13 114.55 8.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.84 0.353 . . . . 0.0 110.873 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 720' ' ' GLU . . . . . 0.416 ' CD ' ' HE3' ' A' ' 715' ' ' LYS . 5.3 mt-10 -73.34 126.1 29.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.878 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 721' ' ' ILE . . . . . 0.665 HG21 HD12 ' A' ' 716' ' ' LEU . 44.9 pt -100.0 162.77 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.118 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -119.07 101.38 7.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.878 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 10.0 t -100.83 132.12 47.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.122 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 50.7 mtp180 -155.99 163.55 39.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.874 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 725' ' ' ILE . . . . . 0.55 HD11 ' HA ' ' A' ' 705' ' ' GLU . 25.0 mm -64.8 135.77 27.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.148 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 31.0 t70 . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.893 179.832 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 64.4 m . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.753 0.311 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -96.56 154.06 17.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.945 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 654' ' ' ILE . . . . . 0.505 HG22 HD13 ' A' ' 725' ' ' ILE . 28.7 pt -141.87 170.05 13.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.114 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -122.39 153.73 38.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.891 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 3.5 t -139.95 148.41 22.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.142 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 38.4 mtp180 -146.73 155.79 42.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.871 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 658' ' ' ASN . . . . . 0.607 ' O ' HG22 ' A' ' 721' ' ' ILE . 3.8 t30 71.28 51.57 0.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.52 HD22 ' CD2' ' A' ' 663' ' ' PHE . 39.2 mt -101.35 143.48 26.67 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.623 0.725 . . . . 0.0 110.893 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 660' ' ' PRO . . . . . 0.477 ' O ' ' N ' ' A' ' 663' ' ' PHE . 66.6 Cg_exo -48.01 126.0 12.5 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.701 2.267 . . . . 0.0 112.336 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -40.79 -40.69 1.39 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.864 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 662' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 663' ' ' PHE . 22.8 t70 -73.16 -33.67 65.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.853 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 663' ' ' PHE . . . . . 0.52 ' CD2' HD22 ' A' ' 659' ' ' LEU . 4.1 t80 -36.31 119.91 0.63 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.895 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 74.4 p -104.88 -179.95 4.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.174 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 665' ' ' TRP . . . . . 0.62 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 6.5 p-90 -71.54 -50.23 33.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.894 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 666' ' ' LYS . . . . . 0.62 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 22.7 tptt -48.7 -43.72 37.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.872 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 667' ' ' MET . . . . . 0.401 ' CE ' ' HA ' ' A' ' 663' ' ' PHE . 27.4 mtm -66.09 -51.92 53.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.912 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 15.5 tp -46.21 -45.9 17.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.885 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 29.9 tttm -60.54 -73.99 0.08 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.885 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -47.07 -28.46 1.73 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.887 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 17.5 tptt -64.6 -41.24 96.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.888 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 672' ' ' PHE . . . . . 0.53 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 21.8 m-85 -88.89 -14.57 36.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.848 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -52.51 -40.19 62.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.897 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -44.6 -37.49 3.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.863 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 88.4 m -73.2 -58.51 3.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.883 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -152.95 -153.92 6.52 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.485 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 677' ' ' HIS . . . . . 0.445 ' CD2' HD23 ' A' ' 679' ' ' LEU . 8.9 t60 -92.84 106.57 18.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.87 0.367 . . . . 0.0 110.829 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 678' ' ' VAL . . . . . 0.467 HG13 HG13 ' A' ' 696' ' ' VAL . 87.0 t -84.34 127.66 39.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.105 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 679' ' ' LEU . . . . . 0.574 HD11 ' HG2' ' A' ' 699' ' ' GLU . 12.0 mt -103.57 -60.16 1.61 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.937 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -99.27 129.06 45.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.921 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -157.65 121.41 4.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.092 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -153.23 156.77 39.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.871 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 37.9 mm -99.44 102.65 13.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.109 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.898 179.824 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm . . . . . 0 C--O 1.23 0.066 0 CA-C-O 120.831 0.348 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 692' ' ' GLY . . . . . 0.42 ' C ' ' HB2' ' A' ' 659' ' ' LEU . . . 53.36 25.9 28.11 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.56 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 31.8 p -127.44 142.13 51.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.843 0.354 . . . . 0.0 110.903 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -150.62 -168.07 15.13 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.503 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 7.1 m -141.62 157.97 21.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.87 0.366 . . . . 0.0 111.131 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 696' ' ' VAL . . . . . 0.467 HG13 HG13 ' A' ' 678' ' ' VAL . 91.6 t -147.52 118.67 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.139 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 14.5 ttpt -105.96 137.24 44.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.922 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -111.91 173.71 6.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.845 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 699' ' ' GLU . . . . . 0.574 ' HG2' HD11 ' A' ' 679' ' ' LEU . 44.9 mt-10 -79.14 -40.77 30.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.865 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 5.5 m -110.18 148.64 38.76 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.63 0.729 . . . . 0.0 110.825 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -17.68 37.4 Favored 'Trans proline' 0 N--CA 1.465 -0.153 0 C-N-CA 122.693 2.262 . . . . 0.0 112.351 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -78.21 -49.27 14.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.862 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 60.9 t -46.51 -42.1 5.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.159 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -59.48 -61.54 2.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.126 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -45.7 -32.43 2.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.897 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 44.5 ttt180 -80.77 -43.98 19.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.867 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -61.06 -62.5 1.81 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.137 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 708' ' ' CYS . . . . . 0.475 ' HA ' ' CG1' ' A' ' 723' ' ' VAL . 26.5 p -47.13 -29.71 2.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.912 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 16.6 mtt85 -89.56 -25.24 21.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.838 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 44.2 mtp -87.57 -12.02 46.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.874 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 711' ' ' MET . . . . . 0.53 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 8.9 mmm -110.82 -23.15 11.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 712' ' ' ASN . . . . . 0.43 ' O ' ' CG ' ' A' ' 712' ' ' ASN . 0.5 OUTLIER -42.6 117.29 1.0 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.857 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 79.78 21.58 65.83 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.49 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 714' ' ' MET . . . . . 0.489 ' HB3' HD11 ' A' ' 721' ' ' ILE . 31.8 ttp -65.54 94.1 0.18 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.843 0.354 . . . . 0.0 110.871 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 715' ' ' LYS . . . . . 0.417 ' NZ ' ' HA2' ' A' ' 718' ' ' GLY . 1.7 mmmt -55.91 99.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.881 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 716' ' ' LEU . . . . . 0.677 HD12 HG21 ' A' ' 721' ' ' ILE . 58.2 mt -100.08 132.28 45.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.871 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 717' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 716' ' ' LEU . 15.7 t 35.92 36.41 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.874 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 718' ' ' GLY . . . . . 0.417 ' HA2' ' NZ ' ' A' ' 715' ' ' LYS . . . 77.99 38.98 25.26 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.502 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 719' ' ' ARG . . . . . 0.499 ' N ' ' O ' ' A' ' 716' ' ' LEU . 39.3 mtt85 -149.23 107.52 3.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.77 0.319 . . . . 0.0 110.883 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -62.73 123.83 19.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 721' ' ' ILE . . . . . 0.677 HG21 HD12 ' A' ' 716' ' ' LEU . 24.9 pt -99.62 155.89 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.13 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -110.73 110.12 20.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.876 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 723' ' ' VAL . . . . . 0.475 ' CG1' ' HA ' ' A' ' 708' ' ' CYS . 2.7 t -109.39 136.87 43.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.14 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -157.95 169.99 23.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.851 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 725' ' ' ILE . . . . . 0.505 HD13 HG22 ' A' ' 654' ' ' ILE . 46.6 mm -77.31 143.09 13.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.126 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 9.5 t70 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.889 179.842 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 81.6 m . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.804 0.335 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -95.09 150.19 20.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.888 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 654' ' ' ILE . . . . . 0.501 HD11 ' CE2' ' A' ' 672' ' ' PHE . 29.2 pt -135.47 176.5 8.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.139 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -131.53 143.47 50.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.884 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 11.1 t -129.97 145.93 34.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.134 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -136.25 168.97 18.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.874 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 658' ' ' ASN . . . . . 0.436 ' O ' HG22 ' A' ' 721' ' ' ILE . 8.5 t30 60.08 47.23 9.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.869 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.607 HD22 ' CE2' ' A' ' 663' ' ' PHE . 53.8 mt -95.14 143.59 26.37 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.629 0.728 . . . . 0.0 110.916 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -47.94 145.04 10.83 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.651 2.234 . . . . 0.0 112.345 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -61.88 -33.18 73.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.91 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -89.41 7.91 33.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.864 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 663' ' ' PHE . . . . . 0.607 ' CE2' HD22 ' A' ' 659' ' ' LEU . 2.9 t80 -73.87 114.17 11.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 57.9 p -100.14 166.01 11.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.184 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 665' ' ' TRP . . . . . 0.587 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 10.6 p-90 -55.9 -46.72 78.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.906 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 666' ' ' LYS . . . . . 0.587 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 4.2 tppp? -48.53 -52.61 21.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.889 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 14.5 mtm -60.58 -54.81 40.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.869 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 26.2 tp -45.97 -45.59 15.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.942 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.4 ' C ' ' N ' ' A' ' 671' ' ' LYS . 33.9 tttm -64.57 -74.79 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.855 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -45.91 -21.73 0.15 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.851 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 671' ' ' LYS . . . . . 0.419 ' HG3' ' CE ' ' A' ' 711' ' ' MET . 6.2 tppt? -71.61 -45.75 61.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.893 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 672' ' ' PHE . . . . . 0.573 ' CD1' HG21 ' A' ' 696' ' ' VAL . 23.7 m-85 -84.36 -8.81 58.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.904 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -58.88 -30.08 67.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.89 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -49.01 -43.3 40.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.897 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 675' ' ' CYS . . . . . 0.502 ' SG ' ' HB2' ' A' ' 707' ' ' ALA . 19.2 t -66.6 -62.27 1.54 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.873 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -147.6 -148.19 4.7 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.489 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -98.68 101.64 13.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.794 0.33 . . . . 0.0 110.889 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 678' ' ' VAL . . . . . 0.431 ' CG1' HG13 ' A' ' 696' ' ' VAL . 98.8 t -76.81 136.29 24.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.122 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 18.2 mt -110.33 -62.74 1.47 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.928 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 680' ' ' TYR . . . . . 0.422 ' CE2' HG21 ' A' ' 695' ' ' VAL . 9.1 t80 -95.98 126.4 41.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.94 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -156.84 125.9 5.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.103 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -157.5 157.24 33.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.862 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 45.5 mm -97.74 104.17 15.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.155 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 179.893 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt . . . . . 0 C--O 1.23 0.051 0 CA-C-O 120.816 0.341 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 43.77 36.37 3.55 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.447 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 28.9 p -137.97 142.49 40.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.845 0.355 . . . . 0.0 110.906 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -152.56 -160.78 9.82 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.468 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 695' ' ' VAL . . . . . 0.422 HG21 ' CE2' ' A' ' 680' ' ' TYR . 10.3 m -149.54 156.73 7.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.869 0.366 . . . . 0.0 111.127 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 696' ' ' VAL . . . . . 0.573 HG21 ' CD1' ' A' ' 672' ' ' PHE . 67.0 t -146.14 118.37 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.086 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 15.8 tttt -104.22 146.03 29.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.901 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -122.11 164.79 17.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.861 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 699' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -68.76 -42.16 77.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.88 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 26.4 m -110.92 147.16 35.94 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.703 0.763 . . . . 0.0 110.824 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -29.16 24.17 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.698 2.265 . . . . 0.0 112.333 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -63.5 -40.92 98.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 94.7 t -58.83 -57.1 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.058 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -43.19 -66.71 0.34 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.127 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 705' ' ' GLU . . . . . 0.738 ' HA ' HD11 ' A' ' 725' ' ' ILE . 27.9 mt-10 -39.34 -39.29 0.63 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.902 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 706' ' ' ARG . . . . . 0.429 ' O ' ' N ' ' A' ' 708' ' ' CYS . 16.1 ttm-85 -73.46 -64.11 1.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.882 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 707' ' ' ALA . . . . . 0.502 ' HB2' ' SG ' ' A' ' 675' ' ' CYS . . . -38.95 -29.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.087 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 708' ' ' CYS . . . . . 0.429 ' N ' ' O ' ' A' ' 706' ' ' ARG . 1.2 t -61.81 -49.47 76.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.832 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -77.19 -33.11 56.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.851 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 59.7 mtp -70.04 -16.37 63.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.843 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 711' ' ' MET . . . . . 0.431 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 5.3 mmm -118.93 -20.41 8.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.892 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 712' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -53.28 122.48 9.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.92 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 74.68 23.5 74.97 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.515 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 714' ' ' MET . . . . . . . . . . . . . 42.4 ttp -76.4 111.05 11.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.859 0.362 . . . . 0.0 110.885 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 19.4 mmtt -63.34 102.53 0.41 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.942 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 716' ' ' LEU . . . . . 1.081 HD12 HG21 ' A' ' 721' ' ' ILE . 36.9 mt -99.98 122.98 43.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.905 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 717' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 716' ' ' LEU . 1.3 t 37.3 42.1 0.28 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 76.97 32.7 48.4 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.418 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 719' ' ' ARG . . . . . 0.498 ' N ' ' O ' ' A' ' 716' ' ' LEU . 21.9 mtp180 -146.83 110.73 5.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.805 0.336 . . . . 0.0 110.867 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -68.55 125.38 26.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.842 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 721' ' ' ILE . . . . . 1.081 HG21 HD12 ' A' ' 716' ' ' LEU . 26.7 pt -99.55 155.0 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.111 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -111.32 104.58 13.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.885 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 723' ' ' VAL . . . . . 0.411 HG21 ' CB ' ' A' ' 711' ' ' MET . 3.7 t -100.67 131.99 47.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.096 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -155.56 160.37 40.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.897 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 725' ' ' ILE . . . . . 0.738 HD11 ' HA ' ' A' ' 705' ' ' GLU . 33.9 mm -60.86 135.96 25.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.118 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 21.8 t70 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.917 179.856 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 60.2 m . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.751 0.31 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -98.31 156.27 16.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.913 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 654' ' ' ILE . . . . . 0.452 HD11 ' CE2' ' A' ' 672' ' ' PHE . 43.7 pt -142.7 166.94 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.125 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -119.12 156.49 29.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.926 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 3.3 t -143.75 151.06 16.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.133 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 49.3 mtp180 -147.27 156.74 43.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.858 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 658' ' ' ASN . . . . . 0.56 ' O ' HG22 ' A' ' 721' ' ' ILE . 6.6 t30 70.44 51.91 0.35 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.926 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.801 HD23 HD12 ' A' ' 716' ' ' LEU . 37.6 mt -100.75 143.55 26.78 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.63 0.728 . . . . 0.0 110.902 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 660' ' ' PRO . . . . . 0.447 ' O ' ' N ' ' A' ' 663' ' ' PHE . 64.4 Cg_exo -47.97 128.64 16.78 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.683 2.255 . . . . 0.0 112.346 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -43.09 -31.96 0.63 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.869 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 662' ' ' ASP . . . . . 0.446 ' O ' HG23 ' A' ' 664' ' ' THR . 9.1 m-20 -82.81 -32.54 27.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.864 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 663' ' ' PHE . . . . . 0.447 ' N ' ' O ' ' A' ' 660' ' ' PRO . 4.2 t80 -40.23 113.16 0.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 664' ' ' THR . . . . . 0.446 HG23 ' O ' ' A' ' 662' ' ' ASP . 24.8 p -104.81 -177.48 3.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.121 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 665' ' ' TRP . . . . . 0.646 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 8.2 p-90 -66.76 -52.26 46.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 666' ' ' LYS . . . . . 0.646 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 22.8 tptp -44.78 -55.0 5.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.907 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 11.9 mtm -60.42 -46.01 91.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.866 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 27.9 tp -51.44 -42.97 61.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.919 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.41 ' O ' ' ND2' ' A' ' 673' ' ' ASN . 29.2 tttm -65.64 -74.41 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.909 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -45.86 -24.42 0.39 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.821 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? -68.9 -52.74 26.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.898 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 672' ' ' PHE . . . . . 0.455 ' CD1' HG21 ' A' ' 696' ' ' VAL . 23.3 m-85 -76.99 -13.72 59.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.899 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 673' ' ' ASN . . . . . 0.41 ' ND2' ' O ' ' A' ' 669' ' ' LYS . 1.5 m-80 -52.86 -28.37 22.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.871 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -50.49 -46.64 57.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.897 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 675' ' ' CYS . . . . . 0.612 ' SG ' ' HB2' ' A' ' 707' ' ' ALA . 12.4 t -64.4 -61.18 2.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.902 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -152.33 -147.38 4.58 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.465 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -95.41 114.13 25.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.79 0.329 . . . . 0.0 110.867 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 77.7 t -88.39 123.51 40.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.135 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 679' ' ' LEU . . . . . 0.739 HD11 ' HG2' ' A' ' 699' ' ' GLU . 19.2 mt -97.11 -61.93 1.33 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.916 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -99.84 123.7 44.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.935 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -149.41 121.68 8.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.099 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -155.8 155.81 33.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.878 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 28.1 mm -101.62 105.95 18.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.123 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.874 179.87 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 35.5 mmtm . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.818 0.342 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 58.47 16.81 30.31 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.472 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 1.9 p -123.45 129.68 51.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.826 0.346 . . . . 0.0 110.895 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -136.45 -159.6 8.45 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.5 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 13.5 m -148.13 155.82 9.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.872 0.367 . . . . 0.0 111.134 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 696' ' ' VAL . . . . . 0.455 HG21 ' CD1' ' A' ' 672' ' ' PHE . 91.7 t -143.8 119.42 4.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.182 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 28.2 tttt -104.36 140.45 37.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.916 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -117.99 167.99 10.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.899 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 699' ' ' GLU . . . . . 0.739 ' HG2' HD11 ' A' ' 679' ' ' LEU . 9.7 mm-40 -76.2 -39.25 55.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 1.8 t -108.83 142.98 26.64 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.633 0.73 . . . . 0.0 110.847 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -24.59 29.75 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.676 2.251 . . . . 0.0 112.373 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 702' ' ' GLU . . . . . 0.435 ' HG3' ' N ' ' A' ' 703' ' ' VAL . 6.9 pt-20 -73.76 -34.11 64.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.886 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 703' ' ' VAL . . . . . 0.435 ' N ' ' HG3' ' A' ' 702' ' ' GLU . 38.2 t -61.7 -56.96 14.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.142 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -43.39 -62.44 1.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.107 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -43.35 -43.08 4.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.906 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 16.0 ttm180 -66.08 -58.31 5.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.834 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 707' ' ' ALA . . . . . 0.612 ' HB2' ' SG ' ' A' ' 675' ' ' CYS . . . -50.64 -34.05 24.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.097 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 708' ' ' CYS . . . . . 0.425 ' SG ' ' CG2' ' A' ' 654' ' ' ILE . 2.4 m -61.18 -42.25 98.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.892 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 709' ' ' ARG . . . . . 0.407 ' O ' ' ND2' ' A' ' 712' ' ' ASN . 18.8 mtt180 -84.15 -20.11 33.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.849 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 17.1 mtm -88.79 -9.76 50.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.873 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 711' ' ' MET . . . . . . . . . . . . . 5.7 mmm -120.45 -10.62 9.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.9 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 712' ' ' ASN . . . . . 0.407 ' ND2' ' O ' ' A' ' 709' ' ' ARG . 0.9 OUTLIER -53.98 126.74 23.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.857 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 69.63 8.12 59.58 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.496 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 714' ' ' MET . . . . . 0.58 ' HB3' HD11 ' A' ' 721' ' ' ILE . 10.3 ttp -49.38 99.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.857 0.36 . . . . 0.0 110.859 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 10.3 mmtp -56.05 102.56 0.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.888 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 716' ' ' LEU . . . . . 0.801 HD12 HD23 ' A' ' 659' ' ' LEU . 12.2 mt -99.88 117.0 33.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.923 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 717' ' ' SER . . . . . . . . . . . . . 2.3 t 40.91 44.41 1.96 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.912 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 76.33 31.28 55.18 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.493 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 719' ' ' ARG . . . . . 0.44 ' HB3' ' ND2' ' A' ' 658' ' ' ASN . 23.9 mtp180 -144.26 106.89 4.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.757 0.313 . . . . 0.0 110.876 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -66.18 125.77 26.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.881 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 721' ' ' ILE . . . . . 0.58 HD11 ' HB3' ' A' ' 714' ' ' MET . 38.2 pt -97.79 156.4 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.109 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -110.61 98.09 7.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.855 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 3.2 t -94.84 134.93 30.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.12 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 25.6 mtt-85 -158.08 176.11 12.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.859 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 725' ' ' ILE . . . . . 0.46 ' HA ' HD13 ' A' ' 725' ' ' ILE . 10.1 mm -78.23 138.95 19.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.125 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 18.7 t0 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.817 179.906 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 26.4 p . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.792 0.329 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -104.29 146.6 28.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.895 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 654' ' ' ILE . . . . . . . . . . . . . 25.4 pt -135.27 172.66 15.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.138 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -128.21 149.59 50.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.868 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 4.0 t -132.19 152.87 37.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.095 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 69.8 mtt180 -146.81 160.08 42.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.88 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 658' ' ' ASN . . . . . 0.467 ' O ' HG22 ' A' ' 721' ' ' ILE . 1.1 t30 66.94 48.51 1.27 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.914 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . . . . . . . . . 40.5 mt -98.71 145.41 29.87 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.635 0.731 . . . . 0.0 110.909 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_exo -47.98 126.17 12.74 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.692 2.261 . . . . 0.0 112.337 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -49.35 -25.97 2.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.857 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -88.01 -24.95 23.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -41.09 147.69 0.13 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.861 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 35.5 p -128.07 169.55 13.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.115 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 665' ' ' TRP . . . . . 0.644 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 5.6 p-90 -63.96 -53.0 57.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.894 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 666' ' ' LYS . . . . . 0.644 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 3.7 tppp? -47.55 -47.71 28.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.924 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 46.1 mtm -63.16 -50.64 69.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.88 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 29.7 tp -46.66 -45.65 19.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.931 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 30.9 tttm -60.72 -72.36 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.925 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -47.04 -25.07 0.74 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.902 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 17.0 tptt -68.76 -43.63 75.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.892 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 672' ' ' PHE . . . . . 0.517 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 23.8 m-85 -87.38 -13.42 43.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.889 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -50.71 -36.69 37.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.852 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -51.22 -39.79 57.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.857 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 37.4 m -72.01 -42.29 66.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 676' ' ' GLY . . . . . 0.417 ' HA3' HG11 ' A' ' 703' ' ' VAL . . . -177.16 170.12 42.64 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.483 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -59.56 114.91 2.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.85 0.357 . . . . 0.0 110.888 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 41.4 t -90.63 139.69 17.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.1 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 679' ' ' LEU . . . . . 0.402 HD21 ' HG2' ' A' ' 699' ' ' GLU . 13.8 mt -110.62 -63.8 1.35 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.932 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -99.06 131.27 45.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.97 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -157.22 120.86 4.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.115 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -148.26 164.11 34.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.904 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 38.3 mm -109.18 106.58 20.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.11 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.935 179.832 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt . . . . . 0 N--CA 1.458 -0.062 0 CA-C-O 120.811 0.339 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 55.14 15.51 7.31 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.528 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 27.0 p -123.38 139.43 54.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.848 0.356 . . . . 0.0 110.896 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -143.39 -157.19 7.06 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.429 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 6.9 m -152.58 151.86 11.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.885 0.374 . . . . 0.0 111.126 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 94.3 t -141.95 119.43 7.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.111 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 17.6 tttt -106.36 134.06 50.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.879 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -109.25 169.06 8.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.864 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 699' ' ' GLU . . . . . 0.402 ' HG2' HD21 ' A' ' 679' ' ' LEU . 21.4 mt-10 -72.11 -37.67 69.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.867 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -115.15 143.96 31.26 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.658 0.742 . . . . 0.0 110.828 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -10.84 29.57 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.709 2.272 . . . . 0.0 112.327 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -82.6 -46.48 13.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.91 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 703' ' ' VAL . . . . . 0.417 HG11 ' HA3' ' A' ' 676' ' ' GLY . 65.8 t -50.42 -47.84 26.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.162 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -49.3 -61.32 2.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.145 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 705' ' ' GLU . . . . . 0.481 ' HA ' HD11 ' A' ' 725' ' ' ILE . 42.8 mt-10 -47.57 -23.5 0.67 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.878 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 706' ' ' ARG . . . . . 0.408 ' HG2' ' HE2' ' A' ' 710' ' ' MET . 45.1 ttt180 -87.08 -43.45 12.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.821 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 707' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' ' 711' ' ' MET . . . -65.03 -56.94 10.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.108 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 708' ' ' CYS . . . . . 0.431 ' HA ' ' CG1' ' A' ' 723' ' ' VAL . 13.8 p -42.98 -42.13 3.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.876 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 709' ' ' ARG . . . . . 0.405 ' N ' ' SG ' ' A' ' 708' ' ' CYS . 15.8 mtt180 -80.16 -34.91 37.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.897 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 710' ' ' MET . . . . . 0.408 ' HE2' ' HG2' ' A' ' 706' ' ' ARG . 14.8 mtm -78.07 -9.14 59.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.886 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 711' ' ' MET . . . . . 0.517 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 5.9 mmm -116.14 -20.18 9.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.888 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 712' ' ' ASN . . . . . 0.435 ' OD1' ' C ' ' A' ' 712' ' ' ASN . 10.3 t-20 -55.03 115.21 2.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.914 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 85.75 18.67 59.49 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.543 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 714' ' ' MET . . . . . . . . . . . . . 44.7 ttp -71.11 96.64 1.38 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.834 0.35 . . . . 0.0 110.887 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 5.4 mmtp -51.54 101.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 716' ' ' LEU . . . . . 1.077 HD12 HG21 ' A' ' 721' ' ' ILE . 33.9 mt -100.2 120.4 39.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.925 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 717' ' ' SER . . . . . . . . . . . . . 1.2 t 40.32 44.95 1.72 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.857 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 74.13 27.25 66.67 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.503 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 719' ' ' ARG . . . . . 0.452 ' N ' ' O ' ' A' ' 716' ' ' LEU . 44.1 mtt85 -139.31 109.57 6.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.728 0.299 . . . . 0.0 110.882 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -67.11 125.28 25.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.866 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 721' ' ' ILE . . . . . 1.077 HG21 HD12 ' A' ' 716' ' ' LEU . 27.5 pt -99.96 156.22 4.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.161 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -116.28 104.55 11.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.862 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 723' ' ' VAL . . . . . 0.431 ' CG1' ' HA ' ' A' ' 708' ' ' CYS . 3.6 t -104.72 135.37 42.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.137 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 22.1 mtp85 -157.89 159.05 36.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.885 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 725' ' ' ILE . . . . . 0.481 HD11 ' HA ' ' A' ' 705' ' ' GLU . 35.6 mm -61.19 135.12 26.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.121 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 5.4 t70 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 179.842 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 22.6 p . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.748 0.308 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 653' ' ' GLN . . . . . 0.45 ' HG3' ' N ' ' A' ' 654' ' ' ILE . 8.1 tp60 -93.1 146.52 23.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.917 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 654' ' ' ILE . . . . . 0.59 HG22 HD13 ' A' ' 725' ' ' ILE . 40.2 pt -134.51 177.24 7.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.112 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -132.8 159.69 39.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.861 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 6.5 t -140.71 150.44 20.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.069 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 657' ' ' ARG . . . . . 0.418 ' NH2' ' HB3' ' A' ' 722' ' ' ASP . 81.6 mtm-85 -146.68 157.43 43.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.883 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 658' ' ' ASN . . . . . 0.634 ' O ' HG22 ' A' ' 721' ' ' ILE . 0.3 OUTLIER 67.15 54.43 0.74 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.905 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.449 HD22 ' CD2' ' A' ' 663' ' ' PHE . 38.7 mt -102.42 144.88 29.5 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.628 0.728 . . . . 0.0 110.908 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -48.0 133.47 23.33 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.648 2.232 . . . . 0.0 112.356 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -53.08 -28.34 24.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.867 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -86.64 -19.67 28.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.866 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 663' ' ' PHE . . . . . 0.449 ' CD2' HD22 ' A' ' 659' ' ' LEU . 3.6 t80 -49.25 136.02 16.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.893 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 72.7 p -120.93 175.27 6.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.114 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 665' ' ' TRP . . . . . 0.65 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 5.3 p-90 -66.57 -51.05 60.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.889 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 666' ' ' LYS . . . . . 0.65 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 0.0 OUTLIER -45.86 -45.02 14.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.859 179.94 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 38.8 mtm -68.54 -52.19 34.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.925 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 30.0 tp -45.89 -42.4 12.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.933 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 44.8 tttt -65.95 -73.09 0.14 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.912 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -48.37 -23.77 1.03 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.876 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 16.1 tptt -69.68 -44.09 71.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.914 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 672' ' ' PHE . . . . . 0.512 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 16.9 m-85 -85.49 -14.8 44.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.911 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -55.25 -27.93 49.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.876 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -63.34 -19.87 65.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 34.1 m -89.38 -36.19 15.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.912 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -177.32 -154.78 12.54 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.485 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -91.93 108.64 20.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.884 0.373 . . . . 0.0 110.87 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 63.7 t -90.58 136.32 24.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.125 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 679' ' ' LEU . . . . . 0.526 HD11 ' HG2' ' A' ' 699' ' ' GLU . 27.0 mt -110.44 -61.87 1.6 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.964 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -98.67 131.06 45.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.93 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -155.39 125.84 6.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.105 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -156.18 159.57 39.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.878 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 34.3 mm -105.38 97.44 5.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.126 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.943 179.834 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 6.4 mmtp . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.811 0.339 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 60.48 28.17 67.04 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.482 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 26.5 p -136.18 142.24 44.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.88 0.371 . . . . 0.0 110.852 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -152.3 -164.91 12.71 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.499 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 6.8 m -148.51 155.9 8.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.853 0.359 . . . . 0.0 111.128 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 88.5 t -143.13 123.64 10.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.15 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 14.8 ttpt -103.28 139.07 39.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 698' ' ' PHE . . . . . 0.433 ' CD2' HG11 ' A' ' 703' ' ' VAL . 96.0 m-85 -116.71 165.15 13.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.89 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 699' ' ' GLU . . . . . 0.526 ' HG2' HD11 ' A' ' 679' ' ' LEU . 38.8 mt-10 -72.32 -43.25 64.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.864 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 700' ' ' SER . . . . . 0.667 ' OG ' HG23 ' A' ' 703' ' ' VAL . 79.8 p -111.08 149.45 40.5 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.639 0.733 . . . . 0.0 110.836 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -29.29 24.03 Favored 'Trans proline' 0 C--N 1.34 0.122 0 C-N-CA 122.662 2.241 . . . . 0.0 112.346 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 702' ' ' GLU . . . . . 0.409 ' HG3' ' N ' ' A' ' 703' ' ' VAL . 13.9 pt-20 -63.26 -46.7 85.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.909 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 703' ' ' VAL . . . . . 0.667 HG23 ' OG ' ' A' ' 700' ' ' SER . 71.6 t -50.78 -56.51 4.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.128 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -45.05 -60.98 1.81 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.109 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -44.03 -35.16 1.98 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.885 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 -77.95 -59.78 2.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.913 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -43.25 -32.43 0.77 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.087 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 708' ' ' CYS . . . . . 0.498 ' O ' ' N ' ' A' ' 712' ' ' ASN . 7.0 t -57.29 -60.51 3.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.889 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -68.39 -30.63 69.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 15.3 mmm -70.59 -30.72 67.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.854 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 711' ' ' MET . . . . . 0.512 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 4.3 mmm -107.68 -9.71 15.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.915 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 712' ' ' ASN . . . . . 0.498 ' N ' ' O ' ' A' ' 708' ' ' CYS . 10.4 t-20 -62.35 114.49 3.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.859 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 85.14 13.2 71.98 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.467 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 714' ' ' MET . . . . . . . . . . . . . 53.1 ttp -59.66 100.9 0.09 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.86 0.362 . . . . 0.0 110.852 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 8.8 mmtp -62.67 100.51 0.2 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.876 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 716' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 719' ' ' ARG . 31.2 mt -100.0 128.23 46.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.931 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 717' ' ' SER . . . . . 0.435 ' C ' ' O ' ' A' ' 716' ' ' LEU . 3.1 t 35.44 37.99 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.897 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 79.5 37.98 22.3 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.492 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 719' ' ' ARG . . . . . 0.504 ' N ' ' O ' ' A' ' 716' ' ' LEU . 6.7 mtt-85 -148.08 113.46 5.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.797 0.332 . . . . 0.0 110.861 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -74.5 125.69 29.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.889 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 721' ' ' ILE . . . . . 0.634 HG22 ' O ' ' A' ' 658' ' ' ASN . 46.5 pt -99.67 153.66 4.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.108 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 722' ' ' ASP . . . . . 0.418 ' HB3' ' NH2' ' A' ' 657' ' ' ARG . 54.7 m-20 -109.03 97.9 7.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.858 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 723' ' ' VAL . . . . . 0.47 HG21 ' CB ' ' A' ' 711' ' ' MET . 11.9 t -94.46 135.23 29.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.107 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.04 176.04 13.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.832 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 725' ' ' ILE . . . . . 0.59 HD13 HG22 ' A' ' 654' ' ' ILE . 39.0 mm -78.5 143.88 12.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.135 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 45.1 t0 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 179.813 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 36.7 m . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.722 0.296 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -105.16 147.43 27.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.869 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 654' ' ' ILE . . . . . 0.515 HD11 ' CE2' ' A' ' 672' ' ' PHE . 40.9 pt -135.54 171.56 17.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.091 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -121.86 158.77 28.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.872 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 5.5 t -147.52 145.78 18.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.11 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 51.6 mtp180 -143.78 160.94 39.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.883 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 658' ' ' ASN . . . . . 0.481 ' ND2' ' HB3' ' A' ' 719' ' ' ARG . 3.7 t30 69.73 47.86 0.61 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.894 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . . . . . . . . . 51.1 mt -101.41 143.97 27.64 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.614 0.721 . . . . 0.0 110.898 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -48.04 133.71 23.63 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.71 2.273 . . . . 0.0 112.299 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -47.99 -41.58 25.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.877 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -72.25 -29.94 64.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.888 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -38.87 116.3 0.55 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.864 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 40.7 p -101.58 179.39 4.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.185 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 665' ' ' TRP . . . . . 0.583 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 6.4 p-90 -69.09 -47.52 65.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.907 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 666' ' ' LYS . . . . . 0.583 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 0.0 OUTLIER -50.36 -45.78 55.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.893 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 24.9 mtm -66.05 -52.76 46.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.876 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 18.0 tp -46.46 -47.23 19.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.915 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.46 ' HB2' ' CB ' ' A' ' 681' ' ' ALA . 29.9 tttt -63.3 -72.62 0.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.883 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -45.26 -26.61 0.52 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.864 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 15.3 tptt -67.81 -41.75 82.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.917 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 672' ' ' PHE . . . . . 0.581 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 20.9 m-85 -86.19 -18.91 30.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.91 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 673' ' ' ASN . . . . . 0.435 HD21 ' CG ' ' A' ' 669' ' ' LYS . 2.1 m-80 -50.32 -35.02 25.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -40.99 -42.33 1.86 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 6.4 t -70.25 -64.96 0.79 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.904 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -142.17 -151.28 5.49 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.464 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -98.69 101.16 12.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.851 0.358 . . . . 0.0 110.885 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 69.5 t -74.57 141.65 15.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.143 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 679' ' ' LEU . . . . . 0.465 HD11 ' HG2' ' A' ' 699' ' ' GLU . 14.3 mt -114.31 -59.26 2.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.897 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -98.01 126.35 43.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 681' ' ' ALA . . . . . 0.46 ' CB ' ' HB2' ' A' ' 669' ' ' LYS . . . -154.25 123.71 6.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.109 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -151.94 160.89 43.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.868 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 21.8 mm -111.5 117.7 55.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.114 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.911 179.836 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 120.833 0.349 . . . . 0.0 110.959 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 80.29 18.9 70.45 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.446 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 15.1 p -131.67 123.99 28.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.896 0.379 . . . . 0.0 110.875 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -132.86 -162.14 10.13 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.483 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 16.8 m -144.31 167.2 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.857 0.361 . . . . 0.0 111.159 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 696' ' ' VAL . . . . . 0.491 HG21 ' CD1' ' A' ' 672' ' ' PHE . 99.1 t -150.9 122.55 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.13 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 10.6 ttpp -107.5 136.74 46.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -113.67 172.34 7.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.903 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 699' ' ' GLU . . . . . 0.465 ' HG2' HD11 ' A' ' 679' ' ' LEU . 65.9 mt-10 -79.22 -42.3 26.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.903 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 21.7 m -108.18 143.97 28.48 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.632 0.729 . . . . 0.0 110.882 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 -28.42 25.47 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.676 2.25 . . . . 0.0 112.397 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -68.28 -33.42 74.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.895 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 76.0 t -64.15 -57.36 11.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.161 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -44.65 -52.46 8.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.122 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -53.97 -30.36 46.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.919 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 45.0 ttt180 -82.23 -43.55 17.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.87 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -61.35 -56.71 17.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.083 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 708' ' ' CYS . . . . . . . . . . . . . 28.8 p -46.3 -32.81 3.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.881 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 11.8 mtp180 -83.16 -35.93 25.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.819 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 29.0 mtm -77.85 -11.39 59.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.88 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 711' ' ' MET . . . . . 0.581 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 4.3 mmt -112.51 -34.58 5.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.874 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 712' ' ' ASN . . . . . 0.401 ' OD1' ' C ' ' A' ' 712' ' ' ASN . 2.2 t-20 -39.16 106.77 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.882 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 91.04 20.01 40.79 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.512 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 714' ' ' MET . . . . . 0.58 ' HE3' HD11 ' A' ' 721' ' ' ILE . 2.9 ttm -64.7 99.79 0.35 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.839 0.352 . . . . 0.0 110.866 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 715' ' ' LYS . . . . . 0.457 ' CD ' ' HG3' ' A' ' 720' ' ' GLU . 22.4 mmtt -59.92 99.78 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.906 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 716' ' ' LEU . . . . . 0.501 ' O ' ' N ' ' A' ' 719' ' ' ARG . 32.6 mt -99.8 125.64 45.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.9 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 717' ' ' SER . . . . . 0.403 ' C ' ' O ' ' A' ' 716' ' ' LEU . 1.7 t 37.72 40.03 0.24 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.846 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 77.96 32.93 42.96 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.476 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 719' ' ' ARG . . . . . 0.501 ' N ' ' O ' ' A' ' 716' ' ' LEU . 18.4 mtp85 -141.9 110.42 6.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.763 0.316 . . . . 0.0 110.894 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 720' ' ' GLU . . . . . 0.457 ' HG3' ' CD ' ' A' ' 715' ' ' LYS . 27.9 mt-10 -71.53 127.73 33.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.886 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 721' ' ' ILE . . . . . 0.58 HD11 ' HE3' ' A' ' 714' ' ' MET . 21.2 pt -97.97 160.5 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.127 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -116.8 100.13 7.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.831 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 3.3 t -100.32 136.09 33.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.11 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.89 148.38 20.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.852 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 725' ' ' ILE . . . . . 0.413 HD13 HG22 ' A' ' 654' ' ' ILE . 31.3 mm -56.62 134.74 20.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.114 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 21.5 t0 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 179.874 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 30.2 p . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.739 0.304 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -105.44 147.24 28.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.879 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 654' ' ' ILE . . . . . 0.454 HD11 ' CE2' ' A' ' 672' ' ' PHE . 33.4 pt -135.12 171.17 18.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.13 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -125.13 151.63 45.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.862 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 23.2 t -133.22 152.45 35.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.159 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -147.86 157.99 43.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.877 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 658' ' ' ASN . . . . . 0.48 ' ND2' ' HB3' ' A' ' 719' ' ' ARG . 6.7 t30 71.5 35.13 1.54 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.903 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.815 HD22 ' CD2' ' A' ' 663' ' ' PHE . 23.8 mt -85.14 143.58 39.82 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.631 0.729 . . . . 0.0 110.86 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -47.94 146.48 8.81 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.686 2.257 . . . . 0.0 112.353 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -64.45 -28.87 69.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.11 13.92 23.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.852 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 663' ' ' PHE . . . . . 0.815 ' CD2' HD22 ' A' ' 659' ' ' LEU . 2.9 t80 -79.04 121.92 25.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.906 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 62.9 p -104.9 169.55 8.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.156 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 665' ' ' TRP . . . . . 0.601 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 5.0 p-90 -62.85 -45.13 94.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.917 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 666' ' ' LYS . . . . . 0.601 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 5.5 tppp? -51.52 -46.11 63.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 30.1 mtm -67.54 -51.9 45.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.887 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 24.3 tp -47.62 -44.81 27.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.908 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 34.7 tttm -64.23 -70.8 0.2 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.903 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -47.36 -24.75 0.84 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.856 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 17.8 tptt -69.41 -42.35 75.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.901 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 672' ' ' PHE . . . . . 0.466 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 20.5 m-85 -85.99 -21.98 27.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.861 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 673' ' ' ASN . . . . . 0.407 ' ND2' ' HB ' ' A' ' 678' ' ' VAL . 1.5 m-80 -45.02 -37.34 4.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -46.69 -45.37 19.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.914 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 86.4 m -66.9 -54.99 16.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.864 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -153.93 -170.27 19.73 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.478 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 677' ' ' HIS . . . . . 0.401 ' CD2' ' C ' ' A' ' 677' ' ' HIS . 2.5 t-160 -82.88 93.56 7.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.873 0.368 . . . . 0.0 110.867 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 678' ' ' VAL . . . . . 0.407 ' HB ' ' ND2' ' A' ' 673' ' ' ASN . 84.8 t -70.09 141.21 17.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.149 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 679' ' ' LEU . . . . . 0.786 HD11 ' HG2' ' A' ' 699' ' ' GLU . 12.1 mt -115.24 -59.75 1.97 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.902 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 680' ' ' TYR . . . . . 0.408 ' HB3' ' CB ' ' A' ' 697' ' ' LYS . 9.8 t80 -98.39 125.83 43.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.889 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -154.61 121.02 5.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.112 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -151.64 157.81 42.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.835 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 50.0 mm -104.34 103.89 15.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.121 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 179.857 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 10.7 mmpt? . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.82 0.343 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 41.05 30.55 0.4 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.466 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 17.7 p -137.38 128.24 27.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.884 0.373 . . . . 0.0 110.863 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -140.96 -150.56 5.42 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.525 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 24.7 m -153.08 161.9 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.84 0.353 . . . . 0.0 111.11 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 82.1 t -149.06 114.81 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.122 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 697' ' ' LYS . . . . . 0.408 ' CB ' ' HB3' ' A' ' 680' ' ' TYR . 8.3 ttpt -100.9 145.37 28.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -121.01 166.3 14.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.923 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 699' ' ' GLU . . . . . 0.786 ' HG2' HD11 ' A' ' 679' ' ' LEU . 29.2 mt-10 -69.55 -41.17 76.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.941 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 11.5 m -116.45 151.28 46.78 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.712 0.768 . . . . 0.0 110.806 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.77 -44.72 1.91 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.712 2.274 . . . . 0.0 112.351 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -50.88 -33.74 25.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.891 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 53.9 t -63.11 -58.95 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.147 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -44.06 -58.4 2.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.133 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -46.49 -32.69 3.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.929 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 16.4 ttm180 -82.51 -40.12 21.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.832 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -67.23 -57.73 6.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.149 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 708' ' ' CYS . . . . . 0.467 ' HA ' HG12 ' A' ' 723' ' ' VAL . 21.5 p -38.57 -41.53 0.69 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.875 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -83.42 -44.54 14.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.88 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 56.7 mtp -57.44 -13.4 3.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 711' ' ' MET . . . . . 0.466 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 5.1 mmm -118.48 -29.26 5.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 712' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -39.04 105.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.918 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 89.16 26.87 24.86 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.496 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 714' ' ' MET . . . . . 0.456 ' SD ' ' HE1' ' A' ' 711' ' ' MET . 46.0 ttp -72.55 97.84 2.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.83 0.348 . . . . 0.0 110.895 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -53.79 99.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.899 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 716' ' ' LEU . . . . . 0.94 HD12 HG21 ' A' ' 721' ' ' ILE . 23.9 mt -99.92 129.8 46.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.899 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 717' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 716' ' ' LEU . 9.5 t 35.21 37.32 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.9 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 718' ' ' GLY . . . . . 0.43 ' C ' ' HG3' ' A' ' 719' ' ' ARG . . . 79.84 38.66 19.2 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.517 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 719' ' ' ARG . . . . . 0.5 ' N ' ' O ' ' A' ' 716' ' ' LEU . 25.1 mtp85 -148.45 113.66 5.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.791 0.329 . . . . 0.0 110.842 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -70.19 122.6 19.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.887 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 721' ' ' ILE . . . . . 0.94 HG21 HD12 ' A' ' 716' ' ' LEU . 18.1 pt -99.0 150.6 4.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.109 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.03 99.71 9.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.884 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 723' ' ' VAL . . . . . 0.467 HG12 ' HA ' ' A' ' 708' ' ' CYS . 5.3 t -102.59 130.14 53.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.126 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 64.8 mtm180 -157.85 159.7 36.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.9 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 725' ' ' ILE . . . . . . . . . . . . . 17.5 mm -53.34 136.6 14.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.13 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 14.5 t70 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.88 179.824 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 3.6 p . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.738 0.304 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -115.59 154.37 29.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.895 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 654' ' ' ILE . . . . . 0.484 HD11 ' CE2' ' A' ' 672' ' ' PHE . 43.5 pt -138.24 167.21 22.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.108 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -118.14 154.84 31.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.889 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 2.9 t -141.19 150.67 19.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.105 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -149.73 165.41 32.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.86 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 658' ' ' ASN . . . . . 0.466 ' ND2' HH11 ' A' ' 719' ' ' ARG . 0.2 OUTLIER 65.18 44.21 3.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.889 -179.942 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . . . . . . . . . 60.6 mt -97.44 143.8 26.82 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.619 0.723 . . . . 0.0 110.95 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -47.97 129.76 18.66 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.693 2.262 . . . . 0.0 112.355 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -48.93 -27.96 3.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.905 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -85.57 -28.71 24.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.85 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -38.62 119.75 0.87 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.861 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 75.6 p -100.23 171.36 7.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.17 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 665' ' ' TRP . . . . . 0.637 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 7.5 p-90 -66.86 -52.29 45.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.948 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 666' ' ' LYS . . . . . 0.637 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 4.3 tppp? -45.42 -47.29 13.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 25.6 mtm -62.95 -53.03 60.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.893 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 16.9 tp -44.46 -48.71 10.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.896 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . 0.403 ' HG2' ' N ' ' A' ' 670' ' ' ASP . 25.9 tttt -60.09 -71.16 0.14 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.864 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 670' ' ' ASP . . . . . 0.403 ' N ' ' HG2' ' A' ' 669' ' ' LYS . 14.9 t70 -49.61 -24.36 2.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.847 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 19.0 tptt -69.0 -42.4 76.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.884 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 672' ' ' PHE . . . . . 0.564 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 21.8 m-85 -87.13 -13.57 43.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -52.64 -39.35 61.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.884 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -48.65 -37.6 18.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.892 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 91.7 m -74.56 -54.96 6.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.87 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -160.04 -175.31 30.88 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.478 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -71.24 116.76 11.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.851 0.358 . . . . 0.0 110.852 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 678' ' ' VAL . . . . . 0.422 HG13 HG13 ' A' ' 696' ' ' VAL . 84.3 t -96.97 125.06 50.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.125 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 17.5 mt -99.29 -62.4 1.24 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.929 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -98.3 132.63 43.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.923 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -157.01 123.3 4.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.096 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -157.14 156.64 33.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.837 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 32.6 mm -97.35 102.16 13.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.13 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.906 179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.783 0.325 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 48.22 32.35 9.56 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.495 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 30.6 p -132.94 129.61 38.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.863 0.363 . . . . 0.0 110.907 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -139.04 -173.32 12.95 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.442 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 17.0 m -139.53 155.38 25.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.835 0.35 . . . . 0.0 111.141 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 696' ' ' VAL . . . . . 0.422 HG13 HG13 ' A' ' 678' ' ' VAL . 89.9 t -143.48 121.51 6.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.084 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 15.5 tttt -105.28 143.35 33.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.899 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -120.7 171.0 8.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 699' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -73.68 -44.7 55.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.866 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 29.9 m -112.92 149.63 41.58 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.636 0.731 . . . . 0.0 110.855 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -34.72 14.04 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.692 2.261 . . . . 0.0 112.356 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -57.95 -38.42 75.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.883 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 62.7 t -61.78 -49.77 82.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.125 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -51.85 -55.58 19.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.091 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 705' ' ' GLU . . . . . 0.405 ' HA ' HD11 ' A' ' 725' ' ' ILE . 56.4 mt-10 -46.94 -25.47 0.79 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.911 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 706' ' ' ARG . . . . . 0.441 ' O ' ' N ' ' A' ' 709' ' ' ARG . 21.7 ttt180 -90.39 -62.34 1.48 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.827 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 707' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 706' ' ' ARG . . . -35.75 -39.79 0.16 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.105 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 708' ' ' CYS . . . . . . . . . . . . . 66.7 m -56.56 -47.08 80.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 709' ' ' ARG . . . . . 0.441 ' N ' ' O ' ' A' ' 706' ' ' ARG . 11.6 mtp180 -73.55 -32.89 64.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.864 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 33.3 mmm -71.84 -20.5 61.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.86 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 711' ' ' MET . . . . . 0.564 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 2.7 mmt -114.02 -10.65 12.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.857 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 712' ' ' ASN . . . . . 0.419 ' OD1' ' C ' ' A' ' 712' ' ' ASN . 28.8 t-20 -57.75 105.08 0.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.877 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 91.83 15.44 54.46 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.508 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 714' ' ' MET . . . . . 0.542 ' HB3' HD11 ' A' ' 721' ' ' ILE . 34.4 ttp -62.7 101.29 0.24 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.877 0.37 . . . . 0.0 110.869 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 4.6 mmmt -66.22 102.76 0.88 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.905 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 716' ' ' LEU . . . . . 0.56 HD12 HG21 ' A' ' 721' ' ' ILE . 23.3 mt -100.01 134.75 42.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.91 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 717' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 716' ' ' LEU . 7.3 t 35.12 31.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.889 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 718' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 716' ' ' LEU . . . 83.65 41.87 8.07 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.475 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 719' ' ' ARG . . . . . 0.485 ' N ' ' O ' ' A' ' 716' ' ' LEU . 2.7 mtt-85 -151.68 117.51 5.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.807 0.337 . . . . 0.0 110.853 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -72.88 125.79 28.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.904 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 721' ' ' ILE . . . . . 0.56 HG21 HD12 ' A' ' 716' ' ' LEU . 41.4 pt -100.11 156.08 4.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.148 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -110.88 103.23 11.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.882 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 723' ' ' VAL . . . . . 0.521 HG21 ' CB ' ' A' ' 711' ' ' MET . 3.4 t -103.98 131.31 52.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.122 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 42.2 mtm-85 -158.18 161.09 37.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.858 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 725' ' ' ILE . . . . . 0.405 HD11 ' HA ' ' A' ' 705' ' ' GLU . 19.8 mm -60.3 131.08 24.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.162 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 6.7 t0 . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 179.854 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 2.8 p . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.783 0.325 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -85.83 148.71 25.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.952 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 654' ' ' ILE . . . . . . . . . . . . . 22.0 pt -134.32 174.29 13.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.121 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -125.79 157.44 37.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.88 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 3.4 t -143.58 151.07 16.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.105 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 27.3 mtp180 -146.62 162.54 38.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.885 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 658' ' ' ASN . . . . . 0.461 ' ND2' ' HB3' ' A' ' 719' ' ' ARG . 9.4 t30 69.19 31.16 4.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.852 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . . . . . . . . . 64.9 mt -82.14 144.44 50.75 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.628 0.728 . . . . 0.0 110.917 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -47.97 150.84 4.38 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.725 2.283 . . . . 0.0 112.326 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -71.26 -22.36 61.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.859 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -98.19 4.74 48.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.854 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 663' ' ' PHE . . . . . 0.412 ' CE2' ' HA ' ' A' ' 668' ' ' LEU . 3.2 t80 -72.62 118.55 15.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 43.3 p -100.45 169.84 8.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.141 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 665' ' ' TRP . . . . . 0.583 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 15.7 p-90 -57.43 -51.41 69.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.937 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 666' ' ' LYS . . . . . 0.583 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 5.3 tppp? -48.76 -60.06 3.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.885 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 22.5 mtm -51.21 -44.63 61.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.888 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 668' ' ' LEU . . . . . 0.412 ' HA ' ' CE2' ' A' ' 663' ' ' PHE . 12.3 tp -56.79 -44.27 81.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.916 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 29.1 ttmt -64.55 -67.85 0.4 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.27 -23.76 2.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.855 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? -69.85 -39.63 76.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.944 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 672' ' ' PHE . . . . . 0.585 ' CD1' HG21 ' A' ' 696' ' ' VAL . 27.0 m-85 -90.87 -8.39 49.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.899 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -59.41 -27.07 65.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.909 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -62.16 -37.18 84.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.934 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 3.7 m -73.18 -41.4 63.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.879 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -171.02 -167.24 31.06 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.48 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 677' ' ' HIS . . . . . 0.41 ' CD2' ' C ' ' A' ' 677' ' ' HIS . 3.0 t-160 -83.18 106.07 14.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.792 0.329 . . . . 0.0 110.86 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 69.0 t -84.83 144.43 9.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.102 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 16.0 mt -119.15 -61.12 1.67 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.939 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -99.77 125.3 45.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.899 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -149.29 122.12 8.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.058 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -150.95 157.79 43.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.822 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 33.0 mm -104.71 105.0 17.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.115 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.831 179.885 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 24.3 mmmt . . . . . 0 N--CA 1.458 -0.061 0 CA-C-O 120.866 0.365 . . . . 0.0 110.922 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 45.65 38.37 7.4 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.477 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 29.3 p -139.46 130.44 26.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.843 0.354 . . . . 0.0 110.892 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -147.93 -174.69 19.99 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.502 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 14.9 m -133.63 164.09 35.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.848 0.356 . . . . 0.0 111.134 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 696' ' ' VAL . . . . . 0.585 HG21 ' CD1' ' A' ' 672' ' ' PHE . 58.3 t -148.91 114.22 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.123 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 27.1 tttt -94.14 146.48 23.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.966 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -122.34 165.79 15.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.896 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 699' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -68.16 -41.82 80.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.918 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 14.3 m -116.21 152.32 47.73 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.684 0.754 . . . . 0.0 110.84 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -39.54 6.39 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.659 2.24 . . . . 0.0 112.339 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -53.57 -47.67 69.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.926 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 69.2 t -50.55 -55.21 6.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.112 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -41.4 -65.89 0.39 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.124 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 705' ' ' GLU . . . . . 0.695 ' HA ' HD11 ' A' ' 725' ' ' ILE . 49.5 mt-10 -42.65 -38.1 1.93 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.936 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 706' ' ' ARG . . . . . 0.401 ' O ' ' C ' ' A' ' 707' ' ' ALA . 12.6 ttt180 -73.91 -65.95 0.77 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.878 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 707' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 706' ' ' ARG . . . -36.9 -55.23 0.91 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.065 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 708' ' ' CYS . . . . . 0.498 ' HA ' HG11 ' A' ' 723' ' ' VAL . 0.9 OUTLIER -45.31 -51.2 11.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.876 -179.894 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 12.8 mtp180 -66.72 -34.44 77.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 78.1 mtp -73.33 -21.83 60.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.9 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 711' ' ' MET . . . . . 0.564 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 3.8 mmt -108.67 -14.78 14.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.844 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 712' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 708' ' ' CYS . 1.2 p-10 -50.16 121.18 5.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.918 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 70.38 26.48 74.12 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.455 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 714' ' ' MET . . . . . 0.401 ' HB3' HD11 ' A' ' 721' ' ' ILE . 30.5 ttp -69.44 103.53 2.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.794 0.331 . . . . 0.0 110.888 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 15.6 mmtt -59.93 101.41 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.924 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 716' ' ' LEU . . . . . 0.956 HD12 HG21 ' A' ' 721' ' ' ILE . 31.4 mt -100.29 126.06 46.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.901 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 717' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 716' ' ' LEU . 3.4 t 36.57 39.79 0.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.876 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 718' ' ' GLY . . . . . 0.429 ' C ' ' HG3' ' A' ' 719' ' ' ARG . . . 78.45 35.03 34.17 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.493 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 719' ' ' ARG . . . . . 0.497 ' N ' ' O ' ' A' ' 716' ' ' LEU . 5.0 mtt-85 -146.63 111.02 5.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.75 0.31 . . . . 0.0 110.869 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -67.76 123.01 19.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.884 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 721' ' ' ILE . . . . . 0.956 HG21 HD12 ' A' ' 716' ' ' LEU . 26.6 pt -99.27 149.49 5.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.088 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -106.14 112.7 25.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.824 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 723' ' ' VAL . . . . . 0.498 HG11 ' HA ' ' A' ' 708' ' ' CYS . 2.7 t -105.8 138.57 30.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.113 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 26.5 ptt180 -154.25 171.56 19.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 725' ' ' ILE . . . . . 0.695 HD11 ' HA ' ' A' ' 705' ' ' GLU . 19.3 mm -89.98 137.0 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.14 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 10.6 t0 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.885 179.842 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 2.4 p . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.715 0.293 . . . . 0.0 110.845 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -109.86 150.72 28.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.893 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 654' ' ' ILE . . . . . 0.598 HG22 HD13 ' A' ' 725' ' ' ILE . 23.0 pt -139.64 163.8 24.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.171 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -117.6 144.54 45.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.898 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 10.1 t -131.92 150.63 34.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.16 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -146.54 160.31 42.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.849 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 658' ' ' ASN . . . . . 0.613 ' O ' HG22 ' A' ' 721' ' ' ILE . 2.7 t30 65.88 53.81 1.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.935 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.513 HD22 ' CD2' ' A' ' 663' ' ' PHE . 33.4 mt -102.74 143.48 26.7 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.58 0.705 . . . . 0.0 110.924 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 660' ' ' PRO . . . . . 0.478 ' O ' ' N ' ' A' ' 663' ' ' PHE . 65.9 Cg_exo -48.01 125.13 11.13 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.706 2.271 . . . . 0.0 112.32 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -40.63 -37.87 0.79 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.903 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 662' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 663' ' ' PHE . 2.2 m-20 -74.99 -35.07 62.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 663' ' ' PHE . . . . . 0.513 ' CD2' HD22 ' A' ' 659' ' ' LEU . 3.7 t80 -37.5 115.24 0.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.893 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 78.9 p -102.79 178.08 4.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.136 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 665' ' ' TRP . . . . . 0.647 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 3.4 p-90 -64.13 -48.27 76.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.908 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 666' ' ' LYS . . . . . 0.647 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 18.8 tptm -49.0 -56.88 7.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.898 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 32.4 mtm -55.99 -51.48 67.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.846 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 15.1 tp -45.34 -42.84 10.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.905 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -66.55 -70.72 0.23 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -48.51 -24.93 1.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.854 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 18.4 tptt -68.91 -46.08 69.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.934 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 672' ' ' PHE . . . . . 0.554 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 22.4 m-85 -83.38 -15.42 49.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.867 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -49.18 -41.4 36.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.9 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -45.64 -37.11 5.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.893 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 34.1 m -73.62 -48.2 34.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.871 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -164.53 -164.21 19.31 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.779 -0.725 . . . . 0.0 112.504 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -85.48 93.6 8.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.806 0.336 . . . . 0.0 110.86 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 71.1 t -69.37 133.39 31.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.114 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 10.7 mt -108.67 -60.18 1.78 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.946 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -99.62 130.25 45.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.918 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -156.01 125.76 6.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.107 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -154.62 156.55 36.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.822 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 28.9 mm -105.24 108.48 25.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.166 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.885 179.876 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 14.1 mmmt . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.813 0.339 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 81.91 11.67 82.33 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.521 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 5.6 p -119.92 139.48 52.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.858 0.361 . . . . 0.0 110.88 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -148.38 -158.07 7.82 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.475 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 15.6 m -151.0 156.98 5.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.866 0.365 . . . . 0.0 111.125 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 696' ' ' VAL . . . . . 0.468 HG21 ' CD1' ' A' ' 672' ' ' PHE . 85.9 t -144.89 121.05 4.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.147 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 9.9 ttpp -104.84 147.41 27.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.911 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -123.48 168.4 12.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.893 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 699' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -68.55 -48.24 64.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.858 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 70.8 m -111.25 148.1 38.03 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.66 0.743 . . . . 0.0 110.819 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -23.52 30.6 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.657 2.238 . . . . 0.0 112.359 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 702' ' ' GLU . . . . . 0.453 ' HG3' ' N ' ' A' ' 703' ' ' VAL . 6.8 pt-20 -69.26 -34.51 74.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.905 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 703' ' ' VAL . . . . . 0.453 ' N ' ' HG3' ' A' ' 702' ' ' GLU . 24.7 t -61.19 -59.86 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.149 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -41.3 -61.41 1.03 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.116 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -41.55 -31.74 0.3 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.861 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -80.3 -48.93 12.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.855 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -60.39 -53.04 62.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.109 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 708' ' ' CYS . . . . . 0.434 ' SG ' ' N ' ' A' ' 709' ' ' ARG . 1.8 p -39.15 -41.69 0.86 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.884 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 709' ' ' ARG . . . . . 0.434 ' N ' ' SG ' ' A' ' 708' ' ' CYS . 12.6 mtt85 -84.51 -39.84 18.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.839 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 18.1 mtm -68.03 -7.74 31.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.853 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 711' ' ' MET . . . . . 0.554 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 14.2 mmm -121.57 -30.26 4.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.889 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 712' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -45.54 107.09 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.925 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 90.03 25.98 25.37 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.479 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 714' ' ' MET . . . . . . . . . . . . . 41.9 ttp -75.3 100.31 4.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.864 0.364 . . . . 0.0 110.874 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 18.3 mmtt -56.27 102.12 0.07 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.899 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 716' ' ' LEU . . . . . 0.849 HD12 HG21 ' A' ' 721' ' ' ILE . 34.6 mt -99.86 121.97 42.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.879 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 717' ' ' SER . . . . . . . . . . . . . 36.8 t 37.62 41.83 0.33 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.846 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 718' ' ' GLY . . . . . 0.422 ' C ' ' HG3' ' A' ' 719' ' ' ARG . . . 77.68 34.27 39.83 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.482 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 719' ' ' ARG . . . . . 0.475 ' HB3' ' ND2' ' A' ' 658' ' ' ASN . 1.9 mtp-105 -146.01 109.6 4.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.777 0.323 . . . . 0.0 110.887 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -69.99 124.97 25.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.897 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 721' ' ' ILE . . . . . 0.849 HG21 HD12 ' A' ' 716' ' ' LEU . 31.4 pt -98.9 152.33 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.13 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -106.08 98.27 7.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.869 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 5.1 t -101.69 132.0 48.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.137 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 34.5 mtp180 -156.0 167.58 29.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.857 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 725' ' ' ILE . . . . . 0.598 HD13 HG22 ' A' ' 654' ' ' ILE . 33.9 mm -73.92 131.62 34.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.103 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 35.5 t0 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 179.853 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 652' ' ' CYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 704' ' ' ALA . 25.5 p . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.731 0.3 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -90.06 146.36 24.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.918 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 654' ' ' ILE . . . . . 0.425 HD11 ' CE2' ' A' ' 672' ' ' PHE . 40.5 pt -132.91 176.06 9.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.113 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -127.53 159.76 33.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.904 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . 0.411 HG13 HD12 ' A' ' 721' ' ' ILE . 21.9 t -146.13 148.68 16.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.116 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 32.0 mtp180 -146.85 162.99 37.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.877 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 658' ' ' ASN . . . . . 0.431 ' O ' HG22 ' A' ' 721' ' ' ILE . 2.6 t30 65.97 46.41 2.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.922 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.474 HD22 ' CD2' ' A' ' 663' ' ' PHE . 27.8 mt -97.58 142.02 23.9 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.631 0.729 . . . . 0.0 110.939 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -48.01 127.91 15.65 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.678 2.252 . . . . 0.0 112.342 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -39.91 -50.48 2.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.885 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 662' ' ' ASP . . . . . 0.428 ' O ' HG23 ' A' ' 664' ' ' THR . 0.9 OUTLIER -61.79 -38.16 87.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.83 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 663' ' ' PHE . . . . . 0.477 ' HA ' ' CE ' ' A' ' 667' ' ' MET . 4.0 t80 -35.45 116.26 0.35 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.844 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 664' ' ' THR . . . . . 0.428 HG23 ' O ' ' A' ' 662' ' ' ASP . 78.6 p -106.15 174.82 5.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.135 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 665' ' ' TRP . . . . . 0.647 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 3.3 p-90 -62.1 -51.8 66.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.911 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 666' ' ' LYS . . . . . 0.647 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 1.7 tppp? -45.15 -48.93 12.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.884 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 667' ' ' MET . . . . . 0.477 ' CE ' ' HA ' ' A' ' 663' ' ' PHE . 24.3 mtm -64.3 -52.1 60.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.91 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 15.3 tp -43.52 -45.27 6.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -64.61 -70.74 0.21 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.885 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -48.49 -21.48 0.57 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.855 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 671' ' ' LYS . . . . . 0.44 ' HE2' HD21 ' A' ' 716' ' ' LEU . 17.2 tptt -72.81 -43.54 62.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.859 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 672' ' ' PHE . . . . . 0.534 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 25.8 m-85 -86.62 -15.95 38.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.9 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -50.38 -38.75 44.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.896 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -46.83 -39.94 12.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.888 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 675' ' ' CYS . . . . . 0.448 ' HA ' ' HE3' ' A' ' 710' ' ' MET . 62.8 m -67.65 -60.46 2.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.879 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -152.7 -157.59 8.08 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.524 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -87.77 100.72 13.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.791 0.329 . . . . 0.0 110.899 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 98.1 t -79.55 140.91 16.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.167 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 679' ' ' LEU . . . . . 0.419 HD11 ' HG2' ' A' ' 699' ' ' GLU . 12.8 mt -117.29 -60.03 1.88 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.88 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 680' ' ' TYR . . . . . 0.402 ' HB3' ' CB ' ' A' ' 697' ' ' LYS . 7.9 t80 -99.46 126.59 45.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.974 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -153.4 122.51 6.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.103 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -149.67 164.8 34.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 27.3 mm -114.72 101.38 12.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.116 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.878 179.868 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.847 0.356 . . . . 0.0 110.893 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 692' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 658' ' ' ASN . . . 39.15 39.1 0.93 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.49 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 31.3 p -138.09 139.43 39.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.896 0.379 . . . . 0.0 110.858 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -158.7 -173.65 27.38 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.434 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 27.0 m -134.13 164.25 34.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.882 0.372 . . . . 0.0 111.114 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 85.5 t -148.94 116.91 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.079 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 697' ' ' LYS . . . . . 0.402 ' CB ' ' HB3' ' A' ' 680' ' ' TYR . 11.8 tttp -101.24 140.36 35.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -116.34 173.79 6.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.871 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 699' ' ' GLU . . . . . 0.419 ' HG2' HD11 ' A' ' 679' ' ' LEU . 48.0 mt-10 -73.19 -48.47 34.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.903 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 14.0 m -109.01 149.53 39.75 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.664 0.745 . . . . 0.0 110.824 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 -6.88 19.64 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.661 2.24 . . . . 0.0 112.327 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -86.17 -46.79 10.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.892 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 88.9 t -50.88 -42.16 22.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.182 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 704' ' ' ALA . . . . . 0.407 ' HB2' ' O ' ' A' ' 652' ' ' CYS . . . -56.63 -59.14 5.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.093 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -47.48 -38.76 14.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 706' ' ' ARG . . . . . 0.517 ' HD3' ' HE1' ' A' ' 710' ' ' MET . 16.5 ttt-85 -70.67 -52.95 17.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.84 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -53.64 -42.24 67.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.074 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 708' ' ' CYS . . . . . . . . . . . . . 1.1 t -47.49 -43.98 24.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 3.5 mtt-85 -81.91 -45.76 15.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.899 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 710' ' ' MET . . . . . 0.517 ' HE1' ' HD3' ' A' ' 706' ' ' ARG . 13.9 mtm -57.09 -17.31 9.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.875 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 711' ' ' MET . . . . . 0.534 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 4.2 mmt -113.8 -34.5 5.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.881 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 712' ' ' ASN . . . . . 0.437 ' C ' ' O ' ' A' ' 711' ' ' MET . 3.9 t30 -35.02 117.24 0.38 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.863 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 72.38 31.95 62.88 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.479 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 714' ' ' MET . . . . . 0.669 ' HE3' HD21 ' A' ' 716' ' ' LEU . 20.1 ttp -74.16 91.53 2.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.887 0.375 . . . . 0.0 110.869 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 715' ' ' LYS . . . . . 0.497 ' CD ' ' HG3' ' A' ' 720' ' ' GLU . 0.7 OUTLIER -50.84 99.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.898 179.979 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 716' ' ' LEU . . . . . 0.669 HD21 ' HE3' ' A' ' 714' ' ' MET . 30.4 mt -99.43 117.82 34.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.908 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 717' ' ' SER . . . . . . . . . . . . . 1.5 t 41.04 37.27 0.53 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.854 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 84.1 25.26 45.2 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.505 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 719' ' ' ARG . . . . . 0.481 ' N ' ' O ' ' A' ' 716' ' ' LEU . 39.2 mtt85 -138.73 106.38 5.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.774 0.321 . . . . 0.0 110.836 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 720' ' ' GLU . . . . . 0.497 ' HG3' ' CD ' ' A' ' 715' ' ' LYS . 30.2 mt-10 -72.45 127.94 34.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.875 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 721' ' ' ILE . . . . . 0.606 HG21 HD12 ' A' ' 716' ' ' LEU . 43.1 pt -98.07 159.76 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.089 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -111.33 99.44 8.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.834 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 12.7 t -98.97 134.03 39.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.154 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 63.5 mtm180 -156.9 174.91 14.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.844 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 725' ' ' ILE . . . . . . . . . . . . . 25.4 mm -77.28 139.3 18.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.126 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 8.1 t70 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.852 179.852 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 25.7 p . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.791 0.329 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -85.71 144.68 27.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.937 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 654' ' ' ILE . . . . . 0.668 HG22 HD13 ' A' ' 725' ' ' ILE . 35.6 pt -131.47 174.64 12.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.083 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -131.31 148.75 52.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.864 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 11.2 t -131.31 148.47 32.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.129 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -143.89 157.84 44.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.881 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 658' ' ' ASN . . . . . . . . . . . . . 4.9 t30 71.2 46.22 0.45 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.904 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 659' ' ' LEU . . . . . 0.503 HD23 ' CD1' ' A' ' 716' ' ' LEU . 52.5 mt -94.71 142.47 24.77 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.62 0.724 . . . . 0.0 110.886 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -47.95 127.84 15.38 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.666 2.244 . . . . 0.0 112.348 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -44.18 -37.34 3.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.85 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 662' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 663' ' ' PHE . 51.3 m-20 -75.26 -35.56 61.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.864 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 663' ' ' PHE . . . . . 0.433 ' C ' ' O ' ' A' ' 662' ' ' ASP . 3.8 t80 -34.68 142.9 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.862 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 45.1 p -127.38 172.51 10.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.179 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 665' ' ' TRP . . . . . 0.614 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 6.0 p-90 -63.46 -50.27 70.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.929 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 666' ' ' LYS . . . . . 0.614 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 5.0 tppp? -46.42 -51.0 15.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.867 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 32.3 mtm -62.06 -46.85 87.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.889 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 39.3 tp -48.9 -46.09 42.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.936 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 25.3 ttmt -65.02 -72.97 0.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.917 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -46.17 -25.71 0.64 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.86 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 671' ' ' LYS . . . . . 0.432 ' HE3' HD21 ' A' ' 716' ' ' LEU . 10.1 tppt? -67.9 -51.66 45.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.899 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 672' ' ' PHE . . . . . 0.576 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 23.7 m-85 -77.77 -16.99 58.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.84 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -48.93 -33.41 10.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -55.83 -39.28 71.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.884 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 60.4 m -71.58 -41.71 68.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.899 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -174.75 170.84 44.01 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.436 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 677' ' ' HIS . . . . . 0.409 ' CD2' ' C ' ' A' ' 677' ' ' HIS . 2.9 t-160 -62.01 103.71 0.39 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.805 0.336 . . . . 0.0 110.861 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 65.1 t -80.32 147.62 6.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.085 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 679' ' ' LEU . . . . . 0.699 HD11 ' HG2' ' A' ' 699' ' ' GLU . 13.7 mt -120.37 -63.83 1.32 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.913 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 680' ' ' TYR . . . . . 0.435 ' HB3' ' CB ' ' A' ' 697' ' ' LYS . 10.1 t80 -98.66 125.32 43.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -152.78 124.59 7.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.131 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -157.41 156.68 32.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.873 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 40.9 mm -96.23 99.28 8.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.152 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.878 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt . . . . . 0 N--CA 1.457 -0.081 0 CA-C-O 120.842 0.354 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 51.89 37.09 43.49 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.448 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 27.2 p -137.81 149.76 46.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.875 0.369 . . . . 0.0 110.882 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -155.68 -175.71 27.01 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.516 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 13.8 m -138.25 156.32 30.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.812 0.339 . . . . 0.0 111.162 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 90.7 t -142.96 118.0 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.115 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 697' ' ' LYS . . . . . 0.435 ' CB ' ' HB3' ' A' ' 680' ' ' TYR . 23.7 tttp -101.96 137.39 40.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.88 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -113.49 166.65 11.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.871 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 699' ' ' GLU . . . . . 0.699 ' HG2' HD11 ' A' ' 679' ' ' LEU . 22.5 mt-10 -68.53 -44.92 73.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.853 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 3.7 m -113.56 151.04 44.19 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.658 0.742 . . . . 0.0 110.869 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -36.7 10.21 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.657 2.238 . . . . 0.0 112.335 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 702' ' ' GLU . . . . . 0.443 ' OE1' ' C ' ' A' ' 702' ' ' GLU . 0.6 OUTLIER -56.81 -40.56 76.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.932 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 79.6 t -53.8 -57.07 6.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.087 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -43.23 -63.25 0.85 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.08 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -41.4 -29.96 0.17 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.883 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 19.8 ttm-85 -82.62 -47.79 11.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.846 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 707' ' ' ALA . . . . . 0.421 ' O ' ' C ' ' A' ' 708' ' ' CYS . . . -62.9 -59.34 4.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.06 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 708' ' ' CYS . . . . . 0.421 ' C ' ' O ' ' A' ' 707' ' ' ALA . 11.5 p -36.18 -36.69 0.1 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.877 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 6.3 mtt180 -85.29 -46.16 11.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.872 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 18.7 mtm -61.89 -9.45 6.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.886 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 711' ' ' MET . . . . . 0.576 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 6.3 mmm -120.2 -17.72 8.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.881 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 712' ' ' ASN . . . . . 0.404 ' OD1' ' C ' ' A' ' 712' ' ' ASN . 3.5 t-20 -53.5 117.41 3.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.905 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 80.8 10.4 85.16 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.533 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 714' ' ' MET . . . . . 0.575 ' HB3' HD11 ' A' ' 721' ' ' ILE . 46.3 ttp -61.32 91.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.857 0.36 . . . . 0.0 110.9 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 2.9 mttp -58.56 112.0 1.45 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.893 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 716' ' ' LEU . . . . . 0.59 HD12 HG21 ' A' ' 721' ' ' ILE . 30.5 mt -100.19 127.46 46.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 717' ' ' SER . . . . . . . . . . . . . 31.1 t 37.66 31.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.861 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 718' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 716' ' ' LEU . . . 89.3 43.11 5.36 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.463 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 719' ' ' ARG . . . . . . . . . . . . . 19.0 mtt180 -152.02 107.37 3.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.764 0.316 . . . . 0.0 110.886 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -62.69 124.22 20.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.884 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 721' ' ' ILE . . . . . 0.59 HG21 HD12 ' A' ' 716' ' ' LEU . 18.9 pt -100.09 151.18 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.161 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -111.1 97.79 7.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.853 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 8.1 t -97.35 136.11 29.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.143 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 79.8 mtt-85 -156.18 161.95 40.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 725' ' ' ILE . . . . . 0.668 HD13 HG22 ' A' ' 654' ' ' ILE . 23.0 mm -70.23 131.73 33.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.123 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 35.9 t0 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.823 179.875 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 645' ' ' SER . . . . . . . . . . . . . 7.7 t -164.6 172.3 13.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.876 0.37 . . . . 0.0 110.857 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 646' ' ' SER . . . . . . . . . . . . . 1.3 t -125.16 42.44 3.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.869 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -98.57 -150.46 25.99 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.48 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 49.6 m -56.16 129.3 39.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.901 0.382 . . . . 0.0 110.856 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 69.0 p -73.44 95.8 2.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.871 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 104.93 105.89 3.07 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.467 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 651' ' ' ALA . . . . . 0.71 ' HB1' ' CG2' ' A' ' 725' ' ' ILE . . . -85.79 90.4 8.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.769 0.318 . . . . 0.0 111.113 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 652' ' ' CYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 704' ' ' ALA . 18.8 p -100.23 -29.87 12.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.83 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -93.24 153.23 18.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.882 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 654' ' ' ILE . . . . . 0.652 HG22 HD13 ' A' ' 725' ' ' ILE . 32.7 pt -136.51 177.75 5.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.157 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -130.56 149.56 52.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.875 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 3.3 t -134.58 151.89 32.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.136 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 38.1 mtt85 -148.39 161.99 40.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 658' ' ' ASN . . . . . 0.48 ' ND2' ' HB3' ' A' ' 719' ' ' ARG . 4.6 t30 65.27 47.97 2.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.739 HD22 ' CD2' ' A' ' 663' ' ' PHE . 26.3 mt -96.98 143.65 26.48 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.599 0.714 . . . . 0.0 110.942 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 660' ' ' PRO . . . . . 0.445 ' O ' ' N ' ' A' ' 663' ' ' PHE . 65.5 Cg_exo -47.95 127.82 15.34 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.685 2.257 . . . . 0.0 112.344 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -45.45 -30.96 1.53 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.881 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -83.8 -28.36 28.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.896 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 663' ' ' PHE . . . . . 0.739 ' CD2' HD22 ' A' ' 659' ' ' LEU . 3.8 t80 -40.62 123.14 1.79 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.924 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 80.4 p -106.02 176.77 5.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.138 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 665' ' ' TRP . . . . . 0.648 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 6.6 p-90 -68.97 -50.66 47.09 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.888 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 666' ' ' LYS . . . . . 0.648 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 2.8 tppp? -47.29 -50.73 20.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.858 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 31.4 mtm -63.37 -46.52 86.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.875 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 14.1 tp -51.52 -42.53 61.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.9 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 29.3 tttm -65.2 -74.15 0.11 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.873 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -46.01 -23.68 0.33 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.874 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 671' ' ' LYS . . . . . 0.442 ' HG3' ' CE ' ' A' ' 711' ' ' MET . 7.5 tppt? -69.88 -40.37 75.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.91 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 672' ' ' PHE . . . . . 0.466 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 20.6 m-85 -90.14 -9.3 48.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -57.63 -34.97 69.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.874 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -43.16 -44.76 5.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.903 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 9.4 t -66.98 -63.94 0.96 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.871 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -145.83 -155.06 6.35 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.462 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -93.08 102.83 15.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.88 0.372 . . . . 0.0 110.861 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 43.1 t -75.86 132.88 32.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.073 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 679' ' ' LEU . . . . . 0.403 HD21 ' HG2' ' A' ' 699' ' ' GLU . 10.2 mt -107.3 -61.53 1.54 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.887 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -97.91 129.61 44.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.918 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -155.48 123.07 5.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.138 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -152.17 165.52 34.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.83 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 18.5 mm -115.8 117.2 54.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.13 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -60.05 137.59 58.06 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.855 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 685' ' ' MET . . . . . . . . . . . . . 29.4 mtp -139.74 156.16 46.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.913 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -131.94 114.38 14.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.902 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 687' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 53.14 35.36 19.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.937 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 688' ' ' GLY . . . . . . . . . . . . . . . 78.18 36.42 31.33 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.462 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 4.9 mmmm -137.99 119.74 15.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.776 0.322 . . . . 0.0 110.883 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 690' ' ' SER . . . . . . . . . . . . . 4.0 m -57.29 136.91 56.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.796 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 4.6 mmtp -102.71 -15.04 16.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.866 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 80.91 13.36 81.4 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.496 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 8.9 p -126.81 131.89 51.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.835 0.35 . . . . 0.0 110.931 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -139.75 -170.87 12.09 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.518 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 5.2 m -141.07 153.5 20.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.865 0.364 . . . . 0.0 111.116 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 98.9 t -139.64 124.31 20.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.091 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 23.9 tttt -107.57 139.72 41.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.885 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -115.55 172.27 7.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.923 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 699' ' ' GLU . . . . . 0.403 ' HG2' HD21 ' A' ' 679' ' ' LEU . 25.7 mt-10 -75.52 -44.07 45.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.844 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 58.3 m -107.36 147.71 35.77 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.66 0.743 . . . . 0.0 110.843 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -32.97 17.55 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.649 2.233 . . . . 0.0 112.375 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -63.07 -42.92 99.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.891 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 95.5 t -51.14 -60.24 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.149 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 704' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 651' ' ' ALA . . . -42.13 -59.44 1.77 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.098 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.761 ' HA ' HD11 ' A' ' 725' ' ' ILE . 22.0 mt-10 -43.55 -31.23 0.69 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.89 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 26.2 ttm-85 -81.99 -58.1 3.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.867 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -44.93 -30.15 0.95 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.095 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 708' ' ' CYS . . . . . 0.49 ' O ' ' N ' ' A' ' 712' ' ' ASN . 1.4 t -56.43 -63.96 1.02 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.883 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.15 -41.25 94.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.88 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 58.4 mtp -55.34 -33.6 63.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.871 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 711' ' ' MET . . . . . 0.469 ' CB ' HG21 ' A' ' 723' ' ' VAL . 3.7 mmt -105.8 -14.46 15.22 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.856 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 712' ' ' ASN . . . . . 0.49 ' N ' ' O ' ' A' ' 708' ' ' CYS . 40.1 t-20 -54.22 109.72 0.52 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.889 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 83.65 24.06 51.28 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.487 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 714' ' ' MET . . . . . 0.436 ' CE ' ' CE ' ' A' ' 711' ' ' MET . 38.2 ttp -72.16 98.91 2.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.825 0.345 . . . . 0.0 110.854 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 5.5 mmtm -51.94 101.15 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.887 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 716' ' ' LEU . . . . . 0.883 HD12 HG21 ' A' ' 721' ' ' ILE . 24.6 mt -99.78 120.02 39.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.926 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 717' ' ' SER . . . . . . . . . . . . . 20.4 t 40.27 43.67 1.46 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.874 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 75.6 26.52 65.15 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.521 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 719' ' ' ARG . . . . . 0.48 ' HB3' ' ND2' ' A' ' 658' ' ' ASN . 28.5 mtp180 -140.16 110.95 6.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.777 0.322 . . . . 0.0 110.89 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -68.2 127.84 34.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.933 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . 0.883 HG21 HD12 ' A' ' 716' ' ' LEU . 26.4 pt -99.69 151.41 4.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.137 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -106.11 99.88 9.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.878 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 723' ' ' VAL . . . . . 0.469 HG21 ' CB ' ' A' ' 711' ' ' MET . 4.4 t -97.53 135.77 30.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.141 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 74.3 mtm180 -158.21 163.97 36.97 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.876 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 725' ' ' ILE . . . . . 0.761 HD11 ' HA ' ' A' ' 705' ' ' GLU . 31.9 mm -79.27 134.86 26.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.127 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 40.6 t0 -89.05 116.86 27.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 727' ' ' ARG . . . . . . . . . . . . . 34.4 mmt180 -91.4 -24.25 19.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.867 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 728' ' ' ASN . . . . . . . . . . . . . 33.8 m120 -114.36 71.36 0.75 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 729' ' ' ALA . . . . . . . . . . . . . . . -107.97 24.5 12.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.094 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 45.8 t -96.18 104.02 15.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.864 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 731' ' ' GLY . . . . . . . . . . . . . . . 86.53 177.33 49.54 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.514 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 732' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 144.25 53.68 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.729 2.286 . . . . 0.0 112.339 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 733' ' ' SER . . . . . . . . . . . . . 31.1 t -115.17 86.37 2.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.902 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 734' ' ' SER . . . . . . . . . . . . . 22.8 t -165.13 132.82 3.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.895 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 735' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.48 -179.971 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 645' ' ' SER . . . . . . . . . . . . . 3.2 m -83.53 166.36 18.33 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.881 0.372 . . . . 0.0 110.868 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 646' ' ' SER . . . . . . . . . . . . . 88.8 p -159.99 124.04 3.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.867 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . 169.58 111.27 0.24 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.503 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 9.8 m -119.14 127.6 53.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.865 0.364 . . . . 0.0 110.826 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 67.3 m -115.29 168.8 9.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.876 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . -66.41 92.68 0.18 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.52 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 651' ' ' ALA . . . . . 0.437 ' HB1' ' CG2' ' A' ' 725' ' ' ILE . . . -81.78 55.39 2.7 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.789 0.328 . . . . 0.0 111.073 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 29.8 m -81.36 -20.5 40.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.911 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -94.53 143.1 26.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.932 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 654' ' ' ILE . . . . . 0.455 HD11 ' CE2' ' A' ' 672' ' ' PHE . 36.3 pt -132.94 174.97 12.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.154 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -121.09 158.58 27.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.832 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 21.9 t -147.01 146.47 18.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.095 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 65.6 mtm180 -146.42 157.86 43.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.87 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 658' ' ' ASN . . . . . 0.444 ' O ' HG22 ' A' ' 721' ' ' ILE . 0.6 OUTLIER 71.17 50.17 0.31 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.853 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.525 HD22 ' CD2' ' A' ' 663' ' ' PHE . 29.0 mt -100.59 143.83 27.3 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.615 0.722 . . . . 0.0 110.872 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 660' ' ' PRO . . . . . 0.483 ' O ' ' N ' ' A' ' 663' ' ' PHE . 65.8 Cg_exo -47.97 124.55 10.23 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.684 2.256 . . . . 0.0 112.331 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -42.37 -36.89 1.4 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.828 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -76.0 -31.5 58.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.881 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 663' ' ' PHE . . . . . 0.525 ' CD2' HD22 ' A' ' 659' ' ' LEU . 3.8 t80 -38.85 128.4 1.57 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.863 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 72.1 p -113.18 174.99 5.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.139 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 665' ' ' TRP . . . . . 0.644 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 5.3 p-90 -64.35 -51.66 62.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.897 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 666' ' ' LYS . . . . . 0.644 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 7.4 tppt? -45.42 -53.31 8.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.877 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 28.2 mtm -58.05 -54.38 47.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.892 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 15.3 tp -41.85 -49.72 4.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.881 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 20.3 ttmt -60.66 -74.2 0.08 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.913 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -46.73 -23.3 0.4 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.9 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 10.3 tptt -70.83 -45.43 64.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.892 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 672' ' ' PHE . . . . . 0.455 ' CE2' HD11 ' A' ' 654' ' ' ILE . 23.4 m-85 -84.57 -11.58 55.76 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.908 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -54.57 -36.04 63.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.876 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -52.79 -32.08 42.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 10.2 m -80.9 -49.33 11.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.894 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 676' ' ' GLY . . . . . 0.621 ' HA3' HG11 ' A' ' 703' ' ' VAL . . . -164.21 168.92 38.85 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.482 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -61.95 101.08 0.18 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.836 0.35 . . . . 0.0 110.85 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 73.5 t -80.35 132.83 30.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.114 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 13.3 mt -107.47 -61.85 1.5 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.89 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -95.79 130.15 42.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.922 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -157.77 128.45 6.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.114 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -161.12 156.93 25.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.872 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 30.5 mm -102.11 111.97 33.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.121 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -64.05 134.33 54.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.912 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 685' ' ' MET . . . . . . . . . . . . . 23.6 mtp -132.87 147.26 52.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.873 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -118.92 88.05 2.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.889 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 687' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 70.98 48.68 0.37 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.86 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 688' ' ' GLY . . . . . . . . . . . . . . . 62.92 36.63 93.69 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.494 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 689' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 690' ' ' SER . 6.0 mtmp? -134.31 87.5 2.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.751 0.31 . . . . 0.0 110.901 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 690' ' ' SER . . . . . 0.403 ' C ' ' O ' ' A' ' 689' ' ' LYS . 19.9 t -37.69 128.3 1.15 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.899 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 25.0 mmmt -102.54 8.45 39.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.904 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 59.25 18.7 43.44 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.506 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 19.5 p -126.13 151.0 47.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.834 0.349 . . . . 0.0 110.889 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 694' ' ' GLY . . . . . 0.415 ' O ' HG13 ' A' ' 695' ' ' VAL . . . -155.9 -152.0 6.09 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.487 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . 0.415 HG13 ' O ' ' A' ' 694' ' ' GLY . 15.3 m -155.84 152.4 8.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.831 0.348 . . . . 0.0 111.143 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 99.2 t -141.7 120.06 9.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.078 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 14.4 ttpt -104.87 138.1 41.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.902 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -113.95 173.87 6.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.903 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 699' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -75.06 -36.79 61.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.913 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 700' ' ' SER . . . . . 0.456 ' OG ' HG23 ' A' ' 703' ' ' VAL . 69.0 p -124.57 151.25 67.03 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.636 0.731 . . . . 0.0 110.873 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 -30.27 22.63 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.681 2.254 . . . . 0.0 112.357 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -61.68 -39.0 89.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.844 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 703' ' ' VAL . . . . . 0.621 HG11 ' HA3' ' A' ' 676' ' ' GLY . 82.6 t -66.23 -47.21 85.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.086 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 704' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 651' ' ' ALA . . . -51.47 -47.12 63.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.112 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.76 ' HA ' HD11 ' A' ' 725' ' ' ILE . 14.4 mt-10 -55.45 -43.12 75.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.901 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 22.0 ttm180 -68.92 -54.81 13.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.837 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -43.07 -47.53 5.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.107 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 708' ' ' CYS . . . . . 0.48 ' O ' ' CB ' ' A' ' 712' ' ' ASN . 21.3 m -54.54 -34.57 62.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.87 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 8.7 mtm105 -81.66 -45.18 16.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.881 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 22.1 mtm -66.06 -15.27 62.92 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.921 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 711' ' ' MET . . . . . 0.476 ' O ' ' N ' ' A' ' 714' ' ' MET . 3.2 mmt -113.78 -30.83 6.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.873 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 712' ' ' ASN . . . . . 0.48 ' CB ' ' O ' ' A' ' 708' ' ' CYS . 0.4 OUTLIER -39.79 112.27 0.25 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.875 -179.955 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 77.25 25.61 63.4 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.48 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 714' ' ' MET . . . . . 0.553 ' HE3' HD21 ' A' ' 716' ' ' LEU . 48.9 ttp -71.38 100.35 2.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.863 0.363 . . . . 0.0 110.91 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 10.9 mmtp -54.07 99.13 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.889 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 716' ' ' LEU . . . . . 0.846 HD12 HG21 ' A' ' 721' ' ' ILE . 29.1 mt -99.89 125.21 45.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.929 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 717' ' ' SER . . . . . . . . . . . . . 1.1 t 40.06 43.68 1.35 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.883 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 72.41 29.09 66.57 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.508 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 719' ' ' ARG . . . . . 0.47 ' N ' ' O ' ' A' ' 716' ' ' LEU . 44.1 mtt180 -141.19 114.85 8.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.801 0.334 . . . . 0.0 110.885 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -70.18 128.03 34.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.902 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . 0.846 HG21 HD12 ' A' ' 716' ' ' LEU . 37.3 pt -100.03 161.89 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.129 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -118.39 98.21 6.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.845 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 723' ' ' VAL . . . . . 0.457 ' CG1' ' HA ' ' A' ' 708' ' ' CYS . 6.2 t -96.59 132.83 40.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.146 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 64.1 mtt180 -155.19 154.15 31.83 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.879 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 725' ' ' ILE . . . . . 0.76 HD11 ' HA ' ' A' ' 705' ' ' GLU . 15.1 mm -64.15 134.51 28.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.15 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 17.9 t0 -81.89 87.33 6.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 727' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -44.11 -51.34 8.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.886 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 728' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -95.35 91.47 6.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.91 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 729' ' ' ALA . . . . . . . . . . . . . . . -131.38 -49.65 0.99 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.094 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 22.7 t -132.64 109.52 9.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.875 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 731' ' ' GLY . . . . . . . . . . . . . . . -73.33 145.01 35.33 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.488 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 732' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 93.83 0.53 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.66 2.24 . . . . 0.0 112.343 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 733' ' ' SER . . . . . . . . . . . . . 36.2 m -100.7 82.17 2.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.881 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 734' ' ' SER . . . . . . . . . . . . . 16.4 m -123.55 104.98 9.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.854 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 735' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.492 -179.996 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 645' ' ' SER . . . . . . . . . . . . . 35.1 m -110.75 42.97 1.5 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.923 0.392 . . . . 0.0 110.876 -179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 646' ' ' SER . . . . . . . . . . . . . 12.8 t -113.21 154.43 26.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.906 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . 156.14 43.01 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.446 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 38.5 p -42.38 158.08 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.877 0.37 . . . . 0.0 110.903 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 20.0 t -72.71 -57.99 3.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.828 -179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . -174.64 169.35 42.29 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.502 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 651' ' ' ALA . . . . . 0.711 ' HB1' HD12 ' A' ' 725' ' ' ILE . . . -121.22 99.5 6.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.772 0.32 . . . . 0.0 111.066 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 652' ' ' CYS . . . . . 0.461 ' SG ' ' N ' ' A' ' 701' ' ' PRO . 22.3 m -106.5 -23.18 12.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.869 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -104.32 146.49 28.74 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.928 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 654' ' ' ILE . . . . . 0.587 HD11 ' CE2' ' A' ' 672' ' ' PHE . 38.9 pt -131.32 169.34 21.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.096 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -122.75 149.85 43.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.889 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 3.4 t -132.8 153.38 37.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.152 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 53.4 mtt85 -148.68 160.44 43.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.896 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 658' ' ' ASN . . . . . 0.448 ' O ' HG22 ' A' ' 721' ' ' ILE . 0.6 OUTLIER 66.93 44.95 1.91 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.927 -179.918 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.439 HD23 HD12 ' A' ' 716' ' ' LEU . 54.1 mt -93.84 143.52 26.64 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.586 0.707 . . . . 0.0 110.907 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 660' ' ' PRO . . . . . 0.406 ' O ' ' N ' ' A' ' 663' ' ' PHE . 66.7 Cg_exo -48.04 124.12 9.7 Favored 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.687 2.258 . . . . 0.0 112.32 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -47.43 -24.43 0.81 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.896 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 662' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 663' ' ' PHE . 73.5 m-20 -88.49 -29.67 19.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.876 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 663' ' ' PHE . . . . . 0.408 ' C ' ' O ' ' A' ' 662' ' ' ASP . 3.5 t80 -37.6 140.03 0.25 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.888 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 82.2 p -120.34 169.82 9.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.122 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 665' ' ' TRP . . . . . 0.644 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 6.7 p-90 -63.45 -52.16 62.63 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.96 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 666' ' ' LYS . . . . . 0.644 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 9.7 tppt? -44.63 -51.57 8.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.877 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 24.3 mtm -61.74 -47.17 86.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.866 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 668' ' ' LEU . . . . . 0.443 HD22 HD13 ' A' ' 683' ' ' ILE . 35.6 tp -47.85 -47.55 31.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.91 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.448 ' HG2' ' N ' ' A' ' 670' ' ' ASP . 0.3 OUTLIER -64.76 -73.69 0.12 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.91 179.789 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 670' ' ' ASP . . . . . 0.448 ' N ' ' HG2' ' A' ' 669' ' ' LYS . 4.5 m-20 -45.2 -24.22 0.24 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.903 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 671' ' ' LYS . . . . . 0.479 ' HG3' ' CE ' ' A' ' 711' ' ' MET . 7.8 tppt? -69.88 -51.3 34.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.897 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 672' ' ' PHE . . . . . 0.587 ' CE2' HD11 ' A' ' 654' ' ' ILE . 27.7 m-85 -78.43 -11.15 59.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.878 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -55.9 -39.38 71.51 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.881 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -47.4 -36.02 9.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.895 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 64.8 m -74.66 -56.5 4.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.826 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -160.41 -175.95 31.97 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.474 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -68.43 109.44 3.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.832 0.348 . . . . 0.0 110.831 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 53.2 t -88.57 128.7 40.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.139 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 679' ' ' LEU . . . . . 0.535 HD11 ' HG2' ' A' ' 699' ' ' GLU . 11.4 mt -100.5 -64.42 1.05 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.893 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 6.9 t80 -97.94 130.34 44.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.879 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -153.9 125.96 7.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.104 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -163.61 157.94 20.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.894 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 683' ' ' ILE . . . . . 0.443 HD13 HD22 ' A' ' 668' ' ' LEU . 25.2 mm -93.87 101.72 12.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.126 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 16.2 mmmt -60.77 129.73 42.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.901 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 685' ' ' MET . . . . . . . . . . . . . 14.1 mtp -128.36 176.19 7.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.864 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -130.21 114.83 16.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.87 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 687' ' ' ASN . . . . . . . . . . . . . 18.7 t30 50.07 35.19 9.48 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.881 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 688' ' ' GLY . . . . . . . . . . . . . . . 79.36 34.9 31.13 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.462 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 21.0 mtmm -134.71 118.21 16.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.75 0.31 . . . . 0.0 110.905 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 690' ' ' SER . . . . . . . . . . . . . 7.3 p -51.09 124.89 12.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.901 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 691' ' ' LYS . . . . . 0.418 ' O ' ' N ' ' A' ' 693' ' ' CYS . 33.3 mmtt -112.05 26.15 10.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.932 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' A' ' 658' ' ' ASN . . . 37.71 31.28 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.512 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 693' ' ' CYS . . . . . 0.418 ' N ' ' O ' ' A' ' 691' ' ' LYS . 26.0 p -132.92 125.43 29.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.896 0.379 . . . . 0.0 110.88 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -130.01 172.91 20.02 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.475 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 8.7 m -129.35 150.98 35.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.857 0.36 . . . . 0.0 111.13 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 696' ' ' VAL . . . . . 0.485 HG21 ' CD1' ' A' ' 672' ' ' PHE . 62.9 t -140.77 122.31 14.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.079 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 13.6 tttt -106.78 134.22 50.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.948 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 698' ' ' PHE . . . . . 0.506 ' CD2' HG11 ' A' ' 703' ' ' VAL . 94.0 m-85 -109.81 171.39 7.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.893 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 699' ' ' GLU . . . . . 0.535 ' HG2' HD11 ' A' ' 679' ' ' LEU . 10.2 mm-40 -75.75 -45.19 37.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.921 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 57.7 m -109.83 145.62 32.4 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.673 0.749 . . . . 0.0 110.871 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 701' ' ' PRO . . . . . 0.461 ' N ' ' SG ' ' A' ' 652' ' ' CYS . 53.7 Cg_endo -69.8 -10.89 29.63 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.629 2.22 . . . . 0.0 112.343 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 702' ' ' GLU . . . . . 0.4 ' OE1' ' C ' ' A' ' 702' ' ' GLU . 1.4 pp20? -82.9 -31.02 28.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.866 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 703' ' ' VAL . . . . . 0.506 HG11 ' CD2' ' A' ' 698' ' ' PHE . 66.5 t -67.72 -57.4 9.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.121 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -44.23 -58.54 2.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.091 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.498 ' HA ' HD11 ' A' ' 725' ' ' ILE . 19.0 mt-10 -44.31 -36.32 2.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.896 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 29.2 ttm180 -76.91 -64.77 1.05 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.823 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -39.61 -34.95 0.27 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.105 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 708' ' ' CYS . . . . . 0.446 ' HA ' ' CG1' ' A' ' 723' ' ' VAL . 56.8 m -52.82 -56.69 13.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.945 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -71.14 -39.75 71.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.92 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 18.6 mtm -64.4 -13.1 49.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 711' ' ' MET . . . . . 0.545 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 6.3 mmm -119.21 -16.68 9.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.887 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 712' ' ' ASN . . . . . 0.491 ' O ' ' ND2' ' A' ' 712' ' ' ASN . 0.1 OUTLIER -55.97 122.24 11.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.868 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 76.75 13.53 83.47 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.46 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 714' ' ' MET . . . . . . . . . . . . . 43.4 ttp -61.34 97.15 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.845 0.355 . . . . 0.0 110.823 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 15.4 mmtt -54.08 101.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.887 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 716' ' ' LEU . . . . . 0.946 HD12 HG21 ' A' ' 721' ' ' ILE . 46.0 mt -99.91 123.81 44.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.908 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 717' ' ' SER . . . . . . . . . . . . . 2.0 t 37.64 41.34 0.3 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.838 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 77.05 34.1 43.07 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.487 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 719' ' ' ARG . . . . . 0.48 ' N ' ' O ' ' A' ' 716' ' ' LEU . 9.6 mtt-85 -146.93 111.51 5.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.716 0.293 . . . . 0.0 110.862 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 7.9 mt-10 -68.83 125.6 27.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.888 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . 0.946 HG21 HD12 ' A' ' 716' ' ' LEU . 22.7 pt -100.0 160.36 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.138 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -115.2 109.43 17.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.832 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 723' ' ' VAL . . . . . 0.446 ' CG1' ' HA ' ' A' ' 708' ' ' CYS . 5.4 t -108.72 129.28 63.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.134 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 36.1 mtp180 -157.56 158.73 36.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.827 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 725' ' ' ILE . . . . . 0.711 HD12 ' HB1' ' A' ' 651' ' ' ALA . 31.6 mm -51.43 136.32 11.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.134 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -81.23 91.63 6.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.88 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 727' ' ' ARG . . . . . . . . . . . . . 7.2 tpt180 -55.33 -55.41 31.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 728' ' ' ASN . . . . . . . . . . . . . 59.5 m-20 -98.2 90.29 4.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.862 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 729' ' ' ALA . . . . . . . . . . . . . . . -116.4 -56.15 2.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.1 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 1.4 t -73.58 -52.38 13.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.868 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 731' ' ' GLY . . . . . . . . . . . . . . . -167.01 -172.11 33.87 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.517 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 732' ' ' PRO . . . . . 0.434 ' O ' ' C ' ' A' ' 733' ' ' SER . 53.7 Cg_endo -69.81 -5.94 17.43 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.683 2.255 . . . . 0.0 112.355 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 733' ' ' SER . . . . . 0.434 ' C ' ' O ' ' A' ' 732' ' ' PRO . 7.6 m -35.38 110.72 0.11 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.891 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 734' ' ' SER . . . . . . . . . . . . . 12.0 t -58.86 -44.81 91.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.866 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 735' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.504 -179.986 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 112.524 -0.231 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 645' ' ' SER . . . . . . . . . . . . . 23.3 t -42.92 -50.09 5.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.885 0.374 . . . . 0.0 110.844 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 646' ' ' SER . . . . . . . . . . . . . 2.3 p -92.8 -16.43 25.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.855 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . 50.01 -126.61 22.74 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.52 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 12.0 t -91.08 137.71 32.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.874 0.368 . . . . 0.0 110.884 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 96.3 p -135.54 130.92 35.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.814 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 57.11 41.08 92.45 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.526 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 651' ' ' ALA . . . . . 0.645 ' O ' ' HB3' ' A' ' 704' ' ' ALA . . . -70.09 100.45 1.64 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.79 0.329 . . . . 0.0 111.075 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 24.8 p -109.45 -33.64 6.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.849 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -92.12 150.72 20.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.945 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 654' ' ' ILE . . . . . 0.581 HG22 HD13 ' A' ' 725' ' ' ILE . 30.0 pt -137.26 167.07 23.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.169 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -120.7 159.47 25.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.865 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.436 HG12 ' N ' ' A' ' 657' ' ' ARG . 16.7 t -145.64 156.77 12.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.174 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 657' ' ' ARG . . . . . 0.436 ' N ' HG12 ' A' ' 656' ' ' VAL . 57.4 mtt180 -153.49 162.79 40.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.898 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 658' ' ' ASN . . . . . . . . . . . . . 4.6 t30 69.03 36.83 2.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.895 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.521 HD22 ' CD2' ' A' ' 663' ' ' PHE . 37.6 mt -86.74 143.34 35.5 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.669 0.747 . . . . 0.0 110.935 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 660' ' ' PRO . . . . . 0.47 ' O ' ' N ' ' A' ' 663' ' ' PHE . 64.8 Cg_exo -47.88 126.5 13.03 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.655 2.237 . . . . 0.0 112.375 179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -42.42 -33.66 0.7 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.858 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 662' ' ' ASP . . . . . 0.432 ' O ' ' C ' ' A' ' 663' ' ' PHE . 44.1 m-20 -81.12 -32.59 33.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.912 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 663' ' ' PHE . . . . . 0.521 ' CD2' HD22 ' A' ' 659' ' ' LEU . 4.3 t80 -35.74 124.92 0.7 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.901 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 68.5 p -108.44 174.84 5.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.145 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 665' ' ' TRP . . . . . 0.646 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 8.0 p-90 -65.93 -51.97 53.97 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.896 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 666' ' ' LYS . . . . . 0.646 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 2.3 tppp? -44.57 -54.35 6.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.882 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 20.1 mtm -57.86 -49.45 76.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.9 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 56.6 tp -46.8 -44.56 19.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.887 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 29.7 tttm -65.47 -74.92 0.1 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.85 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -46.36 -22.93 0.3 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.864 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 671' ' ' LYS . . . . . 0.468 ' HG3' ' CE ' ' A' ' 711' ' ' MET . 9.3 tppt? -70.88 -41.83 70.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.898 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 672' ' ' PHE . . . . . 0.56 ' CE2' ' CD1' ' A' ' 654' ' ' ILE . 18.5 m-85 -88.58 -11.65 44.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.892 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -54.28 -34.31 60.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.846 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -46.3 -44.91 17.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.899 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 12.9 t -64.47 -55.63 19.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.867 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -159.53 -157.16 8.42 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.476 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -86.5 110.42 19.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.889 0.376 . . . . 0.0 110.862 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 76.3 t -85.87 138.4 19.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.111 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 679' ' ' LEU . . . . . 0.591 HD11 ' HG2' ' A' ' 699' ' ' GLU . 25.4 mt -112.68 -62.47 1.58 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.908 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -96.68 131.87 42.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.94 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -155.84 125.17 6.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.102 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -158.13 160.82 37.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.875 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 23.2 mm -109.05 108.16 24.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.151 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -57.77 136.44 56.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.914 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 685' ' ' MET . . . . . . . . . . . . . 39.7 mtp -135.13 168.73 18.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.89 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -132.11 110.45 10.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.893 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 687' ' ' ASN . . . . . . . . . . . . . 36.8 m-20 45.64 43.97 9.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.87 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 688' ' ' GLY . . . . . . . . . . . . . . . 76.71 32.39 50.5 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.484 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 36.2 mtpt -130.46 118.64 21.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.845 0.355 . . . . 0.0 110.886 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 690' ' ' SER . . . . . . . . . . . . . 2.8 m -58.91 134.13 56.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.828 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -115.44 18.7 15.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.925 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 40.42 33.82 0.59 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.514 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 28.4 p -140.02 133.73 30.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.888 0.375 . . . . 0.0 110.908 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 694' ' ' GLY . . . . . 0.402 ' O ' HG13 ' A' ' 695' ' ' VAL . . . -141.81 -154.4 6.17 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.496 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . 0.402 HG13 ' O ' ' A' ' 694' ' ' GLY . 14.3 m -155.75 155.84 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.818 0.342 . . . . 0.0 111.123 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 48.7 t -143.7 125.76 11.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.164 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 13.8 ttpt -109.79 137.6 47.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -111.6 169.77 8.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.925 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 699' ' ' GLU . . . . . 0.591 ' HG2' HD11 ' A' ' 679' ' ' LEU . 15.7 mt-10 -74.89 -42.06 58.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.892 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 39.7 m -109.94 151.09 42.21 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.684 0.754 . . . . 0.0 110.864 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -39.26 6.74 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.696 2.264 . . . . 0.0 112.349 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -54.71 -47.82 73.27 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.899 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 93.0 t -49.26 -59.08 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.089 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 704' ' ' ALA . . . . . 0.645 ' HB3' ' O ' ' A' ' 651' ' ' ALA . . . -41.47 -67.46 0.25 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.066 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 704' ' ' ALA . 9.7 mt-10 -36.77 -42.61 0.39 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.91 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 706' ' ' ARG . . . . . 0.425 ' O ' ' C ' ' A' ' 707' ' ' ALA . 15.9 ttm180 -69.25 -64.21 0.92 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.848 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 707' ' ' ALA . . . . . 0.425 ' C ' ' O ' ' A' ' 706' ' ' ARG . . . -35.78 -47.87 0.52 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.087 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 708' ' ' CYS . . . . . 0.468 ' O ' ' N ' ' A' ' 712' ' ' ASN . 1.2 t -43.96 -60.62 1.76 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.924 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 11.9 mtt180 -69.15 -38.0 78.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.908 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 49.4 mtp -64.04 -16.04 60.8 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.905 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 711' ' ' MET . . . . . 0.468 ' CE ' ' HG3' ' A' ' 671' ' ' LYS . 4.1 mmt -123.54 -8.83 7.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.85 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 712' ' ' ASN . . . . . 0.468 ' N ' ' O ' ' A' ' 708' ' ' CYS . 27.7 t30 -64.58 118.36 8.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.911 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 78.89 30.06 49.11 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.493 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 714' ' ' MET . . . . . . . . . . . . . 34.2 ttp -80.22 110.46 15.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.851 0.357 . . . . 0.0 110.899 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 18.9 mmtt -67.19 102.27 1.02 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.881 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 716' ' ' LEU . . . . . 0.945 HD12 HG21 ' A' ' 721' ' ' ILE . 26.7 mt -99.93 123.08 43.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.939 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 717' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 716' ' ' LEU . 8.7 t 36.66 38.73 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.87 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 80.96 34.18 27.75 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.471 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 719' ' ' ARG . . . . . 0.501 ' N ' ' O ' ' A' ' 716' ' ' LEU . 8.1 mtt-85 -147.27 110.95 4.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.795 0.331 . . . . 0.0 110.887 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -71.33 126.54 29.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.876 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . 0.945 HG21 HD12 ' A' ' 716' ' ' LEU . 32.9 pt -97.75 158.82 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.089 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -113.92 99.23 7.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.872 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 723' ' ' VAL . . . . . 0.45 HG21 ' HB3' ' A' ' 711' ' ' MET . 10.6 t -99.07 128.91 50.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.127 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 81.3 mtm180 -148.23 173.65 12.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 725' ' ' ILE . . . . . 0.581 HD13 HG22 ' A' ' 654' ' ' ILE . 31.5 mm -81.05 134.37 27.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.128 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -85.34 103.5 14.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.894 179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 727' ' ' ARG . . . . . 0.431 ' O ' ' C ' ' A' ' 728' ' ' ASN . 0.9 OUTLIER -62.67 -50.3 71.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.888 -179.878 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 728' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 727' ' ' ARG . 32.0 t30 -35.92 -44.93 0.38 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.889 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 729' ' ' ALA . . . . . . . . . . . . . . . -39.93 -61.47 0.85 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.078 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 39.2 p -137.8 129.92 28.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.863 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 731' ' ' GLY . . . . . . . . . . . . . . . -176.02 83.66 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.484 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 732' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.73 132.91 24.37 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.701 2.267 . . . . 0.0 112.34 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 733' ' ' SER . . . . . . . . . . . . . 92.5 p -96.2 167.07 11.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.868 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 734' ' ' SER . . . . . . . . . . . . . 21.3 m -139.62 167.31 22.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.817 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 735' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.512 -179.986 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 645' ' ' SER . . . . . . . . . . . . . 50.8 p -90.46 149.71 22.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.849 0.357 . . . . 0.0 110.834 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 646' ' ' SER . . . . . . . . . . . . . 71.3 m -138.04 172.81 12.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.871 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -146.38 41.76 0.98 Allowed Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.477 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 3.9 m -93.16 106.1 18.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.862 0.363 . . . . 0.0 110.883 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 6.2 t -134.03 130.4 37.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.845 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 107.32 56.09 0.62 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.528 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 651' ' ' ALA . . . . . 0.637 ' HB1' HD12 ' A' ' 725' ' ' ILE . . . -87.15 91.7 8.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.77 0.319 . . . . 0.0 111.135 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 25.8 p -107.14 -28.51 9.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.87 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 653' ' ' GLN . . . . . 0.466 ' NE2' ' HB ' ' A' ' 695' ' ' VAL . 10.3 tp60 -89.92 146.32 24.49 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.876 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 654' ' ' ILE . . . . . 0.485 HD12 ' CG1' ' A' ' 723' ' ' VAL . 23.6 pt -138.04 178.07 4.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.106 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -134.27 153.02 52.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.897 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 20.5 t -135.77 153.43 32.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.138 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -147.67 157.41 43.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.846 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 658' ' ' ASN . . . . . 0.668 ' O ' HG22 ' A' ' 721' ' ' ILE . 4.5 t30 68.63 52.11 0.59 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.87 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.556 HD22 ' CE2' ' A' ' 663' ' ' PHE . 39.8 mt -100.2 143.45 26.54 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.594 0.712 . . . . 0.0 110.924 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -47.96 132.97 22.89 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.672 2.248 . . . . 0.0 112.377 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 16.2 m-85 -44.26 -45.66 8.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.884 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 662' ' ' ASP . . . . . 0.479 ' O ' HG23 ' A' ' 664' ' ' THR . 22.8 t0 -68.16 -34.32 76.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.839 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 663' ' ' PHE . . . . . 0.556 ' CE2' HD22 ' A' ' 659' ' ' LEU . 4.2 t80 -36.84 116.59 0.45 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.925 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 664' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 662' ' ' ASP . 59.1 p -107.73 -177.89 3.47 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.115 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 665' ' ' TRP . . . . . 0.616 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 5.5 p-90 -64.73 -48.65 73.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.866 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 666' ' ' LYS . . . . . 0.616 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 13.8 tptm -48.84 -59.24 3.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.912 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 667' ' ' MET . . . . . 0.492 ' O ' ' CB ' ' A' ' 671' ' ' LYS . 28.6 mtm -53.69 -48.79 69.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 668' ' ' LEU . . . . . 0.427 HD11 ' CG2' ' A' ' 696' ' ' VAL . 15.3 tp -48.56 -46.67 39.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.908 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 30.9 ttmt -65.49 -73.12 0.13 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.914 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -48.59 -23.9 1.15 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.88 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 671' ' ' LYS . . . . . 0.492 ' CB ' ' O ' ' A' ' 667' ' ' MET . 0.3 OUTLIER -69.98 -42.49 73.06 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.897 179.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 672' ' ' PHE . . . . . 0.582 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 15.6 m-85 -86.9 -16.09 37.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.854 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -49.52 -38.62 31.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.905 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -39.45 -44.35 1.36 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.898 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 5.9 t -67.48 -64.09 0.93 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.881 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -148.82 -158.86 8.23 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.516 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 677' ' ' HIS . . . . . 0.449 ' C ' ' CD2' ' A' ' 677' ' ' HIS . 3.4 t60 -86.88 107.52 18.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.871 0.367 . . . . 0.0 110.878 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 60.0 t -81.11 143.2 12.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.109 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 679' ' ' LEU . . . . . 0.597 HD11 ' HG2' ' A' ' 699' ' ' GLU . 23.6 mt -116.14 -62.77 1.54 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.872 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -99.91 128.98 45.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.909 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -155.89 123.75 5.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.08 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -152.5 155.85 38.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.875 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 18.1 mm -104.87 107.3 22.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.114 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 46.0 mmtm -54.51 136.26 44.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 685' ' ' MET . . . . . . . . . . . . . 17.9 mtp -135.07 150.87 50.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.88 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 12.0 tt0 -126.04 95.14 4.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.858 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 687' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 65.03 40.21 5.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.83 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 688' ' ' GLY . . . . . . . . . . . . . . . 72.86 31.86 61.74 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.51 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 689' ' ' LYS . . . . . 0.428 ' O ' ' C ' ' A' ' 690' ' ' SER . 1.0 OUTLIER -134.19 85.95 2.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.792 0.33 . . . . 0.0 110.859 -179.926 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 690' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 689' ' ' LYS . 4.9 t -35.26 137.56 0.16 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.819 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 19.3 mmmt -108.1 18.21 21.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.881 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . 0.493 ' O ' ' N ' ' A' ' 658' ' ' ASN . . . 48.62 25.95 5.02 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.478 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 19.1 p -135.16 131.17 36.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.884 0.373 . . . . 0.0 110.847 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -143.52 -164.97 10.56 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.483 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . 0.466 ' HB ' ' NE2' ' A' ' 653' ' ' GLN . 17.1 m -140.08 160.1 26.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.922 0.391 . . . . 0.0 111.126 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 696' ' ' VAL . . . . . 0.438 HG21 ' CD1' ' A' ' 672' ' ' PHE . 70.7 t -146.52 115.01 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.099 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 37.0 tttt -96.69 138.37 34.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -116.69 164.38 14.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.906 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 699' ' ' GLU . . . . . 0.597 ' HG2' HD11 ' A' ' 679' ' ' LEU . 48.9 mt-10 -71.11 -41.87 69.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.892 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 3.2 m -113.81 149.51 41.91 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.671 0.748 . . . . 0.0 110.887 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -33.53 16.37 Favored 'Trans proline' 0 C--N 1.341 0.14 0 C-N-CA 122.638 2.225 . . . . 0.0 112.349 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 702' ' ' GLU . . . . . 0.449 ' HG3' ' N ' ' A' ' 703' ' ' VAL . 9.2 pt-20 -61.86 -42.36 98.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.893 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 703' ' ' VAL . . . . . 0.449 ' N ' ' HG3' ' A' ' 702' ' ' GLU . 84.2 t -55.31 -60.51 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.126 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 704' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' A' ' 651' ' ' ALA . . . -39.04 -61.43 0.75 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.097 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.44 ' HG2' HD11 ' A' ' 725' ' ' ILE . 12.7 mt-10 -44.29 -41.03 5.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.92 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 15.7 ttt180 -67.05 -59.26 3.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.875 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -46.3 -44.0 16.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.056 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 708' ' ' CYS . . . . . 0.495 ' O ' ' CB ' ' A' ' 712' ' ' ASN . 1.8 m -50.74 -41.16 56.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.873 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 3.2 mtt-85 -82.47 -37.66 25.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.868 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 8.7 mtm -72.34 -9.44 58.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.869 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 711' ' ' MET . . . . . 0.582 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 5.5 mmm -120.5 -35.57 3.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.87 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 712' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 708' ' ' CYS . 0.3 OUTLIER -40.87 112.02 0.26 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.862 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 84.79 19.54 59.53 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.51 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 714' ' ' MET . . . . . 0.457 ' N ' ' O ' ' A' ' 711' ' ' MET . 57.2 ttp -69.28 94.07 0.68 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.847 0.356 . . . . 0.0 110.868 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 8.6 mmtp -51.13 98.92 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.899 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 716' ' ' LEU . . . . . 1.027 HD12 HG21 ' A' ' 721' ' ' ILE . 38.1 mt -99.94 129.92 46.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.951 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 717' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 716' ' ' LEU . 27.8 t 36.51 38.93 0.08 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.885 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 76.76 36.76 36.1 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.479 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 719' ' ' ARG . . . . . 0.498 ' N ' ' O ' ' A' ' 716' ' ' LEU . 21.7 mtt180 -147.22 116.04 6.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.748 0.308 . . . . 0.0 110.848 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -71.41 122.89 21.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.865 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . 1.027 HG21 HD12 ' A' ' 716' ' ' LEU . 19.4 pt -98.99 156.89 3.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.133 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 722' ' ' ASP . . . . . 0.446 ' OD1' ' C ' ' A' ' 722' ' ' ASP . 2.9 t0 -116.01 108.23 15.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.837 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 723' ' ' VAL . . . . . 0.485 ' CG1' HD12 ' A' ' 654' ' ' ILE . 17.3 t -107.32 136.02 43.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.177 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 724' ' ' ARG . . . . . 0.45 ' C ' ' SG ' ' A' ' 708' ' ' CYS . 13.5 ptt85 -158.13 165.97 33.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.872 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 725' ' ' ILE . . . . . 0.637 HD12 ' HB1' ' A' ' 651' ' ' ALA . 27.0 mm -62.18 138.0 23.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.126 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 726' ' ' ASP . . . . . 0.406 ' HB2' ' CA ' ' A' ' 654' ' ' ILE . 35.7 t0 -88.03 86.49 7.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.87 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 727' ' ' ARG . . . . . . . . . . . . . 27.2 mmt85 -60.15 -65.66 0.65 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.892 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 728' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -75.5 89.02 2.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.852 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 729' ' ' ALA . . . . . . . . . . . . . . . -140.31 109.18 6.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.088 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 15.2 t -122.16 -67.9 0.93 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 731' ' ' GLY . . . . . . . . . . . . . . . 128.97 174.92 13.86 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.501 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 732' ' ' PRO . . . . . 0.447 ' O ' ' C ' ' A' ' 733' ' ' SER . 53.6 Cg_endo -69.72 0.28 5.84 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.657 2.238 . . . . 0.0 112.357 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 733' ' ' SER . . . . . 0.447 ' C ' ' O ' ' A' ' 732' ' ' PRO . 34.3 m -34.59 98.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.864 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 734' ' ' SER . . . . . . . . . . . . . 14.0 t -89.99 -39.87 12.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.886 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 735' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.48 -179.986 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 645' ' ' SER . . . . . . . . . . . . . 51.2 p -122.64 175.74 6.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.861 0.362 . . . . 0.0 110.867 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 646' ' ' SER . . . . . . . . . . . . . 23.9 t -52.31 98.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.821 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . 86.32 151.72 18.97 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.457 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 73.4 m -94.35 -52.88 4.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.855 0.359 . . . . 0.0 110.829 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 14.1 m -76.99 168.91 19.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.872 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 176.3 43.27 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.459 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 651' ' ' ALA . . . . . 0.553 ' O ' ' HB3' ' A' ' 704' ' ' ALA . . . -89.98 96.79 10.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.756 0.312 . . . . 0.0 111.09 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 24.5 p -104.08 -30.91 9.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.847 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -94.51 152.06 18.86 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.91 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 654' ' ' ILE . . . . . 0.479 HD11 ' CE2' ' A' ' 672' ' ' PHE . 27.6 pt -136.01 174.54 12.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.113 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -127.76 157.04 41.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.901 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 3.1 t -140.72 151.07 20.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.114 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 4.1 mtp-105 -148.23 156.16 42.22 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.902 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 658' ' ' ASN . . . . . 0.436 ' O ' HG22 ' A' ' 721' ' ' ILE . 0.5 OUTLIER 69.61 45.71 0.77 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.895 -179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.546 HD22 ' CD2' ' A' ' 663' ' ' PHE . 24.0 mt -94.51 143.71 26.73 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.653 0.74 . . . . 0.0 110.902 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -48.03 136.02 23.75 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.617 2.211 . . . . 0.0 112.383 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -52.34 -33.91 45.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.886 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.16 -30.12 43.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.915 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 663' ' ' PHE . . . . . 0.546 ' CD2' HD22 ' A' ' 659' ' ' LEU . 4.1 t80 -39.13 124.96 1.54 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.91 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 77.2 p -110.0 176.6 5.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.21 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 665' ' ' TRP . . . . . 0.644 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 3.5 p-90 -68.26 -50.05 56.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.959 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 666' ' ' LYS . . . . . 0.644 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 13.1 tptp -52.04 -47.48 65.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.943 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 21.2 mtm -64.78 -39.55 93.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.864 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 38.9 tp -56.43 -46.48 80.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.949 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.44 ' O ' ' ND2' ' A' ' 673' ' ' ASN . 0.0 OUTLIER -62.22 -61.07 2.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 179.791 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -54.59 -27.74 41.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 671' ' ' LYS . . . . . 0.431 ' O ' ' HE2' ' A' ' 711' ' ' MET . 11.0 tptt -66.56 -39.48 88.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.872 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 672' ' ' PHE . . . . . 0.479 ' CE2' HD11 ' A' ' 654' ' ' ILE . 25.1 m-85 -90.86 -10.51 42.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.856 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 673' ' ' ASN . . . . . 0.44 ' ND2' ' O ' ' A' ' 669' ' ' LYS . 1.0 OUTLIER -54.53 -32.73 58.75 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.863 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -58.58 -28.88 65.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.89 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 17.3 m -81.81 -53.46 6.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.86 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -161.72 -179.0 36.12 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.492 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -70.2 107.1 3.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.8 0.333 . . . . 0.0 110.855 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 58.8 t -84.68 137.53 20.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.143 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 679' ' ' LEU . . . . . 0.829 HD11 ' HG2' ' A' ' 699' ' ' GLU . 12.1 mt -116.43 -57.98 2.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 680' ' ' TYR . . . . . 0.411 ' HB3' ' CB ' ' A' ' 697' ' ' LYS . 8.3 t80 -99.41 126.11 45.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.925 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -155.6 123.8 5.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.138 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -154.02 158.17 40.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.84 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 27.2 mm -106.87 126.82 62.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.089 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 56.0 mmtt -72.89 137.87 45.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.89 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 685' ' ' MET . . . . . . . . . . . . . 31.7 mtp -139.38 156.21 47.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.872 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 49.6 tt0 -133.31 120.33 20.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.936 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 687' ' ' ASN . . . . . . . . . . . . . 15.9 m120 50.63 38.49 19.12 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.898 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 688' ' ' GLY . . . . . . . . . . . . . . . 70.05 35.63 71.63 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.473 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt -137.35 111.67 8.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.793 0.33 . . . . 0.0 110.888 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 690' ' ' SER . . . . . . . . . . . . . 3.0 m -41.09 154.16 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.886 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -118.86 -34.59 3.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.893 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 95.51 14.63 46.71 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.479 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 21.4 p -133.24 132.22 41.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.871 0.367 . . . . 0.0 110.851 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -139.11 -160.8 8.49 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.509 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 19.3 m -147.21 160.29 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.904 0.383 . . . . 0.0 111.11 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 97.1 t -148.0 113.54 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.137 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 697' ' ' LYS . . . . . 0.411 ' CB ' ' HB3' ' A' ' 680' ' ' TYR . 18.9 ttpt -96.24 143.63 27.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 698' ' ' PHE . . . . . 0.437 ' CD2' HG11 ' A' ' 703' ' ' VAL . 96.2 m-85 -119.66 168.66 10.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.834 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 699' ' ' GLU . . . . . 0.829 ' HG2' HD11 ' A' ' 679' ' ' LEU . 17.7 mt-10 -75.05 -34.44 61.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.918 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 700' ' ' SER . . . . . 0.416 ' CB ' ' OE2' ' A' ' 702' ' ' GLU . 1.4 m -125.34 152.86 71.89 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.696 0.76 . . . . 0.0 110.826 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -50.37 0.47 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.698 2.265 . . . . 0.0 112.36 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 702' ' ' GLU . . . . . 0.416 ' OE2' ' CB ' ' A' ' 700' ' ' SER . 25.6 pm0 -44.54 -27.48 0.47 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.863 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 703' ' ' VAL . . . . . 0.437 HG11 ' CD2' ' A' ' 698' ' ' PHE . 47.0 t -73.4 -54.5 15.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.095 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 704' ' ' ALA . . . . . 0.553 ' HB3' ' O ' ' A' ' 651' ' ' ALA . . . -48.61 -57.14 6.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.067 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.576 ' HA ' HD11 ' A' ' 725' ' ' ILE . 26.5 mt-10 -45.86 -38.07 6.94 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.858 -179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 9.4 ttm-85 -74.03 -58.15 3.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.897 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -47.99 -25.78 1.52 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.11 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 708' ' ' CYS . . . . . 0.5 ' HA ' HG12 ' A' ' 723' ' ' VAL . 1.5 t -60.47 -60.03 4.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.858 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -73.38 -36.97 66.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.812 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 12.1 mmm -59.42 -30.29 68.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.909 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 711' ' ' MET . . . . . 0.442 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 4.8 mmm -107.03 -15.9 14.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.88 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 712' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -53.91 121.83 8.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.923 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 77.14 12.82 84.27 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.524 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 714' ' ' MET . . . . . . . . . . . . . 55.8 ttp -59.64 104.31 0.27 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.849 0.356 . . . . 0.0 110.867 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 7.9 mmtm -61.98 100.22 0.15 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.898 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 716' ' ' LEU . . . . . 0.616 HD12 HG21 ' A' ' 721' ' ' ILE . 31.6 mt -99.89 126.86 46.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.958 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 717' ' ' SER . . . . . 0.409 ' C ' ' O ' ' A' ' 716' ' ' LEU . 1.6 t 36.7 39.7 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.887 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 77.18 36.18 35.89 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.484 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 719' ' ' ARG . . . . . 0.494 ' N ' ' O ' ' A' ' 716' ' ' LEU . 5.9 mtt-85 -148.68 114.54 5.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.804 0.335 . . . . 0.0 110.864 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -72.27 127.48 32.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . 0.616 HG21 HD12 ' A' ' 716' ' ' LEU . 28.5 pt -100.04 157.05 4.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.149 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -109.22 98.48 7.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.847 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 723' ' ' VAL . . . . . 0.5 HG12 ' HA ' ' A' ' 708' ' ' CYS . 17.9 t -97.61 130.13 46.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.121 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.19 175.22 13.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.923 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 725' ' ' ILE . . . . . 0.576 HD11 ' HA ' ' A' ' 705' ' ' GLU . 49.4 mm -80.31 133.37 29.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.114 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -84.01 118.92 24.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.861 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 727' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -83.44 -30.82 26.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.895 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 728' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -96.18 56.74 1.66 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.891 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 729' ' ' ALA . . . . . . . . . . . . . . . -99.95 -55.64 2.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.149 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 84.1 p -111.62 169.16 9.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.838 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 731' ' ' GLY . . . . . . . . . . . . . . . -106.18 144.24 15.81 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.49 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 732' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -173.05 0.64 Allowed 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.659 2.239 . . . . 0.0 112.37 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 733' ' ' SER . . . . . . . . . . . . . 16.0 m -136.58 105.35 5.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.894 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 734' ' ' SER . . . . . . . . . . . . . 5.0 t -169.83 114.66 0.52 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.843 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 735' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.455 179.966 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 645' ' ' SER . . . . . . . . . . . . . 43.4 m 54.83 43.36 30.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.908 0.385 . . . . 0.0 110.89 -179.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 646' ' ' SER . . . . . . . . . . . . . 5.8 t -94.69 -58.85 2.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.835 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . 127.93 95.85 0.87 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.473 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 91.8 p -89.82 -49.63 6.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.896 0.379 . . . . 0.0 110.88 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 7.5 t -100.13 123.94 44.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.887 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . -71.99 119.76 7.6 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.462 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 651' ' ' ALA . . . . . 0.481 ' HB1' ' CG2' ' A' ' 725' ' ' ILE . . . -69.6 74.78 0.41 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.726 0.298 . . . . 0.0 111.082 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 29.7 p -97.14 47.2 1.04 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.879 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -163.94 149.44 10.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.913 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 654' ' ' ILE . . . . . 0.659 HG22 HD13 ' A' ' 725' ' ' ILE . 37.8 pt -140.66 173.29 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.14 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -130.5 144.69 51.57 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.871 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 27.6 t -126.99 139.25 52.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.081 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 36.7 mtp85 -133.73 155.76 49.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.86 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 658' ' ' ASN . . . . . 0.559 ' O ' HG22 ' A' ' 721' ' ' ILE . 4.7 t30 70.66 52.12 0.32 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.92 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.659 HD22 ' CD2' ' A' ' 663' ' ' PHE . 36.7 mt -100.04 145.11 29.64 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.643 0.735 . . . . 0.0 110.875 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -47.92 142.46 15.07 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.654 2.236 . . . . 0.0 112.395 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -60.53 -24.75 65.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.889 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -98.17 13.4 31.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.85 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 663' ' ' PHE . . . . . 0.659 ' CD2' HD22 ' A' ' 659' ' ' LEU . 3.4 t80 -80.14 118.48 21.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 69.4 p -105.45 168.99 8.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.079 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 665' ' ' TRP . . . . . 0.639 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 6.9 p-90 -57.23 -49.72 75.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.927 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 666' ' ' LYS . . . . . 0.639 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 5.3 tptm -46.27 -54.35 9.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.886 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 16.6 mtm -59.72 -55.62 32.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.84 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 14.7 tp -42.97 -46.91 5.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.902 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.4 ' CG ' HD21 ' A' ' 673' ' ' ASN . 46.1 tttt -62.49 -71.45 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -46.28 -24.11 0.43 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.878 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 8.8 tptp -68.79 -51.49 40.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.927 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 672' ' ' PHE . . . . . 0.56 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 23.1 m-85 -78.53 -15.24 58.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.892 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 673' ' ' ASN . . . . . 0.4 HD21 ' CG ' ' A' ' 669' ' ' LYS . 1.6 m-80 -49.92 -34.58 20.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.923 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -53.66 -39.76 65.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.881 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 31.9 m -71.42 -47.54 55.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.888 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -165.69 -177.33 37.86 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.479 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -73.21 96.45 2.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.843 0.354 . . . . 0.0 110.862 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 78.9 t -73.26 138.3 21.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.143 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 679' ' ' LEU . . . . . 0.474 HD11 ' HG2' ' A' ' 699' ' ' GLU . 12.9 mt -113.21 -61.52 1.73 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.931 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 680' ' ' TYR . . . . . 0.433 ' HB3' ' CB ' ' A' ' 697' ' ' LYS . 4.5 t80 -95.71 129.11 43.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.93 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -156.91 125.2 5.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.075 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -156.0 161.72 40.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.84 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 42.9 mm -109.25 107.27 22.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.129 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 27.8 mmtm -60.82 132.44 53.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.882 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 685' ' ' MET . . . . . . . . . . . . . 32.6 mtp -133.62 146.54 51.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.897 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -107.66 113.74 27.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.88 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 687' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 50.53 41.98 26.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.875 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 688' ' ' GLY . . . . . . . . . . . . . . . 76.9 38.19 31.5 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.527 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 39.7 mtpt -135.81 130.18 33.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.785 0.326 . . . . 0.0 110.897 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 690' ' ' SER . . . . . . . . . . . . . 3.1 m -70.02 131.46 44.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.836 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 691' ' ' LYS . . . . . 0.461 ' O ' ' N ' ' A' ' 693' ' ' CYS . 29.0 mmtt -113.4 24.38 12.29 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.867 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . 0.413 ' C ' ' HB2' ' A' ' 659' ' ' LEU . . . 38.14 27.84 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.493 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 693' ' ' CYS . . . . . 0.461 ' N ' ' O ' ' A' ' 691' ' ' LYS . 31.2 p -132.46 129.13 38.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.843 0.354 . . . . 0.0 110.89 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -141.79 -163.47 9.62 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.487 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 13.4 m -142.93 153.1 17.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.857 0.36 . . . . 0.0 111.086 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 696' ' ' VAL . . . . . 0.501 HG21 ' CD1' ' A' ' 672' ' ' PHE . 93.4 t -139.34 118.04 12.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.136 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 697' ' ' LYS . . . . . 0.433 ' CB ' ' HB3' ' A' ' 680' ' ' TYR . 27.0 tttt -101.43 148.04 25.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.906 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -123.31 173.99 7.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 699' ' ' GLU . . . . . 0.474 ' HG2' HD11 ' A' ' 679' ' ' LEU . 4.6 mt-10 -82.47 -44.13 16.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.918 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 1.1 t -103.41 143.01 25.77 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.692 0.758 . . . . 0.0 110.863 -179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.71 -20.71 34.73 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.682 2.254 . . . . 0.0 112.343 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -75.56 -41.68 54.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.853 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 66.0 t -56.02 -55.71 16.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.108 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -46.75 -43.91 18.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.092 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.548 ' HA ' HD11 ' A' ' 725' ' ' ILE . 13.3 mt-10 -60.03 -34.07 72.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.845 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 26.9 ttm180 -79.95 -57.83 3.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.89 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -45.4 -33.13 2.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.059 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 708' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -53.17 -52.67 58.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.887 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.73 -40.85 32.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 61.1 mtp -56.86 -17.64 10.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 711' ' ' MET . . . . . 0.56 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 4.9 mmm -117.59 -24.81 7.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.856 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 712' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -48.55 114.06 0.89 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.926 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 82.58 31.88 29.05 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.532 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 714' ' ' MET . . . . . . . . . . . . . 63.0 ttp -82.75 105.86 14.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.84 0.352 . . . . 0.0 110.915 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 7.0 mmtp -60.66 100.42 0.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.889 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 716' ' ' LEU . . . . . 0.922 HD12 HG21 ' A' ' 721' ' ' ILE . 31.2 mt -99.89 125.56 45.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.945 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 717' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 716' ' ' LEU . 48.3 t 36.93 38.62 0.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.854 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 718' ' ' GLY . . . . . 0.406 ' C ' ' HG3' ' A' ' 719' ' ' ARG . . . 79.39 34.78 31.37 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.517 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 719' ' ' ARG . . . . . 0.498 ' N ' ' O ' ' A' ' 716' ' ' LEU . 37.3 mtp85 -146.65 112.76 5.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.748 0.308 . . . . 0.0 110.891 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -70.74 123.6 22.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.854 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . 0.922 HG21 HD12 ' A' ' 716' ' ' LEU . 31.7 pt -99.95 156.23 4.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.16 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -114.46 105.04 12.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.875 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 723' ' ' VAL . . . . . 0.429 HG21 ' CB ' ' A' ' 711' ' ' MET . 21.9 t -100.79 132.42 46.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.09 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 29.4 ptt180 -154.66 161.43 41.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.878 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 725' ' ' ILE . . . . . 0.659 HD13 HG22 ' A' ' 654' ' ' ILE . 14.9 mm -72.53 134.64 29.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.134 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -84.98 82.39 8.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.884 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 727' ' ' ARG . . . . . . . . . . . . . 33.0 mtt180 -81.65 40.79 0.6 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.843 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 728' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -129.22 -37.76 1.64 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.87 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 729' ' ' ALA . . . . . . . . . . . . . . . -42.38 -47.54 4.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.141 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 34.5 t -53.26 108.05 0.29 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.835 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 731' ' ' GLY . . . . . . . . . . . . . . . 114.56 76.43 0.69 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.516 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 732' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.81 -7.62 21.53 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.628 2.219 . . . . 0.0 112.344 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 733' ' ' SER . . . . . . . . . . . . . 20.7 t 64.23 37.42 8.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.891 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 734' ' ' SER . . . . . . . . . . . . . 28.6 t -137.93 125.94 22.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.879 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 735' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.479 -179.956 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 645' ' ' SER . . . . . . . . . . . . . 41.5 t -139.02 110.22 6.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.859 0.362 . . . . 0.0 110.84 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 646' ' ' SER . . . . . . . . . . . . . 35.5 p -109.64 -44.41 3.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.899 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -150.12 -149.19 4.95 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.519 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 2.2 t -99.9 91.24 4.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.874 0.368 . . . . 0.0 110.839 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 82.5 p -97.68 152.46 19.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.877 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . -175.69 127.88 1.32 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.453 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 651' ' ' ALA . . . . . 0.627 ' O ' ' HB3' ' A' ' 704' ' ' ALA . . . -73.81 110.71 8.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.76 0.314 . . . . 0.0 111.061 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 63.1 m -113.32 -36.86 4.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.917 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -94.05 151.42 19.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.911 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 654' ' ' ILE . . . . . 0.483 HD11 ' CE2' ' A' ' 672' ' ' PHE . 20.7 pt -138.69 174.04 10.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.162 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -126.56 156.43 40.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.888 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 3.4 t -142.05 149.68 19.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.152 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -144.81 154.64 42.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.874 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 658' ' ' ASN . . . . . 0.468 ' ND2' ' HB3' ' A' ' 719' ' ' ARG . 4.1 t30 73.56 44.88 0.28 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.868 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . . . . . . . . . 36.3 mt -96.71 144.45 27.86 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.66 0.743 . . . . 0.0 110.86 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -48.0 139.5 20.19 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.676 2.251 . . . . 0.0 112.364 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -62.11 -24.92 67.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.894 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -94.32 3.26 55.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.921 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -70.72 124.39 24.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.881 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 38.7 p -104.22 169.04 8.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.155 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 665' ' ' TRP . . . . . 0.642 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 7.6 p-90 -63.51 -52.15 62.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.947 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 666' ' ' LYS . . . . . 0.642 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 0.0 OUTLIER -47.06 -43.1 19.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.883 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 30.5 mtm -68.31 -50.86 50.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 14.2 tp -48.2 -47.26 35.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.866 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 44.2 tttt -59.54 -74.07 0.08 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.901 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -45.38 -28.23 0.82 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.845 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 671' ' ' LYS . . . . . 0.467 ' HE2' HD21 ' A' ' 716' ' ' LEU . 26.6 tptt -68.64 -39.65 80.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.855 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 672' ' ' PHE . . . . . 0.483 ' CE2' HD11 ' A' ' 654' ' ' ILE . 13.6 m-85 -88.37 -14.01 39.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.866 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -56.53 -35.85 68.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.877 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 51.0 mm-40 -42.22 -41.86 2.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.877 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 3.0 t -70.62 -59.78 2.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.852 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -148.81 -153.96 6.17 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.494 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -95.54 104.52 16.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.859 0.361 . . . . 0.0 110.86 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 57.9 t -82.7 136.06 23.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.128 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 679' ' ' LEU . . . . . 0.463 HD11 ' HG2' ' A' ' 699' ' ' GLU . 12.8 mt -109.97 -59.12 1.97 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.935 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -96.99 129.79 44.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.956 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -157.78 122.96 4.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.093 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -148.09 166.54 27.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.835 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 45.2 mm -114.47 106.86 21.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.115 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 36.5 mmtm -62.03 143.29 56.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.912 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 685' ' ' MET . . . . . . . . . . . . . 40.7 mtp -138.13 154.98 49.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.851 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -137.12 118.09 14.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.899 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 687' ' ' ASN . . . . . . . . . . . . . 21.4 t30 73.56 27.8 1.77 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.898 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 688' ' ' GLY . . . . . . . . . . . . . . . 78.84 17.17 77.78 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.526 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 17.7 pttt -138.42 131.46 29.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.771 0.319 . . . . 0.0 110.882 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 690' ' ' SER . . . . . . . . . . . . . 7.9 t -48.93 162.78 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.885 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 19.3 mmtt -129.8 17.29 5.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.925 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 55.76 23.7 38.12 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.488 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 27.5 p -131.95 127.34 36.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.866 0.365 . . . . 0.0 110.91 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -142.25 -169.16 12.02 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.489 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 27.5 m -139.07 166.97 21.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.891 0.377 . . . . 0.0 111.127 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 93.0 t -154.75 121.86 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.129 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 20.7 ttpt -105.97 143.08 34.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.911 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 698' ' ' PHE . . . . . 0.429 ' CD2' HG11 ' A' ' 703' ' ' VAL . 96.6 m-85 -118.4 169.24 9.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.878 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 699' ' ' GLU . . . . . 0.463 ' HG2' HD11 ' A' ' 679' ' ' LEU . 6.2 mm-40 -76.7 -45.3 30.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.869 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 31.4 m -104.49 147.37 34.28 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.667 0.746 . . . . 0.0 110.887 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -31.53 20.37 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.687 2.258 . . . . 0.0 112.343 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 702' ' ' GLU . . . . . 0.452 ' HG3' ' N ' ' A' ' 703' ' ' VAL . 11.2 pt-20 -61.47 -42.92 99.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.873 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 703' ' ' VAL . . . . . 0.452 ' N ' ' HG3' ' A' ' 702' ' ' GLU . 94.6 t -53.0 -59.36 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.168 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 704' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 651' ' ' ALA . . . -40.63 -65.74 0.39 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.084 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.55 ' HA ' HD11 ' A' ' 725' ' ' ILE . 9.8 mt-10 -41.07 -37.69 0.89 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.891 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 17.3 ttm180 -75.43 -64.47 1.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.845 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -40.17 -35.33 0.39 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.109 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 708' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -53.26 -56.19 18.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.887 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -77.36 -38.63 49.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.861 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 17.8 mmm -57.12 -23.15 45.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.903 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 711' ' ' MET . . . . . 0.403 ' O ' ' C ' ' A' ' 712' ' ' ASN . 4.7 mmm -111.74 -34.75 5.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 712' ' ' ASN . . . . . 0.436 ' OD1' ' C ' ' A' ' 712' ' ' ASN . 9.9 t-20 -38.03 112.71 0.23 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.894 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 84.21 27.96 35.2 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.493 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 714' ' ' MET . . . . . . . . . . . . . 37.2 ttp -77.67 99.04 5.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.861 0.363 . . . . 0.0 110.902 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 715' ' ' LYS . . . . . 0.416 ' HE3' ' CD ' ' A' ' 720' ' ' GLU . 11.8 mmtp -56.06 98.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.874 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 716' ' ' LEU . . . . . 0.665 HD12 HG21 ' A' ' 721' ' ' ILE . 31.5 mt -100.0 125.35 46.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.918 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 717' ' ' SER . . . . . . . . . . . . . 34.7 t 38.86 38.49 0.28 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.843 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 78.55 30.96 47.19 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.487 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 719' ' ' ARG . . . . . 0.499 ' N ' ' O ' ' A' ' 716' ' ' LEU . 45.5 mtt180 -141.13 114.55 8.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.84 0.353 . . . . 0.0 110.873 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 720' ' ' GLU . . . . . 0.416 ' CD ' ' HE3' ' A' ' 715' ' ' LYS . 5.3 mt-10 -73.34 126.1 29.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.878 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . 0.665 HG21 HD12 ' A' ' 716' ' ' LEU . 44.9 pt -100.0 162.77 3.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.118 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -119.07 101.38 7.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.878 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 10.0 t -100.83 132.12 47.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.122 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 50.7 mtp180 -155.99 163.55 39.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.874 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 725' ' ' ILE . . . . . 0.55 HD11 ' HA ' ' A' ' 705' ' ' GLU . 25.0 mm -64.8 135.77 27.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.148 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -91.79 74.6 5.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.893 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 727' ' ' ARG . . . . . . . . . . . . . 2.7 tpm_? -49.04 149.63 1.85 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.884 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 728' ' ' ASN . . . . . . . . . . . . . 33.7 t-20 63.95 44.04 4.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.93 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 729' ' ' ALA . . . . . . . . . . . . . . . -75.2 -59.65 2.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.093 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 11.5 t -99.05 -57.38 2.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.863 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 731' ' ' GLY . . . . . . . . . . . . . . . 151.57 167.79 15.32 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.478 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 732' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.69 136.31 32.86 Favored 'Trans proline' 0 N--CA 1.465 -0.153 0 C-N-CA 122.726 2.284 . . . . 0.0 112.363 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 733' ' ' SER . . . . . . . . . . . . . 82.6 p -78.39 130.03 35.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.843 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 734' ' ' SER . . . . . . . . . . . . . 15.5 t -88.22 -49.6 6.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.877 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 735' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.272 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.439 179.979 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 645' ' ' SER . . . . . . . . . . . . . 1.8 t -81.59 126.41 31.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.855 0.36 . . . . 0.0 110.887 -179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 646' ' ' SER . . . . . . . . . . . . . 26.1 m -142.35 163.88 31.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.836 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . 85.46 -60.48 4.71 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.506 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 28.7 p -86.34 92.68 8.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.858 0.361 . . . . 0.0 110.84 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 14.7 m -85.12 131.37 34.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.85 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 97.75 119.48 3.95 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.503 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 651' ' ' ALA . . . . . 0.747 ' O ' ' HB3' ' A' ' 704' ' ' ALA . . . -133.85 107.84 8.09 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.793 0.33 . . . . 0.0 111.111 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 64.4 m -108.14 -30.43 8.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.852 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -96.56 154.06 17.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.945 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 654' ' ' ILE . . . . . 0.505 HG22 HD13 ' A' ' 725' ' ' ILE . 28.7 pt -141.87 170.05 13.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.114 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -122.39 153.73 38.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.891 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 3.5 t -139.95 148.41 22.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.142 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 38.4 mtp180 -146.73 155.79 42.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.871 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 658' ' ' ASN . . . . . 0.607 ' O ' HG22 ' A' ' 721' ' ' ILE . 3.8 t30 71.28 51.57 0.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.52 HD22 ' CD2' ' A' ' 663' ' ' PHE . 39.2 mt -101.35 143.48 26.67 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.623 0.725 . . . . 0.0 110.893 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 660' ' ' PRO . . . . . 0.477 ' O ' ' N ' ' A' ' 663' ' ' PHE . 66.6 Cg_exo -48.01 126.0 12.5 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.701 2.267 . . . . 0.0 112.336 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -40.79 -40.69 1.39 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.864 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 662' ' ' ASP . . . . . 0.421 ' O ' ' C ' ' A' ' 663' ' ' PHE . 22.8 t70 -73.16 -33.67 65.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.853 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 663' ' ' PHE . . . . . 0.52 ' CD2' HD22 ' A' ' 659' ' ' LEU . 4.1 t80 -36.31 119.91 0.63 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.895 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 74.4 p -104.88 -179.95 4.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.174 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 665' ' ' TRP . . . . . 0.62 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 6.5 p-90 -71.54 -50.23 33.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.894 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 666' ' ' LYS . . . . . 0.62 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 22.7 tptt -48.7 -43.72 37.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.872 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 667' ' ' MET . . . . . 0.401 ' CE ' ' HA ' ' A' ' 663' ' ' PHE . 27.4 mtm -66.09 -51.92 53.56 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.912 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 15.5 tp -46.21 -45.9 17.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.885 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 29.9 tttm -60.54 -73.99 0.08 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.885 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -47.07 -28.46 1.73 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.887 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 17.5 tptt -64.6 -41.24 96.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.888 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 672' ' ' PHE . . . . . 0.53 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 21.8 m-85 -88.89 -14.57 36.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.848 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -52.51 -40.19 62.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.897 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -44.6 -37.49 3.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.863 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 88.4 m -73.2 -58.51 3.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.883 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -152.95 -153.92 6.52 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.485 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 677' ' ' HIS . . . . . 0.445 ' CD2' HD23 ' A' ' 679' ' ' LEU . 8.9 t60 -92.84 106.57 18.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.87 0.367 . . . . 0.0 110.829 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 678' ' ' VAL . . . . . 0.467 HG13 HG13 ' A' ' 696' ' ' VAL . 87.0 t -84.34 127.66 39.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.105 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 679' ' ' LEU . . . . . 0.574 HD11 ' HG2' ' A' ' 699' ' ' GLU . 12.0 mt -103.57 -60.16 1.61 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.937 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -99.27 129.06 45.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.921 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -157.65 121.41 4.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.092 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -153.23 156.77 39.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.871 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 37.9 mm -99.44 102.65 13.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.109 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -57.64 139.22 54.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.898 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 685' ' ' MET . . . . . . . . . . . . . 21.6 mtp -137.06 166.82 22.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.904 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -129.59 94.88 3.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.86 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 687' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 70.93 39.36 1.03 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.892 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 688' ' ' GLY . . . . . . . . . . . . . . . 74.04 43.64 32.74 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.496 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -139.14 135.69 34.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.788 0.328 . . . . 0.0 110.889 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 690' ' ' SER . . . . . . . . . . . . . 35.9 p -75.61 119.78 20.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.824 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 40.8 mmtm -103.53 13.96 32.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.941 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . 0.42 ' C ' ' HB2' ' A' ' 659' ' ' LEU . . . 53.36 25.9 28.11 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.56 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 31.8 p -127.44 142.13 51.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.843 0.354 . . . . 0.0 110.903 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -150.62 -168.07 15.13 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.503 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 7.1 m -141.62 157.97 21.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.87 0.366 . . . . 0.0 111.131 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 696' ' ' VAL . . . . . 0.467 HG13 HG13 ' A' ' 678' ' ' VAL . 91.6 t -147.52 118.67 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.139 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 14.5 ttpt -105.96 137.24 44.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.922 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -111.91 173.71 6.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.845 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 699' ' ' GLU . . . . . 0.574 ' HG2' HD11 ' A' ' 679' ' ' LEU . 44.9 mt-10 -79.14 -40.77 30.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.865 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 5.5 m -110.18 148.64 38.76 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.63 0.729 . . . . 0.0 110.825 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -17.68 37.4 Favored 'Trans proline' 0 N--CA 1.465 -0.153 0 C-N-CA 122.693 2.262 . . . . 0.0 112.351 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -78.21 -49.27 14.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.862 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 60.9 t -46.51 -42.1 5.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.159 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 704' ' ' ALA . . . . . 0.747 ' HB3' ' O ' ' A' ' 651' ' ' ALA . . . -59.48 -61.54 2.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.126 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -45.7 -32.43 2.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.897 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 44.5 ttt180 -80.77 -43.98 19.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.867 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -61.06 -62.5 1.81 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.137 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 708' ' ' CYS . . . . . 0.475 ' HA ' ' CG1' ' A' ' 723' ' ' VAL . 26.5 p -47.13 -29.71 2.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.912 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 16.6 mtt85 -89.56 -25.24 21.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.838 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 44.2 mtp -87.57 -12.02 46.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.874 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 711' ' ' MET . . . . . 0.53 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 8.9 mmm -110.82 -23.15 11.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.9 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 712' ' ' ASN . . . . . 0.43 ' O ' ' CG ' ' A' ' 712' ' ' ASN . 0.5 OUTLIER -42.6 117.29 1.0 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.857 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 79.78 21.58 65.83 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.49 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 714' ' ' MET . . . . . 0.489 ' HB3' HD11 ' A' ' 721' ' ' ILE . 31.8 ttp -65.54 94.1 0.18 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.843 0.354 . . . . 0.0 110.871 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 715' ' ' LYS . . . . . 0.417 ' NZ ' ' HA2' ' A' ' 718' ' ' GLY . 1.7 mmmt -55.91 99.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.881 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 716' ' ' LEU . . . . . 0.677 HD12 HG21 ' A' ' 721' ' ' ILE . 58.2 mt -100.08 132.28 45.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.871 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 717' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 716' ' ' LEU . 15.7 t 35.92 36.41 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.874 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 718' ' ' GLY . . . . . 0.417 ' HA2' ' NZ ' ' A' ' 715' ' ' LYS . . . 77.99 38.98 25.26 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.502 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 719' ' ' ARG . . . . . 0.499 ' N ' ' O ' ' A' ' 716' ' ' LEU . 39.3 mtt85 -149.23 107.52 3.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.77 0.319 . . . . 0.0 110.883 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -62.73 123.83 19.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . 0.677 HG21 HD12 ' A' ' 716' ' ' LEU . 24.9 pt -99.62 155.89 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.13 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 40.7 t0 -110.73 110.12 20.64 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.876 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 723' ' ' VAL . . . . . 0.475 ' CG1' ' HA ' ' A' ' 708' ' ' CYS . 2.7 t -109.39 136.87 43.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.14 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 12.9 ptt180 -157.95 169.99 23.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.851 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 725' ' ' ILE . . . . . 0.505 HD13 HG22 ' A' ' 654' ' ' ILE . 46.6 mm -77.31 143.09 13.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.126 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -94.12 98.95 11.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.889 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 727' ' ' ARG . . . . . . . . . . . . . 8.9 mpt_? -59.69 -45.96 90.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.836 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 728' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -96.1 77.92 3.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.871 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 729' ' ' ALA . . . . . . . . . . . . . . . -119.89 114.52 22.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.127 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 3.5 m -156.57 159.18 38.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.854 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 731' ' ' GLY . . . . . . . . . . . . . . . 170.75 172.42 37.03 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.494 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 732' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 -14.94 36.8 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.727 2.284 . . . . 0.0 112.347 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 733' ' ' SER . . . . . 0.425 ' O ' ' C ' ' A' ' 734' ' ' SER . 4.5 t -46.6 104.61 0.05 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.889 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 734' ' ' SER . . . . . 0.425 ' C ' ' O ' ' A' ' 733' ' ' SER . 32.5 p -36.56 -47.27 0.62 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.832 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 735' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.547 -179.922 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 645' ' ' SER . . . . . . . . . . . . . 6.3 t -66.07 -57.21 8.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.897 0.379 . . . . 0.0 110.861 -179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 646' ' ' SER . . . . . . . . . . . . . 56.9 p -105.82 139.96 39.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.867 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . 165.01 67.79 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.472 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 29.0 t -105.75 131.59 52.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.885 0.374 . . . . 0.0 110.881 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 39.7 m -116.36 94.53 4.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.886 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 138.22 70.27 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.481 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 651' ' ' ALA . . . . . 0.714 ' O ' ' HB3' ' A' ' 704' ' ' ALA . . . -128.96 110.45 12.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.748 0.309 . . . . 0.0 111.094 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 81.6 m -105.37 -34.71 7.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.883 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -95.09 150.19 20.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.888 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 654' ' ' ILE . . . . . 0.501 HD11 ' CE2' ' A' ' 672' ' ' PHE . 29.2 pt -135.47 176.5 8.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.139 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -131.53 143.47 50.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.884 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 11.1 t -129.97 145.93 34.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.134 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -136.25 168.97 18.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.874 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 658' ' ' ASN . . . . . 0.436 ' O ' HG22 ' A' ' 721' ' ' ILE . 8.5 t30 60.08 47.23 9.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.869 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.607 HD22 ' CE2' ' A' ' 663' ' ' PHE . 53.8 mt -95.14 143.59 26.37 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.629 0.728 . . . . 0.0 110.916 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -47.94 145.04 10.83 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.651 2.234 . . . . 0.0 112.345 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -61.88 -33.18 73.74 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.91 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -89.41 7.91 33.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.864 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 663' ' ' PHE . . . . . 0.607 ' CE2' HD22 ' A' ' 659' ' ' LEU . 2.9 t80 -73.87 114.17 11.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 57.9 p -100.14 166.01 11.22 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.184 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 665' ' ' TRP . . . . . 0.587 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 10.6 p-90 -55.9 -46.72 78.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.906 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 666' ' ' LYS . . . . . 0.587 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 4.2 tppp? -48.53 -52.61 21.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.889 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 14.5 mtm -60.58 -54.81 40.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.869 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 26.2 tp -45.97 -45.59 15.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.942 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.4 ' C ' ' N ' ' A' ' 671' ' ' LYS . 33.9 tttm -64.57 -74.79 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.855 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -45.91 -21.73 0.15 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.851 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 671' ' ' LYS . . . . . 0.419 ' HG3' ' CE ' ' A' ' 711' ' ' MET . 6.2 tppt? -71.61 -45.75 61.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.893 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 672' ' ' PHE . . . . . 0.573 ' CD1' HG21 ' A' ' 696' ' ' VAL . 23.7 m-85 -84.36 -8.81 58.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.904 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -58.88 -30.08 67.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.89 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 66.9 mm-40 -49.01 -43.3 40.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.897 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 675' ' ' CYS . . . . . 0.502 ' SG ' ' HB2' ' A' ' 707' ' ' ALA . 19.2 t -66.6 -62.27 1.54 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.873 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -147.6 -148.19 4.7 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.489 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -98.68 101.64 13.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.794 0.33 . . . . 0.0 110.889 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 678' ' ' VAL . . . . . 0.431 ' CG1' HG13 ' A' ' 696' ' ' VAL . 98.8 t -76.81 136.29 24.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.122 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 18.2 mt -110.33 -62.74 1.47 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.928 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 680' ' ' TYR . . . . . 0.422 ' CE2' HG21 ' A' ' 695' ' ' VAL . 9.1 t80 -95.98 126.4 41.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.94 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -156.84 125.9 5.97 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.103 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -157.5 157.24 33.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.862 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 45.5 mm -97.74 104.17 15.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.155 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -60.19 135.87 57.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.872 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 685' ' ' MET . . . . . . . . . . . . . 25.5 mtp -134.8 167.42 20.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.926 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -131.12 106.85 8.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.9 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 687' ' ' ASN . . . . . . . . . . . . . 45.8 t30 56.26 43.38 26.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.917 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 688' ' ' GLY . . . . . . . . . . . . . . . 74.21 37.51 48.48 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.458 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 25.9 mtmm -139.38 129.69 25.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.844 0.354 . . . . 0.0 110.89 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 690' ' ' SER . . . . . . . . . . . . . 19.4 t -72.62 132.24 43.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.857 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -112.27 24.41 12.59 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.886 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 43.77 36.37 3.55 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.447 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 28.9 p -137.97 142.49 40.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.845 0.355 . . . . 0.0 110.906 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -152.56 -160.78 9.82 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.468 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . 0.422 HG21 ' CE2' ' A' ' 680' ' ' TYR . 10.3 m -149.54 156.73 7.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.869 0.366 . . . . 0.0 111.127 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 696' ' ' VAL . . . . . 0.573 HG21 ' CD1' ' A' ' 672' ' ' PHE . 67.0 t -146.14 118.37 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.086 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 15.8 tttt -104.22 146.03 29.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.901 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -122.11 164.79 17.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.861 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 699' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -68.76 -42.16 77.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.88 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 26.4 m -110.92 147.16 35.94 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.703 0.763 . . . . 0.0 110.824 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.79 -29.16 24.17 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.698 2.265 . . . . 0.0 112.333 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -63.5 -40.92 98.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 94.7 t -58.83 -57.1 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.058 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 704' ' ' ALA . . . . . 0.714 ' HB3' ' O ' ' A' ' 651' ' ' ALA . . . -43.19 -66.71 0.34 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.127 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.738 ' HA ' HD11 ' A' ' 725' ' ' ILE . 27.9 mt-10 -39.34 -39.29 0.63 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.902 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 706' ' ' ARG . . . . . 0.429 ' O ' ' N ' ' A' ' 708' ' ' CYS . 16.1 ttm-85 -73.46 -64.11 1.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.882 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 707' ' ' ALA . . . . . 0.502 ' HB2' ' SG ' ' A' ' 675' ' ' CYS . . . -38.95 -29.32 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.087 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 708' ' ' CYS . . . . . 0.429 ' N ' ' O ' ' A' ' 706' ' ' ARG . 1.2 t -61.81 -49.47 76.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.832 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -77.19 -33.11 56.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.851 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 59.7 mtp -70.04 -16.37 63.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.843 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 711' ' ' MET . . . . . 0.431 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 5.3 mmm -118.93 -20.41 8.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.892 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 712' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -53.28 122.48 9.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.92 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 74.68 23.5 74.97 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.515 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 714' ' ' MET . . . . . . . . . . . . . 42.4 ttp -76.4 111.05 11.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.859 0.362 . . . . 0.0 110.885 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 19.4 mmtt -63.34 102.53 0.41 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.942 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 716' ' ' LEU . . . . . 1.081 HD12 HG21 ' A' ' 721' ' ' ILE . 36.9 mt -99.98 122.98 43.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.905 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 717' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 716' ' ' LEU . 1.3 t 37.3 42.1 0.28 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 76.97 32.7 48.4 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.418 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 719' ' ' ARG . . . . . 0.498 ' N ' ' O ' ' A' ' 716' ' ' LEU . 21.9 mtp180 -146.83 110.73 5.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.805 0.336 . . . . 0.0 110.867 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -68.55 125.38 26.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.842 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . 1.081 HG21 HD12 ' A' ' 716' ' ' LEU . 26.7 pt -99.55 155.0 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.111 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -111.32 104.58 13.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.885 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 723' ' ' VAL . . . . . 0.411 HG21 ' CB ' ' A' ' 711' ' ' MET . 3.7 t -100.67 131.99 47.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.096 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 78.7 mtp180 -155.56 160.37 40.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.897 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 725' ' ' ILE . . . . . 0.738 HD11 ' HA ' ' A' ' 705' ' ' GLU . 33.9 mm -60.86 135.96 25.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.118 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -87.38 86.39 7.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.917 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 727' ' ' ARG . . . . . . . . . . . . . 4.1 tpt85 -44.98 144.6 1.16 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.889 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 728' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 63.62 54.53 1.86 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.914 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 729' ' ' ALA . . . . . . . . . . . . . . . -99.0 41.41 1.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.081 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 77.9 p -123.69 118.44 27.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.852 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 731' ' ' GLY . . . . . . . . . . . . . . . -51.06 -76.28 0.18 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.496 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 732' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.79 85.18 0.63 Allowed 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.666 2.244 . . . . 0.0 112.35 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 733' ' ' SER . . . . . . . . . . . . . 37.5 t -72.44 -42.96 64.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.874 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 734' ' ' SER . . . . . . . . . . . . . 58.2 m -53.66 171.74 0.08 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.802 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 735' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.477 179.95 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 645' ' ' SER . . . . . . . . . . . . . 84.7 p -167.97 112.48 0.65 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.854 0.359 . . . . 0.0 110.885 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 646' ' ' SER . . . . . . . . . . . . . 38.7 m -43.94 126.95 5.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.882 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . 142.11 105.59 0.57 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.493 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 22.1 m -138.74 148.16 43.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.881 0.372 . . . . 0.0 110.861 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 70.1 p -98.53 115.48 28.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.879 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 156.48 83.6 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.513 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 651' ' ' ALA . . . . . 0.807 ' HB1' HD12 ' A' ' 725' ' ' ILE . . . -134.22 90.54 2.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.801 0.334 . . . . 0.0 111.119 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 60.2 m -96.52 -30.84 13.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.868 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 653' ' ' GLN . . . . . 0.607 ' OE1' ' HB1' ' A' ' 729' ' ' ALA . 50.3 tt0 -98.31 156.27 16.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.913 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 654' ' ' ILE . . . . . 0.452 HD11 ' CE2' ' A' ' 672' ' ' PHE . 43.7 pt -142.7 166.94 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.125 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -119.12 156.49 29.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.926 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 3.3 t -143.75 151.06 16.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.133 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 49.3 mtp180 -147.27 156.74 43.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.858 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 658' ' ' ASN . . . . . 0.56 ' O ' HG22 ' A' ' 721' ' ' ILE . 6.6 t30 70.44 51.91 0.35 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.926 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.801 HD23 HD12 ' A' ' 716' ' ' LEU . 37.6 mt -100.75 143.55 26.78 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.63 0.728 . . . . 0.0 110.902 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 660' ' ' PRO . . . . . 0.447 ' O ' ' N ' ' A' ' 663' ' ' PHE . 64.4 Cg_exo -47.97 128.64 16.78 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.683 2.255 . . . . 0.0 112.346 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -43.09 -31.96 0.63 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.869 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 662' ' ' ASP . . . . . 0.446 ' O ' HG23 ' A' ' 664' ' ' THR . 9.1 m-20 -82.81 -32.54 27.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.864 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 663' ' ' PHE . . . . . 0.447 ' N ' ' O ' ' A' ' 660' ' ' PRO . 4.2 t80 -40.23 113.16 0.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 664' ' ' THR . . . . . 0.446 HG23 ' O ' ' A' ' 662' ' ' ASP . 24.8 p -104.81 -177.48 3.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.121 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 665' ' ' TRP . . . . . 0.646 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 8.2 p-90 -66.76 -52.26 46.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 666' ' ' LYS . . . . . 0.646 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 22.8 tptp -44.78 -55.0 5.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.907 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 11.9 mtm -60.42 -46.01 91.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.866 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 27.9 tp -51.44 -42.97 61.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.919 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.41 ' O ' ' ND2' ' A' ' 673' ' ' ASN . 29.2 tttm -65.64 -74.41 0.11 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.909 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -45.86 -24.42 0.39 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.821 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 9.3 tppt? -68.9 -52.74 26.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.898 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 672' ' ' PHE . . . . . 0.455 ' CD1' HG21 ' A' ' 696' ' ' VAL . 23.3 m-85 -76.99 -13.72 59.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.899 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 673' ' ' ASN . . . . . 0.41 ' ND2' ' O ' ' A' ' 669' ' ' LYS . 1.5 m-80 -52.86 -28.37 22.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.871 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -50.49 -46.64 57.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.897 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 675' ' ' CYS . . . . . 0.612 ' SG ' ' HB2' ' A' ' 707' ' ' ALA . 12.4 t -64.4 -61.18 2.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.902 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -152.33 -147.38 4.58 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.465 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -95.41 114.13 25.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.79 0.329 . . . . 0.0 110.867 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 77.7 t -88.39 123.51 40.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.135 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 679' ' ' LEU . . . . . 0.739 HD11 ' HG2' ' A' ' 699' ' ' GLU . 19.2 mt -97.11 -61.93 1.33 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.916 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -99.84 123.7 44.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.935 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -149.41 121.68 8.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.099 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -155.8 155.81 33.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.878 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 28.1 mm -101.62 105.95 18.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.123 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -53.76 142.1 24.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.874 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 685' ' ' MET . . . . . . . . . . . . . 31.3 mtp -139.94 166.26 25.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -134.72 115.47 13.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.863 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 687' ' ' ASN . . . . . . . . . . . . . 23.5 m-20 46.69 40.84 9.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.887 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 688' ' ' GLY . . . . . . . . . . . . . . . 76.42 32.62 50.87 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.483 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 33.5 mtpt -131.82 128.97 39.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.789 0.328 . . . . 0.0 110.873 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 690' ' ' SER . . . . . . . . . . . . . 7.3 m -72.63 143.16 48.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.872 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 35.5 mmtm -120.53 7.75 10.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.921 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 58.47 16.81 30.31 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.472 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 1.9 p -123.45 129.68 51.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.826 0.346 . . . . 0.0 110.895 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -136.45 -159.6 8.45 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.5 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 13.5 m -148.13 155.82 9.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.872 0.367 . . . . 0.0 111.134 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 696' ' ' VAL . . . . . 0.455 HG21 ' CD1' ' A' ' 672' ' ' PHE . 91.7 t -143.8 119.42 4.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.182 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 28.2 tttt -104.36 140.45 37.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.916 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -117.99 167.99 10.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.899 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 699' ' ' GLU . . . . . 0.739 ' HG2' HD11 ' A' ' 679' ' ' LEU . 9.7 mm-40 -76.2 -39.25 55.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 1.8 t -108.83 142.98 26.64 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.633 0.73 . . . . 0.0 110.847 -179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -24.59 29.75 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.676 2.251 . . . . 0.0 112.373 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 702' ' ' GLU . . . . . 0.435 ' HG3' ' N ' ' A' ' 703' ' ' VAL . 6.9 pt-20 -73.76 -34.11 64.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.886 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 703' ' ' VAL . . . . . 0.435 ' N ' ' HG3' ' A' ' 702' ' ' GLU . 38.2 t -61.7 -56.96 14.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.142 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 704' ' ' ALA . . . . . 0.721 ' HB3' ' O ' ' A' ' 651' ' ' ALA . . . -43.39 -62.44 1.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.107 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 66.8 mt-10 -43.35 -43.08 4.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.906 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 16.0 ttm180 -66.08 -58.31 5.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.834 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 707' ' ' ALA . . . . . 0.612 ' HB2' ' SG ' ' A' ' 675' ' ' CYS . . . -50.64 -34.05 24.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.097 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 708' ' ' CYS . . . . . 0.425 ' SG ' ' CG2' ' A' ' 654' ' ' ILE . 2.4 m -61.18 -42.25 98.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.892 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 709' ' ' ARG . . . . . 0.407 ' O ' ' ND2' ' A' ' 712' ' ' ASN . 18.8 mtt180 -84.15 -20.11 33.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.849 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 17.1 mtm -88.79 -9.76 50.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.873 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 711' ' ' MET . . . . . . . . . . . . . 5.7 mmm -120.45 -10.62 9.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.9 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 712' ' ' ASN . . . . . 0.407 ' ND2' ' O ' ' A' ' 709' ' ' ARG . 0.9 OUTLIER -53.98 126.74 23.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.857 -179.955 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 69.63 8.12 59.58 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.496 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 714' ' ' MET . . . . . 0.58 ' HB3' HD11 ' A' ' 721' ' ' ILE . 10.3 ttp -49.38 99.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.857 0.36 . . . . 0.0 110.859 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 10.3 mmtp -56.05 102.56 0.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.888 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 716' ' ' LEU . . . . . 0.801 HD12 HD23 ' A' ' 659' ' ' LEU . 12.2 mt -99.88 117.0 33.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.923 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 717' ' ' SER . . . . . . . . . . . . . 2.3 t 40.91 44.41 1.96 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.912 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 76.33 31.28 55.18 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.493 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 719' ' ' ARG . . . . . 0.44 ' HB3' ' ND2' ' A' ' 658' ' ' ASN . 23.9 mtp180 -144.26 106.89 4.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.757 0.313 . . . . 0.0 110.876 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -66.18 125.77 26.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.881 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . 0.58 HD11 ' HB3' ' A' ' 714' ' ' MET . 38.2 pt -97.79 156.4 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.109 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -110.61 98.09 7.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.855 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 3.2 t -94.84 134.93 30.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.12 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 25.6 mtt-85 -158.08 176.11 12.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.859 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 725' ' ' ILE . . . . . 0.807 HD12 ' HB1' ' A' ' 651' ' ' ALA . 10.1 mm -78.23 138.95 19.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.125 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -92.15 77.42 5.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.817 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 727' ' ' ARG . . . . . . . . . . . . . 7.1 tpp85 -45.34 -62.09 1.4 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.872 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 728' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -83.41 91.49 7.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.878 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 729' ' ' ALA . . . . . 0.607 ' HB1' ' OE1' ' A' ' 653' ' ' GLN . . . -128.46 110.52 12.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.125 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 41.6 t -115.44 -50.77 2.71 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 731' ' ' GLY . . . . . . . . . . . . . . . 117.92 -159.68 14.1 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.454 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 732' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 152.54 69.51 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.696 2.264 . . . . 0.0 112.351 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 733' ' ' SER . . . . . . . . . . . . . 49.9 m -44.73 -62.75 1.09 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.881 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 734' ' ' SER . . . . . . . . . . . . . 24.7 p -64.73 155.1 34.73 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.882 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 735' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.283 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.475 -179.998 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.467 -0.253 . . . . 0.0 112.467 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 645' ' ' SER . . . . . . . . . . . . . 26.5 p -53.69 117.61 3.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.851 0.357 . . . . 0.0 110.888 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 646' ' ' SER . . . . . . . . . . . . . 14.9 t -100.79 129.6 46.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.877 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . 149.95 121.51 1.07 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.531 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 34.0 p -138.64 141.27 39.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.841 0.353 . . . . 0.0 110.84 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 61.0 p -131.95 -53.63 0.99 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.882 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . -156.72 167.13 33.58 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.503 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 651' ' ' ALA . . . . . 0.649 ' O ' ' HB3' ' A' ' 704' ' ' ALA . . . -101.34 95.86 6.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.793 0.33 . . . . 0.0 111.06 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 26.4 p -104.21 -26.13 12.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.883 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -104.29 146.6 28.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.895 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 654' ' ' ILE . . . . . . . . . . . . . 25.4 pt -135.27 172.66 15.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.138 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -128.21 149.59 50.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.868 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 4.0 t -132.19 152.87 37.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.095 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 69.8 mtt180 -146.81 160.08 42.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.88 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 658' ' ' ASN . . . . . 0.467 ' O ' HG22 ' A' ' 721' ' ' ILE . 1.1 t30 66.94 48.51 1.27 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.914 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . . . . . . . . . 40.5 mt -98.71 145.41 29.87 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.635 0.731 . . . . 0.0 110.909 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_exo -47.98 126.17 12.74 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.692 2.261 . . . . 0.0 112.337 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -49.35 -25.97 2.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.857 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -88.01 -24.95 23.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -41.09 147.69 0.13 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.861 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 35.5 p -128.07 169.55 13.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.115 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 665' ' ' TRP . . . . . 0.644 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 5.6 p-90 -63.96 -53.0 57.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.894 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 666' ' ' LYS . . . . . 0.644 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 3.7 tppp? -47.55 -47.71 28.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.924 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 46.1 mtm -63.16 -50.64 69.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.88 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 29.7 tp -46.66 -45.65 19.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.931 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 30.9 tttm -60.72 -72.36 0.11 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.925 179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -47.04 -25.07 0.74 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.902 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 17.0 tptt -68.76 -43.63 75.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.892 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 672' ' ' PHE . . . . . 0.517 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 23.8 m-85 -87.38 -13.42 43.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.889 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -50.71 -36.69 37.37 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.852 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -51.22 -39.79 57.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.857 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 37.4 m -72.01 -42.29 66.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.896 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 676' ' ' GLY . . . . . 0.417 ' HA3' HG11 ' A' ' 703' ' ' VAL . . . -177.16 170.12 42.64 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.483 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -59.56 114.91 2.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.85 0.357 . . . . 0.0 110.888 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 41.4 t -90.63 139.69 17.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.1 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 679' ' ' LEU . . . . . 0.402 HD21 ' HG2' ' A' ' 699' ' ' GLU . 13.8 mt -110.62 -63.8 1.35 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.932 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -99.06 131.27 45.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.97 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -157.22 120.86 4.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.115 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -148.26 164.11 34.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.904 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 38.3 mm -109.18 106.58 20.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.11 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 28.4 mmtp -57.02 133.34 54.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.935 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 685' ' ' MET . . . . . . . . . . . . . 22.0 mtp -130.54 160.84 32.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.881 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -133.05 96.73 3.83 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.887 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 687' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 61.51 39.29 15.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.865 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 688' ' ' GLY . . . . . . . . . . . . . . . 77.24 36.5 34.69 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.49 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 43.9 mttp -139.29 113.63 8.95 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.813 0.339 . . . . 0.0 110.856 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 690' ' ' SER . . . . . . . . . . . . . 77.1 p -56.99 131.58 50.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt -104.49 12.66 32.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 55.14 15.51 7.31 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.528 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 27.0 p -123.38 139.43 54.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.848 0.356 . . . . 0.0 110.896 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -143.39 -157.19 7.06 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.429 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 6.9 m -152.58 151.86 11.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.885 0.374 . . . . 0.0 111.126 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 94.3 t -141.95 119.43 7.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.111 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 17.6 tttt -106.36 134.06 50.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.879 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -109.25 169.06 8.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.864 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 699' ' ' GLU . . . . . 0.402 ' HG2' HD21 ' A' ' 679' ' ' LEU . 21.4 mt-10 -72.11 -37.67 69.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.867 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -115.15 143.96 31.26 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.658 0.742 . . . . 0.0 110.828 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.74 -10.84 29.57 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.709 2.272 . . . . 0.0 112.327 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -82.6 -46.48 13.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.91 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 703' ' ' VAL . . . . . 0.417 HG11 ' HA3' ' A' ' 676' ' ' GLY . 65.8 t -50.42 -47.84 26.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.162 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 704' ' ' ALA . . . . . 0.649 ' HB3' ' O ' ' A' ' 651' ' ' ALA . . . -49.3 -61.32 2.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.145 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.481 ' HA ' HD11 ' A' ' 725' ' ' ILE . 42.8 mt-10 -47.57 -23.5 0.67 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.878 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 706' ' ' ARG . . . . . 0.408 ' HG2' ' HE2' ' A' ' 710' ' ' MET . 45.1 ttt180 -87.08 -43.45 12.29 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.821 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 707' ' ' ALA . . . . . 0.421 ' O ' ' N ' ' A' ' 711' ' ' MET . . . -65.03 -56.94 10.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.108 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 708' ' ' CYS . . . . . 0.431 ' HA ' ' CG1' ' A' ' 723' ' ' VAL . 13.8 p -42.98 -42.13 3.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.876 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 709' ' ' ARG . . . . . 0.405 ' N ' ' SG ' ' A' ' 708' ' ' CYS . 15.8 mtt180 -80.16 -34.91 37.21 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.897 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 710' ' ' MET . . . . . 0.408 ' HE2' ' HG2' ' A' ' 706' ' ' ARG . 14.8 mtm -78.07 -9.14 59.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.886 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 711' ' ' MET . . . . . 0.517 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 5.9 mmm -116.14 -20.18 9.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.888 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 712' ' ' ASN . . . . . 0.435 ' OD1' ' C ' ' A' ' 712' ' ' ASN . 10.3 t-20 -55.03 115.21 2.09 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.914 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 85.75 18.67 59.49 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.543 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 714' ' ' MET . . . . . . . . . . . . . 44.7 ttp -71.11 96.64 1.38 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.834 0.35 . . . . 0.0 110.887 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 5.4 mmtp -51.54 101.91 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.896 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 716' ' ' LEU . . . . . 1.077 HD12 HG21 ' A' ' 721' ' ' ILE . 33.9 mt -100.2 120.4 39.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.925 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 717' ' ' SER . . . . . . . . . . . . . 1.2 t 40.32 44.95 1.72 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.857 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 74.13 27.25 66.67 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.503 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 719' ' ' ARG . . . . . 0.452 ' N ' ' O ' ' A' ' 716' ' ' LEU . 44.1 mtt85 -139.31 109.57 6.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.728 0.299 . . . . 0.0 110.882 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -67.11 125.28 25.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.866 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . 1.077 HG21 HD12 ' A' ' 716' ' ' LEU . 27.5 pt -99.96 156.22 4.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.161 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -116.28 104.55 11.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.862 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 723' ' ' VAL . . . . . 0.431 ' CG1' ' HA ' ' A' ' 708' ' ' CYS . 3.6 t -104.72 135.37 42.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.137 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 22.1 mtp85 -157.89 159.05 36.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.885 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 725' ' ' ILE . . . . . 0.481 HD11 ' HA ' ' A' ' 705' ' ' GLU . 35.6 mm -61.19 135.12 26.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.121 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -87.43 80.02 8.24 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 727' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -45.24 -45.07 11.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.817 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 728' ' ' ASN . . . . . 0.407 ' O ' ' C ' ' A' ' 729' ' ' ALA . 25.1 t-20 -86.62 41.47 0.95 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.907 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 729' ' ' ALA . . . . . 0.407 ' C ' ' O ' ' A' ' 728' ' ' ASN . . . -36.78 -55.46 0.89 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.13 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 1.4 t 41.53 36.29 0.54 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.867 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 731' ' ' GLY . . . . . . . . . . . . . . . -142.88 70.78 0.41 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.501 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 732' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -22.08 32.63 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.685 2.256 . . . . 0.0 112.347 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 733' ' ' SER . . . . . . . . . . . . . 33.5 t -40.1 145.36 0.16 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.846 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 734' ' ' SER . . . . . . . . . . . . . 32.9 t -149.36 112.75 4.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.806 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 735' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.498 179.984 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.371 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 645' ' ' SER . . . . . . . . . . . . . 83.5 p -131.81 139.88 49.01 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.915 0.388 . . . . 0.0 110.809 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 646' ' ' SER . . . . . . . . . . . . . 30.4 t -56.04 164.13 1.32 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.896 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . 74.27 96.54 0.11 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.494 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 2.5 m -122.45 44.8 2.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.857 0.361 . . . . 0.0 110.869 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 14.5 m -75.25 114.73 14.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.878 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 134.47 93.47 0.46 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.494 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 651' ' ' ALA . . . . . 0.489 ' O ' ' HB3' ' A' ' 704' ' ' ALA . . . -166.64 105.32 0.61 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.779 0.323 . . . . 0.0 111.11 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 22.6 p -108.05 -24.79 11.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.867 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 653' ' ' GLN . . . . . 0.45 ' HG3' ' N ' ' A' ' 654' ' ' ILE . 8.1 tp60 -93.1 146.52 23.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.917 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 654' ' ' ILE . . . . . 0.59 HG22 HD13 ' A' ' 725' ' ' ILE . 40.2 pt -134.51 177.24 7.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.112 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -132.8 159.69 39.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.861 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 6.5 t -140.71 150.44 20.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.069 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 657' ' ' ARG . . . . . 0.418 ' NH2' ' HB3' ' A' ' 722' ' ' ASP . 81.6 mtm-85 -146.68 157.43 43.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.883 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 658' ' ' ASN . . . . . 0.634 ' O ' HG22 ' A' ' 721' ' ' ILE . 0.3 OUTLIER 67.15 54.43 0.74 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.905 -179.971 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.449 HD22 ' CD2' ' A' ' 663' ' ' PHE . 38.7 mt -102.42 144.88 29.5 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.628 0.728 . . . . 0.0 110.908 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -48.0 133.47 23.33 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.648 2.232 . . . . 0.0 112.356 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -53.08 -28.34 24.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.867 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -86.64 -19.67 28.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.866 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 663' ' ' PHE . . . . . 0.449 ' CD2' HD22 ' A' ' 659' ' ' LEU . 3.6 t80 -49.25 136.02 16.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.893 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 72.7 p -120.93 175.27 6.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.114 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 665' ' ' TRP . . . . . 0.65 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 5.3 p-90 -66.57 -51.05 60.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.889 179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 666' ' ' LYS . . . . . 0.65 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 0.0 OUTLIER -45.86 -45.02 14.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.859 179.94 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 38.8 mtm -68.54 -52.19 34.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.925 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 30.0 tp -45.89 -42.4 12.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.933 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 44.8 tttt -65.95 -73.09 0.14 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.912 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -48.37 -23.77 1.03 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.876 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 16.1 tptt -69.68 -44.09 71.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.914 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 672' ' ' PHE . . . . . 0.512 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 16.9 m-85 -85.49 -14.8 44.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.911 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -55.25 -27.93 49.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.876 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -63.34 -19.87 65.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.897 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 34.1 m -89.38 -36.19 15.64 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.912 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -177.32 -154.78 12.54 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.485 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 6.8 t60 -91.93 108.64 20.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.884 0.373 . . . . 0.0 110.87 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 63.7 t -90.58 136.32 24.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.125 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 679' ' ' LEU . . . . . 0.526 HD11 ' HG2' ' A' ' 699' ' ' GLU . 27.0 mt -110.44 -61.87 1.6 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.964 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -98.67 131.06 45.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.93 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -155.39 125.84 6.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.105 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -156.18 159.57 39.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.878 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 34.3 mm -105.38 97.44 5.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.126 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 46.6 mmtt -52.5 133.8 35.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.943 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 685' ' ' MET . . . . . . . . . . . . . 33.7 mtp -130.34 170.37 14.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.902 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -128.13 89.51 2.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.85 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 687' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 72.21 36.97 1.02 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.915 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 688' ' ' GLY . . . . . . . . . . . . . . . 78.59 35.01 33.67 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.444 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -135.58 125.65 26.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.778 0.323 . . . . 0.0 110.903 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 690' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -58.5 128.76 38.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.843 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 6.4 mmtp -110.15 4.78 21.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.871 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 60.48 28.17 67.04 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.482 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 26.5 p -136.18 142.24 44.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.88 0.371 . . . . 0.0 110.852 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -152.3 -164.91 12.71 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.499 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 6.8 m -148.51 155.9 8.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.853 0.359 . . . . 0.0 111.128 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 88.5 t -143.13 123.64 10.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.15 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 14.8 ttpt -103.28 139.07 39.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.878 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 698' ' ' PHE . . . . . 0.433 ' CD2' HG11 ' A' ' 703' ' ' VAL . 96.0 m-85 -116.71 165.15 13.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.89 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 699' ' ' GLU . . . . . 0.526 ' HG2' HD11 ' A' ' 679' ' ' LEU . 38.8 mt-10 -72.32 -43.25 64.41 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.864 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 700' ' ' SER . . . . . 0.667 ' OG ' HG23 ' A' ' 703' ' ' VAL . 79.8 p -111.08 149.45 40.5 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.639 0.733 . . . . 0.0 110.836 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 -29.29 24.03 Favored 'Trans proline' 0 C--N 1.34 0.122 0 C-N-CA 122.662 2.241 . . . . 0.0 112.346 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 702' ' ' GLU . . . . . 0.409 ' HG3' ' N ' ' A' ' 703' ' ' VAL . 13.9 pt-20 -63.26 -46.7 85.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.909 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 703' ' ' VAL . . . . . 0.667 HG23 ' OG ' ' A' ' 700' ' ' SER . 71.6 t -50.78 -56.51 4.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.128 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 704' ' ' ALA . . . . . 0.489 ' HB3' ' O ' ' A' ' 651' ' ' ALA . . . -45.05 -60.98 1.81 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.109 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -44.03 -35.16 1.98 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.885 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 -77.95 -59.78 2.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.913 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -43.25 -32.43 0.77 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.087 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 708' ' ' CYS . . . . . 0.498 ' O ' ' N ' ' A' ' 712' ' ' ASN . 7.0 t -57.29 -60.51 3.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.889 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -68.39 -30.63 69.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.873 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 15.3 mmm -70.59 -30.72 67.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.854 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 711' ' ' MET . . . . . 0.512 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 4.3 mmm -107.68 -9.71 15.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.915 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 712' ' ' ASN . . . . . 0.498 ' N ' ' O ' ' A' ' 708' ' ' CYS . 10.4 t-20 -62.35 114.49 3.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.859 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 85.14 13.2 71.98 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.467 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 714' ' ' MET . . . . . . . . . . . . . 53.1 ttp -59.66 100.9 0.09 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.86 0.362 . . . . 0.0 110.852 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 8.8 mmtp -62.67 100.51 0.2 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.876 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 716' ' ' LEU . . . . . 0.504 ' O ' ' N ' ' A' ' 719' ' ' ARG . 31.2 mt -100.0 128.23 46.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.931 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 717' ' ' SER . . . . . 0.435 ' C ' ' O ' ' A' ' 716' ' ' LEU . 3.1 t 35.44 37.99 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.897 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 79.5 37.98 22.3 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.492 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 719' ' ' ARG . . . . . 0.504 ' N ' ' O ' ' A' ' 716' ' ' LEU . 6.7 mtt-85 -148.08 113.46 5.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.797 0.332 . . . . 0.0 110.861 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -74.5 125.69 29.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.889 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . 0.634 HG22 ' O ' ' A' ' 658' ' ' ASN . 46.5 pt -99.67 153.66 4.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.108 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 722' ' ' ASP . . . . . 0.418 ' HB3' ' NH2' ' A' ' 657' ' ' ARG . 54.7 m-20 -109.03 97.9 7.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.858 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 723' ' ' VAL . . . . . 0.47 HG21 ' CB ' ' A' ' 711' ' ' MET . 11.9 t -94.46 135.23 29.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.107 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.04 176.04 13.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.832 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 725' ' ' ILE . . . . . 0.59 HD13 HG22 ' A' ' 654' ' ' ILE . 39.0 mm -78.5 143.88 12.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.135 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 726' ' ' ASP . . . . . 0.554 ' OD2' ' HB2' ' A' ' 729' ' ' ALA . 45.1 t0 -97.82 103.25 15.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 727' ' ' ARG . . . . . 0.426 ' HB3' ' NH1' ' A' ' 727' ' ' ARG . 5.4 mmm180 -74.66 -54.96 6.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.859 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 728' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -42.9 -37.56 1.88 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.877 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 729' ' ' ALA . . . . . 0.554 ' HB2' ' OD2' ' A' ' 726' ' ' ASP . . . -46.1 -69.53 0.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.092 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 41.2 p -72.37 107.45 4.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.837 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 731' ' ' GLY . . . . . . . . . . . . . . . 79.23 86.09 0.55 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.507 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 732' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 -23.94 30.29 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.645 2.23 . . . . 0.0 112.396 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 733' ' ' SER . . . . . . . . . . . . . 7.3 m -91.1 -54.18 4.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.87 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 734' ' ' SER . . . . . . . . . . . . . 11.9 t -63.95 116.98 6.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.882 -179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 735' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.466 -179.996 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 645' ' ' SER . . . . . . . . . . . . . 26.9 t -173.63 123.15 0.36 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.85 0.357 . . . . 0.0 110.833 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 646' ' ' SER . . . . . . . . . . . . . 27.1 p -136.98 144.42 43.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.868 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . 119.92 -127.73 7.24 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.457 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 67.0 p -145.74 144.86 30.59 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.842 0.353 . . . . 0.0 110.865 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 95.4 p -95.54 107.69 19.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.882 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . -175.59 69.32 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.45 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 651' ' ' ALA . . . . . 0.463 ' O ' ' HB3' ' A' ' 704' ' ' ALA . . . -106.83 97.01 6.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.733 0.301 . . . . 0.0 111.089 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 36.7 m -108.23 -19.88 13.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.815 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 -105.16 147.43 27.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.869 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 654' ' ' ILE . . . . . 0.515 HD11 ' CE2' ' A' ' 672' ' ' PHE . 40.9 pt -135.54 171.56 17.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.091 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -121.86 158.77 28.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.872 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 5.5 t -147.52 145.78 18.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.11 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 51.6 mtp180 -143.78 160.94 39.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.883 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 658' ' ' ASN . . . . . 0.481 ' ND2' ' HB3' ' A' ' 719' ' ' ARG . 3.7 t30 69.73 47.86 0.61 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.894 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . . . . . . . . . 51.1 mt -101.41 143.97 27.64 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.614 0.721 . . . . 0.0 110.898 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -48.04 133.71 23.63 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.71 2.273 . . . . 0.0 112.299 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 661' ' ' PHE . . . . . 0.501 ' CE1' ' HB3' ' A' ' 690' ' ' SER . 4.0 t80 -47.99 -41.58 25.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.877 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -72.25 -29.94 64.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.888 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -38.87 116.3 0.55 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.864 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 40.7 p -101.58 179.39 4.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.185 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 665' ' ' TRP . . . . . 0.583 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 6.4 p-90 -69.09 -47.52 65.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.907 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 666' ' ' LYS . . . . . 0.583 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 0.0 OUTLIER -50.36 -45.78 55.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.893 179.94 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 24.9 mtm -66.05 -52.76 46.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.876 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 18.0 tp -46.46 -47.23 19.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.915 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.46 ' HB2' ' CB ' ' A' ' 681' ' ' ALA . 29.9 tttt -63.3 -72.62 0.13 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.883 179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -45.26 -26.61 0.52 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.864 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 15.3 tptt -67.81 -41.75 82.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.917 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 672' ' ' PHE . . . . . 0.581 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 20.9 m-85 -86.19 -18.91 30.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.91 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 673' ' ' ASN . . . . . 0.435 HD21 ' CG ' ' A' ' 669' ' ' LYS . 2.1 m-80 -50.32 -35.02 25.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -40.99 -42.33 1.86 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 6.4 t -70.25 -64.96 0.79 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.904 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -142.17 -151.28 5.49 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.464 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -98.69 101.16 12.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.851 0.358 . . . . 0.0 110.885 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 69.5 t -74.57 141.65 15.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.143 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 679' ' ' LEU . . . . . 0.465 HD11 ' HG2' ' A' ' 699' ' ' GLU . 14.3 mt -114.31 -59.26 2.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.897 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -98.01 126.35 43.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.91 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 681' ' ' ALA . . . . . 0.46 ' CB ' ' HB2' ' A' ' 669' ' ' LYS . . . -154.25 123.71 6.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.109 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -151.94 160.89 43.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.868 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 21.8 mm -111.5 117.7 55.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.114 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 37.0 mmtm -61.58 134.96 57.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.911 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 685' ' ' MET . . . . . . . . . . . . . 33.7 mtp -139.77 144.36 37.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.853 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -125.24 116.38 21.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.916 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 687' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 53.73 41.14 32.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.9 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 688' ' ' GLY . . . . . . . . . . . . . . . 66.81 32.16 80.35 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.502 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 689' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 690' ' ' SER . 23.3 mtmm -131.21 93.93 3.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.802 0.334 . . . . 0.0 110.867 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 690' ' ' SER . . . . . 0.501 ' HB3' ' CE1' ' A' ' 661' ' ' PHE . 28.3 t -37.7 139.23 0.31 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.842 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 27.1 mmmt -103.79 -17.93 14.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.959 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 80.29 18.9 70.45 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.446 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 15.1 p -131.67 123.99 28.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.896 0.379 . . . . 0.0 110.875 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -132.86 -162.14 10.13 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.483 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 16.8 m -144.31 167.2 11.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.857 0.361 . . . . 0.0 111.159 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 696' ' ' VAL . . . . . 0.491 HG21 ' CD1' ' A' ' 672' ' ' PHE . 99.1 t -150.9 122.55 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.13 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 10.6 ttpp -107.5 136.74 46.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -113.67 172.34 7.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.903 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 699' ' ' GLU . . . . . 0.465 ' HG2' HD11 ' A' ' 679' ' ' LEU . 65.9 mt-10 -79.22 -42.3 26.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.903 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 21.7 m -108.18 143.97 28.48 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.632 0.729 . . . . 0.0 110.882 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.72 -28.42 25.47 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.676 2.25 . . . . 0.0 112.397 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -68.28 -33.42 74.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.895 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 76.0 t -64.15 -57.36 11.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.161 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 704' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 651' ' ' ALA . . . -44.65 -52.46 8.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.122 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -53.97 -30.36 46.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.919 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 45.0 ttt180 -82.23 -43.55 17.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.87 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -61.35 -56.71 17.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.083 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 708' ' ' CYS . . . . . . . . . . . . . 28.8 p -46.3 -32.81 3.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.881 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 11.8 mtp180 -83.16 -35.93 25.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.819 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 29.0 mtm -77.85 -11.39 59.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.88 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 711' ' ' MET . . . . . 0.581 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 4.3 mmt -112.51 -34.58 5.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.874 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 712' ' ' ASN . . . . . 0.401 ' OD1' ' C ' ' A' ' 712' ' ' ASN . 2.2 t-20 -39.16 106.77 0.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.882 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 91.04 20.01 40.79 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.512 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 714' ' ' MET . . . . . 0.58 ' HE3' HD11 ' A' ' 721' ' ' ILE . 2.9 ttm -64.7 99.79 0.35 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.839 0.352 . . . . 0.0 110.866 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 715' ' ' LYS . . . . . 0.457 ' CD ' ' HG3' ' A' ' 720' ' ' GLU . 22.4 mmtt -59.92 99.78 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.906 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 716' ' ' LEU . . . . . 0.501 ' O ' ' N ' ' A' ' 719' ' ' ARG . 32.6 mt -99.8 125.64 45.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.9 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 717' ' ' SER . . . . . 0.403 ' C ' ' O ' ' A' ' 716' ' ' LEU . 1.7 t 37.72 40.03 0.24 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.846 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 77.96 32.93 42.96 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.476 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 719' ' ' ARG . . . . . 0.501 ' N ' ' O ' ' A' ' 716' ' ' LEU . 18.4 mtp85 -141.9 110.42 6.07 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.763 0.316 . . . . 0.0 110.894 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 720' ' ' GLU . . . . . 0.457 ' HG3' ' CD ' ' A' ' 715' ' ' LYS . 27.9 mt-10 -71.53 127.73 33.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.886 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . 0.58 HD11 ' HE3' ' A' ' 714' ' ' MET . 21.2 pt -97.97 160.5 3.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.127 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -116.8 100.13 7.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.831 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 3.3 t -100.32 136.09 33.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.11 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.89 148.38 20.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.852 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 725' ' ' ILE . . . . . 0.419 HG23 ' HB1' ' A' ' 651' ' ' ALA . 31.3 mm -56.62 134.74 20.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.114 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -91.73 77.87 5.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.862 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 727' ' ' ARG . . . . . . . . . . . . . 37.3 mtt180 -69.79 -41.18 75.44 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.835 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 728' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -48.17 -42.79 30.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.881 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 729' ' ' ALA . . . . . . . . . . . . . . . -39.45 97.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.126 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 91.5 p -50.25 -47.13 55.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.839 -179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 731' ' ' GLY . . . . . . . . . . . . . . . 84.64 -156.71 31.96 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.496 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 732' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.81 162.26 42.77 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.686 2.257 . . . . 0.0 112.352 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 733' ' ' SER . . . . . . . . . . . . . 4.8 t -154.48 159.84 41.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.859 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 734' ' ' SER . . . . . . . . . . . . . 58.3 p -88.15 -54.06 4.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.811 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 735' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.508 -179.938 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.318 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 645' ' ' SER . . . . . . . . . . . . . 12.2 m -96.87 151.02 20.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.87 0.367 . . . . 0.0 110.893 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 646' ' ' SER . . . . . . . . . . . . . 1.7 t -165.85 137.04 3.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.836 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . -121.35 112.79 2.16 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.477 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 48.8 m -88.76 50.9 2.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.902 0.382 . . . . 0.0 110.856 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 34.4 p -45.04 -47.3 11.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.838 -179.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 75.79 -75.37 1.48 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.459 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 651' ' ' ALA . . . . . 0.654 ' HB1' HD12 ' A' ' 725' ' ' ILE . . . 59.88 54.49 4.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.803 0.335 . . . . 0.0 111.098 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 30.2 p -78.45 -10.53 59.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -105.44 147.24 28.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.879 -179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 654' ' ' ILE . . . . . 0.454 HD11 ' CE2' ' A' ' 672' ' ' PHE . 33.4 pt -135.12 171.17 18.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.13 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -125.13 151.63 45.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.862 179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 23.2 t -133.22 152.45 35.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.159 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -147.86 157.99 43.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.877 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 658' ' ' ASN . . . . . 0.48 ' ND2' ' HB3' ' A' ' 719' ' ' ARG . 6.7 t30 71.5 35.13 1.54 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.903 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.815 HD22 ' CD2' ' A' ' 663' ' ' PHE . 23.8 mt -85.14 143.58 39.82 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.631 0.729 . . . . 0.0 110.86 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -47.94 146.48 8.81 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.686 2.257 . . . . 0.0 112.353 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -64.45 -28.87 69.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -95.11 13.92 23.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.852 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 663' ' ' PHE . . . . . 0.815 ' CD2' HD22 ' A' ' 659' ' ' LEU . 2.9 t80 -79.04 121.92 25.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.906 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 62.9 p -104.9 169.55 8.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.156 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 665' ' ' TRP . . . . . 0.601 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 5.0 p-90 -62.85 -45.13 94.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.917 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 666' ' ' LYS . . . . . 0.601 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 5.5 tppp? -51.52 -46.11 63.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 30.1 mtm -67.54 -51.9 45.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.887 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 24.3 tp -47.62 -44.81 27.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.908 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 34.7 tttm -64.23 -70.8 0.2 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.903 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -47.36 -24.75 0.84 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.856 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 17.8 tptt -69.41 -42.35 75.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.901 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 672' ' ' PHE . . . . . 0.466 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 20.5 m-85 -85.99 -21.98 27.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.861 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 673' ' ' ASN . . . . . 0.407 ' ND2' ' HB ' ' A' ' 678' ' ' VAL . 1.5 m-80 -45.02 -37.34 4.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -46.69 -45.37 19.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.914 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 86.4 m -66.9 -54.99 16.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.864 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -153.93 -170.27 19.73 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.478 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 677' ' ' HIS . . . . . 0.401 ' CD2' ' C ' ' A' ' 677' ' ' HIS . 2.5 t-160 -82.88 93.56 7.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.873 0.368 . . . . 0.0 110.867 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 678' ' ' VAL . . . . . 0.407 ' HB ' ' ND2' ' A' ' 673' ' ' ASN . 84.8 t -70.09 141.21 17.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.149 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 679' ' ' LEU . . . . . 0.786 HD11 ' HG2' ' A' ' 699' ' ' GLU . 12.1 mt -115.24 -59.75 1.97 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.902 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 680' ' ' TYR . . . . . 0.408 ' HB3' ' CB ' ' A' ' 697' ' ' LYS . 9.8 t80 -98.39 125.83 43.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.889 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -154.61 121.02 5.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.112 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -151.64 157.81 42.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.835 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 50.0 mm -104.34 103.89 15.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.121 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 43.3 mmtm -62.12 136.78 58.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 685' ' ' MET . . . . . . . . . . . . . 22.9 mtp -131.34 150.15 52.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.828 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -111.11 97.05 6.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.873 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 687' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 67.54 44.08 1.78 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.886 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 688' ' ' GLY . . . . . . . . . . . . . . . 72.5 30.74 63.99 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.46 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 18.9 mmmt -134.46 118.11 17.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.832 0.349 . . . . 0.0 110.874 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 690' ' ' SER . . . . . . . . . . . . . 3.1 t -60.72 125.4 23.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.843 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 10.7 mmpt? -103.81 27.79 7.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.924 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 41.05 30.55 0.4 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.466 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 17.7 p -137.38 128.24 27.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.884 0.373 . . . . 0.0 110.863 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -140.96 -150.56 5.42 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.525 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 24.7 m -153.08 161.9 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.84 0.353 . . . . 0.0 111.11 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 82.1 t -149.06 114.81 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.122 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 697' ' ' LYS . . . . . 0.408 ' CB ' ' HB3' ' A' ' 680' ' ' TYR . 8.3 ttpt -100.9 145.37 28.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.901 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -121.01 166.3 14.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.923 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 699' ' ' GLU . . . . . 0.786 ' HG2' HD11 ' A' ' 679' ' ' LEU . 29.2 mt-10 -69.55 -41.17 76.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.941 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 11.5 m -116.45 151.28 46.78 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.712 0.768 . . . . 0.0 110.806 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.77 -44.72 1.91 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.712 2.274 . . . . 0.0 112.351 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -50.88 -33.74 25.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.891 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 53.9 t -63.11 -58.95 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.147 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -44.06 -58.4 2.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.133 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -46.49 -32.69 3.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.929 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 16.4 ttm180 -82.51 -40.12 21.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.832 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -67.23 -57.73 6.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.149 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 708' ' ' CYS . . . . . 0.467 ' HA ' HG12 ' A' ' 723' ' ' VAL . 21.5 p -38.57 -41.53 0.69 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.875 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 13.6 mtt180 -83.42 -44.54 14.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.88 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 56.7 mtp -57.44 -13.4 3.51 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 711' ' ' MET . . . . . 0.466 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 5.1 mmm -118.48 -29.26 5.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.879 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 712' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -39.04 105.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.918 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 89.16 26.87 24.86 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.496 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 714' ' ' MET . . . . . 0.456 ' SD ' ' HE1' ' A' ' 711' ' ' MET . 46.0 ttp -72.55 97.84 2.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.83 0.348 . . . . 0.0 110.895 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 6.0 mmtp -53.79 99.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.899 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 716' ' ' LEU . . . . . 0.94 HD12 HG21 ' A' ' 721' ' ' ILE . 23.9 mt -99.92 129.8 46.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.899 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 717' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 716' ' ' LEU . 9.5 t 35.21 37.32 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.9 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 718' ' ' GLY . . . . . 0.43 ' C ' ' HG3' ' A' ' 719' ' ' ARG . . . 79.84 38.66 19.2 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.517 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 719' ' ' ARG . . . . . 0.5 ' N ' ' O ' ' A' ' 716' ' ' LEU . 25.1 mtp85 -148.45 113.66 5.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.791 0.329 . . . . 0.0 110.842 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -70.19 122.6 19.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.887 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . 0.94 HG21 HD12 ' A' ' 716' ' ' LEU . 18.1 pt -99.0 150.6 4.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.109 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -107.03 99.71 9.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.884 179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 723' ' ' VAL . . . . . 0.467 HG12 ' HA ' ' A' ' 708' ' ' CYS . 5.3 t -102.59 130.14 53.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.126 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 64.8 mtm180 -157.85 159.7 36.94 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.9 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 725' ' ' ILE . . . . . 0.654 HD12 ' HB1' ' A' ' 651' ' ' ALA . 17.5 mm -53.34 136.6 14.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.13 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -84.24 89.69 7.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.88 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 727' ' ' ARG . . . . . . . . . . . . . 9.1 tpt85 -45.89 153.04 0.32 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.873 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 728' ' ' ASN . . . . . . . . . . . . . 50.2 t30 65.09 47.55 2.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.908 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 729' ' ' ALA . . . . . . . . . . . . . . . -112.3 91.21 3.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.132 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 1.3 t -139.51 112.24 7.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.903 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 731' ' ' GLY . . . . . . . . . . . . . . . -63.51 140.24 44.46 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.488 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 732' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 96.16 0.58 Allowed 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.689 2.26 . . . . 0.0 112.349 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 733' ' ' SER . . . . . . . . . . . . . 3.3 t -107.93 160.2 15.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.903 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 734' ' ' SER . . . . . . . . . . . . . 59.8 m -122.72 154.01 38.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.887 -179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 735' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.5 -179.971 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 N-CA-C 112.486 -0.245 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 645' ' ' SER . . . . . . . . . . . . . 53.9 p -162.3 148.36 13.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.855 0.36 . . . . 0.0 110.875 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 646' ' ' SER . . . . . . . . . . . . . 2.1 m -90.1 -56.38 3.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.839 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . 55.59 60.12 9.37 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.465 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 24.3 p -82.99 124.6 30.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.879 0.371 . . . . 0.0 110.892 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 86.7 p -106.78 102.94 12.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.836 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 58.19 74.54 0.34 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.477 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 651' ' ' ALA . . . . . 0.665 ' HB1' HG23 ' A' ' 725' ' ' ILE . . . -80.26 68.64 6.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.777 0.322 . . . . 0.0 111.094 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 3.6 p -83.81 -6.92 59.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.846 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -115.59 154.37 29.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.895 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 654' ' ' ILE . . . . . 0.484 HD11 ' CE2' ' A' ' 672' ' ' PHE . 43.5 pt -138.24 167.21 22.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.108 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -118.14 154.84 31.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.889 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 2.9 t -141.19 150.67 19.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.105 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 42.7 mtt180 -149.73 165.41 32.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.86 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 658' ' ' ASN . . . . . 0.466 ' ND2' HH11 ' A' ' 719' ' ' ARG . 0.2 OUTLIER 65.18 44.21 3.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.889 -179.942 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . . . . . . . . . 60.6 mt -97.44 143.8 26.82 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.619 0.723 . . . . 0.0 110.95 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -47.97 129.76 18.66 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.693 2.262 . . . . 0.0 112.355 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -48.93 -27.96 3.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.905 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -85.57 -28.71 24.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.85 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -38.62 119.75 0.87 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.861 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 75.6 p -100.23 171.36 7.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.17 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 665' ' ' TRP . . . . . 0.637 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 7.5 p-90 -66.86 -52.29 45.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.948 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 666' ' ' LYS . . . . . 0.637 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 4.3 tppp? -45.42 -47.29 13.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 25.6 mtm -62.95 -53.03 60.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.893 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 16.9 tp -44.46 -48.71 10.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.896 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . 0.403 ' HG2' ' N ' ' A' ' 670' ' ' ASP . 25.9 tttt -60.09 -71.16 0.14 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.864 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 670' ' ' ASP . . . . . 0.403 ' N ' ' HG2' ' A' ' 669' ' ' LYS . 14.9 t70 -49.61 -24.36 2.15 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.847 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 19.0 tptt -69.0 -42.4 76.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.884 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 672' ' ' PHE . . . . . 0.564 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 21.8 m-85 -87.13 -13.57 43.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.899 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -52.64 -39.35 61.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.884 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -48.65 -37.6 18.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.892 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 91.7 m -74.56 -54.96 6.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.87 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -160.04 -175.31 30.88 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.478 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -71.24 116.76 11.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.851 0.358 . . . . 0.0 110.852 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 678' ' ' VAL . . . . . 0.422 HG13 HG13 ' A' ' 696' ' ' VAL . 84.3 t -96.97 125.06 50.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.125 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 17.5 mt -99.29 -62.4 1.24 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.929 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -98.3 132.63 43.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.923 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -157.01 123.3 4.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.096 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -157.14 156.64 33.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.837 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 32.6 mm -97.35 102.16 13.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.13 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -58.3 135.9 57.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.906 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 685' ' ' MET . . . . . . . . . . . . . 15.3 mtp -134.31 172.59 12.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.899 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -130.66 95.44 3.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.939 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 687' ' ' ASN . . . . . . . . . . . . . 50.6 t30 68.79 37.37 2.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.863 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 688' ' ' GLY . . . . . . . . . . . . . . . 77.38 40.88 22.36 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.472 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 5.3 mmmm -139.29 128.54 24.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.768 0.318 . . . . 0.0 110.865 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 690' ' ' SER . . . . . . . . . . . . . 17.6 t -67.75 122.38 17.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.879 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -108.9 20.07 18.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.891 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 48.22 32.35 9.56 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.495 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 30.6 p -132.94 129.61 38.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.863 0.363 . . . . 0.0 110.907 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -139.04 -173.32 12.95 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.442 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 17.0 m -139.53 155.38 25.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.835 0.35 . . . . 0.0 111.141 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 696' ' ' VAL . . . . . 0.422 HG13 HG13 ' A' ' 678' ' ' VAL . 89.9 t -143.48 121.51 6.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.084 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 15.5 tttt -105.28 143.35 33.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.899 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -120.7 171.0 8.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 699' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -73.68 -44.7 55.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.866 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 29.9 m -112.92 149.63 41.58 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.636 0.731 . . . . 0.0 110.855 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.75 -34.72 14.04 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.692 2.261 . . . . 0.0 112.356 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -57.95 -38.42 75.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.883 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 62.7 t -61.78 -49.77 82.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.125 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 704' ' ' ALA . . . . . 0.465 ' HB3' ' O ' ' A' ' 651' ' ' ALA . . . -51.85 -55.58 19.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.091 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.405 ' HA ' HD11 ' A' ' 725' ' ' ILE . 56.4 mt-10 -46.94 -25.47 0.79 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.911 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 706' ' ' ARG . . . . . 0.441 ' O ' ' N ' ' A' ' 709' ' ' ARG . 21.7 ttt180 -90.39 -62.34 1.48 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.827 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 707' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 706' ' ' ARG . . . -35.75 -39.79 0.16 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.105 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 708' ' ' CYS . . . . . . . . . . . . . 66.7 m -56.56 -47.08 80.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 709' ' ' ARG . . . . . 0.441 ' N ' ' O ' ' A' ' 706' ' ' ARG . 11.6 mtp180 -73.55 -32.89 64.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.864 -179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 33.3 mmm -71.84 -20.5 61.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.86 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 711' ' ' MET . . . . . 0.564 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 2.7 mmt -114.02 -10.65 12.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.857 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 712' ' ' ASN . . . . . 0.419 ' OD1' ' C ' ' A' ' 712' ' ' ASN . 28.8 t-20 -57.75 105.08 0.22 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.877 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 91.83 15.44 54.46 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.508 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 714' ' ' MET . . . . . 0.542 ' HB3' HD11 ' A' ' 721' ' ' ILE . 34.4 ttp -62.7 101.29 0.24 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.877 0.37 . . . . 0.0 110.869 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 4.6 mmmt -66.22 102.76 0.88 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.905 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 716' ' ' LEU . . . . . 0.56 HD12 HG21 ' A' ' 721' ' ' ILE . 23.3 mt -100.01 134.75 42.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.91 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 717' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 716' ' ' LEU . 7.3 t 35.12 31.74 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.889 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 718' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 716' ' ' LEU . . . 83.65 41.87 8.07 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.475 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 719' ' ' ARG . . . . . 0.485 ' N ' ' O ' ' A' ' 716' ' ' LEU . 2.7 mtt-85 -151.68 117.51 5.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.807 0.337 . . . . 0.0 110.853 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -72.88 125.79 28.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.904 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . 0.56 HG21 HD12 ' A' ' 716' ' ' LEU . 41.4 pt -100.11 156.08 4.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.148 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -110.88 103.23 11.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.882 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 723' ' ' VAL . . . . . 0.521 HG21 ' CB ' ' A' ' 711' ' ' MET . 3.4 t -103.98 131.31 52.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.122 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 42.2 mtm-85 -158.18 161.09 37.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.858 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 725' ' ' ILE . . . . . 0.665 HG23 ' HB1' ' A' ' 651' ' ' ALA . 19.8 mm -60.3 131.08 24.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.162 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -80.11 107.23 12.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 727' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -63.98 -34.92 79.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 728' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -88.24 68.32 8.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.91 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 729' ' ' ALA . . . . . . . . . . . . . . . -115.71 19.05 15.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.126 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 86.6 p -127.88 149.36 50.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.875 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 731' ' ' GLY . . . . . . . . . . . . . . . -90.86 177.37 41.68 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.48 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 732' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.74 -8.23 23.07 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.674 2.25 . . . . 0.0 112.367 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 733' ' ' SER . . . . . . . . . . . . . 68.8 m 61.86 46.2 6.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.866 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 734' ' ' SER . . . . . . . . . . . . . 69.4 p -87.1 122.67 31.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.858 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 735' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.482 -179.958 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 645' ' ' SER . . . . . . . . . . . . . 77.9 p -120.45 -44.3 2.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.886 0.374 . . . . 0.0 110.883 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 646' ' ' SER . . . . . . . . . . . . . 56.9 p -73.12 -42.94 62.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.887 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . 118.55 116.35 2.69 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.496 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 62.0 m -105.55 140.51 38.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.866 0.365 . . . . 0.0 110.831 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 3.9 t -159.69 110.64 1.97 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.849 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 159.16 36.61 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.468 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 651' ' ' ALA . . . . . 0.812 ' HB1' ' CG2' ' A' ' 725' ' ' ILE . . . -109.28 97.35 6.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.763 0.315 . . . . 0.0 111.098 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 2.8 p -101.34 -30.0 11.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.857 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -85.83 148.71 25.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.952 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 654' ' ' ILE . . . . . . . . . . . . . 22.0 pt -134.32 174.29 13.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.121 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -125.79 157.44 37.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.88 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 3.4 t -143.58 151.07 16.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.105 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 27.3 mtp180 -146.62 162.54 38.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.885 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 658' ' ' ASN . . . . . 0.461 ' ND2' ' HB3' ' A' ' 719' ' ' ARG . 9.4 t30 69.19 31.16 4.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.852 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . . . . . . . . . 64.9 mt -82.14 144.44 50.75 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.628 0.728 . . . . 0.0 110.917 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_exo -47.97 150.84 4.38 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.725 2.283 . . . . 0.0 112.326 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -71.26 -22.36 61.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.859 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 662' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -98.19 4.74 48.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.854 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 663' ' ' PHE . . . . . 0.412 ' CE2' ' HA ' ' A' ' 668' ' ' LEU . 3.2 t80 -72.62 118.55 15.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 -179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 43.3 p -100.45 169.84 8.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.141 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 665' ' ' TRP . . . . . 0.583 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 15.7 p-90 -57.43 -51.41 69.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.937 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 666' ' ' LYS . . . . . 0.583 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 5.3 tppp? -48.76 -60.06 3.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.885 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 22.5 mtm -51.21 -44.63 61.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.888 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 668' ' ' LEU . . . . . 0.412 ' HA ' ' CE2' ' A' ' 663' ' ' PHE . 12.3 tp -56.79 -44.27 81.71 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.916 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 29.1 ttmt -64.55 -67.85 0.4 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.884 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -50.27 -23.76 2.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.855 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 12.6 tppt? -69.85 -39.63 76.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.944 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 672' ' ' PHE . . . . . 0.585 ' CD1' HG21 ' A' ' 696' ' ' VAL . 27.0 m-85 -90.87 -8.39 49.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.899 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -59.41 -27.07 65.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.909 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -62.16 -37.18 84.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.934 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 3.7 m -73.18 -41.4 63.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.879 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -171.02 -167.24 31.06 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.48 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 677' ' ' HIS . . . . . 0.41 ' CD2' ' C ' ' A' ' 677' ' ' HIS . 3.0 t-160 -83.18 106.07 14.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.792 0.329 . . . . 0.0 110.86 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 69.0 t -84.83 144.43 9.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.102 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 16.0 mt -119.15 -61.12 1.67 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.939 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -99.77 125.3 45.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.899 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -149.29 122.12 8.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.058 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -150.95 157.79 43.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.822 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 33.0 mm -104.71 105.0 17.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.115 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -58.34 133.54 55.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.831 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 685' ' ' MET . . . . . . . . . . . . . 31.8 mtp -130.53 158.71 39.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.895 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -119.95 111.12 17.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.888 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 687' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 53.62 39.28 29.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.904 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 688' ' ' GLY . . . . . . . . . . . . . . . 76.18 40.99 27.82 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.52 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 3.9 mmpt? -140.0 141.93 36.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.774 0.321 . . . . 0.0 110.921 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 690' ' ' SER . . . . . . . . . . . . . 17.3 m -77.01 122.76 25.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.816 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 24.3 mmmt -107.88 18.0 21.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.922 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 45.65 38.37 7.4 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.477 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 29.3 p -139.46 130.44 26.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.843 0.354 . . . . 0.0 110.892 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -147.93 -174.69 19.99 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.502 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 14.9 m -133.63 164.09 35.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.848 0.356 . . . . 0.0 111.134 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 696' ' ' VAL . . . . . 0.585 HG21 ' CD1' ' A' ' 672' ' ' PHE . 58.3 t -148.91 114.22 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.123 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 27.1 tttt -94.14 146.48 23.95 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.966 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -122.34 165.79 15.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.896 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 699' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -68.16 -41.82 80.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.918 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 14.3 m -116.21 152.32 47.73 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.684 0.754 . . . . 0.0 110.84 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 -39.54 6.39 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.659 2.24 . . . . 0.0 112.339 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -53.57 -47.67 69.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.926 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 69.2 t -50.55 -55.21 6.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.112 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 704' ' ' ALA . . . . . 0.468 ' HB3' ' O ' ' A' ' 651' ' ' ALA . . . -41.4 -65.89 0.39 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.124 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . 0.695 ' HA ' HD11 ' A' ' 725' ' ' ILE . 49.5 mt-10 -42.65 -38.1 1.93 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.936 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 706' ' ' ARG . . . . . 0.401 ' O ' ' C ' ' A' ' 707' ' ' ALA . 12.6 ttt180 -73.91 -65.95 0.77 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.878 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 707' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 706' ' ' ARG . . . -36.9 -55.23 0.91 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.065 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 708' ' ' CYS . . . . . 0.498 ' HA ' HG11 ' A' ' 723' ' ' VAL . 0.9 OUTLIER -45.31 -51.2 11.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.876 -179.894 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 12.8 mtp180 -66.72 -34.44 77.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.905 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 78.1 mtp -73.33 -21.83 60.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.9 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 711' ' ' MET . . . . . 0.564 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 3.8 mmt -108.67 -14.78 14.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.844 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 712' ' ' ASN . . . . . 0.492 ' N ' ' O ' ' A' ' 708' ' ' CYS . 1.2 p-10 -50.16 121.18 5.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.918 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 70.38 26.48 74.12 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.455 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 714' ' ' MET . . . . . 0.401 ' HB3' HD11 ' A' ' 721' ' ' ILE . 30.5 ttp -69.44 103.53 2.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.794 0.331 . . . . 0.0 110.888 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 15.6 mmtt -59.93 101.41 0.12 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.924 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 716' ' ' LEU . . . . . 0.956 HD12 HG21 ' A' ' 721' ' ' ILE . 31.4 mt -100.29 126.06 46.57 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.901 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 717' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 716' ' ' LEU . 3.4 t 36.57 39.79 0.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.876 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 718' ' ' GLY . . . . . 0.429 ' C ' ' HG3' ' A' ' 719' ' ' ARG . . . 78.45 35.03 34.17 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.493 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 719' ' ' ARG . . . . . 0.497 ' N ' ' O ' ' A' ' 716' ' ' LEU . 5.0 mtt-85 -146.63 111.02 5.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.75 0.31 . . . . 0.0 110.869 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -67.76 123.01 19.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.884 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . 0.956 HG21 HD12 ' A' ' 716' ' ' LEU . 26.6 pt -99.27 149.49 5.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.088 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -106.14 112.7 25.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.824 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 723' ' ' VAL . . . . . 0.498 HG11 ' HA ' ' A' ' 708' ' ' CYS . 2.7 t -105.8 138.57 30.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.113 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 26.5 ptt180 -154.25 171.56 19.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.902 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 725' ' ' ILE . . . . . 0.812 ' CG2' ' HB1' ' A' ' 651' ' ' ALA . 19.3 mm -89.98 137.0 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.14 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -92.91 92.0 7.68 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.885 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 727' ' ' ARG . . . . . . . . . . . . . 8.5 tpt85 -53.0 -43.04 66.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.893 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 728' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -86.64 74.34 9.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.942 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 729' ' ' ALA . . . . . . . . . . . . . . . -109.31 120.39 42.36 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.087 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 3.2 t -85.78 124.76 32.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.843 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 731' ' ' GLY . . . . . . . . . . . . . . . -149.02 175.57 28.2 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.502 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 732' ' ' PRO . . . . . 0.442 ' O ' ' C ' ' A' ' 733' ' ' SER . 53.4 Cg_endo -69.77 -5.23 15.72 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.675 2.25 . . . . 0.0 112.324 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 733' ' ' SER . . . . . 0.442 ' C ' ' O ' ' A' ' 732' ' ' PRO . 21.5 t -34.86 120.06 0.48 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.884 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 734' ' ' SER . . . . . . . . . . . . . 14.8 t -147.76 108.28 4.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.86 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 735' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.536 -179.979 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.298 0 N-CA-C 112.471 -0.252 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 645' ' ' SER . . . . . . . . . . . . . 5.1 m -71.81 -54.45 10.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.877 0.37 . . . . 0.0 110.853 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 646' ' ' SER . . . . . . . . . . . . . 41.1 t -48.11 126.91 11.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.831 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . 145.38 82.78 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.481 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 41.8 t -57.17 -51.17 70.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.84 0.353 . . . . 0.0 110.858 -179.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 32.8 m -87.71 103.11 15.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.877 -179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . -77.03 144.88 30.33 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.487 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 651' ' ' ALA . . . . . 0.599 ' O ' ' HB3' ' A' ' 704' ' ' ALA . . . -91.61 90.39 7.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.788 0.328 . . . . 0.0 111.142 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 2.4 p -103.95 -10.97 17.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.845 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 23.5 tt0 -109.86 150.72 28.0 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.893 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 654' ' ' ILE . . . . . 0.598 HG22 HD13 ' A' ' 725' ' ' ILE . 23.0 pt -139.64 163.8 24.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.171 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -117.6 144.54 45.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.898 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 10.1 t -131.92 150.63 34.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.16 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -146.54 160.31 42.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.849 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 658' ' ' ASN . . . . . 0.613 ' O ' HG22 ' A' ' 721' ' ' ILE . 2.7 t30 65.88 53.81 1.1 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.935 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.513 HD22 ' CD2' ' A' ' 663' ' ' PHE . 33.4 mt -102.74 143.48 26.7 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.58 0.705 . . . . 0.0 110.924 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 660' ' ' PRO . . . . . 0.478 ' O ' ' N ' ' A' ' 663' ' ' PHE . 65.9 Cg_exo -48.01 125.13 11.13 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.706 2.271 . . . . 0.0 112.32 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 661' ' ' PHE . . . . . 0.498 ' CE1' ' HB3' ' A' ' 690' ' ' SER . 4.6 t80 -40.63 -37.87 0.79 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.903 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 662' ' ' ASP . . . . . 0.405 ' O ' ' C ' ' A' ' 663' ' ' PHE . 2.2 m-20 -74.99 -35.07 62.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.892 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 663' ' ' PHE . . . . . 0.513 ' CD2' HD22 ' A' ' 659' ' ' LEU . 3.7 t80 -37.5 115.24 0.39 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.893 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 78.9 p -102.79 178.08 4.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.136 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 665' ' ' TRP . . . . . 0.647 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 3.4 p-90 -64.13 -48.27 76.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.908 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 666' ' ' LYS . . . . . 0.647 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 18.8 tptm -49.0 -56.88 7.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.898 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 32.4 mtm -55.99 -51.48 67.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.846 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 15.1 tp -45.34 -42.84 10.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.905 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 27.6 ttmt -66.55 -70.72 0.23 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -48.51 -24.93 1.45 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.854 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 671' ' ' LYS . . . . . . . . . . . . . 18.4 tptt -68.91 -46.08 69.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.934 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 672' ' ' PHE . . . . . 0.554 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 22.4 m-85 -83.38 -15.42 49.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.867 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -49.18 -41.4 36.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.9 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -45.64 -37.11 5.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.893 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 34.1 m -73.62 -48.2 34.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.871 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -164.53 -164.21 19.31 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.779 -0.725 . . . . 0.0 112.504 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -85.48 93.6 8.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.806 0.336 . . . . 0.0 110.86 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 71.1 t -69.37 133.39 31.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.114 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 679' ' ' LEU . . . . . . . . . . . . . 10.7 mt -108.67 -60.18 1.78 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.946 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 680' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -99.62 130.25 45.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.918 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -156.01 125.76 6.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.107 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -154.62 156.55 36.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.822 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 28.9 mm -105.24 108.48 25.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.166 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -60.8 142.49 56.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.885 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 685' ' ' MET . . . . . . . . . . . . . 25.6 mtp -137.93 148.24 45.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.914 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 686' ' ' GLU . . . . . 0.402 ' OE1' ' C ' ' A' ' 686' ' ' GLU . 0.0 OUTLIER -115.63 98.78 6.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.888 -179.958 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 687' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 71.04 38.8 1.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.896 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 688' ' ' GLY . . . . . . . . . . . . . . . 70.47 30.3 69.11 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.464 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 28.7 mmtm -134.62 111.97 10.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.794 0.33 . . . . 0.0 110.891 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 690' ' ' SER . . . . . 0.498 ' HB3' ' CE1' ' A' ' 661' ' ' PHE . 29.6 t -47.1 131.86 12.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.862 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 14.1 mmmt -106.13 -9.29 17.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.891 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 81.91 11.67 82.33 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.521 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 5.6 p -119.92 139.48 52.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.858 0.361 . . . . 0.0 110.88 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -148.38 -158.07 7.82 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.475 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 15.6 m -151.0 156.98 5.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.866 0.365 . . . . 0.0 111.125 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 696' ' ' VAL . . . . . 0.468 HG21 ' CD1' ' A' ' 672' ' ' PHE . 85.9 t -144.89 121.05 4.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.147 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 697' ' ' LYS . . . . . . . . . . . . . 9.9 ttpp -104.84 147.41 27.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.911 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -123.48 168.4 12.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.893 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 699' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -68.55 -48.24 64.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.858 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 70.8 m -111.25 148.1 38.03 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.66 0.743 . . . . 0.0 110.819 -179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 -23.52 30.6 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.657 2.238 . . . . 0.0 112.359 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 702' ' ' GLU . . . . . 0.453 ' HG3' ' N ' ' A' ' 703' ' ' VAL . 6.8 pt-20 -69.26 -34.51 74.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.905 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 703' ' ' VAL . . . . . 0.453 ' N ' ' HG3' ' A' ' 702' ' ' GLU . 24.7 t -61.19 -59.86 3.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.149 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 704' ' ' ALA . . . . . 0.599 ' HB3' ' O ' ' A' ' 651' ' ' ALA . . . -41.3 -61.41 1.03 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.116 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -41.55 -31.74 0.3 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.861 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 20.4 ttm180 -80.3 -48.93 12.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.855 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -60.39 -53.04 62.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.109 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 708' ' ' CYS . . . . . 0.434 ' SG ' ' N ' ' A' ' 709' ' ' ARG . 1.8 p -39.15 -41.69 0.86 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.884 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 709' ' ' ARG . . . . . 0.434 ' N ' ' SG ' ' A' ' 708' ' ' CYS . 12.6 mtt85 -84.51 -39.84 18.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.839 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 18.1 mtm -68.03 -7.74 31.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.853 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 711' ' ' MET . . . . . 0.554 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 14.2 mmm -121.57 -30.26 4.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.889 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 712' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -45.54 107.09 0.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.925 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 90.03 25.98 25.37 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.479 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 714' ' ' MET . . . . . . . . . . . . . 41.9 ttp -75.3 100.31 4.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.864 0.364 . . . . 0.0 110.874 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 18.3 mmtt -56.27 102.12 0.07 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.899 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 716' ' ' LEU . . . . . 0.849 HD12 HG21 ' A' ' 721' ' ' ILE . 34.6 mt -99.86 121.97 42.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.879 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 717' ' ' SER . . . . . . . . . . . . . 36.8 t 37.62 41.83 0.33 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.846 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 718' ' ' GLY . . . . . 0.422 ' C ' ' HG3' ' A' ' 719' ' ' ARG . . . 77.68 34.27 39.83 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.482 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 719' ' ' ARG . . . . . 0.475 ' HB3' ' ND2' ' A' ' 658' ' ' ASN . 1.9 mtp-105 -146.01 109.6 4.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.777 0.323 . . . . 0.0 110.887 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -69.99 124.97 25.39 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.897 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . 0.849 HG21 HD12 ' A' ' 716' ' ' LEU . 31.4 pt -98.9 152.33 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.13 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -106.08 98.27 7.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.869 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 5.1 t -101.69 132.0 48.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.137 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 34.5 mtp180 -156.0 167.58 29.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.857 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 725' ' ' ILE . . . . . 0.598 HD13 HG22 ' A' ' 654' ' ' ILE . 33.9 mm -73.92 131.62 34.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.103 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 35.5 t0 -78.25 135.04 37.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 727' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.04 -44.23 6.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.875 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 728' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -95.6 41.28 1.1 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.886 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 729' ' ' ALA . . . . . . . . . . . . . . . -61.11 -44.13 97.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.092 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 4.8 m -158.99 154.58 26.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.854 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 731' ' ' GLY . . . . . . . . . . . . . . . -52.88 122.37 19.84 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.484 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 732' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.71 174.32 9.64 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.722 2.281 . . . . 0.0 112.364 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 733' ' ' SER . . . . . . . . . . . . . 74.8 m -53.67 150.6 6.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.85 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 734' ' ' SER . . . . . . . . . . . . . 30.0 t -100.75 -48.82 4.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.839 -179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 735' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.344 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.501 -179.941 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.308 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 645' ' ' SER . . . . . . . . . . . . . 74.6 m -145.54 173.8 11.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.855 0.359 . . . . 0.0 110.876 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 646' ' ' SER . . . . . . . . . . . . . 1.8 m -147.71 118.53 7.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.883 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . 163.3 -150.25 18.78 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.503 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 648' ' ' SER . . . . . . . . . . . . . 78.3 p 44.72 43.32 6.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.86 0.362 . . . . 0.0 110.861 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 52.0 p -145.38 124.7 13.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.832 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 42.22 69.69 0.56 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.452 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 651' ' ' ALA . . . . . 0.579 ' HB1' HG23 ' A' ' 725' ' ' ILE . . . -92.74 109.11 20.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.771 0.32 . . . . 0.0 111.133 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 652' ' ' CYS . . . . . 0.407 ' O ' ' HB2' ' A' ' 704' ' ' ALA . 25.5 p -109.69 -33.97 6.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.895 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -90.06 146.36 24.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.918 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 654' ' ' ILE . . . . . 0.425 HD11 ' CE2' ' A' ' 672' ' ' PHE . 40.5 pt -132.91 176.06 9.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.113 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -127.53 159.76 33.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.904 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . 0.411 HG13 HD12 ' A' ' 721' ' ' ILE . 21.9 t -146.13 148.68 16.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.116 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 32.0 mtp180 -146.85 162.99 37.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.877 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 658' ' ' ASN . . . . . 0.431 ' O ' HG22 ' A' ' 721' ' ' ILE . 2.6 t30 65.97 46.41 2.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.922 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.474 HD22 ' CD2' ' A' ' 663' ' ' PHE . 27.8 mt -97.58 142.02 23.9 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.631 0.729 . . . . 0.0 110.939 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_exo -48.01 127.91 15.65 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.678 2.252 . . . . 0.0 112.342 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -39.91 -50.48 2.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.885 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 662' ' ' ASP . . . . . 0.428 ' O ' HG23 ' A' ' 664' ' ' THR . 0.9 OUTLIER -61.79 -38.16 87.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.83 -179.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 663' ' ' PHE . . . . . 0.477 ' HA ' ' CE ' ' A' ' 667' ' ' MET . 4.0 t80 -35.45 116.26 0.35 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.844 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 664' ' ' THR . . . . . 0.428 HG23 ' O ' ' A' ' 662' ' ' ASP . 78.6 p -106.15 174.82 5.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.135 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 665' ' ' TRP . . . . . 0.647 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 3.3 p-90 -62.1 -51.8 66.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.911 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 666' ' ' LYS . . . . . 0.647 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 1.7 tppp? -45.15 -48.93 12.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.884 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 667' ' ' MET . . . . . 0.477 ' CE ' ' HA ' ' A' ' 663' ' ' PHE . 24.3 mtm -64.3 -52.1 60.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.91 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 15.3 tp -43.52 -45.27 6.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -64.61 -70.74 0.21 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.885 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -48.49 -21.48 0.57 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.855 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 671' ' ' LYS . . . . . 0.44 ' HE2' HD21 ' A' ' 716' ' ' LEU . 17.2 tptt -72.81 -43.54 62.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.859 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 672' ' ' PHE . . . . . 0.534 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 25.8 m-85 -86.62 -15.95 38.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.9 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -50.38 -38.75 44.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.896 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -46.83 -39.94 12.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.888 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 675' ' ' CYS . . . . . 0.448 ' HA ' ' HE3' ' A' ' 710' ' ' MET . 62.8 m -67.65 -60.46 2.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.879 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -152.7 -157.59 8.08 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.524 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 677' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -87.77 100.72 13.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.791 0.329 . . . . 0.0 110.899 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 98.1 t -79.55 140.91 16.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.167 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 679' ' ' LEU . . . . . 0.419 HD11 ' HG2' ' A' ' 699' ' ' GLU . 12.8 mt -117.29 -60.03 1.88 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.88 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 680' ' ' TYR . . . . . 0.402 ' HB3' ' CB ' ' A' ' 697' ' ' LYS . 7.9 t80 -99.46 126.59 45.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.974 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -153.4 122.51 6.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.103 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -149.67 164.8 34.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 27.3 mm -114.72 101.38 12.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.116 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 29.9 mmtp -54.74 141.88 30.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.878 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 685' ' ' MET . . . . . . . . . . . . . 26.5 mtp -135.84 168.47 19.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.889 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -129.53 94.41 3.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.863 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 687' ' ' ASN . . . . . . . . . . . . . 5.0 t30 67.33 39.83 2.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.912 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 688' ' ' GLY . . . . . . . . . . . . . . . 79.73 28.39 51.29 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.504 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.59 128.78 43.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.788 0.328 . . . . 0.0 110.896 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 690' ' ' SER . . . . . . . . . . . . . 44.7 p -72.26 120.29 17.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.811 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -102.5 30.25 4.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.893 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 658' ' ' ASN . . . 39.15 39.1 0.93 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.49 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 31.3 p -138.09 139.43 39.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.896 0.379 . . . . 0.0 110.858 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -158.7 -173.65 27.38 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.434 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 27.0 m -134.13 164.25 34.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.882 0.372 . . . . 0.0 111.114 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 85.5 t -148.94 116.91 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.079 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 697' ' ' LYS . . . . . 0.402 ' CB ' ' HB3' ' A' ' 680' ' ' TYR . 11.8 tttp -101.24 140.36 35.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.903 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -116.34 173.79 6.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.871 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 699' ' ' GLU . . . . . 0.419 ' HG2' HD11 ' A' ' 679' ' ' LEU . 48.0 mt-10 -73.19 -48.47 34.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.903 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 14.0 m -109.01 149.53 39.75 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.664 0.745 . . . . 0.0 110.824 -179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 -6.88 19.64 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.661 2.24 . . . . 0.0 112.327 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 702' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -86.17 -46.79 10.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.892 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 88.9 t -50.88 -42.16 22.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.182 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 704' ' ' ALA . . . . . 0.415 ' HB3' ' O ' ' A' ' 651' ' ' ALA . . . -56.63 -59.14 5.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.093 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -47.48 -38.76 14.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 706' ' ' ARG . . . . . 0.517 ' HD3' ' HE1' ' A' ' 710' ' ' MET . 16.5 ttt-85 -70.67 -52.95 17.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.84 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 707' ' ' ALA . . . . . . . . . . . . . . . -53.64 -42.24 67.6 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.074 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 708' ' ' CYS . . . . . . . . . . . . . 1.1 t -47.49 -43.98 24.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 3.5 mtt-85 -81.91 -45.76 15.01 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.899 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 710' ' ' MET . . . . . 0.517 ' HE1' ' HD3' ' A' ' 706' ' ' ARG . 13.9 mtm -57.09 -17.31 9.94 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.875 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 711' ' ' MET . . . . . 0.534 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 4.2 mmt -113.8 -34.5 5.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.881 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 712' ' ' ASN . . . . . 0.437 ' C ' ' O ' ' A' ' 711' ' ' MET . 3.9 t30 -35.02 117.24 0.38 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.863 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 72.38 31.95 62.88 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.479 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 714' ' ' MET . . . . . 0.669 ' HE3' HD21 ' A' ' 716' ' ' LEU . 20.1 ttp -74.16 91.53 2.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.887 0.375 . . . . 0.0 110.869 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 715' ' ' LYS . . . . . 0.497 ' CD ' ' HG3' ' A' ' 720' ' ' GLU . 0.7 OUTLIER -50.84 99.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.898 179.979 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 716' ' ' LEU . . . . . 0.669 HD21 ' HE3' ' A' ' 714' ' ' MET . 30.4 mt -99.43 117.82 34.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.908 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 717' ' ' SER . . . . . . . . . . . . . 1.5 t 41.04 37.27 0.53 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.854 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 718' ' ' GLY . . . . . . . . . . . . . . . 84.1 25.26 45.2 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.505 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 719' ' ' ARG . . . . . 0.481 ' N ' ' O ' ' A' ' 716' ' ' LEU . 39.2 mtt85 -138.73 106.38 5.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.774 0.321 . . . . 0.0 110.836 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 720' ' ' GLU . . . . . 0.497 ' HG3' ' CD ' ' A' ' 715' ' ' LYS . 30.2 mt-10 -72.45 127.94 34.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.875 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . 0.606 HG21 HD12 ' A' ' 716' ' ' LEU . 43.1 pt -98.07 159.76 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.089 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -111.33 99.44 8.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.834 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 12.7 t -98.97 134.03 39.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.154 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 63.5 mtm180 -156.9 174.91 14.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.844 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 725' ' ' ILE . . . . . 0.579 HG23 ' HB1' ' A' ' 651' ' ' ALA . 25.4 mm -77.28 139.3 18.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.126 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -90.83 100.21 13.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.852 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 727' ' ' ARG . . . . . . . . . . . . . 20.4 mmm-85 -69.36 155.75 39.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.901 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 728' ' ' ASN . . . . . . . . . . . . . 34.6 m-20 49.24 43.23 22.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.879 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 729' ' ' ALA . . . . . . . . . . . . . . . -94.31 -60.38 1.74 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.115 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 17.6 m -154.73 137.36 15.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.834 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 731' ' ' GLY . . . . . . . . . . . . . . . -161.75 83.64 0.12 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.488 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 732' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.72 -46.56 1.2 Allowed 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.661 2.24 . . . . 0.0 112.359 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 733' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 734' ' ' SER . 1.6 t -92.89 119.35 32.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.831 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 734' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 733' ' ' SER . 40.6 p -36.18 151.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.854 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 735' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.51 -179.978 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 644' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.507 -0.237 . . . . 0.0 112.507 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 645' ' ' SER . . . . . . . . . . . . . 13.0 t -138.73 154.47 48.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.934 0.397 . . . . 0.0 110.851 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 646' ' ' SER . . . . . . . . . . . . . 1.2 t -59.03 127.17 30.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.83 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 647' ' ' GLY . . . . . . . . . . . . . . . 169.24 106.14 0.19 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.475 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 648' ' ' SER . . . . . 0.403 ' HA ' ' NH1' ' A' ' 727' ' ' ARG . 73.7 m -92.95 130.53 38.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.922 0.392 . . . . 0.0 110.843 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 649' ' ' SER . . . . . . . . . . . . . 15.6 m -97.38 119.74 36.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.879 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 49.87 63.16 4.39 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.469 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 651' ' ' ALA . . . . . 0.654 ' HB1' ' CG2' ' A' ' 725' ' ' ILE . . . -107.42 86.8 2.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.755 0.312 . . . . 0.0 111.104 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 652' ' ' CYS . . . . . . . . . . . . . 25.7 p -101.96 -22.9 14.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.892 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 653' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -85.71 144.68 27.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.937 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 654' ' ' ILE . . . . . 0.668 HG22 HD13 ' A' ' 725' ' ' ILE . 35.6 pt -131.47 174.64 12.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.083 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 655' ' ' PHE . . . . . . . . . . . . . 7.7 t80 -131.31 148.75 52.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.864 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 656' ' ' VAL . . . . . . . . . . . . . 11.2 t -131.31 148.47 32.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.129 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 657' ' ' ARG . . . . . . . . . . . . . 71.1 mtt180 -143.89 157.84 44.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.881 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 658' ' ' ASN . . . . . . . . . . . . . 4.9 t30 71.2 46.22 0.45 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.904 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 659' ' ' LEU . . . . . 0.503 HD23 ' CD1' ' A' ' 716' ' ' LEU . 52.5 mt -94.71 142.47 24.77 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.62 0.724 . . . . 0.0 110.886 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 660' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -47.95 127.84 15.38 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.666 2.244 . . . . 0.0 112.348 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 661' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -44.18 -37.34 3.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.85 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 662' ' ' ASP . . . . . 0.433 ' O ' ' C ' ' A' ' 663' ' ' PHE . 51.3 m-20 -75.26 -35.56 61.34 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.864 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 663' ' ' PHE . . . . . 0.433 ' C ' ' O ' ' A' ' 662' ' ' ASP . 3.8 t80 -34.68 142.9 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.862 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 664' ' ' THR . . . . . . . . . . . . . 45.1 p -127.38 172.51 10.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.179 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 665' ' ' TRP . . . . . 0.614 ' CD2' ' N ' ' A' ' 666' ' ' LYS . 6.0 p-90 -63.46 -50.27 70.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.929 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 666' ' ' LYS . . . . . 0.614 ' N ' ' CD2' ' A' ' 665' ' ' TRP . 5.0 tppp? -46.42 -51.0 15.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.867 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 667' ' ' MET . . . . . . . . . . . . . 32.3 mtm -62.06 -46.85 87.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.889 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 668' ' ' LEU . . . . . . . . . . . . . 39.3 tp -48.9 -46.09 42.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.936 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 669' ' ' LYS . . . . . . . . . . . . . 25.3 ttmt -65.02 -72.97 0.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.917 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 670' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -46.17 -25.71 0.64 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.86 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 671' ' ' LYS . . . . . 0.432 ' HE3' HD21 ' A' ' 716' ' ' LEU . 10.1 tppt? -67.9 -51.66 45.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.899 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 672' ' ' PHE . . . . . 0.576 ' CE2' ' HG3' ' A' ' 711' ' ' MET . 23.7 m-85 -77.77 -16.99 58.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.84 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 673' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -48.93 -33.41 10.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 674' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -55.83 -39.28 71.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.884 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 675' ' ' CYS . . . . . . . . . . . . . 60.4 m -71.58 -41.71 68.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.899 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -174.75 170.84 44.01 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.436 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 677' ' ' HIS . . . . . 0.409 ' CD2' ' C ' ' A' ' 677' ' ' HIS . 2.9 t-160 -62.01 103.71 0.39 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.805 0.336 . . . . 0.0 110.861 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 678' ' ' VAL . . . . . . . . . . . . . 65.1 t -80.32 147.62 6.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.085 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 679' ' ' LEU . . . . . 0.699 HD11 ' HG2' ' A' ' 699' ' ' GLU . 13.7 mt -120.37 -63.83 1.32 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.913 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 680' ' ' TYR . . . . . 0.435 ' HB3' ' CB ' ' A' ' 697' ' ' LYS . 10.1 t80 -98.66 125.32 43.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 681' ' ' ALA . . . . . . . . . . . . . . . -152.78 124.59 7.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.131 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 682' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -157.41 156.68 32.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.873 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 683' ' ' ILE . . . . . . . . . . . . . 40.9 mm -96.23 99.28 8.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.152 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 684' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.62 141.6 20.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.878 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 685' ' ' MET . . . . . . . . . . . . . 31.2 mtp -137.31 158.65 43.95 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.847 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 686' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -125.0 106.01 9.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.887 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 687' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 62.98 40.27 9.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.876 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 688' ' ' GLY . . . . . . . . . . . . . . . 67.93 39.44 89.35 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.463 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 689' ' ' LYS . . . . . . . . . . . . . 35.0 mmtt -137.32 124.34 21.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.82 0.343 . . . . 0.0 110.891 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 690' ' ' SER . . . . . . . . . . . . . 16.5 m -59.49 120.86 10.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.866 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 691' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -104.65 13.44 31.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.907 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 51.89 37.09 43.49 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.448 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 693' ' ' CYS . . . . . . . . . . . . . 27.2 p -137.81 149.76 46.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.875 0.369 . . . . 0.0 110.882 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 694' ' ' GLY . . . . . . . . . . . . . . . -155.68 -175.71 27.01 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.516 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 695' ' ' VAL . . . . . . . . . . . . . 13.8 m -138.25 156.32 30.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.812 0.339 . . . . 0.0 111.162 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 696' ' ' VAL . . . . . . . . . . . . . 90.7 t -142.96 118.0 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.115 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 697' ' ' LYS . . . . . 0.435 ' CB ' ' HB3' ' A' ' 680' ' ' TYR . 23.7 tttp -101.96 137.39 40.32 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.88 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 698' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -113.49 166.65 11.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.871 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 699' ' ' GLU . . . . . 0.699 ' HG2' HD11 ' A' ' 679' ' ' LEU . 22.5 mt-10 -68.53 -44.92 73.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.853 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 700' ' ' SER . . . . . . . . . . . . . 3.7 m -113.56 151.04 44.19 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.658 0.742 . . . . 0.0 110.869 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 701' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -36.7 10.21 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.657 2.238 . . . . 0.0 112.335 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 702' ' ' GLU . . . . . 0.443 ' OE1' ' C ' ' A' ' 702' ' ' GLU . 0.6 OUTLIER -56.81 -40.56 76.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.932 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 703' ' ' VAL . . . . . . . . . . . . . 79.6 t -53.8 -57.07 6.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.087 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 704' ' ' ALA . . . . . . . . . . . . . . . -43.23 -63.25 0.85 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.08 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 705' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -41.4 -29.96 0.17 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.883 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 706' ' ' ARG . . . . . . . . . . . . . 19.8 ttm-85 -82.62 -47.79 11.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.846 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 707' ' ' ALA . . . . . 0.421 ' O ' ' C ' ' A' ' 708' ' ' CYS . . . -62.9 -59.34 4.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.06 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 708' ' ' CYS . . . . . 0.421 ' C ' ' O ' ' A' ' 707' ' ' ALA . 11.5 p -36.18 -36.69 0.1 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.877 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 709' ' ' ARG . . . . . . . . . . . . . 6.3 mtt180 -85.29 -46.16 11.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.872 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 710' ' ' MET . . . . . . . . . . . . . 18.7 mtm -61.89 -9.45 6.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.886 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 711' ' ' MET . . . . . 0.576 ' HG3' ' CE2' ' A' ' 672' ' ' PHE . 6.3 mmm -120.2 -17.72 8.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.881 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 712' ' ' ASN . . . . . 0.404 ' OD1' ' C ' ' A' ' 712' ' ' ASN . 3.5 t-20 -53.5 117.41 3.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.905 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 713' ' ' GLY . . . . . . . . . . . . . . . 80.8 10.4 85.16 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.533 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 714' ' ' MET . . . . . 0.575 ' HB3' HD11 ' A' ' 721' ' ' ILE . 46.3 ttp -61.32 91.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.857 0.36 . . . . 0.0 110.9 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 715' ' ' LYS . . . . . . . . . . . . . 2.9 mttp -58.56 112.0 1.45 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.893 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 716' ' ' LEU . . . . . 0.59 HD12 HG21 ' A' ' 721' ' ' ILE . 30.5 mt -100.19 127.46 46.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 717' ' ' SER . . . . . . . . . . . . . 31.1 t 37.66 31.26 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.861 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 718' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 716' ' ' LEU . . . 89.3 43.11 5.36 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.463 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 719' ' ' ARG . . . . . . . . . . . . . 19.0 mtt180 -152.02 107.37 3.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.764 0.316 . . . . 0.0 110.886 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 720' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -62.69 124.22 20.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.884 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . 0.59 HG21 HD12 ' A' ' 716' ' ' LEU . 18.9 pt -100.09 151.18 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.161 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 722' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -111.1 97.79 7.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.853 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 8.1 t -97.35 136.11 29.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.143 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 724' ' ' ARG . . . . . . . . . . . . . 79.8 mtt-85 -156.18 161.95 40.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.873 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 725' ' ' ILE . . . . . 0.668 HD13 HG22 ' A' ' 654' ' ' ILE . 23.0 mm -70.23 131.73 33.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.123 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -90.61 83.84 5.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.823 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 727' ' ' ARG . . . . . 0.403 ' NH1' ' HA ' ' A' ' 648' ' ' SER . 27.4 ttt180 -80.37 -36.79 33.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.882 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 728' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -86.19 41.96 0.96 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.866 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 729' ' ' ALA . . . . . . . . . . . . . . . -86.8 -53.9 4.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.1 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 33.9 m -129.08 172.85 11.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.865 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 731' ' ' GLY . . . . . . . . . . . . . . . -150.06 -175.86 22.61 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.501 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 732' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.76 100.28 0.81 Allowed 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.725 2.283 . . . . 0.0 112.355 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 733' ' ' SER . . . . . . . . . . . . . 3.6 t -58.25 112.74 1.65 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.833 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 734' ' ' SER . . . . . . . . . . . . . 3.1 m -108.78 153.85 22.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.895 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 735' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.511 -179.971 . . . . . . . . 0 0 . 1 stop_ save_